##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.1-753-gd2b1864
##SAMPLE=<ID=NA12878_38,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=ExAC_sub=Sub-population allele frequenciens for populations AFR,AMR,EAS,NFE,SAS of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	ExAC_sub	gnomAD	phyloP	Sift	MetaLR	PolyPhen2	FATHMM	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	
chr1	888659	888659	T	C	hom		QUAL=5228;DP=159;AF=0.99;MQM=60	NOC2L	missense	NOC2L:ENST00000327044:missense:MODERATE:exon9/19:c.898A>G:p.Ile300Val		rs3748597	0.9227	0.9355	52529,29074,4243	0.9096,0.9557,0.9126,0.9407,0.9183	0.9378	0.5380	T	T	B	T	0.01				COSM4144219	n/a (AF>5%)	n/a (AF>5%)					NOC2L (inh=n/a pLI=0.00)
chr1	2328714	2328714	A	G	hom	off-target	QUAL=1730;DP=58;AF=1.00;MQM=60	RER1	intron	RER1:ENST00000488353:intron:MODIFIER:exon2/5:c.186+55A>G:,RER1:ENST00000378518:intron:MODIFIER:exon3/4:c.186+55A>G:,RER1:ENST00000605895:intron:MODIFIER:exon3/6:c.186+55A>G:,RER1:ENST00000378513:intron:MODIFIER:exon3/5:c.186+55A>G:,RER1:ENST00000378512:intron:MODIFIER:exon3/6:c.186+55A>G:		rs2645081	0.8059	0.0000	0,0,0	0,0,0,0,0	0.8391											n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a pLI=0.96)
chr1	5934490	5934490	A	G	hom	off-target	QUAL=4397;DP=136;AF=1.00;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron:MODIFIER:exon22/29:c.3231+41T>C:		rs868163	0.5693	0.6566	2192,1290,405	0.7272,0.5223,0.3302,0.6748,0.6626	0.6451							607215 [NPHP4 (provisional) Nephronophthisis 4,606966|Senior-Loken syndrome 4,606996];	260554 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR pLI=0.00)
chr1	9324213	9324213	C	T	het		QUAL=1947;DP=169;AF=0.46;MQM=60	H6PD	missense	H6PD:ENST00000602477:missense:MODERATE:exon5/5:c.1694C>T:p.Pro565Leu,H6PD:ENST00000377403:missense:MODERATE:exon5/5:c.1661C>T:p.Pro554Leu		rs17368528	0.0968	0.1185	965,485,4	0.0247,0.1514,0.0554,0.1210,0.1871	0.1166	1.8170	D	T	B	D	20.40	138090 [H6PD (confirmed) Cortisone reductase deficiency 1,604931];		CM102361 [CLASS=DP MUT=ALT PHEN="Multiple sclerosis reduced risk association with" GENE=H6PD]; 	COSM3747117	n/a (AF>5%)	n/a (AF>5%)					H6PD (inh=AR pLI=0.01)
chr1	10339210	10339211	AT	-	het		QUAL=3189;DP=234;AF=0.53;MQM=60	KIF1B	splice_region&intron,intron	KIF1B:ENST00000377081:splice_region&intron:LOW:exon13/47:c.1222+16_1222+17delAT:,KIF1B:ENST00000377086:splice_region&intron:LOW:exon14/48:c.1222+16_1222+17delAT:,KIF1B:ENST00000377093:intron:MODIFIER:exon12/20:c.1162+1026_1162+1027delAT:,KIF1B:ENST00000263934:intron:MODIFIER:exon12/46:c.1162+1026_1162+1027delAT:,KIF1B:ENST00000377083:intron:MODIFIER:exon12/20:c.1162+1026_1162+1027delAT:		rs529524575	0.2346	0.2526	576,251,7	0.1228,0.3383,0.2918,0.2929,0.2201	0.2795							605995 [KIF1B (confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700];				n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD pLI=1.00)
chr1	11301714	11301714	A	G	hom		QUAL=4081;DP=129;AF=0.98;MQM=60	MTOR	synonymous	MTOR:ENST00000361445:synonymous:LOW:exon10/58:c.1437T>C:p.Asp479Asp		rs1135172	0.6396	0.7170	32381,17807,451	0.2905,0.8029,0.8811,0.7313,0.7681	0.7257							601231 [MTOR (provisional) Smith-Kingsmore syndrome,616638|Focal cortical dysplasia,type II,somatic,607341];			COSM4142157	n/a (AF>5%)	n/a (AF>5%)					MTOR (inh=AD pLI=1.00)
chr1	11782781	11782781	G	C	het		QUAL=662;DP=53;AF=0.51;MQM=60	DRAXIN	3'UTR	DRAXIN:ENST00000294485:3'UTR:MODIFIER:exon7/7:c.*3028G>C:	MER58B	rs7533583	0.4121	0.0000	0,0,0	0,0,0,0,0	0.4127											n/a (AF>5%)	n/a (AF>5%)					DRAXIN (inh=n/a pLI=0.00)
chr1	11782814	11782814	G	A	het		QUAL=537;DP=42;AF=0.50;MQM=60	DRAXIN	3'UTR	DRAXIN:ENST00000294485:3'UTR:MODIFIER:exon7/7:c.*3061G>A:	MER58B	rs7414943	0.3866	0.0000	0,0,0	0,0,0,0,0	0.4610											n/a (AF>5%)	n/a (AF>5%)					DRAXIN (inh=n/a pLI=0.00)
chr1	11883731	11883731	C	T	het	off-target	QUAL=156;DP=13;AF=0.62;MQM=60	CLCN6	intron	CLCN6:ENST00000376496:intron:MODIFIER:exon6/21:c.454-33C>T:,CLCN6:ENST00000312413:intron:MODIFIER:exon6/21:c.454-33C>T:,CLCN6:ENST00000346436:intron:MODIFIER:exon6/22:c.454-33C>T:,CLCN6:ENST00000376487:intron:MODIFIER:exon5/21:c.388-33C>T:		rs12567136	0.1294	0.1405	1320,722,69	0.1078,0.0886,0.1203,0.1460,0.1830	0.1391											n/a (AF>5%)	n/a (AF>5%)					CLCN6 (inh=n/a pLI=0.06)
chr1	12418700	12418700	T	C	hom	off-target	QUAL=668;DP=23;AF=1.00;MQM=60	VPS13D	intron	VPS13D:ENST00000358136:intron:MODIFIER:exon50/69:c.10141+43T>C:,VPS13D:ENST00000356315:intron:MODIFIER:exon49/68:c.10066+43T>C:		rs10864552	0.9641	0.9310	51839,27087,4985	0.9822,0.9652,0.9998,0.9064,0.9262	0.9383											n/a (AF>5%)	n/a (AF>5%)					VPS13D (inh=n/a pLI=1.00)
chr1	12776134	12776134	C	A	hom	off-target	QUAL=535;DP=21;AF=1.00;MQM=60	AADACL3	5'UTR	AADACL3:ENST00000332530:5'UTR:MODIFIER:exon1/3:c.-210C>A:		rs3010874	0.7085	0.0000	0,0,0	0,0,0,0,0	0.7638											n/a (AF>5%)	n/a (AF>5%)					AADACL3 (inh=n/a pLI=0.00)
chr1	14105298	14105298	G	A	het		QUAL=1370;DP=92;AF=0.55;MQM=60	PRDM2	synonymous,intron	PRDM2:ENST00000235372:synonymous:LOW:exon8/10:c.1008G>A:p.Glu336Glu,PRDM2:ENST00000311066:synonymous:LOW:exon8/9:c.1008G>A:p.Glu336Glu,PRDM2:ENST00000413440:synonymous:LOW:exon3/4:c.405G>A:p.Glu135Glu,PRDM2:ENST00000343137:synonymous:LOW:exon4/5:c.405G>A:p.Glu135Glu,PRDM2:ENST00000376048:intron:MODIFIER:exon6/7:c.511+29316G>A:,PRDM2:ENST00000503842:intron:MODIFIER:exon3/4:c.19+5615G>A:,PRDM2:ENST00000505823:intron:MODIFIER:exon2/3:c.19+5615G>A:		rs1203678	0.3163	0.3560	8282,3936,305	0.2471,0.6248,0.3673,0.3432,0.2831	0.3662										COSM3750308	n/a (AF>5%)	n/a (AF>5%)					PRDM2 (inh=n/a pLI=1.00)
chr1	14109114	14109114	A	G	het		QUAL=920;DP=74;AF=0.49;MQM=60	PRDM2	synonymous,intron	PRDM2:ENST00000235372:synonymous:LOW:exon8/10:c.4824A>G:p.Ser1608Ser,PRDM2:ENST00000311066:synonymous:LOW:exon8/9:c.4824A>G:p.Ser1608Ser,PRDM2:ENST00000413440:synonymous:LOW:exon3/4:c.4221A>G:p.Ser1407Ser,PRDM2:ENST00000343137:synonymous:LOW:exon4/5:c.4221A>G:p.Ser1407Ser,PRDM2:ENST00000376048:intron:MODIFIER:exon6/7:c.511+33132A>G:,PRDM2:ENST00000503842:intron:MODIFIER:exon3/4:c.19+9431A>G:,PRDM2:ENST00000505823:intron:MODIFIER:exon2/3:c.19+9431A>G:		rs1203651	0.3650	0.3881	9614,4378,369	0.2705,0.6302,0.3830,0.3631,0.4059	0.3958										COSM3750310	n/a (AF>5%)	n/a (AF>5%)					PRDM2 (inh=n/a pLI=1.00)
chr1	15707137	15707137	C	T	het	off-target	QUAL=2587;DP=158;AF=0.59;MQM=60	FHAD1	intron	FHAD1:ENST00000375999:intron:MODIFIER:exon27/32:c.3640-60C>T:,FHAD1:ENST00000358897:intron:MODIFIER:exon27/30:c.3640-60C>T:,FHAD1:ENST00000417793:intron:MODIFIER:exon26/29:c.3532-60C>T:,FHAD1:ENST00000375998:intron:MODIFIER:exon26/29:c.3640-60C>T:,FHAD1:ENST00000314740:intron:MODIFIER:exon11/15:c.1399-60C>T:		rs3737690	0.1246	0.0000	0,0,0	0,0,0,0,0	0.0969											n/a (AF>5%)	n/a (AF>5%)					FHAD1 (inh=n/a pLI=n/a)
chr1	17033758	17033758	A	G	het	off-target	QUAL=2705;DP=240;AF=0.46;MQM=50	ESPNP	intron	ESPNP:ENST00000492551:intron:MODIFIER:exon4/10:n.696+25T>C:	MIRb	rs1736691	0.0000	0.5386	3614,2426,94	0.4888,0.5307,0.5220,0.5512,0.5284	0.5224											n/a (AF>5%)	n/a (AF>5%)					ESPNP (inh=n/a pLI=n/a)
chr1	17086538	17086538	T	G	hom	off-target;gene_blacklist	QUAL=128;DP=6;AF=0.83;MQM=7	MST1L,CROCC				rs1736755	0.0000	0.0094	3,2,0	0.0000,0.0000,0.0000,0.0103,0.0097	0.8776											n/a (AF>5%)	n/a (AF>5%)					MST1L (inh=n/a pLI=n/a), CROCC (inh=n/a pLI=0.00)
chr1	17396703	17396703	T	C	hom		QUAL=3326;DP=101;AF=1.00;MQM=60	PADI2	synonymous	PADI2:ENST00000375486:synonymous:LOW:exon15/16:c.1644A>G:p.Leu548Leu,PADI2:ENST00000444885:synonymous:LOW:exon12/13:c.1296A>G:p.Leu432Leu		rs2076595	0.4447	0.5538	19129,12392,723	0.3768,0.5760,0.4075,0.6085,0.4979	0.5553										COSM3750623	n/a (AF>5%)	n/a (AF>5%)					PADI2 (inh=n/a pLI=0.00)
chr1	19415304	19415304	C	T	hom		QUAL=988;DP=32;AF=1.00;MQM=60	UBR4	synonymous	UBR4:ENST00000375267:synonymous:LOW:exon98/107:c.14379G>A:p.Lys4793Lys,UBR4:ENST00000375217:synonymous:LOW:exon98/106:c.14358G>A:p.Lys4786Lys,UBR4:ENST00000375226:synonymous:LOW:exon98/106:c.14307G>A:p.Lys4769Lys,UBR4:ENST00000375254:synonymous:LOW:exon98/106:c.14379G>A:p.Lys4793Lys,UBR4:ENST00000429347:synonymous:LOW:exon8/16:c.948G>A:p.Lys316Lys,UBR4:ENST00000375224:synonymous:LOW:exon13/21:c.1500G>A:p.Lys500Lys,UBR4:ENST00000543981:synonymous:LOW:exon10/18:c.1371G>A:p.Lys457Lys		rs1043899	0.5919	0.5807	21054,10805,1421	0.5249,0.7729,0.7607,0.5671,0.4744	0.5871										COSM3750717, COSM3750718	n/a (AF>5%)	n/a (AF>5%)					UBR4 (inh=n/a pLI=1.00)
chr1	19557713	19557713	G	C	hom	off-target	QUAL=229;DP=8;AF=1.00;MQM=60	RP1-43E13.2,EMC1	intron	EMC1:ENST00000477853:intron:MODIFIER:exon16/22:c.1944+42C>G:,EMC1:ENST00000375199:intron:MODIFIER:exon16/22:c.1941+42C>G:,EMC1:ENST00000375208:intron:MODIFIER:exon15/21:c.1878+42C>G:		rs2275403	0.6679	0.5809	20299,9068,3428	0.8186,0.7602,0.7257,0.5260,0.5194	0.6097							616846 [EMC1 (provisional) Cerebellar atrophy,visual impairment,and psychomotor retardation,616875];				n/a (AF>5%)	n/a (AF>5%)					RP1-43E13.2 (inh=n/a pLI=n/a), EMC1 (inh=AR pLI=0.00)
chr1	20662938	20662938	A	G	het		QUAL=1658;DP=116;AF=0.53;MQM=60	VWA5B1	missense	VWA5B1:ENST00000375079:missense:MODERATE:exon13/22:c.1901A>G:p.Lys634Arg,VWA5B1:ENST00000289825:missense:MODERATE:exon13/15:c.1052A>G:p.Lys351Arg,VWA5B1:ENST00000375083:missense:MODERATE:exon13/19:c.1901A>G:p.Lys634Arg,VWA5B1:ENST00000289815:missense:MODERATE:exon13/21:c.1901A>G:p.Lys634Arg		rs10916769	0.2240	0.2499	464,142,26	0.1840,0.2380,0.3641,0.2072,0.3179	0.2223	0.0250	T,T,T,T,T	T	B,B,B,B	T,T,T,T	0.09				COSM3984659, COSM3984660, COSM3984661	n/a (AF>5%)	n/a (AF>5%)					VWA5B1 (inh=n/a pLI=n/a)
chr1	20992819	20992819	G	C	hom		QUAL=2466;DP=80;AF=1.00;MQM=60	KIF17	missense	KIF17:ENST00000247986:missense:MODERATE:exon14/15:c.2799C>G:p.Asp933Glu,KIF17:ENST00000375044:missense:MODERATE:exon14/15:c.2499C>G:p.Asp833Glu,KIF17:ENST00000400463:missense:MODERATE:exon14/15:c.2796C>G:p.Asp932Glu		rs631357	0.7045	0.7523	34791,21553,3016	0.7609,0.7037,0.5474,0.8033,0.6607	0.7728	0.8720	T,T,T,T	T	B,B	T,T,T	0.63					n/a (AF>5%)	n/a (AF>5%)					KIF17 (inh=n/a pLI=0.00)
chr1	21953436	21953436	A	G	het		QUAL=2263;DP=160;AF=0.53;MQM=60	RAP1GAP	intron	RAP1GAP:ENST00000290101:intron:MODIFIER:exon2/24:c.81-546T>C:,RAP1GAP:ENST00000374765:intron:MODIFIER:exon2/24:c.-112-546T>C:,RAP1GAP:ENST00000542643:intron:MODIFIER:exon3/26:c.-112-546T>C:	MIRb	rs829412	0.8638	0.8739	4781,1292,165	0.7526,0.0000,0.9800,0.8382,0.8971	0.8724											n/a (AF>5%)	n/a (AF>5%)					RAP1GAP (inh=n/a pLI=0.94)
chr1	23419261	23419261	G	A	hom		QUAL=4388;DP=143;AF=0.99;MQM=60	LUZP1	synonymous	LUZP1:ENST00000302291:synonymous:LOW:exon4/5:c.1494C>T:p.Ser498Ser,LUZP1:ENST00000374623:synonymous:LOW:exon2/3:c.1494C>T:p.Ser498Ser,LUZP1:ENST00000418342:synonymous:LOW:exon3/4:c.1494C>T:p.Ser498Ser,LUZP1:ENST00000314174:synonymous:LOW:exon2/3:c.1494C>T:p.Ser498Ser		rs477717	0.6905	0.7529	35523,23353,2248	0.6559,0.4889,0.8124,0.8365,0.5764	0.7853											n/a (AF>5%)	n/a (AF>5%)					LUZP1 (inh=n/a pLI=0.16)
chr1	24409165	24409165	C	T	het		QUAL=656;DP=73;AF=0.38;MQM=60	MYOM3,RP11-293P20.2,RP11-293P20.4	synonymous	MYOM3:ENST00000330966:synonymous:LOW:exon17/37:c.2013G>A:p.Glu671Glu,MYOM3:ENST00000374434:synonymous:LOW:exon17/37:c.2010G>A:p.Glu670Glu,MYOM3:ENST00000329601:synonymous:LOW:exon17/30:c.2010G>A:p.Glu670Glu		rs4320728	0.1845	0.1593	1718,745,145	0.1781,0.1254,0.1917,0.1404,0.2491	0.1564										COSM3997373, COSM3997374	n/a (AF>5%)	n/a (AF>5%)					MYOM3 (inh=n/a pLI=0.00), RP11-293P20.2 (inh=n/a pLI=n/a), RP11-293P20.4 (inh=n/a pLI=n/a)
chr1	24454688	24454688	C	T	het		QUAL=1682;DP=124;AF=0.52;MQM=60	IL22RA1	missense	IL22RA1:ENST00000270800:missense:MODERATE:exon5/7:c.613G>A:p.Val205Ile		rs16829204	0.1526	0.1643	1832,1066,274	0.2262,0.0886,0.0004,0.1775,0.2346	0.1727	-0.0120	T	T	B,B	T	1.46					n/a (AF>5%)	n/a (AF>5%)					IL22RA1 (inh=n/a pLI=0.54)
chr1	25098341	25098341	C	T	het		QUAL=2340;DP=208;AF=0.43;MQM=60	CLIC4	intron	CLIC4:ENST00000374379:intron:MODIFIER:exon1/5:c.73-25892C>T:		rs7548438	0.5413	0.6422	23911,15042,741	0.4319,0.7042,0.5154,0.6973,0.5263	0.6418											n/a (AF>5%)	n/a (AF>5%)					CLIC4 (inh=n/a pLI=0.20)
chr1	26508293	26508293	G	A	het	off-target	QUAL=2139;DP=155;AF=0.53;MQM=60	CNKSR1	intron	CNKSR1:ENST00000374253:intron:MODIFIER:exon3/20:c.393-55G>A:,CNKSR1:ENST00000361530:intron:MODIFIER:exon3/20:c.393-55G>A:,CNKSR1:ENST00000531191:intron:MODIFIER:exon2/19:c.-382-55G>A:	MIRb	rs3819033	0.2859	0.0000	0,0,0	0,0,0,0,0	0.1085											n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a pLI=0.00)
chr1	31347399	31347399	C	T	het		QUAL=729;DP=77;AF=0.40;MQM=60	SDC3	missense	SDC3:ENST00000339394:missense:MODERATE:exon4/5:c.907G>A:p.Asp303Asn,SDC3:ENST00000336798:missense:MODERATE:exon2/3:c.733G>A:p.Asp245Asn		rs4949184	0.2344	0.1940	2693,1111,594	0.3322,0.1072,0.0481,0.1825,0.2994	0.2251	3.0450	D,D	T	B,B	T,T	22.40	186357 [SDC3 (confirmed) Obesity,association with,601665];				n/a (AF>5%)	n/a (AF>5%)					SDC3 (inh=n/a pLI=0.49)
chr1	31413972	31413972	T	C	het	off-target	QUAL=1106;DP=77;AF=0.58;MQM=60	PUM1	intron	PUM1:ENST00000373741:intron:MODIFIER:exon20/21:c.3350+26A>G:,PUM1:ENST00000424085:intron:MODIFIER:exon16/17:c.2510+26A>G:,PUM1:ENST00000257075:intron:MODIFIER:exon20/21:c.3236+26A>G:,PUM1:ENST00000373747:intron:MODIFIER:exon20/21:c.3245+26A>G:,PUM1:ENST00000426105:intron:MODIFIER:exon20/21:c.3242+26A>G:,PUM1:ENST00000440538:intron:MODIFIER:exon20/21:c.3164+26A>G:,PUM1:ENST00000423018:intron:MODIFIER:exon17/18:c.2810+26A>G:,PUM1:ENST00000373742:intron:MODIFIER:exon18/19:c.3059+26A>G:		rs3795433	0.1228	0.1072	1000,158,4	0.0151,0.1696,0.2801,0.0700,0.1672	0.1110							607204 [PUM1 (provisional) Spinocerebellar ataxia 47,617931];			COSN163027	n/a (AF>5%)	n/a (AF>5%)					PUM1 (inh=n/a pLI=1.00)
chr1	31883295	31883295	T	C	het		QUAL=428;DP=45;AF=0.40;MQM=60	SERINC2	splice_region&intron	SERINC2:ENST00000373710:splice_region&intron:LOW:exon2/10:c.66+13T>C:,SERINC2:ENST00000536859:splice_region&intron:LOW:exon1/9:c.51+13T>C:		rs6701521	0.5935	0.5414	2529,463,132	0.5373,0.5000,0.8049,0.4217,0.6236	0.5080											n/a (AF>5%)	n/a (AF>5%)					SERINC2 (inh=n/a pLI=0.00)
chr1	32119431	32119431	T	C	hom	off-target	QUAL=1773;DP=57;AF=1.00;MQM=60	RP11-73M7.6,COL16A1	intron	COL16A1:ENST00000271069:intron:MODIFIER:exon70/71:c.4534+37A>G:,COL16A1:ENST00000373672:intron:MODIFIER:exon69/70:c.4534+37A>G:		rs3817398	0.4050	0.5107	15990,10433,488	0.3121,0.4879,0.2076,0.5654,0.5721	0.5102											n/a (AF>5%)	n/a (AF>5%)					RP11-73M7.6 (inh=n/a pLI=n/a), COL16A1 (inh=n/a pLI=0.00)
chr1	38030696	38030696	T	C	het	off-target	QUAL=464;DP=52;AF=0.44;MQM=60	DNALI1	3'UTR	DNALI1:ENST00000296218:3'UTR:MODIFIER:exon6/6:c.*34T>C:,DNALI1:ENST00000541606:3'UTR:MODIFIER:exon5/5:c.*34T>C:		rs6619	0.4109	0.4452	12791,6912,298	0.2423,0.6129,0.5627,0.4527,0.3234	0.4559										COSN163046	n/a (AF>5%)	n/a (AF>5%)					DNALI1 (inh=n/a pLI=0.00)
chr1	40219065	40219065	C	T	het	off-target	QUAL=1021;DP=79;AF=0.52;MQM=60	PPIE	3'UTR,intron	PPIE:ENST00000324379:3'UTR:MODIFIER:exon10/10:c.*38C>T:,PPIE:ENST00000372830:intron:MODIFIER:exon9/10:c.837+341C>T:,PPIE:ENST00000356511:intron:MODIFIER:exon9/9:c.837+341C>T:		rs1046988	0.2816	0.3309	6619,4186,201	0.1954,0.2272,0.2491,0.3608,0.4043	0.3299											n/a (AF>5%)	n/a (AF>5%)					PPIE (inh=n/a pLI=0.97)
chr1	42047208	42047208	C	G	het		QUAL=3729;DP=251;AF=0.53;MQM=60	HIVEP3	missense	HIVEP3:ENST00000247584:missense:MODERATE:exon3/8:c.3261G>C:p.Gln1087His,HIVEP3:ENST00000372583:missense:MODERATE:exon4/9:c.3261G>C:p.Gln1087His,HIVEP3:ENST00000372584:missense:MODERATE:exon3/8:c.3261G>C:p.Gln1087His,HIVEP3:ENST00000429157:missense:MODERATE:exon3/8:c.3261G>C:p.Gln1087His		rs17363472	0.0489	0.0560	239,96,2	0.0126,0.0888,0.0029,0.0550,0.1248	0.0566	0.1920	T,T,T,T	T	B,B	T,T,T,T	0.32					n/a (AF>5%)	n/a (AF>5%)					HIVEP3 (inh=n/a pLI=0.01)
chr1	44083110	44083110	C	T	hom		QUAL=2324;DP=73;AF=0.99;MQM=60	PTPRF	splice_region&intron	PTPRF:ENST00000359947:splice_region&intron:LOW:exon23/33:c.4072-6C>T:,PTPRF:ENST00000438120:splice_region&intron:LOW:exon22/32:c.4045-6C>T:,PTPRF:ENST00000372413:splice_region&intron:LOW:exon20/30:c.4045-6C>T:,PTPRF:ENST00000372414:splice_region&intron:LOW:exon21/31:c.4072-6C>T:,PTPRF:ENST00000422171:splice_region&intron:LOW:exon14/24:c.2149-6C>T:		rs571862	0.7374	0.7191	32157,18745,4452	0.9245,0.5141,0.7871,0.7496,0.5655	0.7972							179590 [PTPRF (provisional) Breasts and/or nipples,aplasia or hypoplasia of,2,616001];				n/a (AF>5%)	n/a (AF>5%)					PTPRF (inh=AR pLI=1.00)
chr1	44686322	44686322	T	C	het	off-target	QUAL=1081;DP=83;AF=0.51;MQM=60	DMAP1	3'UTR	DMAP1:ENST00000315913:3'UTR:MODIFIER:exon11/11:c.*32T>C:,DMAP1:ENST00000361745:3'UTR:MODIFIER:exon11/11:c.*32T>C:,DMAP1:ENST00000372289:3'UTR:MODIFIER:exon10/10:c.*32T>C:		rs12419	0.2742	0.3022	5436,2789,195	0.2020,0.3483,0.2327,0.2993,0.3850	0.3013											n/a (AF>5%)	n/a (AF>5%)					DMAP1 (inh=n/a pLI=0.24)
chr1	45224998	45224998	A	C	het		QUAL=3325;DP=223;AF=0.55;MQM=60	KIF2C,RP11-269F19.2	missense	KIF2C:ENST00000372224:missense:MODERATE:exon14/21:c.1345A>C:p.Ile449Leu,KIF2C:ENST00000372218:missense:MODERATE:exon13/20:c.1222A>C:p.Ile408Leu,KIF2C:ENST00000372222:missense:MODERATE:exon13/20:c.1006A>C:p.Ile336Leu,KIF2C:ENST00000372217:missense:MODERATE:exon13/20:c.1183A>C:p.Ile395Leu		rs4342887	0.2031	0.1882	2279,996,176	0.1887,0.2337,0.2589,0.1718,0.1878	0.1939	5.1780	D,T,T,D	T	B,B,B	T,T,T,T	23.40				COSM3735969	n/a (AF>5%)	n/a (AF>5%)					KIF2C (inh=n/a pLI=0.15), RP11-269F19.2 (inh=n/a pLI=n/a)
chr1	45362992	45362992	T	C	hom	off-target	QUAL=2196;DP=68;AF=1.00;MQM=60	EIF2B3	intron	EIF2B3:ENST00000360403:intron:MODIFIER:exon6/11:c.656+35A>G:,EIF2B3:ENST00000372183:intron:MODIFIER:exon6/9:c.656+35A>G:		rs263978	0.7911	0.6589	24785,9102,4065	0.9077,0.8086,0.9733,0.5618,0.6594	0.6874							606273 [EIF2B3 (provisional) Leukoencephalopathy with vanishing white matter,603896];	261222 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR pLI=0.67)
chr1	47398743	47398743	G	C	het	off-target	QUAL=2085;DP=168;AF=0.47;MQM=60	CYP4A11	intron	CYP4A11:ENST00000371904:intron:MODIFIER:exon9/12:c.1226-24C>G:,CYP4A11:ENST00000310638:intron:MODIFIER:exon9/11:c.1223-24C>G:,CYP4A11:ENST00000462347:intron:MODIFIER:exon7/9:c.929-24C>G:,CYP4A11:ENST00000371905:intron:MODIFIER:exon9/10:c.1223-24C>G:		rs3890011	0.5715	0.7019	30788,20423,914	0.4125,0.6987,0.5197,0.7823,0.6265	0.7078											n/a (AF>5%)	n/a (AF>5%)					CYP4A11 (inh=n/a pLI=0.00)
chr1	49100332	49100332	C	T	het	off-target	QUAL=835;DP=74;AF=0.47;MQM=60	AGBL4	intron	AGBL4:ENST00000371839:intron:MODIFIER:exon8/13:c.840-56G>A:,AGBL4:ENST00000334103:intron:MODIFIER:exon3/7:c.39-56G>A:,AGBL4:ENST00000371838:intron:MODIFIER:exon8/8:c.840-56G>A:		rs319983	0.3960	0.0000	0,0,0	0,0,0,0,0	0.4692											n/a (AF>5%)	n/a (AF>5%)					AGBL4 (inh=n/a pLI=0.01)
chr1	54375570	54375570	C	A	het	off-target	QUAL=2991;DP=221;AF=0.50;MQM=60	DIO1	intron	DIO1:ENST00000361921:intron:MODIFIER:exon3/3:c.682-34C>A:,DIO1:ENST00000322679:intron:MODIFIER:exon2/2:c.482-34C>A:,DIO1:ENST00000388876:intron:MODIFIER:exon2/2:c.538-34C>A:,DIO1:ENST00000524406:intron:MODIFIER:exon4/4:c.295-34C>A:,DIO1:ENST00000525202:intron:MODIFIER:exon3/3:c.490-34C>A:,DIO1:ENST00000532493:intron:MODIFIER:exon1/1:c.338-34C>A:		rs2235544	0.4603	0.5206	17433,8442,308	0.2372,0.7380,0.4859,0.5003,0.6394	0.5321											n/a (AF>5%)	n/a (AF>5%)					DIO1 (inh=AD pLI=0.23)
chr1	55139741	55139741	A	G	hom		QUAL=3019;DP=91;AF=1.00;MQM=60	MROH7,MROH7-TTC4	missense	MROH7:ENST00000421030:missense:MODERATE:exon10/24:c.1853A>G:p.His618Arg,MROH7-TTC4:ENST00000414150:missense:MODERATE:exon10/33:c.1853A>G:p.His618Arg,MROH7:ENST00000545244:missense:MODERATE:exon8/15:c.557A>G:p.His186Arg,MROH7:ENST00000339553:missense:MODERATE:exon10/19:c.1853A>G:p.His618Arg,MROH7:ENST00000409996:missense:MODERATE:exon8/22:c.557A>G:p.His186Arg,MROH7:ENST00000454855:missense:MODERATE:exon8/22:c.407A>G:p.His136Arg,MROH7:ENST00000395690:missense:MODERATE:exon10/19:c.1853A>G:p.His618Arg		rs570218	0.9097	0.8441	43376,20591,4064	0.9103,0.8978,0.9997,0.7850,0.9236	0.8448	3.0450	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	9.64				COSM3747021, COSM3747020, COSM3747022	n/a (AF>5%)	n/a (AF>5%)					MROH7 (inh=n/a pLI=0.00), MROH7-TTC4 (inh=n/a pLI=n/a)
chr1	55251689	55251689	T	C	hom		QUAL=3991;DP=125;AF=1.00;MQM=60	TTC22	synonymous	TTC22:ENST00000371276:synonymous:LOW:exon5/7:c.987A>G:p.Glu329Glu,TTC22:ENST00000371274:synonymous:LOW:exon5/6:c.987A>G:p.Glu329Glu		rs586462	0.9990	0.9993	60586,33349,5125	0.9926,0.9991,1.0000,1.0000,1.0000	0.9995											n/a (AF>5%)	n/a (AF>5%)					TTC22 (inh=n/a pLI=0.00)
chr1	55518467	55518467	A	G	hom		QUAL=2329;DP=72;AF=1.00;MQM=60	PCSK9	splice_region&intron	PCSK9:ENST00000302118:splice_region&intron:LOW:exon5/11:c.799+3A>G:,PCSK9:ENST00000543384:splice_region&intron:LOW:exon3/9:c.199+3A>G:		rs2495477	0.4663	0.4312	11699,5517,2600	0.7194,0.3036,0.2631,0.4152,0.4907	0.4935							607786 [PCSK9 (confirmed) Hypercholesterolemia,familial,3,603776|Low density lipoprotein cholesterol level QTL 1,603776];	262908 [benign/likely benign DISEASE=familial_hypercholesterolemia,familial_hypobetalipoproteinemia,not_specified]; 	CS1617562 [CLASS=DP MUT=ALT PHEN="LDL-cholesterol levels association with" GENE=PCSK9]; 		n/a (AF>5%)	n/a (AF>5%)					PCSK9 (inh=AD pLI=0.00)
chr1	57349407	57349407	A	T	het	off-target	QUAL=422;DP=33;AF=0.55;MQM=60	C8A	intron	C8A:ENST00000361249:intron:MODIFIER:exon6/10:c.855+53A>T:		rs6694643	0.2111	0.0000	0,0,0	0,0,0,0,0	0.1538							120950 [C8A (confirmed) C8 deficiency,type I,613790];				n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR pLI=0.00)
chr1	59844471	59844471	G	A	hom		QUAL=2335;DP=72;AF=1.00;MQM=60	FGGY	synonymous	FGGY:ENST00000371218:synonymous:LOW:exon5/17:c.516G>A:p.Pro172Pro,FGGY:ENST00000303721:synonymous:LOW:exon5/16:c.516G>A:p.Pro172Pro,FGGY:ENST00000371212:synonymous:LOW:exon3/14:c.252G>A:p.Pro84Pro		rs835435	0.4932	0.4234	11298,4928,2108	0.6345,0.3870,0.4865,0.3826,0.4263	0.4826										COSM3997616, COSM3997615	n/a (AF>5%)	n/a (AF>5%)					FGGY (inh=n/a pLI=0.00)
chr1	60299820	60299820	C	G	hom	off-target	QUAL=3574;DP=108;AF=1.00;MQM=60	HOOK1	intron	HOOK1:ENST00000371208:intron:MODIFIER:exon5/21:c.406+611C>G:,HOOK1:ENST00000395561:intron:MODIFIER:exon5/21:c.280+611C>G:		rs618716	0.9585	0.0000	0,0,0	0,0,0,0,0	0.9433											n/a (AF>5%)	n/a (AF>5%)					HOOK1 (inh=n/a pLI=0.01)
chr1	62579823	62579823	G	A	het		QUAL=1015;DP=74;AF=0.53;MQM=60	INADL	synonymous	INADL:ENST00000371158:synonymous:LOW:exon35/43:c.4560G>A:p.Glu1520Glu,INADL:ENST00000316485:synonymous:LOW:exon36/36:c.4650G>A:p.Glu1550Glu,INADL:ENST00000543708:synonymous:LOW:exon10/12:c.1002G>A:p.Glu334Glu,INADL:ENST00000545929:synonymous:LOW:exon7/7:c.495G>A:p.Glu165Glu		rs1475563	0.6090	0.6621	27064,15649,1092	0.4582,0.7665,0.7816,0.6838,0.6058	0.6695											n/a (AF>5%)	n/a (AF>5%)					PATJ (inh=n/a pLI=0.00)
chr1	62728861	62728861	T	C	hom		QUAL=2289;DP=70;AF=1.00;MQM=60	KANK4	synonymous,5'UTR	KANK4:ENST00000371153:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys,KANK4:ENST00000371150:synonymous:LOW:exon4/7:c.510A>G:p.Lys170Lys,KANK4:ENST00000354381:synonymous:LOW:exon6/9:c.558A>G:p.Lys186Lys,KANK4:ENST00000317477:5'UTR:MODIFIER:exon1/4:c.-145A>G:		rs2260581	0.7163	0.7426	33625,18069,1593	0.5555,0.8632,0.8404,0.7381,0.7021	0.7546											n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a pLI=0.00)
chr1	64643277	64643277	C	T	het		QUAL=3214;DP=223;AF=0.53;MQM=60	ROR1	missense,5'UTR_premature_start_codon_gain,5'UTR	ROR1:ENST00000371079:missense:MODERATE:exon9/9:c.1553C>T:p.Thr518Met,ROR1:ENST00000545203:5'UTR_premature_start_codon_gain:LOW:exon6/6:c.-95C>T:,ROR1:ENST00000545203:5'UTR:MODIFIER:exon6/6:c.-95C>T:		rs7527017	0.2432	0.3043	6080,3731,40	0.0770,0.3485,0.3000,0.3329,0.2743	0.3103	1.7850	D,D	T	P	D	24.00	602336 [ROR1 (provisional) Deafness,autosomal recessive 108,617654];			COSM3747052	n/a (AF>5%)	n/a (AF>5%)					ROR1 (inh=n/a pLI=0.97)
chr1	67288045	67288045	C	T	het		QUAL=778;DP=87;AF=0.38;MQM=60	WDR78	missense&splice_region	WDR78:ENST00000371026:missense&splice_region:MODERATE:exon16/17:c.2495G>A:p.Arg832Gln,WDR78:ENST00000431318:missense&splice_region:MODERATE:exon15/16:c.1634G>A:p.Arg545Gln		rs482082	0.5148	0.5009	15457,8034,1661	0.5654,0.5993,0.6522,0.4902,0.4115	0.4984	1.5510	T,T,T	T	B,B	T,T,T	15.34				COSM3997640	n/a (AF>5%)	n/a (AF>5%)					WDR78 (inh=n/a pLI=0.00)
chr1	68944792	68944792	C	G	het		QUAL=944;DP=71;AF=0.52;MQM=60	DEPDC1	intron	DEPDC1:ENST00000456315:intron:MODIFIER:exon10/11:c.2112+35G>C:,DEPDC1:ENST00000370966:intron:MODIFIER:exon9/10:c.1260+35G>C:		rs3762282	0.0773	0.0624	261,69,110	0.1390,0.0486,0.0814,0.0478,0.0721	0.0747											n/a (AF>5%)	n/a (AF>5%)					DEPDC1 (inh=n/a pLI=0.00)
chr1	75609049	75609049	A	C	hom	off-target	QUAL=449;DP=15;AF=1.00;MQM=60	LHX8	intron	LHX8:ENST00000294638:intron:MODIFIER:exon6/9:c.610+26A>C:,LHX8:ENST00000356261:intron:MODIFIER:exon5/8:c.580+26A>C:		rs12041465	0.3225	0.2856	4975,1019,43	0.1197,0.4643,0.7942,0.2109,0.2798	0.2754											n/a (AF>5%)	n/a (AF>5%)					LHX8 (inh=n/a pLI=0.59)
chr1	76878156	76878156	C	T	hom	off-target	QUAL=1290;DP=42;AF=1.00;MQM=60	ST6GALNAC3	intron	ST6GALNAC3:ENST00000328299:intron:MODIFIER:exon3/4:c.623+54C>T:		rs17098942	0.2520	0.0000	0,0,0	0,0,0,0,0	0.2149											n/a (AF>5%)	n/a (AF>5%)					ST6GALNAC3 (inh=n/a pLI=0.46)
chr1	87368917	87368917	A	G	het	off-target	QUAL=367;DP=35;AF=0.46;MQM=60	SEP15	intron	SEP15:ENST00000331835:intron:MODIFIER:exon2/4:c.243+47T>C:,SEP15:ENST00000370554:intron:MODIFIER:exon2/3:c.243+47T>C:,SEP15:ENST00000401030:intron:MODIFIER:exon2/5:c.243+47T>C:		rs573680	0.2318	0.2045	2159,1034,776	0.4555,0.1315,0.0260,0.2137,0.1721	0.2681											n/a (AF>5%)	n/a (AF>5%)					SELENOF (inh=n/a pLI=0.40)
chr1	89474818	89474818	A	G	het		QUAL=1280;DP=107;AF=0.49;MQM=60	GBP3	missense	GBP3:ENST00000370481:missense:MODERATE:exon10/11:c.1471T>C:p.Cys491Arg		rs17433780	0.2602	0.2829	4917,3350,323	0.2630,0.2135,0.1990,0.3200,0.2595	0.2815	0.4090	.,T,T	T	B,B	T,T	0.01				COSM3751431	n/a (AF>5%)	n/a (AF>5%)					GBP3 (inh=n/a pLI=0.00)
chr1	89849742	89849742	A	T	hom		QUAL=829;DP=25;AF=1.00;MQM=60	GBP6	missense	GBP6:ENST00000370456:missense:MODERATE:exon10/11:c.1559A>T:p.Asp520Val,GBP6:ENST00000535065:missense:MODERATE:exon8/9:c.1169A>T:p.Asp390Val		rs959460	0.8606	0.8828	47310,26374,4294	0.9083,0.9180,0.7505,0.8900,0.8706	0.8903	3.7070	D,D,D	T	B	T,T	13.41					n/a (AF>5%)	n/a (AF>5%)					GBP6 (inh=n/a pLI=0.00)
chr1	94471075	94471075	A	G	hom		QUAL=4514;DP=138;AF=0.99;MQM=60	ABCA4	synonymous	ABCA4:ENST00000370225:synonymous:LOW:exon44/50:c.6069T>C:p.Ile2023Ile,ABCA4:ENST00000535881:synonymous:LOW:exon7/13:c.426T>C:p.Ile142Ile,ABCA4:ENST00000536513:synonymous:LOW:exon9/15:c.879T>C:p.Ile293Ile		rs1762114	0.7700	0.8894	49214,29258,1086	0.4474,0.9413,0.8885,0.9363,0.9142	0.8995							601691 [ABCA4 (confirmed) Stargardt disease 1,248200|Retinitis pigmentosa 19,601718|Cone-rod dystrophy 3,604116|Macular degeneration,age-related,2,153800|Fundus flavimaculatus,248200|Retinal dystrophy,early-onset severe,248200];	136235 [benign DISEASE=macular_degeneration,not_specified,cone-rod_dystrophy,_recessive,stargardt_disease,_recessive,retinitis_pigmentosa,_recessive,not_provided]; 		COSM3997712	n/a (AF>5%)	n/a (AF>5%)					ABCA4 (inh=AR pLI=0.00)
chr1	109734541	109734541	C	T	hom	off-target	QUAL=2071;DP=67;AF=1.00;MQM=60	KIAA1324	intron	KIAA1324:ENST00000369939:intron:MODIFIER:exon13/21:c.1683+56C>T:,KIAA1324:ENST00000529753:intron:MODIFIER:exon11/19:c.1422+56C>T:		rs645128	0.8726	0.0000	0,0,0	0,0,0,0,0	0.8410											n/a (AF>5%)	n/a (AF>5%)					KIAA1324 (inh=n/a pLI=0.00)
chr1	109884775	109884775	T	G	hom		QUAL=2562;DP=81;AF=0.99;MQM=60	SORT1	synonymous	SORT1:ENST00000256637:synonymous:LOW:exon9/20:c.969A>C:p.Thr323Thr,SORT1:ENST00000538502:synonymous:LOW:exon9/20:c.558A>C:p.Thr186Thr		rs2228604	0.6855	0.7290	33069,17474,866	0.4121,0.8822,0.9611,0.7244,0.7241	0.7416							602458 [SORT1 (provisional) Low density lipoprotein cholesterol level QTL6,613589];				n/a (AF>5%)	n/a (AF>5%)					SORT1 (inh=n/a pLI=1.00)
chr1	111778241	111778241	C	T	hom		QUAL=4079;DP=123;AF=1.00;MQM=60	CHI3L2	splice_region&intron	CHI3L2:ENST00000369748:splice_region&intron:LOW:exon5/10:c.481-20C>T:,CHI3L2:ENST00000445067:splice_region&intron:LOW:exon7/12:c.481-20C>T:,CHI3L2:ENST00000369744:splice_region&intron:LOW:exon4/9:c.451-20C>T:,CHI3L2:ENST00000466741:splice_region&intron:LOW:exon4/9:c.244-20C>T:,CHI3L2:ENST00000524472:splice_region&intron:LOW:exon4/8:c.244-20C>T:		rs2764544	0.9613	0.9892	59129,33249,4032	0.8819,0.9956,1.0000,0.9997,0.9998	0.9913											n/a (AF>5%)	n/a (AF>5%)					CHI3L2 (inh=n/a pLI=0.00)
chr1	117618067	117618067	C	T	het		QUAL=814;DP=48;AF=0.67;MQM=60	TTF2	synonymous	TTF2:ENST00000369466:synonymous:LOW:exon5/23:c.861C>T:p.Asn287Asn		rs1289673	0.5138	0.5747	21166,11887,198	0.1845,0.6942,0.7417,0.5950,0.5855	0.5858										COSM3750275	n/a (AF>5%)	n/a (AF>5%)					TTF2 (inh=n/a pLI=0.00)
chr1	118053126	118053126	T	C	hom		QUAL=4404;DP=134;AF=1.00;MQM=60	MAN1A2	intron	MAN1A2:ENST00000356554:intron:MODIFIER:exon12/12:c.1793+7534T>C:		rs41506254	0.2366	0.0000	0,0,0	0,0,0,0,0	0.2335											n/a (AF>5%)	n/a (AF>5%)					MAN1A2 (inh=n/a pLI=0.99)
chr1	118583408	118583408	G	A	hom		QUAL=7254;DP=221;AF=1.00;MQM=60	SPAG17	synonymous	SPAG17:ENST00000336338:synonymous:LOW:exon22/49:c.3111C>T:p.Tyr1037Tyr		rs10923477	0.2885	0.3988	10359,7167,196	0.2011,0.3571,0.1517,0.4599,0.3998	0.3973										COSM3747507	n/a (AF>5%)	n/a (AF>5%)					SPAG17 (inh=n/a pLI=0.00)
chr1	120293367	120293367	T	C	hom	off-target	QUAL=4478;DP=137;AF=1.00;MQM=60	HMGCS2	intron	HMGCS2:ENST00000369406:intron:MODIFIER:exon9/9:c.*5+53A>G:,HMGCS2:ENST00000544913:intron:MODIFIER:exon8/8:c.*5+53A>G:		rs667246	0.6887	0.0000	0,0,0	0,0,0,0,0	0.6533							600234 [HMGCS2 (confirmed) HMG-CoA synthase-2 deficiency,605911];				n/a (AF>5%)	n/a (AF>5%)					HMGCS2 (inh=AR pLI=0.00)
chr1	144952078	144952078	C	A	het	off-target;gene_blacklist	QUAL=2924;DP=340;AF=0.38;MQM=50	PDE4DIP	3'UTR,intron	PDE4DIP:ENST00000369347:3'UTR:MODIFIER:exon4/4:c.*119G>T:,PDE4DIP:ENST00000369348:3'UTR:MODIFIER:exon7/7:c.*119G>T:,PDE4DIP:ENST00000369359:intron:MODIFIER:exon7/46:c.929+123G>T:,PDE4DIP:ENST00000313382:intron:MODIFIER:exon7/45:c.716+123G>T:,PDE4DIP:ENST00000369354:intron:MODIFIER:exon4/43:c.518+123G>T:,PDE4DIP:ENST00000369356:intron:MODIFIER:exon4/43:c.518+123G>T:,PDE4DIP:ENST00000530740:intron:MODIFIER:exon7/45:c.929+123G>T:,PDE4DIP:ENST00000369351:intron:MODIFIER:exon4/21:c.518+123G>T:,PDE4DIP:ENST00000369349:intron:MODIFIER:exon4/22:c.518+123G>T:		rs2590121	0.0000	0.4999	0,0,0	0.4997,0.4998,0.5000,0.4999,0.4999	0.5000											n/a (AF>5%)	n/a (AF>5%)					PDE4DIP (inh=n/a pLI=n/a)
chr1	144952220	144952220	C	T	het	gene_blacklist	QUAL=1084;DP=163;AF=0.39;MQM=36	PDE4DIP	missense	PDE4DIP:ENST00000369359:missense:MODERATE:exon7/47:c.910G>A:p.Ala304Thr,PDE4DIP:ENST00000313382:missense:MODERATE:exon7/46:c.697G>A:p.Ala233Thr,PDE4DIP:ENST00000369354:missense:MODERATE:exon4/44:c.499G>A:p.Ala167Thr,PDE4DIP:ENST00000369356:missense:MODERATE:exon4/44:c.499G>A:p.Ala167Thr,PDE4DIP:ENST00000530740:missense:MODERATE:exon7/46:c.910G>A:p.Ala304Thr,PDE4DIP:ENST00000369351:missense:MODERATE:exon4/22:c.499G>A:p.Ala167Thr,PDE4DIP:ENST00000369349:missense:MODERATE:exon4/23:c.499G>A:p.Ala167Thr,PDE4DIP:ENST00000369347:missense:MODERATE:exon4/4:c.499G>A:p.Ala167Thr,PDE4DIP:ENST00000369348:missense:MODERATE:exon7/7:c.910G>A:p.Ala304Thr		rs2590120	0.0000	0.5000	0,0,0	0.5000,0.4998,0.4998,0.5000,0.5000	0.5000	0.3460	T,T,T,T,T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T,T,T,T,T	22.40					n/a (AF>5%)	n/a (AF>5%)					PDE4DIP (inh=n/a pLI=n/a)
chr1	145103844	145103844	G	A	het	off-target	QUAL=1003;DP=114;AF=0.39;MQM=60	SEC22B	intron	SEC22B:ENST00000453618:intron:MODIFIER:exon1/4:n.403-64G>A:		rs2590144	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5000											n/a (AF>5%)	n/a (AF>5%)					SEC22B (inh=n/a pLI=n/a)
chr1	145112414	145112414	T	C	het		QUAL=1439;DP=427;AF=0.22;MQM=60	SEC22B	non_coding_transcript_exon	SEC22B:ENST00000453618:non_coding_transcript_exon:MODIFIER:exon4/5:n.715T>C:		rs2590131	0.0000	0.4987	0,0,0	0.4991,0.4987,0.4957,0.4989,0.4995	0.5000											n/a (AF>5%)	n/a (AF>5%)					SEC22B (inh=n/a pLI=n/a)
chr1	145597116	145597116	C	T	hom	off-target	QUAL=3725;DP=116;AF=1.00;MQM=60	POLR3C	intron	POLR3C:ENST00000334163:intron:MODIFIER:exon10/14:c.1071-62G>A:,POLR3C:ENST00000369294:intron:MODIFIER:exon10/11:c.1071-62G>A:		rs9728311	0.9597	0.0000	0,0,0	0,0,0,0,0	0.9645											n/a (AF>5%)	n/a (AF>5%)					POLR3C (inh=n/a pLI=0.00)
chr1	146684173	146684173	T	G	het	off-target	QUAL=153;DP=16;AF=0.50;MQM=60	RP11-337C18.10,FMO5	intron	FMO5:ENST00000254090:intron:MODIFIER:exon4/8:c.488-70A>C:,FMO5:ENST00000441068:intron:MODIFIER:exon4/8:c.488-70A>C:,FMO5:ENST00000369272:intron:MODIFIER:exon3/6:c.488-70A>C:		rs17360066	0.0513	0.0000	0,0,0	0,0,0,0,0	0.0306											n/a (AF>5%)	n/a (AF>5%)					RP11-337C18.10 (inh=n/a pLI=n/a), FMO5 (inh=n/a pLI=0.00)
chr1	146767062	146767062	A	G	het	off-target	QUAL=300;DP=29;AF=0.52;MQM=60	CHD1L	intron	CHD1L:ENST00000369258:intron:MODIFIER:exon22/22:c.2616-50A>G:,CHD1L:ENST00000369259:intron:MODIFIER:exon16/16:c.2004-50A>G:,CHD1L:ENST00000431239:intron:MODIFIER:exon19/19:c.2334-50A>G:,CHD1L:ENST00000361293:intron:MODIFIER:exon17/17:c.1773-50A>G:		rs7516430	0.2592	0.1577	2044,303,797	0.3862,0.1826,0.3335,0.0972,0.1502	0.1956											n/a (AF>5%)	n/a (AF>5%)					CHD1L (inh=n/a pLI=0.00)
chr1	147119273	147119273	G	A	hom		QUAL=3710;DP=113;AF=1.00;MQM=60	ACP6	synonymous	ACP6:ENST00000369238:synonymous:LOW:exon10/10:c.1239C>T:p.His413His		rs1344	0.4792	0.5342	17816,11032,1090	0.4534,0.6485,0.3729,0.5752,0.4039	0.5414											n/a (AF>5%)	n/a (AF>5%)					ACP6 (inh=n/a pLI=0.00)
chr1	147124310	147124310	T	G	hom		QUAL=3656;DP=111;AF=1.00;MQM=60	ACP6	synonymous	ACP6:ENST00000369238:synonymous:LOW:exon7/10:c.823A>C:p.Arg275Arg		rs2153463	0.0000	0.7107	30934,16907,3075	0.7639,0.8290,0.7137,0.7119,0.5795	0.7313											n/a (AF>5%)	n/a (AF>5%)					ACP6 (inh=n/a pLI=0.00)
chr1	147131465	147131465	T	C	hom	off-target	QUAL=2156;DP=68;AF=1.00;MQM=60	ACP6	intron	ACP6:ENST00000369238:intron:MODIFIER:exon3/9:c.479+46A>G:,ACP6:ENST00000392988:intron:MODIFIER:exon3/6:c.479+46A>G:		rs6674938	0.7013	0.7109	29870,16658,2895	0.7430,0.8296,0.7116,0.7132,0.5603	0.7286											n/a (AF>5%)	n/a (AF>5%)					ACP6 (inh=n/a pLI=0.00)
chr1	150970577	150970577	G	T	hom		QUAL=2496;DP=76;AF=0.99;MQM=60	FAM63A	missense	FAM63A:ENST00000361738:missense:MODERATE:exon9/11:c.1298C>A:p.Thr433Lys,FAM63A:ENST00000312210:missense:MODERATE:exon8/10:c.728C>A:p.Thr243Lys,FAM63A:ENST00000361936:missense:MODERATE:exon9/11:c.1154C>A:p.Thr385Lys,FAM63A:ENST00000493834:missense:MODERATE:exon8/10:c.869C>A:p.Thr290Lys		rs2925741	0.9433	0.9830	58725,33283,3444	0.8149,0.9918,1.0000,0.9995,0.9997	0.9866	0.7170	.,T,T,T,T	T,T	.,B,B	.,T,T,T,T	14.47					n/a (AF>5%)	n/a (AF>5%)					MINDY1 (inh=n/a pLI=0.00)
chr1	151373200	151373200	T	C	hom	off-target	QUAL=5075;DP=155;AF=1.00;MQM=60	PSMB4	intron	PSMB4:ENST00000290541:intron:MODIFIER:exon3/6:c.495-40T>C:	L3	rs2495391	0.9758	0.9923	59800,33362,4356	0.9152,0.9966,1.0000,0.9999,0.9996	0.9939											n/a (AF>5%)	n/a (AF>5%)					PSMB4 (inh=n/a pLI=0.31)
chr1	151754112	151754112	T	C	hom	off-target	QUAL=2926;DP=89;AF=1.00;MQM=60	TDRKH	intron	TDRKH:ENST00000368822:intron:MODIFIER:exon2/13:c.125-49A>G:,TDRKH:ENST00000368827:intron:MODIFIER:exon2/13:c.125-49A>G:,TDRKH:ENST00000368825:intron:MODIFIER:exon2/12:c.125-49A>G:,TDRKH:ENST00000368824:intron:MODIFIER:exon2/12:c.125-49A>G:,TDRKH:ENST00000368823:intron:MODIFIER:exon2/12:c.125-49A>G:,TDRKH:ENST00000458431:intron:MODIFIER:exon2/12:c.125-49A>G:,TDRKH:ENST00000440583:intron:MODIFIER:exon2/13:c.-448-49A>G:		rs35077383	0.3207	0.4252	11455,8245,376	0.2740,0.2546,0.2317,0.5016,0.4051	0.4231										COSN163239	n/a (AF>5%)	n/a (AF>5%)					TDRKH (inh=n/a pLI=0.10)
chr1	151780177	151780177	C	T	het	off-target	QUAL=964;DP=79;AF=0.47;MQM=60	RORC	intron	RORC:ENST00000392697:intron:MODIFIER:exon11/11:c.1558-68G>A:,RORC:ENST00000356728:intron:MODIFIER:exon9/9:c.1333-68G>A:,RORC:ENST00000318247:intron:MODIFIER:exon10/10:c.1396-68G>A:		rs3828057	0.2851	0.0000	0,0,0	0,0,0,0,0	0.3763							602943 [RORC (provisional) Immunodeficiency 42,616622];			COSN163241	n/a (AF>5%)	n/a (AF>5%)					RORC (inh=AR pLI=1.00)
chr1	152975495	152975495	G	A	het		QUAL=1729;DP=124;AF=0.52;MQM=60	SPRR3	5'UTR	SPRR3:ENST00000295367:5'UTR:MODIFIER:exon2/2:c.-2G>A:,SPRR3:ENST00000331860:5'UTR:MODIFIER:exon3/3:c.-2G>A:		rs2075739	0.5250	0.5337	17264,9612,1401	0.5203,0.4416,0.6746,0.5368,0.5366	0.5359											n/a (AF>5%)	n/a (AF>5%)					SPRR3 (inh=n/a pLI=0.01)
chr1	153277423	153277423	C	T	het		QUAL=2338;DP=146;AF=0.58;MQM=60	PGLYRP3	missense&splice_region	PGLYRP3:ENST00000290722:missense&splice_region:MODERATE:exon3/7:c.376G>A:p.Gly126Ser		rs843971	0.4698	0.4235	11221,4893,791	0.3820,0.4984,0.5301,0.3792,0.5360	0.4247	2.5390	T	T	P	T	24.20				COSM3750376	n/a (AF>5%)	n/a (AF>5%)					PGLYRP3 (inh=n/a pLI=0.00)
chr1	153431406	153431406	C	G	hom		QUAL=7083;DP=215;AF=1.00;MQM=60	S100A7	missense	S100A7:ENST00000368722:missense:MODERATE:exon2/3:c.84G>C:p.Glu28Asp,S100A7:ENST00000368723:missense:MODERATE:exon2/3:c.84G>C:p.Glu28Asp		rs3014837	0.9834	0.9609	56080,29754,5009	0.9815,0.9794,1.0000,0.9441,0.9805	0.9648	0.2430	T,T	T	B	T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					S100A7 (inh=n/a pLI=0.54)
chr1	154744807	154744807	C	G	het		QUAL=2544;DP=174;AF=0.54;MQM=60	KCNN3	synonymous	KCNN3:ENST00000271915:synonymous:LOW:exon3/8:c.1092G>C:p.Leu364Leu,KCNN3:ENST00000361147:synonymous:LOW:exon3/8:c.177G>C:p.Leu59Leu,KCNN3:ENST00000358505:synonymous:LOW:exon3/8:c.153G>C:p.Leu51Leu		rs1051614	0.5353	0.5813	20507,11967,1280	0.4978,0.4786,0.5098,0.6013,0.6533	0.5814								403001 [benign DISEASE=not_specified]; 		COSM4142768, COSM4142769	n/a (AF>5%)	n/a (AF>5%)					KCNN3 (inh=n/a pLI=0.79)
chr1	154744852	154744852	A	G	het		QUAL=1391;DP=95;AF=0.57;MQM=60	KCNN3	synonymous	KCNN3:ENST00000271915:synonymous:LOW:exon3/8:c.1047T>C:p.Asn349Asn,KCNN3:ENST00000361147:synonymous:LOW:exon3/8:c.132T>C:p.Asn44Asn,KCNN3:ENST00000358505:synonymous:LOW:exon3/8:c.108T>C:p.Asn36Asn		rs1131820	0.7792	0.7616	35402,17196,1973	0.6225,0.8859,0.9863,0.7218,0.8302	0.7683								403002 [benign DISEASE=not_specified]; 		COSM4142770, COSM4142771	n/a (AF>5%)	n/a (AF>5%)					KCNN3 (inh=n/a pLI=0.79)
chr1	155899020	155899020	A	T	het	off-target	QUAL=353;DP=54;AF=0.35;MQM=60	KIAA0907	intron	KIAA0907:ENST00000368321:intron:MODIFIER:exon4/13:c.464+67T>A:,KIAA0907:ENST00000368320:intron:MODIFIER:exon4/12:c.464+67T>A:,KIAA0907:ENST00000368319:intron:MODIFIER:exon4/9:c.464+67T>A:		rs539602	0.3990	0.0000	0,0,0	0,0,0,0,0	0.5161											n/a (AF>5%)	n/a (AF>5%)					KHDC4 (inh=n/a pLI=0.99)
chr1	155935244	155935244	C	A	het	off-target	QUAL=536;DP=66;AF=0.36;MQM=60	ARHGEF2	intron	ARHGEF2:ENST00000462460:intron:MODIFIER:exon9/25:c.606-41G>T:,ARHGEF2:ENST00000368315:intron:MODIFIER:exon5/21:c.474-41G>T:,ARHGEF2:ENST00000313695:intron:MODIFIER:exon5/21:c.390-41G>T:,ARHGEF2:ENST00000361247:intron:MODIFIER:exon5/21:c.471-41G>T:,ARHGEF2:ENST00000368316:intron:MODIFIER:exon9/25:c.390-41G>T:,ARHGEF2:ENST00000313667:intron:MODIFIER:exon5/21:c.471-41G>T:		rs2297649	0.3634	0.3089	6831,1786,235	0.2250,0.4642,0.7896,0.2399,0.3041	0.3153							607560 [ARHGEF2 (provisional) Neurodevelopmental disorder with midbrain and hindbrain malformations,617523];				n/a (AF>5%)	n/a (AF>5%)					ARHGEF2 (inh=AR pLI=1.00)
chr1	156206121	156206121	G	A	het		QUAL=3326;DP=285;AF=0.45;MQM=60	PMF1-BGLAP,PMF1	missense,splice_region&intron,intron	PMF1-BGLAP:ENST00000490491:missense:MODERATE:exon4/7:c.411G>A:p.Met137Ile,PMF1:ENST00000368273:missense:MODERATE:exon4/5:c.417G>A:p.Met139Ile,PMF1:ENST00000368277:missense:MODERATE:exon4/5:c.411G>A:p.Met137Ile,PMF1:ENST00000567140:splice_region&intron:LOW:exon3/6:c.369-19G>A:,PMF1-BGLAP:ENST00000368276:splice_region&intron:LOW:exon3/6:c.369-19G>A:,PMF1:ENST00000368279:splice_region&intron:LOW:exon3/4:c.369-19G>A:,PMF1:ENST00000565805:intron:MODIFIER:exon3/5:c.368+2602G>A:,PMF1-BGLAP:ENST00000320139:intron:MODIFIER:exon3/5:c.368+2602G>A:		rs1052067	0.1937	0.2345	3528,2539,124	0.1488,0.1516,0.1882,0.2771,0.1768	0.2373	2.0570	T,T	T	B	T,T	12.50				COSM424117	n/a (AF>5%)	n/a (AF>5%)					PMF1-BGLAP (inh=n/a pLI=0.00), PMF1 (inh=n/a pLI=0.00)
chr1	156518379	156518379	G	A	hom		QUAL=3193;DP=98;AF=1.00;MQM=60	IQGAP3	missense	IQGAP3:ENST00000361170:missense:MODERATE:exon17/38:c.1987C>T:p.Arg663Cys		rs744224	0.4071	0.3403	7594,2637,450	0.3000,0.3846,0.5532,0.2804,0.5213	0.3416	-0.0290	T	T	B	T	12.96				COSM3750427	n/a (AF>5%)	n/a (AF>5%)					IQGAP3 (inh=n/a pLI=0.00)
chr1	156902281	156902281	T	G	het		QUAL=713;DP=63;AF=0.46;MQM=60	LRRC71	missense	LRRC71:ENST00000337428:missense:MODERATE:exon14/15:c.1507T>G:p.Ser503Ala		rs822431	0.2829	0.2127	3276,1028,892	0.4177,0.3119,0.3230,0.1702,0.1512	0.2461	-0.1540	T	T	B,B	T	8.39				COSM146644	n/a (AF>5%)	n/a (AF>5%)					LRRC71 (inh=n/a pLI=0.01)
chr1	160136350	160136350	G	A	het		QUAL=981;DP=65;AF=0.60;MQM=52	ATP1A4	synonymous	ATP1A4:ENST00000368081:synonymous:LOW:exon8/22:c.1080G>A:p.Ala360Ala		rs7529215	0.4683	0.5294	17432,10583,580	0.3225,0.5305,0.4521,0.5622,0.5761	0.5333										COSM3750509	n/a (AF>5%)	n/a (AF>5%)					ATP1A4 (inh=n/a pLI=0.00)
chr1	160151421	160151421	G	C	hom	off-target	QUAL=2202;DP=71;AF=1.00;MQM=60	ATP1A4	intron	ATP1A4:ENST00000368081:intron:MODIFIER:exon18/21:c.2737-53G>C:,ATP1A4:ENST00000470705:intron:MODIFIER:exon1/4:c.145-53G>C:		rs11265350	0.3103	0.0000	0,0,0	0,0,0,0,0	0.2914											n/a (AF>5%)	n/a (AF>5%)					ATP1A4 (inh=n/a pLI=0.00)
chr1	161126975	161126975	C	G	het	off-target	QUAL=1233;DP=110;AF=0.45;MQM=60	UFC1,RP11-297K8.2	intron	UFC1:ENST00000368003:intron:MODIFIER:exon2/5:c.192-69C>G:		rs12031437	0.3546	0.0000	0,0,0	0,0,0,0,0	0.3377											n/a (AF>5%)	n/a (AF>5%)					UFC1 (inh=n/a pLI=0.07), RP11-297K8.2 (inh=n/a pLI=n/a)
chr1	170521376	170521376	G	A	hom		QUAL=2243;DP=68;AF=1.00;MQM=60	GORAB	missense	GORAB:ENST00000367763:missense:MODERATE:exon5/5:c.958G>A:p.Glu320Lys		rs913257	0.5927	0.5395	18612,7605,1457	0.5278,0.6807,0.9121,0.4776,0.4932	0.5429	2.5660	T	T	B	T	25.90	607983 [GORAB (provisional) Geroderma osteodysplasticum,231070];	262629 [benign DISEASE=geroderma_osteodysplastica,not_specified]; 		COSM3750583	n/a (AF>5%)	n/a (AF>5%)					GORAB (inh=AR pLI=0.00)
chr1	171112490	171112490	C	T	het		QUAL=250;DP=22;AF=0.50;MQM=60	FMO6P	stop_gained	FMO6P:ENST00000236166:stop_gained:HIGH:exon2/8:c.313C>T:p.Gln105*		rs1736565	0.6380	0.6040	2423,511,131	0.7447,0.0000,0.0000,0.5621,0.6264	0.6110	0.2810					39.00				COSM4143022	n/a (AF>5%)	n/a (AF>5%)					FMO6P (inh=n/a pLI=0.38)
chr1	171558516	171558516	C	T	hom		QUAL=927;DP=32;AF=1.00;MQM=60	PRRC2C	synonymous,intron	PRRC2C:ENST00000392078:synonymous:LOW:exon34/35:c.8208C>T:p.Ser2736Ser,PRRC2C:ENST00000426496:intron:MODIFIER:exon31/31:c.7998+872C>T:,PRRC2C:ENST00000367742:intron:MODIFIER:exon33/33:c.8199+872C>T:,PRRC2C:ENST00000338920:intron:MODIFIER:exon33/33:c.8193+872C>T:		rs235503	0.7969	0.8503	4459,1237,176	0.7891,0.0000,0.8650,0.8286,0.8656	0.8146											n/a (AF>5%)	n/a (AF>5%)					PRRC2C (inh=n/a pLI=1.00)
chr1	172547465	172547465	A	G	het		QUAL=1557;DP=125;AF=0.50;MQM=60	SUCO	synonymous	SUCO:ENST00000608151:synonymous:LOW:exon13/23:c.1824A>G:p.Glu608Glu,SUCO:ENST00000367723:synonymous:LOW:exon13/23:c.1821A>G:p.Glu607Glu,SUCO:ENST00000610051:synonymous:LOW:exon13/23:c.1257A>G:p.Glu419Glu,SUCO:ENST00000263688:synonymous:LOW:exon14/24:c.1368A>G:p.Glu456Glu		rs2285664	0.2542	0.2439	3908,1923,288	0.2298,0.2038,0.1908,0.2367,0.3688	0.2390										COSM3750599, COSM3750600	n/a (AF>5%)	n/a (AF>5%)					SUCO (inh=n/a pLI=0.30)
chr1	175375334	175375334	C	T	het		QUAL=224;DP=35;AF=0.34;MQM=60	TNR	splice_region&intron	TNR:ENST00000263525:splice_region&intron:LOW:exon4/23:c.499+18G>A:,TNR:ENST00000367674:splice_region&intron:LOW:exon3/22:c.499+18G>A:		rs859400	0.4185	0.3994	9758,4074,990	0.4351,0.5868,0.5237,0.3510,0.3678	0.4148											n/a (AF>5%)	n/a (AF>5%)					TNR (inh=n/a pLI=0.99)
chr1	176012807	176012807	G	A	hom	off-target	QUAL=586;DP=19;AF=1.00;MQM=60	RFWD2	intron	RFWD2:ENST00000367669:intron:MODIFIER:exon13/19:c.1530+39C>T:,RFWD2:ENST00000308769:intron:MODIFIER:exon12/18:c.1458+39C>T:		rs4233165	0.9379	0.9715	57254,32486,3421	0.8134,0.9902,1.0000,0.9879,0.9663	0.9753											n/a (AF>5%)	n/a (AF>5%)					COP1 (inh=n/a pLI=1.00)
chr1	179041011	179041011	A	G	hom	off-target	QUAL=1873;DP=58;AF=1.00;MQM=60	FAM20B	intron	FAM20B:ENST00000263733:intron:MODIFIER:exon7/7:c.999-37A>G:		rs3820163	0.6907	0.6461	25732,13711,4032	0.8841,0.4816,0.6181,0.6407,0.6069	0.7247											n/a (AF>5%)	n/a (AF>5%)					FAM20B (inh=n/a pLI=0.57)
chr1	180243524	180243524	A	G	het		QUAL=929;DP=83;AF=0.45;MQM=60	LHX4,RP5-1180C10.2	missense	LHX4:ENST00000263726:missense:MODERATE:exon6/6:c.983A>G:p.Asn328Ser		rs7536561	0.4263	0.4850	15435,9207,216	0.1875,0.2390,0.5837,0.5253,0.5981	0.4835	2.5290	T	T	B	D	0.46	602146 [LHX4 (confirmed) Pituitary hormone deficiency,combined,4,262700];	262225 [benign DISEASE=not_specified,combined_pituitary_hormone_deficiency,_dominant]; 		COSM3746684	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD pLI=0.32), RP5-1180C10.2 (inh=n/a pLI=n/a)
chr1	183486859	183486859	G	A	hom		QUAL=6765;DP=206;AF=1.00;MQM=60	SMG7	synonymous	SMG7:ENST00000507469:synonymous:LOW:exon4/23:c.216G>A:p.Leu72Leu,SMG7:ENST00000456731:synonymous:LOW:exon4/22:c.90G>A:p.Leu30Leu,SMG7:ENST00000367537:synonymous:LOW:exon5/24:c.303G>A:p.Leu101Leu,SMG7:ENST00000508461:synonymous:LOW:exon3/22:c.90G>A:p.Leu30Leu,SMG7:ENST00000347615:synonymous:LOW:exon4/22:c.216G>A:p.Leu72Leu,SMG7:ENST00000515829:synonymous:LOW:exon4/22:c.216G>A:p.Leu72Leu		rs789169	0.9419	0.9037	49732,25237,4707	0.9510,0.9365,0.9992,0.8689,0.9399	0.9089											n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a pLI=1.00)
chr1	184777177	184777177	C	A	het		QUAL=1189;DP=100;AF=0.48;MQM=60	FAM129A	intron	FAM129A:ENST00000367511:intron:MODIFIER:exon10/13:c.1335+31G>T:		rs543912	0.2171	0.2172	3266,1241,9	0.0406,0.2799,0.3573,0.1903,0.2991	0.2211											n/a (AF>5%)	n/a (AF>5%)					FAM129A (inh=n/a pLI=0.00)
chr1	186081918	186081918	C	T	hom	off-target;gene_blacklist	QUAL=3296;DP=107;AF=0.98;MQM=60	HMCN1	intron	HMCN1:ENST00000271588:intron:MODIFIER:exon71/106:c.10990-26C>T:,HMCN1:ENST00000367492:intron:MODIFIER:exon71/105:c.10990-26C>T:		rs7555520	0.6861	0.5854	21544,8772,4236	0.9046,0.6886,0.6346,0.5148,0.5921	0.6409							608548 [HMCN1 (provisional) Macular degeneration,age-related,1,603075];				n/a (AF>5%)	n/a (AF>5%)					HMCN1 (inh=n/a pLI=0.00)
chr1	190769033	190769033	T	C	het		QUAL=324;DP=30;AF=0.47;MQM=60	RP11-463J7.2			L1MC	rs12119860	0.1424	0.0000	0,0,0	0,0,0,0,0	0.1208											n/a (AF>5%)	n/a (AF>5%)					RP11-463J7.2 (inh=n/a pLI=n/a)
chr1	193150219	193150219	A	G	het		QUAL=1633;DP=116;AF=0.53;MQM=60	B3GALT2,CDC73	synonymous,intron	B3GALT2:ENST00000367434:synonymous:LOW:exon2/2:c.474T>C:p.Ala158Ala,CDC73:ENST00000367435:intron:MODIFIER:exon10/16:c.973-22706A>G:		rs28930674	0.0288	0.0365	85,72,5	0.0384,0.0220,0.0001,0.0483,0.0144	0.0385							607393 [CDC73 (confirmed) Hyperparathyroidism-jaw tumor syndrome,145001|Hyperparathyroidism,familial primary,145000|Parathyroid adenoma with cystic changes,145001|Parathyroid carcinoma,608266];				7	264					B3GALT2 (inh=n/a pLI=0.43), CDC73 (inh=AD pLI=1.00)
chr1	200567596	200567596	T	G	het	off-target	QUAL=175;DP=13;AF=0.69;MQM=60	KIF14	intron	KIF14:ENST00000367350:intron:MODIFIER:exon13/29:c.2365-47A>C:		rs2809358	0.2885	0.3294	5762,3541,556	0.3581,0.3039,0.1618,0.3521,0.2629	0.3549							611279 [KIF14 (confirmed) Meckel syndrome 12,616258|Microcephaly 20,primary,autosomal recessive,617914];			COSN163383	n/a (AF>5%)	n/a (AF>5%)					KIF14 (inh=AR pLI=0.00)
chr1	200943794	200943797	AGGA	-	hom	off-target	QUAL=940;DP=34;AF=0.97;MQM=60	KIF21B	intron	KIF21B:ENST00000422435:intron:MODIFIER:exon34/34:c.4814+45_4814+48delTCCT:,KIF21B:ENST00000332129:intron:MODIFIER:exon33/33:c.4775+45_4775+48delTCCT:,KIF21B:ENST00000360529:intron:MODIFIER:exon33/33:c.4775+45_4775+48delTCCT:,KIF21B:ENST00000461742:intron:MODIFIER:exon34/34:c.4814+45_4814+48delTCCT:		rs536920116	0.9988	0.9997	60436,33269,5156	0.9964,0.9999,1.0000,1.0000,1.0000	0.9998											n/a (AF>5%)	n/a (AF>5%)					KIF21B (inh=n/a pLI=1.00)
chr1	201252866	201252866	C	T	het		QUAL=809;DP=58;AF=0.55;MQM=60	PKP1	synonymous	PKP1:ENST00000263946:synonymous:LOW:exon1/15:c.36C>T:p.Tyr12Tyr,PKP1:ENST00000367324:synonymous:LOW:exon1/14:c.36C>T:p.Tyr12Tyr,PKP1:ENST00000352845:synonymous:LOW:exon1/14:c.36C>T:p.Tyr12Tyr		rs2268147	0.1803	0.1217	1230,256,614	0.3493,0.0890,0.0730,0.0890,0.1553	0.1672							601975 [PKP1 (confirmed) Ectodermal dysplasia/skin fragility syndrome,604536];	256861 [benign DISEASE=ectodermal_dysplasia_skin_fragility_syndrome,not_specified]; 		COSM3750759, COSM3750760	n/a (AF>5%)	n/a (AF>5%)					PKP1 (inh=n/a pLI=0.06)
chr1	201749520	201749520	G	C	het	off-target	QUAL=1154;DP=105;AF=0.44;MQM=60	NAV1,IPO9-AS1	intron	NAV1:ENST00000367296:intron:MODIFIER:exon3/29:c.1227-29G>C:,IPO9-AS1:ENST00000413035:intron:MODIFIER:exon2/2:n.684+36835C>G:,NAV1:ENST00000367302:intron:MODIFIER:exon5/29:c.1266-29G>C:,NAV1:ENST00000295624:intron:MODIFIER:exon3/28:c.1227-29G>C:,NAV1:ENST00000367297:intron:MODIFIER:exon3/28:c.1227-29G>C:,NAV1:ENST00000367300:intron:MODIFIER:exon3/27:c.1227-29G>C:,NAV1:ENST00000367295:intron:MODIFIER:exon1/26:c.54-29G>C:		rs529581	0.2903	0.3588	8328,5257,148	0.1658,0.4939,0.3118,0.3971,0.2436	0.3703											n/a (AF>5%)	n/a (AF>5%)					NAV1 (inh=n/a pLI=1.00), IPO9-AS1 (inh=n/a pLI=n/a)
chr1	202705455	202705455	G	C	het		QUAL=1202;DP=92;AF=0.49;MQM=60	KDM5B	synonymous	KDM5B:ENST00000367264:synonymous:LOW:exon22/28:c.3258C>G:p.Pro1086Pro,KDM5B:ENST00000367265:synonymous:LOW:exon21/27:c.3150C>G:p.Pro1050Pro		rs1141109	0.6396	0.7394	34103,20195,720	0.3645,0.8558,0.7737,0.7784,0.6878	0.7528											n/a (AF>5%)	n/a (AF>5%)					KDM5B (inh=n/a pLI=0.00)
chr1	203800735	203800735	G	C	het	off-target	QUAL=210;DP=20;AF=0.50;MQM=60	ZC3H11A	intron	ZC3H11A:ENST00000332127:intron:MODIFIER:exon10/19:c.701-54G>C:,ZC3H11A:ENST00000367214:intron:MODIFIER:exon10/19:c.701-54G>C:,ZC3H11A:ENST00000367212:intron:MODIFIER:exon10/19:c.701-54G>C:,ZC3H11A:ENST00000545588:intron:MODIFIER:exon7/16:c.701-54G>C:,ZC3H11A:ENST00000367210:intron:MODIFIER:exon7/16:c.701-54G>C:		rs2275325	0.2736	0.0000	0,0,0	0,0,0,0,0	0.2660											n/a (AF>5%)	n/a (AF>5%)					ZC3H11A (inh=n/a pLI=0.99)
chr1	204172096	204172096	G	A	het		QUAL=1153;DP=68;AF=0.63;MQM=60	GOLT1A	synonymous	GOLT1A:ENST00000308302:synonymous:LOW:exon2/5:c.45C>T:p.Thr15Thr		rs6689607	0.0911	0.0647	407,104,240	0.2245,0.0771,0.0019,0.0546,0.0366	0.0945										COSM1338060	n/a (AF>5%)	n/a (AF>5%)					GOLT1A (inh=n/a pLI=0.03)
chr1	204429838	204429838	C	G	hom	off-target	QUAL=6419;DP=193;AF=1.00;MQM=60	PIK3C2B	intron	PIK3C2B:ENST00000367187:intron:MODIFIER:exon6/33:c.1311-49G>C:,PIK3C2B:ENST00000424712:intron:MODIFIER:exon6/34:c.1311-49G>C:		rs2271414	0.7644	0.9138	49900,31798,1043	0.4589,0.8640,0.7964,0.9914,0.9429	0.9195											n/a (AF>5%)	n/a (AF>5%)					PIK3C2B (inh=n/a pLI=0.97)
chr1	207109167	207109167	G	A	het		QUAL=784;DP=62;AF=0.52;MQM=60	PIGR	splice_region&intron	PIGR:ENST00000356495:splice_region&intron:LOW:exon4/10:c.1046-4C>T:		rs6695632	0.2867	0.3861	8626,6502,178	0.1920,0.2924,0.3176,0.4587,0.2762	0.3783											n/a (AF>5%)	n/a (AF>5%)					PIGR (inh=n/a pLI=0.51)
chr1	207143422	207143422	A	G	het		QUAL=461;DP=50;AF=0.40;MQM=60	FCAMR	splice_region&intron	FCAMR:ENST00000324852:splice_region&intron:LOW:exon1/7:c.39+10T>C:,FCAMR:ENST00000400962:splice_region&intron:LOW:exon2/7:c.39+10T>C:,FCAMR:ENST00000450945:splice_region&intron:LOW:exon1/6:c.39+10T>C:		rs1856746	0.5501	0.4725	14605,7330,3657	0.8643,0.5034,0.4322,0.4680,0.2938	0.5684											n/a (AF>5%)	n/a (AF>5%)					FCAMR (inh=n/a pLI=0.00)
chr1	207679307	207679307	A	G	het		QUAL=2602;DP=218;AF=0.47;MQM=55	CR1	synonymous	CR1:ENST00000367049:synonymous:LOW:exon2/47:c.180A>G:p.Glu60Glu,CR1:ENST00000367051:synonymous:LOW:exon2/39:c.180A>G:p.Glu60Glu,CR1:ENST00000367052:synonymous:LOW:exon2/39:c.180A>G:p.Glu60Glu,CR1:ENST00000367053:synonymous:LOW:exon2/39:c.180A>G:p.Glu60Glu,CR1:ENST00000400960:synonymous:LOW:exon2/39:c.180A>G:p.Glu60Glu		rs4844600	0.8504	0.8217	41101,21283,4303	0.9368,0.9096,0.6336,0.7984,0.8931	0.8297	-1.1760		T			0.49	120620 [CR1 (confirmed) CR1 deficiency|SLE susceptibility|Blood group,Knops system,607486|Malaria,severe,resistance to,611162];				n/a (AF>5%)	n/a (AF>5%)					CR1 (inh=n/a pLI=0.00)
chr1	207782707	207782707	A	G	het		QUAL=1885;DP=168;AF=0.44;MQM=60	CR1	missense	CR1:ENST00000367049:missense:MODERATE:exon37/47:c.5969A>G:p.Asn1990Ser,CR1:ENST00000367051:missense:MODERATE:exon29/39:c.4619A>G:p.Asn1540Ser,CR1:ENST00000367052:missense:MODERATE:exon29/39:c.4619A>G:p.Asn1540Ser,CR1:ENST00000367053:missense:MODERATE:exon29/39:c.4619A>G:p.Asn1540Ser,CR1:ENST00000400960:missense:MODERATE:exon29/39:c.4619A>G:p.Asn1540Ser		rs17259045	0.0571	0.0890	621,342,3	0.0219,0.1767,0.0014,0.0957,0.0771	0.0944	-0.1400	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	0.01	120620 [CR1 (confirmed) CR1 deficiency|SLE susceptibility|Blood group,Knops system,607486|Malaria,severe,resistance to,611162];				n/a (AF>5%)	n/a (AF>5%)					CR1 (inh=n/a pLI=0.00)
chr1	209799253	209799253	A	G	het		QUAL=1387;DP=114;AF=0.46;MQM=60	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys,LAMB3:ENST00000391911:synonymous:LOW:exon13/22:c.1716T>C:p.Cys572Cys,LAMB3:ENST00000367030:synonymous:LOW:exon14/23:c.1716T>C:p.Cys572Cys		rs2179402	0.7650	0.7565	34184,18267,3036	0.7736,0.7755,0.8259,0.7469,0.7425	0.7538							150310 [LAMB3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Amelogenesis imperfecta,type IA,104530];	255587 [benign DISEASE=epidermolysis_bullosa,_junctional,not_specified]; 		COSM3746765	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD pLI=0.00)
chr1	210536278	210536278	C	A	het		QUAL=748;DP=95;AF=0.36;MQM=60	HHAT	splice_region&intron,intron	HHAT:ENST00000391905:splice_region&intron:LOW:exon3/11:c.159+15C>A:,HHAT:ENST00000413764:splice_region&intron:LOW:exon3/11:c.159+15C>A:,HHAT:ENST00000541565:splice_region&intron:LOW:exon3/9:c.159+15C>A:,HHAT:ENST00000537898:splice_region&intron:LOW:exon3/10:c.159+15C>A:,HHAT:ENST00000545154:splice_region&intron:LOW:exon2/10:c.162+15C>A:,HHAT:ENST00000261458:splice_region&intron:LOW:exon3/11:c.159+15C>A:,HHAT:ENST00000367010:splice_region&intron:LOW:exon3/11:c.159+15C>A:,HHAT:ENST00000545781:intron:MODIFIER:exon1/9:c.-30-24534C>A:,HHAT:ENST00000308852:intron:MODIFIER:exon2/10:c.24+13868C>A:		rs11119469	0.0713	0.1145	954,752,8	0.0378,0.0656,0.0015,0.1475,0.1108	0.1134											n/a (AF>5%)	n/a (AF>5%)					HHAT (inh=n/a pLI=0.00)
chr1	212911836	212911836	T	C	het		QUAL=1468;DP=117;AF=0.49;MQM=60	NSL1	missense,3'UTR,intron	NSL1:ENST00000366977:missense:MODERATE:exon6/6:c.760A>G:p.Met254Val,NSL1:ENST00000366975:missense:MODERATE:exon4/4:c.637A>G:p.Met213Val,NSL1:ENST00000422588:3'UTR:MODIFIER:exon7/7:c.*203A>G:,NSL1:ENST00000366976:3'UTR:MODIFIER:exon5/5:c.*173A>G:,NSL1:ENST00000366978:intron:MODIFIER:exon4/4:c.191-11315A>G:		rs15702	0.6074	0.6402	25737,16086,2350	0.6723,0.3624,0.5234,0.6921,0.6245	0.6821	-3.5460	T,T	T	B	T,T	0.01				COSM3746776	n/a (AF>5%)	n/a (AF>5%)					NSL1 (inh=n/a pLI=0.48)
chr1	219706428	219706428	T	C	hom		QUAL=6271;DP=190;AF=1.00;MQM=60	RP11,95P13.1,95P13.2	intergenic_region	95P13.2:ENSG00000230024-ENSG00000238232:intergenic_region:MODIFIER::n.219706428T>C:		rs10746385	0.5365	0.5622	18435,10746,601	0.3827,0.3813,0.7423,0.5909,0.5996	0.5597											n/a (AF>5%)	n/a (AF>5%)					PRPF31 (inh=AD pLI=0.95), 95P13.1 (inh=n/a pLI=n/a), 95P13.2 (inh=n/a pLI=n/a)
chr1	221054761	221054761	C	G	het	off-target	QUAL=445;DP=47;AF=0.40;MQM=60	HLX	5'UTR,intron	HLX:ENST00000549319:5'UTR:MODIFIER:exon1/2:c.-615C>G:,HLX:ENST00000366903:intron:MODIFIER:exon2/3:c.772+46C>G:		rs17597773	0.2107	0.2388	3516,1782,183	0.1880,0.3400,0.2256,0.2335,0.1983	0.2454											n/a (AF>5%)	n/a (AF>5%)					HLX (inh=n/a pLI=0.49)
chr1	221055463	221055463	G	A	het		QUAL=1297;DP=145;AF=0.39;MQM=60	HLX	missense,intron	HLX:ENST00000549319:missense:MODERATE:exon1/2:c.88G>A:p.Gly30Ser,HLX:ENST00000366903:intron:MODIFIER:exon2/3:c.773-43G>A:		rs2247213	0.2989	0.3211	6285,3848,982	0.4502,0.2687,0.0670,0.3541,0.2616	0.3578	-3.7950	D	T		D	3.00					n/a (AF>5%)	n/a (AF>5%)					HLX (inh=n/a pLI=0.49)
chr1	222751034	222751034	T	C	het	off-target	QUAL=499;DP=48;AF=0.50;MQM=60	TAF1A	intron	TAF1A:ENST00000350027:intron:MODIFIER:exon4/11:c.406-49A>G:,TAF1A:ENST00000366890:intron:MODIFIER:exon3/10:c.64-49A>G:,TAF1A:ENST00000352967:intron:MODIFIER:exon4/10:c.406-49A>G:,TAF1A:ENST00000391882:intron:MODIFIER:exon3/9:c.64-49A>G:,TAF1A:ENST00000543857:intron:MODIFIER:exon4/7:c.406-49A>G:		rs2936033	0.5459	0.6452	25754,16905,852	0.4125,0.4522,0.5730,0.7151,0.6206	0.6415											n/a (AF>5%)	n/a (AF>5%)					TAF1A (inh=n/a pLI=0.00)
chr1	225546172	225546172	C	G	het	off-target	QUAL=55;DP=5;AF=0.60;MQM=60	DNAH14	intron	DNAH14:ENST00000430092:intron:MODIFIER:exon71/83:c.11341-26C>G:,DNAH14:ENST00000445597:intron:MODIFIER:exon52/60:c.9049-26C>G:,DNAH14:ENST00000439375:intron:MODIFIER:exon70/82:c.11341-26C>G:		rs9659299	0.4509	0.3859	1200,332,217	0.4766,0.4814,0.6466,0.3088,0.4181	0.3622											n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a pLI=0.00)
chr1	225555602	225555602	T	G	hom		QUAL=2965;DP=92;AF=1.00;MQM=60	DNAH14	missense,intron	DNAH14:ENST00000430092:missense:MODERATE:exon75/84:c.11907T>G:p.Asn3969Lys,DNAH14:ENST00000439375:missense:MODERATE:exon74/83:c.11907T>G:p.Asn3969Lys,DNAH14:ENST00000445597:intron:MODIFIER:exon53/60:c.9205+9248T>G:		rs12737248	0.3295	0.4334	2084,1472,82	0.2519,0.4634,0.1913,0.5866,0.3351	0.4601	-1.5570	T,T	T	B	T,T	0.48		402662 [benign DISEASE=not_specified]; 		COSM3750920	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a pLI=0.00)
chr1	226353521	226353521	T	A	het	off-target	QUAL=747;DP=81;AF=0.40;MQM=60	ACBD3	intron	ACBD3:ENST00000366812:intron:MODIFIER:exon2/7:c.428+39A>T:		rs2306121	0.4129	0.4179	10661,5900,1247	0.4969,0.4806,0.3533,0.4217,0.3076	0.4543											n/a (AF>5%)	n/a (AF>5%)					ACBD3 (inh=n/a pLI=0.97)
chr1	226555302	226555302	A	G	hom		QUAL=7020;DP=211;AF=1.00;MQM=60	PARP1	missense	PARP1:ENST00000366794:missense:MODERATE:exon17/23:c.2285T>C:p.Val762Ala		rs1136410	0.1969	0.2018	3399,997,11	0.0507,0.4470,0.4376,0.1740,0.1018	0.2127	8.9570	T	T	P	T	32.00			CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1]; 	COSM3997295	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a pLI=0.06)
chr1	228412308	228412308	G	A	het	gene_blacklist	QUAL=2863;DP=222;AF=0.48;MQM=60	OBSCN	synonymous,5'UTR	OBSCN:ENST00000570156:synonymous:LOW:exon10/116:c.3078G>A:p.Ser1026Ser,OBSCN:ENST00000284548:synonymous:LOW:exon9/81:c.2802G>A:p.Ser934Ser,OBSCN:ENST00000422127:synonymous:LOW:exon9/105:c.2802G>A:p.Ser934Ser,OBSCN:ENST00000366709:5'UTR:MODIFIER:exon9/81:c.-5842G>A:,OBSCN:ENST00000366707:5'UTR:MODIFIER:exon9/111:c.-5842G>A:		rs1757152	0.4125	0.4010	10105,5171,1687	0.5867,0.4760,0.4144,0.3933,0.2848	0.4421											n/a (AF>5%)	n/a (AF>5%)					OBSCN (inh=n/a pLI=0.00)
chr1	230561700	230561700	-	C	hom	off-target	QUAL=151;DP=5;AF=1.00;MQM=60	PGBD5,RP11,543E8.1	intergenic_region	543E8.1:ENSG00000177614-ENSG00000232964:intergenic_region:MODIFIER::n.230561700_230561701insC:		rs535188248	0.9998	0.0000	0,0,0	0,0,0,0,0	0.9997											n/a (AF>5%)	n/a (AF>5%)					PGBD5 (inh=n/a pLI=0.02), PRPF31 (inh=AD pLI=0.95), 543E8.1 (inh=n/a pLI=n/a)
chr1	232564297	232564297	T	A	het		QUAL=1327;DP=117;AF=0.44;MQM=60	SIPA1L2	missense	SIPA1L2:ENST00000262861:missense:MODERATE:exon15/21:c.4270A>T:p.Met1424Leu,SIPA1L2:ENST00000366630:missense:MODERATE:exon16/22:c.4270A>T:p.Met1424Leu,SIPA1L2:ENST00000308942:missense:MODERATE:exon9/14:c.1492A>T:p.Met498Leu		rs3210731	0.0938	0.1534	1593,1197,20	0.0664,0.1462,0.0016,0.1893,0.1212	0.1538	0.5290	T,T,T	T	B,B	T,T,T	15.60				COSM3746859, COSM3746860	n/a (AF>5%)	n/a (AF>5%)					SIPA1L2 (inh=n/a pLI=1.00)
chr1	233225848	233225848	T	C	het		QUAL=1128;DP=121;AF=0.40;MQM=60	PCNXL2	synonymous	PCNXL2:ENST00000258229:synonymous:LOW:exon23/34:c.4035A>G:p.Thr1345Thr		rs12059884	0.1336	0.1036	997,469,451	0.3045,0.0612,0.0004,0.1165,0.0331	0.1562											n/a (AF>5%)	n/a (AF>5%)					PCNX2 (inh=n/a pLI=0.00)
chr1	233759864	233759864	C	T	het	off-target	QUAL=651;DP=71;AF=0.39;MQM=60	KCNK1	intron	KCNK1:ENST00000366621:intron:MODIFIER:exon1/2:c.355+9592C>T:		rs12092901	0.1450	0.0000	0,0,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.1427											n/a (AF>5%)	n/a (AF>5%)					KCNK1 (inh=n/a pLI=0.54)
chr1	234546245	234546245	C	T	het		QUAL=321;DP=38;AF=0.39;MQM=60	TARBP1	synonymous	TARBP1:ENST00000040877:synonymous:LOW:exon23/30:c.3738G>A:p.Thr1246Thr		rs1141264	0.3371	0.3638	8147,4794,270	0.2315,0.3770,0.4190,0.3815,0.3416	0.3571										COSM3751007	n/a (AF>5%)	n/a (AF>5%)					TARBP1 (inh=n/a pLI=0.00)
chr1	234582651	234582651	T	C	hom		QUAL=7371;DP=223;AF=1.00;MQM=60	TARBP1	missense	TARBP1:ENST00000040877:missense:MODERATE:exon12/30:c.2032A>G:p.Ser678Gly		rs4920246	0.3031	0.2991	5617,2543,609	0.3323,0.4333,0.3146,0.2782,0.2566	0.3050	1.5300	T	T	B	T	0.02				COSM3997345	n/a (AF>5%)	n/a (AF>5%)					TARBP1 (inh=n/a pLI=0.00)
chr1	236385360	236385360	C	T	het	off-target	QUAL=857;DP=104;AF=0.38;MQM=60	ERO1LB	intron	ERO1LB:ENST00000354619:intron:MODIFIER:exon13/15:c.1123-50G>A:		rs2477587	0.5695	0.5003	14310,4854,1081	0.4897,0.7075,0.8886,0.4164,0.5018	0.5053											n/a (AF>5%)	n/a (AF>5%)					ERO1B (inh=n/a pLI=0.00)
chr1	236724605	236724605	G	T	hom	off-target	QUAL=4061;DP=123;AF=1.00;MQM=60	HEATR1	intron	HEATR1:ENST00000366582:intron:MODIFIER:exon32/44:c.4600-34C>A:,HEATR1:ENST00000366581:intron:MODIFIER:exon31/43:c.4357-34C>A:		rs1077438	0.5787	0.6630	27172,17195,1272	0.4872,0.6250,0.6315,0.7175,0.5634	0.6686											n/a (AF>5%)	n/a (AF>5%)					HEATR1 (inh=n/a pLI=1.00)
chr1	237617757	237617757	C	T	hom		QUAL=2730;DP=84;AF=1.00;MQM=60	RYR2	synonymous	RYR2:ENST00000360064:synonymous:LOW:exon16/107:c.1353C>T:p.Ser451Ser,RYR2:ENST00000366574:synonymous:LOW:exon15/105:c.1359C>T:p.Ser453Ser,RYR2:ENST00000542537:synonymous:LOW:exon14/104:c.1311C>T:p.Ser437Ser		rs3765097	0.5357	0.5755	20576,11672,479	0.3050,0.6026,0.7367,0.5907,0.5625	0.5819							180902 [RYR2 (confirmed) Ventricular tachycardia,catecholaminergic polymorphic,1,604772|Arrhythmogenic right ventricular dysplasia 2,600996];	43728 [benign/likely benign DISEASE=catecholaminergic_polymorphic_ventricular_tachycardia,not_specified,cardiovascular_phenotype,cardiomyopathy,_arvc]; 			n/a (AF>5%)	n/a (AF>5%)					RYR2 (inh=AD pLI=1.00)
chr1	244747150	244747150	G	A	het		QUAL=927;DP=95;AF=0.42;MQM=60	C1orf101	splice_region&intron	C1orf101:ENST00000366534:splice_region&intron:LOW:exon12/21:c.2010-16G>A:,C1orf101:ENST00000366533:splice_region&intron:LOW:exon12/20:c.2010-16G>A:,C1orf101:ENST00000366531:splice_region&intron:LOW:exon9/18:c.1557-16G>A:		rs6429487	0.2564	0.1608	2238,241,587	0.3384,0.2892,0.4006,0.0867,0.1573	0.1797											n/a (AF>5%)	n/a (AF>5%)					CATSPERE (inh=n/a pLI=0.00)
chr1	248005213	248005213	G	C	het	gene_blacklist	QUAL=1409;DP=109;AF=0.50;MQM=60	OR11L1	5'UTR_premature_start_codon_gain,5'UTR	OR11L1:ENST00000355784:5'UTR_premature_start_codon_gain:LOW:exon1/1:c.-15C>G:,OR11L1:ENST00000355784:5'UTR:MODIFIER:exon1/1:c.-15C>G:		rs7522811	0.8448	0.8926	47247,25886,2108	0.6612,0.9376,0.9975,0.8923,0.9345	0.8970											n/a (AF>5%)	n/a (AF>5%)					OR11L1 (inh=n/a pLI=0.02)
chr1	248129240	248129240	G	A	hom	gene_blacklist	QUAL=7154;DP=217;AF=1.00;MQM=60	OR2AK2,OR2L13	missense,intron	OR2AK2:ENST00000366480:missense:MODERATE:exon1/1:c.607G>A:p.Val203Met,OR2L13:ENST00000366478:intron:MODIFIER:exon1/2:c.-144+28554G>A:		rs4478844	0.4313	0.5658	20089,13284,159	0.1728,0.5962,0.4562,0.6355,0.5306	0.5745	-1.7490	D	T	D	T	23.60				COSM3997400	n/a (AF>5%)	n/a (AF>5%)					OR2AK2 (inh=n/a pLI=0.01), OR2L13 (inh=n/a pLI=0.01)
chr1	248512064	248512064	T	G	hom	gene_blacklist	QUAL=4318;DP=132;AF=1.00;MQM=60	OR2M7,OR14C36	intergenic_region	OR14C36:ENSG00000177186-ENSG00000177174:intergenic_region:MODIFIER::n.248512064T>G:		rs28372410	0.4647	0.5290	15856,10449,827	0.4060,0.4669,0.4226,0.5683,0.5372	0.5298											n/a (AF>5%)	n/a (AF>5%)					OR2M7 (inh=n/a pLI=0.01), OR14C36 (inh=n/a pLI=0.06)
chr1	248845458	248845458	C	T	het	gene_blacklist	QUAL=2139;DP=128;AF=0.60;MQM=60	OR14I1	missense	OR14I1:ENST00000342623:missense:MODERATE:exon1/1:c.148G>A:p.Asp50Asn		rs4509608	0.7464	0.8264	42377,25680,1083	0.4504,0.8196,0.8304,0.8770,0.8612	0.8327	-1.4410	T	T	P	T	23.50					n/a (AF>5%)	n/a (AF>5%)					OR14I1 (inh=n/a pLI=0.00)
chr2	3217908	3217908	G	C	hom		QUAL=4224;DP=133;AF=0.99;MQM=60	TSSC1	splice_region&intron	TSSC1:ENST00000398659:splice_region&intron:LOW:exon6/9:c.597+12C>G:,TSSC1:ENST00000382125:splice_region&intron:LOW:exon5/8:c.516+12C>G:,TSSC1:ENST00000443925:splice_region&intron:LOW:exon5/5:c.516+12C>G:		rs11682452	0.9207	0.9417	53911,30344,3654	0.8359,0.9788,0.9709,0.9540,0.9206	0.9452											n/a (AF>5%)	n/a (AF>5%)					EIPR1 (inh=n/a pLI=0.09)
chr2	8871342	8871342	C	A	het		QUAL=3282;DP=239;AF=0.51;MQM=60	KIDINS220	missense	KIDINS220:ENST00000256707:missense:MODERATE:exon30/30:c.4824G>T:p.Gln1608His,KIDINS220:ENST00000418530:missense:MODERATE:exon28/28:c.4527G>T:p.Gln1509His,KIDINS220:ENST00000427284:missense:MODERATE:exon29/29:c.4767G>T:p.Gln1589His,KIDINS220:ENST00000473731:missense:MODERATE:exon29/29:c.4767G>T:p.Gln1589His		rs1044280	0.2350	0.2627	4352,2389,247	0.2288,0.2862,0.1786,0.2654,0.2534	0.2693	-0.0470	T,D,D,D	T	B,B,B	T,T,T,T	15.21	615759 [KIDINS220 (provisional) Spastic paraplegia,intellectual disability,nystagmus,and obesity,617296];			COSM3758409	n/a (AF>5%)	n/a (AF>5%)					KIDINS220 (inh=AD pLI=0.01)
chr2	10928777	10928777	A	C	hom	off-target	QUAL=2179;DP=68;AF=1.00;MQM=60	PDIA6	intron	PDIA6:ENST00000404371:intron:MODIFIER:exon12/14:c.1154+46T>G:,PDIA6:ENST00000272227:intron:MODIFIER:exon10/12:c.998+46T>G:,PDIA6:ENST00000404824:intron:MODIFIER:exon11/13:c.1142+46T>G:,PDIA6:ENST00000540494:intron:MODIFIER:exon11/13:c.989+46T>G:,PDIA6:ENST00000381611:intron:MODIFIER:exon11/13:c.1013+46T>G:		rs2952626	0.4601	0.5498	19041,11814,362	0.2564,0.5910,0.4562,0.5933,0.5754	0.5542											n/a (AF>5%)	n/a (AF>5%)					PDIA6 (inh=n/a pLI=0.30)
chr2	10942687	10942687	C	T	hom		QUAL=3123;DP=95;AF=1.00;MQM=60	PDIA6	synonymous	PDIA6:ENST00000404371:synonymous:LOW:exon4/15:c.255G>A:p.Ser85Ser,PDIA6:ENST00000272227:synonymous:LOW:exon2/13:c.99G>A:p.Ser33Ser,PDIA6:ENST00000404824:synonymous:LOW:exon3/14:c.243G>A:p.Ser81Ser,PDIA6:ENST00000540494:synonymous:LOW:exon3/14:c.90G>A:p.Ser30Ser,PDIA6:ENST00000381611:synonymous:LOW:exon3/14:c.114G>A:p.Ser38Ser		rs4758	0.4599	0.5499	18507,11666,361	0.2562,0.5926,0.4519,0.5934,0.5826	0.5275										COSM4001126	n/a (AF>5%)	n/a (AF>5%)					PDIA6 (inh=n/a pLI=0.30)
chr2	11932173	11932173	G	T	hom	off-target	QUAL=1010;DP=34;AF=1.00;MQM=60	LPIN1	intron	LPIN1:ENST00000449576:intron:MODIFIER:exon14/21:c.1953+41G>T:,LPIN1:ENST00000396099:intron:MODIFIER:exon14/21:c.1824+41G>T:,LPIN1:ENST00000425416:intron:MODIFIER:exon13/20:c.1716+41G>T:,LPIN1:ENST00000256720:intron:MODIFIER:exon12/19:c.1698+41G>T:,LPIN1:ENST00000396097:intron:MODIFIER:exon8/15:c.888+41G>T:,LPIN1:ENST00000404113:intron:MODIFIER:exon4/11:c.201+41G>T:		rs7561070	0.5369	0.5598	18415,11154,3817	0.8931,0.3445,0.2107,0.6130,0.4347	0.6593							605518 [LPIN1 (provisional) Myoglobinuria,acute recurrent,autosomal recessive,268200];	262586 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					LPIN1 (inh=AR pLI=0.00)
chr2	21360583	21360583	A	G	het		QUAL=1168;DP=88;AF=0.50;MQM=60	TDRD15	missense	TDRD15:ENST00000405799:missense:MODERATE:exon4/4:c.244A>G:p.Met82Val		rs312966	0.5154	0.4938	2207,449,107	0.4418,0.4608,0.7332,0.3938,0.5796	0.4525	-0.1950	T	T		T	0.01					n/a (AF>5%)	n/a (AF>5%)					TDRD15 (inh=n/a pLI=n/a)
chr2	25022598	25022598	A	G	het		QUAL=138;DP=22;AF=0.36;MQM=60	CENPO	missense	CENPO:ENST00000260662:missense:MODERATE:exon3/8:c.101A>G:p.Gln34Arg,CENPO:ENST00000380834:missense:MODERATE:exon3/8:c.101A>G:p.Gln34Arg,CENPO:ENST00000473706:missense:MODERATE:exon2/7:c.83A>G:p.Gln28Arg		rs1550116	0.1324	0.1321	1142,647,51	0.1023,0.0889,0.2174,0.1390,0.1033	0.1341	0.2880	T,T,T	T	B,B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					CENPO (inh=n/a pLI=0.00)
chr2	27263122	27263122	T	C	het	off-target	QUAL=1565;DP=117;AF=0.50;MQM=60	TMEM214	intron	TMEM214:ENST00000238788:intron:MODIFIER:exon15/16:c.1791+56T>C:,TMEM214:ENST00000404032:intron:MODIFIER:exon14/15:c.1656+56T>C:		rs1866654	0.5617	0.0000	0,0,0	0,0,0,0,0	0.5403											n/a (AF>5%)	n/a (AF>5%)					TMEM214 (inh=n/a pLI=0.00)
chr2	29152456	29152456	A	G	het		QUAL=612;DP=41;AF=0.59;MQM=60	WDR43	synonymous	WDR43:ENST00000407426:synonymous:LOW:exon11/18:c.1317A>G:p.Glu439Glu		rs1140697	0.4177	0.5701	21752,16181,811	0.4083,0.3013,0.0639,0.6998,0.5971	0.5609											n/a (AF>5%)	n/a (AF>5%)					WDR43 (inh=n/a pLI=1.00)
chr2	29356567	29356567	G	C	het		QUAL=1430;DP=104;AF=0.52;MQM=60	CLIP4	synonymous	CLIP4:ENST00000320081:synonymous:LOW:exon5/16:c.414G>C:p.Leu138Leu,CLIP4:ENST00000401605:synonymous:LOW:exon5/15:c.414G>C:p.Leu138Leu,CLIP4:ENST00000401617:synonymous:LOW:exon4/16:c.93G>C:p.Leu31Leu,CLIP4:ENST00000404424:synonymous:LOW:exon5/16:c.414G>C:p.Leu138Leu		rs17749904	0.1248	0.1953	2709,1831,41	0.0838,0.1152,0.0083,0.2334,0.2505	0.1917											n/a (AF>5%)	n/a (AF>5%)					CLIP4 (inh=n/a pLI=0.00)
chr2	31401499	31401499	G	A	het	off-target	QUAL=393;DP=37;AF=0.46;MQM=60	CAPN14	intron	CAPN14:ENST00000403897:intron:MODIFIER:exon17/21:c.1711-54C>T:,CAPN14:ENST00000444918:intron:MODIFIER:exon17/21:c.1711-54C>T:		rs28684727	0.3429	0.0000	0,0,0	0,0,0,0,0	0.3080										COSN166049	n/a (AF>5%)	n/a (AF>5%)					CAPN14 (inh=n/a pLI=n/a)
chr2	32713706	32713706	A	T	hom		QUAL=1322;DP=40;AF=1.00;MQM=60	BIRC6	missense	BIRC6:ENST00000421745:missense:MODERATE:exon42/74:c.8020A>T:p.Thr2674Ser		rs2366894	0.5609	0.5871	4173,2011,642	0.6945,0.6204,0.3503,0.6393,0.4881	0.6243	1.2420	T	T	B	T	7.41				COSM148833, COSM1483065	n/a (AF>5%)	n/a (AF>5%)					BIRC6 (inh=n/a pLI=1.00)
chr2	32855615	32855615	A	G	hom		QUAL=1104;DP=34;AF=1.00;MQM=60	TTC27	synonymous	TTC27:ENST00000317907:synonymous:LOW:exon2/20:c.114A>G:p.Leu38Leu		rs2710623	0.9878	0.9969	60131,33287,4767	0.9665,0.9988,1.0000,0.9997,0.9999	0.9975											n/a (AF>5%)	n/a (AF>5%)					TTC27 (inh=n/a pLI=0.00)
chr2	33784161	33784161	G	A	hom	off-target	QUAL=3304;DP=100;AF=1.00;MQM=60	RASGRP3,AC020594.5	intron	RASGRP3:ENST00000402538:intron:MODIFIER:exon18/18:c.2064+64G>A:,RASGRP3:ENST00000403687:intron:MODIFIER:exon17/17:c.2064+64G>A:,RASGRP3:ENST00000407811:intron:MODIFIER:exon16/16:c.2061+64G>A:		rs2278955	0.2492	0.0000	0,0,0	0,0,0,0,0	0.2809											n/a (AF>5%)	n/a (AF>5%)					RASGRP3 (inh=n/a pLI=0.26), AC020594.5 (inh=n/a pLI=n/a)
chr2	39030074	39030074	C	T	het		QUAL=881;DP=90;AF=0.42;MQM=60	DHX57	splice_region&intron	DHX57:ENST00000295373:splice_region&intron:LOW:exon22/23:c.3817-17G>A:		rs13029406	0.5809	0.6154	23690,13113,587	0.3365,0.5552,0.8209,0.6256,0.6763	0.6187											n/a (AF>5%)	n/a (AF>5%)					DHX57 (inh=n/a pLI=0.00)
chr2	43015757	43015757	G	A	het		QUAL=641;DP=84;AF=0.35;MQM=60	HAAO	splice_region&intron	HAAO:ENST00000294973:splice_region&intron:LOW:exon1/9:c.81-10C>T:		rs3816184	0.8584	0.8035	39560,19174,3920	0.8661,0.9140,0.7688,0.7572,0.9236	0.8015							604521 [HAAO (provisional) Vertebral,cardiac,renal,and limb defects syndrome 1,617660];				n/a (AF>5%)	n/a (AF>5%)					HAAO (inh=n/a pLI=0.00)
chr2	43947760	43947760	T	C	het	off-target	QUAL=1942;DP=135;AF=0.55;MQM=60	PLEKHH2	intron	PLEKHH2:ENST00000282406:intron:MODIFIER:exon15/29:c.2461-48T>C:		rs10206389	0.1502	0.2165	3193,1631,11	0.0422,0.3810,0.1053,0.2231,0.2431	0.2206											n/a (AF>5%)	n/a (AF>5%)					PLEKHH2 (inh=n/a pLI=0.00)
chr2	44547574	44547574	G	A	hom		QUAL=3404;DP=104;AF=1.00;MQM=60	SLC3A1,PREPL	missense,3'UTR	SLC3A1:ENST00000260649:missense:MODERATE:exon10/10:c.1854G>A:p.Met618Ile,SLC3A1:ENST00000409380:missense:MODERATE:exon7/7:c.1020G>A:p.Met340Ile,SLC3A1:ENST00000409740:missense:MODERATE:exon4/4:c.747G>A:p.Met249Ile,PREPL:ENST00000541738:3'UTR:MODIFIER:exon14/14:c.*921C>T:,PREPL:ENST00000409411:3'UTR:MODIFIER:exon14/14:c.*921C>T:,PREPL:ENST00000409957:3'UTR:MODIFIER:exon14/14:c.*921C>T:,PREPL:ENST00000409936:3'UTR:MODIFIER:exon15/15:c.*921C>T:		rs698761	0.4609	0.5960	22885,15531,389	0.2701,0.4998,0.3221,0.6811,0.6676	0.5954	-0.1630	T,T,T,T	T	B	D,D,D	1.51	104614 [SLC3A1 (confirmed) Cystinuria,220100]:609557 [PREPL (confirmed) Myasthenic syndrome,congenital,22,616224];	336214 [benign DISEASE=cystinuria]; 			n/a (AF>5%)	n/a (AF>5%)					SLC3A1 (inh=AR+AD pLI=0.00), PREPL (inh=AR pLI=0.00)
chr2	46234568	46234568	A	G	het	off-target	QUAL=1419;DP=127;AF=0.46;MQM=60	PRKCE	intron	PRKCE:ENST00000306156:intron:MODIFIER:exon8/14:c.1064-33A>G:,PRKCE:ENST00000394874:intron:MODIFIER:exon3/5:c.233-33A>G:		rs10188306	0.1875	0.1904	2349,1415,434	0.3157,0.1013,0.0420,0.2121,0.1716	0.2140											n/a (AF>5%)	n/a (AF>5%)					PRKCE (inh=n/a pLI=1.00)
chr2	46739157	46739157	A	G	het		QUAL=2151;DP=145;AF=0.56;MQM=60	ATP6V1E2	3'UTR	ATP6V1E2:ENST00000306448:3'UTR:MODIFIER:exon2/2:c.*13T>C:,ATP6V1E2:ENST00000522587:3'UTR:MODIFIER:exon5/5:c.*13T>C:		rs3814045	0.4475	0.4370	11037,5378,773	0.3845,0.5808,0.6071,0.4075,0.3766	0.4337											n/a (AF>5%)	n/a (AF>5%)					ATP6V1E2 (inh=n/a pLI=0.00)
chr2	48033551	48033551	C	G	hom	off-target	QUAL=5452;DP=165;AF=1.00;MQM=60	MSH6,FBXO11	intron	MSH6:ENST00000234420:intron:MODIFIER:exon8/9:c.3802-40C>G:,MSH6:ENST00000540021:intron:MODIFIER:exon6/7:c.3412-40C>G:,MSH6:ENST00000538136:intron:MODIFIER:exon8/9:c.2896-40C>G:,FBXO11:ENST00000405808:intron:MODIFIER:exon3/3:c.169+1783G>C:		rs3136367	0.8091	0.7427	33739,17563,4350	0.9197,0.6173,0.8813,0.7273,0.7431	0.7725							600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5,614350|Endometrial cancer,familial,608089|Mismatch repair cancer syndrome,276300];	36594 [benign DISEASE=lynch_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD pLI=n/a), FBXO11 (inh=AD pLI=1.00)
chr2	48808882	48808882	T	A	het		QUAL=626;DP=63;AF=0.43;MQM=60	STON1-GTF2A1L,STON1	synonymous	STON1-GTF2A1L:ENST00000309827:synonymous:LOW:exon1/10:c.1110T>A:p.Pro370Pro,STON1:ENST00000309835:synonymous:LOW:exon1/3:c.1110T>A:p.Pro370Pro,STON1-GTF2A1L:ENST00000405008:synonymous:LOW:exon2/11:c.1110T>A:p.Pro370Pro,STON1-GTF2A1L:ENST00000402114:synonymous:LOW:exon2/11:c.1110T>A:p.Pro370Pro,STON1:ENST00000404752:synonymous:LOW:exon2/4:c.1110T>A:p.Pro370Pro,STON1:ENST00000406226:synonymous:LOW:exon3/5:c.1110T>A:p.Pro370Pro,STON1-GTF2A1L:ENST00000394754:synonymous:LOW:exon2/11:c.1110T>A:p.Pro370Pro,STON1-GTF2A1L:ENST00000394751:synonymous:LOW:exon1/8:c.1110T>A:p.Pro370Pro		rs3749144	0.3361	0.3381	7266,3586,430	0.2902,0.2995,0.4171,0.3208,0.3780	0.3466										COSM3758263, COSM3758264	n/a (AF>5%)	n/a (AF>5%)					STON1-GTF2A1L (inh=n/a pLI=0.00), STON1 (inh=n/a pLI=0.00)
chr2	48921375	48921375	T	C	het		QUAL=1021;DP=91;AF=0.45;MQM=60	LHCGR,STON1-GTF2A1L,GTF2A1L	missense,intron	LHCGR:ENST00000294954:missense:MODERATE:exon10/11:c.935A>G:p.Asn312Ser,LHCGR:ENST00000344775:missense:MODERATE:exon9/10:c.749A>G:p.Asn250Ser,LHCGR:ENST00000401907:missense:MODERATE:exon10/11:c.935A>G:p.Asn312Ser,LHCGR:ENST00000403273:missense:MODERATE:exon10/11:c.935A>G:p.Asn312Ser,STON1-GTF2A1L:ENST00000402114:intron:MODIFIER:exon10/10:c.3441+22556T>C:,LHCGR:ENST00000405626:intron:MODIFIER:exon9/9:c.866+4379A>G:		rs2293275	0.5911	0.6376	19594,9485,409	0.3287,0.7501,0.9309,0.6297,0.6340	0.6123	1.1850	T,T,T,T	T	B	T,T,T,T	0.01	152790 [LHCGR (provisional) Precocious puberty,male,176410|Leydig cell hypoplasia with pseudohermaphroditism,238320|Leydig cell hypoplasia with hypergonadotropic hypogonadism,238320|Luteinizing hormone resistance,female,238320|Leydig cell adenoma,somatic,with precocious puberty,176410];	255609 [benign DISEASE=hypergonadotropic_hypogonadism,leydig_cell_agenesis,gonadotropin-independent_familial_sexual_precocity,not_specified]; 		COSM3766585	n/a (AF>5%)	n/a (AF>5%)					LHCGR (inh=AR pLI=0.00), STON1-GTF2A1L (inh=n/a pLI=0.00), GTF2A1L (inh=n/a pLI=0.00)
chr2	54150237	54150237	A	G	het		QUAL=901;DP=94;AF=0.40;MQM=60	PSME4	synonymous,intron	PSME4:ENST00000404125:synonymous:LOW:exon16/47:c.1927T>C:p.Leu643Leu,PSME4:ENST00000421748:intron:MODIFIER:exon1/26:c.44-5824T>C:		rs3213775	0.1128	0.1031	939,228,4	0.0250,0.2184,0.2688,0.0788,0.1011	0.1055										COSM3758278, COSM3758277	n/a (AF>5%)	n/a (AF>5%)					PSME4 (inh=n/a pLI=1.00)
chr2	55771050	55771050	C	G	hom	off-target	QUAL=631;DP=23;AF=1.00;MQM=60	CCDC104	intron	CCDC104:ENST00000339012:intron:MODIFIER:exon8/10:c.716-24C>G:,CCDC104:ENST00000349456:intron:MODIFIER:exon7/9:c.641-24C>G:,CCDC104:ENST00000407816:intron:MODIFIER:exon7/9:c.641-111C>G:		rs3816489	0.6058	0.7110	31232,19937,1635	0.5739,0.7533,0.4453,0.7733,0.6096	0.7180											n/a (AF>5%)	n/a (AF>5%)					CFAP36 (inh=n/a pLI=0.00)
chr2	56102019	56102019	T	C	hom	off-target	QUAL=507;DP=18;AF=1.00;MQM=60	EFEMP1	intron	EFEMP1:ENST00000355426:intron:MODIFIER:exon9/11:c.1000+62A>G:,EFEMP1:ENST00000394555:intron:MODIFIER:exon8/10:c.1000+62A>G:,EFEMP1:ENST00000394554:intron:MODIFIER:exon8/10:c.1000+62A>G:,EFEMP1:ENST00000424836:intron:MODIFIER:exon6/8:c.586+62A>G:		rs55778215	0.1891	0.0000	0,0,0	0,0,0,0,0	0.1532							601548 [EFEMP1 (confirmed) Doyne honeycomb degeneration of retina,126600];				n/a (AF>5%)	n/a (AF>5%)					EFEMP1 (inh=AD pLI=1.00)
chr2	61605614	61605614	T	A	hom	off-target	QUAL=1532;DP=48;AF=0.98;MQM=60	USP34	intron	USP34:ENST00000398571:intron:MODIFIER:exon7/79:c.1015-55A>T:		rs10208769	0.5395	0.0000	0,0,0	0,0,0,0,0	0.4758											n/a (AF>5%)	n/a (AF>5%)					USP34 (inh=n/a pLI=1.00)
chr2	64796847	64796847	A	G	het	off-target	QUAL=1859;DP=127;AF=0.56;MQM=60	AFTPH	intron	AFTPH:ENST00000422803:intron:MODIFIER:exon5/9:c.2271+34A>G:,AFTPH:ENST00000238855:intron:MODIFIER:exon5/9:c.2271+34A>G:,AFTPH:ENST00000238856:intron:MODIFIER:exon5/8:c.2271+34A>G:,AFTPH:ENST00000409933:intron:MODIFIER:exon4/8:c.2271+34A>G:,AFTPH:ENST00000409183:intron:MODIFIER:exon4/8:c.1164+34A>G:		rs2287532	0.3185	0.3517	7855,4978,528	0.3191,0.2358,0.1798,0.3870,0.4021	0.3512										COSN166118	n/a (AF>5%)	n/a (AF>5%)					AFTPH (inh=n/a pLI=0.99)
chr2	69043539	69043539	G	C	hom	off-target	QUAL=599;DP=20;AF=1.00;MQM=60	ARHGAP25	intron	ARHGAP25:ENST00000409202:intron:MODIFIER:exon7/10:c.881+45G>C:,ARHGAP25:ENST00000295381:intron:MODIFIER:exon7/10:c.878+45G>C:,ARHGAP25:ENST00000467265:intron:MODIFIER:exon6/9:c.761+45G>C:,ARHGAP25:ENST00000409030:intron:MODIFIER:exon6/9:c.857+45G>C:,ARHGAP25:ENST00000409220:intron:MODIFIER:exon6/9:c.860+45G>C:,ARHGAP25:ENST00000497079:intron:MODIFIER:exon6/7:c.860+45G>C:		rs2271832	0.5837	0.6529	25512,16071,1463	0.5357,0.5586,0.5024,0.7035,0.6332	0.6527											n/a (AF>5%)	n/a (AF>5%)					ARHGAP25 (inh=n/a pLI=0.68)
chr2	71058835	71058835	A	G	het		QUAL=1455;DP=119;AF=0.48;MQM=60	CD207	missense	CD207:ENST00000410009:missense:MODERATE:exon5/6:c.833T>C:p.Val278Ala		rs741326	0.5453	0.4755	14058,6156,1160	0.4838,0.4706,0.6423,0.4278,0.5548	0.4735	-1.9320	T	T	B	T	0.01	604862 [CD207 (provisional) Birbeck granule deficiency,613393];				n/a (AF>5%)	n/a (AF>5%)					CD207 (inh=n/a pLI=0.00)
chr2	74185876	74185876	A	T	het		QUAL=2248;DP=182;AF=0.47;MQM=60	DGUOK,DGUOK-AS1	3'UTR,intron	DGUOK:ENST00000264093:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK:ENST00000348222:3'UTR:MODIFIER:exon5/5:c.*13A>T:,DGUOK:ENST00000356837:3'UTR:MODIFIER:exon7/7:c.*13A>T:,DGUOK-AS1:ENST00000453103:intron:MODIFIER:exon1/1:n.308-10814T>A:,DGUOK-AS1:ENST00000439192:intron:MODIFIER:exon1/1:n.326-542T>A:,DGUOK-AS1:ENST00000413452:intron:MODIFIER:exon1/1:n.228-542T>A:		rs4777	0.5308	0.5858	21034,12311,1303	0.4999,0.5527,0.5268,0.6063,0.5572	0.5968							601465 [DGUOK (provisional) Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),251880|Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive 4,617070|Portal hypertension,noncirrhotic,617068];	137083 [benign DISEASE=not_specified,mitochondrial_dna_depletion_syndrome]; 			n/a (AF>5%)	n/a (AF>5%)					DGUOK (inh=AR pLI=0.29), DGUOK-AS1 (inh=n/a pLI=n/a)
chr2	75906972	75906972	G	A	het	off-target	QUAL=583;DP=78;AF=0.36;MQM=60	MRPL19,GCFC2	3'UTR,intron	MRPL19:ENST00000358788:3'UTR:MODIFIER:exon5/6:c.*25G>A:,GCFC2:ENST00000321027:intron:MODIFIER:exon12/16:c.1812+347C>T:,GCFC2:ENST00000541687:intron:MODIFIER:exon11/15:c.*931+347C>T:,GCFC2:ENST00000409857:intron:MODIFIER:exon12/16:c.1698+347C>T:	MamSINE1	rs4853169	0.1769	0.0000	1,1,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.2063											n/a (AF>5%)	n/a (AF>5%)					MRPL19 (inh=n/a pLI=0.00), GCFC2 (inh=n/a pLI=0.00)
chr2	85769975	85769975	A	G	het	off-target	QUAL=963;DP=73;AF=0.53;MQM=60	MAT2A	intron	MAT2A:ENST00000306434:intron:MODIFIER:exon7/8:c.952-49A>G:,MAT2A:ENST00000409017:intron:MODIFIER:exon7/7:c.763-49A>G:		rs2043675	0.2873	0.2691	4480,2578,669	0.3705,0.1921,0.3247,0.2790,0.1619	0.3054										COSN166152	n/a (AF>5%)	n/a (AF>5%)					MAT2A (inh=n/a pLI=0.66)
chr2	85808871	85808871	C	T	het	off-target	QUAL=809;DP=76;AF=0.45;MQM=60	VAMP8	3'UTR	VAMP8:ENST00000263864:3'UTR:MODIFIER:exon3/3:c.*32C>T:,VAMP8:ENST00000432071:3'UTR:MODIFIER:exon3/3:c.*32C>T:,VAMP8:ENST00000409760:3'UTR:MODIFIER:exon4/4:c.*168C>T:		rs1058588	0.4167	0.4057	10052,5889,1156	0.4797,0.2924,0.3910,0.4203,0.3746	0.4289										COSN166155	n/a (AF>5%)	n/a (AF>5%)					VAMP8 (inh=n/a pLI=0.26)
chr2	86385668	86385668	T	C	hom	off-target	QUAL=525;DP=18;AF=1.00;MQM=60	IMMT	intron	IMMT:ENST00000410111:intron:MODIFIER:exon10/14:c.1162+47A>G:,IMMT:ENST00000254636:intron:MODIFIER:exon10/14:c.865+47A>G:,IMMT:ENST00000449247:intron:MODIFIER:exon10/14:c.1129+47A>G:,IMMT:ENST00000442664:intron:MODIFIER:exon10/14:c.1159+47A>G:,IMMT:ENST00000409051:intron:MODIFIER:exon9/13:c.1021+47A>G:		rs1057893	0.3754	0.4539	4396,2623,465	0.4421,0.4176,0.1642,0.5003,0.4233	0.4639											n/a (AF>5%)	n/a (AF>5%)					IMMT (inh=n/a pLI=0.00)
chr2	96795608	96795608	T	G	het		QUAL=885;DP=81;AF=0.44;MQM=60	ASTL	missense	ASTL:ENST00000342380:missense:MODERATE:exon8/9:c.829A>C:p.Lys277Gln		rs1657502	0.3842	0.3932	9728,4493,456	0.2945,0.5229,0.6325,0.3668,0.2907	0.3933	0.6770	T	T	B	T	11.51				COSM3758413	n/a (AF>5%)	n/a (AF>5%)					ASTL (inh=n/a pLI=0.00)
chr2	106013216	106013216	T	C	hom	off-target	QUAL=2334;DP=73;AF=1.00;MQM=60	FHL2	5'UTR,intron	FHL2:ENST00000409807:5'UTR:MODIFIER:exon1/6:c.-137A>G:,FHL2:ENST00000409177:intron:MODIFIER:exon1/5:c.324+2463A>G:,FHL2:ENST00000344213:intron:MODIFIER:exon1/6:c.256-62A>G:,FHL2:ENST00000393353:intron:MODIFIER:exon1/5:c.-25+2083A>G:,FHL2:ENST00000393352:intron:MODIFIER:exon1/5:c.-24-10219A>G:,FHL2:ENST00000322142:intron:MODIFIER:exon1/6:c.-75-62A>G:,FHL2:ENST00000336660:intron:MODIFIER:exon1/4:c.-24-10219A>G:,FHL2:ENST00000358129:intron:MODIFIER:exon1/7:c.-196-62A>G:,FHL2:ENST00000408995:intron:MODIFIER:exon1/5:c.-25+2211A>G:,FHL2:ENST00000607522:intron:MODIFIER:exon1/1:c.-24-10219A>G:		rs11891016	0.7009	0.0000	0,0,0	0,0,0,0,0	0.7043											n/a (AF>5%)	n/a (AF>5%)					FHL2 (inh=n/a pLI=0.00)
chr2	107423395	107423395	T	G	het		QUAL=1169;DP=98;AF=0.47;MQM=60	ST6GAL2	synonymous	ST6GAL2:ENST00000361686:synonymous:LOW:exon6/6:c.1329A>C:p.Ile443Ile,ST6GAL2:ENST00000409382:synonymous:LOW:exon6/6:c.1329A>C:p.Ile443Ile		rs1470590	0.4091	0.5316	16719,11498,1165	0.4960,0.4564,0.1728,0.6053,0.4250	0.5411	1.5350		T			10.78					n/a (AF>5%)	n/a (AF>5%)					ST6GAL2 (inh=n/a pLI=0.05)
chr2	107450525	107450525	T	C	het		QUAL=1666;DP=121;AF=0.53;MQM=60	ST6GAL2	missense	ST6GAL2:ENST00000361686:missense:MODERATE:exon3/6:c.1021A>G:p.Ile341Val,ST6GAL2:ENST00000409382:missense:MODERATE:exon3/6:c.1021A>G:p.Ile341Val,ST6GAL2:ENST00000409087:missense:MODERATE:exon3/6:c.1021A>G:p.Ile341Val		rs12615112	0.2556	0.1589	2478,240,274	0.2245,0.2378,0.4979,0.0832,0.2281	0.1587	-0.1330	T,T,T	T	B,B	T,T,T	0.01				COSM148922	n/a (AF>5%)	n/a (AF>5%)					ST6GAL2 (inh=n/a pLI=0.05)
chr2	111907691	111907691	T	C	hom		QUAL=2506;DP=78;AF=1.00;MQM=60	BCL2L11	synonymous	BCL2L11:ENST00000393256:synonymous:LOW:exon3/4:c.465T>C:p.Ile155Ile,BCL2L11:ENST00000393253:synonymous:LOW:exon3/4:c.195T>C:p.Ile65Ile,BCL2L11:ENST00000357757:synonymous:LOW:exon3/4:c.465T>C:p.Ile155Ile,BCL2L11:ENST00000308659:synonymous:LOW:exon4/5:c.285T>C:p.Ile95Ile		rs724710	0.6925	0.6562	26849,15195,3256	0.7927,0.4214,0.8680,0.6746,0.5471	0.7095											n/a (AF>5%)	n/a (AF>5%)					BCL2L11 (inh=n/a pLI=0.94)
chr2	112776979	112776979	C	A	het		QUAL=1415;DP=116;AF=0.47;MQM=60	MERTK	splice_region&intron	MERTK:ENST00000295408:splice_region&intron:LOW:exon15/18:c.2080-11C>A:,MERTK:ENST00000421804:splice_region&intron:LOW:exon15/19:c.2080-11C>A:,MERTK:ENST00000409780:splice_region&intron:LOW:exon14/17:c.1552-11C>A:		rs3811640	0.2969	0.3094	6372,2600,633	0.3488,0.4688,0.1147,0.2775,0.3539	0.3266							604705 [MERTK (confirmed) Retinitis pigmentosa 38,613862];	330766 [likely benign DISEASE=retinitis_pigmentosa,_recessive]; 			n/a (AF>5%)	n/a (AF>5%)					MERTK (inh=AR pLI=0.00)
chr2	113089267	113089267	T	C	het		QUAL=1230;DP=99;AF=0.49;MQM=60	ZC3H6	synonymous	ZC3H6:ENST00000343936:synonymous:LOW:exon12/12:c.2772T>C:p.Asn924Asn,ZC3H6:ENST00000409871:synonymous:LOW:exon12/12:c.2772T>C:p.Asn924Asn		rs7601200	0.7256	0.5962	22288,9001,4080	0.9140,0.6169,0.7739,0.5208,0.6088	0.6576											n/a (AF>5%)	n/a (AF>5%)					ZC3H6 (inh=n/a pLI=0.89)
chr2	113532885	113532885	G	T	hom	off-target	QUAL=2805;DP=89;AF=1.00;MQM=60	IL1A	intron	IL1A:ENST00000263339:intron:MODIFIER:exon6/6:c.616-41C>A:		rs3783550	0.6204	0.6512	26627,16186,3190	0.7846,0.4412,0.2958,0.6997,0.7216	0.6795											n/a (AF>5%)	n/a (AF>5%)					IL1A (inh=n/a pLI=0.00)
chr2	113763463	113763463	A	C	het		QUAL=2057;DP=154;AF=0.50;MQM=60	IL36A	splice_region&intron	IL36A:ENST00000259211:splice_region&intron:LOW:exon1/3:c.10+5A>C:		rs2305152	0.2849	0.3452	8105,3807,19	0.0610,0.5348,0.3343,0.3343,0.3913	0.3552										COSM3766492	n/a (AF>5%)	n/a (AF>5%)					IL36A (inh=n/a pLI=0.00)
chr2	118732831	118732831	G	A	het		QUAL=1878;DP=117;AF=0.59;MQM=60	CCDC93	missense	CCDC93:ENST00000376300:missense:MODERATE:exon9/24:c.683C>T:p.Pro228Leu,CCDC93:ENST00000319432:missense:MODERATE:exon9/24:c.680C>T:p.Pro227Leu		rs17512204	0.0280	0.0572	247,188,1	0.0128,0.0268,0.0005,0.0747,0.0584	0.0616	4.5020	T,T	T	B	T,T	10.95					n/a (AF>5%)	n/a (AF>5%)					CCDC93 (inh=n/a pLI=0.10)
chr2	119732042	119732042	T	C	het	off-target	QUAL=2045;DP=147;AF=0.53;MQM=60	MARCO	intron	MARCO:ENST00000327097:intron:MODIFIER:exon5/16:c.568+26T>C:,MARCO:ENST00000541757:intron:MODIFIER:exon6/17:c.334+26T>C:		rs11693199	0.1683	0.3176	6589,5603,45	0.0987,0.2653,0.0628,0.4312,0.1091	0.3022											n/a (AF>5%)	n/a (AF>5%)					MARCO (inh=n/a pLI=0.00)
chr2	120885310	120885310	G	A	hom		QUAL=4606;DP=139;AF=1.00;MQM=60	EPB41L5	missense	EPB41L5:ENST00000263713:missense:MODERATE:exon17/25:c.1384G>A:p.Ala462Thr,EPB41L5:ENST00000443902:missense:MODERATE:exon17/24:c.1384G>A:p.Ala462Thr,EPB41L5:ENST00000452780:missense:MODERATE:exon16/24:c.1384G>A:p.Ala462Thr		rs1034489	0.5907	0.6719	27983,17671,1035	0.4370,0.6177,0.7101,0.7266,0.6144	0.6774	0.6050	T,T,T	T	B,B,B	T,T,T	3.37				COSM3757600	n/a (AF>5%)	n/a (AF>5%)					EPB41L5 (inh=n/a pLI=0.17)
chr2	121981950	121981950	A	G	het		QUAL=1297;DP=85;AF=0.58;MQM=60	TFCP2L1	synonymous	TFCP2L1:ENST00000263707:synonymous:LOW:exon15/15:c.1407T>C:p.Asp469Asp		rs11890430	0.3638	0.3376	6944,2860,944	0.4290,0.3420,0.2592,0.2993,0.4696	0.3399										COSM148937	n/a (AF>5%)	n/a (AF>5%)					TFCP2L1 (inh=n/a pLI=1.00)
chr2	121992921	121992921	T	C	het	off-target	QUAL=832;DP=83;AF=0.42;MQM=60	TFCP2L1	intron	TFCP2L1:ENST00000263707:intron:MODIFIER:exon10/14:c.1004-34A>G:		rs2250092	0.1935	0.1024	1276,46,251	0.2212,0.2225,0.3777,0.0338,0.0791	0.1132											n/a (AF>5%)	n/a (AF>5%)					TFCP2L1 (inh=n/a pLI=1.00)
chr2	138237038	138237038	C	T	hom		QUAL=1327;DP=42;AF=1.00;MQM=60	THSD7B	splice_region&intron,intron	THSD7B:ENST00000272643:splice_region&intron:LOW:exon14/27:c.3139-7C>T:,THSD7B:ENST00000413152:splice_region&intron:LOW:exon14/27:c.3046-7C>T:,THSD7B:ENST00000409968:intron:MODIFIER:exon15/27:c.3138+28445C>T:,THSD7B:ENST00000543459:intron:MODIFIER:exon3/5:c.814-177627C>T:	L1MA4A	rs1584435	0.6152	0.7033	2032,831,58	0.4561,0.0000,0.7933,0.7867,0.6814	0.7114											n/a (AF>5%)	n/a (AF>5%)					THSD7B (inh=n/a pLI=0.00)
chr2	141110677	141110677	C	A	het	off-target	QUAL=1032;DP=84;AF=0.49;MQM=60	LRP1B	intron	LRP1B:ENST00000389484:intron:MODIFIER:exon75/90:c.11531-36G>T:		rs13034302	0.0499	0.0643	302,239,22	0.0652,0.0320,0.0005,0.0835,0.0466	0.0671											n/a (AF>5%)	n/a (AF>5%)					LRP1B (inh=n/a pLI=1.00)
chr2	141625410	141625410	A	C	het		QUAL=381;DP=33;AF=0.52;MQM=60	LRP1B	splice_region&intron	LRP1B:ENST00000389484:splice_region&intron:LOW:exon26/90:c.4335-7T>G:		rs12987572	0.1038	0.1456	1319,937,25	0.0657,0.1696,0.0498,0.1689,0.0922	0.1456											n/a (AF>5%)	n/a (AF>5%)					LRP1B (inh=n/a pLI=1.00)
chr2	141747293	141747293	T	C	het	off-target	QUAL=313;DP=25;AF=0.56;MQM=60	LRP1B	intron	LRP1B:ENST00000389484:intron:MODIFIER:exon16/90:c.2645-67A>G:		rs1429366	0.4864	0.0000	0,0,0	0,0,0,0,0	0.3776											n/a (AF>5%)	n/a (AF>5%)					LRP1B (inh=n/a pLI=1.00)
chr2	152295141	152295141	A	G	het	off-target	QUAL=348;DP=46;AF=0.37;MQM=60	RIF1	intron	RIF1:ENST00000243326:intron:MODIFIER:exon12/34:c.1484-57A>G:,RIF1:ENST00000444746:intron:MODIFIER:exon13/35:c.1484-57A>G:,RIF1:ENST00000453091:intron:MODIFIER:exon13/34:c.1484-57A>G:,RIF1:ENST00000428287:intron:MODIFIER:exon13/34:c.1484-57A>G:,RIF1:ENST00000433166:intron:MODIFIER:exon11/14:c.*247-57A>G:,RIF1:ENST00000430328:intron:MODIFIER:exon12/33:c.1484-57A>G:		rs16830036	0.2179	0.0000	0,0,0	0,0,0,0,0	0.2241											n/a (AF>5%)	n/a (AF>5%)					RIF1 (inh=n/a pLI=1.00)
chr2	152311570	152311570	G	A	hom		QUAL=5093;DP=153;AF=1.00;MQM=60	RIF1	missense	RIF1:ENST00000243326:missense:MODERATE:exon21/35:c.2506G>A:p.Gly836Ser,RIF1:ENST00000444746:missense:MODERATE:exon22/36:c.2506G>A:p.Gly836Ser,RIF1:ENST00000453091:missense:MODERATE:exon22/35:c.2506G>A:p.Gly836Ser,RIF1:ENST00000428287:missense:MODERATE:exon22/35:c.2506G>A:p.Gly836Ser,RIF1:ENST00000430328:missense:MODERATE:exon21/34:c.2506G>A:p.Gly836Ser		rs2444263	0.6394	0.6607	26866,14710,1790	0.5854,0.7745,0.7801,0.6633,0.5432	0.6674	1.0880	T,T,T,T,T,.	T,T	B,B,.	D,D,D,D,D,.	10.27					n/a (AF>5%)	n/a (AF>5%)					RIF1 (inh=n/a pLI=1.00)
chr2	152387553	152387553	T	C	hom	gene_blacklist	QUAL=5285;DP=161;AF=0.99;MQM=60	NEB	synonymous	NEB:ENST00000397345:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:ENST00000409198:synonymous:LOW:exon118/150:c.16482A>G:p.Thr5494Thr,NEB:ENST00000427231:synonymous:LOW:exon145/182:c.21585A>G:p.Thr7195Thr,NEB:ENST00000172853:synonymous:LOW:exon117/149:c.16482A>G:p.Thr5494Thr,NEB:ENST00000603639:synonymous:LOW:exon143/180:c.21585A>G:p.Thr7195Thr,NEB:ENST00000604864:synonymous:LOW:exon143/180:c.21585A>G:p.Thr7195Thr		rs4664475	0.4916	0.5830	20606,12509,761	0.3977,0.7277,0.5825,0.6176,0.4196	0.5888							161650 [NEB (confirmed) Nemaline myopathy 2,autosomal recessive,256030];	95114 [benign/likely benign DISEASE=not_specified,nemaline_myopathy,_recessive]; 			n/a (AF>5%)	n/a (AF>5%)					NEB (inh=AR pLI=0.00)
chr2	160116281	160116281	A	G	het	off-target	QUAL=602;DP=50;AF=0.50;MQM=60	WDSUB1	intron	WDSUB1:ENST00000359774:intron:MODIFIER:exon6/10:c.804+40T>C:,WDSUB1:ENST00000358147:intron:MODIFIER:exon4/6:c.677-3395T>C:,WDSUB1:ENST00000392796:intron:MODIFIER:exon6/10:c.804+40T>C:,WDSUB1:ENST00000409990:intron:MODIFIER:exon6/10:c.804+40T>C:,WDSUB1:ENST00000409124:intron:MODIFIER:exon6/9:c.804+40T>C:		rs4665052	0.1925	0.3890	3971,3244,34	0.1040,0.3186,0.0595,0.5474,0.2589	0.3670											n/a (AF>5%)	n/a (AF>5%)					WDSUB1 (inh=n/a pLI=0.00)
chr2	169830155	169830155	G	A	het	off-target	QUAL=1979;DP=137;AF=0.56;MQM=60	ABCB11	intron	ABCB11:ENST00000263817:intron:MODIFIER:exon13/27:c.1434+70C>T:		rs2287623	0.5970	0.0000	0,0,0	0,0,0,0,0	0.5720							603201 [ABCB11 (confirmed) Cholestasis,progressive familial intrahepatic 2,601847|Cholestasis,benign recurrent intrahepatic,2,605479];				n/a (AF>5%)	n/a (AF>5%)					ABCB11 (inh=AR pLI=0.00)
chr2	170355944	170355944	A	T	het	off-target	QUAL=200;DP=13;AF=0.77;MQM=60	RP11-724O16.1,BBS5	intron	BBS5:ENST00000554017:intron:MODIFIER:exon8/15:c.682-52A>T:,BBS5:ENST00000295240:intron:MODIFIER:exon8/11:c.682-52A>T:,BBS5:ENST00000392663:intron:MODIFIER:exon7/10:c.619-52A>T:		rs12692909	0.3828	0.0000	0,0,0	0,0,0,0,0	0.4031							603650 [BBS5 (confirmed) Bardet-Biedl syndrome 5,615983]:607701 [KLHL41 (provisional) Nemaline myopathy 9,615731];				n/a (AF>5%)	n/a (AF>5%)					RP11-724O16.1 (inh=n/a pLI=n/a), BBS5 (inh=AR pLI=0.01)
chr2	173659913	173659913	T	C	hom		QUAL=512;DP=17;AF=1.00;MQM=60	RAPGEF4	splice_region&intron	RAPGEF4:ENST00000397081:splice_region&intron:LOW:exon2/30:c.208+18T>C:,RAPGEF4:ENST00000264111:splice_region&intron:LOW:exon2/30:c.208+18T>C:,RAPGEF4:ENST00000409036:splice_region&intron:LOW:exon2/27:c.208+18T>C:		rs7585729	0.9702	0.9917	59373,33321,4029	0.9065,0.9957,1.0000,0.9997,0.9997	0.9931											n/a (AF>5%)	n/a (AF>5%)					RAPGEF4 (inh=n/a pLI=0.96)
chr2	179632710	179632710	T	C	hom	off-target	QUAL=6093;DP=184;AF=1.00;MQM=60	TTN,TTN-AS1	intron	TTN:ENST00000589042:intron:MODIFIER:exon39/362:c.9305+31A>G:,TTN-AS1:ENST00000585451:intron:MODIFIER:exon3/4:n.456+3615T>C:,TTN:ENST00000342992:intron:MODIFIER:exon39/311:c.9305+31A>G:,TTN:ENST00000342175:intron:MODIFIER:exon38/191:c.9167+31A>G:,TTN:ENST00000359218:intron:MODIFIER:exon38/191:c.9167+31A>G:,TTN:ENST00000460472:intron:MODIFIER:exon38/190:c.9167+31A>G:,TTN:ENST00000591111:intron:MODIFIER:exon39/312:c.9305+31A>G:,TTN:ENST00000360870:intron:MODIFIER:exon39/45:c.9305+31A>G:,TTN-AS1:ENST00000610005:intron:MODIFIER:exon3/4:n.561+3615T>C:		rs2291313	0.5040	0.6657	28848,21187,1063	0.4586,0.3937,0.3135,0.7975,0.5841	0.6682							188840 [TTN (confirmed) Cardiomyopathy,familial hypertrophic,9,613765|Cardiomyopathy,dilated,1G,604145|Tibial muscular dystrophy,tardive,600334|Muscular dystrophy,limb-girdle,type 2J,608807|Myopathy,proximal,with early respiratory muscle involvement,603689|Salih myopathy,611705];			COSN166344	n/a (AF>5%)	n/a (AF>5%)					TTN (inh=AR+AD pLI=0.00), TTN-AS1 (inh=n/a pLI=n/a)
chr2	179721046	179721046	G	A	het		QUAL=1351;DP=106;AF=0.50;MQM=60	CCDC141	missense	CCDC141:ENST00000420890:missense:MODERATE:exon18/24:c.2803C>T:p.Arg935Trp,CCDC141:ENST00000295723:missense:MODERATE:exon8/13:c.1078C>T:p.Arg360Trp		rs17362588	0.0357	0.0619	283,229,1	0.0147,0.0463,0.0002,0.0865,0.0295	0.0608	1.8600	D,D,D,D	T	D	T,T,T,T	29.10				COSM1579597, COSM1579596	n/a (AF>5%)	n/a (AF>5%)					CCDC141 (inh=AR+AD pLI=0.00)
chr2	179989039	179989039	G	A	het	off-target	QUAL=342;DP=29;AF=0.55;MQM=60	SESTD1	intron	SESTD1:ENST00000428443:intron:MODIFIER:exon11/17:c.1167+52C>T:		rs2289992	0.4742	0.0000	0,0,0	0,0,0,0,0	0.4329											n/a (AF>5%)	n/a (AF>5%)					SESTD1 (inh=n/a pLI=0.97)
chr2	183070619	183070619	A	T	hom	off-target	QUAL=1755;DP=56;AF=1.00;MQM=60	PDE1A	intron	PDE1A:ENST00000456212:intron:MODIFIER:exon8/12:c.950+48T>A:,PDE1A:ENST00000435564:intron:MODIFIER:exon8/14:c.950+48T>A:,PDE1A:ENST00000346717:intron:MODIFIER:exon7/13:c.848+48T>A:,PDE1A:ENST00000536095:intron:MODIFIER:exon9/15:c.638+48T>A:,PDE1A:ENST00000409365:intron:MODIFIER:exon8/13:c.902+48T>A:,PDE1A:ENST00000331935:intron:MODIFIER:exon8/13:c.950+48T>A:,PDE1A:ENST00000351439:intron:MODIFIER:exon8/13:c.902+48T>A:,PDE1A:ENST00000410103:intron:MODIFIER:exon9/14:c.950+48T>A:,PDE1A:ENST00000358139:intron:MODIFIER:exon8/13:c.950+48T>A:		rs1344773	0.2556	0.3181	5975,3599,215	0.2122,0.3580,0.2916,0.3374,0.2396	0.3180											n/a (AF>5%)	n/a (AF>5%)					PDE1A (inh=n/a pLI=0.59)
chr2	186665432	186665432	G	A	hom	gene_blacklist	QUAL=9348;DP=280;AF=1.00;MQM=60	FSIP2	missense	FSIP2:ENST00000343098:missense:MODERATE:exon17/23:c.11666G>A:p.Gly3889Glu,FSIP2:ENST00000424728:missense:MODERATE:exon17/23:c.11399G>A:p.Gly3800Glu		rs36004074	0.5405	0.5844	2681,599,144	0.5917,0.5529,0.0000,0.5063,0.6271	0.5554	1.2040	T,T	T		T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					FSIP2 (inh=n/a pLI=0.00)
chr2	189867844	189867844	T	A	het	off-target	QUAL=798;DP=51;AF=0.59;MQM=60	COL3A1	intron	COL3A1:ENST00000304636:intron:MODIFIER:exon36/50:c.2553+56T>A:,COL3A1:ENST00000317840:intron:MODIFIER:exon36/41:c.2520+89T>A:	(TCTA)n	rs3736489	0.2542	0.0000	0,0,0	0,0,0,0,0	0.2365							120180 [COL3A1 (confirmed) Ehlers-Danlos syndrome,vascular type,130050];				n/a (AF>5%)	n/a (AF>5%)					COL3A1 (inh=AD pLI=1.00)
chr2	196673533	196673533	A	G	hom	gene_blacklist	QUAL=6968;DP=213;AF=1.00;MQM=60	DNAH7	missense	DNAH7:ENST00000312428:missense:MODERATE:exon53/65:c.9956T>C:p.Leu3319Pro		rs13411834	0.9613	0.9894	59112,33352,3767	0.8777,0.9944,1.0000,0.9998,0.9996	0.9913	7.0260	T	T	B	D	17.26		402748 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					DNAH7 (inh=n/a pLI=0.00)
chr2	196849453	196849453	C	T	het	gene_blacklist	QUAL=529;DP=49;AF=0.49;MQM=60	DNAH7	splice_region&intron	DNAH7:ENST00000312428:splice_region&intron:LOW:exon14/64:c.1755-19G>A:		rs17363011	0.0767	0.1339	1325,926,11	0.0392,0.0870,0.0047,0.1660,0.1413	0.1344											n/a (AF>5%)	n/a (AF>5%)					DNAH7 (inh=n/a pLI=0.00)
chr2	201254049	201254049	G	C	hom	off-target	QUAL=5023;DP=151;AF=0.99;MQM=60	SPATS2L	intron	SPATS2L:ENST00000409755:intron:MODIFIER:exon3/12:c.129+43G>C:,SPATS2L:ENST00000409718:intron:MODIFIER:exon3/12:c.39+43G>C:,SPATS2L:ENST00000358677:intron:MODIFIER:exon3/12:c.39+43G>C:,SPATS2L:ENST00000409988:intron:MODIFIER:exon3/12:c.39+43G>C:,SPATS2L:ENST00000409385:intron:MODIFIER:exon2/11:c.-141-22985G>C:,SPATS2L:ENST00000451764:intron:MODIFIER:exon4/13:c.39+43G>C:,SPATS2L:ENST00000360760:intron:MODIFIER:exon3/11:c.39+43G>C:,SPATS2L:ENST00000409140:intron:MODIFIER:exon3/12:c.39+43G>C:,SPATS2L:ENST00000409151:intron:MODIFIER:exon2/11:c.63+43G>C:		rs3820881	0.7181	0.8089	12966,6667,419	0.4783,0.8793,0.8094,0.8240,0.9031	0.8156											n/a (AF>5%)	n/a (AF>5%)					SPATS2L (inh=n/a pLI=0.96)
chr2	203690387	203690387	G	A	het		QUAL=106;DP=9;AF=0.56;MQM=60	ICA1L	intron	ICA1L:ENST00000358299:intron:MODIFIER:exon3/12:c.235+31C>T:,ICA1L:ENST00000392237:intron:MODIFIER:exon4/13:c.235+31C>T:,ICA1L:ENST00000425178:intron:MODIFIER:exon2/3:c.235+31C>T:,ICA1L:ENST00000418208:intron:MODIFIER:exon2/2:c.162+3184C>T:		rs1344959	0.8688	0.9199	48569,28294,2548	0.7378,0.8310,0.9280,0.9510,0.9440	0.9231											n/a (AF>5%)	n/a (AF>5%)					ICA1L (inh=n/a pLI=0.32)
chr2	207025444	207025444	T	C	het		QUAL=948;DP=100;AF=0.40;MQM=60	EEF1B2	splice_region&intron	EEF1B2:ENST00000236957:splice_region&intron:LOW:exon3/6:c.203+10T>C:,EEF1B2:ENST00000392221:splice_region&intron:LOW:exon3/6:c.203+10T>C:,EEF1B2:ENST00000392222:splice_region&intron:LOW:exon2/5:c.203+10T>C:		rs11689362	0.4603	0.4556	13110,7024,2162	0.6451,0.5180,0.2843,0.4571,0.3463	0.4989										COSM4001477	n/a (AF>5%)	n/a (AF>5%)					EEF1B2 (inh=n/a pLI=0.29)
chr2	207041441	207041441	G	A	het		QUAL=1029;DP=93;AF=0.44;MQM=60	GPR1	synonymous	GPR1:ENST00000407325:synonymous:LOW:exon3/3:c.531C>T:p.Asp177Asp,GPR1:ENST00000437420:synonymous:LOW:exon4/4:c.531C>T:p.Asp177Asp		rs3732082	0.3452	0.3501	7551,4204,1044	0.4443,0.3184,0.2834,0.3551,0.3056	0.3734										COSM4001479	n/a (AF>5%)	n/a (AF>5%)					GPR1 (inh=n/a pLI=0.00)
chr2	209215448	209215448	A	G	hom	off-target	QUAL=929;DP=32;AF=1.00;MQM=60	PIKFYVE	intron	PIKFYVE:ENST00000264380:intron:MODIFIER:exon36/41:c.5435-47A>G:		rs994696	0.9111	0.9599	55836,32243,3228	0.7982,0.9843,0.9434,0.9841,0.9375	0.9648							609414 [PIKFYVE (confirmed) Corneal fleck dystrophy,121850];				n/a (AF>5%)	n/a (AF>5%)					PIKFYVE (inh=AD pLI=1.00)
chr2	212587321	212587321	G	A	hom	off-target	QUAL=778;DP=26;AF=1.00;MQM=60	ERBB4	intron	ERBB4:ENST00000342788:intron:MODIFIER:exon6/27:c.742-62C>T:,ERBB4:ENST00000436443:intron:MODIFIER:exon6/26:c.742-62C>T:,ERBB4:ENST00000402597:intron:MODIFIER:exon6/27:c.742-62C>T:		rs13002712	0.6957	0.0000	0,0,0	0,0,0,0,0	0.6836							600543 [ERBB4 (provisional) Amyotrophic lateral sclerosis 19,615515];				n/a (AF>5%)	n/a (AF>5%)					ERBB4 (inh=AD pLI=1.00)
chr2	215595645	215595645	C	T	het		QUAL=1348;DP=102;AF=0.50;MQM=60	BARD1	start_lost,intron	BARD1:ENST00000432456:start_lost:HIGH:exon1/3:c.3G>A:p.Met1?,BARD1:ENST00000260947:intron:MODIFIER:exon9/10:c.1904-413G>A:,BARD1:ENST00000449967:intron:MODIFIER:exon8/9:c.1472-413G>A:	L2c	rs16852600	0.2754	0.3674	991,204,9	0.1683,0.0000,0.3200,0.3179,0.4056	0.3064	2.8700	T	T		T	7.23	601593 [BARD1 (confirmed) Breast cancer,susceptibility to,114480];				n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=n/a pLI=0.00)
chr2	215820013	215820013	G	A	het		QUAL=1042;DP=106;AF=0.40;MQM=60	ABCA12,AC072062.1	synonymous	ABCA12:ENST00000272895:synonymous:LOW:exon43/53:c.6306C>T:p.Tyr2102Tyr,ABCA12:ENST00000389661:synonymous:LOW:exon35/45:c.5352C>T:p.Tyr1784Tyr		rs10498027	0.3500	0.4051	10283,6091,513	0.3127,0.3855,0.2320,0.4250,0.4772	0.4065							607800 [ABCA12 (confirmed) Ichthyosis,congenital,autosomal recessive 4A,601277|Ichthyosis,congenital,autosomal recessive 4B (harlequin),242500];	262831 [benign DISEASE=congenital_ichthyosiform_erythroderma,not_specified]; 		COSM3757935	n/a (AF>5%)	n/a (AF>5%)					ABCA12 (inh=AR pLI=0.00), AC072062.1 (inh=n/a pLI=n/a)
chr2	216232556	216232556	C	T	het	off-target	QUAL=1069;DP=91;AF=0.46;MQM=60	FN1	intron	FN1:ENST00000354785:intron:MODIFIER:exon42/45:c.7018+30G>A:,FN1:ENST00000421182:intron:MODIFIER:exon41/44:c.6307+30G>A:,FN1:ENST00000323926:intron:MODIFIER:exon43/46:c.6925+30G>A:,FN1:ENST00000336916:intron:MODIFIER:exon42/45:c.6652+30G>A:,FN1:ENST00000357867:intron:MODIFIER:exon40/43:c.6115+30G>A:,FN1:ENST00000345488:intron:MODIFIER:exon39/42:c.6139+30G>A:,FN1:ENST00000346544:intron:MODIFIER:exon40/43:c.6221-2203G>A:,FN1:ENST00000357009:intron:MODIFIER:exon40/43:c.*150+30G>A:,FN1:ENST00000359671:intron:MODIFIER:exon41/44:c.6745+30G>A:,FN1:ENST00000446046:intron:MODIFIER:exon42/45:c.6577+30G>A:,FN1:ENST00000443816:intron:MODIFIER:exon41/44:c.6382+30G>A:,FN1:ENST00000432072:intron:MODIFIER:exon41/44:c.6388+30G>A:,FN1:ENST00000356005:intron:MODIFIER:exon40/43:c.6475+30G>A:		rs7568287	0.1296	0.2219	3749,3142,77	0.1178,0.1266,0.0004,0.3082,0.0709	0.2420							135600 [FN1 (confirmed) Glomerulopathy with fibronectin deposits 2,601894|Spondylometaphyseal dysplasia,corner fracture type,184255|Plasma fibronectin deficiency,614101];				n/a (AF>5%)	n/a (AF>5%)					FN1 (inh=AD pLI=0.09)
chr2	216811707	216811707	G	T	het	off-target	QUAL=60;DP=18;AF=0.28;MQM=60	MREG	intron	MREG:ENST00000263268:intron:MODIFIER:exon3/4:c.346+39C>A:		rs1344695	0.4421	0.5388	12433,8094,794	0.4574,0.5486,0.3418,0.5933,0.4665	0.5224											n/a (AF>5%)	n/a (AF>5%)					MREG (inh=n/a pLI=0.00)
chr2	219103580	219103580	A	G	het		QUAL=559;DP=74;AF=0.38;MQM=60	ARPC2	splice_region&intron	ARPC2:ENST00000295685:splice_region&intron:LOW:exon5/9:c.455+7A>G:,ARPC2:ENST00000315717:splice_region&intron:LOW:exon6/10:c.455+7A>G:		rs10169718	0.4267	0.4969	15593,8374,113	0.1527,0.4655,0.5799,0.5022,0.6237	0.5023											n/a (AF>5%)	n/a (AF>5%)					ARPC2 (inh=n/a pLI=0.99)
chr2	219140288	219140288	G	C	het		QUAL=1978;DP=179;AF=0.44;MQM=60	TMBIM1,PNKD	synonymous,intron	TMBIM1:ENST00000258412:synonymous:LOW:exon12/12:c.846C>G:p.Pro282Pro,TMBIM1:ENST00000396809:synonymous:LOW:exon12/12:c.846C>G:p.Pro282Pro,TMBIM1:ENST00000444881:synonymous:LOW:exon13/13:c.846C>G:p.Pro282Pro,TMBIM1:ENST00000445635:synonymous:LOW:exon11/11:c.324C>G:p.Pro108Pro,PNKD:ENST00000273077:intron:MODIFIER:exon2/9:c.236+4016G>C:		rs2292550	0.3321	0.3809	8883,5336,318	0.2524,0.4569,0.3879,0.4013,0.3514	0.3838							609023 [PNKD (confirmed) Paroxysmal nonkinesigenic dyskinesia 1,118800];			COSM3757952	n/a (AF>5%)	n/a (AF>5%)					TMBIM1 (inh=n/a pLI=0.00), PNKD (inh=AD pLI=0.00)
chr2	219319657	219319657	A	G	hom		QUAL=2375;DP=72;AF=1.00;MQM=60	USP37	missense	USP37:ENST00000258399:missense:MODERATE:exon26/26:c.2936T>C:p.Leu979Ser,USP37:ENST00000454775:missense:MODERATE:exon26/26:c.2936T>C:p.Leu979Ser,USP37:ENST00000415516:missense:MODERATE:exon24/24:c.2654T>C:p.Leu885Ser,USP37:ENST00000418019:missense:MODERATE:exon26/26:c.2936T>C:p.Leu979Ser		rs6436058	0.9838	0.9967	60266,33344,4817	0.9637,0.9986,1.0000,0.9998,0.9999	0.9975	0.5020	D,D,D,D	T	B,B	T,T,T,T	21.40					n/a (AF>5%)	n/a (AF>5%)					USP37 (inh=n/a pLI=0.99)
chr2	219555262	219555262	G	A	hom		QUAL=5892;DP=177;AF=1.00;MQM=60	STK36	missense	STK36:ENST00000295709:missense:MODERATE:exon14/27:c.1748G>A:p.Arg583Gln,STK36:ENST00000392106:missense:MODERATE:exon14/27:c.1748G>A:p.Arg583Gln,STK36:ENST00000392105:missense:MODERATE:exon14/27:c.1748G>A:p.Arg583Gln,STK36:ENST00000440309:missense:MODERATE:exon14/27:c.1748G>A:p.Arg583Gln		rs1344642	0.4217	0.4195	11514,6564,2207	0.6489,0.3899,0.1418,0.4412,0.3433	0.4774	1.6460	T,T,T,T	T	B,B	T,T,T,T	15.45		403497 [benign DISEASE=not_specified]; 		COSM3736240	n/a (AF>5%)	n/a (AF>5%)					STK36 (inh=n/a pLI=0.00)
chr2	227973623	227973623	A	G	het	off-target	QUAL=732;DP=58;AF=0.52;MQM=60	COL4A4	intron	COL4A4:ENST00000396625:intron:MODIFIER:exon10/47:c.658-39T>C:,COL4A4:ENST00000329662:intron:MODIFIER:exon10/46:c.658-39T>C:	A-rich	rs12475686	0.6004	0.6137	20005,12199,1575	0.6034,0.4944,0.5904,0.6509,0.5656	0.6249							120131 [COL4A4 (confirmed) Alport syndrome,autosomal recessive,203780|Hematuria,familial benign];				n/a (AF>5%)	n/a (AF>5%)					COL4A4 (inh=AR pLI=0.00)
chr2	233412820	233412820	A	G	het		QUAL=251;DP=24;AF=0.46;MQM=60	TIGD1	synonymous	TIGD1:ENST00000408957:synonymous:LOW:exon1/1:c.1773T>C:p.Asp591Asp	Tigger1	rs4973539	0.1520	0.2013	145,103,13	0.1175,0.0000,0.1381,0.2252,0.3604	0.1831											n/a (AF>5%)	n/a (AF>5%)					TIGD1 (inh=n/a pLI=n/a)
chr2	233721455	233721455	G	A	hom	off-target	QUAL=5798;DP=177;AF=1.00;MQM=60	GIGYF2	intron	GIGYF2:ENST00000373566:intron:MODIFIER:exon29/29:c.3899-48G>A:,GIGYF2:ENST00000373563:intron:MODIFIER:exon28/28:c.3833-48G>A:,GIGYF2:ENST00000409480:intron:MODIFIER:exon30/30:c.3899-48G>A:,GIGYF2:ENST00000409547:intron:MODIFIER:exon30/30:c.3833-48G>A:,GIGYF2:ENST00000409196:intron:MODIFIER:exon27/27:c.3815-48G>A:,GIGYF2:ENST00000409451:intron:MODIFIER:exon30/30:c.3896-48G>A:		rs1947105	0.6402	0.6460	26139,14873,2782	0.7351,0.7480,0.6843,0.6690,0.3601	0.7019							612003 [GIGYF2 (confirmed) Parkinson disease 11,607688];				n/a (AF>5%)	n/a (AF>5%)					GIGYF2 (inh=AD pLI=1.00)
chr2	233750074	233750074	C	T	hom		QUAL=6238;DP=194;AF=1.00;MQM=60	NGEF	synonymous	NGEF:ENST00000264051:synonymous:LOW:exon10/15:c.1353G>A:p.Val451Val,NGEF:ENST00000373552:synonymous:LOW:exon8/13:c.1077G>A:p.Val359Val,NGEF:ENST00000539537:synonymous:LOW:exon6/11:c.522G>A:p.Val174Val		rs2292725	0.1544	0.1933	2484,1737,154	0.1813,0.1586,0.0944,0.2306,0.0895	0.2158											n/a (AF>5%)	n/a (AF>5%)					NGEF (inh=n/a pLI=0.98)
chr2	234713706	234713706	T	C	het		QUAL=1723;DP=137;AF=0.48;MQM=60	MROH2A	synonymous	MROH2A:ENST00000389758:synonymous:LOW:exon19/42:c.2001T>C:p.Ser667Ser		rs4430949	0.3353	0.2128	393,100,118	0.5011,0.3182,0.3203,0.2111,0.1544	0.3221										COSM4133559	n/a (AF>5%)	n/a (AF>5%)					MROH2A (inh=n/a pLI=0.33)
chr2	234905078	234905078	C	T	het		QUAL=2708;DP=190;AF=0.53;MQM=60	TRPM8	synonymous	TRPM8:ENST00000324695:synonymous:LOW:exon22/26:c.3048C>T:p.Ile1016Ile,TRPM8:ENST00000433712:synonymous:LOW:exon21/25:c.1782C>T:p.Ile594Ile		rs11563208	0.1587	0.2453	4180,2689,58	0.1048,0.3920,0.0853,0.2831,0.1796	0.2490										COSM3758055	n/a (AF>5%)	n/a (AF>5%)					TRPM8 (inh=n/a pLI=0.00)
chr2	236708166	236708166	C	T	het		QUAL=794;DP=104;AF=0.35;MQM=60	AGAP1	splice_region&synonymous	AGAP1:ENST00000409538:splice_region&synonymous:LOW:exon8/17:c.1752C>T:p.Thr584Thr,AGAP1:ENST00000409457:splice_region&synonymous:LOW:exon8/10:c.957C>T:p.Thr319Thr,AGAP1:ENST00000336665:splice_region&synonymous:LOW:exon8/17:c.957C>T:p.Thr319Thr,AGAP1:ENST00000304032:splice_region&synonymous:LOW:exon8/18:c.957C>T:p.Thr319Thr,AGAP1:ENST00000428334:splice_region&synonymous:LOW:exon4/14:c.474C>T:p.Thr158Thr		rs2292708	0.1917	0.2723	5333,2860,23	0.0590,0.5174,0.2807,0.2937,0.1361	0.2871										COSM1129278	n/a (AF>5%)	n/a (AF>5%)					AGAP1 (inh=n/a pLI=1.00)
chr2	238303906	238303906	A	G	het	off-target	QUAL=35;DP=8;AF=0.38;MQM=60	COL6A3	intron	COL6A3:ENST00000295550:intron:MODIFIER:exon2/43:c.92-59T>C:,COL6A3:ENST00000347401:intron:MODIFIER:exon2/42:c.92-59T>C:,COL6A3:ENST00000353578:intron:MODIFIER:exon2/42:c.91+1464T>C:,COL6A3:ENST00000472056:intron:MODIFIER:exon2/40:c.91+1464T>C:,COL6A3:ENST00000409809:intron:MODIFIER:exon1/41:c.91+1464T>C:,COL6A3:ENST00000346358:intron:MODIFIER:exon2/42:c.92-59T>C:,COL6A3:ENST00000392004:intron:MODIFIER:exon2/7:c.91+1464T>C:,COL6A3:ENST00000392003:intron:MODIFIER:exon2/6:c.91+1464T>C:		rs2645778	0.3928	0.0000	0,0,0	0,0,0,0,0	0.3556							120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];				n/a (AF>5%)	n/a (AF>5%)					COL6A3 (inh=AR+AD pLI=0.00)
chr2	241452212	241452212	T	C	hom		QUAL=4235;DP=130;AF=1.00;MQM=60	ANKMY1	splice_region&intron	ANKMY1:ENST00000401804:splice_region&intron:LOW:exon10/17:c.2145+7A>G:,ANKMY1:ENST00000373318:splice_region&intron:LOW:exon8/13:c.1455+7A>G:,ANKMY1:ENST00000373320:splice_region&intron:LOW:exon8/15:c.1188+7A>G:,ANKMY1:ENST00000391987:splice_region&intron:LOW:exon10/17:c.1878+7A>G:,ANKMY1:ENST00000406958:splice_region&intron:LOW:exon9/16:c.1161+7A>G:,ANKMY1:ENST00000272972:splice_region&intron:LOW:exon9/16:c.1878+7A>G:,ANKMY1:ENST00000361678:splice_region&intron:LOW:exon8/13:c.1455+7A>G:,ANKMY1:ENST00000403283:splice_region&intron:LOW:exon8/14:c.1692+7A>G:		rs12695026	0.6771	0.6952	28992,14982,1671	0.5734,0.6687,0.7710,0.6773,0.7701	0.6965											n/a (AF>5%)	n/a (AF>5%)					ANKMY1 (inh=n/a pLI=0.00)
chr2	242062162	242062162	C	T	het		QUAL=1064;DP=81;AF=0.52;MQM=60	PASK	synonymous	PASK:ENST00000358649:synonymous:LOW:exon12/18:c.3057G>A:p.Lys1019Lys,PASK:ENST00000234040:synonymous:LOW:exon12/18:c.3057G>A:p.Lys1019Lys,PASK:ENST00000544142:synonymous:LOW:exon9/15:c.2499G>A:p.Lys833Lys,PASK:ENST00000405260:synonymous:LOW:exon12/18:c.3057G>A:p.Lys1019Lys,PASK:ENST00000539818:synonymous:LOW:exon9/15:c.2409G>A:p.Lys803Lys,PASK:ENST00000403638:synonymous:LOW:exon12/14:c.3057G>A:p.Lys1019Lys		rs2302050	0.2947	0.1756	2975,283,948	0.4209,0.3276,0.4462,0.0922,0.1283	0.2095										COSM4001609, COSM4001608	n/a (AF>5%)	n/a (AF>5%)					PASK (inh=n/a pLI=0.00)
chr2	242077496	242077496	C	T	het		QUAL=936;DP=94;AF=0.41;MQM=60	PASK	missense	PASK:ENST00000358649:missense:MODERATE:exon6/18:c.748G>A:p.Val250Ile,PASK:ENST00000234040:missense:MODERATE:exon6/18:c.748G>A:p.Val250Ile,PASK:ENST00000544142:missense:MODERATE:exon3/15:c.190G>A:p.Val64Ile,PASK:ENST00000405260:missense:MODERATE:exon6/18:c.748G>A:p.Val250Ile,PASK:ENST00000539818:missense:MODERATE:exon3/15:c.100G>A:p.Val34Ile,PASK:ENST00000403638:missense:MODERATE:exon6/14:c.748G>A:p.Val250Ile		rs1470414	0.2224	0.3168	6341,4691,101	0.1369,0.2609,0.1729,0.3803,0.2530	0.3182	-0.2650	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T,T	0.01				COSM149120, COSM149119	n/a (AF>5%)	n/a (AF>5%)					PASK (inh=n/a pLI=0.00)
chr3	1424718	1424718	G	A	het		QUAL=1376;DP=121;AF=0.45;MQM=60	CNTN6	synonymous	CNTN6:ENST00000350110:synonymous:LOW:exon18/23:c.2259G>A:p.Val753Val,CNTN6:ENST00000446702:synonymous:LOW:exon18/23:c.2259G>A:p.Val753Val,CNTN6:ENST00000539053:synonymous:LOW:exon17/22:c.2043G>A:p.Val681Val		rs2291101	0.4834	0.4449	12531,5728,723	0.3753,0.5401,0.6396,0.4123,0.5174	0.4490								402550 [benign DISEASE=not_specified]; 		COSM3759804	n/a (AF>5%)	n/a (AF>5%)					CNTN6 (inh=n/a pLI=0.00)
chr3	2924986	2924986	A	G	het	off-target	QUAL=2599;DP=204;AF=0.48;MQM=60	CNTN4	intron	CNTN4:ENST00000397461:intron:MODIFIER:exon8/23:c.755+55A>G:,CNTN4:ENST00000418658:intron:MODIFIER:exon9/24:c.755+55A>G:,CNTN4:ENST00000427331:intron:MODIFIER:exon6/21:c.755+55A>G:,CNTN4:ENST00000358480:intron:MODIFIER:exon3/18:c.98+55A>G:		rs13089241	0.0321	0.0000	0,0,0	0,0,0,0,0	0.0418											9	320					CNTN4 (inh=n/a pLI=1.00)
chr3	4403837	4403837	A	G	het		QUAL=492;DP=58;AF=0.38;MQM=60	SUMF1	synonymous,intron	SUMF1:ENST00000272902:synonymous:LOW:exon9/9:c.1116T>C:p.Thr372Thr,SUMF1:ENST00000383843:synonymous:LOW:exon8/8:c.1041T>C:p.Thr347Thr,SUMF1:ENST00000458465:synonymous:LOW:exon5/5:c.720T>C:p.Thr240Thr,SUMF1:ENST00000405420:synonymous:LOW:exon8/8:c.1056T>C:p.Thr352Thr,SUMF1:ENST00000534863:intron:MODIFIER:exon8/9:c.1014+14177T>C:		rs2633852	0.7604	0.6441	26090,10370,3935	0.8686,0.7590,0.7685,0.5554,0.7404	0.6427							607939 [SUMF1 (provisional) Multiple sulfatase deficiency,272200];	96559 [benign DISEASE=multiple_sulfatase_deficiency,not_specified]; 		COSM3760098	n/a (AF>5%)	n/a (AF>5%)					SUMF1 (inh=AR pLI=0.03)
chr3	4842231	4842231	C	T	het		QUAL=2406;DP=160;AF=0.56;MQM=60	ITPR1	synonymous,intron	ITPR1:ENST00000302640:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000354582:synonymous:LOW:exon53/61:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000423119:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:ENST00000357086:synonymous:LOW:exon51/59:c.6910C>T:p.Leu2304Leu,ITPR1:ENST00000456211:synonymous:LOW:exon50/58:c.6865C>T:p.Leu2289Leu,ITPR1:ENST00000443694:synonymous:LOW:exon51/59:c.7009C>T:p.Leu2337Leu,ITPR1:ENST00000544951:intron:MODIFIER:exon12/19:c.997-5556C>T:		rs2291862	0.2646	0.2868	5218,2657,88	0.1355,0.3827,0.4144,0.2812,0.2876	0.2923							147265 [ITPR1 (confirmed) Spinocerebellar ataxia 15,606658|Spinocerebellar ataxia 29,congenital nonprogressive,117360|Gillespie syndrome,206700];	129302 [benign/likely benign DISEASE=not_specified,spinocerebellar_ataxia,_dominant]; 		COSM3760145, COSM3760144, COSM3760146	n/a (AF>5%)	n/a (AF>5%)					ITPR1 (inh=AR+AD pLI=1.00)
chr3	6828364	6828364	A	G	hom		QUAL=3441;DP=107;AF=1.00;MQM=60	GRM7,GRM7-AS3				rs1533434	0.5511	0.6519	2594,641,76	0.5269,0.0000,0.0000,0.6053,0.6851	0.5924											n/a (AF>5%)	n/a (AF>5%)					GRM7 (inh=n/a pLI=1.00), GRM7-AS3 (inh=n/a pLI=n/a)
chr3	9515054	9515054	T	C	het		QUAL=1481;DP=97;AF=0.56;MQM=60	SETD5	synonymous	SETD5:ENST00000407969:synonymous:LOW:exon18/21:c.3387T>C:p.Thr1129Thr,SETD5:ENST00000402198:synonymous:LOW:exon20/23:c.3330T>C:p.Thr1110Thr,SETD5:ENST00000402466:synonymous:LOW:exon21/24:c.3036T>C:p.Thr1012Thr,SETD5:ENST00000406341:synonymous:LOW:exon19/22:c.3330T>C:p.Thr1110Thr,SETD5:ENST00000302463:synonymous:LOW:exon19/22:c.3036T>C:p.Thr1012Thr		rs73026975	0.0134	0.0233	45,36,0	0.0059,0.0291,0.0001,0.0295,0.0100	0.0291	-0.4380		T			6.69	615743 [SETD5 (provisional) Mental retardation,autosomal dominant 23,615761];			COSM3760262, COSM3760263	3	158					SETD5 (inh=AD pLI=1.00)
chr3	9870414	9870414	C	T	het	off-target	QUAL=741;DP=74;AF=0.41;MQM=60	ARPC4-TTLL3,TTLL3	intron	ARPC4-TTLL3:ENST00000397256:intron:MODIFIER:exon10/11:c.1302-230C>T:,TTLL3:ENST00000426895:intron:MODIFIER:exon9/12:c.1548-230C>T:,TTLL3:ENST00000397241:intron:MODIFIER:exon9/11:c.483-230C>T:,TTLL3:ENST00000547186:intron:MODIFIER:exon9/12:c.1119-230C>T:,TTLL3:ENST00000427853:intron:MODIFIER:exon7/8:c.483-230C>T:,TTLL3:ENST00000383827:intron:MODIFIER:exon3/4:c.483-230C>T:,TTLL3:ENST00000455274:intron:MODIFIER:exon3/4:c.483-230C>T:,TTLL3:ENST00000430793:intron:MODIFIER:exon3/5:c.483-230C>T:		rs17050593	0.2238	0.0000	0,0,0	0,0,0,0,0	0.1476											n/a (AF>5%)	n/a (AF>5%)					ARPC4-TTLL3 (inh=n/a pLI=0.00), TTLL3 (inh=n/a pLI=0.00)
chr3	10045030	10045030	C	A	het	off-target	QUAL=596;DP=55;AF=0.45;MQM=60	EMC3,EMC3-AS1	non_coding_transcript_exon	EMC3-AS1:ENST00000326237:non_coding_transcript_exon:MODIFIER:exon2/2:n.984C>A:		rs13066757	0.2129	0.0000	0,0,0	0,0,0,0,0	0.2070							612120 [CIDEC (provisional) Lipodystrophy,familial partial,type 5,615238];				n/a (AF>5%)	n/a (AF>5%)					EMC3 (inh=n/a pLI=0.73), EMC3-AS1 (inh=n/a pLI=n/a)
chr3	10140696	10140696	A	G	het	off-target	QUAL=1252;DP=161;AF=0.37;MQM=60	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647:3'UTR:MODIFIER:exon43/43:c.*62A>G:,FANCD2:ENST00000383806:intron:MODIFIER:exon42/42:c.*437+197A>G:,FANCD2:ENST00000383807:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2:ENST00000419585:intron:MODIFIER:exon43/43:c.4281+197A>G:,FANCD2OS:ENST00000524279:intron:MODIFIER:exon2/2:c.*43+5186T>C:		rs7647987	0.2412	0.0000	0,0,0	0,0,0,0,0	0.2408							613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2,227646];	342383 [benign DISEASE=fanconi_anemia]; 			n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR pLI=0.00), FANCD2OS (inh=n/a pLI=0.05)
chr3	11886365	11886365	T	C	het		QUAL=739;DP=64;AF=0.47;MQM=60	TAMM41	intron	TAMM41:ENST00000444133:intron:MODIFIER:exon1/6:c.136-680A>G:,TAMM41:ENST00000455809:intron:MODIFIER:exon1/7:c.136-680A>G:,TAMM41:ENST00000273037:intron:MODIFIER:exon1/6:c.136-680A>G:		rs392621	0.3576	0.4707	1362,412,22	0.3020,0.0000,0.0000,0.4869,0.4806	0.4112											n/a (AF>5%)	n/a (AF>5%)					TAMM41 (inh=n/a pLI=0.00)
chr3	12626516	12626516	G	A	het	off-target	QUAL=2470;DP=149;AF=0.61;MQM=60	RAF1	intron	RAF1:ENST00000442415:intron:MODIFIER:exon16/17:c.1729-36C>T:,RAF1:ENST00000251849:intron:MODIFIER:exon15/16:c.1669-36C>T:,RAF1:ENST00000534997:intron:MODIFIER:exon11/12:c.1024-36C>T:,RAF1:ENST00000542177:intron:MODIFIER:exon14/15:c.1426-36C>T:		rs3729931	0.3646	0.3504	8447,4286,1919	0.6093,0.4930,0.0556,0.3593,0.1990	0.4177							164760 [RAF1 (confirmed) Noonan syndrome 5,611553|LEOPARD syndrome 2,611554|Cardiomyopathy,dilated,1NN,615916];	40624 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					RAF1 (inh=AD pLI=1.00)
chr3	14520560	14520560	G	C	hom	off-target	QUAL=4362;DP=132;AF=1.00;MQM=60	SLC6A6	intron	SLC6A6:ENST00000360861:intron:MODIFIER:exon12/14:c.1451-33G>C:,SLC6A6:ENST00000454876:intron:MODIFIER:exon12/14:c.1451-33G>C:		rs2304510	0.2398	0.1867	2357,747,242	0.2164,0.2280,0.3752,0.1485,0.2129	0.1881											n/a (AF>5%)	n/a (AF>5%)					SLC6A6 (inh=n/a pLI=0.99)
chr3	15518731	15518731	G	C	het	off-target	QUAL=627;DP=71;AF=0.38;MQM=60	COLQ	intron	COLQ:ENST00000603808:intron:MODIFIER:exon5/16:c.394-27C>G:,COLQ:ENST00000435459:intron:MODIFIER:exon5/16:c.364-27C>G:,COLQ:ENST00000383785:intron:MODIFIER:exon5/17:c.394-27C>G:,COLQ:ENST00000383787:intron:MODIFIER:exon4/15:c.367-27C>G:,COLQ:ENST00000383788:intron:MODIFIER:exon5/16:c.394-27C>G:,COLQ:ENST00000383781:intron:MODIFIER:exon5/16:c.364-27C>G:,COLQ:ENST00000383786:intron:MODIFIER:exon4/15:c.292-27C>G:		rs2305612	0.4024	0.4560	5985,3291,418	0.3953,0.4273,0.5544,0.4655,0.4253	0.3961							603033 [COLQ (confirmed) Myasthenic syndrome,congenital,5,603034];	259857 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					COLQ (inh=AR pLI=0.00)
chr3	16450872	16450872	T	C	het		QUAL=2262;DP=195;AF=0.44;MQM=60	RFTN1	splice_region&intron	RFTN1:ENST00000334133:splice_region&intron:LOW:exon4/9:c.441+10A>G:,RFTN1:ENST00000432519:splice_region&intron:LOW:exon3/8:c.333+10A>G:		rs1546650	0.6310	0.5627	19464,10017,2886	0.7434,0.5131,0.6021,0.5497,0.5591	0.5954											n/a (AF>5%)	n/a (AF>5%)					RFTN1 (inh=n/a pLI=0.00)
chr3	27343376	27343376	G	A	het	off-target	QUAL=300;DP=29;AF=0.52;MQM=60	NEK10	intron	NEK10:ENST00000429845:intron:MODIFIER:exon13/38:c.1029-50C>T:,NEK10:ENST00000341435:intron:MODIFIER:exon13/24:c.1029-50C>T:	L1ME3	rs6551192	0.3898	0.2809	1066,286,543	0.7472,0.2698,0.1922,0.2604,0.2009	0.4029											n/a (AF>5%)	n/a (AF>5%)					NEK10 (inh=n/a pLI=0.00)
chr3	27353716	27353716	C	A	het	off-target	QUAL=485;DP=56;AF=0.39;MQM=60	NEK10	intron	NEK10:ENST00000429845:intron:MODIFIER:exon8/38:c.490-48G>T:,NEK10:ENST00000341435:intron:MODIFIER:exon8/24:c.490-48G>T:		rs552647	0.5978	0.5611	14796,7259,3464	0.9125,0.6523,0.2552,0.5436,0.5121	0.6216											n/a (AF>5%)	n/a (AF>5%)					NEK10 (inh=n/a pLI=0.00)
chr3	33458266	33458266	T	C	het		QUAL=2359;DP=170;AF=0.52;MQM=60	UBP1	missense	UBP1:ENST00000283628:missense:MODERATE:exon4/17:c.326A>G:p.Asn109Ser,UBP1:ENST00000283629:missense:MODERATE:exon3/16:c.326A>G:p.Asn109Ser,UBP1:ENST00000447368:missense:MODERATE:exon3/15:c.326A>G:p.Asn109Ser		rs3736563	0.4790	0.3842	10347,2647,1484	0.5363,0.6939,0.6260,0.2829,0.3678	0.3946	1.0410	T,T,T,T	T	B,B	T,T,T,T	7.48				COSM3760053	n/a (AF>5%)	n/a (AF>5%)					UBP1 (inh=n/a pLI=1.00)
chr3	38404472	38404472	C	A	het		QUAL=2554;DP=210;AF=0.47;MQM=60	XYLB	missense,intron	XYLB:ENST00000207870:missense:MODERATE:exon4/19:c.255C>A:p.Asp85Glu,XYLB:ENST00000542835:intron:MODIFIER:exon2/16:c.-120-2218C>A:		rs17118	0.2350	0.3012	5776,4042,107	0.1398,0.2655,0.2738,0.3467,0.2410	0.2898	0.1550	T	T	P	T	23.50				COSM4157998	n/a (AF>5%)	n/a (AF>5%)					XYLB (inh=n/a pLI=0.00)
chr3	38951753	38951753	T	C	hom	off-target	QUAL=208;DP=7;AF=1.00;MQM=60	SCN11A	intron	SCN11A:ENST00000302328:intron:MODIFIER:exon7/25:c.960-55A>G:,SCN11A:ENST00000450244:intron:MODIFIER:exon7/25:c.960-55A>G:,SCN11A:ENST00000456224:intron:MODIFIER:exon7/24:c.960-55A>G:,SCN11A:ENST00000444237:intron:MODIFIER:exon7/24:c.960-55A>G:		rs7429404	0.8928	0.0000	0,0,0	0,0,0,0,0	0.8982							604385 [SCN11A (confirmed) Neuropathy,hereditary sensory and autonomic,type VII,615548|Episodic pain syndrome,familial,3,615552];				n/a (AF>5%)	n/a (AF>5%)					SCN11A (inh=AD pLI=0.00)
chr3	40498845	40498845	C	T	hom		QUAL=3095;DP=93;AF=1.00;MQM=60	RPL14	5'UTR_premature_start_codon_gain,5'UTR	RPL14:ENST00000338970:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-7C>T:,RPL14:ENST00000396203:5'UTR_premature_start_codon_gain:LOW:exon1/6:c.-118C>T:,RPL14:ENST00000338970:5'UTR:MODIFIER:exon1/6:c.-7C>T:,RPL14:ENST00000396203:5'UTR:MODIFIER:exon1/6:c.-118C>T:,RPL14:ENST00000416518:5'UTR:MODIFIER:exon1/6:c.-118C>T:		rs2276868	0.4710	0.6028	21266,14869,444	0.3249,0.6185,0.4264,0.6863,0.4964	0.5972											n/a (AF>5%)	n/a (AF>5%)					RPL14 (inh=n/a pLI=0.92)
chr3	44284584	44284584	G	A	hom		QUAL=1334;DP=41;AF=1.00;MQM=60	TOPAZ1	missense	TOPAZ1:ENST00000309765:missense:MODERATE:exon2/20:c.586G>A:p.Val196Ile		rs9284879	0.5635	0.5608	3424,951,88	0.3109,0.5796,0.8108,0.4835,0.6831	0.5550	1.3170	D	T	B	T	15.04				COSM446533, COSM446532	n/a (AF>5%)	n/a (AF>5%)					TOPAZ1 (inh=n/a pLI=n/a)
chr3	44884647	44884647	C	A	hom		QUAL=2467;DP=75;AF=1.00;MQM=60	KIF15	missense	KIF15:ENST00000326047:missense:MODERATE:exon30/35:c.3616C>A:p.Leu1206Met,KIF15:ENST00000425755:missense:MODERATE:exon21/26:c.2521C>A:p.Leu841Met		rs3804583	0.5278	0.5201	17585,7704,248	0.2198,0.5696,0.8398,0.4809,0.6731	0.5260	0.5260	T,T	T	B	T,T	21.10				COSM3760104	n/a (AF>5%)	n/a (AF>5%)					KIF15 (inh=n/a pLI=0.00)
chr3	45677639	45677639	A	C	hom		QUAL=4067;DP=142;AF=0.96;MQM=60	LIMD1	splice_region&intron	LIMD1:ENST00000273317:splice_region&intron:LOW:exon1/7:c.1409-3A>C:,LIMD1:ENST00000440097:splice_region&intron:LOW:exon1/5:c.1409-3A>C:		rs63132361	0.4950	0.9868	296,161,27	0.0000,0.0000,0.0000,0.9939,0.0000	0.0000											n/a (AF>5%)	n/a (AF>5%)					LIMD1 (inh=n/a pLI=0.08)
chr3	45779136	45779136	A	T	het		QUAL=396;DP=52;AF=0.35;MQM=60	SACM1L	missense	SACM1L:ENST00000389061:missense:MODERATE:exon15/20:c.1301A>T:p.Tyr434Phe,SACM1L:ENST00000418611:missense:MODERATE:exon16/21:c.992A>T:p.Tyr331Phe,SACM1L:ENST00000541314:missense:MODERATE:exon14/19:c.1118A>T:p.Tyr373Phe		rs1468542	0.5483	0.6017	22561,14689,2098	0.6385,0.5120,0.3902,0.6636,0.4751	0.6311	5.8050	T,T,T,T	T	B,B	T,T,T,T	12.30				COSM149368	n/a (AF>5%)	n/a (AF>5%)					SACM1L (inh=n/a pLI=0.85)
chr3	46021218	46021218	G	T	het		QUAL=1617;DP=134;AF=0.46;MQM=60	FYCO1	synonymous	FYCO1:ENST00000535325:synonymous:LOW:exon3/18:c.267C>A:p.Arg89Arg,FYCO1:ENST00000296137:synonymous:LOW:exon4/18:c.267C>A:p.Arg89Arg		rs4682801	0.7630	0.7989	39911,20585,978	0.4337,0.9088,0.9997,0.7838,0.9027	0.8085							607182 [FYCO1 (provisional) Cataract 18,autosomal recessive,610019];	261723 [benign DISEASE=congenital_cataract,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FYCO1 (inh=AR pLI=0.00)
chr3	46480958	46480958	C	G	het		QUAL=1165;DP=139;AF=0.37;MQM=60	LTF	missense	LTF:ENST00000231751:missense:MODERATE:exon15/17:c.1737G>C:p.Glu579Asp,LTF:ENST00000426532:missense:MODERATE:exon15/17:c.1605G>C:p.Glu535Asp,LTF:ENST00000417439:missense:MODERATE:exon15/17:c.1731G>C:p.Glu577Asp		rs2073495	0.2772	0.3237	6422,3780,47	0.0980,0.3935,0.3427,0.3412,0.3587	0.3272	-4.2840	T,T,T,T	T	B,B,B	T,T,T,T	0.01			CM051945 [CLASS=DP MUT=ALT PHEN="Secondary amyloidosis in the cornea association with" GENE=LTF]; 	COSM4002701	n/a (AF>5%)	n/a (AF>5%)					LTF (inh=n/a pLI=0.00)
chr3	46620518	46620518	T	C	het	off-target	QUAL=469;DP=39;AF=0.56;MQM=60	LRRC2,TDGF1	intron	LRRC2:ENST00000296144:intron:MODIFIER:exon1/8:c.-20+909A>G:,TDGF1:ENST00000296145:intron:MODIFIER:exon1/5:c.36-67T>C:,TDGF1:ENST00000542931:intron:MODIFIER:exon1/5:c.-13-67T>C:		rs73073734	0.0779	0.0000	0,0,0	0,0,0,0,0	0.0315							187395 [TDGF1 (confirmed) Forebrain defects];				n/a (AF>5%)	n/a (AF>5%)					LRRC2 (inh=n/a pLI=0.00), TDGF1 (inh=n/a pLI=0.00)
chr3	48505964	48505964	C	A	hom		QUAL=4140;DP=124;AF=1.00;MQM=60	ATRIP	splice_region&intron,intron	ATRIP:ENST00000320211:splice_region&intron:LOW:exon10/12:c.1975-17C>A:,ATRIP:ENST00000357105:splice_region&intron:LOW:exon11/13:c.1594-17C>A:,ATRIP:ENST00000412052:splice_region&intron:LOW:exon10/12:c.1696-17C>A:,ATRIP:ENST00000346691:intron:MODIFIER:exon10/11:c.1975-266C>A:		rs2242150	0.3836	0.3998	10168,6824,1132	0.4668,0.2168,0.3106,0.4522,0.3229	0.4324							606609 [TREX1 (confirmed) Aicardi-Goutieres syndrome 1,dominant and recessive,225750|Chilblain lupus,610448|Vasculopathy,retinal,with cerebral leukodystrophy,192315|Systemic lupus erythematosus,susceptibility to,152700];				n/a (AF>5%)	n/a (AF>5%)					ATRIP (inh=n/a pLI=0.02)
chr3	49070499	49070499	C	T	hom	off-target	QUAL=3989;DP=121;AF=1.00;MQM=60	QRICH1	intron	QRICH1:ENST00000357496:intron:MODIFIER:exon8/10:c.1895+54G>A:,QRICH1:ENST00000395443:intron:MODIFIER:exon7/9:c.1895+54G>A:,QRICH1:ENST00000424300:intron:MODIFIER:exon8/10:c.1895+54G>A:		rs4974081	0.9034	0.0000	0,0,0	0,0,0,0,0	0.8130							617387 [QRICH1 (provisional) Ververi-Brady syndrome,617982];				n/a (AF>5%)	n/a (AF>5%)					QRICH1 (inh=n/a pLI=0.99)
chr3	51907736	51907736	A	G	hom		QUAL=3543;DP=107;AF=1.00;MQM=60	IQCF5-AS1	non_coding_transcript_exon	IQCF5-AS1:ENST00000440723:non_coding_transcript_exon:MODIFIER:exon1/3:n.125A>G:		rs7635409	0.7173	0.7519	5884,2665,186	0.4195,0.7970,0.9115,0.7956,0.7853	0.7891											n/a (AF>5%)	n/a (AF>5%)					IQCF5-AS1 (inh=n/a pLI=n/a)
chr3	57131529	57131529	A	C	hom		QUAL=6362;DP=193;AF=1.00;MQM=60	IL17RD	intron	IL17RD:ENST00000296318:intron:MODIFIER:exon12/12:c.2107+95T>G:,IL17RD:ENST00000427856:intron:MODIFIER:exon12/12:c.2035+95T>G:,IL17RD:ENST00000320057:intron:MODIFIER:exon13/13:c.1675+95T>G:,IL17RD:ENST00000463523:intron:MODIFIER:exon12/12:c.1675+95T>G:	MER46C	rs6764188	0.6056	0.7396	3707,1588,406	0.6920,0.6767,0.2979,0.7530,0.7844	0.6870							606807 [IL17RD (provisional) Hypogonadotropic hypogonadism 18 with or without anosmia,615267];				n/a (AF>5%)	n/a (AF>5%)					IL17RD (inh=AR+AD pLI=0.00)
chr3	57138419	57138419	G	A	hom		QUAL=4504;DP=137;AF=1.00;MQM=60	IL17RD	missense	IL17RD:ENST00000296318:missense:MODERATE:exon8/13:c.764C>T:p.Thr255Met,IL17RD:ENST00000427856:missense:MODERATE:exon8/13:c.692C>T:p.Thr231Met,IL17RD:ENST00000320057:missense:MODERATE:exon9/14:c.332C>T:p.Thr111Met,IL17RD:ENST00000463523:missense:MODERATE:exon8/13:c.332C>T:p.Thr111Met		rs6780995	0.5302	0.6490	24340,15437,1693	0.5927,0.5049,0.1452,0.7091,0.7308	0.6306	0.8310	T,T,T,T	T	B,B,B	T,T,T,T	20.70	606807 [IL17RD (provisional) Hypogonadotropic hypogonadism 18 with or without anosmia,615267];				n/a (AF>5%)	n/a (AF>5%)					IL17RD (inh=AR+AD pLI=0.00)
chr3	57386148	57386148	C	G	het	gene_blacklist	QUAL=159;DP=39;AF=0.26;MQM=60	DNAH12	synonymous,5'UTR	DNAH12:ENST00000351747:synonymous:LOW:exon45/59:c.7035G>C:p.Leu2345Leu,DNAH12:ENST00000344804:5'UTR:MODIFIER:exon1/14:c.-67G>C:		rs12053975	0.2774	0.2993	1015,319,14	0.1109,0.2906,0.4164,0.2686,0.3692	0.2788	-0.2530		T			13.56		402631 [benign DISEASE=not_specified]; 		COSM4158253	n/a (AF>5%)	n/a (AF>5%)					DNAH12 (inh=n/a pLI=0.00)
chr3	58368449	58368449	T	C	het	off-target	QUAL=1071;DP=82;AF=0.51;MQM=60	PXK	intron	PXK:ENST00000356151:intron:MODIFIER:exon4/17:c.388+22T>C:,PXK:ENST00000302779:intron:MODIFIER:exon3/16:c.337+22T>C:,PXK:ENST00000383716:intron:MODIFIER:exon2/15:c.289+22T>C:,PXK:ENST00000463280:intron:MODIFIER:exon2/16:c.289+22T>C:,PXK:ENST00000383715:intron:MODIFIER:exon3/16:c.337+22T>C:,PXK:ENST00000484288:intron:MODIFIER:exon4/17:c.388+22T>C:,PXK:ENST00000479241:intron:MODIFIER:exon3/17:c.337+22T>C:,PXK:ENST00000536660:intron:MODIFIER:exon1/14:c.-23-7860T>C:		rs11917591	0.2005	0.2854	5419,4353,213	0.1989,0.2288,0.0009,0.3625,0.2268	0.2925											n/a (AF>5%)	n/a (AF>5%)					PXK (inh=n/a pLI=0.85)
chr3	58409126	58409126	C	A	het	off-target	QUAL=782;DP=71;AF=0.46;MQM=60	PXK	intron	PXK:ENST00000356151:intron:MODIFIER:exon17/17:c.1529-1353C>A:,PXK:ENST00000302779:intron:MODIFIER:exon16/16:c.1478-1353C>A:,PXK:ENST00000383716:intron:MODIFIER:exon15/15:c.1430-1353C>A:,PXK:ENST00000463280:intron:MODIFIER:exon16/16:c.*14-1353C>A:,PXK:ENST00000479241:intron:MODIFIER:exon16/17:c.1475-62C>A:,PXK:ENST00000536660:intron:MODIFIER:exon14/14:c.1118-1353C>A:		rs6767498	0.3742	0.0000	0,0,0	0,0,0,0,0	0.4882											n/a (AF>5%)	n/a (AF>5%)					PXK (inh=n/a pLI=0.85)
chr3	64009508	64009508	T	C	het		QUAL=807;DP=72;AF=0.44;MQM=60	PSMD6	missense	PSMD6:ENST00000394431:missense:MODERATE:exon1/8:c.4A>G:p.Asn2Asp	MIRb	rs40610	0.2624	0.2355	384,95,13	0.2375,0.0000,0.0000,0.2244,0.2277	0.2464	-0.1600	D	T	B		0.18					n/a (AF>5%)	n/a (AF>5%)					PSMD6 (inh=n/a pLI=0.94)
chr3	69271032	69271032	G	A	het		QUAL=1402;DP=105;AF=0.50;MQM=60	FRMD4B	synonymous	FRMD4B:ENST00000398540:synonymous:LOW:exon9/23:c.708C>T:p.Leu236Leu,FRMD4B:ENST00000542259:synonymous:LOW:exon10/24:c.546C>T:p.Leu182Leu		rs62254461	0.0395	0.1465	493,427,1	0.0280,0.1485,0.0009,0.2036,0.0653	0.0865										COSM3760221, COSM3760222	n/a (AF>5%)	n/a (AF>5%)					FRMD4B (inh=n/a pLI=0.56)
chr3	81698130	81698130	T	C	het		QUAL=615;DP=43;AF=0.56;MQM=60	GBE1	missense	GBE1:ENST00000429644:missense:MODERATE:exon5/16:c.568A>G:p.Arg190Gly,GBE1:ENST00000489715:missense:MODERATE:exon5/16:c.445A>G:p.Arg149Gly		rs2229519	0.3215	0.3746	5135,2559,322	0.3184,0.3881,0.4875,0.3675,0.3357	0.3263	3.4770	D,D,D	T	B,B	D,D	23.10	607839 [GBE1 (provisional) Glycogen storage disease IV,232500|Polyglucosan body disease,adult form,263570];	197636 [benign DISEASE=glycogen_storage_disease,_type_iv,polyglucosan_body_disease,_adult,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					GBE1 (inh=AR pLI=0.00)
chr3	87295049	87295049	T	C	hom		QUAL=1053;DP=34;AF=1.00;MQM=60	CHMP2B	synonymous,intron	CHMP2B:ENST00000263780:synonymous:LOW:exon3/6:c.312T>C:p.Thr104Thr,CHMP2B:ENST00000471660:synonymous:LOW:exon2/5:c.189T>C:p.Thr63Thr,CHMP2B:ENST00000494980:intron:MODIFIER:exon3/5:c.231+81T>C:		rs11540913	0.8157	0.9060	50407,29597,1685	0.5710,0.9390,0.8974,0.9421,0.9410	0.9125							609512 [CHMP2B (confirmed) Dementia,familial,nonspecific,600795|Amyotrophic lateral sclerosis 17,614696];	98000 [benign DISEASE=frontotemporal_dementia,not_specified,not_provided]; 			n/a (AF>5%)	n/a (AF>5%)					CHMP2B (inh=AD pLI=0.05)
chr3	97365074	97365074	A	G	het		QUAL=1694;DP=134;AF=0.49;MQM=60	EPHA6	missense,intron	EPHA6:ENST00000514100:missense:MODERATE:exon12/13:c.1072A>G:p.Met358Val,EPHA6:ENST00000389672:intron:MODIFIER:exon14/17:c.2784+8148A>G:,EPHA6:ENST00000502694:intron:MODIFIER:exon11/11:c.961-2056A>G:		rs301949	0.6605	0.6255	2425,607,143	0.7246,0.0000,0.0000,0.5856,0.6375	0.6254	-0.8620	D	T	B	T	4.53					n/a (AF>5%)	n/a (AF>5%)					EPHA6 (inh=n/a pLI=0.89)
chr3	100544756	100544756	C	T	het	off-target	QUAL=147;DP=23;AF=0.43;MQM=60	ABI3BP	intron	ABI3BP:ENST00000471714:intron:MODIFIER:exon34/66:c.2624-68G>A:,ABI3BP:ENST00000284322:intron:MODIFIER:exon18/34:c.1598-17677G>A:,ABI3BP:ENST00000383691:intron:MODIFIER:exon13/44:c.455-68G>A:,ABI3BP:ENST00000495063:intron:MODIFIER:exon31/38:c.2423-971G>A:		rs56387789	0.1134	0.0000	0,0,0	0,0,0,0,0	0.1433											n/a (AF>5%)	n/a (AF>5%)					ABI3BP (inh=n/a pLI=0.00)
chr3	113010466	113010466	T	C	het		QUAL=1810;DP=129;AF=0.54;MQM=60	WDR52	missense,3'UTR	WDR52:ENST00000393845:missense:MODERATE:exon35/35:c.5503A>G:p.Ser1835Gly,WDR52:ENST00000308346:3'UTR:MODIFIER:exon10/10:c.*193A>G:		rs2291905	0.7750	0.7861	6136,2082,360	0.6249,0.8333,0.8413,0.7475,0.8388	0.8022	2.7710	.,T	T,T	.,B	.,T	0.35	617559 [WDR52 (provisional) Spermatogenic failure 20,617593];			COSM4157133	n/a (AF>5%)	n/a (AF>5%)					CFAP44 (inh=n/a pLI=0.00)
chr3	119434527	119434527	G	C	hom		QUAL=5242;DP=158;AF=1.00;MQM=60	MAATS1	missense	MAATS1:ENST00000273390:missense:MODERATE:exon6/18:c.619G>C:p.Ala207Pro,MAATS1:ENST00000463700:missense:MODERATE:exon6/6:c.619G>C:p.Ala207Pro		rs6438544	0.9099	0.9727	57874,33318,2579	0.7015,0.9877,1.0000,0.9992,0.9996	0.9785	3.1250	T,T	T	B,B,B,B	T,T	14.58					n/a (AF>5%)	n/a (AF>5%)					MAATS1 (inh=n/a pLI=0.00)
chr3	121100414	121100414	A	G	het	off-target	QUAL=380;DP=35;AF=0.54;MQM=60	STXBP5L	intron	STXBP5L:ENST00000273666:intron:MODIFIER:exon23/27:c.2659+35A>G:,STXBP5L:ENST00000471454:intron:MODIFIER:exon22/26:c.2587+35A>G:,STXBP5L:ENST00000472879:intron:MODIFIER:exon22/22:c.2587+35A>G:,STXBP5L:ENST00000492541:intron:MODIFIER:exon23/23:c.2659+35A>G:,STXBP5L:ENST00000497029:intron:MODIFIER:exon23/23:c.2581+35A>G:		rs17740072	0.0966	0.1411	1409,1128,52	0.1117,0.0924,0.0015,0.1851,0.0792	0.1432											n/a (AF>5%)	n/a (AF>5%)					STXBP5L (inh=n/a pLI=1.00)
chr3	121631841	121631841	G	A	het	off-target	QUAL=3880;DP=304;AF=0.48;MQM=60	SLC15A2	intron	SLC15A2:ENST00000489711:intron:MODIFIER:exon4/21:c.429-27G>A:,SLC15A2:ENST00000295605:intron:MODIFIER:exon3/20:c.336-27G>A:		rs1523519	0.2596	0.3168	6475,3655,202	0.1976,0.4332,0.1657,0.3273,0.3320	0.3234											n/a (AF>5%)	n/a (AF>5%)					SLC15A2 (inh=n/a pLI=0.00)
chr3	122186188	122186188	C	T	hom		QUAL=3698;DP=111;AF=1.00;MQM=60	KPNA1	missense	KPNA1:ENST00000344337:missense:MODERATE:exon3/14:c.218G>A:p.Ser73Asn		rs4678193	0.9938	0.9980	60442,33354,4972	0.9775,0.9996,1.0000,1.0000,1.0000	0.9985	4.4640	T,T,T,T,T	T	B	T,T,T,T,T	16.45					n/a (AF>5%)	n/a (AF>5%)					KPNA1 (inh=n/a pLI=0.99)
chr3	124896861	124896861	C	G	hom	off-target	QUAL=986;DP=32;AF=1.00;MQM=60	SLC12A8	intron	SLC12A8:ENST00000423114:intron:MODIFIER:exon4/13:c.478-43G>C:,SLC12A8:ENST00000393469:intron:MODIFIER:exon3/12:c.391-43G>C:,SLC12A8:ENST00000469902:intron:MODIFIER:exon4/13:c.391-43G>C:,SLC12A8:ENST00000314584:intron:MODIFIER:exon3/9:c.-351-43G>C:		rs545103	0.9633	0.9901	36596,19895,2299	0.8902,0.9918,1.0000,0.9992,0.9995	0.9914											n/a (AF>5%)	n/a (AF>5%)					SLC12A8 (inh=n/a pLI=0.00)
chr3	126158622	126158622	A	C	hom	off-target	QUAL=4070;DP=126;AF=1.00;MQM=60	ZXDC	intron	ZXDC:ENST00000389709:intron:MODIFIER:exon8/9:c.2395-52T>G:		rs1799404	0.5767	0.5230	2173,946,590	0.7434,0.5147,0.5211,0.5100,0.4500	0.5848											n/a (AF>5%)	n/a (AF>5%)					ZXDC (inh=n/a pLI=0.00)
chr3	129546729	129546729	T	C	hom		QUAL=3100;DP=95;AF=1.00;MQM=60	TMCC1	missense	TMCC1:ENST00000393238:missense:MODERATE:exon3/6:c.493A>G:p.Ser165Gly,TMCC1:ENST00000426664:missense:MODERATE:exon3/6:c.151A>G:p.Ser51Gly		rs784689	0.9653	0.9893	59371,33316,4095	0.8872,0.9943,0.9974,0.9997,0.9996	0.9915	4.5770	D,T,T	T	B	T,T,T	13.28					n/a (AF>5%)	n/a (AF>5%)					TMCC1 (inh=n/a pLI=0.15)
chr3	130162395	130162395	A	G	hom		QUAL=2761;DP=86;AF=1.00;MQM=60	COL6A5	missense	COL6A5:ENST00000265379:missense:MODERATE:exon36/42:c.6563A>G:p.Gln2188Arg,COL6A5:ENST00000432398:missense:MODERATE:exon36/40:c.6563A>G:p.Gln2188Arg		rs9883988	0.8542	0.9144	50563,29840,3006	0.7835,0.9072,0.8459,0.9459,0.8787	0.9163	-0.9280	T,T,T,T	T	B,B	D,D,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					COL6A5 (inh=n/a pLI=0.00)
chr3	130289617	130289617	T	C	hom	off-target	QUAL=2610;DP=80;AF=1.00;MQM=60	COL6A6	intron	COL6A6:ENST00000358511:intron:MODIFIER:exon5/35:c.2402-45T>C:,COL6A6:ENST00000453409:intron:MODIFIER:exon5/35:c.2402-45T>C:		rs10934949	0.8227	0.9341	49164,30820,1485	0.5580,0.9653,0.8961,0.9806,0.9523	0.9365											n/a (AF>5%)	n/a (AF>5%)					COL6A6 (inh=n/a pLI=0.00)
chr3	130828790	130828790	G	A	het	off-target	QUAL=353;DP=35;AF=0.43;MQM=60	NEK11	intron	NEK11:ENST00000383366:intron:MODIFIER:exon5/17:c.455+25G>A:,NEK11:ENST00000356918:intron:MODIFIER:exon4/13:c.455+25G>A:,NEK11:ENST00000510769:intron:MODIFIER:exon4/13:c.455+25G>A:,NEK11:ENST00000429253:intron:MODIFIER:exon4/16:c.455+25G>A:,NEK11:ENST00000510688:intron:MODIFIER:exon4/15:c.455+25G>A:,NEK11:ENST00000511262:intron:MODIFIER:exon5/14:c.455+25G>A:,NEK11:ENST00000412440:intron:MODIFIER:exon3/14:c.11+25G>A:,NEK11:ENST00000507910:intron:MODIFIER:exon4/13:c.455+25G>A:,NEK11:ENST00000508196:intron:MODIFIER:exon3/15:c.455+25G>A:		rs9850655	0.4006	0.5098	16560,10975,383	0.2717,0.4233,0.2589,0.5721,0.5756	0.5148											n/a (AF>5%)	n/a (AF>5%)					NEK11 (inh=n/a pLI=0.00)
chr3	134967368	134967368	G	A	het		QUAL=1339;DP=111;AF=0.47;MQM=60	EPHB1	splice_region&intron	EPHB1:ENST00000398015:splice_region&intron:LOW:exon14/15:c.2690+17G>A:,EPHB1:ENST00000493838:splice_region&intron:LOW:exon12/13:c.1373+17G>A:		rs11717042	0.2808	0.3120	2345,971,196	0.3059,0.3243,0.3691,0.2842,0.3701	0.2571											n/a (AF>5%)	n/a (AF>5%)					EPHB1 (inh=n/a pLI=1.00)
chr3	138329862	138329862	G	A	het		QUAL=2261;DP=168;AF=0.52;MQM=60	FAIM	synonymous,intron	FAIM:ENST00000338446:synonymous:LOW:exon2/6:c.63G>A:p.Pro21Pro,FAIM:ENST00000360570:intron:MODIFIER:exon1/5:c.-17+2083G>A:,FAIM:ENST00000393035:intron:MODIFIER:exon1/4:c.-23+2083G>A:,FAIM:ENST00000393034:intron:MODIFIER:exon1/4:c.-23+1874G>A:		rs811322	0.7065	0.6504	26757,10835,1640	0.5631,0.8091,0.9895,0.5685,0.7303	0.6566											n/a (AF>5%)	n/a (AF>5%)					FAIM (inh=n/a pLI=0.24)
chr3	138433568	138433568	C	T	het		QUAL=873;DP=58;AF=0.57;MQM=60	PIK3CB	splice_region&intron	PIK3CB:ENST00000289153:splice_region&intron:LOW:exon6/21:c.1051-7G>A:,PIK3CB:ENST00000477593:splice_region&intron:LOW:exon7/22:c.1051-7G>A:		rs497900	0.7019	0.6224	24427,9553,2016	0.6267,0.7922,0.9903,0.5350,0.6487	0.6253											n/a (AF>5%)	n/a (AF>5%)					PIK3CB (inh=n/a pLI=1.00)
chr3	142078759	142078759	C	T	het		QUAL=567;DP=50;AF=0.48;MQM=60	XRN1	missense	XRN1:ENST00000264951:missense:MODERATE:exon30/42:c.3409G>A:p.Asp1137Asn,XRN1:ENST00000392981:missense:MODERATE:exon30/41:c.3409G>A:p.Asp1137Asn		rs73238159	0.0833	0.1108	792,561,12	0.0451,0.0799,0.0949,0.1306,0.0899	0.1059	6.6560	T,T	T	P,B	T,T	24.70					n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a pLI=0.99)
chr3	142523349	142523349	G	A	het		QUAL=1441;DP=121;AF=0.45;MQM=60	TRPC1	synonymous	TRPC1:ENST00000476941:synonymous:LOW:exon12/13:c.2031G>A:p.Thr677Thr,TRPC1:ENST00000273482:synonymous:LOW:exon11/12:c.1929G>A:p.Thr643Thr		rs3821647	0.1941	0.1796	2155,1122,245	0.2119,0.1477,0.2664,0.1771,0.1491	0.1981										COSM149491, COSM4002482	n/a (AF>5%)	n/a (AF>5%)					TRPC1 (inh=n/a pLI=0.90)
chr3	167754573	167754573	A	G	het	off-target	QUAL=153;DP=15;AF=0.53;MQM=60	GOLIM4	intron	GOLIM4:ENST00000470487:intron:MODIFIER:exon8/15:c.843+51T>C:,GOLIM4:ENST00000309027:intron:MODIFIER:exon7/14:c.759+51T>C:		rs6786410	0.4535	0.4714	14790,9540,3014	0.7583,0.2623,0.0922,0.5378,0.3402	0.5633											n/a (AF>5%)	n/a (AF>5%)					GOLIM4 (inh=n/a pLI=0.00)
chr3	169566090	169566090	A	G	het		QUAL=1232;DP=89;AF=0.53;MQM=60	LRRC31	splice_region&intron	LRRC31:ENST00000316428:splice_region&intron:LOW:exon7/8:c.1160-15T>C:,LRRC31:ENST00000264676:splice_region&intron:LOW:exon6/7:c.992-15T>C:,LRRC31:ENST00000523069:splice_region&intron:LOW:exon7/8:c.1160-15T>C:		rs9290375	0.5589	0.4734	14337,4706,1313	0.5282,0.7338,0.7404,0.3804,0.5253	0.4763											n/a (AF>5%)	n/a (AF>5%)					LRRC31 (inh=n/a pLI=0.00)
chr3	183900836	183900836	G	A	het	off-target	QUAL=761;DP=59;AF=0.53;MQM=60	AP2M1,EIF2B5	intron	AP2M1:ENST00000411763:intron:MODIFIER:exon13/13:c.1248+180G>A:,EIF2B5:ENST00000444495:intron:MODIFIER:exon15/15:c.2106+38341G>A:,AP2M1:ENST00000382456:intron:MODIFIER:exon10/10:c.1167+180G>A:,AP2M1:ENST00000292807:intron:MODIFIER:exon11/11:c.1173+180G>A:,AP2M1:ENST00000439647:intron:MODIFIER:exon9/9:c.1167+180G>A:		rs843364	0.5535	0.0000	0,0,0	0,0,0,0,0	0.5317											n/a (AF>5%)	n/a (AF>5%)					AP2M1 (inh=n/a pLI=0.99), EIF2B5 (inh=AR pLI=0.99)
chr3	186572089	186572089	T	C	het		QUAL=2700;DP=181;AF=0.54;MQM=60	ADIPOQ,ADIPOQ-AS1	missense,non_coding_transcript_exon	ADIPOQ:ENST00000320741:missense:MODERATE:exon3/3:c.331T>C:p.Tyr111His,ADIPOQ:ENST00000412955:missense:MODERATE:exon3/3:c.331T>C:p.Tyr111His,ADIPOQ:ENST00000444204:missense:MODERATE:exon4/4:c.331T>C:p.Tyr111His,ADIPOQ-AS1:ENST00000422718:non_coding_transcript_exon:MODIFIER:exon1/3:n.1824A>G:		rs17366743	0.0114	0.0212	43,34,0	0.0074,0.0086,0.0000,0.0286,0.0125	0.0222	1.0110	T,T,T	T	B	D,D,D	11.63	605441 [ADIPOQ (provisional) Adiponectin deficiency,612556];		CM056934 [CLASS=DP MUT=ALT PHEN="Diabetes mellitus type 2 association with" GENE=ADIPOQ]; 		2	171					ADIPOQ (inh=n/a pLI=0.00), ADIPOQ-AS1 (inh=n/a pLI=n/a)
chr3	193153562	193153562	T	C	hom	off-target	QUAL=1834;DP=63;AF=1.00;MQM=60	ATP13A4	intron	ATP13A4:ENST00000342695:intron:MODIFIER:exon23/29:c.2673-29A>G:,ATP13A4:ENST00000392443:intron:MODIFIER:exon23/29:c.2616-29A>G:	GA-rich	rs1996735	0.7338	0.7570	34853,19596,3062	0.7665,0.8053,0.6030,0.7676,0.7525	0.7565										COSN167121	n/a (AF>5%)	n/a (AF>5%)					ATP13A4 (inh=n/a pLI=0.00)
chr3	193209178	193209178	T	C	het		QUAL=888;DP=81;AF=0.44;MQM=60	ATP13A4	missense	ATP13A4:ENST00000342695:missense:MODERATE:exon6/30:c.543A>G:p.Ile181Met,ATP13A4:ENST00000392443:missense:MODERATE:exon6/30:c.543A>G:p.Ile181Met,ATP13A4:ENST00000295548:missense:MODERATE:exon6/14:c.543A>G:p.Ile181Met		rs6788448	0.4714	0.4274	11300,5290,1326	0.5085,0.5320,0.4431,0.3970,0.4496	0.4273	-0.4470	T,T,T	T	D,D	T,T,T	23.60				COSM3759936, COSM3759937	n/a (AF>5%)	n/a (AF>5%)					ATP13A4 (inh=n/a pLI=0.00)
chr4	1729425	1729425	C	G	hom		QUAL=6674;DP=203;AF=1.00;MQM=60	TACC3	splice_region&intron	TACC3:ENST00000313288:splice_region&intron:LOW:exon3/15:c.306-10C>G:		rs2592828	0.3095	0.3799	8231,6017,568	0.3531,0.2979,0.1759,0.4412,0.3188	0.3984										COSM4155045	n/a (AF>5%)	n/a (AF>5%)					TACC3 (inh=n/a pLI=0.05)
chr4	4304337	4304337	C	T	hom		QUAL=5927;DP=179;AF=1.00;MQM=60	ZBTB49	synonymous,5'UTR_premature_start_codon_gain,5'UTR	ZBTB49:ENST00000337872:synonymous:LOW:exon3/8:c.774C>T:p.Ala258Ala,ZBTB49:ENST00000355834:synonymous:LOW:exon3/4:c.774C>T:p.Ala258Ala,ZBTB49:ENST00000538529:5'UTR_premature_start_codon_gain:LOW:exon3/6:c.-657C>T:,ZBTB49:ENST00000538529:5'UTR:MODIFIER:exon3/6:c.-657C>T:		rs2916382	0.7995	0.8263	41495,23339,3145	0.7763,0.8756,0.7703,0.8362,0.7872	0.8333											n/a (AF>5%)	n/a (AF>5%)					ZBTB49 (inh=n/a pLI=0.03)
chr4	6302519	6302519	G	A	hom		QUAL=14297;DP=435;AF=1.00;MQM=60	WFS1	missense	WFS1:ENST00000226760:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile,WFS1:ENST00000503569:missense:MODERATE:exon8/8:c.997G>A:p.Val333Ile		rs1801212	0.8844	0.7818	37650,17117,4752	0.9555,0.8124,0.9979,0.7173,0.8433	0.7950	3.7380	T,T	T	B	D,D	5.06	606201 [WFS1 (confirmed) Wolfram syndrome 1,222300|Deafness,autosomal dominant 6/14/38,600965|Wolfram-like syndrome,autosomal dominant,614296|Diabetes mellitus,noninsulin-dependent,association with,125853|Cataract 41,116400];	45463 [benign DISEASE=not_specified,wfs1-related_spectrum_disorders]; 	CM115388 [CLASS=DFP MUT=ALT PHEN="Wolframin variant" GENE=WFS1]; 		n/a (AF>5%)	n/a (AF>5%)					WFS1 (inh=AR+AD pLI=n/a)
chr4	6619204	6619204	G	A	hom		QUAL=2387;DP=74;AF=1.00;MQM=60	MAN2B2	synonymous	MAN2B2:ENST00000285599:synonymous:LOW:exon17/19:c.2799G>A:p.Val933Val,MAN2B2:ENST00000504248:synonymous:LOW:exon17/19:c.2646G>A:p.Val882Val		rs4689490	0.6885	0.8099	41151,24962,665	0.3572,0.9082,0.8958,0.8652,0.7239	0.8224											n/a (AF>5%)	n/a (AF>5%)					MAN2B2 (inh=n/a pLI=0.00)
chr4	10099340	10099340	T	C	hom		QUAL=2561;DP=79;AF=1.00;MQM=60	WDR1	missense,intron	WDR1:ENST00000382452:missense:MODERATE:exon5/15:c.553A>G:p.Ile185Val,WDR1:ENST00000499869:missense:MODERATE:exon5/15:c.553A>G:p.Ile185Val,WDR1:ENST00000382451:intron:MODIFIER:exon2/11:c.139-8975A>G:,WDR1:ENST00000502702:intron:MODIFIER:exon2/11:c.139-8975A>G:		rs13441	0.5753	0.6492	25821,16577,952	0.4402,0.6649,0.6582,0.7053,0.5218	0.6562	1.1620	T,T,T	T	B	T,T,T	2.37				COSM4002877, COSM4002878	n/a (AF>5%)	n/a (AF>5%)					WDR1 (inh=n/a pLI=0.99)
chr4	15539779	15539779	C	T	het		QUAL=1221;DP=101;AF=0.49;MQM=60	CC2D2A	splice_region&intron	CC2D2A:ENST00000413206:splice_region&intron:LOW:exon16/36:c.2003+19C>T:,CC2D2A:ENST00000424120:splice_region&intron:LOW:exon16/36:c.2003+19C>T:,CC2D2A:ENST00000503292:splice_region&intron:LOW:exon17/37:c.2003+19C>T:,CC2D2A:ENST00000389652:splice_region&intron:LOW:exon14/33:c.1856+19C>T:		rs17476642	0.0779	0.1537	227,166,5	0.0562,0.2181,0.1304,0.1723,0.1250	0.1121							612013 [CC2D2A (confirmed) Joubert syndrome 9,612285|Meckel syndrome 6,612284|COACH syndrome,216360];	93532 [benign/likely benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CC2D2A (inh=AR pLI=0.00)
chr4	15587897	15587897	A	T	hom	off-target	QUAL=2811;DP=86;AF=1.00;MQM=60	CC2D2A	intron	CC2D2A:ENST00000413206:intron:MODIFIER:exon31/36:c.4065+28A>T:,CC2D2A:ENST00000424120:intron:MODIFIER:exon31/36:c.4065+28A>T:,CC2D2A:ENST00000503292:intron:MODIFIER:exon32/37:c.4065+28A>T:,CC2D2A:ENST00000389652:intron:MODIFIER:exon28/33:c.3741+28A>T:		rs6832789	0.9489	0.9875	58917,33317,3611	0.8580,0.9932,0.9998,0.9997,0.9997	0.9898							612013 [CC2D2A (confirmed) Joubert syndrome 9,612285|Meckel syndrome 6,612284|COACH syndrome,216360];	126243 [benign/likely benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CC2D2A (inh=AR pLI=0.00)
chr4	15964573	15964573	A	G	hom		QUAL=2276;DP=70;AF=1.00;MQM=60	FGFBP2	synonymous	FGFBP2:ENST00000259989:synonymous:LOW:exon1/2:c.180T>C:p.Arg60Arg		rs758328	0.9235	0.9773	57939,33065,3026	0.7614,0.9885,0.9998,0.9984,0.9990	0.9812										COSM4158889	n/a (AF>5%)	n/a (AF>5%)					FGFBP2 (inh=n/a pLI=0.00)
chr4	16024885	16024885	A	G	het	off-target	QUAL=715;DP=74;AF=0.42;MQM=60	PROM1	intron	PROM1:ENST00000447510:intron:MODIFIER:exon7/26:c.784+64T>C:,PROM1:ENST00000539194:intron:MODIFIER:exon7/24:c.784+64T>C:,PROM1:ENST00000540805:intron:MODIFIER:exon7/25:c.784+64T>C:,PROM1:ENST00000505450:intron:MODIFIER:exon7/26:c.757+64T>C:,PROM1:ENST00000508167:intron:MODIFIER:exon7/26:c.757+64T>C:,PROM1:ENST00000510224:intron:MODIFIER:exon8/27:c.784+64T>C:,PROM1:ENST00000543373:intron:MODIFIER:exon7/24:c.757+64T>C:		rs2013854	0.7021	0.0000	0,0,0	0,0,0,0,0	0.7620							604365 [PROM1 (confirmed) Retinitis pigmentosa 41,612095|Cone-rod dystrophy 12,612657|Stargardt disease 4,603786|Macular dystrophy,retinal,2,608051];				n/a (AF>5%)	n/a (AF>5%)					PROM1 (inh=AR+AD pLI=0.00)
chr4	17660082	17660082	C	T	hom		QUAL=2262;DP=69;AF=1.00;MQM=60	FAM184B	missense	FAM184B:ENST00000265018:missense:MODERATE:exon10/18:c.1928G>A:p.Arg643His		rs1860596	0.6044	0.5824	3448,1512,229	0.4789,0.6318,0.8657,0.5921,0.5742	0.6363	-0.4220	T	T	B	T	7.49					n/a (AF>5%)	n/a (AF>5%)					FAM184B (inh=n/a pLI=n/a)
chr4	20570787	20570787	G	A	hom	off-target	QUAL=79;DP=3;AF=1.00;MQM=60	SLIT2	intron	SLIT2:ENST00000273739:intron:MODIFIER:exon30/38:c.3100+160G>A:,SLIT2:ENST00000503823:intron:MODIFIER:exon28/35:c.3064+160G>A:,SLIT2:ENST00000504154:intron:MODIFIER:exon29/36:c.3088+160G>A:,SLIT2:ENST00000503837:intron:MODIFIER:exon29/36:c.3076+160G>A:		rs17620615	0.1847	0.0000	0,0,0	0,0,0,0,0	0.2782											n/a (AF>5%)	n/a (AF>5%)					SLIT2 (inh=n/a pLI=1.00)
chr4	20751278	20751278	A	G	hom		QUAL=2208;DP=70;AF=1.00;MQM=60	KCNIP4,PACRGL	splice_region&intron,intron	KCNIP4:ENST00000382152:splice_region&intron:LOW:exon5/8:c.429+7T>C:,KCNIP4:ENST00000382148:splice_region&intron:LOW:exon4/7:c.354+7T>C:,KCNIP4:ENST00000447367:splice_region&intron:LOW:exon4/7:c.327+7T>C:,KCNIP4:ENST00000382150:splice_region&intron:LOW:exon4/7:c.366+7T>C:,KCNIP4:ENST00000509207:splice_region&intron:LOW:exon4/7:c.243+7T>C:,KCNIP4:ENST00000359001:splice_region&intron:LOW:exon4/7:c.243+7T>C:,PACRGL:ENST00000507634:intron:MODIFIER:exon8/8:c.*57-2910A>G:		rs2322688	0.3369	0.3096	5887,3235,1026	0.4430,0.1701,0.1604,0.3239,0.3679	0.3154											n/a (AF>5%)	n/a (AF>5%)					KCNIP4 (inh=n/a pLI=0.96), PACRGL (inh=n/a pLI=0.00)
chr4	36292018	36292018	T	A	hom		QUAL=9126;DP=278;AF=1.00;MQM=60	DTHD1	missense	DTHD1:ENST00000507598:missense:MODERATE:exon2/9:c.656T>A:p.Val219Asp,DTHD1:ENST00000357504:missense:MODERATE:exon2/9:c.41T>A:p.Val14Asp,DTHD1:ENST00000456874:missense:MODERATE:exon2/9:c.536T>A:p.Val179Asp		rs1995319	0.9631	0.9443	10383,4251,1188	0.9833,0.8800,0.9968,0.9277,0.9618	0.9366	-0.1350	T,T,T	T	B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					DTHD1 (inh=n/a pLI=n/a)
chr4	36340753	36340753	G	A	het		QUAL=2241;DP=140;AF=0.59;MQM=60	DTHD1,RP11-431M7.2	missense	DTHD1:ENST00000507598:missense:MODERATE:exon8/9:c.2105G>A:p.Arg702His,DTHD1:ENST00000357504:missense:MODERATE:exon8/9:c.1490G>A:p.Arg497His,DTHD1:ENST00000456874:missense:MODERATE:exon8/9:c.1985G>A:p.Arg662His		rs9654132	0.1965	0.2392	675,277,47	0.2047,0.2014,0.1238,0.2451,0.2211	0.2400	0.8170	T,T,T	T	B	T,T,T	23.00				COSM1137185, COSM149660	n/a (AF>5%)	n/a (AF>5%)					DTHD1 (inh=n/a pLI=n/a), RP11-431M7.2 (inh=n/a pLI=n/a)
chr4	37445315	37445315	C	A	het		QUAL=2475;DP=210;AF=0.46;MQM=60	KIAA1239	missense	KIAA1239:ENST00000309447:missense:MODERATE:exon7/7:c.1705C>A:p.Leu569Met		rs4634233	0.1512	0.2040	493,306,17	0.1315,0.2014,0.0559,0.2478,0.1792	0.2090	0.9520	D	T	D	D	23.00				COSM3760599	n/a (AF>5%)	n/a (AF>5%)					NWD2 (inh=n/a pLI=n/a)
chr4	38047545	38047545	A	G	het	off-target	QUAL=712;DP=61;AF=0.48;MQM=60	TBC1D1	intron	TBC1D1:ENST00000261439:intron:MODIFIER:exon10/19:c.1629+21A>G:,TBC1D1:ENST00000508802:intron:MODIFIER:exon10/20:c.1629+21A>G:		rs6845120	0.3874	0.3300	7160,2815,660	0.3566,0.3008,0.6284,0.2915,0.3696	0.3261											n/a (AF>5%)	n/a (AF>5%)					TBC1D1 (inh=n/a pLI=0.00)
chr4	39205365	39205365	C	T	hom		QUAL=2991;DP=93;AF=1.00;MQM=60	WDR19	intron	WDR19:ENST00000399820:intron:MODIFIER:exon7/36:c.603+23C>T:,WDR19:ENST00000288634:intron:MODIFIER:exon6/35:c.123+23C>T:,WDR19:ENST00000506503:intron:MODIFIER:exon7/13:c.603+23C>T:		rs1451817	0.9645	0.9910	50337,28455,3496	0.9004,0.9957,1.0000,0.9998,0.9998	0.9928							608151 [WDR19 (provisional) Nephronophthisis 13,614377|Cranioectodermal dysplasia 4,614378|Short-rib thoracic dysplasia 5 with or without polydactyly,614376|Senior-Loken syndrome 8,616307];				n/a (AF>5%)	n/a (AF>5%)					WDR19 (inh=AR pLI=0.00)
chr4	40121562	40121562	G	A	het		QUAL=90;DP=11;AF=0.45;MQM=60	N4BP2	missense	N4BP2:ENST00000261435:missense:MODERATE:exon9/18:c.1831G>A:p.Asp611Asn		rs794001	0.8247	0.8107	37410,19111,2260	0.6896,0.9002,0.9661,0.7723,0.9319	0.8098	0.5650	T,T,.	T,T	B,B,.	T,.	8.24				COSM447847	n/a (AF>5%)	n/a (AF>5%)					N4BP2 (inh=n/a pLI=0.00)
chr4	41615690	41615690	T	A	hom		QUAL=579;DP=22;AF=1.00;MQM=60	LIMCH1	splice_region&intron	LIMCH1:ENST00000503057:splice_region&intron:LOW:exon5/31:c.205+12T>A:,LIMCH1:ENST00000513024:splice_region&intron:LOW:exon7/25:c.205+12T>A:,LIMCH1:ENST00000509638:splice_region&intron:LOW:exon6/6:c.205+12T>A:,LIMCH1:ENST00000508501:splice_region&intron:LOW:exon7/25:c.682+12T>A:,LIMCH1:ENST00000512946:splice_region&intron:LOW:exon7/25:c.682+12T>A:,LIMCH1:ENST00000313860:splice_region&intron:LOW:exon7/26:c.682+12T>A:,LIMCH1:ENST00000512632:splice_region&intron:LOW:exon7/22:c.682+12T>A:,LIMCH1:ENST00000512820:splice_region&intron:LOW:exon7/25:c.682+12T>A:,LIMCH1:ENST00000511496:splice_region&intron:LOW:exon4/22:c.205+12T>A:,LIMCH1:ENST00000514096:splice_region&intron:LOW:exon2/19:c.241+12T>A:,LIMCH1:ENST00000509277:splice_region&intron:LOW:exon2/20:c.220+12T>A:,LIMCH1:ENST00000509454:splice_region&intron:LOW:exon2/2:c.226+12T>A:,LIMCH1:ENST00000396595:splice_region&intron:LOW:exon2/20:c.220+12T>A:,LIMCH1:ENST00000381753:splice_region&intron:LOW:exon2/19:c.220+12T>A:		rs13146318	0.4976	0.6569	27931,18033,148	0.1485,0.7305,0.7398,0.7365,0.5184	0.6689											n/a (AF>5%)	n/a (AF>5%)					LIMCH1 (inh=n/a pLI=1.00)
chr4	44652187	44652187	C	G	hom	off-target	QUAL=857;DP=30;AF=1.00;MQM=60	YIPF7	intron	YIPF7:ENST00000332990:intron:MODIFIER:exon1/5:c.72-69G>C:,YIPF7:ENST00000415895:intron:MODIFIER:exon1/5:c.-1-69G>C:		rs1113098	0.5529	0.0000	0,0,0	0,0,0,0,0	0.6269											n/a (AF>5%)	n/a (AF>5%)					YIPF7 (inh=n/a pLI=0.00)
chr4	47626034	47626034	C	T	hom	off-target	QUAL=2144;DP=65;AF=1.00;MQM=60	CORIN	intron	CORIN:ENST00000273857:intron:MODIFIER:exon17/21:c.2316-69G>A:,CORIN:ENST00000508498:intron:MODIFIER:exon16/20:c.1899-69G>A:,CORIN:ENST00000502252:intron:MODIFIER:exon16/20:c.2115-69G>A:,CORIN:ENST00000505909:intron:MODIFIER:exon16/20:c.2205-69G>A:		rs1344122	0.2290	0.0000	0,0,0	0,0,0,0,0	0.2712							605236 [CORIN (provisional) Preeclampsia/eclampsia 5,614595];				n/a (AF>5%)	n/a (AF>5%)					CORIN (inh=AD pLI=0.00)
chr4	47667064	47667064	T	C	hom		QUAL=3403;DP=104;AF=1.00;MQM=60	CORIN	missense	CORIN:ENST00000273857:missense:MODERATE:exon11/22:c.1574A>G:p.His525Arg,CORIN:ENST00000508498:missense:MODERATE:exon10/21:c.1157A>G:p.His386Arg,CORIN:ENST00000502252:missense:MODERATE:exon10/21:c.1373A>G:p.His458Arg,CORIN:ENST00000505909:missense:MODERATE:exon10/21:c.1463A>G:p.His488Arg,CORIN:ENST00000504584:missense:MODERATE:exon10/14:c.1463A>G:p.His488Arg		rs11934749	0.9109	0.8763	46793,24588,4962	0.9769,0.9137,0.9764,0.8576,0.7928	0.9078	1.5010	T,T,T,T,T	T	B,B	T,T,T,T,T	0.04	605236 [CORIN (provisional) Preeclampsia/eclampsia 5,614595];				n/a (AF>5%)	n/a (AF>5%)					CORIN (inh=AD pLI=0.00)
chr4	47682174	47682174	A	G	het		QUAL=1802;DP=134;AF=0.51;MQM=60	CORIN	synonymous,intron	CORIN:ENST00000273857:synonymous:LOW:exon8/22:c.1116T>C:p.Ser372Ser,CORIN:ENST00000508498:synonymous:LOW:exon7/21:c.699T>C:p.Ser233Ser,CORIN:ENST00000502252:synonymous:LOW:exon7/21:c.915T>C:p.Ser305Ser,CORIN:ENST00000505909:intron:MODIFIER:exon7/20:c.1022-2103T>C:,CORIN:ENST00000504584:intron:MODIFIER:exon7/13:c.1022-2103T>C:		rs10517195	0.3710	0.5021	16375,11448,453	0.2964,0.4996,0.1190,0.5865,0.4747	0.5046							605236 [CORIN (provisional) Preeclampsia/eclampsia 5,614595];				n/a (AF>5%)	n/a (AF>5%)					CORIN (inh=AD pLI=0.00)
chr4	48091768	48091768	G	A	het		QUAL=1684;DP=132;AF=0.48;MQM=60	TXK	splice_region&synonymous	TXK:ENST00000264316:splice_region&synonymous:LOW:exon9/15:c.783C>T:p.Tyr261Tyr		rs17470585	0.0196	0.0186	33,26,2	0.0353,0.0158,0.0000,0.0237,0.0032	0.0197											1	161					TXK (inh=n/a pLI=0.00)
chr4	52938243	52938243	T	C	hom		QUAL=2586;DP=80;AF=1.00;MQM=60	SPATA18	missense	SPATA18:ENST00000295213:missense:MODERATE:exon6/13:c.679T>C:p.Ser227Pro,SPATA18:ENST00000419395:missense:MODERATE:exon5/12:c.583T>C:p.Ser195Pro		rs3860707	0.3834	0.5554	20335,14578,149	0.1566,0.6315,0.4024,0.6600,0.4000	0.5635	0.2870	T,T	T	B,B	T,T	0.12				COSM3927814, COSM3927815	n/a (AF>5%)	n/a (AF>5%)					SPATA18 (inh=n/a pLI=0.00)
chr4	56475338	56475338	G	A	hom		QUAL=5403;DP=162;AF=1.00;MQM=60	NMU	synonymous	NMU:ENST00000264218:synonymous:LOW:exon4/10:c.228C>T:p.Asn76Asn,NMU:ENST00000511469:synonymous:LOW:exon3/9:c.180C>T:p.Asn60Asn,NMU:ENST00000505262:synonymous:LOW:exon4/8:c.228C>T:p.Asn76Asn,NMU:ENST00000507338:synonymous:LOW:exon4/9:c.228C>T:p.Asn76Asn		rs3805383	0.1971	0.2312	3549,2154,115	0.1441,0.1943,0.0846,0.2529,0.2585	0.2394											n/a (AF>5%)	n/a (AF>5%)					NMU (inh=n/a pLI=0.01)
chr4	56734701	56734701	C	T	het		QUAL=1206;DP=96;AF=0.51;MQM=60	EXOC1	splice_region&intron	EXOC1:ENST00000346134:splice_region&intron:LOW:exon5/18:c.603+12C>T:,EXOC1:ENST00000381295:splice_region&intron:LOW:exon5/18:c.603+12C>T:,EXOC1:ENST00000349598:splice_region&intron:LOW:exon5/17:c.603+12C>T:		rs3213948	0.5443	0.5610	19198,10612,1314	0.5051,0.5525,0.6699,0.5654,0.4879	0.5739											n/a (AF>5%)	n/a (AF>5%)					EXOC1 (inh=n/a pLI=0.04)
chr4	56770708	56770708	A	C	het	off-target	QUAL=453;DP=41;AF=0.51;MQM=60	EXOC1	3'UTR	EXOC1:ENST00000346134:3'UTR:MODIFIER:exon19/19:c.*47A>C:,EXOC1:ENST00000381295:3'UTR:MODIFIER:exon19/19:c.*47A>C:,EXOC1:ENST00000349598:3'UTR:MODIFIER:exon18/18:c.*47A>C:		rs17086150	0.0671	0.0674	354,217,77	0.1186,0.0252,0.0005,0.0770,0.0584	0.0868											n/a (AF>5%)	n/a (AF>5%)					EXOC1 (inh=n/a pLI=0.04)
chr4	57340592	57340592	C	T	het		QUAL=486;DP=60;AF=0.38;MQM=60	SRP72	synonymous,intron	SRP72:ENST00000504757:synonymous:LOW:exon5/5:c.645C>T:p.Asn215Asn,SRP72:ENST00000342756:intron:MODIFIER:exon5/18:c.610+35C>T:,SRP72:ENST00000510663:intron:MODIFIER:exon5/16:c.610+35C>T:		rs11610	0.4026	0.3559	7066,2307,711	0.3897,0.5773,0.4897,0.2889,0.3558	0.3407							602122 [SRP72 (provisional) Bone marrow failure syndrome 1,614675];				n/a (AF>5%)	n/a (AF>5%)					SRP72 (inh=AD pLI=0.14)
chr4	65146700	65146700	A	G	hom	off-target	QUAL=1352;DP=44;AF=1.00;MQM=60	TECRL	intron	TECRL:ENST00000381210:intron:MODIFIER:exon11/11:c.964+59T>C:,TECRL:ENST00000507440:intron:MODIFIER:exon11/11:c.964+59T>C:		rs10012755	0.8486	0.0000	0,0,0	0,0,0,0,0	0.8564							617242 [TECRL (provisional) Ventricular tachycardia,catecholaminergic polymorphic,3,614021];				n/a (AF>5%)	n/a (AF>5%)					TECRL (inh=AR pLI=0.00)
chr4	68447249	68447249	A	G	het	off-target	QUAL=726;DP=47;AF=0.60;MQM=60	STAP1	intron	STAP1:ENST00000265404:intron:MODIFIER:exon5/8:c.530+60A>G:,STAP1:ENST00000396225:intron:MODIFIER:exon5/9:c.530+60A>G:		rs2242330	0.2077	0.0000	0,0,0	0,0,0,0,0	0.2081											n/a (AF>5%)	n/a (AF>5%)					STAP1 (inh=n/a pLI=0.00)
chr4	68780399	68780399	A	G	het		QUAL=2996;DP=242;AF=0.47;MQM=60	TMPRSS11A,UBA6-AS1	synonymous,intron	TMPRSS11A:ENST00000334830:synonymous:LOW:exon9/10:c.1011T>C:p.Asp337Asp,TMPRSS11A:ENST00000508048:synonymous:LOW:exon9/10:c.999T>C:p.Asp333Asp,TMPRSS11A:ENST00000396188:synonymous:LOW:exon9/10:c.1002T>C:p.Asp334Asp,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1906-147926A>G:		rs1371932	0.4842	0.5341	17807,10529,631	0.3436,0.4683,0.6727,0.5586,0.5080	0.5352										COSM3760697	n/a (AF>5%)	n/a (AF>5%)					TMPRSS11A (inh=n/a pLI=0.00), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	68795815	68795815	A	G	het	off-target	QUAL=2323;DP=133;AF=0.62;MQM=60	UBA6-AS1,TMPRSS11A	intron	UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1906-132510A>G:,TMPRSS11A:ENST00000334830:intron:MODIFIER:exon4/9:c.330-57T>C:,TMPRSS11A:ENST00000508048:intron:MODIFIER:exon4/9:c.318-57T>C:,TMPRSS11A:ENST00000396188:intron:MODIFIER:exon4/9:c.321-57T>C:		rs17578509	0.1284	0.0000	0,0,0	0,0,0,0,0	0.1160											n/a (AF>5%)	n/a (AF>5%)					UBA6-AS1 (inh=n/a pLI=n/a), TMPRSS11A (inh=n/a pLI=0.00)
chr4	68919617	68919617	G	A	hom		QUAL=3008;DP=91;AF=1.00;MQM=60	TMPRSS11F,UBA6-AS1	3'UTR,intron	TMPRSS11F:ENST00000356291:3'UTR:MODIFIER:exon10/10:c.*10C>T:,UBA6-AS1:ENST00000500538:intron:MODIFIER:exon6/7:n.1906-8708G>A:		rs10018943	0.6579	0.7292	33011,19979,1405	0.5196,0.4949,0.8817,0.7739,0.7627	0.7229											n/a (AF>5%)	n/a (AF>5%)					TMPRSS11F (inh=n/a pLI=0.00), UBA6-AS1 (inh=n/a pLI=n/a)
chr4	72412029	72412029	G	A	het	off-target	QUAL=1172;DP=87;AF=0.53;MQM=60	SLC4A4	intron	SLC4A4:ENST00000425175:intron:MODIFIER:exon18/24:c.2443-38G>A:,SLC4A4:ENST00000264485:intron:MODIFIER:exon18/25:c.2443-38G>A:,SLC4A4:ENST00000351898:intron:MODIFIER:exon18/23:c.2443-8828G>A:,SLC4A4:ENST00000340595:intron:MODIFIER:exon15/22:c.2311-38G>A:		rs3733362	0.3005	0.1680	2904,177,726	0.3724,0.2059,0.4880,0.0713,0.2796	0.1700							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				n/a (AF>5%)	n/a (AF>5%)					SLC4A4 (inh=AR pLI=1.00)
chr4	72429452	72429452	G	A	hom	off-target	QUAL=349;DP=12;AF=1.00;MQM=60	SLC4A4	intron	SLC4A4:ENST00000425175:intron:MODIFIER:exon23/24:c.3100-3269G>A:,SLC4A4:ENST00000264485:intron:MODIFIER:exon23/25:c.3100-58G>A:,SLC4A4:ENST00000351898:intron:MODIFIER:exon21/23:c.2848-58G>A:,SLC4A4:ENST00000340595:intron:MODIFIER:exon20/22:c.2968-58G>A:		rs2290397	0.7871	0.0000	0,0,0	0,0,0,0,0	0.8604							603345 [SLC4A4 (provisional) Renal tubular acidosis,proximal,with ocular abnormalities,604278];				n/a (AF>5%)	n/a (AF>5%)					SLC4A4 (inh=AR pLI=1.00)
chr4	76857309	76857309	C	T	het		QUAL=1285;DP=102;AF=0.49;MQM=60	NAAA	missense	NAAA:ENST00000286733:missense:MODERATE:exon3/11:c.451G>A:p.Val151Ile,NAAA:ENST00000399497:missense:MODERATE:exon3/9:c.451G>A:p.Val151Ile,NAAA:ENST00000507956:missense:MODERATE:exon3/9:c.451G>A:p.Val151Ile,NAAA:ENST00000505594:missense:MODERATE:exon2/7:c.148G>A:p.Val50Ile,NAAA:ENST00000507187:missense:MODERATE:exon3/3:c.451G>A:p.Val151Ile		rs4859571	0.2181	0.2367	3690,1881,74	0.1059,0.3169,0.3575,0.2352,0.1897	0.2428	-0.8180	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					NAAA (inh=n/a pLI=0.00)
chr4	77204500	77204500	C	T	hom	off-target	QUAL=3088;DP=96;AF=1.00;MQM=60	FAM47E-STBD1,FAM47E	intron	FAM47E-STBD1:ENST00000515604:intron:MODIFIER:exon6/6:c.1026+5123C>T:,FAM47E:ENST00000424749:intron:MODIFIER:exon7/7:c.1105-34C>T:,FAM47E:ENST00000510197:intron:MODIFIER:exon7/7:c.811-34C>T:,FAM47E:ENST00000339906:intron:MODIFIER:exon6/6:c.811-34C>T:,FAM47E-STBD1:ENST00000539752:intron:MODIFIER:exon4/4:c.-228+11579C>T:		rs1542096	0.6288	0.6556	4662,2050,301	0.5303,0.6756,0.7516,0.6876,0.6368	0.6756											n/a (AF>5%)	n/a (AF>5%)					FAM47E-STBD1 (inh=n/a pLI=0.00), FAM47E (inh=n/a pLI=0.35)
chr4	77660731	77660731	C	G	hom		QUAL=2463;DP=77;AF=1.00;MQM=60	SHROOM3	missense	SHROOM3:ENST00000296043:missense:MODERATE:exon5/11:c.1405C>G:p.Pro469Ala		rs344141	0.4385	0.5343	18119,12545,984	0.4359,0.4963,0.2508,0.6119,0.4416	0.5378	3.2570	D	T	D,B	T	2.88		403439 [benign DISEASE=not_specified]; 		COSM1431106	n/a (AF>5%)	n/a (AF>5%)					SHROOM3 (inh=n/a pLI=0.80)
chr4	78987157	78987157	A	G	hom		QUAL=4044;DP=129;AF=1.00;MQM=60	FRAS1	missense	FRAS1:ENST00000264895:missense:MODERATE:exon2/74:c.95A>G:p.Asp32Gly,FRAS1:ENST00000264899:missense:MODERATE:exon2/19:c.95A>G:p.Asp32Gly,FRAS1:ENST00000325942:missense:MODERATE:exon2/42:c.95A>G:p.Asp32Gly		rs4859905	0.5515	0.4563	12251,5275,2377	0.6954,0.5082,0.4962,0.4143,0.4452	0.4982	2.6910	T,T,T,T	T	B,B	T,T,T	14.83	607830 [FRAS1 (confirmed) Fraser syndrome 1,219000];	261821 [benign DISEASE=cryptophthalmos_syndrome,not_specified]; 		COSM3760764, COSM3760763, COSM3760765, COSM3760762	n/a (AF>5%)	n/a (AF>5%)					FRAS1 (inh=AR pLI=0.00)
chr4	79403146	79403146	A	T	het	off-target	QUAL=318;DP=37;AF=0.43;MQM=60	FRAS1	intron	FRAS1:ENST00000264895:intron:MODIFIER:exon57/73:c.8604+28A>T:		rs34505482	0.2666	0.3438	7626,4645,66	0.1103,0.4651,0.2634,0.3737,0.2902	0.3512							607830 [FRAS1 (confirmed) Fraser syndrome 1,219000];				n/a (AF>5%)	n/a (AF>5%)					FRAS1 (inh=AR pLI=0.00)
chr4	79455714	79455714	C	G	hom		QUAL=3972;DP=121;AF=1.00;MQM=60	FRAS1	synonymous	FRAS1:ENST00000264895:synonymous:LOW:exon71/74:c.11037C>G:p.Pro3679Pro		rs4975070	0.5150	0.4884	15351,6473,591	0.3385,0.4744,0.7841,0.4381,0.6524	0.4898	0.4930		T			10.72	607830 [FRAS1 (confirmed) Fraser syndrome 1,219000];	261801 [benign DISEASE=cryptophthalmos_syndrome,not_specified]; 		COSM4005806, COSM4005805	n/a (AF>5%)	n/a (AF>5%)					FRAS1 (inh=AR pLI=0.00)
chr4	84232104	84232104	T	C	hom	off-target	QUAL=182;DP=7;AF=1.00;MQM=60	HPSE	intron	HPSE:ENST00000311412:intron:MODIFIER:exon4/11:c.674-61A>G:,HPSE:ENST00000405413:intron:MODIFIER:exon5/12:c.674-61A>G:,HPSE:ENST00000512196:intron:MODIFIER:exon5/10:c.674-61A>G:,HPSE:ENST00000513463:intron:MODIFIER:exon3/10:c.500-61A>G:		rs6535455	0.8137	0.0000	0,0,0	0,0,0,0,0	0.7976											n/a (AF>5%)	n/a (AF>5%)					HPSE (inh=n/a pLI=0.00)
chr4	85762385	85762385	T	C	het		QUAL=2059;DP=167;AF=0.47;MQM=60	WDFY3	synonymous	WDFY3:ENST00000295888:synonymous:LOW:exon6/68:c.336A>G:p.Leu112Leu,WDFY3:ENST00000322366:synonymous:LOW:exon6/67:c.336A>G:p.Leu112Leu		rs2046402	0.4427	0.3985	10001,4981,1202	0.4829,0.4889,0.4934,0.3846,0.3334	0.4053	1.2970					2.18	617485 [WDFY3 (provisional) Microcephaly 18,primary,autosomal dominant,617520];			COSM4003176	n/a (AF>5%)	n/a (AF>5%)					WDFY3 (inh=AD pLI=1.00)
chr4	88052219	88052219	T	C	hom		QUAL=5066;DP=154;AF=1.00;MQM=60	AFF1	splice_region&intron	AFF1:ENST00000395146:splice_region&intron:LOW:exon16/20:c.2965-16T>C:,AFF1:ENST00000307808:splice_region&intron:LOW:exon15/19:c.2944-16T>C:,AFF1:ENST00000544085:splice_region&intron:LOW:exon13/17:c.1858-16T>C:		rs342467	0.5673	0.5937	21675,12319,1660	0.5574,0.7117,0.5819,0.6065,0.5107	0.6006											n/a (AF>5%)	n/a (AF>5%)					AFF1 (inh=n/a pLI=0.90)
chr4	90169925	90169925	A	G	het		QUAL=2428;DP=190;AF=0.48;MQM=60	GPRIN3	missense	GPRIN3:ENST00000333209:missense:MODERATE:exon1/1:c.1337T>C:p.Val446Ala,GPRIN3:ENST00000609438:missense:MODERATE:exon2/2:c.1337T>C:p.Val446Ala		rs7653897	0.6230	0.5613	19832,9386,2732	0.7271,0.3563,0.6000,0.5300,0.7217	0.5806	-2.2390	T	T	B	T	0.01				COSM3760833	n/a (AF>5%)	n/a (AF>5%)					GPRIN3 (inh=n/a pLI=0.00)
chr4	94180159	94180159	A	G	hom	off-target	QUAL=769;DP=29;AF=1.00;MQM=60	GRID2	intron	GRID2:ENST00000282020:intron:MODIFIER:exon8/15:c.1245+20518A>G:,GRID2:ENST00000510992:intron:MODIFIER:exon7/14:c.960+20518A>G:		rs7687990	0.7274	0.0000	0,0,0	0,0,0,0,0	0.6976							602368 [GRID2 (confirmed) Spinocerebellar ataxia,autosomal recessive 18,616204];				n/a (AF>5%)	n/a (AF>5%)					GRID2 (inh=AR pLI=1.00)
chr4	95169682	95169682	G	T	hom	off-target	QUAL=3642;DP=111;AF=1.00;MQM=60	SMARCAD1	intron	SMARCAD1:ENST00000457823:intron:MODIFIER:exon6/23:c.706-1123G>T:,SMARCAD1:ENST00000354268:intron:MODIFIER:exon6/23:c.706-1123G>T:		rs10034781	0.7228	0.6200	2100,453,71	0.0000,0.0000,0.0000,0.5734,0.6273	0.6832							612761 [SMARCAD1 (provisional) Adermatoglyphia,136000|Basan syndrome,129200];				n/a (AF>5%)	n/a (AF>5%)					SMARCAD1 (inh=AD pLI=1.00)
chr4	100047929	100047929	G	A	het	off-target	QUAL=710;DP=76;AF=0.42;MQM=60	RP11-696N14.1,ADH4	intron	ADH4:ENST00000423445:intron:MODIFIER:exon7/8:c.1037-46C>T:,ADH4:ENST00000508393:intron:MODIFIER:exon8/9:c.1037-46C>T:,ADH4:ENST00000265512:intron:MODIFIER:exon7/8:c.980-46C>T:,ADH4:ENST00000505590:intron:MODIFIER:exon8/9:c.1037-46C>T:	L2c	rs10009145	0.2817	0.3928	10122,6287,86	0.1334,0.3329,0.1139,0.4394,0.5259	0.3956											n/a (AF>5%)	n/a (AF>5%)					RP11-696N14.1 (inh=n/a pLI=n/a), ADH4 (inh=n/a pLI=0.00)
chr4	109745336	109745336	T	G	het		QUAL=1368;DP=101;AF=0.52;MQM=60	COL25A1	synonymous	COL25A1:ENST00000399132:synonymous:LOW:exon35/38:c.1839A>C:p.Gly613Gly,COL25A1:ENST00000399127:synonymous:LOW:exon33/33:c.1848A>C:p.Gly616Gly,COL25A1:ENST00000399126:synonymous:LOW:exon35/35:c.1839A>C:p.Gly613Gly		rs7689008	0.3101	0.3279	6690,4160,632	0.3582,0.2131,0.3882,0.3528,0.2520	0.3558							610004 [COL25A1 (provisional) Fibrosis of extraocular muscles,congenital,5,616219];				n/a (AF>5%)	n/a (AF>5%)					COL25A1 (inh=AR pLI=0.00)
chr4	110737549	110737549	G	A	hom		QUAL=4448;DP=139;AF=1.00;MQM=60	GAR1	splice_region&intron	GAR1:ENST00000226796:splice_region&intron:LOW:exon2/6:c.214+15G>A:,GAR1:ENST00000394631:splice_region&intron:LOW:exon2/6:c.214+15G>A:		rs6828254	0.9848	0.9939	59391,32906,4520	0.9472,0.9969,1.0000,0.9977,0.9989	0.9944											n/a (AF>5%)	n/a (AF>5%)					GAR1 (inh=n/a pLI=0.75)
chr4	110791361	110791361	G	A	het		QUAL=1329;DP=98;AF=0.51;MQM=60	LRIT3	missense	LRIT3:ENST00000594814:missense:MODERATE:exon4/4:c.1456G>A:p.Ala486Thr,LRIT3:ENST00000379920:missense:MODERATE:exon3/3:c.1321G>A:p.Ala441Thr,LRIT3:ENST00000327908:missense:MODERATE:exon4/4:c.907G>A:p.Ala303Thr,LRIT3:ENST00000409621:missense:MODERATE:exon3/3:c.907G>A:p.Ala303Thr		rs2347131	0.2486	0.1951	3116,615,319	0.2434,0.4903,0.2819,0.1358,0.1708	0.2051	1.2010	T,T,T	T	B,B	T,T,T	1.94	615004 [LRIT3 (provisional) Night blindness,congenital stationary (complete),1F,autosomal recessive,615058];	347195 [benign DISEASE=congenital_stationary_night_blindness,_recessive]; 		COSM3760334, COSM1426365, COSM1426366	n/a (AF>5%)	n/a (AF>5%)					LRIT3 (inh=AR pLI=0.00)
chr4	111398208	111398208	A	G	hom		QUAL=860;DP=29;AF=1.00;MQM=60	ENPEP	missense	ENPEP:ENST00000265162:missense:MODERATE:exon1/20:c.638A>G:p.Gln213Arg		rs10004516	0.8476	0.8650	44800,25068,3778	0.8799,0.9472,0.8068,0.8748,0.8095	0.8680	-0.2430	T	T	B	T	5.42				COSM3760340	n/a (AF>5%)	n/a (AF>5%)					ENPEP (inh=n/a pLI=0.00)
chr4	119737885	119737885	T	C	het		QUAL=742;DP=91;AF=0.36;MQM=60	SEC24D	intron	SEC24D:ENST00000379735:intron:MODIFIER:exon4/22:c.397+534A>G:,SEC24D:ENST00000280551:intron:MODIFIER:exon4/22:c.397+534A>G:,SEC24D:ENST00000419654:intron:MODIFIER:exon5/22:c.-1369+534A>G:		rs3775839	0.3722	0.4569	1097,300,3	0.0000,0.0000,0.0000,0.4726,0.4611	0.4378							607186 [SEC24D (provisional) Cole-Carpenter syndrome 2,616294];				n/a (AF>5%)	n/a (AF>5%)					SEC24D (inh=AR pLI=0.09)
chr4	122739183	122739183	C	G	het		QUAL=832;DP=66;AF=0.52;MQM=60	CCNA2	splice_region&intron	CCNA2:ENST00000274026:splice_region&intron:LOW:exon7/7:c.1250+16G>C:		rs3217772	0.2768	0.3623	8477,4602,34	0.0717,0.5194,0.4242,0.3758,0.3265	0.3736											n/a (AF>5%)	n/a (AF>5%)					CCNA2 (inh=n/a pLI=0.99)
chr4	122749541	122749541	C	T	het		QUAL=1256;DP=100;AF=0.48;MQM=60	BBS7	splice_region&intron	BBS7:ENST00000264499:splice_region&intron:LOW:exon17/18:c.1890+16G>A:,BBS7:ENST00000506636:splice_region&intron:LOW:exon17/17:c.1890+16G>A:		rs1507994	0.3766	0.3539	7929,4009,1516	0.5413,0.3391,0.2291,0.3464,0.3330	0.4131							607590 [BBS7 (confirmed) Bardet-Biedl syndrome 7,615984];	262921 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BBS7 (inh=AR pLI=0.00)
chr4	123664204	123664204	G	A	het		QUAL=967;DP=90;AF=0.42;MQM=60	BBS12	missense	BBS12:ENST00000314218:missense:MODERATE:exon2/2:c.1157G>A:p.Arg386Gln,BBS12:ENST00000542236:missense:MODERATE:exon3/3:c.1157G>A:p.Arg386Gln		rs309370	0.5064	0.4140	11186,3891,1688	0.5684,0.4949,0.6574,0.3422,0.4733	0.4157	-0.1010	T,T	T	B	T,T	9.75	610683 [BBS12 (confirmed) Bardet-Biedl syndrome 12,615989];	166725 [benign DISEASE=bardet-biedl_syndrome,not_specified]; 		COSM4002928	n/a (AF>5%)	n/a (AF>5%)					BBS12 (inh=AR pLI=0.00)
chr4	126412575	126412575	A	G	hom		QUAL=5830;DP=177;AF=0.99;MQM=60	FAT4	synonymous	FAT4:ENST00000394329:synonymous:LOW:exon17/17:c.14598A>G:p.Arg4866Arg,FAT4:ENST00000335110:synonymous:LOW:exon15/15:c.9321A>G:p.Arg3107Arg		rs1014866	0.7406	0.7569	34892,19201,2508	0.6970,0.7117,0.8726,0.7586,0.7354	0.7578							612411 [FAT4 (provisional) Van Maldergem syndrome 2,615546|Hennekam lymphangiectasia-lymphedema syndrome 2,616006];	380802 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FAT4 (inh=AR pLI=1.00)
chr4	139100372	139100372	C	T	hom		QUAL=620;DP=20;AF=1.00;MQM=60	SLC7A11	splice_region&synonymous	SLC7A11:ENST00000280612:splice_region&synonymous:LOW:exon11/12:c.1443G>A:p.Ser481Ser		rs4479754	0.9135	0.9749	57768,33205,2733	0.7295,0.9868,1.0000,0.9990,0.9995	0.9805											n/a (AF>5%)	n/a (AF>5%)					SLC7A11 (inh=n/a pLI=0.00)
chr4	141264871	141264871	A	G	het		QUAL=1022;DP=80;AF=0.53;MQM=60	SCOC,RP11-425I13.3	splice_region&intron	SCOC:ENST00000394205:splice_region&intron:LOW:exon2/4:c.70+9A>G:,SCOC:ENST00000338517:splice_region&intron:LOW:exon2/4:c.70+9A>G:,SCOC:ENST00000394203:splice_region&intron:LOW:exon1/3:c.70+9A>G:,SCOC:ENST00000506322:splice_region&intron:LOW:exon1/4:c.-155+9A>G:		rs16998462	0.2354	0.1736	2068,510,653	0.3595,0.1762,0.2365,0.1265,0.2191	0.1980											n/a (AF>5%)	n/a (AF>5%)					SCOC (inh=n/a pLI=0.27), RP11-425I13.3 (inh=n/a pLI=n/a)
chr4	151242312	151242312	C	T	het	off-target	QUAL=1590;DP=114;AF=0.55;MQM=60	LRBA	intron	LRBA:ENST00000357115:intron:MODIFIER:exon51/57:c.7663+31G>A:,LRBA:ENST00000535741:intron:MODIFIER:exon50/56:c.7630+31G>A:,LRBA:ENST00000510413:intron:MODIFIER:exon50/56:c.7630+31G>A:,LRBA:ENST00000507224:intron:MODIFIER:exon50/50:c.7630+31G>A:		rs11737450	0.1440	0.1859	2357,1760,32	0.0652,0.1024,0.2411,0.2299,0.1088	0.1862							606453 [LRBA (provisional) Immunodeficiency,common variable,8,with autoimmunity,614700];				n/a (AF>5%)	n/a (AF>5%)					LRBA (inh=AR pLI=0.57)
chr4	151765243	151765243	G	A	het		QUAL=1299;DP=124;AF=0.43;MQM=60	LRBA	splice_region&intron	LRBA:ENST00000357115:splice_region&intron:LOW:exon28/57:c.4569+9C>T:,LRBA:ENST00000535741:splice_region&intron:LOW:exon28/56:c.4569+9C>T:,LRBA:ENST00000510413:splice_region&intron:LOW:exon28/56:c.4569+9C>T:,LRBA:ENST00000507224:splice_region&intron:LOW:exon28/50:c.4569+9C>T:		rs186080	0.7530	0.8569	45251,28674,2024	0.6258,0.8467,0.8607,0.9273,0.7273	0.8617							606453 [LRBA (provisional) Immunodeficiency,common variable,8,with autoimmunity,614700];	196133 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					LRBA (inh=AR pLI=0.57)
chr4	159858736	159858736	T	A	hom	off-target	QUAL=4445;DP=138;AF=1.00;MQM=60	C4orf45	intron	C4orf45:ENST00000434826:intron:MODIFIER:exon3/4:c.357-22225A>T:		rs11737459	0.7478	0.0000	0,0,0	0,0,0,0,0	0.6901											n/a (AF>5%)	n/a (AF>5%)					C4orf45 (inh=n/a pLI=0.00)
chr4	169393595	169393595	A	G	hom	gene_blacklist	QUAL=2972;DP=91;AF=1.00;MQM=60	DDX60L	splice_region&intron	DDX60L:ENST00000260184:splice_region&intron:LOW:exon3/37:c.74+11T>C:,DDX60L:ENST00000511577:splice_region&intron:LOW:exon3/37:c.74+11T>C:,DDX60L:ENST00000505890:splice_region&intron:LOW:exon3/29:c.74+11T>C:		rs13149639	0.7336	0.7698	9465,4491,411	0.5354,0.7787,0.8620,0.7707,0.8174	0.7797											n/a (AF>5%)	n/a (AF>5%)					DDX60L (inh=n/a pLI=0.00)
chr4	170994555	170994555	T	-	het	off-target	QUAL=192;DP=25;AF=0.56;MQM=60	AADAT	intron	AADAT:ENST00000509167:intron:MODIFIER:exon5/13:c.457-59delA:,AADAT:ENST00000337664:intron:MODIFIER:exon4/12:c.445-59delA:,AADAT:ENST00000515480:intron:MODIFIER:exon5/13:c.445-59delA:,AADAT:ENST00000353187:intron:MODIFIER:exon5/13:c.445-59delA:		rs5864015;rs796190674	0.6112	0.0000	0,0,0	0,0,0,0,0	0.5466											n/a (AF>5%)	n/a (AF>5%)					AADAT (inh=n/a pLI=0.18)
chr4	175429371	175429371	T	-	het	off-target	QUAL=1106;DP=81;AF=0.54;MQM=60	HPGD	intron	HPGD:ENST00000296522:intron:MODIFIER:exon4/6:c.421+476delA:,HPGD:ENST00000296521:intron:MODIFIER:exon4/5:c.421+476delA:,HPGD:ENST00000510901:intron:MODIFIER:exon4/6:c.58+476delA:,HPGD:ENST00000422112:intron:MODIFIER:exon2/4:c.218-12596delA:,HPGD:ENST00000541923:intron:MODIFIER:exon3/5:c.58+476delA:,HPGD:ENST00000542498:intron:MODIFIER:exon4/4:c.421+476delA:,HPGD:ENST00000504433:intron:MODIFIER:exon4/4:c.422-37delA:		rs5864277	0.6731	0.6584	2743,1078,117	0.6464,0.0000,0.0000,0.7716,0.6006	0.7162							601688 [HPGD (provisional) Cranioosteoarthropathy,259100|Hypertrophic osteoarthropathy,primary,autosomal recessive 1,259100|Digital clubbing,isolated congenital,119900];				n/a (AF>5%)	n/a (AF>5%)					HPGD (inh=AR+AD pLI=0.00)
chr4	177113764	177113764	A	C	hom		QUAL=1306;DP=41;AF=1.00;MQM=60	SPATA4	splice_region&intron	SPATA4:ENST00000280191:splice_region&intron:LOW:exon4/5:c.688+14T>G:,SPATA4:ENST00000515234:splice_region&intron:LOW:exon3/4:c.169+14T>G:		rs6857056	0.6863	0.6668	26733,14743,2041	0.6429,0.6110,0.8732,0.6722,0.5949	0.6637											n/a (AF>5%)	n/a (AF>5%)					SPATA4 (inh=n/a pLI=0.00)
chr4	183815688	183815688	A	G	het		QUAL=1860;DP=127;AF=0.55;MQM=60	DCTD	synonymous	DCTD:ENST00000357067:synonymous:LOW:exon4/6:c.348T>C:p.Val116Val,DCTD:ENST00000438320:synonymous:LOW:exon4/6:c.315T>C:p.Val105Val,DCTD:ENST00000510370:synonymous:LOW:exon5/7:c.315T>C:p.Val105Val		rs4742	0.3107	0.2947	5775,3188,1309	0.5010,0.1277,0.2188,0.3076,0.2493	0.3584										COSM3760499	n/a (AF>5%)	n/a (AF>5%)					DCTD (inh=n/a pLI=0.00)
chr4	184171187	184171187	T	C	hom	off-target	QUAL=4748;DP=142;AF=1.00;MQM=60	WWC2	intron	WWC2:ENST00000448232:intron:MODIFIER:exon8/22:c.953+41T>C:,WWC2:ENST00000403733:intron:MODIFIER:exon8/22:c.953+41T>C:,WWC2:ENST00000378925:intron:MODIFIER:exon8/15:c.659+41T>C:,WWC2:ENST00000513834:intron:MODIFIER:exon8/22:c.953+41T>C:,WWC2:ENST00000504005:intron:MODIFIER:exon1/15:c.-1-3723T>C:		rs10020261	0.4485	0.5022	14575,9166,916	0.4359,0.2613,0.2202,0.5539,0.6212	0.4860											n/a (AF>5%)	n/a (AF>5%)					WWC2 (inh=n/a pLI=0.00)
chr4	185634144	185634144	T	C	het		QUAL=71;DP=16;AF=0.31;MQM=60	CENPU	missense	CENPU:ENST00000281453:missense:MODERATE:exon7/13:c.642A>G:p.Ile214Met,CENPU:ENST00000541971:missense:MODERATE:exon7/12:c.642A>G:p.Ile214Met		rs4616798	0.1446	0.1468	1550,863,372	0.2690,0.1258,0.0004,0.1578,0.1163	0.1743	-3.0750	T,T,T	T	B,B	T,T	0.01				COSM3760510	n/a (AF>5%)	n/a (AF>5%)					CENPU (inh=n/a pLI=0.00)
chr4	185999587	185999587	T	A	het	off-target	QUAL=636;DP=45;AF=0.56;MQM=60	RP11-386B13.3				rs6818170	0.6675	0.6436	23810,13741,2802	0.8290,0.5382,0.4129,0.6704,0.6561	0.6815											n/a (AF>5%)	n/a (AF>5%)					RP11-386B13.3 (inh=n/a pLI=n/a)
chr4	186097045	186097045	C	T	het		QUAL=2055;DP=190;AF=0.43;MQM=60	KIAA1430	synonymous	KIAA1430:ENST00000458385:synonymous:LOW:exon3/5:c.1215G>A:p.Pro405Pro,KIAA1430:ENST00000514798:synonymous:LOW:exon3/4:c.1215G>A:p.Pro405Pro,KIAA1430:ENST00000296775:synonymous:LOW:exon3/4:c.1215G>A:p.Pro405Pro		rs6855305	0.5056	0.4846	14394,7482,1889	0.6186,0.5229,0.3974,0.4745,0.4629	0.5023											n/a (AF>5%)	n/a (AF>5%)					CFAP97 (inh=n/a pLI=0.02)
chr4	187115632	187115632	C	A	het	off-target	QUAL=811;DP=68;AF=0.49;MQM=60	CYP4V2	intron	CYP4V2:ENST00000378802:intron:MODIFIER:exon1/10:c.215-22C>A:	L1MC4a	rs10013653	0.4040	0.3615	8904,5244,2209	0.6626,0.2156,0.2842,0.3954,0.1654	0.4711							608614 [CYP4V2 (confirmed) Bietti crystalline corneoretinal dystrophy,210370];			COSN167384	n/a (AF>5%)	n/a (AF>5%)					CYP4V2 (inh=AR pLI=0.00)
chr4	187118662	187118662	G	T	het	off-target	QUAL=2503;DP=190;AF=0.49;MQM=60	CYP4V2	intron	CYP4V2:ENST00000378802:intron:MODIFIER:exon4/10:c.605-25G>T:		rs4862662	0.3119	0.3432	7650,5234,770	0.3884,0.2199,0.3311,0.3955,0.1655	0.3938							608614 [CYP4V2 (confirmed) Bietti crystalline corneoretinal dystrophy,210370];				n/a (AF>5%)	n/a (AF>5%)					CYP4V2 (inh=AR pLI=0.00)
chr4	187201211	187201211	A	G	het		QUAL=1384;DP=81;AF=0.64;MQM=60	F11	synonymous	F11:ENST00000403665:synonymous:LOW:exon8/15:c.801A>G:p.Thr267Thr,F11:ENST00000264692:synonymous:LOW:exon8/15:c.645A>G:p.Thr215Thr		rs5974	0.1671	0.1513	1560,743,254	0.2209,0.1015,0.0449,0.1485,0.2040	0.1631	-0.9920		T			0.60	264900 [F11 (confirmed) Factor XI deficiency,autosomal recessive,612416|Factor XI deficiency,autosomal dominant,612416];	255181 [benign DISEASE=hereditary_factor_xi_deficiency_disease,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					F11 (inh=AR+AD pLI=0.00)
chr4	187557893	187557893	T	C	het	gene_blacklist	QUAL=2816;DP=207;AF=0.50;MQM=60	FAT1	missense	FAT1:ENST00000441802:missense:MODERATE:exon5/27:c.3818A>G:p.His1273Arg		rs328418	0.6458	0.5876	21533,10403,3314	0.8200,0.6915,0.6868,0.5562,0.4578	0.6358	5.9400	T,T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					FAT1 (inh=n/a pLI=0.00)
chr5	915958	915958	T	C	het	off-target	QUAL=1371;DP=101;AF=0.51;MQM=60	TRIP13	intron	TRIP13:ENST00000166345:intron:MODIFIER:exon11/12:c.1134-61T>C:		rs56313889	0.0711	0.0000	0,0,0	0,0,0,0,0	0.0806							604507 [TRIP13 (provisional) Mosaic variegated aneuploidy syndrome 3,617598];				n/a (AF>5%)	n/a (AF>5%)					TRIP13 (inh=n/a pLI=1.00)
chr5	1212647	1212647	C	T	hom	off-target	QUAL=521;DP=19;AF=1.00;MQM=60	SLC6A19	intron	SLC6A19:ENST00000304460:intron:MODIFIER:exon4/11:c.663+48C>T:		rs13180809	0.3161	0.4174	11129,8293,180	0.1917,0.2049,0.3092,0.5087,0.3691	0.4078							608893 [SLC6A19 (confirmed) Hartnup disorder,234500|Iminoglycinuria,digenic,242600|Hyperglycinuria,138500];				n/a (AF>5%)	n/a (AF>5%)					SLC6A19 (inh=AR+AD pLI=0.00)
chr5	1325803	1325803	A	G	het	off-target	QUAL=288;DP=43;AF=0.37;MQM=60	CLPTM1L	intron	CLPTM1L:ENST00000320895:intron:MODIFIER:exon10/16:c.1146+63T>C:,CLPTM1L:ENST00000507807:intron:MODIFIER:exon7/13:c.639+63T>C:,CLPTM1L:ENST00000320927:intron:MODIFIER:exon9/15:c.1038+63T>C:		rs465498	0.3630	0.0000	0,0,0	0,0,0,0,0	0.4591											n/a (AF>5%)	n/a (AF>5%)					CLPTM1L (inh=n/a pLI=0.20)
chr5	1568463	1568463	T	C	hom		QUAL=5313;DP=161;AF=1.00;MQM=60	CTD,2245E15.3,SDHAP3	intergenic_region	SDHAP3:ENSG00000251532-ENSG00000185986:intergenic_region:MODIFIER::n.1568463T>C:		rs13188792	0.6320	0.0000	0,0,0	0,0,0,0,0	0.7313											n/a (AF>5%)	n/a (AF>5%)					CTD (inh=n/a pLI=n/a), 2245E15.3 (inh=n/a pLI=n/a), SDHAP3 (inh=n/a pLI=n/a)
chr5	5240002	5240002	C	A	het		QUAL=1200;DP=88;AF=0.51;MQM=60	ADAMTS16	synonymous	ADAMTS16:ENST00000274181:synonymous:LOW:exon16/23:c.2487C>A:p.Ile829Ile		rs11742370	0.1134	0.1663	1958,1378,6	0.0320,0.0801,0.0884,0.2001,0.2163	0.1630											n/a (AF>5%)	n/a (AF>5%)					ADAMTS16 (inh=n/a pLI=0.00)
chr5	7866967	7866967	G	C	hom		QUAL=3546;DP=108;AF=1.00;MQM=60	FASTKD3,MTRR	synonymous	FASTKD3:ENST00000264669:synonymous:LOW:exon2/7:c.1230C>G:p.Ala410Ala		rs162030	0.8205	0.8198	40956,22792,4203	0.9014,0.8282,0.7023,0.8254,0.7962	0.8448											n/a (AF>5%)	n/a (AF>5%)					FASTKD3 (inh=n/a pLI=0.00), MTRR (inh=AR pLI=0.00)
chr5	13692279	13692279	A	T	hom	off-target;gene_blacklist	QUAL=1192;DP=38;AF=1.00;MQM=60	DNAH5	intron	DNAH5:ENST00000265104:intron:MODIFIER:exon78/78:c.13724-35T>A:		rs2166337	0.5088	0.5258	16531,10044,1615	0.5686,0.4989,0.4361,0.5550,0.4370	0.5388							603335 [DNAH5 (confirmed) Ciliary dyskinesia,primary,3,with or without situs inversus,608644];	258001 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					DNAH5 (inh=AR pLI=0.00)
chr5	13867819	13867819	C	T	het	off-target	QUAL=196;DP=18;AF=0.56;MQM=60	DNAH5,CTB-51A17.1	intron	DNAH5:ENST00000265104:intron:MODIFIER:exon25/78:c.4053+64G>A:		rs1445810	0.3474	0.0000	0,0,0	0,0,0,0,0	0.4128							603335 [DNAH5 (confirmed) Ciliary dyskinesia,primary,3,with or without situs inversus,608644];				n/a (AF>5%)	n/a (AF>5%)					DNAH5 (inh=AR pLI=0.00), CTB-51A17.1 (inh=n/a pLI=n/a)
chr5	13894894	13894894	T	A	hom		QUAL=5766;DP=175;AF=1.00;MQM=60	DNAH5,CTB-51A17.1	missense	DNAH5:ENST00000265104:missense:MODERATE:exon16/79:c.2296A>T:p.Ile766Leu		rs4701997	0.4878	0.5073	16146,8643,1501	0.5399,0.5023,0.2434,0.5092,0.6322	0.5013	3.0120	T	T	B	T	16.20	603335 [DNAH5 (confirmed) Ciliary dyskinesia,primary,3,with or without situs inversus,608644];	178753 [benign DISEASE=primary_ciliary_dyskinesia,not_specified]; 		COSM149798	n/a (AF>5%)	n/a (AF>5%)					DNAH5 (inh=AR pLI=0.00), CTB-51A17.1 (inh=n/a pLI=n/a)
chr5	14378068	14378068	T	G	het	off-target	QUAL=1271;DP=106;AF=0.48;MQM=60	TRIO	intron	TRIO:ENST00000344204:intron:MODIFIER:exon19/56:c.3332-53T>G:,TRIO:ENST00000537187:intron:MODIFIER:exon19/57:c.3332-53T>G:,TRIO:ENST00000509967:intron:MODIFIER:exon19/29:c.3185-53T>G:		rs30770	0.8243	0.0000	0,0,0	0,0,0,0,0	0.8912							601893 [TRIO (provisional) Mental retardation,autosomal dominant 44,617061];				n/a (AF>5%)	n/a (AF>5%)					TRIO (inh=AD pLI=1.00)
chr5	16673975	16673975	C	G	het		QUAL=1949;DP=217;AF=0.37;MQM=60	MYO10	missense	MYO10:ENST00000513610:missense:MODERATE:exon36/41:c.4988G>C:p.Ser1663Thr,MYO10:ENST00000274203:missense:MODERATE:exon18/23:c.3059G>C:p.Ser1020Thr,MYO10:ENST00000515803:missense:MODERATE:exon18/23:c.3005G>C:p.Ser1002Thr,MYO10:ENST00000427430:missense:MODERATE:exon18/23:c.3059G>C:p.Ser1020Thr,MYO10:ENST00000505695:missense:MODERATE:exon18/23:c.3005G>C:p.Ser1002Thr		rs25901	0.8237	0.7407	33743,14814,4355	0.9430,0.8471,0.7753,0.6651,0.8298	0.7681	8.0330	T,T,T,T,T	T	B,B,B	D,D,D,D,D	16.35				COSM4159701, COSM4159700	n/a (AF>5%)	n/a (AF>5%)					MYO10 (inh=n/a pLI=0.01)
chr5	19721490	19721490	T	C	hom		QUAL=7569;DP=230;AF=1.00;MQM=60	CDH18	synonymous	CDH18:ENST00000274170:synonymous:LOW:exon5/13:c.609A>G:p.Gln203Gln,CDH18:ENST00000382275:synonymous:LOW:exon5/13:c.609A>G:p.Gln203Gln,CDH18:ENST00000507958:synonymous:LOW:exon7/15:c.609A>G:p.Gln203Gln,CDH18:ENST00000506372:synonymous:LOW:exon5/13:c.609A>G:p.Gln203Gln,CDH18:ENST00000502796:synonymous:LOW:exon5/13:c.609A>G:p.Gln203Gln,CDH18:ENST00000511273:synonymous:LOW:exon4/10:c.609A>G:p.Gln203Gln		rs12187552	0.9637	0.9887	59407,33348,4010	0.8775,0.9939,1.0000,0.9998,0.9995	0.9912											n/a (AF>5%)	n/a (AF>5%)					CDH18 (inh=n/a pLI=0.34)
chr5	21760602	21760602	C	A	hom	off-target	QUAL=762;DP=27;AF=1.00;MQM=60	RP11-804N13.1,CDH12	intron	CDH12:ENST00000382254:intron:MODIFIER:exon13/14:c.1633+65G>T:,CDH12:ENST00000504376:intron:MODIFIER:exon12/13:c.1633+65G>T:,CDH12:ENST00000522262:intron:MODIFIER:exon10/11:c.1513+65G>T:		rs2303748	0.5078	0.0000	0,0,0	0,0,0,0,0	0.5873											n/a (AF>5%)	n/a (AF>5%)					RP11-804N13.1 (inh=n/a pLI=n/a), CDH12 (inh=n/a pLI=0.00)
chr5	32789852	32789852	T	C	het		QUAL=1698;DP=150;AF=0.45;MQM=60	AC026703.1,NPR3	3'UTR	NPR3:ENST00000265074:3'UTR:MODIFIER:exon8/8:c.*3401T>C:		rs1173756	0.6260	0.5660	19734,9650,2777	0.7272,0.4733,0.6588,0.5384,0.5973	0.5957							108962 [NPR3 (provisional) Hypertension,salt-resistant];				n/a (AF>5%)	n/a (AF>5%)					AC026703.1 (inh=n/a pLI=n/a), NPR3 (inh=n/a pLI=0.01)
chr5	33595996	33595996	C	T	het	off-target	QUAL=2072;DP=175;AF=0.45;MQM=60	ADAMTS12	intron	ADAMTS12:ENST00000504830:intron:MODIFIER:exon17/23:c.2654+43G>A:,ADAMTS12:ENST00000352040:intron:MODIFIER:exon15/21:c.2399+43G>A:		rs10461924	0.4643	0.5257	17166,9955,381	0.2699,0.5092,0.5822,0.5474,0.6119	0.5262											n/a (AF>5%)	n/a (AF>5%)					ADAMTS12 (inh=n/a pLI=0.00)
chr5	33649637	33649637	G	A	het	off-target	QUAL=1069;DP=92;AF=0.46;MQM=60	ADAMTS12	intron	ADAMTS12:ENST00000504830:intron:MODIFIER:exon8/23:c.1334+22C>T:,ADAMTS12:ENST00000352040:intron:MODIFIER:exon8/21:c.1334+22C>T:		rs4242082	0.5403	0.5911	21382,13056,909	0.4174,0.5834,0.6665,0.6264,0.5286	0.5959											n/a (AF>5%)	n/a (AF>5%)					ADAMTS12 (inh=n/a pLI=0.00)
chr5	33989518	33989518	C	T	hom		QUAL=3741;DP=113;AF=1.00;MQM=60	AMACR,RP11-1084J3.4	missense,3'UTR	AMACR:ENST00000382085:missense:MODERATE:exon5/6:c.829G>A:p.Glu277Lys,AMACR:ENST00000335606:missense:MODERATE:exon5/5:c.829G>A:p.Glu277Lys,AMACR:ENST00000502637:missense:MODERATE:exon5/5:c.784G>A:p.Glu262Lys,AMACR:ENST00000382072:3'UTR:MODIFIER:exon4/4:c.*71G>A:		rs2278008	0.6961	0.7016	30827,18374,3205	0.7825,0.6460,0.8556,0.7429,0.4216	0.7488	2.0460	T,T,T	T	B,B,B	T,T,T	19.02	604489 [AMACR (provisional) Alpha-methylacyl-CoA racemase deficiency,614307|Bile acid synthesis defect,congenital,4,214950];	128360 [benign/likely benign DISEASE=oculocutaneous_albinism,alpha-methylacyl-coa_racemase_deficiency,not_specified]; 		COSM3761202	n/a (AF>5%)	n/a (AF>5%)					AMACR (inh=AR pLI=0.37), RP11-1084J3.4 (inh=n/a pLI=n/a)
chr5	34807928	34807928	C	T	hom		QUAL=2549;DP=79;AF=0.99;MQM=60	RAI14	synonymous	RAI14:ENST00000515799:synonymous:LOW:exon8/20:c.354C>T:p.Val118Val,RAI14:ENST00000265109:synonymous:LOW:exon6/18:c.345C>T:p.Val115Val,RAI14:ENST00000512629:synonymous:LOW:exon6/17:c.345C>T:p.Val115Val,RAI14:ENST00000428746:synonymous:LOW:exon6/18:c.345C>T:p.Val115Val,RAI14:ENST00000503673:synonymous:LOW:exon7/19:c.345C>T:p.Val115Val,RAI14:ENST00000506376:synonymous:LOW:exon5/17:c.321C>T:p.Val107Val,RAI14:ENST00000397449:synonymous:LOW:exon5/17:c.324C>T:p.Val108Val		rs6895634	0.3898	0.4079	10423,5402,400	0.2698,0.5676,0.3618,0.4034,0.4427	0.4170										COSM3761206, COSM3761205	n/a (AF>5%)	n/a (AF>5%)					RAI14 (inh=n/a pLI=0.27)
chr5	34918415	34918415	A	G	het	off-target	QUAL=93;DP=9;AF=0.56;MQM=60	RAD1,BRIX1	splice_region&intron,intron	RAD1:ENST00000341754:splice_region&intron:LOW:exon1/8:c.-431-13T>C:,BRIX1:ENST00000336767:intron:MODIFIER:exon1/9:c.160-54A>G:		rs37434	0.2566	0.0000	0,0,0	0,0,0,0,0	0.2190											n/a (AF>5%)	n/a (AF>5%)					RAD1 (inh=n/a pLI=0.00), BRIX1 (inh=n/a pLI=0.97)
chr5	35047845	35047845	C	T	het	off-target	QUAL=156;DP=17;AF=0.47;MQM=60	AGXT2	intron	AGXT2:ENST00000231420:intron:MODIFIER:exon1/13:c.88+65G>A:		rs40201	0.3199	0.0000	0,0,0	0,0,0,0,0	0.2721							612471 [AGXT2 (provisional) Beta-aminoisobutyric acid,urinary excretion of,210100];				n/a (AF>5%)	n/a (AF>5%)					AGXT2 (inh=n/a pLI=0.00)
chr5	35700598	35700598	T	C	het		QUAL=559;DP=39;AF=0.56;MQM=60	SPEF2,CTD-2113L7.1	splice_region&synonymous	SPEF2:ENST00000356031:splice_region&synonymous:LOW:exon16/37:c.2142T>C:p.Asn714Asn,SPEF2:ENST00000509059:splice_region&synonymous:LOW:exon16/19:c.2127T>C:p.Asn709Asn,SPEF2:ENST00000440995:splice_region&synonymous:LOW:exon16/37:c.2127T>C:p.Asn709Asn		rs6451206	0.4405	0.5096	16182,10696,1490	0.5610,0.3369,0.2679,0.5672,0.4519	0.5496								403477 [benign DISEASE=not_specified]; 		COSM449580	n/a (AF>5%)	n/a (AF>5%)					SPEF2 (inh=n/a pLI=0.00), CTD-2113L7.1 (inh=n/a pLI=n/a)
chr5	35874575	35874575	C	T	het		QUAL=1813;DP=142;AF=0.48;MQM=60	IL7R	missense,intron	IL7R:ENST00000303115:missense:MODERATE:exon6/8:c.731C>T:p.Thr244Ile,IL7R:ENST00000343305:intron:MODIFIER:exon5/6:c.706+825C>T:,IL7R:ENST00000506850:intron:MODIFIER:exon5/5:c.706+825C>T:		rs6897932	0.1725	0.2327	3554,2394,61	0.1016,0.1834,0.1727,0.2640,0.2109	0.2329	-0.4500	T	T	B	D	0.93	146661 [IL7R (confirmed) Severe combined immunodeficiency,T-cell negative,B-cell/natural killer cell-positive type,608971];	134530 [benign DISEASE=not_specified,severe_combined_immune_deficiency]; 		COSM132904	n/a (AF>5%)	n/a (AF>5%)					IL7R (inh=AR pLI=0.00)
chr5	38527228	38527228	T	G	hom	off-target	QUAL=2279;DP=73;AF=0.96;MQM=60	LIFR	intron	LIFR:ENST00000263409:intron:MODIFIER:exon4/19:c.397+29A>C:,LIFR:ENST00000453190:intron:MODIFIER:exon4/19:c.397+29A>C:		rs2289779	0.3842	0.4720	8110,4702,169	0.2299,0.3148,0.5834,0.5155,0.4869	0.4287							151443 [LIFR (confirmed) Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome,601559];				n/a (AF>5%)	n/a (AF>5%)					LIFR (inh=AR pLI=0.19)
chr5	39108322	39108322	A	G	hom		QUAL=2269;DP=71;AF=1.00;MQM=60	FYB	splice_region&intron	FYB:ENST00000540520:splice_region&intron:LOW:exon18/18:c.2497+11T>C:,FYB:ENST00000351578:splice_region&intron:LOW:exon17/17:c.2329+11T>C:,FYB:ENST00000515010:splice_region&intron:LOW:exon16/16:c.2329+11T>C:,FYB:ENST00000505428:splice_region&intron:LOW:exon18/18:c.2467+11T>C:,FYB:ENST00000512982:splice_region&intron:LOW:exon18/18:c.2467+11T>C:		rs430630	0.8564	0.9053	9659,4064,820	0.8285,0.7982,0.8401,0.8909,0.9529	0.8810							602731 [FYB (provisional) Thrombocytopenia 3,273900];				n/a (AF>5%)	n/a (AF>5%)					FYB1 (inh=AR pLI=0.67)
chr5	41018452	41018452	A	T	het		QUAL=1818;DP=111;AF=0.59;MQM=60	MROH2B	missense	MROH2B:ENST00000399564:missense:MODERATE:exon27/42:c.2754T>A:p.Asn918Lys,MROH2B:ENST00000506092:missense:MODERATE:exon17/32:c.1419T>A:p.Asn473Lys		rs10054110	0.3456	0.3762	7359,3678,538	0.3631,0.4427,0.2912,0.3625,0.4678	0.3562	0.0660	T,T,T	T	B	T,T	0.47					n/a (AF>5%)	n/a (AF>5%)					MROH2B (inh=n/a pLI=0.00)
chr5	41149284	41149284	G	A	het	off-target	QUAL=750;DP=58;AF=0.59;MQM=60	C6	intron	C6:ENST00000263413:intron:MODIFIER:exon17/17:c.2623+59C>T:,C6:ENST00000337836:intron:MODIFIER:exon17/17:c.2623+59C>T:		rs1014588	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1672							217050 [C6 (confirmed) C6 deficiency,612446|Combined C6/C7 deficiency];				n/a (AF>5%)	n/a (AF>5%)					C6 (inh=AR pLI=0.00)
chr5	43609272	43609272	T	C	het	off-target	QUAL=352;DP=53;AF=0.38;MQM=60	NNT	5'UTR,intron	NNT:ENST00000264663:5'UTR:MODIFIER:exon2/22:c.-26T>C:,NNT:ENST00000344920:5'UTR:MODIFIER:exon2/22:c.-26T>C:,NNT:ENST00000512996:intron:MODIFIER:exon1/20:c.-242-3738T>C:		rs12187908	0.1647	0.2638	4906,3697,27	0.0584,0.1634,0.0684,0.3326,0.2505	0.2642							607878 [NNT (provisional) Glucocorticoid deficiency 4,with or without mineralocorticoid deficiency,614736];				n/a (AF>5%)	n/a (AF>5%)					NNT (inh=AR pLI=1.00)
chr5	52223350	52223350	A	G	het	off-target	QUAL=2739;DP=188;AF=0.54;MQM=60	ITGA1	intron	ITGA1:ENST00000282588:intron:MODIFIER:exon19/28:c.2614-64A>G:		rs923837	0.3688	0.0000	0,0,0	0,0,0,0,0	0.4717											n/a (AF>5%)	n/a (AF>5%)					ITGA1 (inh=n/a pLI=0.00)
chr5	54960609	54960609	A	G	hom		QUAL=2174;DP=67;AF=1.00;MQM=60	SLC38A9	synonymous	SLC38A9:ENST00000318672:synonymous:LOW:exon6/14:c.609T>C:p.Leu203Leu,SLC38A9:ENST00000396865:synonymous:LOW:exon8/16:c.609T>C:p.Leu203Leu,SLC38A9:ENST00000539768:synonymous:LOW:exon6/13:c.609T>C:p.Leu203Leu,SLC38A9:ENST00000515629:synonymous:LOW:exon6/14:c.420T>C:p.Leu140Leu,SLC38A9:ENST00000416547:synonymous:LOW:exon5/13:c.237T>C:p.Leu79Leu,SLC38A9:ENST00000512595:synonymous:LOW:exon7/14:c.528T>C:p.Leu176Leu		rs4865614	0.5585	0.6353	24886,14965,1176	0.4747,0.5859,0.4570,0.6702,0.7000	0.6258											n/a (AF>5%)	n/a (AF>5%)					SLC38A9 (inh=n/a pLI=0.65)
chr5	55155402	55155402	C	T	hom		QUAL=5372;DP=161;AF=1.00;MQM=60	IL31RA	synonymous,5'UTR	IL31RA:ENST00000447346:synonymous:LOW:exon2/15:c.129C>T:p.Pro43Pro,IL31RA:ENST00000396836:synonymous:LOW:exon2/11:c.129C>T:p.Pro43Pro,IL31RA:ENST00000396834:synonymous:LOW:exon4/18:c.72C>T:p.Pro24Pro,IL31RA:ENST00000359040:synonymous:LOW:exon2/16:c.129C>T:p.Pro43Pro,IL31RA:ENST00000354961:synonymous:LOW:exon2/16:c.72C>T:p.Pro24Pro,IL31RA:ENST00000297015:5'UTR:MODIFIER:exon2/10:c.-180C>T:,IL31RA:ENST00000490985:5'UTR:MODIFIER:exon2/16:c.-442C>T:		rs1009639	0.6284	0.6877	29714,18280,2241	0.6581,0.3942,0.4625,0.7393,0.7844	0.7081							609510 [IL31RA (provisional) Amyloidosis,primary localized cutaneous,2,613955];				n/a (AF>5%)	n/a (AF>5%)					IL31RA (inh=AD pLI=0.00)
chr5	56207123	56207123	T	A	het		QUAL=563;DP=82;AF=0.33;MQM=60	SETD9	missense	SETD9:ENST00000285947:missense:MODERATE:exon2/6:c.226T>A:p.Ser76Thr,SETD9:ENST00000541720:missense:MODERATE:exon2/6:c.226T>A:p.Ser76Thr		rs2257505	0.4892	0.6323	25902,18787,1171	0.4742,0.4259,0.2285,0.7522,0.5509	0.6317	-0.0760	T,T	T	B	T,T	0.87				COSM4003566	n/a (AF>5%)	n/a (AF>5%)					SETD9 (inh=n/a pLI=0.00)
chr5	58297881	58297881	A	G	hom		QUAL=3314;DP=102;AF=1.00;MQM=60	PDE4D	intron	PDE4D:ENST00000340635:intron:MODIFIER:exon6/14:c.922-8589T>C:,PDE4D:ENST00000360047:intron:MODIFIER:exon6/14:c.514-8589T>C:,PDE4D:ENST00000507116:intron:MODIFIER:exon6/14:c.730-8589T>C:,PDE4D:ENST00000358923:intron:MODIFIER:exon2/10:c.16-8589T>C:,PDE4D:ENST00000503258:intron:MODIFIER:exon6/14:c.532-8589T>C:,PDE4D:ENST00000405755:intron:MODIFIER:exon6/14:c.556-8589T>C:,PDE4D:ENST00000502484:intron:MODIFIER:exon8/16:c.739-8589T>C:,PDE4D:ENST00000546160:intron:MODIFIER:exon7/15:c.739-8589T>C:		rs2968014	0.0000	0.8657	41599,21891,3385	0.9279,0.9452,0.8898,0.8523,0.8303	0.8712							600129 [PDE4D (confirmed) Stroke,susceptibility to,1,606799|Acrodysostosis 2,with or without hormone resistance,614613];				n/a (AF>5%)	n/a (AF>5%)					PDE4D (inh=AD pLI=0.97)
chr5	63905068	63905068	A	G	hom		QUAL=4729;DP=147;AF=0.99;MQM=60	RGS7BP	missense	RGS7BP:ENST00000334025:missense:MODERATE:exon6/6:c.763A>G:p.Ile255Val		rs889248	0.7821	0.8321	42319,24806,3717	0.8456,0.8900,0.5921,0.8620,0.8235	0.8316	3.9290	T	T	B	T	2.74				COSM149845	n/a (AF>5%)	n/a (AF>5%)					RGS7BP (inh=n/a pLI=0.97)
chr5	64859592	64859592	T	A	hom	off-target	QUAL=3763;DP=117;AF=1.00;MQM=60	PPWD1	intron	PPWD1:ENST00000261308:intron:MODIFIER:exon1/10:c.196+259T>A:,PPWD1:ENST00000535264:intron:MODIFIER:exon1/11:c.70-38T>A:,PPWD1:ENST00000538977:intron:MODIFIER:exon1/9:c.-170+259T>A:		rs261252	0.2564	0.2336	318,90,14	0.3565,0.0000,0.0000,0.2567,0.2220	0.3186											n/a (AF>5%)	n/a (AF>5%)					PPWD1 (inh=n/a pLI=0.29)
chr5	65317181	65317181	C	T	hom		QUAL=3920;DP=120;AF=1.00;MQM=60	ERBB2IP	synonymous	ERBB2IP:ENST00000506030:synonymous:LOW:exon8/26:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000284037:synonymous:LOW:exon8/26:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000380943:synonymous:LOW:exon8/25:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000416865:synonymous:LOW:exon8/19:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000380935:synonymous:LOW:exon8/24:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000380936:synonymous:LOW:exon8/24:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000380939:synonymous:LOW:exon8/26:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000380938:synonymous:LOW:exon8/24:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000511297:synonymous:LOW:exon8/25:c.565C>T:p.Leu189Leu,ERBB2IP:ENST00000508515:synonymous:LOW:exon7/23:c.565C>T:p.Leu189Leu		rs706679	0.6721	0.7708	37313,24226,1472	0.5284,0.5289,0.5172,0.8530,0.8559	0.7623											n/a (AF>5%)	n/a (AF>5%)					ERBIN (inh=n/a pLI=0.99)
chr5	68409094	68409094	A	C	het	off-target	QUAL=501;DP=44;AF=0.50;MQM=60	SLC30A5,CTC-498J12.3	intron	SLC30A5:ENST00000396591:intron:MODIFIER:exon6/15:c.535+40A>C:		rs164393	0.7290	0.6699	26253,11769,3138	0.7867,0.7613,0.8615,0.6149,0.6404	0.6888											n/a (AF>5%)	n/a (AF>5%)					SLC30A5 (inh=n/a pLI=0.95), CTC-498J12.3 (inh=n/a pLI=n/a)
chr5	68411010	68411010	C	T	het	off-target	QUAL=199;DP=31;AF=0.45;MQM=60	SLC30A5,CTC-498J12.3	intron	SLC30A5:ENST00000396591:intron:MODIFIER:exon7/15:c.613-54C>T:		rs240809	0.4024	0.0000	0,0,0	0,0,0,0,0	0.3817											n/a (AF>5%)	n/a (AF>5%)					SLC30A5 (inh=n/a pLI=0.95), CTC-498J12.3 (inh=n/a pLI=n/a)
chr5	68471247	68471247	G	A	het		QUAL=2278;DP=177;AF=0.49;MQM=60	CCNB1	synonymous	CCNB1:ENST00000256442:synonymous:LOW:exon7/9:c.966G>A:p.Leu322Leu		rs1128761	0.1428	0.1355	1284,479,328	0.2571,0.1893,0.0460,0.1229,0.0997	0.1688										COSM4159958	n/a (AF>5%)	n/a (AF>5%)					CCNB1 (inh=n/a pLI=0.02)
chr5	68602746	68602746	G	C	hom		QUAL=1253;DP=39;AF=1.00;MQM=60	CCDC125	splice_region&intron	CCDC125:ENST00000396496:splice_region&intron:LOW:exon5/11:c.532-17C>G:,CCDC125:ENST00000396499:splice_region&intron:LOW:exon4/10:c.532-17C>G:,CCDC125:ENST00000383374:splice_region&intron:LOW:exon5/9:c.529-17C>G:,CCDC125:ENST00000511257:splice_region&intron:LOW:exon6/12:c.157-17C>G:		rs6881767	0.4085	0.4508	11978,6848,580	0.3429,0.4334,0.4292,0.4574,0.4873	0.4532											n/a (AF>5%)	n/a (AF>5%)					CCDC125 (inh=n/a pLI=0.00)
chr5	70834926	70834926	T	C	het	off-target;gene_blacklist	QUAL=1670;DP=122;AF=0.52;MQM=60	BDP1	intron	BDP1:ENST00000358731:intron:MODIFIER:exon27/38:c.5929+21T>C:,BDP1:ENST00000380675:intron:MODIFIER:exon27/37:c.340+21T>C:		rs276589	0.0000	0.3551	8492,3970,107	0.1418,0.6260,0.5103,0.3464,0.2743	0.3670											n/a (AF>5%)	n/a (AF>5%)					BDP1 (inh=n/a pLI=0.00)
chr5	72347223	72347223	A	G	het		QUAL=879;DP=63;AF=0.56;MQM=60	FCHO2	synonymous	FCHO2:ENST00000341845:synonymous:LOW:exon12/25:c.987A>G:p.Thr329Thr,FCHO2:ENST00000430046:synonymous:LOW:exon12/26:c.987A>G:p.Thr329Thr,FCHO2:ENST00000512348:synonymous:LOW:exon11/25:c.888A>G:p.Thr296Thr		rs7712838	0.3021	0.2787	903,453,97	0.2995,0.1914,0.4804,0.3140,0.2138	0.3160											n/a (AF>5%)	n/a (AF>5%)					FCHO2 (inh=n/a pLI=1.00)
chr5	75932869	75932869	C	T	hom		QUAL=1613;DP=51;AF=1.00;MQM=60	IQGAP2	synonymous	IQGAP2:ENST00000274364:synonymous:LOW:exon16/36:c.1791C>T:p.Asp597Asp,IQGAP2:ENST00000379730:synonymous:LOW:exon16/35:c.468C>T:p.Asp156Asp,IQGAP2:ENST00000396234:synonymous:LOW:exon5/24:c.450C>T:p.Asp150Asp,IQGAP2:ENST00000502745:synonymous:LOW:exon5/24:c.450C>T:p.Asp150Asp		rs2910819	0.5505	0.5625	19312,11559,1550	0.5470,0.4140,0.4857,0.5895,0.6022	0.5631	1.2480	D	T		T	15.07				COSM149859	n/a (AF>5%)	n/a (AF>5%)					IQGAP2 (inh=n/a pLI=0.00)
chr5	75960825	75960825	G	C	het	off-target	QUAL=64;DP=22;AF=0.27;MQM=60	IQGAP2	intron	IQGAP2:ENST00000274364:intron:MODIFIER:exon21/35:c.2530-26G>C:,IQGAP2:ENST00000379730:intron:MODIFIER:exon20/34:c.1036-26G>C:,IQGAP2:ENST00000396234:intron:MODIFIER:exon9/23:c.1018-26G>C:,IQGAP2:ENST00000502745:intron:MODIFIER:exon9/23:c.1018-26G>C:		rs253092	0.3117	0.8674	41830,22593,2953	0.7879,0.8596,0.9116,0.8638,0.8993	0.8692											n/a (AF>5%)	n/a (AF>5%)					IQGAP2 (inh=n/a pLI=0.00)
chr5	79375724	79375724	G	C	het		QUAL=2452;DP=188;AF=0.48;MQM=60	THBS4,CTD-2201I18.1	splice_region&intron	THBS4:ENST00000350881:splice_region&intron:LOW:exon19/21:c.2512-4G>C:,THBS4:ENST00000511733:splice_region&intron:LOW:exon19/21:c.2239-4G>C:		rs2288395	0.3912	0.3111	6118,2180,965	0.4334,0.3827,0.4178,0.2539,0.3582	0.3125											n/a (AF>5%)	n/a (AF>5%)					THBS4 (inh=n/a pLI=0.00), CTD-2201I18.1 (inh=n/a pLI=n/a)
chr5	89820984	89820984	T	C	hom		QUAL=4353;DP=134;AF=1.00;MQM=60	LYSMD3	synonymous	LYSMD3:ENST00000315948:synonymous:LOW:exon2/3:c.123A>G:p.Glu41Glu,LYSMD3:ENST00000500869:synonymous:LOW:exon3/4:c.123A>G:p.Glu41Glu,LYSMD3:ENST00000509384:synonymous:LOW:exon2/3:c.123A>G:p.Glu41Glu		rs10069050	0.6126	0.5627	19445,10229,2582	0.7307,0.4075,0.5911,0.5530,0.6037	0.6046											n/a (AF>5%)	n/a (AF>5%)					LYSMD3 (inh=n/a pLI=0.73)
chr5	89938434	89938434	G	T	het		QUAL=865;DP=72;AF=0.47;MQM=60	GPR98	splice_region&intron	GPR98:ENST00000405460:splice_region&intron:LOW:exon11/89:c.2241-19G>T:		rs1344030	0.2404	0.1914	2532,862,194	0.2008,0.1453,0.4003,0.1615,0.2299	0.1910							602851 [GPR98 (confirmed) Febrile seizures,familial,4,604352|Usher syndrome,type 2C,605472|Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472];	137502 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ADGRV1 (inh=AR+AD pLI=0.00)
chr5	95194686	95194686	C	T	het		QUAL=912;DP=76;AF=0.49;MQM=60	C5orf27	missense	C5orf27:ENST00000357880:missense:MODERATE:exon3/3:c.253C>T:p.Arg85Cys,C5orf27:ENST00000436592:missense:MODERATE:exon4/4:c.253C>T:p.Arg85Cys	X12_LINE	rs17366761	0.0851	0.1549	157,105,5	0.0643,0.1423,0.0588,0.2230,0.1264	0.1463	-0.0070		T		T,T	13.13					n/a (AF>5%)	n/a (AF>5%)					LINC01554 (inh=n/a pLI=n/a)
chr5	96078309	96078309	G	A	hom	off-target	QUAL=1724;DP=54;AF=1.00;MQM=60	CAST,CTC-506B8.1	intron	CAST:ENST00000395813:intron:MODIFIER:exon15/31:c.1099-50G>A:,CAST:ENST00000338252:intron:MODIFIER:exon14/30:c.811-50G>A:,CAST:ENST00000508830:intron:MODIFIER:exon16/31:c.1099-50G>A:,CAST:ENST00000325674:intron:MODIFIER:exon13/29:c.994-50G>A:,CAST:ENST00000359176:intron:MODIFIER:exon14/30:c.1042-50G>A:,CAST:ENST00000395812:intron:MODIFIER:exon13/29:c.976-50G>A:,CAST:ENST00000510756:intron:MODIFIER:exon14/29:c.1033-50G>A:,CAST:ENST00000508608:intron:MODIFIER:exon14/30:c.988-50G>A:,CAST:ENST00000341926:intron:MODIFIER:exon13/29:c.850-50G>A:,CAST:ENST00000511049:intron:MODIFIER:exon13/29:c.808-50G>A:,CAST:ENST00000309190:intron:MODIFIER:exon12/28:c.784-50G>A:,CAST:ENST00000509903:intron:MODIFIER:exon11/26:c.745-50G>A:,CAST:ENST00000511782:intron:MODIFIER:exon13/29:c.808-50G>A:,CAST:ENST00000504465:intron:MODIFIER:exon10/26:c.634-50G>A:,CAST:ENST00000508579:intron:MODIFIER:exon1/17:c.-6-50G>A:		rs26503	0.6587	0.7093	25427,14536,1324	0.5667,0.8567,0.6403,0.7303,0.6375	0.7138							114090 [CAST (provisional) Peeling skin with leukonychia,acral punctate keratoses,cheilitis,and knuckle pads,616295];				n/a (AF>5%)	n/a (AF>5%)					CAST (inh=AR pLI=0.00), CTC-506B8.1 (inh=n/a pLI=n/a)
chr5	96127905	96127905	T	C	hom		QUAL=2779;DP=89;AF=1.00;MQM=60	ERAP1	splice_region&intron	ERAP1:ENST00000296754:splice_region&intron:LOW:exon7/19:c.1189-10A>G:,ERAP1:ENST00000443439:splice_region&intron:LOW:exon7/18:c.1189-10A>G:		rs27640	0.6508	0.7203	31972,20416,1898	0.6069,0.6834,0.4801,0.7821,0.6719	0.7218										COSM4003632	n/a (AF>5%)	n/a (AF>5%)					ERAP1 (inh=n/a pLI=0.00)
chr5	96245439	96245439	C	T	hom		QUAL=4741;DP=144;AF=1.00;MQM=60	ERAP2,CTD-2260A17.2	synonymous	ERAP2:ENST00000437043:synonymous:LOW:exon15/19:c.2325C>T:p.Ser775Ser,ERAP2:ENST00000379904:synonymous:LOW:exon14/18:c.2190C>T:p.Ser730Ser		rs1056893	0.5525	0.5484	18321,9029,1712	0.5767,0.6196,0.5870,0.5210,0.5754	0.5495											n/a (AF>5%)	n/a (AF>5%)					ERAP2 (inh=n/a pLI=0.00), CTD-2260A17.2 (inh=n/a pLI=n/a)
chr5	96498783	96498783	G	A	het		QUAL=622;DP=44;AF=0.59;MQM=60	RIOK2,CTD-2215E18.1	synonymous	RIOK2:ENST00000283109:synonymous:LOW:exon10/10:c.1641C>T:p.Ala547Ala		rs8654	0.5543	0.5867	20704,11593,1413	0.5214,0.5504,0.5303,0.5935,0.6258	0.5894	0.1190					13.66				COSM3765217	n/a (AF>5%)	n/a (AF>5%)					RIOK2 (inh=n/a pLI=0.00), CTD-2215E18.1 (inh=n/a pLI=n/a)
chr5	102363858	102363858	C	T	het	off-target	QUAL=642;DP=40;AF=0.63;MQM=60	PAM	intron	PAM:ENST00000304400:intron:MODIFIER:exon23/24:c.2690-28C>T:,PAM:ENST00000438793:intron:MODIFIER:exon23/24:c.2690-31C>T:,PAM:ENST00000346918:intron:MODIFIER:exon22/22:c.2486-733C>T:,PAM:ENST00000379787:intron:MODIFIER:exon24/24:c.835-738C>T:,PAM:ENST00000348126:intron:MODIFIER:exon22/23:c.2369-31C>T:,PAM:ENST00000274392:intron:MODIFIER:exon22/23:c.2396-31C>T:,PAM:ENST00000455264:intron:MODIFIER:exon22/23:c.2486-31C>T:		rs26433	0.6583	0.7018	30295,16178,1494	0.5331,0.7871,0.5686,0.6974,0.8467	0.7025											n/a (AF>5%)	n/a (AF>5%)					PAM (inh=n/a pLI=0.05)
chr5	112227799	112227799	A	G	het		QUAL=873;DP=77;AF=0.47;MQM=59	ZRSR1,CTC-487M23.8,REEP5	missense,intron	ZRSR1:ENST00000391338:missense:MODERATE:exon1/1:c.463A>G:p.Ser155Gly,REEP5:ENST00000379638:intron:MODIFIER:exon3/4:c.352-4919T>C:,REEP5:ENST00000513339:intron:MODIFIER:exon3/3:c.351+10278T>C:,REEP5:ENST00000545426:intron:MODIFIER:exon4/5:c.*323+348T>C:,REEP5:ENST00000504247:intron:MODIFIER:exon2/2:c.213-4919T>C:		rs712665	0.3762	0.3347	7591,3979,2046	0.6313,0.2462,0.1714,0.3416,0.2578	0.4187	2.4630	T	T	B		0.02				COSM3748284, COSM3748283	n/a (AF>5%)	n/a (AF>5%)					ZRSR2P1 (inh=n/a pLI=0.00), CTC-487M23.8 (inh=n/a pLI=n/a), REEP5 (inh=n/a pLI=0.05)
chr5	115811220	115811220	T	C	het	off-target	QUAL=1838;DP=150;AF=0.47;MQM=60	SEMA6A,CTB-118N6.3	intron	SEMA6A:ENST00000257414:intron:MODIFIER:exon16/19:c.1708+21A>G:,SEMA6A:ENST00000343348:intron:MODIFIER:exon16/18:c.1708+21A>G:,SEMA6A:ENST00000282394:intron:MODIFIER:exon4/5:c.304+21A>G:,SEMA6A:ENST00000510263:intron:MODIFIER:exon16/18:c.1708+21A>G:		rs423834	0.4816	0.4656	5319,1888,1189	0.6534,0.5436,0.5853,0.4197,0.4278	0.4225											n/a (AF>5%)	n/a (AF>5%)					SEMA6A (inh=n/a pLI=1.00), CTB-118N6.3 (inh=n/a pLI=n/a)
chr5	122426346	122426346	C	T	het	off-target	QUAL=200;DP=11;AF=0.73;MQM=60	PRDM6	intron	PRDM6:ENST00000407847:intron:MODIFIER:exon2/7:c.592+45C>T:	(GGCGCC)n	rs535172921	0.0431	0.0397	14,11,1	0.0852,0.0000,0.0000,0.0935,0.0158	0.0627							616982 [PRDM6 (provisional) Patent ductus arteriosus 3,617039];				n/a (AF>5%)	n/a (AF>5%)					PRDM6 (inh=AD pLI=n/a)
chr5	127777997	127777997	G	A	het		QUAL=1806;DP=153;AF=0.46;MQM=60	FBN2	intron	FBN2:ENST00000262464:intron:MODIFIER:exon7/64:c.952+4177C>T:,FBN2:ENST00000508053:intron:MODIFIER:exon13/70:c.952+4177C>T:,FBN2:ENST00000508989:intron:MODIFIER:exon6/32:c.853+4177C>T:		rs13180243	0.1344	0.1565	170,64,3	0.1196,0.0000,0.0000,0.1899,0.1466	0.1673	1.5250	D	T	B	T	18.87	612570 [FBN2 (provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118];				n/a (AF>5%)	n/a (AF>5%)					FBN2 (inh=AD pLI=1.00)
chr5	130831365	130831365	T	C	het		QUAL=1072;DP=68;AF=0.60;MQM=60	CTC-432M15.3,RAPGEF6	splice_region&intron	RAPGEF6:ENST00000296859:splice_region&intron:LOW:exon12/28:c.1420-12A>G:,RAPGEF6:ENST00000509018:splice_region&intron:LOW:exon12/27:c.1420-12A>G:,RAPGEF6:ENST00000307984:splice_region&intron:LOW:exon12/28:c.1420-12A>G:,RAPGEF6:ENST00000507093:splice_region&intron:LOW:exon12/27:c.1420-12A>G:,RAPGEF6:ENST00000512052:splice_region&intron:LOW:exon4/17:c.565-12A>G:,RAPGEF6:ENST00000308008:splice_region&intron:LOW:exon12/24:c.1420-12A>G:,RAPGEF6:ENST00000510071:splice_region&intron:LOW:exon12/17:c.1420-12A>G:		rs40400	0.7023	0.7488	33127,19996,3504	0.8286,0.6568,0.5332,0.7894,0.7545	0.7523											n/a (AF>5%)	n/a (AF>5%)					CTC-432M15.3 (inh=n/a pLI=n/a), RAPGEF6 (inh=n/a pLI=0.99)
chr5	131755651	131755651	C	T	het		QUAL=701;DP=78;AF=0.38;MQM=60	C5orf56,AC116366.5	splice_region&intron	C5orf56:ENST00000337752:splice_region&intron:LOW:exon2/3:c.48+19C>T:,C5orf56:ENST00000378953:splice_region&intron:LOW:exon2/3:c.48+19C>T:,C5orf56:ENST00000378947:splice_region&intron:LOW:exon2/3:c.48+19C>T:,C5orf56:ENST00000407797:splice_region&intron:LOW:exon2/3:c.48+19C>T:		rs1003533	0.2722	0.2435	3603,1325,214	0.2134,0.1892,0.3459,0.2079,0.3992	0.2392											n/a (AF>5%)	n/a (AF>5%)					C5orf56 (inh=n/a pLI=0.10), AC116366.5 (inh=n/a pLI=n/a)
chr5	132412299	132412299	A	G	het	off-target	QUAL=565;DP=38;AF=0.63;MQM=60	HSPA4	intron	HSPA4:ENST00000304858:intron:MODIFIER:exon6/18:c.664-47A>G:		rs11747001	0.1685	0.2183	2815,1796,148	0.1692,0.1005,0.1127,0.2447,0.2645	0.2141											n/a (AF>5%)	n/a (AF>5%)					HSPA4 (inh=n/a pLI=1.00)
chr5	134986196	134986196	C	T	hom		QUAL=2682;DP=87;AF=1.00;MQM=60	CTC-321K16.4				rs10045717	0.3906	0.5184	1321,382,5	0.0000,0.0000,0.0000,0.5602,0.5153	0.4671											n/a (AF>5%)	n/a (AF>5%)					CTC-321K16.4 (inh=n/a pLI=n/a)
chr5	137295823	137295823	T	C	hom	off-target	QUAL=385;DP=12;AF=1.00;MQM=60	FAM13B	intron	FAM13B:ENST00000033079:intron:MODIFIER:exon12/22:c.1293+32A>G:,FAM13B:ENST00000425075:intron:MODIFIER:exon11/21:c.939+32A>G:,FAM13B:ENST00000420893:intron:MODIFIER:exon12/21:c.1293+32A>G:		rs9327802	0.7897	0.7988	38097,19816,1862	0.6255,0.8199,0.9674,0.7809,0.8804	0.7936											n/a (AF>5%)	n/a (AF>5%)					FAM13B (inh=n/a pLI=0.77)
chr5	137500665	137500665	G	A	hom		QUAL=10157;DP=308;AF=1.00;MQM=60	BRD8	missense	BRD8:ENST00000254900:missense:MODERATE:exon12/27:c.1469C>T:p.Thr490Met,BRD8:ENST00000230901:missense:MODERATE:exon13/22:c.1688C>T:p.Thr563Met,BRD8:ENST00000402931:missense:MODERATE:exon12/21:c.1469C>T:p.Thr490Met,BRD8:ENST00000411594:missense:MODERATE:exon12/20:c.1478C>T:p.Thr493Met,BRD8:ENST00000455658:missense:MODERATE:exon11/20:c.1346C>T:p.Thr449Met		rs11750814	0.1166	0.1520	1637,1032,27	0.0769,0.0871,0.0111,0.1746,0.2183	0.1486	4.8990	.,D,D,D,D,D,D,D,D	T,T	.,B,B,B,P,B,B,B	.,T,T,T,T,T,T,T	23.70					n/a (AF>5%)	n/a (AF>5%)					BRD8 (inh=n/a pLI=0.02)
chr5	141336264	141336264	G	T	het		QUAL=2216;DP=207;AF=0.42;MQM=60	PCDH12	missense	PCDH12:ENST00000231484:missense:MODERATE:exon1/4:c.1153C>A:p.His385Asn		rs164075	0.0000	0.6281	25044,9277,3988	0.8733,0.7535,0.8187,0.5281,0.7432	0.6419	0.3600	T	T	B	T	4.98	605622 [PCDH12 (provisional) Microcephaly,seizures,spasticity,and brain calcification,251280];				n/a (AF>5%)	n/a (AF>5%)					PCDH12 (inh=n/a pLI=0.00)
chr5	146754839	146754839	C	G	het		QUAL=482;DP=39;AF=0.51;MQM=60	STK32A	intron	STK32A:ENST00000398523:intron:MODIFIER:exon11/13:c.1032+58C>G:,STK32A:ENST00000397936:intron:MODIFIER:exon11/12:c.1032+58C>G:		rs10515585	0.2837	0.3310	3829,1297,27	0.1146,0.4947,0.6080,0.2905,0.3696	0.2831											n/a (AF>5%)	n/a (AF>5%)					STK32A (inh=n/a pLI=0.00)
chr5	147480868	147480868	G	A	het	off-target	QUAL=62;DP=10;AF=0.40;MQM=60	SPINK5	intron	SPINK5:ENST00000359874:intron:MODIFIER:exon13/33:c.1221-50G>A:,SPINK5:ENST00000398454:intron:MODIFIER:exon13/27:c.1221-50G>A:,SPINK5:ENST00000256084:intron:MODIFIER:exon13/32:c.1221-50G>A:		rs2303066	0.4329	0.5041	14903,8033,290	0.2433,0.7180,0.4809,0.5105,0.4910	0.5193							605010 [SPINK5 (provisional) Netherton syndrome,256500];				n/a (AF>5%)	n/a (AF>5%)					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147481018	147481018	G	A	het		QUAL=1224;DP=128;AF=0.39;MQM=60	SPINK5	splice_region&intron	SPINK5:ENST00000359874:splice_region&intron:LOW:exon14/33:c.1302+19G>A:,SPINK5:ENST00000398454:splice_region&intron:LOW:exon14/27:c.1302+19G>A:,SPINK5:ENST00000256084:splice_region&intron:LOW:exon14/32:c.1302+19G>A:		rs2303068	0.4331	0.5067	15895,8632,303	0.2430,0.7202,0.4839,0.5126,0.4923	0.5198							605010 [SPINK5 (provisional) Netherton syndrome,256500];	260044 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SPINK5 (inh=AR+AD pLI=0.00)
chr5	147499616	147499616	C	T	het		QUAL=1144;DP=125;AF=0.38;MQM=60	SPINK5	synonymous	SPINK5:ENST00000359874:synonymous:LOW:exon25/34:c.2358C>T:p.Leu786Leu,SPINK5:ENST00000398454:synonymous:LOW:exon25/28:c.2358C>T:p.Leu786Leu,SPINK5:ENST00000256084:synonymous:LOW:exon25/33:c.2358C>T:p.Leu786Leu		rs17704908	0.4874	0.5829	20947,12512,601	0.3523,0.7542,0.4659,0.6157,0.5089	0.5935							605010 [SPINK5 (provisional) Netherton syndrome,256500];	260050 [benign DISEASE=netherton_syndrome,not_specified]; 		COSM4003388, COSM4003387	n/a (AF>5%)	n/a (AF>5%)					SPINK5 (inh=AR+AD pLI=0.00)
chr5	148997686	148997686	A	G	hom	off-target	QUAL=4378;DP=136;AF=1.00;MQM=60	ARHGEF37	intron	ARHGEF37:ENST00000333677:intron:MODIFIER:exon5/12:c.659-53A>G:		rs6579750	0.9181	0.0000	0,0,0	0,0,0,0,0	0.9260											n/a (AF>5%)	n/a (AF>5%)					ARHGEF37 (inh=n/a pLI=0.00)
chr5	149583336	149583336	T	C	hom		QUAL=2172;DP=71;AF=1.00;MQM=60	SLC6A7	synonymous	SLC6A7:ENST00000524041:synonymous:LOW:exon9/16:c.1194T>C:p.Asp398Asp,SLC6A7:ENST00000230671:synonymous:LOW:exon9/14:c.1194T>C:p.Asp398Asp		rs2240794	0.7935	0.7749	36356,20131,3951	0.8737,0.7974,0.6505,0.7799,0.7851	0.7815											n/a (AF>5%)	n/a (AF>5%)					SLC6A7 (inh=n/a pLI=0.00)
chr5	149602223	149602224	AC	-	het	off-target	QUAL=964;DP=113;AF=0.39;MQM=60	SLC6A7,CAMK2A	3'UTR	SLC6A7:ENST00000524041:3'UTR:MODIFIER:exon16/16:c.*60_*61delCA:,CAMK2A:ENST00000348628:3'UTR:MODIFIER:exon18/18:c.*49_*50delGT:		rs140679603	0.0631	0.0645	348,102,6	0.0247,0.1105,0.0325,0.0545,0.1231	0.0663							114078 [CAMK2A (provisional) Mental retardation,autosomal dominant 53,617798];				n/a (AF>5%)	n/a (AF>5%)					SLC6A7 (inh=n/a pLI=0.00), CAMK2A (inh=n/a pLI=1.00)
chr5	150311678	150311678	A	G	het	off-target;gene_blacklist	QUAL=1832;DP=165;AF=0.45;MQM=60	ZNF300P1	non_coding_transcript_exon	ZNF300P1:ENST00000520773:non_coding_transcript_exon:MODIFIER:exon4/4:n.1644T>C:		rs11167525	0.6823	0.0000	0,0,0	0,0,0,0,0	0.5634											n/a (AF>5%)	n/a (AF>5%)					ZNF300P1 (inh=n/a pLI=n/a)
chr5	150483095	150483095	A	G	het	off-target	QUAL=1284;DP=86;AF=0.58;MQM=60	ANXA6	intron	ANXA6:ENST00000354546:intron:MODIFIER:exon25/25:c.1962+36T>C:,ANXA6:ENST00000523714:intron:MODIFIER:exon24/24:c.1866+36T>C:,ANXA6:ENST00000356496:intron:MODIFIER:exon24/24:c.1944+36T>C:,ANXA6:ENST00000377751:intron:MODIFIER:exon13/13:c.933+36T>C:,ANXA6:ENST00000521512:intron:MODIFIER:exon18/18:c.1323+36T>C:		rs4958892	0.4423	0.3949	9069,3475,668	0.3898,0.5513,0.6690,0.3373,0.4125	0.3925											n/a (AF>5%)	n/a (AF>5%)					ANXA6 (inh=n/a pLI=0.00)
chr5	150498981	150498981	C	G	het	off-target	QUAL=1529;DP=126;AF=0.47;MQM=60	ANXA6	intron	ANXA6:ENST00000354546:intron:MODIFIER:exon17/25:c.1348-30G>C:,ANXA6:ENST00000523714:intron:MODIFIER:exon16/24:c.1252-30G>C:,ANXA6:ENST00000356496:intron:MODIFIER:exon17/24:c.1348-30G>C:,ANXA6:ENST00000377751:intron:MODIFIER:exon5/13:c.319-30G>C:,ANXA6:ENST00000521512:intron:MODIFIER:exon11/18:c.727-30G>C:		rs2303022	0.3377	0.2949	6295,1820,517	0.3263,0.6314,0.4897,0.2357,0.2035	0.3052											n/a (AF>5%)	n/a (AF>5%)					ANXA6 (inh=n/a pLI=0.00)
chr5	156381370	156381370	G	A	hom	off-target	QUAL=1624;DP=54;AF=1.00;MQM=60	TIMD4	intron	TIMD4:ENST00000274532:intron:MODIFIER:exon2/8:c.400+56C>T:,TIMD4:ENST00000407087:intron:MODIFIER:exon2/7:c.400+56C>T:		rs7724832	0.7210	0.0000	0,0,0	0,0,0,0,0	0.6736											n/a (AF>5%)	n/a (AF>5%)					TIMD4 (inh=n/a pLI=0.00)
chr5	156811443	156811443	G	A	het		QUAL=1784;DP=135;AF=0.50;MQM=60	CTB-47B11.3,CYFIP2,CTB-109A12.1	intron	CYFIP2:ENST00000318218:intron:MODIFIER:exon30/32:c.3282+1076G>A:,CYFIP2:ENST00000442283:intron:MODIFIER:exon30/32:c.*407+1076G>A:,CYFIP2:ENST00000522463:intron:MODIFIER:exon23/25:c.2619+1076G>A:,CYFIP2:ENST00000521420:intron:MODIFIER:exon27/29:c.3129+1076G>A:,CYFIP2:ENST00000347377:intron:MODIFIER:exon28/30:c.3207+1076G>A:,CYFIP2:ENST00000377576:intron:MODIFIER:exon28/30:c.3207+1076G>A:,CYFIP2:ENST00000541131:intron:MODIFIER:exon25/27:c.2982+1076G>A:,CYFIP2:ENST00000435847:intron:MODIFIER:exon20/22:c.2304+1076G>A:		rs10063413	0.1122	0.1122	112,33,4	0.1436,0.0000,0.0000,0.1131,0.1081	0.1103	-0.2050		T			4.29	606323 [CYFIP2 (provisional) Epileptic encephalopathy,early infantile,65,618008];				n/a (AF>5%)	n/a (AF>5%)					CTB-47B11.3 (inh=n/a pLI=n/a), CYFIP2 (inh=n/a pLI=1.00), CTB-109A12.1 (inh=n/a pLI=n/a)
chr5	157106785	157106785	C	T	het	off-target	QUAL=564;DP=55;AF=0.44;MQM=60	C5orf52	intron	C5orf52:ENST00000409999:intron:MODIFIER:exon2/2:c.322-64C>T:		rs6556177	0.5204	0.0000	0,0,0	0,0,0,0,0	0.5280											n/a (AF>5%)	n/a (AF>5%)					C5orf52 (inh=n/a pLI=n/a)
chr5	158140222	158140222	G	A	hom	off-target	QUAL=1486;DP=47;AF=1.00;MQM=60	EBF1	intron	EBF1:ENST00000313708:intron:MODIFIER:exon12/15:c.1192-67C>T:,EBF1:ENST00000380654:intron:MODIFIER:exon11/14:c.1099-67C>T:,EBF1:ENST00000517373:intron:MODIFIER:exon12/14:c.1168-67C>T:		rs3734105	0.8281	0.0000	0,0,0	0,0,0,0,0	0.7876											n/a (AF>5%)	n/a (AF>5%)					EBF1 (inh=n/a pLI=0.99)
chr5	158204425	158204425	A	G	het		QUAL=1395;DP=90;AF=0.58;MQM=60	EBF1	synonymous	EBF1:ENST00000313708:synonymous:LOW:exon10/16:c.1032T>C:p.Tyr344Tyr,EBF1:ENST00000380654:synonymous:LOW:exon9/15:c.939T>C:p.Tyr313Tyr,EBF1:ENST00000517373:synonymous:LOW:exon10/15:c.1008T>C:p.Tyr336Tyr		rs1368298	0.5935	0.4822	14933,6435,3462	0.8143,0.5422,0.6457,0.4407,0.3534	0.5451										COSM1132223	n/a (AF>5%)	n/a (AF>5%)					EBF1 (inh=n/a pLI=0.99)
chr5	161128761	161128761	C	G	hom		QUAL=5051;DP=153;AF=1.00;MQM=60	GABRA6	synonymous	GABRA6:ENST00000274545:synonymous:LOW:exon9/9:c.1344C>G:p.Val448Val,GABRA6:ENST00000523217:synonymous:LOW:exon9/9:c.1314C>G:p.Val438Val		rs4277944	0.0000	0.9893	59464,33338,4091	0.8867,0.9924,1.0000,0.9996,0.9999	0.9917											n/a (AF>5%)	n/a (AF>5%)					GABRA6 (inh=n/a pLI=0.00)
chr5	167913510	167913510	G	A	het		QUAL=2735;DP=172;AF=0.58;MQM=60	RARS	missense,5'UTR	RARS:ENST00000231572:missense:MODERATE:exon1/15:c.7G>A:p.Val3Ile,RARS:ENST00000538719:5'UTR:MODIFIER:exon1/14:c.-503G>A:		rs244903	0.6803	0.6021	5264,2014,1117	0.7525,0.6914,0.8709,0.5687,0.5099	0.6339	3.9350	T	T	B	T	18.77	107820 [RARS (confirmed) Leukodystrophy,hypomyelinating,9,616140];	380030 [benign DISEASE=not_specified]; 		COSM3761094	n/a (AF>5%)	n/a (AF>5%)					RARS (inh=AR pLI=0.01)
chr5	172196711	172196711	G	T	hom		QUAL=7166;DP=219;AF=1.00;MQM=60	DUSP1,RP11-779O18.3	synonymous	DUSP1:ENST00000239223:synonymous:LOW:exon3/4:c.600C>A:p.Ile200Ile		rs2431663	0.8514	0.9302	53218,30362,1807	0.5889,0.9658,0.9999,0.9538,0.9812	0.9386											n/a (AF>5%)	n/a (AF>5%)					DUSP1 (inh=n/a pLI=0.32), RP11-779O18.3 (inh=n/a pLI=n/a)
chr5	173380346	173380346	C	T	hom	off-target	QUAL=939;DP=30;AF=1.00;MQM=60	CPEB4	3'UTR,intron	CPEB4:ENST00000519835:3'UTR:MODIFIER:exon7/7:c.*38C>T:,CPEB4:ENST00000265085:intron:MODIFIER:exon9/9:c.1962+71C>T:,CPEB4:ENST00000520867:intron:MODIFIER:exon7/7:c.1887+71C>T:,CPEB4:ENST00000334035:intron:MODIFIER:exon8/8:c.1911+71C>T:,CPEB4:ENST00000522336:intron:MODIFIER:exon8/8:c.792+71C>T:,CPEB4:ENST00000517880:intron:MODIFIER:exon7/7:c.741+71C>T:		rs969518	0.4832	0.5380	15713,10400,1181	0.5088,0.3391,0.3246,0.5846,0.5900	0.5405											n/a (AF>5%)	n/a (AF>5%)					CPEB4 (inh=n/a pLI=0.99)
chr5	175923431	175923431	G	A	het	off-target	QUAL=131;DP=19;AF=0.42;MQM=60	FAF2	intron	FAF2:ENST00000261942:intron:MODIFIER:exon7/10:c.662-56G>A:		rs2963670	0.0000	0.0000	0,0,0	0,0,0,0,0	0.5065											n/a (AF>5%)	n/a (AF>5%)					FAF2 (inh=n/a pLI=1.00)
chr5	178369673	178369673	T	C	het		QUAL=338;DP=25;AF=0.56;MQM=60	ZNF454	splice_region&intron	ZNF454:ENST00000320129:splice_region&intron:LOW:exon1/4:c.-107-13T>C:,ZNF454:ENST00000519564:splice_region&intron:LOW:exon1/4:c.-107-13T>C:		rs10060764	0.5561	0.6273	15392,8618,1210	0.6002,0.6816,0.6053,0.6331,0.5986	0.5775											n/a (AF>5%)	n/a (AF>5%)					ZNF454 (inh=n/a pLI=0.00)
chr5	178410738	178410738	C	T	hom	off-target	QUAL=1339;DP=41;AF=1.00;MQM=60	RP11-281O15.4,GRM6	intron	GRM6:ENST00000231188:intron:MODIFIER:exon8/9:c.2125-516G>A:,GRM6:ENST00000517717:intron:MODIFIER:exon9/10:c.2125-516G>A:		rs903988	0.9870	0.0000	0,0,0	0,0,0,0,0	0.9853							604096 [GRM6 (confirmed) Night blindness,congenital stationary (complete),1B,autosomal recessive,257270];				n/a (AF>5%)	n/a (AF>5%)					RP11-281O15.4 (inh=n/a pLI=n/a), GRM6 (inh=AR pLI=0.00)
chr5	179045142	179045142	G	A	het		QUAL=2111;DP=130;AF=0.59;MQM=60	HNRNPH1	splice_region&intron	HNRNPH1:ENST00000329433:splice_region&intron:LOW:exon5/11:c.715+4C>T:,HNRNPH1:ENST00000393432:splice_region&intron:LOW:exon6/13:c.715+4C>T:,HNRNPH1:ENST00000442819:splice_region&intron:LOW:exon6/13:c.715+4C>T:,HNRNPH1:ENST00000356731:splice_region&intron:LOW:exon5/12:c.715+4C>T:,HNRNPH1:ENST00000510411:splice_region&intron:LOW:exon5/11:c.715+4C>T:		rs4701143	0.3393	0.2965	6677,1788,126	0.1496,0.5168,0.6469,0.2290,0.3812	0.3018											n/a (AF>5%)	n/a (AF>5%)					HNRNPH1 (inh=n/a pLI=1.00)
chr5	179260213	179260213	G	A	het		QUAL=78;DP=14;AF=0.36;MQM=60	SQSTM1	synonymous	SQSTM1:ENST00000389805:synonymous:LOW:exon6/8:c.936G>A:p.Arg312Arg,SQSTM1:ENST00000376929:synonymous:LOW:exon7/9:c.684G>A:p.Arg228Arg,SQSTM1:ENST00000402874:synonymous:LOW:exon6/8:c.684G>A:p.Arg228Arg,SQSTM1:ENST00000510187:synonymous:LOW:exon6/7:c.936G>A:p.Arg312Arg,SQSTM1:ENST00000360718:synonymous:LOW:exon5/7:c.684G>A:p.Arg228Arg		rs4797	0.5873	0.6115	19142,8285,917	0.4728,0.7913,0.8214,0.5637,0.6297	0.5995							601530 [SQSTM1 (confirmed) Paget disease of bone 3,167250|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3,616437|Neurodegeneration with ataxia,dystonia,and gaze palsy,childhood-onset,617145|Myopathy,distal,with rimmed vacuoles,617158];	259191 [benign/likely benign DISEASE=paget_disease_of_bone,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SQSTM1 (inh=AR+AD pLI=0.01)
chr5	179565071	179565071	G	C	hom		QUAL=3490;DP=106;AF=1.00;MQM=60	RASGEF1C	splice_region&intron,5'UTR	RASGEF1C:ENST00000361132:splice_region&intron:LOW:exon1/13:c.-6-13C>G:,RASGEF1C:ENST00000393371:5'UTR:MODIFIER:exon1/13:c.-19C>G:		rs4700878	0.9275	0.9778	52336,31383,3011	0.7767,0.9872,0.9999,0.9994,1.0000	0.9795											n/a (AF>5%)	n/a (AF>5%)					RASGEF1C (inh=n/a pLI=0.01)
chr6	3438738	3438738	G	A	hom		QUAL=5660;DP=176;AF=0.99;MQM=60	SLC22A23	intron	SLC22A23:ENST00000436008:intron:MODIFIER:exon1/10:c.654+17402C>T:,SLC22A23:ENST00000406686:intron:MODIFIER:exon1/9:c.654+17402C>T:,SLC22A23:ENST00000380302:intron:MODIFIER:exon1/9:c.-190+6315C>T:,SLC22A23:ENST00000490273:intron:MODIFIER:exon1/10:c.-434-6166C>T:,SLC22A23:ENST00000380298:intron:MODIFIER:exon1/3:c.654+17402C>T:		rs12197689	0.6194	0.7730	3735,1003,53	0.4391,0.0000,0.0000,0.7464,0.8170	0.6877	-3.0680	D	T		T	0.96					n/a (AF>5%)	n/a (AF>5%)					SLC22A23 (inh=n/a pLI=0.37)
chr6	3739193	3739193	T	C	het	off-target	QUAL=60;DP=4;AF=0.75;MQM=60	PXDC1	intron	PXDC1:ENST00000380283:intron:MODIFIER:exon1/4:c.257-811A>G:		rs4959871	0.3822	0.0000	0,0,0	0,0,0,0,0	0.3888											n/a (AF>5%)	n/a (AF>5%)					PXDC1 (inh=n/a pLI=0.55)
chr6	7247248	7247248	T	C	het		QUAL=670;DP=61;AF=0.49;MQM=60	RREB1	missense,intron	RREB1:ENST00000379938:missense:MODERATE:exon12/13:c.4565T>C:p.Leu1522Pro,RREB1:ENST00000379933:missense:MODERATE:exon11/12:c.4400T>C:p.Leu1467Pro,RREB1:ENST00000349384:missense:MODERATE:exon11/12:c.4400T>C:p.Leu1467Pro,RREB1:ENST00000334984:intron:MODIFIER:exon11/11:c.3974-1496T>C:		rs2256596	0.7821	0.7100	26139,12077,3494	0.9047,0.6587,0.7757,0.6654,0.7589	0.7436	1.8200	T,T,T	T	B,B	T,T,T	0.13					n/a (AF>5%)	n/a (AF>5%)					RREB1 (inh=n/a pLI=1.00)
chr6	7567970	7567970	C	T	hom	off-target	QUAL=3447;DP=103;AF=1.00;MQM=60	DSP	intron	DSP:ENST00000379802:intron:MODIFIER:exon9/23:c.1141-44C>T:,DSP:ENST00000418664:intron:MODIFIER:exon9/23:c.1141-44C>T:		rs2076296	0.7728	0.7586	35023,19692,3321	0.7993,0.7588,0.8122,0.7683,0.6852	0.7644							125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	259381 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					DSP (inh=AR+AD pLI=1.00)
chr6	10894381	10894381	G	A	het		QUAL=2165;DP=132;AF=0.59;MQM=60	SYCP2L,RP11-637O19.3	missense,5'UTR	SYCP2L:ENST00000283141:missense:MODERATE:exon4/30:c.280G>A:p.Val94Ile,SYCP2L:ENST00000543878:5'UTR:MODIFIER:exon6/19:c.-198G>A:		rs6456746	0.1278	0.0777	593,175,310	0.2492,0.0337,0.1349,0.0714,0.0134	0.1202	1.4010	T	T	B	T	0.53					n/a (AF>5%)	n/a (AF>5%)					SYCP2L (inh=n/a pLI=0.00), RP11-637O19.3 (inh=n/a pLI=n/a)
chr6	11190626	11190626	A	G	het		QUAL=1555;DP=141;AF=0.43;MQM=60	NEDD9,RP3-510L9.1	synonymous	NEDD9:ENST00000379446:synonymous:LOW:exon5/7:c.1476T>C:p.Val492Val,NEDD9:ENST00000504387:synonymous:LOW:exon6/8:c.1476T>C:p.Val492Val		rs941982	0.9427	0.8971	48926,24768,4502	0.9302,0.9208,0.9999,0.8625,0.9531	0.8973											n/a (AF>5%)	n/a (AF>5%)					NEDD9 (inh=n/a pLI=0.75), RP3-510L9.1 (inh=n/a pLI=n/a)
chr6	12294258	12294258	A	G	het		QUAL=1719;DP=121;AF=0.53;MQM=60	EDN1	synonymous	EDN1:ENST00000379375:synonymous:LOW:exon3/5:c.318A>G:p.Glu106Glu		rs5369	0.9014	0.9027	49560,26063,3757	0.8496,0.9363,0.9761,0.8835,0.9504	0.9043							131240 [EDN1 (confirmed) Auriculocondylar syndrome 3,615706|Question mark ears,isolated,612798|High density lipoprotein cholesterol level QTL 7];				n/a (AF>5%)	n/a (AF>5%)					EDN1 (inh=AR+AD pLI=0.07)
chr6	15374544	15374544	C	T	het	off-target	QUAL=388;DP=29;AF=0.55;MQM=60	JARID2	intron	JARID2:ENST00000341776:intron:MODIFIER:exon2/17:c.181+61C>T:,JARID2:ENST00000397311:intron:MODIFIER:exon2/17:c.-336+61C>T:		rs2072820	0.5098	0.0000	0,0,0	0,0,0,0,0	0.5019											n/a (AF>5%)	n/a (AF>5%)					JARID2 (inh=n/a pLI=1.00)
chr6	20599628	20599628	C	T	het		QUAL=944;DP=93;AF=0.42;MQM=60	CDKAL1	intron	CDKAL1:ENST00000274695:intron:MODIFIER:exon4/15:c.287-49896C>T:,CDKAL1:ENST00000378624:intron:MODIFIER:exon3/13:c.77-49896C>T:,CDKAL1:ENST00000378610:intron:MODIFIER:exon2/13:c.287-49896C>T:		rs9366357	0.3738	0.3857	929,177,10	0.2240,0.0000,0.0000,0.3260,0.4213	0.3890											n/a (AF>5%)	n/a (AF>5%)					CDKAL1 (inh=n/a pLI=0.41)
chr6	25813150	25813150	G	A	het		QUAL=1014;DP=94;AF=0.45;MQM=60	SLC17A1	missense,intron	SLC17A1:ENST00000244527:missense:MODERATE:exon8/13:c.806C>T:p.Thr269Ile,SLC17A1:ENST00000476801:missense:MODERATE:exon8/12:c.806C>T:p.Thr269Ile,SLC17A1:ENST00000427328:intron:MODIFIER:exon7/11:c.735+173C>T:,SLC17A1:ENST00000468082:intron:MODIFIER:exon6/9:c.735+173C>T:		rs1165196	0.7191	0.6161	24030,9802,3985	0.8749,0.7394,0.8653,0.5425,0.5259	0.6747	1.8800	T,T	T	B	T,T	1.24			CM086146 [CLASS=DFP MUT=ALT PHEN="Uric acid concentration association with" GENE=SLC17A1]; 		n/a (AF>5%)	n/a (AF>5%)					SLC17A1 (inh=n/a pLI=0.00)
chr6	25862466	25862466	C	T	het		QUAL=971;DP=83;AF=0.49;MQM=60	SLC17A3	missense	SLC17A3:ENST00000397060:missense:MODERATE:exon3/13:c.298G>A:p.Ala100Thr,SLC17A3:ENST00000361703:missense:MODERATE:exon3/12:c.298G>A:p.Ala100Thr,SLC17A3:ENST00000360657:missense:MODERATE:exon3/12:c.298G>A:p.Ala100Thr		rs1165165	0.2165	0.2122	2782,1673,458	0.2968,0.1316,0.1502,0.2277,0.1836	0.2403	0.2240	T,T,T	T	B,B,B,B	T,T,T	8.30	611034 [SLC17A3 (provisional) Uric acid concentration,serum,QTL4,612671|Gout susceptibility 4,612671];			COSM3761733, COSM3761732	n/a (AF>5%)	n/a (AF>5%)					SLC17A3 (inh=n/a pLI=0.00)
chr6	26091336	26091336	T	C	het		QUAL=2121;DP=192;AF=0.43;MQM=60	HFE	splice_region&intron,intron	HFE:ENST00000357618:splice_region&intron:LOW:exon2/5:c.340+4T>C:,HFE:ENST00000397022:splice_region&intron:LOW:exon2/5:c.271+4T>C:,HFE:ENST00000317896:splice_region&intron:LOW:exon2/4:c.340+4T>C:,HFE:ENST00000470149:splice_region&intron:LOW:exon2/6:c.340+4T>C:,HFE:ENST00000336625:splice_region&intron:LOW:exon2/4:c.340+4T>C:,HFE:ENST00000461397:splice_region&intron:LOW:exon2/5:c.340+4T>C:,HFE:ENST00000309234:splice_region&intron:LOW:exon2/5:c.340+4T>C:,HFE:ENST00000353147:intron:MODIFIER:exon1/3:c.77-1577T>C:,HFE:ENST00000352392:intron:MODIFIER:exon1/2:c.77-2011T>C:,HFE:ENST00000349999:intron:MODIFIER:exon1/4:c.77-206T>C:,HFE:ENST00000488199:intron:MODIFIER:exon1/4:c.77-206T>C:		rs2071303	0.4267	0.3686	8817,3499,743	0.3756,0.4126,0.6788,0.3205,0.3693	0.3746							613609 [HFE (confirmed) Hemochromatosis,235200|Microvascular complications of diabetes 7,612635|Porphyria variegata,susceptibility to,176200|Porphyria cutanea tarda,susceptibility to,176100|Alzheimer disease,susceptibility to,104300|Transferrin serum level QTL2,614193];	129225 [benign/likely benign DISEASE=hereditary_hemochromatosis,not_specified]; 	CS991415 [CLASS=DP MUT=ALT PHEN="Haemochromatosis association with" GENE=HFE]; 	COSM150061	n/a (AF>5%)	n/a (AF>5%)					HFE (inh=AR pLI=0.00)
chr6	26365595	26365595	T	C	het		QUAL=1548;DP=102;AF=0.57;MQM=60	BTN3A2	splice_region&intron	BTN3A2:ENST00000356386:splice_region&intron:LOW:exon1/10:c.-67+15T>C:,BTN3A2:ENST00000527422:splice_region&intron:LOW:exon1/10:c.-77+15T>C:,BTN3A2:ENST00000396934:splice_region&intron:LOW:exon1/8:c.16+15T>C:,BTN3A2:ENST00000377708:splice_region&intron:LOW:exon1/10:c.-67+15T>C:,BTN3A2:ENST00000396948:splice_region&intron:LOW:exon1/10:c.-67+15T>C:,BTN3A2:ENST00000508906:splice_region&intron:LOW:exon1/9:c.-103+15T>C:		rs12203176	0.1048	0.1588	179,41,7	0.1868,0.0000,0.0000,0.1415,0.1705	0.1317											n/a (AF>5%)	n/a (AF>5%)					BTN3A2 (inh=n/a pLI=0.00)
chr6	26373678	26373678	G	A	het	off-target	QUAL=862;DP=74;AF=0.50;MQM=60	BTN3A2	intron	BTN3A2:ENST00000356386:intron:MODIFIER:exon8/10:c.964+37G>A:,BTN3A2:ENST00000527422:intron:MODIFIER:exon8/10:c.964+37G>A:,BTN3A2:ENST00000396934:intron:MODIFIER:exon6/8:c.895+37G>A:,BTN3A2:ENST00000377708:intron:MODIFIER:exon8/10:c.964+37G>A:,BTN3A2:ENST00000396948:intron:MODIFIER:exon8/10:c.964+37G>A:,BTN3A2:ENST00000508906:intron:MODIFIER:exon7/9:c.838+37G>A:		rs9393713	0.0811	0.0851	503,362,7	0.0363,0.0314,0.0833,0.1011,0.0943	0.0833											n/a (AF>5%)	n/a (AF>5%)					BTN3A2 (inh=n/a pLI=0.00)
chr6	27327349	27327349	C	G	het	gene_blacklist	QUAL=1216;DP=108;AF=0.44;MQM=60	ZNF204P	non_coding_transcript_exon	ZNF204P:ENST00000377448:non_coding_transcript_exon:MODIFIER:exon4/4:n.2262G>C:,ZNF204P:ENST00000416749:non_coding_transcript_exon:MODIFIER:exon1/1:n.652G>C:		rs9357037	0.2422	0.2764	622,283,20	0.1836,0.3560,0.4591,0.2837,0.2299	0.2393											n/a (AF>5%)	n/a (AF>5%)					ZNF204P (inh=n/a pLI=n/a)
chr6	27879982	27879982	A	G	het	gene_blacklist	QUAL=1131;DP=96;AF=0.47;MQM=60	OR2B2	missense	OR2B2:ENST00000303324:missense:MODERATE:exon1/1:c.116T>C:p.Ile39Thr		rs61742093	0.0218	0.0482	221,209,6	0.0287,0.0203,0.0001,0.0756,0.0006	0.0586	5.0720	D	T	P	T	13.66					n/a (AF>5%)	n/a (AF>5%)					OR2B2 (inh=n/a pLI=0.00)
chr6	28219270	28219270	G	A	het		QUAL=1891;DP=127;AF=0.56;MQM=59	ZKSCAN4	intron	ZKSCAN4:ENST00000377294:intron:MODIFIER:exon1/4:c.423+66C>T:,ZKSCAN4:ENST00000423974:intron:MODIFIER:exon1/4:c.-42-1658C>T:		rs1736904	0.3660	0.2820	4422,1011,1478	0.5804,0.3307,0.5209,0.2100,0.2699	0.3002	-0.2840	T	T			15.41					n/a (AF>5%)	n/a (AF>5%)					ZKSCAN4 (inh=n/a pLI=0.00)
chr6	28219826	28219826	G	A	het	off-target	QUAL=85;DP=26;AF=0.27;MQM=60	ZKSCAN4	5'UTR,intron	ZKSCAN4:ENST00000377294:5'UTR:MODIFIER:exon1/5:c.-68C>T:,ZKSCAN4:ENST00000423974:intron:MODIFIER:exon1/4:c.-42-2214C>T:		rs1736895	0.6174	0.0000	0,0,0	0,0,0,0,0	0.5303											n/a (AF>5%)	n/a (AF>5%)					ZKSCAN4 (inh=n/a pLI=0.00)
chr6	29693011	29693011	C	T	hom		QUAL=3031;DP=92;AF=1.00;MQM=60	HLA-F	missense,intron	HLA-F:ENST00000259951:missense:MODERATE:exon4/7:c.814C>T:p.Pro272Ser,HLA-F:ENST00000376861:missense:MODERATE:exon5/8:c.814C>T:p.Pro272Ser,HLA-F:ENST00000334668:missense:MODERATE:exon4/7:c.814C>T:p.Pro272Ser,HLA-F:ENST00000440587:missense:MODERATE:exon4/8:c.460C>T:p.Pro154Ser,HLA-F:ENST00000434407:intron:MODIFIER:exon3/5:c.611-213C>T:		rs1736924	0.8794	0.8474	43854,22500,3471	0.8184,0.9145,0.9860,0.8221,0.9158	0.8491	-0.0180	T,T,T,T,T,T	T	B,B	T,T,T,T	0.29					n/a (AF>5%)	n/a (AF>5%)					HLA-F (inh=n/a pLI=0.00)
chr6	29693969	29693969	C	T	het		QUAL=1247;DP=141;AF=0.37;MQM=60	HLA-F	intron	HLA-F:ENST00000259951:intron:MODIFIER:exon6/6:c.1036+149C>T:,HLA-F:ENST00000376861:intron:MODIFIER:exon7/7:c.1036+149C>T:,HLA-F:ENST00000334668:intron:MODIFIER:exon6/6:c.1036+149C>T:,HLA-F:ENST00000440587:intron:MODIFIER:exon5/7:c.649+629C>T:,HLA-F:ENST00000434407:intron:MODIFIER:exon5/5:c.760+149C>T:		rs1736922	0.2538	0.2480	3839,1683,125	0.1682,0.3001,0.2550,0.2322,0.3584	0.2483											n/a (AF>5%)	n/a (AF>5%)					HLA-F (inh=n/a pLI=0.00)
chr6	29796115	29796115	A	C	hom	off-target	QUAL=2049;DP=63;AF=1.00;MQM=60	HLA-G,HCG4P8	intron,non_coding_transcript_exon	HLA-G:ENST00000376828:intron:MODIFIER:exon3/7:c.358+22A>C:,HLA-G:ENST00000428701:intron:MODIFIER:exon3/7:c.343+22A>C:,HLA-G:ENST00000360323:intron:MODIFIER:exon2/6:c.343+22A>C:,HLA-G:ENST00000376815:intron:MODIFIER:exon2/4:c.343+22A>C:,HLA-G:ENST00000376818:intron:MODIFIER:exon2/5:c.343+22A>C:,HCG4P8:ENST00000443049:non_coding_transcript_exon:MODIFIER:exon1/1:n.27T>G:		rs1736927	0.6234	0.5481	17527,7473,1936	0.6471,0.5754,0.6152,0.4902,0.7602	0.5488							142871 [HLA-G (confirmed) Asthma,susceptibility to,600807]:613609 [HLA-H (confirmed) Hemochromatosis,235200|Microvascular complications of diabetes 7,612635|Porphyria variegata,susceptibility to,176200|Porphyria cutanea tarda,susceptibility to,176100|Alzheimer disease,susceptibility to,104300|Transferrin serum level QTL2,614193];				n/a (AF>5%)	n/a (AF>5%)					HLA-G (inh=n/a pLI=0.00), HCG4P8 (inh=n/a pLI=n/a)
chr6	29797173	29797173	A	G	hom	off-target;gene_blacklist	QUAL=10078;DP=307;AF=1.00;MQM=60	HLA-G	intron	HLA-G:ENST00000376828:intron:MODIFIER:exon4/7:c.635-22A>G:,HLA-G:ENST00000428701:intron:MODIFIER:exon4/7:c.620-22A>G:,HLA-G:ENST00000360323:intron:MODIFIER:exon3/6:c.620-22A>G:,HLA-G:ENST00000376815:intron:MODIFIER:exon2/4:c.344-420A>G:,HLA-G:ENST00000376818:intron:MODIFIER:exon2/5:c.344-22A>G:		rs1736920	0.5980	0.5438	18605,8287,1982	0.6214,0.5790,0.6083,0.4936,0.7264	0.5429							142871 [HLA-G (confirmed) Asthma,susceptibility to,600807]:613609 [HLA-H (confirmed) Hemochromatosis,235200|Microvascular complications of diabetes 7,612635|Porphyria variegata,susceptibility to,176200|Porphyria cutanea tarda,susceptibility to,176100|Alzheimer disease,susceptibility to,104300|Transferrin serum level QTL2,614193];				n/a (AF>5%)	n/a (AF>5%)					HLA-G (inh=n/a pLI=0.00)
chr6	32819836	32819836	T	A	het	off-target	QUAL=415;DP=44;AF=0.41;MQM=60	TAP1,PSMB9	intron	TAP1:ENST00000354258:intron:MODIFIER:exon3/10:c.1024+50A>T:,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-9-4079T>A:,TAP1:ENST00000425148:intron:MODIFIER:exon3/10:c.241+50A>T:		rs116106014	0.0120	0.0224	50,46,0	0.0043,0.0129,0.0004,0.0317,0.0104	0.0218							170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];				9	211					TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23)
chr6	35803283	35803283	C	T	het		QUAL=872;DP=87;AF=0.41;MQM=60	SRPK1	splice_region&intron	SRPK1:ENST00000373825:splice_region&intron:LOW:exon15/15:c.1784-18G>A:,SRPK1:ENST00000423325:splice_region&intron:LOW:exon15/15:c.1736-18G>A:,SRPK1:ENST00000373822:splice_region&intron:LOW:exon15/15:c.1460-18G>A:		rs2859420	0.4475	0.4067	7520,3473,1637	0.6414,0.3814,0.2181,0.3782,0.4937	0.4420											n/a (AF>5%)	n/a (AF>5%)					SRPK1 (inh=n/a pLI=0.00)
chr6	36261885	36261885	A	G	het	off-target	QUAL=343;DP=32;AF=0.47;MQM=60	PNPLA1	intron	PNPLA1:ENST00000312917:intron:MODIFIER:exon3/7:c.220-55A>G:,PNPLA1:ENST00000388715:intron:MODIFIER:exon3/7:c.220-82A>G:,PNPLA1:ENST00000394571:intron:MODIFIER:exon3/7:c.505-82A>G:		rs4713949	0.9878	0.0000	0,0,0	0,0,0,0,0	0.9771							612121 [PNPLA1 (provisional) Ichthyosis,congenital,autosomal recessive 10,615024];				n/a (AF>5%)	n/a (AF>5%)					PNPLA1 (inh=AR pLI=0.01)
chr6	36645696	36645696	A	G	hom		QUAL=5116;DP=157;AF=0.99;MQM=60	CDKN1A	missense	CDKN1A:ENST00000448526:missense:MODERATE:exon1/3:c.83A>G:p.Asp28Gly		rs2395655	0.5276	0.4641	1195,363,50	0.0000,0.0000,0.0000,0.5174,0.4371	0.4816	-1.2590	D	T	B	T	0.10					n/a (AF>5%)	n/a (AF>5%)					CDKN1A (inh=n/a pLI=0.12)
chr6	36713263	36713263	A	G	het		QUAL=2752;DP=246;AF=0.43;MQM=60	CPNE5	synonymous	CPNE5:ENST00000244751:synonymous:LOW:exon17/21:c.1230T>C:p.Cys410Cys,CPNE5:ENST00000393189:synonymous:LOW:exon6/10:c.354T>C:p.Cys118Cys		rs763046	0.8013	0.8071	28606,17392,2911	0.8713,0.5686,0.8255,0.8323,0.7887	0.8298										COSM4161125	n/a (AF>5%)	n/a (AF>5%)					CPNE5 (inh=n/a pLI=0.16)
chr6	37252210	37252210	C	T	hom		QUAL=3741;DP=113;AF=1.00;MQM=60	TBC1D22B	synonymous	TBC1D22B:ENST00000373491:synonymous:LOW:exon6/13:c.771C>T:p.Asn257Asn		rs3818136	0.6973	0.6821	28067,14383,1794	0.5818,0.6800,0.8554,0.6598,0.7857	0.6822											n/a (AF>5%)	n/a (AF>5%)					TBC1D22B (inh=n/a pLI=0.00)
chr6	38771106	38771106	G	A	het		QUAL=1349;DP=112;AF=0.46;MQM=60	DNAH8	splice_region&intron	DNAH8:ENST00000449981:splice_region&intron:LOW:exon22/82:c.3034+19G>A:,DNAH8:ENST00000359357:splice_region&intron:LOW:exon20/90:c.2383+19G>A:,DNAH8:ENST00000441566:splice_region&intron:LOW:exon18/87:c.2383+19G>A:		rs56247993	0.1308	0.1519	1596,721,58	0.0981,0.3214,0.1123,0.1475,0.1125	0.1570											n/a (AF>5%)	n/a (AF>5%)					DNAH8 (inh=n/a pLI=0.00)
chr6	42932715	42932715	C	T	het	off-target	QUAL=2000;DP=157;AF=0.49;MQM=60	PEX6	intron	PEX6:ENST00000304611:intron:MODIFIER:exon15/16:c.2667-48G>A:,PEX6:ENST00000244546:intron:MODIFIER:exon13/14:c.*203-48G>A:		rs2274517	0.5028	0.4935	15953,9106,2981	0.7569,0.3075,0.1922,0.5224,0.5102	0.5592							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];				n/a (AF>5%)	n/a (AF>5%)					PEX6 (inh=AR pLI=0.01)
chr6	42934620	42934620	C	T	het	off-target	QUAL=277;DP=45;AF=0.33;MQM=60	PEX6	intron	PEX6:ENST00000304611:intron:MODIFIER:exon8/16:c.1885-24G>A:,PEX6:ENST00000244546:intron:MODIFIER:exon8/14:c.1885-24G>A:		rs3818554	0.4940	0.4910	15749,9099,2786	0.7328,0.3058,0.1931,0.5221,0.5102	0.5523							601498 [PEX6 (confirmed) Peroxisome biogenesis disorder 4A (Zellweger),614862|Peroxisome biogenesis disorder 4B,614863|Heimler syndrome 2,616617];				n/a (AF>5%)	n/a (AF>5%)					PEX6 (inh=AR pLI=0.01)
chr6	43273604	43273604	A	G	hom		QUAL=4067;DP=123;AF=1.00;MQM=60	CRIP3	missense,3'UTR	CRIP3:ENST00000372569:missense:MODERATE:exon8/8:c.563T>C:p.Ile188Thr,CRIP3:ENST00000274990:3'UTR:MODIFIER:exon7/7:c.*100T>C:		rs2242416	0.4169	0.5337	18514,11738,110	0.1414,0.3727,0.6822,0.5923,0.5189	0.5344	4.5620	T	T	B	D	23.80				COSM4161225	n/a (AF>5%)	n/a (AF>5%)					CRIP3 (inh=n/a pLI=0.12)
chr6	46135489	46135489	T	C	het		QUAL=1558;DP=129;AF=0.47;MQM=60	ENPP5	missense	ENPP5:ENST00000230565:missense:MODERATE:exon2/4:c.511A>G:p.Ile171Val,ENPP5:ENST00000371383:missense:MODERATE:exon3/5:c.511A>G:p.Ile171Val		rs6926570	0.4445	0.5128	16728,9631,292	0.2322,0.4813,0.4202,0.5363,0.6676	0.5144	7.6180	T,T	T	B	T,T	22.60				COSM4161254	n/a (AF>5%)	n/a (AF>5%)					ENPP5 (inh=n/a pLI=0.00)
chr6	46832968	46832968	A	G	het	off-target	QUAL=960;DP=61;AF=0.64;MQM=60	GPR116	intron	GPR116:ENST00000265417:intron:MODIFIER:exon13/20:c.1835-34T>C:,GPR116:ENST00000283296:intron:MODIFIER:exon13/20:c.1835-34T>C:,GPR116:ENST00000362015:intron:MODIFIER:exon13/19:c.1835-34T>C:,GPR116:ENST00000456426:intron:MODIFIER:exon11/18:c.1409-34T>C:,GPR116:ENST00000545669:intron:MODIFIER:exon3/11:c.122-34T>C:		rs1234128	0.0457	0.0919	632,513,3	0.0182,0.0624,0.0002,0.1268,0.0481	0.0908											n/a (AF>5%)	n/a (AF>5%)					ADGRF5 (inh=n/a pLI=0.99)
chr6	46856263	46856263	G	A	hom	off-target	QUAL=3502;DP=106;AF=1.00;MQM=60	GPR116	intron	GPR116:ENST00000265417:intron:MODIFIER:exon3/20:c.158-21C>T:,GPR116:ENST00000283296:intron:MODIFIER:exon3/20:c.158-21C>T:,GPR116:ENST00000362015:intron:MODIFIER:exon3/19:c.158-21C>T:,GPR116:ENST00000456426:intron:MODIFIER:exon3/18:c.158-21C>T:		rs677439	0.3029	0.3937	10371,7046,61	0.0988,0.2592,0.5145,0.4598,0.2800	0.3958											n/a (AF>5%)	n/a (AF>5%)					ADGRF5 (inh=n/a pLI=0.99)
chr6	46996218	46996218	C	G	het	off-target	QUAL=1778;DP=151;AF=0.46;MQM=60	GPR110	intron	GPR110:ENST00000371253:intron:MODIFIER:exon2/14:c.69+511G>C:,GPR110:ENST00000371243:intron:MODIFIER:exon2/7:c.69+511G>C:	L2	rs1226485	0.5481	0.0000	0,0,0	0,0,0,0,0	0.4599											n/a (AF>5%)	n/a (AF>5%)					ADGRF1 (inh=n/a pLI=0.00)
chr6	47563692	47563692	C	T	hom		QUAL=4117;DP=126;AF=1.00;MQM=60	CD2AP	synonymous	CD2AP:ENST00000359314:synonymous:LOW:exon12/18:c.1204C>T:p.Leu402Leu		rs2039503	0.9830	0.9942	60018,33353,4571	0.9367,0.9971,1.0000,0.9998,1.0000	0.9953							604241 [CD2AP (confirmed) Glomerulosclerosis,focal segmental,3,607832];	260181 [benign DISEASE=focal_segmental_glomerulosclerosis,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CD2AP (inh=AR+AD pLI=0.66)
chr6	47626685	47626685	C	T	hom	off-target	QUAL=1925;DP=59;AF=1.00;MQM=60	GPR111	intron	GPR111:ENST00000296862:intron:MODIFIER:exon1/5:c.109-45C>T:,GPR111:ENST00000507065:intron:MODIFIER:exon1/5:c.-30+2265C>T:	MER5B	rs6935668	0.5443	0.6433	2037,872,118	0.5507,0.4701,0.2911,0.6913,0.6788	0.5995											n/a (AF>5%)	n/a (AF>5%)					ADGRF2 (inh=n/a pLI=0.00)
chr6	47682604	47682604	A	C	hom		QUAL=6459;DP=196;AF=1.00;MQM=60	GPR115	missense	GPR115:ENST00000371220:missense:MODERATE:exon7/11:c.1794A>C:p.Lys598Asn,GPR115:ENST00000283303:missense:MODERATE:exon6/10:c.1623A>C:p.Lys541Asn,GPR115:ENST00000327753:missense:MODERATE:exon6/10:c.1623A>C:p.Lys541Asn		rs9369738	0.8245	0.8637	45439,25879,2570	0.7020,0.9187,0.8695,0.8809,0.8559	0.8685	-1.7060	T,T,T	T	B	T,T,T	0.01				COSM4161270, COSM4161271	n/a (AF>5%)	n/a (AF>5%)					ADGRF4 (inh=n/a pLI=0.00)
chr6	49425521	49425521	C	T	het		QUAL=1222;DP=107;AF=0.45;MQM=60	MUT	synonymous	MUT:ENST00000274813:synonymous:LOW:exon3/13:c.636G>A:p.Lys212Lys		rs2229384	0.5515	0.5736	20580,12475,1731	0.5800,0.2897,0.4905,0.6126,0.6504	0.5984							609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	92687 [benign DISEASE=methylmalonic_acidemia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MUT (inh=AR pLI=0.00)
chr6	51890823	51890823	G	A	hom		QUAL=2030;DP=63;AF=1.00;MQM=60	PKHD1	missense	PKHD1:ENST00000371117:missense:MODERATE:exon32/67:c.3785C>T:p.Ala1262Val,PKHD1:ENST00000340994:missense:MODERATE:exon32/61:c.3785C>T:p.Ala1262Val		rs9296669	0.3546	0.4698	14368,9136,109	0.1530,0.6659,0.3563,0.5252,0.3601	0.4799	0.2650	T,T,T	T	B,B	D,D	0.16	606702 [PKHD1 (confirmed) Polycystic kidney disease 4,with or without hepatic disease,263200];	96399 [benign DISEASE=autosomal_recessive_polycystic_kidney_disease,not_specified]; 		COSM4004073, COSM4004072	n/a (AF>5%)	n/a (AF>5%)					PKHD1 (inh=AR pLI=0.00)
chr6	53762092	53762092	A	G	het		QUAL=956;DP=107;AF=0.39;MQM=60	LRRC1	missense	LRRC1:ENST00000370888:missense:MODERATE:exon7/14:c.577A>G:p.Ile193Val		rs9349688	0.1196	0.1116	1084,233,3	0.0249,0.2887,0.2388,0.0873,0.0728	0.1196	4.6330	T	T	B	T	22.90				COSM3762138	n/a (AF>5%)	n/a (AF>5%)					LRRC1 (inh=n/a pLI=0.40)
chr6	54186147	54186147	T	C	hom		QUAL=4874;DP=149;AF=1.00;MQM=60	TINAG	missense	TINAG:ENST00000259782:missense:MODERATE:exon3/11:c.472T>C:p.Ser158Pro,TINAG:ENST00000370869:missense:MODERATE:exon4/6:c.460T>C:p.Ser154Pro,TINAG:ENST00000370864:missense:MODERATE:exon3/4:c.418T>C:p.Ser140Pro		rs1058768	0.7378	0.6839	28654,14767,3322	0.7987,0.6033,0.8450,0.6654,0.6382	0.7134	1.3910	T,T,T	T	B	T,T,T	10.65					n/a (AF>5%)	n/a (AF>5%)					TINAG (inh=n/a pLI=0.00)
chr6	65525121	65525121	C	T	hom		QUAL=2876;DP=87;AF=1.00;MQM=60	EYS	intron	EYS:ENST00000370616:intron:MODIFIER:exon18/40:c.3244-1651G>A:,EYS:ENST00000503581:intron:MODIFIER:exon21/42:c.3244-1651G>A:,EYS:ENST00000370621:intron:MODIFIER:exon21/43:c.3244-1651G>A:		rs1390272	0.4649	0.5562	4488,2152,136	0.3959,0.7616,0.5445,0.5773,0.5001	0.5220							612424 [EYS (confirmed) Retinitis pigmentosa 25,602772];				n/a (AF>5%)	n/a (AF>5%)					EYS (inh=AR pLI=0.00)
chr6	65622463	65622463	A	G	hom		QUAL=4643;DP=142;AF=1.00;MQM=60	EYS	missense	EYS:ENST00000370616:missense:MODERATE:exon13/41:c.2555T>C:p.Leu852Pro,EYS:ENST00000503581:missense:MODERATE:exon16/43:c.2555T>C:p.Leu852Pro,EYS:ENST00000370621:missense:MODERATE:exon16/44:c.2555T>C:p.Leu852Pro		rs9294631	0.6464	0.6107	4191,1642,827	0.8782,0.6415,0.4293,0.6086,0.5623	0.6610	3.9080	T,T,T	T	B	T,T,T	5.12	612424 [EYS (confirmed) Retinitis pigmentosa 25,602772];	93605 [benign DISEASE=not_specified,retinitis_pigmentosa,_recessive,not_provided]; 			n/a (AF>5%)	n/a (AF>5%)					EYS (inh=AR pLI=0.00)
chr6	70916998	70916998	G	A	het		QUAL=740;DP=68;AF=0.46;MQM=60	COL19A1	3'UTR	COL19A1:ENST00000322773:3'UTR:MODIFIER:exon51/51:c.*20G>A:,COL19A1:ENST00000393344:3'UTR:MODIFIER:exon38/38:c.*20G>A:		rs1736	0.3219	0.3521	7816,5001,565	0.3465,0.2578,0.1182,0.3892,0.4048	0.3462											n/a (AF>5%)	n/a (AF>5%)					COL19A1 (inh=n/a pLI=0.00)
chr6	74019376	74019376	T	C	het		QUAL=334;DP=80;AF=0.25;MQM=60	KHDC1	missense	KHDC1:ENST00000370384:missense:MODERATE:exon1/5:c.62A>G:p.Tyr21Cys		rs16883573	0.1641	0.1156	118,31,24	0.2467,0.0959,0.1694,0.1170,0.0896	0.1618	0.0750		T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					KHDC1 (inh=n/a pLI=0.00)
chr6	74079024	74079024	A	G	hom		QUAL=1842;DP=57;AF=1.00;MQM=60	OOEP	missense	OOEP:ENST00000370359:missense:MODERATE:exon2/3:c.275T>C:p.Val92Ala,OOEP:ENST00000370363:missense:MODERATE:exon3/4:c.110T>C:p.Val37Ala		rs496530	0.5114	0.5318	17339,9997,618	0.3548,0.4600,0.5842,0.5471,0.5858	0.5327	-0.0620	T,T,T	T	B,B	T,T,T	0.02					n/a (AF>5%)	n/a (AF>5%)					OOEP (inh=n/a pLI=0.57)
chr6	74079041	74079041	A	C	hom		QUAL=2244;DP=71;AF=1.00;MQM=60	OOEP	synonymous	OOEP:ENST00000370359:synonymous:LOW:exon2/3:c.258T>G:p.Val86Val,OOEP:ENST00000370363:synonymous:LOW:exon3/4:c.93T>G:p.Val31Val		rs497243	0.9716	0.9932	59536,33336,4158	0.9230,0.9971,1.0000,0.9998,0.9990	0.9944											n/a (AF>5%)	n/a (AF>5%)					OOEP (inh=n/a pLI=0.57)
chr6	79679577	79679577	A	G	het		QUAL=1331;DP=136;AF=0.41;MQM=60	PHIP	synonymous	PHIP:ENST00000275034:synonymous:LOW:exon27/40:c.3180T>C:p.Asp1060Asp		rs7742431	0.5517	0.5323	17175,8393,951	0.4397,0.4619,0.7107,0.5089,0.6599	0.5223							612870 [PHIP (provisional) Developmental delay,intellectual disability,obesity,and dysmorphic features,617991];				n/a (AF>5%)	n/a (AF>5%)					PHIP (inh=AD pLI=1.00)
chr6	83822985	83822985	G	A	hom	off-target	QUAL=1773;DP=62;AF=1.00;MQM=60	DOPEY1	intron	DOPEY1:ENST00000369739:intron:MODIFIER:exon5/38:c.682-57G>A:,DOPEY1:ENST00000237163:intron:MODIFIER:exon6/34:c.682-57G>A:,DOPEY1:ENST00000349129:intron:MODIFIER:exon6/38:c.682-57G>A:,DOPEY1:ENST00000536812:intron:MODIFIER:exon5/9:c.682-61G>A:		rs1925782	0.8037	0.0000	0,0,0	0,0,0,0,0	0.7772											n/a (AF>5%)	n/a (AF>5%)					DOPEY1 (inh=n/a pLI=1.00)
chr6	88226641	88226641	A	G	het	off-target	QUAL=1114;DP=86;AF=0.51;MQM=60	RARS2	intron	RARS2:ENST00000369536:intron:MODIFIER:exon17/19:c.1512-43T>C:	(AGACATT)n	rs9450723	0.6392	0.5737	20193,9145,2950	0.7566,0.7195,0.5650,0.5277,0.5667	0.5971							611524 [RARS2 (confirmed) Pontocerebellar hypoplasia,type 6,611523];				n/a (AF>5%)	n/a (AF>5%)					RARS2 (inh=AR pLI=0.00)
chr6	89967498	89967498	G	A	hom		QUAL=5484;DP=165;AF=1.00;MQM=60	GABRR2	missense	GABRR2:ENST00000602399:missense:MODERATE:exon9/9:c.1364C>T:p.Thr455Met,GABRR2:ENST00000402938:missense:MODERATE:exon9/9:c.1289C>T:p.Thr430Met		rs282129	0.2522	0.2554	4306,2487,963	0.4284,0.1500,0.1480,0.2726,0.1870	0.3243	2.8460	T	T	B		17.41			CM0910095 [CLASS=DP MUT=ALT PHEN="Alcohol dependence association with" GENE=GABRR2]; 		n/a (AF>5%)	n/a (AF>5%)					GABRR2 (inh=n/a pLI=0.00)
chr6	90371986	90371986	C	T	het	off-target;gene_blacklist	QUAL=752;DP=59;AF=0.53;MQM=60	MDN1	intron	MDN1:ENST00000369393:intron:MODIFIER:exon86/101:c.14413-28G>A:,MDN1:ENST00000428876:intron:MODIFIER:exon86/101:c.14413-28G>A:		rs3818132	0.6074	0.5391	17716,7506,1809	0.5947,0.7227,0.8926,0.4897,0.4039	0.5442											n/a (AF>5%)	n/a (AF>5%)					MDN1 (inh=n/a pLI=1.00)
chr6	90387233	90387233	C	T	hom	off-target;gene_blacklist	QUAL=2576;DP=80;AF=1.00;MQM=60	MDN1	intron	MDN1:ENST00000369393:intron:MODIFIER:exon76/101:c.12539+56G>A:,MDN1:ENST00000428876:intron:MODIFIER:exon76/101:c.12539+56G>A:		rs6454769	0.8303	0.0000	0,0,0	0,0,0,0,0	0.8009											n/a (AF>5%)	n/a (AF>5%)					MDN1 (inh=n/a pLI=1.00)
chr6	101166095	101166095	G	A	het		QUAL=1166;DP=79;AF=0.57;MQM=60	ASCC3	synonymous	ASCC3:ENST00000369162:synonymous:LOW:exon12/42:c.1935C>T:p.Leu645Leu,ASCC3:ENST00000522650:synonymous:LOW:exon12/13:c.1935C>T:p.Leu645Leu		rs41288423	0.4587	0.4817	14677,8426,1096	0.4560,0.3449,0.3019,0.5011,0.6010	0.4743										COSM150147	n/a (AF>5%)	n/a (AF>5%)					ASCC3 (inh=n/a pLI=0.00)
chr6	101215244	101215244	A	G	het	off-target	QUAL=944;DP=81;AF=0.54;MQM=60	ASCC3	intron	ASCC3:ENST00000369162:intron:MODIFIER:exon8/41:c.1396-23T>C:,ASCC3:ENST00000522650:intron:MODIFIER:exon8/12:c.1396-23T>C:		rs7746961	0.6486	0.5681	20071,8483,2091	0.6388,0.5540,0.7247,0.5041,0.7331	0.5588											n/a (AF>5%)	n/a (AF>5%)					ASCC3 (inh=n/a pLI=0.00)
chr6	108677003	108677003	G	A	hom	off-target	QUAL=3591;DP=108;AF=1.00;MQM=60	LACE1	intron	LACE1:ENST00000368977:intron:MODIFIER:exon4/12:c.517+44G>A:		rs2135941	0.9928	0.9973	60188,33152,4995	0.9812,0.9984,1.0000,0.9983,0.9996	0.9973											n/a (AF>5%)	n/a (AF>5%)					AFG1L (inh=n/a pLI=0.00)
chr6	110107517	110107517	T	C	het		QUAL=938;DP=69;AF=0.55;MQM=60	FIG4	missense	FIG4:ENST00000230124:missense:MODERATE:exon18/23:c.1961T>C:p.Val654Ala,FIG4:ENST00000441478:missense:MODERATE:exon13/17:c.1130T>C:p.Val377Ala		rs9885672	0.4479	0.2753	6314,842,2489	0.6866,0.2709,0.4072,0.1578,0.4443	0.3367	3.5200	T,T	T	B,B	T,T	3.35	609390 [FIG4 (provisional) Charcot-Marie-Tooth disease,type 4J,611228|Amyotrophic lateral sclerosis 11,612577|Yunis-Varon syndrome,216340|Polymicrogyria,bilateral temporooccipital,612691];	137377 [benign DISEASE=not_specified,amyotrophic_lateral_sclerosis,_dominant,charcot-marie-tooth,_type_4]; 			n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD pLI=0.00)
chr6	110746526	110746526	T	C	het	off-target	QUAL=1395;DP=126;AF=0.43;MQM=60	SLC22A16	intron	SLC22A16:ENST00000368919:intron:MODIFIER:exon7/7:c.1522-238A>G:,SLC22A16:ENST00000330550:intron:MODIFIER:exon8/8:c.1420-238A>G:		rs7756222	0.6927	0.5930	3068,742,356	0.8627,0.4907,0.8050,0.5078,0.6115	0.6543											n/a (AF>5%)	n/a (AF>5%)					SLC22A16 (inh=n/a pLI=0.00)
chr6	111919108	111919108	T	C	het		QUAL=862;DP=70;AF=0.49;MQM=60	TRAF3IP2,TRAF3IP2-AS1	intron,non_coding_transcript_exon	TRAF3IP2:ENST00000340026:intron:MODIFIER:exon2/9:c.19+3291A>G:,TRAF3IP2:ENST00000368761:intron:MODIFIER:exon1/8:c.-8-5811A>G:,TRAF3IP2:ENST00000359831:intron:MODIFIER:exon1/8:c.-8-5811A>G:,TRAF3IP2:ENST00000392556:intron:MODIFIER:exon2/9:c.-1245+3291A>G:,TRAF3IP2-AS1:ENST00000532353:non_coding_transcript_exon:MODIFIER:exon2/2:n.179T>C:		rs6941014	0.4489	0.5200	1477,355,10	0.0000,0.0000,0.0000,0.5143,0.5268	0.5264							607043 [TRAF3IP2 (provisional) Psoriasis susceptibility 13,614070|Candidiasis,familial,8,615527];				n/a (AF>5%)	n/a (AF>5%)					TRAF3IP2 (inh=AR pLI=0.01), TRAF3IP2-AS1 (inh=n/a pLI=n/a)
chr6	112493872	112493872	A	G	het		QUAL=1088;DP=85;AF=0.53;MQM=60	LAMA4	missense	LAMA4:ENST00000230538:missense:MODERATE:exon12/39:c.1492T>C:p.Tyr498His,LAMA4:ENST00000522006:missense:MODERATE:exon12/39:c.1471T>C:p.Tyr491His,LAMA4:ENST00000389463:missense:MODERATE:exon12/39:c.1471T>C:p.Tyr491His,LAMA4:ENST00000424408:missense:MODERATE:exon11/38:c.1471T>C:p.Tyr491His		rs1050348	0.7584	0.6649	27246,11950,2931	0.7509,0.7140,0.8228,0.6004,0.7941	0.6640	2.1740	T,T,T,T	T	B,B	T,T,T,T	2.21	600133 [LAMA4 (provisional) Cardiomyopathy,dilated,1JJ,615235];	44348 [benign DISEASE=not_specified]; 		COSM3761440	n/a (AF>5%)	n/a (AF>5%)					LAMA4 (inh=AD pLI=0.00)
chr6	118475798	118475798	G	A	hom		QUAL=2608;DP=81;AF=1.00;MQM=60	SLC35F1	splice_region&intron	SLC35F1:ENST00000360388:splice_region&intron:LOW:exon2/7:c.349+15G>A:		rs205966	0.7620	0.7771	36994,19690,3634	0.8358,0.8265,0.5075,0.7693,0.8929	0.7780											n/a (AF>5%)	n/a (AF>5%)					SLC35F1 (inh=n/a pLI=0.67)
chr6	119509785	119509785	C	G	het	off-target	QUAL=1060;DP=108;AF=0.41;MQM=60	MAN1A1	intron	MAN1A1:ENST00000368468:intron:MODIFIER:exon10/12:c.1547-43G>C:		rs2142887	0.2416	0.3741	9393,7046,71	0.0973,0.1838,0.1821,0.4635,0.3605	0.3825											n/a (AF>5%)	n/a (AF>5%)					MAN1A1 (inh=n/a pLI=0.92)
chr6	121632008	121632008	T	A	hom		QUAL=2937;DP=96;AF=1.00;MQM=60	TBC1D32	splice_region&intron	TBC1D32:ENST00000275159:splice_region&intron:LOW:exon3/32:c.496-15A>T:,TBC1D32:ENST00000398212:splice_region&intron:LOW:exon3/31:c.496-15A>T:		rs9372653	0.9894	0.9966	54609,30041,3930	0.9579,0.9992,1.0000,0.9999,1.0000	0.9971											n/a (AF>5%)	n/a (AF>5%)					TBC1D32 (inh=n/a pLI=0.00)
chr6	133052616	133052616	C	T	het		QUAL=2595;DP=210;AF=0.47;MQM=60	VNN3	missense,intron	VNN3:ENST00000392393:missense:MODERATE:exon3/8:c.395G>A:p.Cys132Tyr,VNN3:ENST00000392394:missense:MODERATE:exon3/3:c.395G>A:p.Cys132Tyr,VNN3:ENST00000207771:intron:MODIFIER:exon2/7:c.345-2544G>A:,VNN3:ENST00000367927:intron:MODIFIER:exon2/6:c.345-2544G>A:,VNN3:ENST00000425515:intron:MODIFIER:exon2/6:c.345-2498G>A:,VNN3:ENST00000275223:intron:MODIFIER:exon2/5:c.345-2498G>A:,VNN3:ENST00000414302:intron:MODIFIER:exon2/5:c.344+2776G>A:,VNN3:ENST00000417437:intron:MODIFIER:exon1/3:c.440+2776G>A:,VNN3:ENST00000423615:intron:MODIFIER:exon2/4:c.344+2776G>A:,VNN3:ENST00000427187:intron:MODIFIER:exon2/5:c.345-2544G>A:,VNN3:ENST00000509351:intron:MODIFIER:exon2/3:c.344+2776G>A:,VNN3:ENST00000519686:intron:MODIFIER:exon2/6:c.345-2498G>A:,VNN3:ENST00000450865:intron:MODIFIER:exon2/3:c.347+2776G>A:		rs4895943	0.6276	0.5773	21193,9713,3964	0.8701,0.7322,0.3941,0.5382,0.5347	0.6349	-1.6970	T,T	T	B	D,D	6.29					n/a (AF>5%)	n/a (AF>5%)					VNN3 (inh=n/a pLI=0.03)
chr6	143828325	143828325	T	C	het	off-target	QUAL=1146;DP=94;AF=0.47;MQM=60	FUCA2,RP1-20N2.6	intron	FUCA2:ENST00000002165:intron:MODIFIER:exon2/6:c.412+49A>G:,FUCA2:ENST00000438118:intron:MODIFIER:exon2/3:c.412+49A>G:		rs1569589	0.1823	0.2101	2780,1854,222	0.2187,0.1008,0.1949,0.2370,0.1527	0.2254										COSN167900	n/a (AF>5%)	n/a (AF>5%)					FUCA2 (inh=n/a pLI=0.00), RP1-20N2.6 (inh=n/a pLI=n/a)
chr6	149983216	149983216	G	A	hom		QUAL=5107;DP=155;AF=1.00;MQM=60	LATS1	synonymous	LATS1:ENST00000253339:synonymous:LOW:exon7/7:c.3042C>T:p.Asp1014Asp,LATS1:ENST00000543571:synonymous:LOW:exon8/8:c.3042C>T:p.Asp1014Asp		rs3924871	0.5507	0.4492	13665,4451,1555	0.5468,0.7002,0.8019,0.3631,0.4059	0.4596										COSM3761530, COSM3761531	n/a (AF>5%)	n/a (AF>5%)					LATS1 (inh=n/a pLI=1.00)
chr6	151152257	151152257	A	G	het		QUAL=1930;DP=158;AF=0.47;MQM=60	PLEKHG1	synonymous	PLEKHG1:ENST00000358517:synonymous:LOW:exon15/16:c.2010A>G:p.Lys670Lys,PLEKHG1:ENST00000367328:synonymous:LOW:exon16/17:c.2010A>G:p.Lys670Lys		rs926624	0.2698	0.3172	6508,3095,101	0.1413,0.4631,0.3905,0.3045,0.3233	0.3244										COSM450680	n/a (AF>5%)	n/a (AF>5%)					PLEKHG1 (inh=n/a pLI=0.01)
chr6	151286224	151286224	A	C	het	off-target	QUAL=1855;DP=159;AF=0.45;MQM=60	MTHFD1L	intron	MTHFD1L:ENST00000367321:intron:MODIFIER:exon19/27:c.2013+51A>C:		rs1627462	0.4852	0.5774	21042,13901,687	0.3586,0.3702,0.3510,0.6497,0.6473	0.5681											n/a (AF>5%)	n/a (AF>5%)					MTHFD1L (inh=n/a pLI=0.80)
chr6	152265522	152265522	G	C	hom		QUAL=6539;DP=195;AF=1.00;MQM=60	ESR1	synonymous,intron	ESR1:ENST00000206249:synonymous:LOW:exon4/8:c.975G>C:p.Pro325Pro,ESR1:ENST00000440973:synonymous:LOW:exon6/10:c.975G>C:p.Pro325Pro,ESR1:ENST00000338799:synonymous:LOW:exon5/9:c.975G>C:p.Pro325Pro,ESR1:ENST00000443427:synonymous:LOW:exon5/9:c.975G>C:p.Pro325Pro,ESR1:ENST00000427531:synonymous:LOW:exon4/7:c.456G>C:p.Pro152Pro,ESR1:ENST00000456483:intron:MODIFIER:exon4/7:c.760+63616G>C:,ESR1:ENST00000406599:intron:MODIFIER:exon1/3:c.453-116604G>C:		rs1801132	0.7177	0.7362	33635,20327,4234	0.9018,0.6912,0.5101,0.7794,0.6045	0.7877	-1.1690		T			3.94	133430 [ESR1 (confirmed) Estrogen resistance,615363|HDL response to hormone replacement,augmented|Migraine,susceptibility to,157300|Atherosclerosis,susceptibility to|Myocardial infarction,susceptibility to,608446|Breast cancer,114480];			COSM4003741, COSM4003740	n/a (AF>5%)	n/a (AF>5%)					ESR1 (inh=AR pLI=0.98)
chr6	152542234	152542234	G	T	het	off-target	QUAL=623;DP=60;AF=0.47;MQM=60	SYNE1	intron	SYNE1:ENST00000265368:intron:MODIFIER:exon118/145:c.21657-53C>A:,SYNE1:ENST00000367255:intron:MODIFIER:exon118/145:c.21657-53C>A:,SYNE1:ENST00000356820:intron:MODIFIER:exon33/60:c.5229-53C>A:,SYNE1:ENST00000423061:intron:MODIFIER:exon117/145:c.21444-53C>A:,SYNE1:ENST00000341594:intron:MODIFIER:exon119/146:c.20493-53C>A:,SYNE1:ENST00000448038:intron:MODIFIER:exon118/146:c.21444-53C>A:		rs9397492	0.3894	0.0000	0,0,0	0,0,0,0,0	0.3319							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];				n/a (AF>5%)	n/a (AF>5%)					SYNE1 (inh=AR+AD pLI=0.00)
chr6	152660310	152660310	A	G	het	off-target	QUAL=231;DP=19;AF=0.58;MQM=60	SYNE1	intron	SYNE1:ENST00000265368:intron:MODIFIER:exon75/145:c.12351+66T>C:,SYNE1:ENST00000367255:intron:MODIFIER:exon75/145:c.12351+66T>C:,SYNE1:ENST00000423061:intron:MODIFIER:exon74/145:c.12138+66T>C:,SYNE1:ENST00000341594:intron:MODIFIER:exon77/146:c.11946+66T>C:,SYNE1:ENST00000448038:intron:MODIFIER:exon75/146:c.12138+66T>C:		rs4870095	0.1571	0.0000	0,0,0	0,0,0,0,0	0.2516							608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];				n/a (AF>5%)	n/a (AF>5%)					SYNE1 (inh=AR+AD pLI=0.00)
chr6	157963550	157963550	T	C	het	off-target	QUAL=1097;DP=107;AF=0.43;MQM=60	ZDHHC14	intron	ZDHHC14:ENST00000359775:intron:MODIFIER:exon1/8:c.246-67T>C:,ZDHHC14:ENST00000414563:intron:MODIFIER:exon1/8:c.246-67T>C:		rs17165416	0.4141	0.0000	0,0,0	0,0,0,0,0	0.4012											n/a (AF>5%)	n/a (AF>5%)					ZDHHC14 (inh=n/a pLI=0.97)
chr6	158571501	158571501	G	A	het		QUAL=731;DP=76;AF=0.41;MQM=60	SERAC1	synonymous	SERAC1:ENST00000367104:synonymous:LOW:exon4/17:c.249C>T:p.Asp83Asp,SERAC1:ENST00000367102:synonymous:LOW:exon4/18:c.249C>T:p.Asp83Asp,SERAC1:ENST00000367101:synonymous:LOW:exon4/16:c.249C>T:p.Asp83Asp,SERAC1:ENST00000607000:synonymous:LOW:exon3/5:c.249C>T:p.Asp83Asp		rs6929274	0.7139	0.7174	31355,16622,2616	0.7094,0.8518,0.7242,0.7072,0.6694	0.7237							614725 [SERAC1 (provisional) 3-methylglutaconic aciduria with deafness,encephalopathy,and Leigh-like syndrome,614739];	139093 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SERAC1 (inh=AR pLI=0.13)
chr6	160206631	160206631	T	C	het		QUAL=1349;DP=98;AF=0.54;MQM=60	TCP1,SNORA29	intron,non_coding_transcript_exon	TCP1:ENST00000321394:intron:MODIFIER:exon4/11:c.378-103A>G:,TCP1:ENST00000544255:intron:MODIFIER:exon2/7:c.-2-1532A>G:,TCP1:ENST00000420894:intron:MODIFIER:exon4/10:c.378-103A>G:,TCP1:ENST00000392168:intron:MODIFIER:exon3/10:c.-88-103A>G:,SNORA29:ENST00000384183:non_coding_transcript_exon:MODIFIER:exon1/1:n.135A>G:		rs3818299	0.3922	0.5270	17534,11028,475	0.3110,0.6634,0.1886,0.5804,0.5030	0.5298											n/a (AF>5%)	n/a (AF>5%)					TCP1 (inh=n/a pLI=1.00), SNORA29 (inh=n/a pLI=n/a)
chr6	163587266	163587266	C	A	het		QUAL=1532;DP=140;AF=0.45;MQM=60	AL078585.1,PACRG	intron	PACRG:ENST00000337019:intron:MODIFIER:exon5/6:c.613+76826C>A:,PACRG:ENST00000366889:intron:MODIFIER:exon5/5:c.613+76826C>A:,PACRG:ENST00000366888:intron:MODIFIER:exon4/4:c.613+76826C>A:		rs13195800	0.0905	0.1517	149,47,0	0.0000,0.0000,0.0000,0.1797,0.1457	0.1058	-0.2970		T	P	T	19.69				COSM4160356, COSM4160355	n/a (AF>5%)	n/a (AF>5%)					AL078585.1 (inh=n/a pLI=n/a), PACRG (inh=n/a pLI=0.00)
chr6	165712927	165712927	G	A	het		QUAL=1596;DP=158;AF=0.40;MQM=60	C6orf118	splice_region&intron	C6orf118:ENST00000230301:splice_region&intron:LOW:exon4/8:c.936+5C>T:,C6orf118:ENST00000543069:splice_region&intron:LOW:exon4/7:c.624+5C>T:		rs56325343	0.0851	0.0775	390,196,82	0.1283,0.0450,0.0126,0.0801,0.0926	0.0888											n/a (AF>5%)	n/a (AF>5%)					C6orf118 (inh=n/a pLI=0.00)
chr6	170592293	170592293	C	G	het	off-target	QUAL=792;DP=42;AF=0.74;MQM=60	DLL1	intron	DLL1:ENST00000366756:intron:MODIFIER:exon9/10:c.2048+26G>C:		rs2295205	0.1791	0.2425	3724,2493,87	0.1328,0.2633,0.1434,0.2755,0.1825	0.2435										COSN167944	n/a (AF>5%)	n/a (AF>5%)					DLL1 (inh=n/a pLI=1.00)
chr7	1132720	1132720	G	A	het		QUAL=2793;DP=205;AF=0.52;MQM=60	GPER1,C7orf50	3'UTR,intron	GPER1:ENST00000297469:3'UTR:MODIFIER:exon2/2:c.*228G>A:,GPER1:ENST00000397092:3'UTR:MODIFIER:exon3/3:c.*228G>A:,GPER1:ENST00000397088:3'UTR:MODIFIER:exon2/2:c.*228G>A:,C7orf50:ENST00000357429:intron:MODIFIER:exon2/4:c.129+34173C>T:,C7orf50:ENST00000397100:intron:MODIFIER:exon2/4:c.129+34173C>T:,C7orf50:ENST00000397098:intron:MODIFIER:exon2/4:c.129+34173C>T:		rs12702047	0.1328	0.1691	221,40,3	0.1267,0.1739,0.0660,0.1482,0.1795	0.1685											n/a (AF>5%)	n/a (AF>5%)					GPER1 (inh=n/a pLI=0.71), C7orf50 (inh=n/a pLI=0.01)
chr7	2613042	2613042	G	C	het		QUAL=849;DP=63;AF=0.54;MQM=60	IQCE	splice_region&intron	IQCE:ENST00000402050:splice_region&intron:LOW:exon5/21:c.395-10G>C:,IQCE:ENST00000404984:splice_region&intron:LOW:exon4/20:c.242-10G>C:,IQCE:ENST00000438376:splice_region&intron:LOW:exon4/20:c.347-10G>C:,IQCE:ENST00000325979:splice_region&intron:LOW:exon3/19:c.200-10G>C:		rs2304540	0.6933	0.7379	33110,18914,2972	0.7781,0.7289,0.4828,0.7541,0.7525	0.7530							617631 [IQCE (provisional) Polydactyly,postaxial,type A7,617642];				n/a (AF>5%)	n/a (AF>5%)					IQCE (inh=n/a pLI=0.00)
chr7	2646723	2646723	A	G	het	off-target	QUAL=1589;DP=108;AF=0.56;MQM=60	IQCE	intron	IQCE:ENST00000402050:intron:MODIFIER:exon20/21:c.1866-35A>G:,IQCE:ENST00000404984:intron:MODIFIER:exon19/20:c.1713-35A>G:,IQCE:ENST00000438376:intron:MODIFIER:exon19/20:c.1818-35A>G:,IQCE:ENST00000325979:intron:MODIFIER:exon18/19:c.1671-35A>G:		rs1464967	0.4143	0.3499	7268,2668,729	0.3904,0.5136,0.5147,0.2875,0.4030	0.3564							617631 [IQCE (provisional) Polydactyly,postaxial,type A7,617642];				n/a (AF>5%)	n/a (AF>5%)					IQCE (inh=n/a pLI=0.00)
chr7	4900095	4900095	A	G	het		QUAL=2110;DP=140;AF=0.55;MQM=60	PAPOLB,RADIL	synonymous,intron	PAPOLB:ENST00000404991:synonymous:LOW:exon1/1:c.1344T>C:p.Asn448Asn,RADIL:ENST00000399583:intron:MODIFIER:exon2/14:c.535+17141T>C:,RADIL:ENST00000536091:intron:MODIFIER:exon2/13:c.535+17141T>C:		rs1553960	0.4531	0.4069	10338,4913,1415	0.5339,0.3290,0.4376,0.3821,0.5143	0.4149										COSM3762729, COSM150227	n/a (AF>5%)	n/a (AF>5%)					PAPOLB (inh=n/a pLI=0.03), RADIL (inh=n/a pLI=0.00)
chr7	5396955	5396955	A	G	hom	off-target;gene_blacklist	QUAL=3785;DP=116;AF=1.00;MQM=60	TNRC18	intron	TNRC18:ENST00000399537:intron:MODIFIER:exon15/29:c.4834-48T>C:,TNRC18:ENST00000430969:intron:MODIFIER:exon15/29:c.4834-48T>C:	MIR	rs7805732	0.5996	0.6364	10885,6112,1886	0.8469,0.5462,0.2903,0.6427,0.6529	0.6817											n/a (AF>5%)	n/a (AF>5%)					TNRC18 (inh=n/a pLI=1.00)
chr7	6550494	6550494	G	A	hom	off-target	QUAL=1805;DP=55;AF=1.00;MQM=60	GRID2IP	intron	GRID2IP:ENST00000457091:intron:MODIFIER:exon9/21:c.1555+45C>T:,GRID2IP:ENST00000452113:intron:MODIFIER:exon8/20:c.982+45C>T:,GRID2IP:ENST00000435185:intron:MODIFIER:exon8/20:c.1003+45C>T:	MIR1_Amn	rs12702520	0.4930	0.5837	3755,2129,337	0.5533,0.6401,0.2443,0.7016,0.4711	0.6384											n/a (AF>5%)	n/a (AF>5%)					GRID2IP (inh=n/a pLI=0.33)
chr7	6566442	6566442	C	T	het	off-target	QUAL=482;DP=52;AF=0.40;MQM=60	GRID2IP	intron	GRID2IP:ENST00000457091:intron:MODIFIER:exon2/21:c.585-42G>A:,GRID2IP:ENST00000452113:intron:MODIFIER:exon1/20:c.15-42G>A:,GRID2IP:ENST00000435185:intron:MODIFIER:exon1/20:c.36-42G>A:		rs12702526	0.2298	0.3648	402,168,2	0.0000,0.0000,0.0000,0.4900,0.3351	0.3984											n/a (AF>5%)	n/a (AF>5%)					GRID2IP (inh=n/a pLI=0.33)
chr7	8132252	8132252	T	C	hom	off-target	QUAL=4637;DP=142;AF=1.00;MQM=60	GLCCI1				rs4725069	0.7288	0.6932	3545,1250,265	0.7614,0.7397,0.7623,0.7000,0.6742	0.7260											n/a (AF>5%)	n/a (AF>5%)					GLCCI1 (inh=n/a pLI=0.17)
chr7	12644334	12644334	G	T	hom	off-target	QUAL=6096;DP=186;AF=1.00;MQM=60	SCIN	intron	SCIN:ENST00000297029:intron:MODIFIER:exon4/15:c.666+46G>T:,SCIN:ENST00000519209:intron:MODIFIER:exon2/13:c.-76+46G>T:,SCIN:ENST00000445618:intron:MODIFIER:exon1/12:c.-76+46G>T:	(GT)n	rs849778	0.8938	0.9088	8600,3518,682	0.7627,0.9461,1.0000,0.8877,0.9675	0.9147											n/a (AF>5%)	n/a (AF>5%)					SCIN (inh=n/a pLI=0.00)
chr7	16913520	16913520	G	A	hom	off-target	QUAL=2641;DP=82;AF=0.99;MQM=60	AGR3	intron	AGR3:ENST00000310398:intron:MODIFIER:exon2/7:c.110-53C>T:,AGR3:ENST00000402239:intron:MODIFIER:exon2/6:c.110-53C>T:		rs4472406	0.9044	0.0000	0,0,0	0,0,0,0,0	0.9332											n/a (AF>5%)	n/a (AF>5%)					AGR3 (inh=n/a pLI=0.00)
chr7	20198440	20198440	G	A	het		QUAL=1984;DP=178;AF=0.44;MQM=60	MACC1	missense	MACC1:ENST00000332878:missense:MODERATE:exon3/5:c.1544C>T:p.Ser515Leu,MACC1:ENST00000400331:missense:MODERATE:exon5/7:c.1544C>T:p.Ser515Leu,MACC1:ENST00000589011:missense:MODERATE:exon3/5:c.1544C>T:p.Ser515Leu		rs975263	0.4255	0.3389	8490,2131,441	0.2983,0.3952,0.8215,0.2507,0.4585	0.3420	2.1520	T,T	T	B	T,T	10.56				COSM3762560	n/a (AF>5%)	n/a (AF>5%)					MACC1 (inh=n/a pLI=0.00)
chr7	20430960	20430960	T	C	hom	off-target	QUAL=1126;DP=36;AF=1.00;MQM=60	ITGB8	intron	ITGB8:ENST00000222573:intron:MODIFIER:exon6/13:c.961-66T>C:,ITGB8:ENST00000537992:intron:MODIFIER:exon7/14:c.556-66T>C:		rs3779506	0.7947	0.0000	0,0,0	0,0,0,0,0	0.8072											n/a (AF>5%)	n/a (AF>5%)					ITGB8 (inh=n/a pLI=1.00)
chr7	21641269	21641269	A	G	het	off-target;gene_blacklist	QUAL=409;DP=32;AF=0.56;MQM=60	DNAH11	intron	DNAH11:ENST00000328843:intron:MODIFIER:exon18/82:c.3648+33A>G:,DNAH11:ENST00000409508:intron:MODIFIER:exon18/81:c.3648+33A>G:	MIRb	rs10499531	0.1012	0.1691	444,338,19	0.1156,0.1110,0.0466,0.2028,0.1783	0.1287							603339 [DNAH11 (confirmed) Ciliary dyskinesia,primary,7,with or without situs inversus,611884];				n/a (AF>5%)	n/a (AF>5%)					DNAH11 (inh=AR pLI=n/a)
chr7	21789442	21789442	T	C	hom	off-target;gene_blacklist	QUAL=2962;DP=94;AF=0.99;MQM=60	DNAH11	intron	DNAH11:ENST00000328843:intron:MODIFIER:exon54/82:c.8818+23T>C:,DNAH11:ENST00000409508:intron:MODIFIER:exon53/81:c.8797+23T>C:		rs4355679	0.4355	0.5825	21895,14956,749	0.3867,0.4903,0.1355,0.6693,0.6094	0.5814							603339 [DNAH11 (confirmed) Ciliary dyskinesia,primary,7,with or without situs inversus,611884];				n/a (AF>5%)	n/a (AF>5%)					DNAH11 (inh=AR pLI=n/a)
chr7	21847457	21847457	A	G	het	off-target;gene_blacklist	QUAL=687;DP=70;AF=0.43;MQM=60	DNAH11	intron	DNAH11:ENST00000328843:intron:MODIFIER:exon63/82:c.10187-44A>G:,DNAH11:ENST00000409508:intron:MODIFIER:exon62/81:c.10166-44A>G:		rs6969900	0.5691	0.4550	11554,3514,1783	0.6467,0.5935,0.8261,0.3577,0.4745	0.4601							603339 [DNAH11 (confirmed) Ciliary dyskinesia,primary,7,with or without situs inversus,611884];				n/a (AF>5%)	n/a (AF>5%)					DNAH11 (inh=AR pLI=n/a)
chr7	22526636	22526636	C	G	het	off-target	QUAL=1763;DP=129;AF=0.51;MQM=60	STEAP1B	intron	STEAP1B:ENST00000404369:intron:MODIFIER:exon4/4:c.762+5548G>C:,STEAP1B:ENST00000406890:intron:MODIFIER:exon4/4:c.705+5548G>C:		rs17146979	0.0847	0.0000	0,0,0	0,0,0,0,0	0.0887											n/a (AF>5%)	n/a (AF>5%)					STEAP1B (inh=n/a pLI=0.00)
chr7	23737891	23737891	A	G	het		QUAL=1481;DP=112;AF=0.51;MQM=60	FAM221A	missense,intron	FAM221A:ENST00000344962:missense:MODERATE:exon5/7:c.718A>G:p.Ser240Gly,FAM221A:ENST00000409653:missense:MODERATE:exon4/6:c.544A>G:p.Ser182Gly,FAM221A:ENST00000409192:intron:MODIFIER:exon4/5:c.638-2514A>G:,FAM221A:ENST00000409994:intron:MODIFIER:exon3/4:c.464-2514A>G:		rs35928055	0.0781	0.0791	443,181,3	0.0280,0.1065,0.1332,0.0721,0.1070	0.0777	1.3450	T,T	T	B	T,T	9.23					n/a (AF>5%)	n/a (AF>5%)					FAM221A (inh=n/a pLI=0.00)
chr7	25194753	25194753	C	T	het		QUAL=2038;DP=162;AF=0.49;MQM=60	C7orf31	missense	C7orf31:ENST00000283905:missense:MODERATE:exon6/10:c.472G>A:p.Ala158Thr,C7orf31:ENST00000409280:missense:MODERATE:exon6/10:c.472G>A:p.Ala158Thr		rs12535348	0.2814	0.4160	11624,8516,73	0.1051,0.3627,0.1509,0.5044,0.4260	0.4194	1.7340	T,T	T	P	T,T	26.00				COSM150253	n/a (AF>5%)	n/a (AF>5%)					C7orf31 (inh=n/a pLI=0.00)
chr7	27886171	27886171	A	G	hom		QUAL=5441;DP=165;AF=1.00;MQM=60	JAZF1	intron	JAZF1:ENST00000283928:intron:MODIFIER:exon3/4:c.386-5685T>C:	L1MA9	rs6462054	0.9381	0.9826	7991,2635,452	0.9967,0.9452,0.7922,0.9927,0.9858	0.9780											n/a (AF>5%)	n/a (AF>5%)					JAZF1 (inh=n/a pLI=0.95)
chr7	29132212	29132212	A	G	het	off-target	QUAL=787;DP=74;AF=0.45;MQM=60	CPVL	intron	CPVL:ENST00000265394:intron:MODIFIER:exon6/12:c.542+27T>C:,CPVL:ENST00000396276:intron:MODIFIER:exon6/12:c.542+27T>C:,CPVL:ENST00000409850:intron:MODIFIER:exon10/16:c.542+27T>C:		rs2687636	0.6983	0.5438	18431,7485,3780	0.8578,0.4277,0.8609,0.4861,0.5084	0.5944											n/a (AF>5%)	n/a (AF>5%)					CPVL (inh=n/a pLI=0.00)
chr7	29523563	29523563	G	A	het		QUAL=2179;DP=166;AF=0.49;MQM=60	CHN2	intron	CHN2:ENST00000539406:intron:MODIFIER:exon8/13:c.879+3591G>A:,CHN2:ENST00000222792:intron:MODIFIER:exon7/12:c.654+3591G>A:,CHN2:ENST00000435288:intron:MODIFIER:exon6/7:c.302-25354G>A:,CHN2:ENST00000495789:intron:MODIFIER:exon8/13:c.693+3591G>A:,CHN2:ENST00000539389:intron:MODIFIER:exon4/9:c.222+3591G>A:,CHN2:ENST00000546235:intron:MODIFIER:exon7/12:c.609+3591G>A:,CHN2:ENST00000409041:intron:MODIFIER:exon1/6:c.246+3591G>A:,CHN2:ENST00000424025:intron:MODIFIER:exon1/6:c.111+3726G>A:,CHN2:ENST00000421775:intron:MODIFIER:exon1/5:c.246+3591G>A:,CHN2:ENST00000439711:intron:MODIFIER:exon1/5:c.246+3591G>A:	MIRb	rs12665897	0.2708	0.3209	759,223,7	0.1446,0.2260,0.3436,0.3052,0.3559	0.2874											n/a (AF>5%)	n/a (AF>5%)					CHN2 (inh=n/a pLI=0.08)
chr7	31691697	31691697	T	C	het	off-target	QUAL=966;DP=101;AF=0.41;MQM=60	CCDC129	intron	CCDC129:ENST00000451887:intron:MODIFIER:exon13/14:c.2901+33T>C:,CCDC129:ENST00000319386:intron:MODIFIER:exon13/13:c.2379+33T>C:,CCDC129:ENST00000407970:intron:MODIFIER:exon13/13:c.2823+33T>C:,CCDC129:ENST00000409210:intron:MODIFIER:exon11/12:c.2547+33T>C:		rs3735424	0.7556	0.7848	14107,7542,1199	0.7120,0.8521,0.8266,0.7909,0.8040	0.7838											n/a (AF>5%)	n/a (AF>5%)					CCDC129 (inh=n/a pLI=0.00)
chr7	31855578	31855578	G	A	hom		QUAL=11417;DP=354;AF=1.00;MQM=60	PDE1C	synonymous	PDE1C:ENST00000396193:synonymous:LOW:exon16/19:c.1953C>T:p.Asn651Asn,PDE1C:ENST00000396191:synonymous:LOW:exon15/18:c.1773C>T:p.Asn591Asn,PDE1C:ENST00000321453:synonymous:LOW:exon16/19:c.1773C>T:p.Asn591Asn,PDE1C:ENST00000396184:synonymous:LOW:exon16/18:c.1773C>T:p.Asn591Asn,PDE1C:ENST00000396182:synonymous:LOW:exon15/17:c.1773C>T:p.Asn591Asn		rs1860790	0.9507	0.9696	57114,31815,4627	0.9427,0.9872,0.9311,0.9764,0.9570	0.9720											n/a (AF>5%)	n/a (AF>5%)					PDE1C (inh=n/a pLI=0.00)
chr7	34192762	34192762	G	C	hom		QUAL=6768;DP=203;AF=1.00;MQM=60	BMPER	synonymous	BMPER:ENST00000297161:synonymous:LOW:exon16/16:c.1935G>C:p.Thr645Thr,BMPER:ENST00000426693:synonymous:LOW:exon15/15:c.1935G>C:p.Thr645Thr		rs6968741	0.9101	0.9353	53212,29297,3546	0.8250,0.9556,0.9997,0.9368,0.9373	0.9390							608699 [BMPER (provisional) Diaphanospondylodysostosis,608022];	360118 [benign DISEASE=diaphanospondylodysostosis]; 		COSM4162182	n/a (AF>5%)	n/a (AF>5%)					BMPER (inh=AR pLI=0.00)
chr7	40314165	40314165	G	A	het		QUAL=1256;DP=91;AF=0.53;MQM=60	SUGCT	synonymous,intron	SUGCT:ENST00000309930:synonymous:LOW:exon8/15:c.651G>A:p.Leu217Leu,SUGCT:ENST00000335693:synonymous:LOW:exon8/14:c.651G>A:p.Leu217Leu,SUGCT:ENST00000401647:intron:MODIFIER:exon7/12:c.597+36840G>A:		rs12669315	0.3161	0.3598	8194,4201,76	0.1269,0.4085,0.4544,0.3547,0.4196	0.3645	0.1640		T			9.17					n/a (AF>5%)	n/a (AF>5%)					SUGCT (inh=AR pLI=0.00)
chr7	44800176	44800176	G	T	het		QUAL=3026;DP=275;AF=0.44;MQM=60	ZMIZ2	missense	ZMIZ2:ENST00000309315:missense:MODERATE:exon9/19:c.1224G>T:p.Leu408Phe,ZMIZ2:ENST00000413916:missense:MODERATE:exon8/18:c.1050G>T:p.Leu350Phe,ZMIZ2:ENST00000441627:missense:MODERATE:exon8/18:c.1224G>T:p.Leu408Phe,ZMIZ2:ENST00000433667:missense:MODERATE:exon8/18:c.1128G>T:p.Leu376Phe,ZMIZ2:ENST00000265346:missense:MODERATE:exon7/17:c.1146G>T:p.Leu382Phe		rs3735478	0.1502	0.2418	4133,2847,21	0.0516,0.2037,0.1306,0.2879,0.1722	0.2465	0.8440	D,D,D,D,D,D	T	D,D,D	T,T,T,T,T	22.70				COSM4004486	n/a (AF>5%)	n/a (AF>5%)					ZMIZ2 (inh=n/a pLI=1.00)
chr7	45225788	45225788	C	A	het		QUAL=1465;DP=166;AF=0.37;MQM=60	RAMP3	splice_region&intron	RAMP3:ENST00000496212:splice_region&intron:LOW:exon3/3:c.444-10C>A:,RAMP3:ENST00000481345:splice_region&intron:LOW:exon3/3:c.*9-10C>A:	MIRc	rs11760627	0.0755	0.0525	18,7,4	0.1667,0.0000,0.0000,0.0609,0.0416	0.0710											n/a (AF>5%)	n/a (AF>5%)					RAMP3 (inh=n/a pLI=0.01)
chr7	45225854	45225854	A	G	het	off-target	QUAL=1268;DP=148;AF=0.36;MQM=60	RAMP3	3'UTR	RAMP3:ENST00000496212:3'UTR:MODIFIER:exon4/4:c.*44A>G:,RAMP3:ENST00000481345:3'UTR:MODIFIER:exon4/4:c.*65A>G:		rs11767365	0.1587	0.1323	58,21,15	0.2530,0.0000,0.0000,0.1271,0.1197	0.1395											n/a (AF>5%)	n/a (AF>5%)					RAMP3 (inh=n/a pLI=0.01)
chr7	47319723	47319723	C	T	het	off-target	QUAL=630;DP=62;AF=0.42;MQM=60	TNS3	intron	TNS3:ENST00000311160:intron:MODIFIER:exon30/30:c.4193+39G>A:,TNS3:ENST00000355730:intron:MODIFIER:exon27/27:c.3473+39G>A:,TNS3:ENST00000398879:intron:MODIFIER:exon30/30:c.4193+39G>A:		rs4720590	0.7105	0.6861	28526,15197,2952	0.7778,0.7209,0.6023,0.6752,0.6922	0.6969											n/a (AF>5%)	n/a (AF>5%)					TNS3 (inh=n/a pLI=1.00)
chr7	47596775	47596775	C	T	hom	off-target	QUAL=2975;DP=91;AF=1.00;MQM=60	TNS3	intron	TNS3:ENST00000311160:intron:MODIFIER:exon1/30:c.-265+24874G>A:		rs615300	0.3842	0.0000	0,0,0	0,0,0,0,0	0.4243											n/a (AF>5%)	n/a (AF>5%)					TNS3 (inh=n/a pLI=1.00)
chr7	47835814	47835814	G	A	hom	off-target	QUAL=181;DP=6;AF=1.00;MQM=60	PKD1L1,C7orf69,HUS1	intron	PKD1L1:ENST00000289672:intron:MODIFIER:exon54/56:c.8194-66C>T:,C7orf69:ENST00000258776:intron:MODIFIER:exon1/2:c.108+773G>A:,C7orf69:ENST00000418326:intron:MODIFIER:exon1/3:c.-94+773G>A:		rs6943728	0.4437	0.0000	0,0,0	0,0,0,0,0	0.4342							609721 [PKD1L1 (provisional) Heterotaxy,visceral,8,autosomal,617205];				n/a (AF>5%)	n/a (AF>5%)					PKD1L1 (inh=AR pLI=0.00), C7orf69 (inh=n/a pLI=0.05), HUS1 (inh=n/a pLI=0.00)
chr7	48443570	48443570	G	A	het	gene_blacklist	QUAL=789;DP=42;AF=0.69;MQM=60	ABCA13	intron	ABCA13:ENST00000435803:intron:MODIFIER:exon39/61:c.12070+94G>A:		rs6978753	0.3732	0.3863	1866,1047,192	0.4244,0.5194,0.4894,0.4470,0.2473	0.4360											n/a (AF>5%)	n/a (AF>5%)					ABCA13 (inh=n/a pLI=0.00)
chr7	48450157	48450157	T	C	het	gene_blacklist	QUAL=5554;DP=435;AF=0.48;MQM=60	ABCA13	synonymous	ABCA13:ENST00000435803:synonymous:LOW:exon40/62:c.12111T>C:p.Ala4037Ala		rs17548783	0.4627	0.4734	14109,7563,1146	0.4848,0.5549,0.6267,0.4740,0.3020	0.5097										COSM3982229, COSM3982230	n/a (AF>5%)	n/a (AF>5%)					ABCA13 (inh=n/a pLI=0.00)
chr7	55220177	55220177	A	G	het	off-target	QUAL=3089;DP=208;AF=0.55;MQM=60	EGFR	intron	EGFR:ENST00000275493:intron:MODIFIER:exon5/27:c.629-62A>G:,EGFR:ENST00000455089:intron:MODIFIER:exon4/25:c.494-62A>G:,EGFR:ENST00000342916:intron:MODIFIER:exon5/15:c.629-62A>G:,EGFR:ENST00000344576:intron:MODIFIER:exon5/15:c.629-62A>G:,EGFR:ENST00000420316:intron:MODIFIER:exon5/9:c.629-62A>G:,EGFR:ENST00000442591:intron:MODIFIER:exon5/17:c.629-62A>G:,EGFR:ENST00000454757:intron:MODIFIER:exon5/27:c.470-62A>G:		rs11506105	0.5509	0.0000	0,0,0	0,0,0,0,0	0.5811							131550 [EGFR (confirmed) Nonsmall cell lung cancer,response to tyrosine kinase inhibitor in,211980|Adenocarcinoma of lung,response to tyrosine kinase inhibitor in,211980|Nonsmall cell lung cancer,susceptibility to,211980|Inflammatory skin and bowel disease,neonatal,2,616069];				n/a (AF>5%)	n/a (AF>5%)					EGFR (inh=AR pLI=1.00)
chr7	55499058	55499058	A	G	hom	off-target	QUAL=1323;DP=42;AF=1.00;MQM=60	LANCL2	3'UTR	LANCL2:ENST00000254770:3'UTR:MODIFIER:exon9/9:c.*45A>G:		rs815988	0.9691	0.9441	51570,27373,4911	0.9888,0.9752,0.9999,0.9233,0.9725	0.9452											n/a (AF>5%)	n/a (AF>5%)					LANCL2 (inh=n/a pLI=0.69)
chr7	63726645	63726645	T	C	hom		QUAL=5310;DP=162;AF=1.00;MQM=60	ZNF679	missense	ZNF679:ENST00000255746:missense:MODERATE:exon4/4:c.634T>C:p.Tyr212His,ZNF679:ENST00000421025:missense:MODERATE:exon5/5:c.634T>C:p.Tyr212His		rs1830035	0.1400	0.1196	441,65,225	0.3013,0.2561,0.1014,0.0790,0.1102	0.1152	0.8030	D,D	T	B	T,T	12.30					n/a (AF>5%)	n/a (AF>5%)					ZNF679 (inh=n/a pLI=0.00)
chr7	63726678	63726678	T	A	hom		QUAL=6850;DP=206;AF=1.00;MQM=60	ZNF679	missense	ZNF679:ENST00000255746:missense:MODERATE:exon4/4:c.667T>A:p.Cys223Ser,ZNF679:ENST00000421025:missense:MODERATE:exon5/5:c.667T>A:p.Cys223Ser		rs1830036	0.1400	0.1140	600,88,301	0.3018,0.2272,0.0960,0.0726,0.1105	0.1152	-6.3540	T,T	T	B	T,T	0.13					n/a (AF>5%)	n/a (AF>5%)					ZNF679 (inh=n/a pLI=0.00)
chr7	64451699	64451699	T	C	hom		QUAL=3389;DP=103;AF=1.00;MQM=60	ERV3-1,ZNF117	missense	ERV3-1:ENST00000394323:missense:MODERATE:exon2/2:c.1706A>G:p.Asn569Ser	HERV3-int	rs4717229	0.8928	0.9423	12124,5913,1031	0.8270,0.9564,0.8744,0.9570,0.9711	0.9385	0.1980	T	T	P	T	21.90					n/a (AF>5%)	n/a (AF>5%)					ERV3-1 (inh=n/a pLI=0.00), ZNF117 (inh=n/a pLI=0.00)
chr7	73279361	73279361	C	T	het		QUAL=1292;DP=93;AF=0.54;MQM=60	WBSCR28	synonymous	WBSCR28:ENST00000320531:synonymous:LOW:exon2/3:c.111C>T:p.Leu37Leu		rs61742124	0.2095	0.2019	2411,1358,412	0.2878,0.2233,0.0757,0.2035,0.2100	0.2086							608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700];			COSM3762821	n/a (AF>5%)	n/a (AF>5%)					TMEM270 (inh=n/a pLI=0.00)
chr7	75630274	75630274	T	C	hom		QUAL=4634;DP=144;AF=0.99;MQM=60	STYXL1	synonymous,3'UTR	STYXL1:ENST00000248600:synonymous:LOW:exon8/9:c.744A>G:p.Gln248Gln,STYXL1:ENST00000359697:synonymous:LOW:exon8/9:c.744A>G:p.Gln248Gln,STYXL1:ENST00000340062:synonymous:LOW:exon6/7:c.456A>G:p.Gln152Gln,STYXL1:ENST00000431581:synonymous:LOW:exon8/9:c.744A>G:p.Gln248Gln,STYXL1:ENST00000451157:synonymous:LOW:exon8/9:c.744A>G:p.Gln248Gln,STYXL1:ENST00000360591:3'UTR:MODIFIER:exon7/8:c.*259A>G:		rs8565	0.6238	0.6783	28171,17812,1996	0.6230,0.6295,0.5612,0.7308,0.6300	0.6768											n/a (AF>5%)	n/a (AF>5%)					STYXL1 (inh=n/a pLI=0.04)
chr7	83764309	83764309	C	G	het	off-target	QUAL=1101;DP=77;AF=0.55;MQM=60	SEMA3A	intron	SEMA3A:ENST00000265362:intron:MODIFIER:exon1/16:c.113-42G>C:,SEMA3A:ENST00000436949:intron:MODIFIER:exon2/17:c.113-42G>C:		rs17241389	0.5048	0.5337	16953,10017,722	0.3676,0.5548,0.6952,0.5537,0.4496	0.5401							603961 [SEMA3A (provisional) Hypogonadotropic hypogonadism 16 with or without anosmia,614897];				n/a (AF>5%)	n/a (AF>5%)					SEMA3A (inh=n/a pLI=0.99)
chr7	87180198	87180198	C	T	hom	off-target	QUAL=1411;DP=45;AF=1.00;MQM=60	ABCB1	intron	ABCB1:ENST00000265724:intron:MODIFIER:exon10/28:c.1000-44G>A:,ABCB1:ENST00000543898:intron:MODIFIER:exon7/25:c.808-44G>A:		rs10276036	0.5677	0.5379	17116,10277,2736	0.7537,0.4948,0.3652,0.5740,0.3947	0.5967							171050 [ABCB1 (confirmed) Colchicine resistance,120080|Inflammatory bowel disease 13,612244];				n/a (AF>5%)	n/a (AF>5%)					ABCB1 (inh=n/a pLI=0.78)
chr7	90338850	90338850	C	T	het		QUAL=1460;DP=127;AF=0.45;MQM=60	CDK14	5'UTR,intron	CDK14:ENST00000265741:5'UTR:MODIFIER:exon1/14:c.-6C>T:,CDK14:ENST00000406263:5'UTR:MODIFIER:exon1/14:c.-437C>T:,CDK14:ENST00000380050:intron:MODIFIER:exon2/14:c.124-17031C>T:		rs11767691	0.1360	0.1475	1433,896,142	0.1658,0.0683,0.0986,0.1637,0.1745	0.1450											n/a (AF>5%)	n/a (AF>5%)					CDK14 (inh=n/a pLI=0.74)
chr7	93055753	93055753	A	G	het		QUAL=2523;DP=201;AF=0.47;MQM=60	CALCR	missense	CALCR:ENST00000359558:missense:MODERATE:exon16/16:c.1442T>C:p.Leu481Pro,CALCR:ENST00000360249:missense:MODERATE:exon15/15:c.1388T>C:p.Leu463Pro,CALCR:ENST00000421592:missense:MODERATE:exon15/15:c.1388T>C:p.Leu463Pro,CALCR:ENST00000394441:missense:MODERATE:exon13/13:c.1340T>C:p.Leu447Pro,CALCR:ENST00000426151:missense:MODERATE:exon14/14:c.1340T>C:p.Leu447Pro		rs1801197	0.5435	0.3800	10639,2309,1248	0.4876,0.5085,0.8668,0.2630,0.4872	0.3840	1.7870	T,T,T,T,T	T	B,B	T,T,T,T,T	0.33	114131 [CALCR (confirmed) Osteoporosis,postmenopausal,susceptibility,166710];	17636 [risk factor DISEASE=bone_mineral_density_quantitative_trait_locus_15]; 		COSM1178513, COSM1178514	n/a (AF>5%)	n/a (AF>5%)					CALCR (inh=n/a pLI=0.00)
chr7	99500911	99500911	A	G	het		QUAL=719;DP=98;AF=0.34;MQM=60	TRIM4	synonymous	TRIM4:ENST00000355947:synonymous:LOW:exon6/7:c.849T>C:p.Ser283Ser,TRIM4:ENST00000349062:synonymous:LOW:exon5/6:c.771T>C:p.Ser257Ser,TRIM4:ENST00000354241:synonymous:LOW:exon5/6:c.771T>C:p.Ser257Ser		rs2247761	0.5787	0.5653	20443,11375,3825	0.8561,0.4399,0.2951,0.5820,0.5312	0.6563	-0.1260	T	T		T	0.01				COSM3762926, COSM3762927	n/a (AF>5%)	n/a (AF>5%)					TRIM4 (inh=n/a pLI=0.00)
chr7	99747130	99747130	G	A	het		QUAL=2092;DP=158;AF=0.50;MQM=60	LAMTOR4	synonymous	LAMTOR4:ENST00000441173:synonymous:LOW:exon2/3:c.12G>A:p.Ala4Ala,LAMTOR4:ENST00000341942:synonymous:LOW:exon2/4:c.12G>A:p.Ala4Ala		rs12878	0.5970	0.5952	21661,11943,1729	0.5749,0.4735,0.6771,0.5987,0.6352	0.5942										COSM3762939	n/a (AF>5%)	n/a (AF>5%)					LAMTOR4 (inh=n/a pLI=0.12)
chr7	100004446	100004446	C	T	het	off-target	QUAL=694;DP=65;AF=0.45;MQM=60	ZCWPW1	intron	ZCWPW1:ENST00000398027:intron:MODIFIER:exon11/17:c.1066-25G>A:,ZCWPW1:ENST00000490721:intron:MODIFIER:exon8/13:c.706-25G>A:,ZCWPW1:ENST00000360951:intron:MODIFIER:exon11/15:c.1069-25G>A:,ZCWPW1:ENST00000324725:intron:MODIFIER:exon11/16:c.706-25G>A:		rs1476679	0.7885	0.7426	33061,16682,4340	0.9439,0.7578,0.6715,0.7131,0.7755	0.7755											n/a (AF>5%)	n/a (AF>5%)					ZCWPW1 (inh=n/a pLI=0.00)
chr7	101256833	101256833	T	C	het		QUAL=1475;DP=126;AF=0.46;MQM=60	MYL10	synonymous	MYL10:ENST00000223167:synonymous:LOW:exon8/8:c.603A>G:p.Ala201Ala		rs2240389	0.2282	0.2431	3790,2477,435	0.2930,0.2378,0.1306,0.2679,0.1684	0.2650										COSM3762288	n/a (AF>5%)	n/a (AF>5%)					MYL10 (inh=n/a pLI=0.01)
chr7	102948040	102948040	T	C	hom		QUAL=3616;DP=118;AF=0.99;MQM=60	PMPCB	splice_region&intron	PMPCB:ENST00000428154:splice_region&intron:LOW:exon6/11:c.737-3T>C:,PMPCB:ENST00000249269:splice_region&intron:LOW:exon6/12:c.737-3T>C:,PMPCB:ENST00000420236:splice_region&intron:LOW:exon6/12:c.422-3T>C:		rs11489600	0.3778	0.5465	19477,14557,185	0.1912,0.4351,0.3214,0.6639,0.4529	0.5496							603131 [PMPCB (provisional) Multiple mitochondrial dysfunctions syndrome 6,617954];				n/a (AF>5%)	n/a (AF>5%)					PMPCB (inh=n/a pLI=0.00)
chr7	111617088	111617088	G	A	het		QUAL=661;DP=47;AF=0.53;MQM=60	DOCK4	intron	DOCK4:ENST00000428084:intron:MODIFIER:exon8/52:c.701+99C>T:,DOCK4:ENST00000437633:intron:MODIFIER:exon8/51:c.701+99C>T:		rs3864649	0.1066	0.0000	0,0,0	0,0,0,0,0	0.1296											n/a (AF>5%)	n/a (AF>5%)					DOCK4 (inh=n/a pLI=1.00)
chr7	116397572	116397572	A	G	het		QUAL=1420;DP=97;AF=0.56;MQM=60	MET	synonymous	MET:ENST00000318493:synonymous:LOW:exon7/21:c.1944A>G:p.Gln648Gln,MET:ENST00000397752:synonymous:LOW:exon7/21:c.1944A>G:p.Gln648Gln,MET:ENST00000436117:synonymous:LOW:exon6/9:c.1944A>G:p.Gln648Gln		rs13223756	0.1879	0.1878	2318,1180,70	0.1251,0.0766,0.3005,0.1896,0.2338	0.1827							164860 [MET (confirmed) Renal cell carcinoma,papillary,1,familial and somatic,605074|Hepatocellular carcinoma,childhood type,somatic,114550|Deafness,autosomal recessive 97,616705|Osteofibrous dysplasia,susceptibility to,607278];	93569 [benign DISEASE=renal_cell_carcinoma,_papillary,_1,hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MET (inh=AR+AD pLI=1.00)
chr7	116528240	116528240	C	T	het		QUAL=1525;DP=119;AF=0.50;MQM=60	CAPZA2	synonymous	CAPZA2:ENST00000361183:synonymous:LOW:exon2/10:c.99C>T:p.Phe33Phe,CAPZA2:ENST00000458284:synonymous:LOW:exon2/9:c.99C>T:p.Phe33Phe,CAPZA2:ENST00000490693:synonymous:LOW:exon2/5:c.99C>T:p.Phe33Phe		rs4808	0.3235	0.2645	4519,1706,733	0.3720,0.3010,0.4196,0.2259,0.2691	0.2748	1.7980		T			14.18					n/a (AF>5%)	n/a (AF>5%)					CAPZA2 (inh=n/a pLI=0.98)
chr7	122303321	122303321	C	T	het		QUAL=1811;DP=122;AF=0.57;MQM=60	CADPS2	synonymous	CADPS2:ENST00000449022:synonymous:LOW:exon3/30:c.756G>A:p.Leu252Leu,CADPS2:ENST00000313070:synonymous:LOW:exon3/28:c.756G>A:p.Leu252Leu,CADPS2:ENST00000334010:synonymous:LOW:exon3/28:c.756G>A:p.Leu252Leu,CADPS2:ENST00000412584:synonymous:LOW:exon3/28:c.756G>A:p.Leu252Leu		rs2251761	0.7181	0.7270	31503,18574,2095	0.6609,0.6123,0.7424,0.7530,0.7739	0.7204										COSM4004269, COSM4004270	n/a (AF>5%)	n/a (AF>5%)					CADPS2 (inh=n/a pLI=1.00)
chr7	125753485	125753485	C	A	hom		QUAL=84;DP=3;AF=1.00;MQM=60	AC003968.1,AC000370.2	intergenic_region	AC000370.2:ENSG00000221418-ENSG00000241921:intergenic_region:MODIFIER::n.125753485C>A:		rs1419526	0.9371	0.0000	0,0,0	0,0,0,0,0	0.9140											n/a (AF>5%)	n/a (AF>5%)					AC003968.1 (inh=n/a pLI=n/a), AC000370.2 (inh=n/a pLI=n/a)
chr7	130022041	130022041	C	T	het		QUAL=3674;DP=264;AF=0.51;MQM=60	CPA1	synonymous	CPA1:ENST00000011292:synonymous:LOW:exon4/10:c.474C>T:p.Tyr158Tyr,CPA1:ENST00000484324:synonymous:LOW:exon3/9:c.210C>T:p.Tyr70Tyr		rs968404	0.0952	0.1327	1199,857,81	0.1242,0.0617,0.0029,0.1613,0.1266	0.1380								258475 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CPA1 (inh=n/a pLI=0.00)
chr7	130148817	130148817	G	A	het	off-target	QUAL=797;DP=82;AF=0.43;MQM=60	COPG2				rs1047456	0.2308	0.2919	1310,703,154	0.3213,0.1768,0.1631,0.3120,0.2884	0.2595											n/a (AF>5%)	n/a (AF>5%)					COPG2 (inh=n/a pLI=0.19)
chr7	132192949	132192949	T	C	hom		QUAL=7544;DP=226;AF=1.00;MQM=60	PLXNA4	synonymous	PLXNA4:ENST00000321063:synonymous:LOW:exon2/32:c.504A>G:p.Ser168Ser,PLXNA4:ENST00000359827:synonymous:LOW:exon2/32:c.504A>G:p.Ser168Ser,PLXNA4:ENST00000423507:synonymous:LOW:exon2/4:c.504A>G:p.Ser168Ser,PLXNA4:ENST00000378539:synonymous:LOW:exon3/5:c.504A>G:p.Ser168Ser		rs156962	0.3934	0.3830	9135,5061,1236	0.4900,0.3130,0.2499,0.3884,0.4066	0.4115										COSM4161808, COSM4161809, COSM150391, COSM150390	n/a (AF>5%)	n/a (AF>5%)					PLXNA4 (inh=n/a pLI=1.00)
chr7	134968479	134968479	A	C	hom	off-target	QUAL=2894;DP=87;AF=1.00;MQM=60	STRA8,CNOT4	intergenic_region	CNOT4:ENSG00000146857-ENSG00000080802:intergenic_region:MODIFIER::n.134968479A>C:		rs11762990	0.2626	0.0000	0,0,0	0,0,0,0,0	0.3191											n/a (AF>5%)	n/a (AF>5%)					STRA8 (inh=n/a pLI=0.01), CNOT4 (inh=n/a pLI=0.99)
chr7	135413626	135413626	C	T	het		QUAL=825;DP=70;AF=0.47;MQM=60	SLC13A4,FAM180A				rs3807338	0.3898	0.3892	948,330,59	0.4753,0.0000,0.4150,0.4378,0.3592	0.4160											n/a (AF>5%)	n/a (AF>5%)					SLC13A4 (inh=n/a pLI=0.86), FAM180A (inh=n/a pLI=0.32)
chr7	137600690	137600690	C	T	het		QUAL=1869;DP=138;AF=0.51;MQM=60	CREB3L2	missense	CREB3L2:ENST00000330387:missense:MODERATE:exon3/12:c.388G>A:p.Val130Ile,CREB3L2:ENST00000456390:missense:MODERATE:exon3/10:c.388G>A:p.Val130Ile,CREB3L2:ENST00000452463:missense:MODERATE:exon3/4:c.388G>A:p.Val130Ile,CREB3L2:ENST00000458726:missense:MODERATE:exon3/4:c.199G>A:p.Val67Ile		rs273957	0.8043	0.6893	29648,12665,4490	0.9287,0.7931,0.9243,0.6164,0.6787	0.7149	0.4200	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T	1.82					n/a (AF>5%)	n/a (AF>5%)					CREB3L2 (inh=n/a pLI=0.50)
chr7	137773563	137773563	T	G	het	off-target	QUAL=165;DP=15;AF=0.53;MQM=60	AKR1D1	intron	AKR1D1:ENST00000242375:intron:MODIFIER:exon2/8:c.261+49T>G:,AKR1D1:ENST00000432161:intron:MODIFIER:exon2/7:c.261+49T>G:,AKR1D1:ENST00000411726:intron:MODIFIER:exon2/7:c.261+49T>G:		rs2166188	0.7556	0.7542	8245,3852,1328	0.8725,0.6507,0.6627,0.7460,0.7466	0.7836							604741 [AKR1D1 (provisional) Bile acid synthesis defect,congenital,2,235555];				n/a (AF>5%)	n/a (AF>5%)					AKR1D1 (inh=AR pLI=0.00)
chr7	137801413	137801413	A	C	het		QUAL=1670;DP=150;AF=0.45;MQM=60	AKR1D1	3'UTR	AKR1D1:ENST00000242375:3'UTR:MODIFIER:exon9/9:c.*5A>C:,AKR1D1:ENST00000432161:3'UTR:MODIFIER:exon8/8:c.*30A>C:,AKR1D1:ENST00000411726:3'UTR:MODIFIER:exon8/8:c.*5A>C:		rs1872929	0.0000	0.7810	37303,21291,3982	0.8757,0.6348,0.7428,0.7973,0.7672	0.8194							604741 [AKR1D1 (provisional) Bile acid synthesis defect,congenital,2,235555];	259891 [benign DISEASE=not_specified,congenital_bile_acid_synthesis_defect]; 			n/a (AF>5%)	n/a (AF>5%)					AKR1D1 (inh=AR pLI=0.00)
chr7	139167934	139167934	T	G	het		QUAL=972;DP=71;AF=0.52;MQM=60	KLRG2	missense	KLRG2:ENST00000340940:missense:MODERATE:exon1/5:c.455A>C:p.Lys152Thr,KLRG2:ENST00000393039:missense:MODERATE:exon1/2:c.455A>C:p.Lys152Thr		rs1860150	0.6266	0.6175	3971,1910,549	0.8362,0.5884,0.7438,0.6373,0.5227	0.5774	0.7600	T,T	T	B,B	T,T	12.93				COSM1622418	n/a (AF>5%)	n/a (AF>5%)					KLRG2 (inh=n/a pLI=0.00)
chr7	140051063	140051063	C	T	hom		QUAL=4318;DP=130;AF=1.00;MQM=60	SLC37A3	splice_region&intron	SLC37A3:ENST00000326232:splice_region&intron:LOW:exon9/14:c.882+10G>A:,SLC37A3:ENST00000340308:splice_region&intron:LOW:exon9/11:c.882+10G>A:,SLC37A3:ENST00000447932:splice_region&intron:LOW:exon9/13:c.882+10G>A:,SLC37A3:ENST00000429996:splice_region&intron:LOW:exon8/9:c.*783+10G>A:		rs12703774	0.3854	0.4327	11189,6885,506	0.3174,0.4103,0.4412,0.4578,0.4090	0.4284										COSM150402	n/a (AF>5%)	n/a (AF>5%)					SLC37A3 (inh=n/a pLI=0.00)
chr7	141898023	141898023	C	A	hom	off-target	QUAL=3911;DP=118;AF=1.00;MQM=60	RP11-1220K2.2				rs4260813	0.4231	0.4390	1465,430,31	0.2879,0.0000,0.5000,0.4446,0.4449	0.4595											n/a (AF>5%)	n/a (AF>5%)					RP11-1220K2.2 (inh=n/a pLI=n/a)
chr7	143036337	143036337	C	T	het		QUAL=2516;DP=214;AF=0.45;MQM=60	CLCN1	splice_region&intron	CLCN1:ENST00000343257:splice_region&intron:LOW:exon12/22:c.1402-9C>T:		rs2272252	0.4143	0.4108	10743,6061,1715	0.5687,0.2995,0.2627,0.4246,0.4228	0.4356							118425 [CLCN1 (provisional) Myotonia congenita,recessive,255700|Myotonia congenita,dominant,160800|Myotonia levior,recessive];	359111 [benign DISEASE=myotonia_congenita,congenital_myotonia,_autosomal_recessive_form,congenital_myotonia,_autosomal_dominant_form,not_specified]; 		COSM4004350	n/a (AF>5%)	n/a (AF>5%)					CLCN1 (inh=AR+AD pLI=0.00)
chr7	143175154	143175154	G	A	het		QUAL=1465;DP=115;AF=0.50;MQM=60	TAS2R41,EPHA1-AS1	synonymous,intron	TAS2R41:ENST00000408916:synonymous:LOW:exon1/1:c.189G>A:p.Thr63Thr,EPHA1-AS1:ENST00000429289:intron:MODIFIER:exon2/4:n.207-26713G>A:		rs1404635	0.2111	0.2623	4455,2417,21	0.0596,0.2952,0.2782,0.2686,0.3244	0.2661											n/a (AF>5%)	n/a (AF>5%)					TAS2R41 (inh=n/a pLI=0.00), EPHA1-AS1 (inh=n/a pLI=n/a)
chr7	143839408	143839408	C	T	het		QUAL=5163;DP=370;AF=0.51;MQM=60	OR2A13P	non_coding_transcript_exon	OR2A13P:ENST00000609258:non_coding_transcript_exon:MODIFIER:exon1/1:n.307C>T:		rs1919954	0.5803	0.5715	20291,9465,1147	0.4846,0.7938,0.7582,0.5331,0.5551	0.5778											n/a (AF>5%)	n/a (AF>5%)					OR2A13P (inh=n/a pLI=n/a)
chr7	144364829	144364829	C	T	het		QUAL=1481;DP=151;AF=0.40;MQM=60	TPK1	missense,5'UTR,intron	TPK1:ENST00000538212:missense:MODERATE:exon3/7:c.160G>A:p.Gly54Arg,TPK1:ENST00000549981:5'UTR:MODIFIER:exon5/12:c.-299G>A:,TPK1:ENST00000360057:intron:MODIFIER:exon4/8:c.185+15173G>A:,TPK1:ENST00000378099:intron:MODIFIER:exon4/7:c.185+15173G>A:	MER21C	rs57405539	0.0653	0.0510	252,115,88	0.1403,0.0291,0.0004,0.0506,0.0379	0.0730	-0.1380	T	T	B	T	0.89	606370 [TPK1 (provisional) Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type),614458];				n/a (AF>5%)	n/a (AF>5%)					TPK1 (inh=AR pLI=0.11)
chr7	149191027	149191027	T	C	het	off-target	QUAL=246;DP=40;AF=0.40;MQM=60	ZNF746	intron	ZNF746:ENST00000458143:intron:MODIFIER:exon3/6:c.406+53A>G:,ZNF746:ENST00000340622:intron:MODIFIER:exon3/6:c.406+53A>G:,ZNF746:ENST00000461958:intron:MODIFIER:exon3/4:c.406+53A>G:		rs13236631	0.7272	0.0000	0,0,0	0,0,0,0,0	0.6430											n/a (AF>5%)	n/a (AF>5%)					ZNF746 (inh=n/a pLI=0.16)
chr7	150389593	150389593	T	C	het		QUAL=1894;DP=157;AF=0.46;MQM=60	GIMAP2	synonymous	GIMAP2:ENST00000223293:synonymous:LOW:exon3/3:c.219T>C:p.Ile73Ile		rs1860871	0.0990	0.0943	628,277,16	0.0447,0.0925,0.1912,0.0877,0.0998	0.0965											n/a (AF>5%)	n/a (AF>5%)					GIMAP2 (inh=n/a pLI=0.00)
chr7	150708089	150708089	A	G	het		QUAL=839;DP=67;AF=0.49;MQM=60	NOS3	splice_region&intron	NOS3:ENST00000297494:splice_region&intron:LOW:exon23/26:c.2984+15A>G:,NOS3:ENST00000461406:splice_region&intron:LOW:exon20/23:c.2366+15A>G:		rs891512	0.8884	0.8441	40584,19449,4498	0.9657,0.8984,0.9649,0.7926,0.8773	0.8634							163729 [NOS3 (confirmed) Coronary artery spasm 1,susceptibility to|Alzheimer disease,late-onset,susceptibility to,104300|Hypertension,susceptibility to,145500|Hypertension,pregnancy-induced,189800|Placental abruption|Ischemic stroke,susceptibility to,601367];	403250 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NOS3 (inh=n/a pLI=0.00)
chr7	150752608	150752608	T	G	het		QUAL=1126;DP=85;AF=0.51;MQM=60	CDK5	splice_region&intron	CDK5:ENST00000485972:splice_region&intron:LOW:exon7/11:c.483+11A>C:,CDK5:ENST00000297518:splice_region&intron:LOW:exon6/10:c.387+11A>C:		rs2069456	0.2752	0.2779	5344,1934,264	0.2338,0.6009,0.3257,0.2445,0.1933	0.2875							123831 [CDK5 (provisional) Lissencephaly 7 with cerebellar hypoplasia,616342];				n/a (AF>5%)	n/a (AF>5%)					CDK5 (inh=AR pLI=0.93)
chr7	150912786	150912786	T	C	het		QUAL=1699;DP=139;AF=0.47;MQM=60	ABCF2	synonymous	ABCF2:ENST00000222388:synonymous:LOW:exon13/16:c.1434A>G:p.Ser478Ser,ABCF2:ENST00000287844:synonymous:LOW:exon13/15:c.1434A>G:p.Ser478Ser		rs7786151	0.0871	0.0934	653,287,107	0.1477,0.1843,0.0150,0.0897,0.0664	0.1025											n/a (AF>5%)	n/a (AF>5%)					ABCF2 (inh=n/a pLI=0.99)
chr7	151097323	151097323	A	G	hom		QUAL=3378;DP=101;AF=1.00;MQM=60	WDR86	synonymous,5'UTR	WDR86:ENST00000469830:synonymous:LOW:exon2/6:c.168T>C:p.His56His,WDR86:ENST00000334493:synonymous:LOW:exon2/6:c.168T>C:p.His56His,WDR86:ENST00000477459:5'UTR:MODIFIER:exon2/5:c.-217T>C:		rs11767693	0.7075	0.7360	30581,16880,2118	0.6876,0.7757,0.8326,0.7328,0.6627	0.7344											n/a (AF>5%)	n/a (AF>5%)					WDR86 (inh=n/a pLI=0.00)
chr7	155499799	155499799	C	T	het	off-target	QUAL=135;DP=8;AF=0.75;MQM=60	RBM33	intron	RBM33:ENST00000401878:intron:MODIFIER:exon7/17:c.948+37C>T:		rs4716543	0.3149	0.2952	737,359,128	0.3536,0.4709,0.2968,0.2951,0.2550	0.3233											n/a (AF>5%)	n/a (AF>5%)					RBM33 (inh=n/a pLI=1.00)
chr7	155755336	155755336	C	T	hom		QUAL=4347;DP=132;AF=1.00;MQM=60	AC021218.2			L2c	rs7807731	0.5637	0.0000	0,0,0	0,0,0,0,0	0.5559											n/a (AF>5%)	n/a (AF>5%)					AC021218.2 (inh=n/a pLI=n/a)
chr7	155755826	155755826	A	G	hom		QUAL=2138;DP=67;AF=1.00;MQM=60	AC021218.2				rs2007015	0.7065	0.7637	4164,1820,194	0.6712,0.7929,0.5426,0.8561,0.7246	0.7811											n/a (AF>5%)	n/a (AF>5%)					AC021218.2 (inh=n/a pLI=n/a)
chr7	156761913	156761913	C	T	hom	off-target	QUAL=4366;DP=134;AF=1.00;MQM=60	NOM1	intron	NOM1:ENST00000275820:intron:MODIFIER:exon10/10:c.2408+23C>T:		rs2302444	0.4363	0.4878	14650,9373,867	0.4200,0.5190,0.2851,0.5315,0.4580	0.4870											n/a (AF>5%)	n/a (AF>5%)					NOM1 (inh=n/a pLI=0.00)
chr7	156762248	156762248	G	A	hom		QUAL=3512;DP=108;AF=1.00;MQM=60	NOM1	missense	NOM1:ENST00000275820:missense:MODERATE:exon11/11:c.2434G>A:p.Val812Met		rs12919	0.4814	0.5160	16486,10261,1537	0.5456,0.5356,0.2851,0.5556,0.4662	0.5160	-0.1990	T	T	B	T	0.01				COSM1568490	n/a (AF>5%)	n/a (AF>5%)					NOM1 (inh=n/a pLI=0.00)
chr7	156762446	156762446	G	T	hom	off-target	QUAL=1710;DP=52;AF=1.00;MQM=60	NOM1	3'UTR	NOM1:ENST00000275820:3'UTR:MODIFIER:exon11/11:c.*49G>T:		rs3087905	0.4631	0.5111	14980,9558,1124	0.4868,0.5322,0.2840,0.5547,0.4712	0.5128											n/a (AF>5%)	n/a (AF>5%)					NOM1 (inh=n/a pLI=0.00)
chr7	158455089	158455089	G	A	hom	off-target	QUAL=1182;DP=36;AF=1.00;MQM=60	NCAPG2	intron	NCAPG2:ENST00000409339:intron:MODIFIER:exon15/27:c.1816-30C>T:,NCAPG2:ENST00000541468:intron:MODIFIER:exon3/14:c.319-30C>T:,NCAPG2:ENST00000356309:intron:MODIFIER:exon15/27:c.1816-30C>T:,NCAPG2:ENST00000409423:intron:MODIFIER:exon16/28:c.1816-30C>T:,NCAPG2:ENST00000275830:intron:MODIFIER:exon10/21:c.1192-30C>T:,NCAPG2:ENST00000449727:intron:MODIFIER:exon16/28:c.1816-30C>T:		rs4484634	0.9603	0.9189	48696,25530,4623	0.9806,0.9710,0.9765,0.8861,0.9643	0.9197											n/a (AF>5%)	n/a (AF>5%)					NCAPG2 (inh=n/a pLI=0.92)
chr7	158566138	158566138	T	C	hom	off-target	QUAL=4186;DP=128;AF=1.00;MQM=60	ESYT2	intron	ESYT2:ENST00000251527:intron:MODIFIER:exon6/21:c.892-51A>G:		rs842447	0.7304	0.8217	40386,25771,2834	0.7469,0.7650,0.5345,0.8914,0.7406	0.8316											n/a (AF>5%)	n/a (AF>5%)					ESYT2 (inh=n/a pLI=0.02)
chr8	2064121	2064121	C	T	hom	off-target	QUAL=2371;DP=72;AF=1.00;MQM=60	MYOM2	intron	MYOM2:ENST00000262113:intron:MODIFIER:exon27/36:c.3385+52C>T:,MYOM2:ENST00000523438:intron:MODIFIER:exon14/23:c.1660+52C>T:		rs12548396	0.4748	0.5429	14883,9905,393	0.3134,0.3637,0.5154,0.6093,0.5504	0.5471											n/a (AF>5%)	n/a (AF>5%)					MYOM2 (inh=n/a pLI=0.00)
chr8	8887566	8887566	A	G	het	off-target	QUAL=428;DP=43;AF=0.44;MQM=60	ERI1	3'UTR	ERI1:ENST00000250263:3'UTR:MODIFIER:exon7/7:c.*22A>G:,ERI1:ENST00000523898:3'UTR:MODIFIER:exon8/8:c.*22A>G:,ERI1:ENST00000519292:3'UTR:MODIFIER:exon7/8:c.*22A>G:		rs34111588	0.1402	0.1334	1248,815,273	0.2284,0.0714,0.0116,0.1582,0.0960	0.1640											n/a (AF>5%)	n/a (AF>5%)					ERI1 (inh=n/a pLI=0.01)
chr8	11416428	11416428	C	T	hom		QUAL=1574;DP=49;AF=1.00;MQM=60	BLK,RP11-148O21.2	intron	BLK:ENST00000259089:intron:MODIFIER:exon10/12:c.1029+881C>T:,BLK:ENST00000529894:intron:MODIFIER:exon9/11:c.816+881C>T:		rs6988443	0.4153	0.5019	1445,612,26	0.5388,0.0000,0.0000,0.6523,0.4544	0.5448	-0.3660		T			6.32	191305 [BLK (provisional) Maturity-onset diabetes of the young,type 11,613375];				n/a (AF>5%)	n/a (AF>5%)					BLK (inh=AD pLI=0.00), RP11-148O21.2 (inh=n/a pLI=n/a)
chr8	11705342	11705342	G	C	het		QUAL=1667;DP=169;AF=0.41;MQM=60	CTSB	splice_region&intron	CTSB:ENST00000345125:splice_region&intron:LOW:exon7/10:c.533-11C>G:,CTSB:ENST00000434271:splice_region&intron:LOW:exon6/9:c.533-11C>G:,CTSB:ENST00000353047:splice_region&intron:LOW:exon6/9:c.533-11C>G:,CTSB:ENST00000530640:splice_region&intron:LOW:exon6/10:c.533-11C>G:,CTSB:ENST00000531089:splice_region&intron:LOW:exon7/11:c.533-11C>G:,CTSB:ENST00000453527:splice_region&intron:LOW:exon7/10:c.533-11C>G:,CTSB:ENST00000415599:splice_region&intron:LOW:exon4/7:c.*81-11C>G:,CTSB:ENST00000533455:splice_region&intron:LOW:exon7/10:c.533-11C>G:,CTSB:ENST00000534510:splice_region&intron:LOW:exon7/10:c.533-11C>G:		rs1736088	0.5493	0.5681	19604,12683,1549	0.5466,0.4593,0.4752,0.6203,0.5200	0.5694											n/a (AF>5%)	n/a (AF>5%)					CTSB (inh=n/a pLI=n/a)
chr8	11705870	11705870	G	A	het		QUAL=1421;DP=122;AF=0.48;MQM=60	CTSB	intron	CTSB:ENST00000345125:intron:MODIFIER:exon6/10:c.447-209C>T:,CTSB:ENST00000434271:intron:MODIFIER:exon5/9:c.447-209C>T:,CTSB:ENST00000353047:intron:MODIFIER:exon5/9:c.447-209C>T:,CTSB:ENST00000530640:intron:MODIFIER:exon5/10:c.447-209C>T:,CTSB:ENST00000531089:intron:MODIFIER:exon6/11:c.447-209C>T:,CTSB:ENST00000453527:intron:MODIFIER:exon6/10:c.447-209C>T:,CTSB:ENST00000415599:intron:MODIFIER:exon3/7:c.328-209C>T:,CTSB:ENST00000533455:intron:MODIFIER:exon6/10:c.447-209C>T:,CTSB:ENST00000534510:intron:MODIFIER:exon6/10:c.447-209C>T:		rs1736089	0.0960	0.1922	235,147,0	0.0711,0.0000,0.0000,0.3112,0.1432	0.1727	-0.7430					1.24					n/a (AF>5%)	n/a (AF>5%)					CTSB (inh=n/a pLI=n/a)
chr8	13356802	13356802	G	A	het		QUAL=1384;DP=138;AF=0.40;MQM=60	DLC1	missense	DLC1:ENST00000276297:missense:MODERATE:exon2/18:c.779C>T:p.Thr260Ile,DLC1:ENST00000316609:missense:MODERATE:exon2/6:c.779C>T:p.Thr260Ile,DLC1:ENST00000511869:missense:MODERATE:exon2/5:c.779C>T:p.Thr260Ile		rs3816747	0.8151	0.8777	47525,29312,3856	0.8618,0.6694,0.6019,0.9375,0.9153	0.8937	-1.1220	T,T,T	T	B,B,B	T,T,T	0.01	604258 [DLC1 (provisional) Colorectal cancer,somatic,114500];				n/a (AF>5%)	n/a (AF>5%)					DLC1 (inh=n/a pLI=1.00)
chr8	17612456	17612456	C	T	hom		QUAL=6982;DP=215;AF=0.99;MQM=60	MTUS1	synonymous	MTUS1:ENST00000262102:synonymous:LOW:exon2/15:c.861G>A:p.Lys287Lys,MTUS1:ENST00000381869:synonymous:LOW:exon2/14:c.861G>A:p.Lys287Lys,MTUS1:ENST00000519263:synonymous:LOW:exon1/13:c.861G>A:p.Lys287Lys,MTUS1:ENST00000381862:synonymous:LOW:exon2/4:c.861G>A:p.Lys287Lys		rs11203910	0.8582	0.9224	51594,30295,2886	0.7676,0.9445,0.8169,0.9528,0.9208	0.9252											n/a (AF>5%)	n/a (AF>5%)					MTUS1 (inh=n/a pLI=0.00)
chr8	17612875	17612875	A	G	het		QUAL=1548;DP=128;AF=0.47;MQM=60	MTUS1	missense	MTUS1:ENST00000262102:missense:MODERATE:exon2/15:c.442T>C:p.Cys148Arg,MTUS1:ENST00000381869:missense:MODERATE:exon2/14:c.442T>C:p.Cys148Arg,MTUS1:ENST00000519263:missense:MODERATE:exon1/13:c.442T>C:p.Cys148Arg,MTUS1:ENST00000381862:missense:MODERATE:exon2/4:c.442T>C:p.Cys148Arg		rs3739407	0.7103	0.7749	36639,21890,1675	0.5861,0.7493,0.6743,0.8087,0.8011	0.7756	1.0060	T,D,T,D	T	B,B,P	T,T,T,T	15.65				COSM3763220, COSM3763221	n/a (AF>5%)	n/a (AF>5%)					MTUS1 (inh=n/a pLI=0.00)
chr8	19362768	19362768	C	T	het		QUAL=1264;DP=108;AF=0.47;MQM=60	CSGALNACT1	missense	CSGALNACT1:ENST00000311540:missense:MODERATE:exon3/9:c.578G>A:p.Ser193Asn,CSGALNACT1:ENST00000454498:missense:MODERATE:exon4/10:c.578G>A:p.Ser193Asn,CSGALNACT1:ENST00000332246:missense:MODERATE:exon4/10:c.578G>A:p.Ser193Asn,CSGALNACT1:ENST00000522854:missense:MODERATE:exon2/8:c.578G>A:p.Ser193Asn,CSGALNACT1:ENST00000544602:missense:MODERATE:exon3/9:c.578G>A:p.Ser193Asn		rs7017776	0.7548	0.7966	38956,21867,2054	0.6223,0.9032,0.8532,0.8088,0.7299	0.8047	-0.8410	T,T,T,T,T	T	B	T,T,T,T,T	0.01				COSM4162882	n/a (AF>5%)	n/a (AF>5%)					CSGALNACT1 (inh=n/a pLI=0.00)
chr8	19682545	19682545	A	G	hom	off-target	QUAL=2125;DP=65;AF=1.00;MQM=60	INTS10	intron	INTS10:ENST00000397977:intron:MODIFIER:exon8/16:c.1006+62A>G:		rs3816246	0.6971	0.0000	0,0,0	0,0,0,0,0	0.7435											n/a (AF>5%)	n/a (AF>5%)					INTS10 (inh=n/a pLI=0.99)
chr8	20038466	20038466	T	G	het		QUAL=480;DP=49;AF=0.43;MQM=60	SLC18A1	missense	SLC18A1:ENST00000276373:missense:MODERATE:exon2/16:c.10A>C:p.Thr4Pro,SLC18A1:ENST00000265808:missense:MODERATE:exon3/16:c.10A>C:p.Thr4Pro,SLC18A1:ENST00000437980:missense:MODERATE:exon3/16:c.10A>C:p.Thr4Pro,SLC18A1:ENST00000440926:missense:MODERATE:exon3/17:c.10A>C:p.Thr4Pro,SLC18A1:ENST00000519026:missense:MODERATE:exon2/15:c.10A>C:p.Thr4Pro,SLC18A1:ENST00000381608:missense:MODERATE:exon1/14:c.10A>C:p.Thr4Pro		rs2270641	0.2462	0.3596	2923,2061,62	0.1727,0.3353,0.3023,0.4103,0.3229	0.3203	-0.8970	T,T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T,T	1.67			CM057213 [CLASS=DP MUT=ALT PHEN="Schizophrenia association with" GENE=SLC18A1]; 	COSM330538	n/a (AF>5%)	n/a (AF>5%)					SLC18A1 (inh=n/a pLI=0.00)
chr8	22491980	22491980	G	T	het	off-target	QUAL=3320;DP=263;AF=0.48;MQM=60	BIN3	intron	BIN3:ENST00000276416:intron:MODIFIER:exon4/8:c.160+2058C>A:,BIN3:ENST00000519513:intron:MODIFIER:exon2/6:c.-2-3889C>A:,BIN3:ENST00000399977:intron:MODIFIER:exon2/6:c.16+2455C>A:,BIN3:ENST00000520292:intron:MODIFIER:exon4/6:c.160+2058C>A:		rs17746902	0.6562	0.6803	2561,527,22	0.4393,0.0000,0.0000,0.6185,0.7113	0.6777											n/a (AF>5%)	n/a (AF>5%)					BIN3 (inh=n/a pLI=0.00)
chr8	25158026	25158026	G	A	hom	off-target	QUAL=4102;DP=125;AF=1.00;MQM=60	DOCK5	intron	DOCK5:ENST00000276440:intron:MODIFIER:exon8/51:c.765-66G>A:,DOCK5:ENST00000481100:intron:MODIFIER:exon8/10:c.765-66G>A:		rs2709639	0.7718	0.0000	0,0,0	0,0,0,0,0	0.8023											n/a (AF>5%)	n/a (AF>5%)					DOCK5 (inh=n/a pLI=0.00)
chr8	25182969	25182969	C	T	hom		QUAL=2106;DP=64;AF=1.00;MQM=60	DOCK5	synonymous	DOCK5:ENST00000276440:synonymous:LOW:exon18/52:c.1809C>T:p.Ser603Ser		rs2666172	0.6689	0.7151	31748,20509,1461	0.5314,0.5548,0.7436,0.7834,0.6337	0.7144	0.5820					10.03					n/a (AF>5%)	n/a (AF>5%)					DOCK5 (inh=n/a pLI=0.00)
chr8	27396208	27396208	G	A	het		QUAL=1954;DP=120;AF=0.60;MQM=60	EPHX2	splice_region&synonymous	EPHX2:ENST00000521400:splice_region&synonymous:LOW:exon14/19:c.1275G>A:p.Ala425Ala,EPHX2:ENST00000517536:splice_region&synonymous:LOW:exon10/15:c.726G>A:p.Ala242Ala,EPHX2:ENST00000521780:splice_region&synonymous:LOW:exon13/18:c.1077G>A:p.Ala359Ala,EPHX2:ENST00000380476:splice_region&synonymous:LOW:exon14/19:c.1116G>A:p.Ala372Ala,EPHX2:ENST00000518379:splice_region&synonymous:LOW:exon13/18:c.1179G>A:p.Ala393Ala		rs4149253	0.1136	0.0780	471,124,71	0.1106,0.0708,0.1643,0.0593,0.1025	0.0766							132811 [EPHX2 (provisional) Hypercholesterolemia,familial,due to LDLR defect,modifier of,143890];			COSM3763290	n/a (AF>5%)	n/a (AF>5%)					EPHX2 (inh=n/a pLI=0.00)
chr8	27880826	27880826	C	T	het		QUAL=723;DP=63;AF=0.46;MQM=60	NUGGC	3'UTR	NUGGC:ENST00000341513:3'UTR:MODIFIER:exon19/19:c.*8G>A:,NUGGC:ENST00000413272:3'UTR:MODIFIER:exon19/19:c.*8G>A:		rs921597	0.3508	0.4949	14341,10230,360	0.2978,0.3913,0.1469,0.5769,0.4749	0.4784											n/a (AF>5%)	n/a (AF>5%)					NUGGC (inh=n/a pLI=0.00)
chr8	27918057	27918057	T	C	hom		QUAL=5627;DP=173;AF=1.00;MQM=60	NUGGC	missense	NUGGC:ENST00000341513:missense:MODERATE:exon8/19:c.983A>G:p.Gln328Arg,NUGGC:ENST00000413272:missense:MODERATE:exon8/19:c.983A>G:p.Gln328Arg		rs7817227	0.9657	0.9900	59165,33252,3913	0.8943,0.9935,1.0000,0.9986,0.9998	0.9913	0.5130	T,T	T	B	D,D	0.01					n/a (AF>5%)	n/a (AF>5%)					NUGGC (inh=n/a pLI=0.00)
chr8	39505826	39505826	C	A	het	off-target	QUAL=508;DP=41;AF=0.49;MQM=60	ADAM18	intron	ADAM18:ENST00000265707:intron:MODIFIER:exon11/19:c.1047-37C>A:,ADAM18:ENST00000379866:intron:MODIFIER:exon10/18:c.975-37C>A:,ADAM18:ENST00000541111:intron:MODIFIER:exon10/17:c.-529+2833C>A:		rs3735880	0.5529	0.6869	27489,19207,1332	0.5320,0.6047,0.2665,0.7767,0.6875	0.6790											n/a (AF>5%)	n/a (AF>5%)					ADAM18 (inh=n/a pLI=0.00)
chr8	40554742	40554742	C	T	het	off-target	QUAL=1366;DP=100;AF=0.51;MQM=60	ZMAT4	intron	ZMAT4:ENST00000297737:intron:MODIFIER:exon4/6:c.349+22G>A:,ZMAT4:ENST00000315769:intron:MODIFIER:exon4/5:c.349+22G>A:		rs11781516	0.5703	0.5191	15762,7261,2041	0.6273,0.5936,0.5667,0.4713,0.5790	0.5261											n/a (AF>5%)	n/a (AF>5%)					ZMAT4 (inh=n/a pLI=0.02)
chr8	59739333	59739333	C	T	het	off-target	QUAL=1332;DP=110;AF=0.47;MQM=60	TOX	intron	TOX:ENST00000361421:intron:MODIFIER:exon6/8:c.1005+48G>A:		rs4737522	0.1546	0.2111	2634,1700,28	0.0890,0.2082,0.0650,0.2397,0.2549	0.2126											n/a (AF>5%)	n/a (AF>5%)					TOX (inh=n/a pLI=0.84)
chr8	59872615	59872615	T	G	hom	off-target	QUAL=2946;DP=95;AF=1.00;MQM=60	TOX	intron	TOX:ENST00000361421:intron:MODIFIER:exon1/8:c.103-48A>C:	(TGTTT)n	rs3780001	0.2750	0.3185	6245,3394,30	0.0830,0.3240,0.4071,0.3261,0.3663	0.3222											n/a (AF>5%)	n/a (AF>5%)					TOX (inh=n/a pLI=0.84)
chr8	62490978	62490978	T	C	hom		QUAL=5694;DP=172;AF=1.00;MQM=60	ASPH,KRT8P3	intron,non_coding_transcript_exon	ASPH:ENST00000379454:intron:MODIFIER:exon15/24:c.1063-1561A>G:,ASPH:ENST00000541428:intron:MODIFIER:exon15/24:c.976-1561A>G:,KRT8P3:ENST00000519669:non_coding_transcript_exon:MODIFIER:exon1/1:n.200T>C:		rs16922684	0.8273	0.0000	0,0,0	0,0,0,0,0	0.8746							600582 [ASPH (confirmed) Traboulsi syndrome,601552];				n/a (AF>5%)	n/a (AF>5%)					ASPH (inh=AR pLI=0.00), KRT8P3 (inh=n/a pLI=n/a)
chr8	69015242	69015242	T	C	het	off-target	QUAL=895;DP=57;AF=0.63;MQM=60	PREX2	intron	PREX2:ENST00000288368:intron:MODIFIER:exon23/39:c.2715+3164T>C:		rs1014663	0.4928	0.4726	8425,3601,1010	0.5924,0.5459,0.4886,0.4344,0.5018	0.4602											n/a (AF>5%)	n/a (AF>5%)					PREX2 (inh=n/a pLI=0.00)
chr8	72966002	72966002	G	A	het		QUAL=554;DP=70;AF=0.37;MQM=60	TRPA1,RP11-383H13.1	synonymous	TRPA1:ENST00000262209:synonymous:LOW:exon13/27:c.1630C>T:p.Leu544Leu		rs3735943	0.5805	0.5476	18198,8157,1306	0.5039,0.7513,0.6777,0.5016,0.5674	0.5535							604775 [TRPA1 (provisional) Episodic pain syndrome,familial,1,615040];				n/a (AF>5%)	n/a (AF>5%)					TRPA1 (inh=AD pLI=0.00), RP11-383H13.1 (inh=n/a pLI=n/a)
chr8	72966124	72966124	A	G	het	off-target	QUAL=120;DP=21;AF=0.38;MQM=60	TRPA1,RP11-383H13.1	intron	TRPA1:ENST00000262209:intron:MODIFIER:exon12/26:c.1530-22T>C:		rs3735944	0.5807	0.5672	15693,6885,1170	0.5196,0.7663,0.6901,0.5257,0.5743	0.5554							604775 [TRPA1 (provisional) Episodic pain syndrome,familial,1,615040];				n/a (AF>5%)	n/a (AF>5%)					TRPA1 (inh=AD pLI=0.00), RP11-383H13.1 (inh=n/a pLI=n/a)
chr8	74204653	74204653	A	T	hom		QUAL=2121;DP=65;AF=1.00;MQM=60	RPL7	splice_region&intron	RPL7:ENST00000352983:splice_region&intron:LOW:exon2/6:c.124-13T>A:,RPL7:ENST00000396467:splice_region&intron:LOW:exon2/5:c.4-13T>A:,RPL7:ENST00000396466:splice_region&intron:LOW:exon2/5:c.4-13T>A:,RPL7:ENST00000396465:splice_region&intron:LOW:exon2/5:c.4-13T>A:		rs2070764	0.4866	0.4316	11187,4446,809	0.4271,0.5144,0.5137,0.3730,0.5558	0.4291											n/a (AF>5%)	n/a (AF>5%)					RPL7 (inh=n/a pLI=0.99)
chr8	86135132	86135132	A	G	het	off-target	QUAL=69;DP=9;AF=0.44;MQM=60	RP11-219B4.5,CA13			MLT1K	rs1021583	0.5645	0.5900	277,86,5	0.0000,0.0000,0.0000,0.6561,0.5816	0.6450											n/a (AF>5%)	n/a (AF>5%)					RP11-219B4.5 (inh=n/a pLI=n/a), CA13 (inh=n/a pLI=0.01)
chr8	90948273	90948273	C	T	het	off-target	QUAL=552;DP=53;AF=0.47;MQM=60	NBN	intron	NBN:ENST00000265433:intron:MODIFIER:exon15/15:c.2235-433G>A:,NBN:ENST00000409330:intron:MODIFIER:exon15/15:c.1989-433G>A:		rs2735384	0.3245	0.3322	152,31,2	0.0000,0.0000,0.0000,0.3072,0.3327	0.3156							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];				n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	90995019	90995019	C	T	het		QUAL=1277;DP=133;AF=0.39;MQM=60	NBN	synonymous,5'UTR	NBN:ENST00000265433:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:ENST00000409330:5'UTR:MODIFIER:exon2/16:c.-145G>A:		rs1063045	0.3792	0.3527	7704,3573,531	0.3136,0.3477,0.4446,0.3283,0.4297	0.3536							602667 [NBN (confirmed) Nijmegen breakage syndrome,251260|Aplastic anemia,609135|Leukemia,acute lymphoblastic,613065];	183697 [benign DISEASE=hereditary_cancer-predisposing_syndrome,microcephaly,_normal_intelligence_and_immunodeficiency,not_specified]; 		COSM3763444	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR pLI=0.00)
chr8	95188850	95188850	T	C	hom		QUAL=3472;DP=103;AF=1.00;MQM=60	CDH17	missense	CDH17:ENST00000027335:missense:MODERATE:exon5/18:c.343A>G:p.Lys115Glu,CDH17:ENST00000441892:missense:MODERATE:exon5/13:c.343A>G:p.Lys115Glu,CDH17:ENST00000450165:missense:MODERATE:exon5/18:c.343A>G:p.Lys115Glu		rs2243518	0.8023	0.7754	36796,20371,4465	0.9262,0.7211,0.6203,0.7806,0.8104	0.7995	0.5370	T,T,T,T	T	B,B	T,T,T,T	10.74					n/a (AF>5%)	n/a (AF>5%)					CDH17 (inh=n/a pLI=0.00)
chr8	95690579	95690579	T	C	hom		QUAL=4409;DP=138;AF=1.00;MQM=60	ESRP1	synonymous	ESRP1:ENST00000433389:synonymous:LOW:exon13/16:c.1800T>C:p.Asn600Asn,ESRP1:ENST00000423620:synonymous:LOW:exon13/15:c.1788T>C:p.Asn596Asn,ESRP1:ENST00000358397:synonymous:LOW:exon13/16:c.1788T>C:p.Asn596Asn,ESRP1:ENST00000454170:synonymous:LOW:exon13/14:c.1800T>C:p.Asn600Asn		rs12677519	0.4924	0.5759	20744,12138,347	0.2591,0.5615,0.5875,0.6003,0.6726	0.5761							612959 [ESRP1 (provisional) Deafness,autosomal recessive 109,618013];			COSM3982620, COSM3982619	n/a (AF>5%)	n/a (AF>5%)					ESRP1 (inh=n/a pLI=1.00)
chr8	96313407	96313407	C	G	het		QUAL=1661;DP=122;AF=0.52;MQM=60	KB-1047C11.2				rs1994793	0.3888	0.0000	0,0,0	0,0,0,0,0	0.4820											n/a (AF>5%)	n/a (AF>5%)					KB-1047C11.2 (inh=n/a pLI=n/a)
chr8	105459793	105459793	C	A	hom	off-target	QUAL=249;DP=10;AF=1.00;MQM=60	DPYS	intron	DPYS:ENST00000351513:intron:MODIFIER:exon2/9:c.424-62G>T:		rs7821992	0.5978	0.0000	0,0,0	0,0,0,0,0	0.6567							613326 [DPYS (provisional) Dihydropyrimidinuria,222748];	100143 [not provided DISEASE=not_provided]; 			n/a (AF>5%)	n/a (AF>5%)					DPYS (inh=AR pLI=0.00)
chr8	106431030	106431030	T	C	het		QUAL=447;DP=36;AF=0.56;MQM=60	ZFPM2,RP11-127H5.1	intron	ZFPM2:ENST00000407775:intron:MODIFIER:exon1/7:c.41-342T>C:,ZFPM2:ENST00000520492:intron:MODIFIER:exon1/7:c.-356-342T>C:		rs59607297	0.3546	0.3149	3638,1080,1117	0.6298,0.4210,0.2306,0.2665,0.2964	0.3333							603693 [ZFPM2 (confirmed) Tetralogy of Fallot,187500|Diaphragmatic hernia 3,610187|46XY sex reversal 9,616067];				n/a (AF>5%)	n/a (AF>5%)					ZFPM2 (inh=AD pLI=1.00), RP11-127H5.1 (inh=n/a pLI=n/a)
chr8	107371924	107371924	C	A	het	off-target	QUAL=401;DP=37;AF=0.46;MQM=60	OXR1	intron	OXR1:ENST00000445937:intron:MODIFIER:exon2/15:c.23+60C>A:,OXR1:ENST00000531443:intron:MODIFIER:exon1/14:c.23+60C>A:,OXR1:ENST00000452423:intron:MODIFIER:exon1/13:c.-1508+60C>A:,OXR1:ENST00000517566:intron:MODIFIER:exon1/15:c.23+60C>A:		rs2022982	0.5990	0.0000	0,0,0	0,0,0,0,0	0.5989											n/a (AF>5%)	n/a (AF>5%)					OXR1 (inh=n/a pLI=0.27)
chr8	110465060	110465060	G	C	het	gene_blacklist	QUAL=1414;DP=117;AF=0.46;MQM=60	PKHD1L1	synonymous	PKHD1L1:ENST00000378402:synonymous:LOW:exon43/78:c.6621G>C:p.Leu2207Leu		rs1673404	0.5006	0.5767	11555,5535,641	0.4657,0.6951,0.4880,0.5639,0.6655	0.5050										COSM3762998	n/a (AF>5%)	n/a (AF>5%)					PKHD1L1 (inh=n/a pLI=0.00)
chr8	131916318	131916318	A	G	hom	off-target	QUAL=5347;DP=166;AF=1.00;MQM=60	ADCY8	intron	ADCY8:ENST00000286355:intron:MODIFIER:exon6/17:c.1641-30T>C:,ADCY8:ENST00000377928:intron:MODIFIER:exon6/14:c.1641-30T>C:		rs11781997	0.4373	0.5236	16452,10427,306	0.2522,0.5403,0.6240,0.5651,0.4128	0.5305											n/a (AF>5%)	n/a (AF>5%)					ADCY8 (inh=n/a pLI=0.03)
chr8	133023163	133023163	G	C	hom	off-target	QUAL=5594;DP=171;AF=1.00;MQM=60	EFR3A	3'UTR	EFR3A:ENST00000254624:3'UTR:MODIFIER:exon23/23:c.*21G>C:,EFR3A:ENST00000334503:3'UTR:MODIFIER:exon23/23:c.*21G>C:,EFR3A:ENST00000519656:3'UTR:MODIFIER:exon23/23:c.*21G>C:		rs4736529	0.9024	0.8593	43683,22292,4216	0.9079,0.9400,0.9352,0.8297,0.8615	0.8601											n/a (AF>5%)	n/a (AF>5%)					EFR3A (inh=n/a pLI=0.09)
chr8	134125682	134125682	G	A	het	gene_blacklist	QUAL=833;DP=65;AF=0.52;MQM=60	TG	missense	TG:ENST00000220616:missense:MODERATE:exon44/48:c.7589G>A:p.Arg2530Gln,TG:ENST00000377869:missense:MODERATE:exon43/47:c.7418G>A:p.Arg2473Gln,TG:ENST00000542445:missense:MODERATE:exon23/27:c.2699G>A:p.Arg900Gln,TG:ENST00000519543:missense:MODERATE:exon15/19:c.1988G>A:p.Arg663Gln		rs1133076	0.5373	0.4976	15712,7964,3181	0.7820,0.3173,0.3900,0.4889,0.5053	0.5747	5.1390	T,T,T,T,T	T	B,B,B	T,T,T,T	19.72	188450 [TG (confirmed) Thyroid dyshormonogenesis 3,274700|Autoimmune thyroid disease,susceptibility to,3,608175];	259002 [benign DISEASE=thyroid_dyshormonogenesis,not_specified]; 		COSM4162677	n/a (AF>5%)	n/a (AF>5%)					TG (inh=AR pLI=0.00)
chr8	139164570	139164570	C	T	hom		QUAL=3284;DP=102;AF=1.00;MQM=60	FAM135B	synonymous	FAM135B:ENST00000395297:synonymous:LOW:exon13/20:c.2148G>A:p.Pro716Pro		rs3750307	0.2137	0.1923	2260,1099,187	0.1995,0.1686,0.2399,0.1812,0.2459	0.1909										COSM1455064, COSM1455065	n/a (AF>5%)	n/a (AF>5%)					FAM135B (inh=n/a pLI=1.00)
chr8	143955916	143955916	C	G	het		QUAL=1352;DP=106;AF=0.51;MQM=60	CYP11B1,GML	splice_region&intron	CYP11B1:ENST00000377675:splice_region&intron:LOW:exon10/10:c.1612-14G>C:,CYP11B1:ENST00000292427:splice_region&intron:LOW:exon8/8:c.1399-14G>C:,CYP11B1:ENST00000517471:splice_region&intron:LOW:exon7/7:c.1201-14G>C:		rs5295	0.1138	0.0897	682,229,327	0.2410,0.0467,0.0006,0.0865,0.0934	0.1180							610613 [CYP11B1 (confirmed) Adrenal hyperplasia,congenital,due to 11-beta-hydroxylase deficiency,202010|Aldosteronism,glucocorticoid-remediable,103900];	362146 [benign DISEASE=congenital_adrenal_hyperplasia,hyperaldosteronism,_familial,_type_i,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CYP11B1 (inh=AR+AD pLI=0.00), GML (inh=n/a pLI=0.41)
chr8	144732450	144732450	G	A	het		QUAL=1212;DP=107;AF=0.45;MQM=60	ZNF623	synonymous	ZNF623:ENST00000501748:synonymous:LOW:exon1/1:c.408G>A:p.Ser136Ser,ZNF623:ENST00000526926:synonymous:LOW:exon2/2:c.288G>A:p.Ser96Ser,ZNF623:ENST00000458270:synonymous:LOW:exon2/2:c.288G>A:p.Ser96Ser		rs3750204	0.3085	0.2577	4225,1739,540	0.3297,0.2873,0.3749,0.2270,0.2654	0.2575										COSM150560	n/a (AF>5%)	n/a (AF>5%)					ZNF623 (inh=n/a pLI=0.08)
chr8	145059425	145059425	T	C	hom		QUAL=5032;DP=153;AF=1.00;MQM=60	PARP10	missense	PARP10:ENST00000525773:missense:MODERATE:exon4/10:c.781A>G:p.Ile261Val,PARP10:ENST00000524918:missense:MODERATE:exon5/11:c.745A>G:p.Ile249Val,PARP10:ENST00000313028:missense:MODERATE:exon5/11:c.745A>G:p.Ile249Val		rs11136344	0.3912	0.3994	10177,6003,1885	0.6100,0.2091,0.1538,0.4311,0.3812	0.4471	-1.9730	T,T,T,T	T	B,B,B	T,T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					PARP10 (inh=n/a pLI=0.01)
chr8	145773342	145773344	CTG	-	het		QUAL=2415;DP=195;AF=0.51;MQM=60	ARHGAP39	conservative_inframe_deletion	ARHGAP39:ENST00000377307:conservative_inframe_deletion:MODERATE:exon4/11:c.1126_1128delCAG:p.Gln376del,ARHGAP39:ENST00000276826:conservative_inframe_deletion:MODERATE:exon4/10:c.1126_1128delCAG:p.Gln376del,ARHGAP39:ENST00000540274:conservative_inframe_deletion:MODERATE:exon5/11:c.1126_1128delCAG:p.Gln376del		rs138155129	0.0178	0.0773	148,123,1	0.0199,0.0451,0.0000,0.1164,0.0154	0.0523										COSM1489137	n/a (AF>5%)	n/a (AF>5%)					ARHGAP39 (inh=n/a pLI=0.02)
chr9	376179	376179	T	A	het	off-target	QUAL=172;DP=26;AF=0.38;MQM=60	DOCK8	intron	DOCK8:ENST00000453981:intron:MODIFIER:exon18/47:c.2110-31T>A:,DOCK8:ENST00000432829:intron:MODIFIER:exon18/47:c.1906-31T>A:,DOCK8:ENST00000469391:intron:MODIFIER:exon17/45:c.1906-31T>A:,DOCK8:ENST00000382331:intron:MODIFIER:exon4/12:c.16-31T>A:,DOCK8:ENST00000382329:intron:MODIFIER:exon5/34:c.511-31T>A:		rs35724655	0.1414	0.2004	2732,1809,11	0.0483,0.1825,0.0691,0.2333,0.2470	0.1994							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];				n/a (AF>5%)	n/a (AF>5%)					DOCK8 (inh=AR+AD pLI=0.00)
chr9	421980	421980	T	A	het	off-target	QUAL=1064;DP=87;AF=0.48;MQM=60	DOCK8	intron	DOCK8:ENST00000453981:intron:MODIFIER:exon32/47:c.4154-68T>A:,DOCK8:ENST00000432829:intron:MODIFIER:exon32/47:c.3950-68T>A:,DOCK8:ENST00000469391:intron:MODIFIER:exon30/45:c.3854-68T>A:,DOCK8:ENST00000382329:intron:MODIFIER:exon19/34:c.2555-68T>A:		rs2297081	0.3946	0.0000	0,0,0	0,0,0,0,0	0.4383							611432 [DOCK8 (provisional) Hyper-IgE recurrent infection syndrome,autosomal recessive,243700];				n/a (AF>5%)	n/a (AF>5%)					DOCK8 (inh=AR+AD pLI=0.00)
chr9	4574022	4574022	A	C	hom		QUAL=3524;DP=110;AF=1.00;MQM=60	SLC1A1,SPATA6L	splice_region&intron	SLC1A1:ENST00000262352:splice_region&intron:LOW:exon8/11:c.875+8A>C:		rs12682807	0.1064	0.1035	860,384,1	0.0196,0.1106,0.2404,0.1031,0.0672	0.1054							133550 [SLC1A1 (provisional) Schizophrenia susceptibility 18,615232|Dicarboxylic aminoaciduria,222730];	367049 [benign DISEASE=dicarboxylic_aminoaciduria]; 			n/a (AF>5%)	n/a (AF>5%)					SLC1A1 (inh=AR pLI=0.00), SPATA6L (inh=n/a pLI=0.00)
chr9	4576680	4576680	T	C	het		QUAL=2000;DP=195;AF=0.41;MQM=60	SLC1A1,SPATA6L	synonymous	SLC1A1:ENST00000262352:synonymous:LOW:exon10/12:c.1110T>C:p.Thr370Thr		rs301430	0.4583	0.3637	8716,2971,1301	0.5052,0.3889,0.6094,0.2927,0.3742	0.3962	-6.1630		T			0.16	133550 [SLC1A1 (provisional) Schizophrenia susceptibility 18,615232|Dicarboxylic aminoaciduria,222730];	367052 [benign DISEASE=dicarboxylic_aminoaciduria]; 		COSM3763952	n/a (AF>5%)	n/a (AF>5%)					SLC1A1 (inh=AR pLI=0.00), SPATA6L (inh=n/a pLI=0.00)
chr9	7798518	7798518	G	C	hom		QUAL=5839;DP=177;AF=1.00;MQM=60	TMEM261	3'UTR	TMEM261:ENST00000358227:3'UTR:MODIFIER:exon2/2:c.*55C>G:		rs4742410	0.9137	0.9548	55448,31982,4520	0.9324,0.9712,0.8486,0.9789,0.9172	0.9576											n/a (AF>5%)	n/a (AF>5%)					DMAC1 (inh=n/a pLI=0.01)
chr9	14851617	14851617	T	C	hom		QUAL=2778;DP=85;AF=1.00;MQM=60	FREM1	splice_region&intron	FREM1:ENST00000380881:splice_region&intron:LOW:exon6/37:c.829-9A>G:,FREM1:ENST00000422223:splice_region&intron:LOW:exon6/37:c.829-12A>G:,FREM1:ENST00000380880:splice_region&intron:LOW:exon5/36:c.829-12A>G:		rs2818940	0.7696	0.8054	39548,21427,1410	0.5452,0.7984,0.9627,0.8023,0.8686	0.8094							608944 [FREM1 (provisional) Bifid nose with or without anorectal and renal anomalies,608980|Manitoba oculotrichoanal syndrome,248450|Trigonocephaly 2,614485];	262546 [benign DISEASE=marles_greenberg_persaud_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FREM1 (inh=AR+AD pLI=n/a)
chr9	16685539	16685539	T	C	hom		QUAL=9357;DP=284;AF=1.00;MQM=60	BNC2	intron	BNC2:ENST00000380672:intron:MODIFIER:exon3/6:c.330+42256A>G:,BNC2:ENST00000380667:intron:MODIFIER:exon2/5:c.129+52819A>G:,BNC2:ENST00000545497:intron:MODIFIER:exon1/4:c.46-102456A>G:,BNC2:ENST00000380666:intron:MODIFIER:exon3/6:c.330+42256A>G:,BNC2:ENST00000471301:intron:MODIFIER:exon1/2:c.3+19212A>G:		rs7046068	0.8676	0.8506	6007,2243,346	0.8775,0.9110,0.8873,0.9165,0.7856	0.9107											n/a (AF>5%)	n/a (AF>5%)					BNC2 (inh=n/a pLI=1.00)
chr9	18950787	18950787	G	A	hom		QUAL=5251;DP=162;AF=1.00;MQM=60	FAM154A	missense,5'UTR	FAM154A:ENST00000380534:missense:MODERATE:exon2/4:c.187C>T:p.Pro63Ser,FAM154A:ENST00000380530:missense:MODERATE:exon2/3:c.187C>T:p.Pro63Ser,FAM154A:ENST00000542071:5'UTR:MODIFIER:exon2/3:c.-187C>T:		rs6475273	0.7602	0.7581	35314,20047,4143	0.8931,0.6616,0.5582,0.7746,0.7967	0.7820	-0.1720	T,T	T	B	T,T	0.01				COSM1685399	n/a (AF>5%)	n/a (AF>5%)					SAXO1 (inh=n/a pLI=0.00)
chr9	19622268	19622268	T	C	het		QUAL=1221;DP=94;AF=0.53;MQM=60	SLC24A2	synonymous	SLC24A2:ENST00000341998:synonymous:LOW:exon2/10:c.960A>G:p.Pro320Pro,SLC24A2:ENST00000286344:synonymous:LOW:exon2/9:c.960A>G:p.Pro320Pro		rs4977308	0.7816	0.7604	35151,17576,2995	0.7614,0.8483,0.8717,0.7263,0.7769	0.7636											n/a (AF>5%)	n/a (AF>5%)					SLC24A2 (inh=AR pLI=0.10)
chr9	20765097	20765097	A	G	het	off-target	QUAL=1595;DP=127;AF=0.50;MQM=60	FOCAD	intron	FOCAD:ENST00000338382:intron:MODIFIER:exon6/42:c.699+25A>G:,FOCAD:ENST00000380249:intron:MODIFIER:exon9/45:c.699+25A>G:		rs7871811	0.6456	0.6369	23149,11563,2122	0.6449,0.7971,0.5638,0.6079,0.6865	0.6399											n/a (AF>5%)	n/a (AF>5%)					FOCAD (inh=n/a pLI=0.00)
chr9	20781979	20781979	C	A	het	off-target	QUAL=525;DP=42;AF=0.55;MQM=60	FOCAD	intron	FOCAD:ENST00000338382:intron:MODIFIER:exon9/42:c.1197+51C>A:,FOCAD:ENST00000380249:intron:MODIFIER:exon12/45:c.1197+51C>A:		rs6475473	0.4237	0.3399	7023,2349,1278	0.5102,0.4905,0.5191,0.2806,0.3112	0.3409											n/a (AF>5%)	n/a (AF>5%)					FOCAD (inh=n/a pLI=0.00)
chr9	32425910	32425910	A	G	het		QUAL=3353;DP=264;AF=0.49;MQM=60	ACO1	synonymous	ACO1:ENST00000309951:synonymous:LOW:exon11/21:c.1263A>G:p.Glu421Glu,ACO1:ENST00000541043:synonymous:LOW:exon12/22:c.966A>G:p.Glu322Glu,ACO1:ENST00000379923:synonymous:LOW:exon12/22:c.1263A>G:p.Glu421Glu		rs3780473	0.3538	0.3445	7562,4082,395	0.2693,0.3400,0.5437,0.3486,0.2897	0.3450										COSM3763878, COSM3763876, COSM3763877	n/a (AF>5%)	n/a (AF>5%)					ACO1 (inh=n/a pLI=0.00)
chr9	34569010	34569010	T	A	hom	off-target	QUAL=2437;DP=77;AF=1.00;MQM=60	CNTFR,CNTFR-AS1	intron	CNTFR:ENST00000351266:intron:MODIFIER:exon1/8:c.1-31A>T:,CNTFR-AS1:ENST00000436360:intron:MODIFIER:exon1/4:n.144-500T>A:,CNTFR:ENST00000378980:intron:MODIFIER:exon2/9:c.1-31A>T:,CNTFR-AS1:ENST00000453642:intron:MODIFIER:exon1/2:n.144-500T>A:,CNTFR-AS1:ENST00000438244:intron:MODIFIER:exon1/1:n.143+855T>A:		rs9695558	0.9529	0.9645	17348,9174,1418	0.9081,0.9674,0.9943,0.9690,0.9691	0.9624											n/a (AF>5%)	n/a (AF>5%)					CNTFR (inh=n/a pLI=0.88), CNTFR-AS1 (inh=n/a pLI=n/a)
chr9	35751221	35751221	C	T	het	off-target	QUAL=2102;DP=197;AF=0.42;MQM=60	RGP1	intron	RGP1:ENST00000456972:intron:MODIFIER:exon6/9:c.608-42C>T:,RGP1:ENST00000378078:intron:MODIFIER:exon5/8:c.488-42C>T:		rs1570248	0.7039	0.6736	27561,14663,2583	0.7270,0.6592,0.8278,0.6627,0.6326	0.6816											n/a (AF>5%)	n/a (AF>5%)					RGP1 (inh=n/a pLI=0.01)
chr9	36105264	36105264	A	G	het		QUAL=1933;DP=179;AF=0.42;MQM=60	RECK	synonymous	RECK:ENST00000377966:synonymous:LOW:exon13/21:c.1560A>G:p.Pro520Pro		rs11788747	0.2554	0.3373	7582,5326,43	0.0890,0.2124,0.2497,0.3994,0.3684	0.3395										COSM3763921	n/a (AF>5%)	n/a (AF>5%)					RECK (inh=n/a pLI=0.00)
chr9	71843023	71843023	C	A	hom		QUAL=3651;DP=111;AF=1.00;MQM=60	TJP2	missense	TJP2:ENST00000539225:missense:MODERATE:exon9/23:c.1539C>A:p.Asp513Glu,TJP2:ENST00000453658:missense:MODERATE:exon10/22:c.1377C>A:p.Asp459Glu,TJP2:ENST00000377245:missense:MODERATE:exon9/23:c.1446C>A:p.Asp482Glu,TJP2:ENST00000348208:missense:MODERATE:exon9/21:c.1446C>A:p.Asp482Glu,TJP2:ENST00000265384:missense:MODERATE:exon9/19:c.1446C>A:p.Asp482Glu,TJP2:ENST00000535702:missense:MODERATE:exon9/22:c.1458C>A:p.Asp486Glu		rs2309428	0.7722	0.8115	35462,20010,2014	0.6709,0.8685,0.8926,0.8230,0.7507	0.8121	-0.0950	T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T	0.05	607709 [TJP2 (provisional) Hypercholanemia,familial,607748|Cholestasis,progressive familial intrahepatic 4,615878];	44091 [benign DISEASE=not_specified,nonsyndromic_hearing_loss,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					TJP2 (inh=AR pLI=0.00)
chr9	71862975	71862975	C	T	het		QUAL=1445;DP=115;AF=0.48;MQM=60	TJP2	synonymous	TJP2:ENST00000539225:synonymous:LOW:exon19/23:c.2808C>T:p.Thr936Thr,TJP2:ENST00000453658:synonymous:LOW:exon20/22:c.2646C>T:p.Thr882Thr,TJP2:ENST00000377245:synonymous:LOW:exon19/23:c.2715C>T:p.Thr905Thr,TJP2:ENST00000348208:synonymous:LOW:exon19/21:c.2715C>T:p.Thr905Thr,TJP2:ENST00000265384:synonymous:LOW:exon19/19:c.2715C>T:p.Thr905Thr,TJP2:ENST00000535702:synonymous:LOW:exon19/22:c.2727C>T:p.Thr909Thr		rs2282336	0.2841	0.2614	5142,1625,194	0.1860,0.5675,0.4370,0.2160,0.2004	0.2705							607709 [TJP2 (provisional) Hypercholanemia,familial,607748|Cholestasis,progressive familial intrahepatic 4,615878];	44105 [benign/likely benign DISEASE=not_specified,nonsyndromic_hearing_loss,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					TJP2 (inh=AR pLI=0.00)
chr9	71862987	71862987	G	A	het		QUAL=1441;DP=113;AF=0.49;MQM=60	TJP2	synonymous	TJP2:ENST00000539225:synonymous:LOW:exon19/23:c.2820G>A:p.Ala940Ala,TJP2:ENST00000453658:synonymous:LOW:exon20/22:c.2658G>A:p.Ala886Ala,TJP2:ENST00000377245:synonymous:LOW:exon19/23:c.2727G>A:p.Ala909Ala,TJP2:ENST00000348208:synonymous:LOW:exon19/21:c.2727G>A:p.Ala909Ala,TJP2:ENST00000265384:synonymous:LOW:exon19/19:c.2727G>A:p.Ala909Ala,TJP2:ENST00000535702:synonymous:LOW:exon19/22:c.2739G>A:p.Ala913Ala		rs2095876	0.2841	0.2606	5126,1632,191	0.1853,0.5658,0.4348,0.2160,0.1982	0.2702							607709 [TJP2 (provisional) Hypercholanemia,familial,607748|Cholestasis,progressive familial intrahepatic 4,615878];	44106 [benign/likely benign DISEASE=not_specified,nonsyndromic_hearing_loss,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					TJP2 (inh=AR pLI=0.00)
chr9	74355185	74355185	T	G	het	off-target	QUAL=1378;DP=138;AF=0.43;MQM=60	TMEM2	intron	TMEM2:ENST00000377044:intron:MODIFIER:exon4/23:c.1035-37A>C:,TMEM2:ENST00000377066:intron:MODIFIER:exon4/22:c.1035-37A>C:		rs3753006	0.2173	0.1696	1962,642,594	0.3418,0.2132,0.1639,0.1387,0.1542	0.2043											n/a (AF>5%)	n/a (AF>5%)					TMEM2 (inh=n/a pLI=0.00)
chr9	75782510	75782510	G	A	het		QUAL=1292;DP=121;AF=0.43;MQM=60	ANXA1	intron	ANXA1:ENST00000257497:intron:MODIFIER:exon11/12:c.861+39G>A:,ANXA1:ENST00000376911:intron:MODIFIER:exon10/11:c.861+39G>A:		rs1342017	0.4571	0.5480	19198,12926,1668	0.5680,0.4751,0.1653,0.6248,0.4260	0.5909											n/a (AF>5%)	n/a (AF>5%)					ANXA1 (inh=n/a pLI=0.00)
chr9	78969059	78969059	C	A	het		QUAL=544;DP=47;AF=0.49;MQM=60	PCSK5	missense	PCSK5:ENST00000545128:missense:MODERATE:exon36/37:c.5097C>A:p.Asp1699Glu		rs7036921	0.2320	0.3334	3025,1818,262	0.3570,0.2079,0.1570,0.3596,0.3591	0.2524	-0.2350	T,T,T	T		T,T	0.20				COSM4164022, COSM4164021	n/a (AF>5%)	n/a (AF>5%)					PCSK5 (inh=n/a pLI=0.00)
chr9	90474097	90474097	A	G	het		QUAL=56;DP=14;AF=0.29;MQM=60	XXyac-YM21GA2.7				rs9695836	0.4704	0.0000	0,0,0	0,0,0,0,0	0.3151											n/a (AF>5%)	n/a (AF>5%)					XXyac-YM21GA2.7 (inh=n/a pLI=n/a)
chr9	91262597	91262597	A	G	het	off-target	QUAL=1035;DP=78;AF=0.53;MQM=60	RP13-60M5.2				rs7862585	0.5110	0.4443	12889,6248,3552	0.8507,0.3993,0.1885,0.4335,0.4313	0.5324											n/a (AF>5%)	n/a (AF>5%)					RP13-60M5.2 (inh=n/a pLI=n/a)
chr9	95766471	95766471	A	T	het	off-target	QUAL=619;DP=58;AF=0.47;MQM=60	FGD3	intron	FGD3:ENST00000337352:intron:MODIFIER:exon5/17:c.680+52A>T:,FGD3:ENST00000375482:intron:MODIFIER:exon5/17:c.680+52A>T:,FGD3:ENST00000416701:intron:MODIFIER:exon5/17:c.680+52A>T:		rs6479445	0.7079	0.6308	24292,11782,3989	0.9056,0.6383,0.5986,0.5956,0.6510	0.6694											n/a (AF>5%)	n/a (AF>5%)					FGD3 (inh=n/a pLI=0.00)
chr9	96407983	96407983	C	T	het		QUAL=579;DP=50;AF=0.48;MQM=60	PHF2	synonymous,intron	PHF2:ENST00000359246:synonymous:LOW:exon4/22:c.372C>T:p.Thr124Thr,PHF2:ENST00000375376:intron:MODIFIER:exon3/8:c.243+9232C>T:		rs9695734	0.1058	0.1316	1138,869,71	0.1255,0.0725,0.0354,0.1627,0.1123	0.1311										COSM456270	n/a (AF>5%)	n/a (AF>5%)					PHF2 (inh=n/a pLI=1.00)
chr9	97365642	97365642	G	A	het	off-target	QUAL=437;DP=34;AF=0.53;MQM=60	FBP1	3'UTR	FBP1:ENST00000375326:3'UTR:MODIFIER:exon7/7:c.*21C>T:,FBP1:ENST00000415431:3'UTR:MODIFIER:exon8/8:c.*21C>T:		rs9695	0.4870	0.5244	14807,8283,1149	0.5091,0.7193,0.4180,0.5337,0.4441	0.5144							611570 [FBP1 (confirmed) Fructose-1,6-bisphosphatase deficiency,229700];	256318 [benign/likely benign DISEASE=fructose-biphosphatase_deficiency,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FBP1 (inh=AR pLI=0.08)
chr9	100190780	100190780	A	G	hom		QUAL=3518;DP=108;AF=1.00;MQM=60	TDRD7	synonymous,intron	TDRD7:ENST00000355295:synonymous:LOW:exon2/17:c.33A>G:p.Leu11Leu,TDRD7:ENST00000422139:intron:MODIFIER:exon1/15:c.-15-2435A>G:		rs1381532	0.5449	0.5075	15891,8111,1929	0.6091,0.5858,0.5583,0.4913,0.4361	0.5351							611258 [TDRD7 (confirmed) Cataract 36,613887];	260382 [benign DISEASE=congenital_cataract,not_specified]; 		COSM3982624	n/a (AF>5%)	n/a (AF>5%)					TDRD7 (inh=AR pLI=0.00)
chr9	101056009	101056009	T	G	het	off-target	QUAL=413;DP=38;AF=0.47;MQM=60	GABBR2	intron	GABBR2:ENST00000259455:intron:MODIFIER:exon18/18:c.2660+58A>C:	MIRc	rs10818743	0.2350	0.0000	0,0,0	0,0,0,0,0	0.2432							607340 [GABBR2 (confirmed) Nicotine dependence,susceptibility to,188890|Nicotine dependence,protection against,188890|Epileptic encephalopathy,early infantile,59,617904|Neurodevelopmental disorder with poor language and loss of hand skills,617903];				n/a (AF>5%)	n/a (AF>5%)					GABBR2 (inh=AD pLI=1.00)
chr9	101552955	101552955	T	C	het	off-target	QUAL=1128;DP=112;AF=0.41;MQM=60	ANKS6	intron	ANKS6:ENST00000375018:intron:MODIFIER:exon1/14:c.360-67A>G:,ANKS6:ENST00000375019:intron:MODIFIER:exon1/14:c.-41-5797A>G:,ANKS6:ENST00000353234:intron:MODIFIER:exon1/14:c.360-67A>G:		rs7027771	0.5032	0.0000	0,0,0	0,0,0,0,0	0.5611							615370 [ANKS6 (provisional) Nephronophthisis 16,615382];				n/a (AF>5%)	n/a (AF>5%)					ANKS6 (inh=AR pLI=0.00)
chr9	105405415	105405415	G	A	het		QUAL=1621;DP=152;AF=0.44;MQM=60	LINC00587	splice_region&non_coding_transcript_exon	LINC00587:ENST00000374801:splice_region&non_coding_transcript_exon:LOW:exon4/5:n.270G>A:	MER41A	rs10820216	0.3251	0.3297	691,232,29	0.2734,0.2826,0.5105,0.3278,0.3272	0.3474	0.2480		T			2.08					n/a (AF>5%)	n/a (AF>5%)					LINC00587 (inh=n/a pLI=n/a)
chr9	107266503	107266503	A	G	het	off-target;gene_blacklist	QUAL=241;DP=24;AF=0.50;MQM=60	OR13F1	5'UTR	OR13F1:ENST00000334726:5'UTR:MODIFIER:exon1/1:c.-41A>G:		rs41277749	0.2242	0.2630	4089,2183,22	0.0521,0.3192,0.3908,0.2637,0.2771	0.2665											n/a (AF>5%)	n/a (AF>5%)					OR13F1 (inh=n/a pLI=0.00)
chr9	107361710	107361710	G	A	het	gene_blacklist	QUAL=1232;DP=127;AF=0.43;MQM=58	OR13C5	5'UTR	OR13C5:ENST00000374779:5'UTR:MODIFIER:exon1/1:c.-16C>T:		rs7856737	0.4365	0.2921	6183,1280,1805	0.5956,0.2800,0.5911,0.1979,0.3607	0.3370											n/a (AF>5%)	n/a (AF>5%)					OR13C5 (inh=n/a pLI=0.61)
chr9	113196733	113196733	A	C	het	gene_blacklist	QUAL=1082;DP=73;AF=0.56;MQM=60	SVEP1	missense	SVEP1:ENST00000401783:missense:MODERATE:exon30/48:c.4942T>G:p.Leu1648Val,SVEP1:ENST00000374469:missense:MODERATE:exon30/48:c.4873T>G:p.Leu1625Val		rs7852962	0.1789	0.1674	1716,824,364	0.2769,0.1876,0.0889,0.1597,0.1514	0.1894	0.0570	T,T	T	B	T,T	3.88					n/a (AF>5%)	n/a (AF>5%)					SVEP1 (inh=n/a pLI=0.92)
chr9	113213726	113213726	A	G	hom	off-target;gene_blacklist	QUAL=3044;DP=94;AF=1.00;MQM=60	SVEP1	intron	SVEP1:ENST00000401783:intron:MODIFIER:exon22/47:c.3788-44T>C:,SVEP1:ENST00000374469:intron:MODIFIER:exon22/47:c.3719-44T>C:,SVEP1:ENST00000302728:intron:MODIFIER:exon23/27:c.3788-44T>C:	MIR3	rs4421419	0.8824	0.8554	38163,19406,3052	0.8244,0.9049,0.9977,0.8276,0.8746	0.8567											n/a (AF>5%)	n/a (AF>5%)					SVEP1 (inh=n/a pLI=0.92)
chr9	114125835	114125835	A	G	hom	off-target	QUAL=2599;DP=82;AF=1.00;MQM=60	KIAA0368	intron	KIAA0368:ENST00000259335:intron:MODIFIER:exon50/50:c.5914+33T>C:,KIAA0368:ENST00000338205:intron:MODIFIER:exon48/48:c.5380+33T>C:,KIAA0368:ENST00000374378:intron:MODIFIER:exon22/22:c.367-1502T>C:		rs2297524	0.6795	0.6588	25893,14404,3053	0.7933,0.6556,0.6643,0.6637,0.5634	0.6993											n/a (AF>5%)	n/a (AF>5%)					ECPAS (inh=n/a pLI=1.00)
chr9	114155899	114155899	G	A	hom	off-target	QUAL=500;DP=16;AF=1.00;MQM=60	KIAA0368	intron	KIAA0368:ENST00000259335:intron:MODIFIER:exon28/50:c.3511+61C>T:,KIAA0368:ENST00000338205:intron:MODIFIER:exon26/48:c.2977+61C>T:,KIAA0368:ENST00000374378:intron:MODIFIER:exon4/22:c.-1632+61C>T:		rs2598360	0.1817	0.0000	0,0,0	0,0,0,0,0	0.2871											n/a (AF>5%)	n/a (AF>5%)					ECPAS (inh=n/a pLI=1.00)
chr9	114804173	114804173	G	A	het		QUAL=2400;DP=166;AF=0.54;MQM=60	SUSD1	synonymous,3'UTR	SUSD1:ENST00000374270:synonymous:LOW:exon16/17:c.2217C>T:p.Leu739Leu,SUSD1:ENST00000374264:3'UTR:MODIFIER:exon17/18:c.*8C>T:,SUSD1:ENST00000374263:3'UTR:MODIFIER:exon15/16:c.*8C>T:		rs3849117	0.0685	0.0885	585,233,0	0.0147,0.0222,0.0702,0.0867,0.1765	0.0837											n/a (AF>5%)	n/a (AF>5%)					SUSD1 (inh=n/a pLI=0.00)
chr9	115918220	115918220	C	A	het	off-target	QUAL=707;DP=74;AF=0.42;MQM=60	SLC31A2	intron	SLC31A2:ENST00000259392:intron:MODIFIER:exon1/3:c.7-1787C>A:		rs10817447	0.3217	0.0000	0,0,0	0,0,0,0,0	0.4184											n/a (AF>5%)	n/a (AF>5%)					SLC31A2 (inh=n/a pLI=0.00)
chr9	116122954	116122954	A	G	hom		QUAL=1268;DP=39;AF=1.00;MQM=60	BSPRY	synonymous	BSPRY:ENST00000374183:synonymous:LOW:exon3/6:c.468A>G:p.Lys156Lys		rs752757	0.3644	0.3017	3981,1212,940	0.5135,0.4067,0.4378,0.2401,0.3054	0.2868										COSM455183	n/a (AF>5%)	n/a (AF>5%)					BSPRY (inh=n/a pLI=0.00)
chr9	119106881	119106881	C	A	hom		QUAL=3700;DP=116;AF=1.00;MQM=60	PAPPA	missense	PAPPA:ENST00000328252:missense:MODERATE:exon14/22:c.3671C>A:p.Ser1224Tyr,PAPPA:ENST00000534838:missense:MODERATE:exon8/16:c.785C>A:p.Ser262Tyr		rs7020782	0.5717	0.6687	27879,16343,533	0.3240,0.6746,0.7130,0.6992,0.7092	0.6767	0.7620	D,T	T	B,B	T,T	17.94					n/a (AF>5%)	n/a (AF>5%)					PAPPA (inh=n/a pLI=0.98)
chr9	127644882	127644882	G	A	hom	off-target	QUAL=2807;DP=85;AF=1.00;MQM=60	GOLGA1	intron	GOLGA1:ENST00000373555:intron:MODIFIER:exon19/22:c.1906-34C>T:		rs596231	0.9820	0.9943	59166,32972,4466	0.9373,0.9974,1.0000,0.9998,1.0000	0.9954											n/a (AF>5%)	n/a (AF>5%)					GOLGA1 (inh=n/a pLI=0.01)
chr9	127969785	127969785	G	A	hom	off-target	QUAL=6333;DP=192;AF=1.00;MQM=60	RABEPK	intron	RABEPK:ENST00000373538:intron:MODIFIER:exon2/7:c.54-58G>A:,RABEPK:ENST00000259460:intron:MODIFIER:exon3/7:c.54-58G>A:,RABEPK:ENST00000394125:intron:MODIFIER:exon3/8:c.54-58G>A:,RABEPK:ENST00000373544:intron:MODIFIER:exon3/6:c.54-58G>A:,RABEPK:ENST00000394124:intron:MODIFIER:exon3/9:c.54-58G>A:		rs420423	0.5379	0.0000	0,0,0	0,0,0,0,0	0.4715											n/a (AF>5%)	n/a (AF>5%)					RABEPK (inh=n/a pLI=0.00)
chr9	130715922	130715922	A	G	hom	off-target	QUAL=1746;DP=54;AF=1.00;MQM=60	FAM102A	intron	FAM102A:ENST00000373095:intron:MODIFIER:exon2/10:c.268-39T>C:		rs2417062	0.8407	0.9240	52371,32292,3815	0.8571,0.9427,0.6687,0.9836,0.8295	0.9300											n/a (AF>5%)	n/a (AF>5%)					FAM102A (inh=n/a pLI=0.34)
chr9	131397479	131397479	G	A	hom		QUAL=5738;DP=174;AF=1.00;MQM=60	WDR34	synonymous	WDR34:ENST00000372715:synonymous:LOW:exon6/9:c.873C>T:p.Thr291Thr		rs4837291	0.6214	0.7883	38778,25949,861	0.4190,0.7823,0.4871,0.8863,0.7709	0.7927							613363 [WDR34 (provisional) Short-rib thoracic dysplasia 11 with or without polydactyly,615633];			COSM4007061	n/a (AF>5%)	n/a (AF>5%)					WDR34 (inh=AR pLI=0.00)
chr9	132395316	132395316	C	T	het		QUAL=2560;DP=235;AF=0.43;MQM=60	NTMT1	3'UTR,intron	NTMT1:ENST00000459968:3'UTR:MODIFIER:exon2/2:c.*4C>T:,NTMT1:ENST00000372480:intron:MODIFIER:exon2/3:c.162+172C>T:,NTMT1:ENST00000372486:intron:MODIFIER:exon2/3:c.162+172C>T:,NTMT1:ENST00000372483:intron:MODIFIER:exon2/3:c.162+172C>T:,NTMT1:ENST00000482347:intron:MODIFIER:exon1/2:c.-102-1017C>T:,NTMT1:ENST00000372481:intron:MODIFIER:exon2/3:c.162+172C>T:		rs12335819	0.7324	0.8055	10159,6566,397	0.5931,0.8428,0.8535,0.8158,0.7967	0.7835											n/a (AF>5%)	n/a (AF>5%)					NTMT1 (inh=n/a pLI=0.38)
chr9	133058082	133058082	G	A	hom	off-target;gene_blacklist	QUAL=4056;DP=124;AF=1.00;MQM=60	HMCN2				rs10739777	0.7913	0.7030	3500,1059,270	0.7813,0.7241,0.9688,0.6615,0.7039	0.7291											n/a (AF>5%)	n/a (AF>5%)					HMCN2 (inh=n/a pLI=n/a)
chr9	134010236	134010236	T	C	het	off-target	QUAL=206;DP=16;AF=0.56;MQM=60	NUP214,RP11-544A12.4	intron	NUP214:ENST00000451030:intron:MODIFIER:exon7/35:c.832-49T>C:,NUP214:ENST00000359428:intron:MODIFIER:exon7/35:c.832-49T>C:,NUP214:ENST00000411637:intron:MODIFIER:exon7/35:c.832-49T>C:		rs16922	0.3111	0.2590	3735,1488,470	0.3327,0.1951,0.4264,0.2320,0.3024	0.2735							114350 [NUP214 (confirmed) Leukemia,acute myeloid,somatic,601626|Leukemia,T-cell acute lymphoblastic,somatic,613065];				n/a (AF>5%)	n/a (AF>5%)					NUP214 (inh=n/a pLI=1.00), RP11-544A12.4 (inh=n/a pLI=n/a)
chr9	137708960	137708960	A	C	hom	off-target	QUAL=1400;DP=46;AF=1.00;MQM=60	COL5A1	intron	COL5A1:ENST00000371817:intron:MODIFIER:exon53/65:c.4176+35A>C:		rs10776910	0.4617	0.4211	10828,5557,2021	0.6322,0.3769,0.4714,0.4119,0.3517	0.4797							120215 [COL5A1 (confirmed) Ehlers-Danlos syndrome,classic type,1,130000];	255085 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					COL5A1 (inh=AD pLI=1.00)
chr9	140158650	140158650	C	T	het	off-target	QUAL=1697;DP=166;AF=0.42;MQM=60	NELFB	intron	NELFB:ENST00000343053:intron:MODIFIER:exon5/12:c.784-47C>T:		rs9695897	0.6164	0.6991	5580,2832,409	0.5309,0.7636,0.5229,0.7593,0.7044	0.7168											n/a (AF>5%)	n/a (AF>5%)					NELFB (inh=n/a pLI=0.90)
chr9	140289696	140289696	A	C	hom	off-target	QUAL=1324;DP=45;AF=1.00;MQM=60	EXD3	intron	EXD3:ENST00000340951:intron:MODIFIER:exon2/21:c.55+59T>G:,EXD3:ENST00000342129:intron:MODIFIER:exon2/20:c.-906+59T>G:,EXD3:ENST00000479452:intron:MODIFIER:exon2/7:c.55+59T>G:,EXD3:ENST00000465160:intron:MODIFIER:exon2/2:c.55+59T>G:		rs9695232	0.6044	0.0000	0,0,0	0,0,0,0,0	0.6838											n/a (AF>5%)	n/a (AF>5%)					EXD3 (inh=n/a pLI=0.00)
chr10	1095601	1095601	-	T	het		QUAL=1244;DP=74;AF=0.54;MQM=60	WDR37	intron	WDR37:ENST00000358220:intron:MODIFIER:exon1/13:c.-41+32dupT:		rs112295224;rs35433489;rs550897837	0.1917	0.0000	0,0,0	0,0,0,0,0	0.2579											n/a (AF>5%)	n/a (AF>5%)					WDR37 (inh=n/a pLI=0.99)
chr10	1170304	1170304	C	G	het		QUAL=1417;DP=132;AF=0.43;MQM=60	WDR37	splice_region&intron	WDR37:ENST00000263150:splice_region&intron:LOW:exon12/13:c.1238+12C>G:,WDR37:ENST00000358220:splice_region&intron:LOW:exon12/13:c.1238+12C>G:		rs7916430	0.1330	0.1560	1694,732,13	0.0535,0.2379,0.2102,0.1455,0.1782	0.1602											n/a (AF>5%)	n/a (AF>5%)					WDR37 (inh=n/a pLI=0.99)
chr10	5139685	5139685	G	A	hom		QUAL=4049;DP=124;AF=1.00;MQM=60	AKR1C3	synonymous,5'UTR	AKR1C3:ENST00000380554:synonymous:LOW:exon3/9:c.312G>A:p.Lys104Lys,AKR1C3:ENST00000605149:synonymous:LOW:exon3/9:c.243G>A:p.Lys81Lys,AKR1C3:ENST00000439082:5'UTR:MODIFIER:exon3/9:c.-46G>A:		rs12387	0.8482	0.8362	42496,22923,3963	0.8734,0.8059,0.8697,0.8288,0.8483	0.8468											n/a (AF>5%)	n/a (AF>5%)					AKR1C3 (inh=n/a pLI=0.00)
chr10	5246584	5246584	C	A	het	off-target	QUAL=939;DP=92;AF=0.42;MQM=60	AKR1C4	intron	AKR1C4:ENST00000263126:intron:MODIFIER:exon3/8:c.369+128C>A:,AKR1C4:ENST00000380448:intron:MODIFIER:exon5/10:c.369+128C>A:		rs11253042	0.2917	0.4089	10247,7385,142	0.1838,0.2724,0.2742,0.4862,0.3217	0.3988							600451 [AKR1C4 (provisional) 46XY sex reversal 8,modifier of,614279];			COSN163533	n/a (AF>5%)	n/a (AF>5%)					AKR1C4 (inh=n/a pLI=0.00)
chr10	6392848	6392848	G	A	hom	off-target	QUAL=1299;DP=41;AF=1.00;MQM=60	DKFZP667F0711			L1MC5a	rs744254	0.5941	0.6785	2005,608,22	0.3915,0.0000,0.0000,0.7122,0.7028	0.6883											n/a (AF>5%)	n/a (AF>5%)					DKFZP667F0711 (inh=n/a pLI=n/a)
chr10	7846152	7846152	T	C	hom	off-target	QUAL=5383;DP=164;AF=1.00;MQM=60	ATP5C1	intron	ATP5C1:ENST00000356708:intron:MODIFIER:exon8/9:c.890+1335T>C:,ATP5C1:ENST00000335698:intron:MODIFIER:exon8/8:c.890+1335T>C:	MER58C	rs914609	0.9465	0.9877	55106,30707,2871	0.8392,0.9950,1.0000,0.9999,0.9995	0.9890											n/a (AF>5%)	n/a (AF>5%)					ATP5F1C (inh=n/a pLI=0.34)
chr10	12197259	12197259	A	G	het	off-target	QUAL=127;DP=6;AF=0.83;MQM=60	SEC61A2	intron	SEC61A2:ENST00000298428:intron:MODIFIER:exon6/11:c.463-518A>G:,SEC61A2:ENST00000379051:intron:MODIFIER:exon6/6:c.463-51A>G:,SEC61A2:ENST00000379033:intron:MODIFIER:exon5/10:c.397-518A>G:,SEC61A2:ENST00000304267:intron:MODIFIER:exon6/11:c.463-518A>G:,SEC61A2:ENST00000379020:intron:MODIFIER:exon6/10:c.463-518A>G:		rs10906089	0.3816	0.0000	0,0,0	0,0,0,0,0	0.3934											n/a (AF>5%)	n/a (AF>5%)					SEC61A2 (inh=n/a pLI=0.91)
chr10	13224886	13224886	G	T	het	off-target	QUAL=168;DP=7;AF=0.86;MQM=60	MCM10	intron	MCM10:ENST00000484800:intron:MODIFIER:exon7/19:c.934-47G>T:,MCM10:ENST00000378714:intron:MODIFIER:exon7/19:c.931-47G>T:,MCM10:ENST00000378694:intron:MODIFIER:exon6/17:c.931-47G>T:		rs3765520	0.2893	0.3052	5032,2991,275	0.2347,0.1739,0.3929,0.3219,0.3185	0.2964											n/a (AF>5%)	n/a (AF>5%)					MCM10 (inh=n/a pLI=0.00)
chr10	13375906	13375906	T	C	het		QUAL=2110;DP=147;AF=0.54;MQM=60	SEPHS1	synonymous	SEPHS1:ENST00000327347:synonymous:LOW:exon5/9:c.471A>G:p.Thr157Thr,SEPHS1:ENST00000378614:synonymous:LOW:exon5/8:c.471A>G:p.Thr157Thr,SEPHS1:ENST00000545675:synonymous:LOW:exon5/10:c.471A>G:p.Thr157Thr,SEPHS1:ENST00000537130:synonymous:LOW:exon4/8:c.270A>G:p.Thr90Thr		rs10752297	0.6779	0.6328	24736,11253,2581	0.7083,0.7749,0.7977,0.5799,0.6290	0.6373										COSM3751625, COSM3751626	n/a (AF>5%)	n/a (AF>5%)					SEPHS1 (inh=n/a pLI=0.97)
chr10	13653653	13653653	A	G	het		QUAL=2356;DP=189;AF=0.48;MQM=60	PRPF18,RP11-295P9.3	synonymous	PRPF18:ENST00000378572:synonymous:LOW:exon6/10:c.549A>G:p.Lys183Lys		rs1135102	0.3664	0.4144	11214,7186,1186	0.4737,0.3917,0.0644,0.4621,0.4016	0.4338											n/a (AF>5%)	n/a (AF>5%)					PRPF18 (inh=n/a pLI=0.29), RP11-295P9.3 (inh=n/a pLI=n/a)
chr10	14368831	14368831	G	T	hom		QUAL=3468;DP=106;AF=1.00;MQM=60	FRMD4A	missense,intron	FRMD4A:ENST00000475141:missense:MODERATE:exon4/4:c.197C>A:p.Thr66Asn,FRMD4A:ENST00000357447:intron:MODIFIER:exon2/24:c.45+3226C>A:,FRMD4A:ENST00000378503:intron:MODIFIER:exon1/22:c.45+3226C>A:,FRMD4A:ENST00000493380:intron:MODIFIER:exon2/3:c.45+3226C>A:		rs1218444	0.8167	0.0000	11,7,2	0.0000,0.0000,0.0000,0.0000,0.0000	0.8573							616305 [FRMD4A (confirmed) Corpus callosum,agenesis of,with facial anomalies and cerebellar ataxia,616819];				n/a (AF>5%)	n/a (AF>5%)					FRMD4A (inh=AR pLI=1.00)
chr10	14943176	14943176	C	G	het		QUAL=1674;DP=136;AF=0.49;MQM=60	SUV39H2,DCLRE1C	synonymous,intron	SUV39H2:ENST00000354919:synonymous:LOW:exon5/6:c.1041C>G:p.Leu347Leu,SUV39H2:ENST00000378325:synonymous:LOW:exon5/6:c.501C>G:p.Leu167Leu,SUV39H2:ENST00000313519:synonymous:LOW:exon4/5:c.861C>G:p.Leu287Leu,DCLRE1C:ENST00000378289:intron:MODIFIER:exon13/13:c.1157-1865G>C:		rs61730323	0.0467	0.0374	117,31,25	0.0611,0.0853,0.0153,0.0328,0.0214	0.0419	-3.4280		T			13.16	605988 [DCLRE1C (confirmed) Severe combined immunodeficiency,Athabascan type,602450|Omenn syndrome,603554];				8	240					SUV39H2 (inh=n/a pLI=0.87), DCLRE1C (inh=AR pLI=0.00)
chr10	16948177	16948177	A	G	hom	off-target;gene_blacklist	QUAL=507;DP=17;AF=1.00;MQM=60	CUBN	intron	CUBN:ENST00000377833:intron:MODIFIER:exon50/66:c.7912+25T>C:		rs780807	0.7520	0.7781	37278,22154,2618	0.7125,0.5324,0.8181,0.8151,0.8324	0.7685							602997 [CUBN (confirmed) Megaloblastic anemia-1,Finnish type,261100];				n/a (AF>5%)	n/a (AF>5%)					CUBN (inh=AR pLI=0.00)
chr10	17216556	17216556	C	T	het		QUAL=1582;DP=138;AF=0.44;MQM=60	TRDMT1	missense,synonymous	TRDMT1:ENST00000457442:missense:MODERATE:exon2/9:c.68G>A:p.Arg23Gln,TRDMT1:ENST00000377799:synonymous:LOW:exon2/11:c.168G>A:p.Thr56Thr,TRDMT1:ENST00000351358:synonymous:LOW:exon2/9:c.168G>A:p.Thr56Thr,TRDMT1:ENST00000358282:synonymous:LOW:exon2/9:c.168G>A:p.Thr56Thr,TRDMT1:ENST00000377766:synonymous:LOW:exon2/8:c.168G>A:p.Thr56Thr,TRDMT1:ENST00000412821:synonymous:LOW:exon2/10:c.168G>A:p.Thr56Thr,TRDMT1:ENST00000488990:synonymous:LOW:exon2/5:c.168G>A:p.Thr56Thr		rs2273734	0.3836	0.4167	10884,7252,913	0.4165,0.3571,0.2438,0.4654,0.3470	0.4287	-0.3030	.,.,D	T,T	.,B	.,T	12.12				COSM3751679	n/a (AF>5%)	n/a (AF>5%)					TRDMT1 (inh=n/a pLI=0.00)
chr10	19641231	19641231	A	G	het		QUAL=910;DP=92;AF=0.42;MQM=60	MALRD1	splice_region&intron	MALRD1:ENST00000454679:splice_region&intron:LOW:exon11/23:c.2329+5A>G:		rs7092566	0.5507	0.5533	2395,928,165	0.6607,0.5704,0.5385,0.6227,0.4791	0.6670											n/a (AF>5%)	n/a (AF>5%)					MALRD1 (inh=n/a pLI=n/a)
chr10	19678286	19678286	C	T	hom		QUAL=4548;DP=138;AF=1.00;MQM=60	MALRD1	missense	MALRD1:ENST00000454679:missense:MODERATE:exon13/24:c.2750C>T:p.Thr917Met		rs10763974	0.8305	0.8008	5741,2257,503	0.9216,0.7821,0.8160,0.8513,0.7150	0.8827	-0.0770	T,T	T		T,T	8.18				COSM3806890	n/a (AF>5%)	n/a (AF>5%)					MALRD1 (inh=n/a pLI=n/a)
chr10	21074724	21074724	T	C	het		QUAL=1177;DP=95;AF=0.49;MQM=60	NEBL	synonymous	NEBL:ENST00000377122:synonymous:LOW:exon28/28:c.2997A>G:p.Thr999Thr,NEBL:ENST00000417816:synonymous:LOW:exon7/7:c.765A>G:p.Thr255Thr,NEBL:ENST00000377159:synonymous:LOW:exon6/6:c.663A>G:p.Thr221Thr		rs2296614	0.0667	0.0779	457,191,63	0.1195,0.1618,0.0008,0.0737,0.0585	0.0830								45497 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NEBL (inh=AD pLI=0.00)
chr10	22896779	22896779	C	T	hom	off-target	QUAL=971;DP=33;AF=0.97;MQM=60	PIP4K2A	intron	PIP4K2A:ENST00000376573:intron:MODIFIER:exon3/9:c.339+77G>A:,PIP4K2A:ENST00000545335:intron:MODIFIER:exon3/9:c.162+77G>A:		rs2765997	0.7694	0.6691	17205,7302,2138	0.7884,0.8306,0.9386,0.6061,0.6171	0.6965											n/a (AF>5%)	n/a (AF>5%)					PIP4K2A (inh=n/a pLI=0.72)
chr10	27454111	27454111	A	T	het		QUAL=1079;DP=83;AF=0.54;MQM=60	MASTL	splice_region&intron	MASTL:ENST00000375940:splice_region&intron:LOW:exon5/11:c.660+12A>T:,MASTL:ENST00000375946:splice_region&intron:LOW:exon5/11:c.660+12A>T:,MASTL:ENST00000342386:splice_region&intron:LOW:exon5/10:c.660+12A>T:		rs7068375	0.5048	0.5924	21561,13922,1511	0.5411,0.5444,0.4339,0.6487,0.4858	0.6060								262126 [benign/likely benign DISEASE=thrombocytopenia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MASTL (inh=AD pLI=0.00)
chr10	29754609	29754609	T	C	het		QUAL=1221;DP=95;AF=0.51;MQM=56	SVIL,PTCHD3P1	synonymous,intron	SVIL:ENST00000355867:synonymous:LOW:exon34/38:c.6048A>G:p.Thr2016Thr,SVIL:ENST00000375400:synonymous:LOW:exon32/36:c.4770A>G:p.Thr1590Thr,SVIL:ENST00000375398:synonymous:LOW:exon36/40:c.6048A>G:p.Thr2016Thr,SVIL:ENST00000535393:synonymous:LOW:exon20/24:c.2790A>G:p.Thr930Thr,PTCHD3P1:ENST00000413405:intron:MODIFIER:exon2/2:n.177-21475T>C:,PTCHD3P1:ENST00000414457:intron:MODIFIER:exon2/2:n.158-17153T>C:,PTCHD3P1:ENST00000446807:intron:MODIFIER:exon3/3:n.407+7160T>C:,PTCHD3P1:ENST00000423223:intron:MODIFIER:exon2/2:n.155-17153T>C:,PTCHD3P1:ENST00000445521:intron:MODIFIER:exon2/2:n.150-1560T>C:,PTCHD3P1:ENST00000455774:intron:MODIFIER:exon2/2:n.276-3240T>C:		rs1057952	0.4231	0.3965	9915,4179,757	0.3878,0.5036,0.5536,0.3508,0.3910	0.4055										COSM146917	n/a (AF>5%)	n/a (AF>5%)					SVIL (inh=n/a pLI=1.00), PTCHD3P1 (inh=n/a pLI=n/a)
chr10	29821523	29821523	T	C	hom		QUAL=2066;DP=65;AF=1.00;MQM=60	SVIL	synonymous,intron	SVIL:ENST00000355867:synonymous:LOW:exon8/38:c.1773A>G:p.Lys591Lys,SVIL:ENST00000375398:synonymous:LOW:exon10/40:c.1773A>G:p.Lys591Lys,SVIL:ENST00000375400:intron:MODIFIER:exon8/35:c.828-1306A>G:		rs1328323	0.2973	0.3784	9420,6682,646	0.3538,0.2743,0.0834,0.4464,0.3149	0.3932											n/a (AF>5%)	n/a (AF>5%)					SVIL (inh=n/a pLI=1.00)
chr10	29822159	29822159	T	C	hom		QUAL=3851;DP=118;AF=1.00;MQM=60	SVIL	synonymous,intron	SVIL:ENST00000355867:synonymous:LOW:exon8/38:c.1137A>G:p.Leu379Leu,SVIL:ENST00000375398:synonymous:LOW:exon10/40:c.1137A>G:p.Leu379Leu,SVIL:ENST00000375400:intron:MODIFIER:exon8/35:c.828-1942A>G:		rs7076239	0.3107	0.3883	9848,6780,687	0.3635,0.2758,0.0914,0.4494,0.3632	0.3975											n/a (AF>5%)	n/a (AF>5%)					SVIL (inh=n/a pLI=1.00)
chr10	29840164	29840164	A	G	hom		QUAL=6488;DP=197;AF=1.00;MQM=60	SVIL	synonymous	SVIL:ENST00000355867:synonymous:LOW:exon6/38:c.189T>C:p.Ser63Ser,SVIL:ENST00000375400:synonymous:LOW:exon8/36:c.189T>C:p.Ser63Ser,SVIL:ENST00000375398:synonymous:LOW:exon8/40:c.189T>C:p.Ser63Ser		rs3740002	0.2550	0.2651	4118,2112,316	0.2573,0.2948,0.3388,0.2585,0.2136	0.2725											n/a (AF>5%)	n/a (AF>5%)					SVIL (inh=n/a pLI=1.00)
chr10	29843833	29843833	C	T	hom		QUAL=5127;DP=157;AF=1.00;MQM=60	SVIL	synonymous	SVIL:ENST00000355867:synonymous:LOW:exon5/38:c.39G>A:p.Gly13Gly,SVIL:ENST00000375400:synonymous:LOW:exon7/36:c.39G>A:p.Gly13Gly,SVIL:ENST00000375398:synonymous:LOW:exon7/40:c.39G>A:p.Gly13Gly		rs1547169	0.2574	0.2600	4225,2155,326	0.2546,0.2942,0.3497,0.2549,0.1944	0.2736											n/a (AF>5%)	n/a (AF>5%)					SVIL (inh=n/a pLI=1.00)
chr10	33018351	33018351	G	C	hom		QUAL=891;DP=28;AF=1.00;MQM=60	C10ORF68	synonymous	C10ORF68:ENST00000375025:synonymous:LOW:exon8/22:c.792G>C:p.Thr264Thr,C10ORF68:ENST00000375028:synonymous:LOW:exon8/21:c.720G>C:p.Thr240Thr,C10ORF68:ENST00000375030:synonymous:LOW:exon13/23:c.816G>C:p.Thr272Thr		rs1414548	0.9165	0.9769	57560,33013,2747	0.7460,0.9877,1.0000,0.9986,0.9994	0.9800											n/a (AF>5%)	n/a (AF>5%)					CCDC7 (inh=n/a pLI=0.00)
chr10	33123824	33123824	G	C	hom		QUAL=1972;DP=60;AF=1.00;MQM=60	C10ORF68	missense&splice_region	C10ORF68:ENST00000375025:missense&splice_region:MODERATE:exon13/22:c.1271G>C:p.Gly424Ala,C10ORF68:ENST00000375028:missense&splice_region:MODERATE:exon12/21:c.1091G>C:p.Gly364Ala,C10ORF68:ENST00000375030:missense&splice_region:MODERATE:exon15/23:c.1040G>C:p.Gly347Ala		rs4448627	0.9836	0.9948	53413,28943,4115	0.9436,0.9969,1.0000,0.9998,1.0000	0.9958	-1.4450	T,T,T,T,T	T	B,B,B	T,T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					CCDC7 (inh=n/a pLI=0.00)
chr10	43119159	43119159	T	C	hom	off-target	QUAL=4291;DP=134;AF=1.00;MQM=60	ZNF33B	intron	ZNF33B:ENST00000486187:intron:MODIFIER:exon3/5:n.229+8218A>G:,ZNF33B:ENST00000359467:intron:MODIFIER:exon4/4:c.250+8218A>G:	L1MB4	rs158378	0.5106	0.0000	0,0,0	0,0,0,0,0	0.5917											n/a (AF>5%)	n/a (AF>5%)					ZNF33B (inh=n/a pLI=0.00)
chr10	43319197	43319197	G	A	het		QUAL=274;DP=36;AF=0.36;MQM=60	BMS1	missense	BMS1:ENST00000374518:missense:MODERATE:exon21/23:c.3421G>A:p.Val1141Ile		rs12764004	0.2049	0.2035	2892,1116,10	0.0553,0.1099,0.4276,0.1899,0.3181	0.2027	0.5540	T	T	B	T	0.58	611448 [BMS1 (provisional) Aplasia cutis congenita,nonsyndromic,107600];				n/a (AF>5%)	n/a (AF>5%)					BMS1 (inh=AR+AD pLI=0.98)
chr10	43976983	43976983	T	C	het		QUAL=2481;DP=187;AF=0.51;MQM=60	ZNF487	synonymous	ZNF487:ENST00000431662:synonymous:LOW:exon4/7:c.432T>C:p.Asn144Asn,ZNF487:ENST00000437590:synonymous:LOW:exon4/4:c.240T>C:p.Asn80Asn		rs12359980	0.1404	0.1825	293,90,29	0.2308,0.1477,0.0041,0.1898,0.1783	0.1938	0.2530		T			0.59					n/a (AF>5%)	n/a (AF>5%)					ZNF487 (inh=n/a pLI=0.39)
chr10	49654403	49654403	C	T	het	off-target	QUAL=810;DP=58;AF=0.55;MQM=60	ARHGAP22	3'UTR	ARHGAP22:ENST00000417912:3'UTR:MODIFIER:exon10/10:c.*31G>A:,ARHGAP22:ENST00000249601:3'UTR:MODIFIER:exon10/10:c.*31G>A:,ARHGAP22:ENST00000477708:3'UTR:MODIFIER:exon2/2:c.*31G>A:,ARHGAP22:ENST00000374170:3'UTR:MODIFIER:exon6/6:c.*31G>A:,ARHGAP22:ENST00000374172:3'UTR:MODIFIER:exon9/9:c.*31G>A:,ARHGAP22:ENST00000417247:3'UTR:MODIFIER:exon8/8:c.*31G>A:,ARHGAP22:ENST00000435790:3'UTR:MODIFIER:exon10/10:c.*31G>A:		rs1051507	0.4746	0.5303	17423,10967,632	0.3509,0.5116,0.6437,0.5759,0.4076	0.5311											n/a (AF>5%)	n/a (AF>5%)					ARHGAP22 (inh=n/a pLI=0.01)
chr10	55568972	55568972	T	G	het		QUAL=1023;DP=104;AF=0.41;MQM=60	PCDH15	missense,3'UTR,intron	PCDH15:ENST00000395440:missense:MODERATE:exon12/12:c.1640A>C:p.Glu547Ala,PCDH15:ENST00000395442:missense:MODERATE:exon11/11:c.1433A>C:p.Glu478Ala,PCDH15:ENST00000395445:missense:MODERATE:exon36/36:c.4838A>C:p.Glu1613Ala,PCDH15:ENST00000395446:missense:MODERATE:exon18/18:c.2426A>C:p.Glu809Ala,PCDH15:ENST00000395438:3'UTR:MODIFIER:exon36/36:c.*268A>C:,PCDH15:ENST00000409834:3'UTR:MODIFIER:exon29/29:c.*268A>C:,PCDH15:ENST00000373965:intron:MODIFIER:exon35/35:c.4503+1344A>C:,PCDH15:ENST00000414778:intron:MODIFIER:exon34/34:c.4494+1344A>C:		rs11003863	0.2981	0.2489	5272,969,66	0.1128,0.4098,0.7138,0.1709,0.3211	0.2530	4.7360	D,D,D,D	T	B,B	T,T,T,D	23.30	605514 [PCDH15 (confirmed) Usher syndrome,type 1F,602083|Deafness,autosomal recessive 23,609533|Usher syndrome,type 1D/F digenic,601067];	44035 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					PCDH15 (inh=AR pLI=0.00)
chr10	64416290	64416290	A	G	het	off-target	QUAL=1114;DP=94;AF=0.47;MQM=60	ZNF365	intron	ZNF365:ENST00000410046:intron:MODIFIER:exon6/7:c.1220+44A>G:,ZNF365:ENST00000395251:intron:MODIFIER:exon5/6:c.482+44A>G:,ZNF365:ENST00000395249:intron:MODIFIER:exon1/2:c.39-9599A>G:	LTR84b	rs12776269	0.0439	0.1046	874,710,1	0.0210,0.0485,0.0004,0.1462,0.0499	0.1072							607818 [ZNF365 (confirmed) Nephrolithiasis,uric acid,susceptibility to,605990];				n/a (AF>5%)	n/a (AF>5%)					ZNF365 (inh=n/a pLI=0.00)
chr10	70143774	70143774	C	T	hom	off-target	QUAL=1733;DP=52;AF=1.00;MQM=60	RUFY2	intron	RUFY2:ENST00000388768:intron:MODIFIER:exon9/17:c.927+34G>A:,RUFY2:ENST00000602465:intron:MODIFIER:exon9/17:c.822+34G>A:,RUFY2:ENST00000399200:intron:MODIFIER:exon8/11:c.720+34G>A:,RUFY2:ENST00000454950:intron:MODIFIER:exon8/11:c.648+34G>A:		rs7899885	0.6639	0.7463	34273,21250,1014	0.4471,0.6464,0.8466,0.7985,0.7083	0.7471											n/a (AF>5%)	n/a (AF>5%)					RUFY2 (inh=n/a pLI=0.89)
chr10	70641860	70641860	T	C	het		QUAL=1345;DP=106;AF=0.52;MQM=60	STOX1	missense	STOX1:ENST00000298596:missense:MODERATE:exon2/4:c.457T>C:p.Tyr153His,STOX1:ENST00000399169:missense:MODERATE:exon2/5:c.457T>C:p.Tyr153His,STOX1:ENST00000399162:missense:MODERATE:exon2/3:c.457T>C:p.Tyr153His,STOX1:ENST00000399165:missense:MODERATE:exon2/4:c.457T>C:p.Tyr153His,STOX1:ENST00000421961:missense:MODERATE:exon2/4:c.127T>C:p.Tyr43His		rs1341667	0.6124	0.6231	24193,13497,792	0.4036,0.5165,0.9041,0.6365,0.6016	0.6238	3.0310	T,T,T,T,T	T	B,B,B	T,T,T,T,T	23.40	609397 [STOX1 (provisional) Preeclampsia/eclampsia 4,609404];	1719 [risk factor DISEASE=preeclampsia/eclampsia_4]; 	CM057373 [CLASS=DM? MUT=ALT PHEN="Preeclampsia" GENE=STOX1]; 	COSM3751904	n/a (AF>5%)	n/a (AF>5%)					STOX1 (inh=n/a pLI=0.00)
chr10	70645697	70645697	C	T	het		QUAL=2375;DP=180;AF=0.50;MQM=60	STOX1	synonymous,intron	STOX1:ENST00000298596:synonymous:LOW:exon3/4:c.2145C>T:p.Asn715Asn,STOX1:ENST00000399169:synonymous:LOW:exon3/5:c.2145C>T:p.Asn715Asn,STOX1:ENST00000421961:synonymous:LOW:exon3/4:c.1815C>T:p.Asn605Asn,STOX1:ENST00000399162:intron:MODIFIER:exon2/2:c.463+3831C>T:,STOX1:ENST00000399165:intron:MODIFIER:exon3/3:c.663+1482C>T:		rs10509306	0.0881	0.1302	1259,493,5	0.0257,0.2736,0.0775,0.1241,0.1253	0.1390							609397 [STOX1 (provisional) Preeclampsia/eclampsia 4,609404];				n/a (AF>5%)	n/a (AF>5%)					STOX1 (inh=n/a pLI=0.00)
chr10	71098195	71098195	G	T	het	off-target	QUAL=357;DP=36;AF=0.44;MQM=60	HK1	intron	HK1:ENST00000448642:intron:MODIFIER:exon6/22:c.169-5388G>T:,HK1:ENST00000360289:intron:MODIFIER:exon5/21:c.28-5388G>T:,HK1:ENST00000404387:intron:MODIFIER:exon2/18:c.76-5388G>T:,HK1:ENST00000298649:intron:MODIFIER:exon1/17:c.61-5388G>T:,HK1:ENST00000359426:intron:MODIFIER:exon1/17:c.64-5388G>T:		rs906216	0.3902	0.0000	0,0,0	0,0,0,0,0	0.4670							142600 [HK1 (confirmed) Hemolytic anemia due to hexokinase deficiency,235700|Neuropathy,hereditary motor and sensory,Russe type,605285|Retinitis pigmentosa 79,617460];				n/a (AF>5%)	n/a (AF>5%)					HK1 (inh=AR+AD pLI=0.72)
chr10	72614421	72614421	T	C	het	off-target	QUAL=1353;DP=107;AF=0.52;MQM=60	SGPL1	intron	SGPL1:ENST00000373202:intron:MODIFIER:exon4/14:c.262-44T>C:		rs2171157	0.3808	0.3913	8880,4596,303	0.2488,0.4895,0.4334,0.3770,0.5134	0.3986							603729 [SGPL1 (provisional) Nephrotic syndrome 14,617575];			COSN163661	n/a (AF>5%)	n/a (AF>5%)					SGPL1 (inh=n/a pLI=0.28)
chr10	73499561	73499561	C	G	het	off-target;gene_blacklist	QUAL=607;DP=35;AF=0.66;MQM=60	CDH23	intron	CDH23:ENST00000224721:intron:MODIFIER:exon35/68:c.4503+32C>G:		rs10762474	0.4159	0.5074	14773,10439,815	0.4191,0.3375,0.3037,0.5829,0.4621	0.5262							605516 [CDH23 (confirmed) Usher syndrome,type 1D,601067|Deafness,autosomal recessive 12,601386|Usher syndrome,type 1D/F digenic,601067|Pituitary adenoma 5,multiple types,617540];	261549 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CDH23 (inh=AR pLI=0.02)
chr10	75525999	75525999	A	G	het	off-target	QUAL=2998;DP=227;AF=0.49;MQM=60	SEC24C	intron	SEC24C:ENST00000339365:intron:MODIFIER:exon12/23:c.1607+31A>G:,SEC24C:ENST00000535742:intron:MODIFIER:exon2/9:c.-75-2569A>G:,SEC24C:ENST00000546025:intron:MODIFIER:exon5/6:c.701-109A>G:,SEC24C:ENST00000345254:intron:MODIFIER:exon11/22:c.1607+31A>G:,SEC24C:ENST00000540668:intron:MODIFIER:exon1/8:c.-75-2569A>G:,SEC24C:ENST00000411652:intron:MODIFIER:exon11/22:c.1250+31A>G:		rs3849969	0.4884	0.6215	25012,18404,1499	0.5334,0.3757,0.2566,0.7413,0.5677	0.6233										COSN163680	n/a (AF>5%)	n/a (AF>5%)					SEC24C (inh=n/a pLI=1.00)
chr10	79590685	79590685	C	T	het	off-target	QUAL=310;DP=34;AF=0.44;MQM=60	DLG5	intron	DLG5:ENST00000372391:intron:MODIFIER:exon9/31:c.1749-54G>A:,DLG5:ENST00000372388:intron:MODIFIER:exon9/30:c.1749-54G>A:		rs10824579	0.3247	0.0000	0,0,0	0,0,0,0,0	0.3315											n/a (AF>5%)	n/a (AF>5%)					DLG5 (inh=n/a pLI=1.00)
chr10	82012954	82012954	A	G	het		QUAL=4391;DP=336;AF=0.50;MQM=60	AL359195.1				rs12773664	0.4089	0.4639	1613,446,30	0.3228,0.0000,0.5194,0.4574,0.4849	0.4559	-1.4890	T	T			0.01				COSM3998100	n/a (AF>5%)	n/a (AF>5%)					AL359195.1 (inh=n/a pLI=n/a)
chr10	84625107	84625107	C	T	hom	off-target	QUAL=5302;DP=167;AF=1.00;MQM=60	NRG3	intron	NRG3:ENST00000404547:intron:MODIFIER:exon3/9:c.1028-60C>T:,NRG3:ENST00000372141:intron:MODIFIER:exon3/8:c.1028-60C>T:,NRG3:ENST00000372142:intron:MODIFIER:exon4/10:c.365-60C>T:,NRG3:ENST00000404576:intron:MODIFIER:exon4/9:c.440-60C>T:,NRG3:ENST00000556918:intron:MODIFIER:exon5/10:c.518-60C>T:,NRG3:ENST00000537893:intron:MODIFIER:exon1/6:c.-23-60C>T:,NRG3:ENST00000545131:intron:MODIFIER:exon2/7:c.-20-63C>T:		rs478010	0.7596	0.0000	0,0,0	0,0,0,0,0	0.7425											n/a (AF>5%)	n/a (AF>5%)					NRG3 (inh=n/a pLI=0.12)
chr10	85972043	85972043	A	G	het		QUAL=1688;DP=120;AF=0.53;MQM=60	CDHR1	synonymous	CDHR1:ENST00000372117:synonymous:LOW:exon15/17:c.1662A>G:p.Glu554Glu,CDHR1:ENST00000332904:synonymous:LOW:exon15/17:c.1662A>G:p.Glu554Glu,CDHR1:ENST00000440770:synonymous:LOW:exon8/10:c.774A>G:p.Glu258Glu		rs10749482	0.4291	0.3557	8567,3108,2434	0.6828,0.4775,0.2502,0.3013,0.3326	0.4183							609502 [CDHR1 (confirmed) Cone-rod dystrophy 15,613660|Retinitis pigmentosa 65,613660];	262210 [benign DISEASE=not_specified,cone-rod_dystrophy,_recessive]; 		COSM3752005, COSM3752004	n/a (AF>5%)	n/a (AF>5%)					CDHR1 (inh=AR pLI=0.00)
chr10	85978991	85978991	C	T	het		QUAL=1577;DP=139;AF=0.46;MQM=60	CDHR1	synonymous	CDHR1:ENST00000332904:synonymous:LOW:exon17/17:c.2197C>T:p.Leu733Leu		rs7895270	0.2780	0.2680	670,206,135	0.5055,0.2872,0.0502,0.2628,0.2366	0.3165							609502 [CDHR1 (confirmed) Cone-rod dystrophy 15,613660|Retinitis pigmentosa 65,613660];			COSM3752006	n/a (AF>5%)	n/a (AF>5%)					CDHR1 (inh=AR pLI=0.00)
chr10	90771829	90771829	T	C	hom		QUAL=3082;DP=95;AF=1.00;MQM=60	FAS	synonymous	FAS:ENST00000355740:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:ENST00000352159:synonymous:LOW:exon7/9:c.642T>C:p.Thr214Thr,FAS:ENST00000357339:synonymous:LOW:exon6/8:c.579T>C:p.Thr193Thr,FAS:ENST00000355279:synonymous:LOW:exon7/8:c.642T>C:p.Thr214Thr		rs2234978	0.7754	0.7561	35133,16231,2363	0.6762,0.8665,0.9831,0.6988,0.8261	0.7651							134637 [FAS (confirmed) Autoimmune lymphoproliferative syndrome,601859|Squamous cell carcinoma,burn scar-related,somatic|Autoimmune lymphoproliferative syndrome,type IA,601859];	254734 [benign DISEASE=autoimmune_lymphoproliferative_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FAS (inh=AD pLI=0.65)
chr10	95132905	95132905	C	T	het	off-target	QUAL=488;DP=44;AF=0.52;MQM=60	MYOF	intron	MYOF:ENST00000359263:intron:MODIFIER:exon23/53:c.2302-63G>A:,MYOF:ENST00000358334:intron:MODIFIER:exon22/52:c.2263-63G>A:,MYOF:ENST00000371501:intron:MODIFIER:exon23/53:c.2302-63G>A:,MYOF:ENST00000371502:intron:MODIFIER:exon23/53:c.2302-63G>A:		rs787647	0.8626	0.0000	0,0,0	0,0,0,0,0	0.8193											n/a (AF>5%)	n/a (AF>5%)					MYOF (inh=n/a pLI=0.00)
chr10	95381773	95381773	T	A	hom		QUAL=6602;DP=198;AF=1.00;MQM=60	PDE6C	missense	PDE6C:ENST00000371447:missense:MODERATE:exon4/22:c.808T>A:p.Ser270Thr		rs701865	0.4143	0.3729	8723,4105,1139	0.4667,0.4387,0.4801,0.3504,0.3207	0.3898	2.6190	T	T	B	T	13.18	600827 [PDE6C (provisional) Cone dystrophy 4,613093];	259947 [benign DISEASE=achromatopsia,not_specified,cone-rod_dystrophy,_recessive]; 	CM1213490 [CLASS=DP MUT=ALT PHEN="Major depressive disorder increased risk" GENE=PDE6C]; 	COSM3752061	n/a (AF>5%)	n/a (AF>5%)					PDE6C (inh=AR pLI=0.00)
chr10	95433124	95433124	A	G	het		QUAL=2055;DP=171;AF=0.46;MQM=60	FRA10AC1	intron	FRA10AC1:ENST00000359204:intron:MODIFIER:exon12/13:c.827-2519T>C:,FRA10AC1:ENST00000536233:intron:MODIFIER:exon12/14:c.827-1278T>C:,FRA10AC1:ENST00000371430:intron:MODIFIER:exon13/13:c.907-1278T>C:	L3	rs1326214	0.4936	0.6104	2714,930,43	0.3939,0.0000,0.0000,0.6905,0.5869	0.5949	0.1420	T	T			2.01					n/a (AF>5%)	n/a (AF>5%)					FRA10AC1 (inh=n/a pLI=0.00)
chr10	96535124	96535124	A	G	het	off-target	QUAL=1850;DP=163;AF=0.46;MQM=60	CYP2C19	intron	CYP2C19:ENST00000371321:intron:MODIFIER:exon2/8:c.332-23A>G:		rs12769205	0.2284	0.1863	2505,730,215	0.2002,0.1023,0.3124,0.1471,0.3310	0.1804							124020 [CYP2C19 (confirmed) Mephenytoin poor metabolizer,609535|Omeprazole poor metabolizer,609535|Proguanil poor metabolizer,609535|Clopidogrel,impaired responsiveness to,609535];		CS155448 [CLASS=FP MUT=ALT PHEN="Poor metaboliser" GENE=CYP2C19]; 		n/a (AF>5%)	n/a (AF>5%)					CYP2C19 (inh=AR pLI=0.00)
chr10	96798749	96798749	T	C	het		QUAL=1865;DP=128;AF=0.54;MQM=60	CYP2C8	missense	CYP2C8:ENST00000371270:missense:MODERATE:exon8/9:c.1196A>G:p.Lys399Arg,CYP2C8:ENST00000535898:missense:MODERATE:exon7/8:c.890A>G:p.Lys297Arg		rs10509681	0.0457	0.0826	544,449,1	0.0210,0.0665,0.0004,0.1132,0.0397	0.0838	-0.0300	T,D,D	T	B,B,B	T,T	0.53	601129 [CYP2C8 (provisional) Drug metabolism,altered,CYP2C8-related,618018];	375654 [drug response DISEASE=rosiglitazone_response_-_dosage]; 	CM014701 [CLASS=FP MUT=ALT PHEN="Poor paclitaxel metabolism" GENE=CYP2C8]; 		n/a (AF>5%)	n/a (AF>5%)					CYP2C8 (inh=n/a pLI=0.00)
chr10	97712119	97712119	C	A	het	off-target	QUAL=1026;DP=93;AF=0.44;MQM=60	RP11-248J23.6,ENTPD1-AS1	intron	ENTPD1-AS1:ENST00000416301:intron:MODIFIER:exon2/5:n.276-75702G>T:,ENTPD1-AS1:ENST00000451364:intron:MODIFIER:exon2/3:n.217-75702G>T:,ENTPD1-AS1:ENST00000452728:intron:MODIFIER:exon2/5:n.260-1834G>T:,ENTPD1-AS1:ENST00000454638:intron:MODIFIER:exon2/2:n.274-30765G>T:	L1ME3G	rs2027200	0.5409	0.0000	0,0,0	0,0,0,0,0	0.5990											n/a (AF>5%)	n/a (AF>5%)					RP11-248J23.6 (inh=n/a pLI=n/a), ENTPD1-AS1 (inh=n/a pLI=n/a)
chr10	98469693	98469693	C	T	het		QUAL=1241;DP=94;AF=0.52;MQM=60	PIK3AP1	missense	PIK3AP1:ENST00000339364:missense:MODERATE:exon2/17:c.61G>A:p.Glu21Lys		rs17112076	0.1254	0.1584	1665,1037,5	0.0387,0.0873,0.2455,0.1773,0.1501	0.1559	-1.4280	T	T	B	T	8.42				COSM428224	n/a (AF>5%)	n/a (AF>5%)					PIK3AP1 (inh=n/a pLI=1.00)
chr10	101553259	101553259	C	T	het	off-target	QUAL=172;DP=15;AF=0.53;MQM=60	ABCC2	intron	ABCC2:ENST00000370449:intron:MODIFIER:exon3/31:c.334-49C>T:,ABCC2:ENST00000370434:intron:MODIFIER:exon3/6:c.334-49C>T:		rs2804400	0.3355	0.3886	9454,6229,422	0.2798,0.3813,0.2402,0.4296,0.3765	0.3916							601107 [ABCC2 (provisional) Dubin-Johnson syndrome,237500];			COSN163735	n/a (AF>5%)	n/a (AF>5%)					ABCC2 (inh=AR pLI=0.00)
chr10	101977883	101977883	C	T	het		QUAL=1212;DP=121;AF=0.41;MQM=60	CHUK	missense	CHUK:ENST00000370397:missense:MODERATE:exon9/21:c.802G>A:p.Val268Ile		rs2230804	0.5457	0.4791	14575,8201,2915	0.7473,0.3409,0.4865,0.4979,0.3328	0.5674	2.5720	T	T	B	T	21.40	600664 [CHUK (confirmed) Cocoon syndrome,613630];			COSM3997731	n/a (AF>5%)	n/a (AF>5%)					CHUK (inh=AR pLI=1.00)
chr10	102750851	102750851	G	A	het	off-target	QUAL=317;DP=26;AF=0.62;MQM=60	C10orf2	intron	C10orf2:ENST00000311916:intron:MODIFIER:exon4/4:c.1734+84G>A:,C10orf2:ENST00000370228:intron:MODIFIER:exon4/4:c.*29+40G>A:		rs3824783	0.3762	0.0000	0,0,0	0,0,0,0,0	0.2872											n/a (AF>5%)	n/a (AF>5%)					TWNK (inh=AR+AD pLI=0.98)
chr10	105824333	105824333	G	A	hom		QUAL=5046;DP=153;AF=1.00;MQM=60	COL17A1	missense	COL17A1:ENST00000353479:missense:MODERATE:exon10/56:c.629C>T:p.Thr210Met,COL17A1:ENST00000369733:missense:MODERATE:exon10/52:c.629C>T:p.Thr210Met,COL17A1:ENST00000393211:missense:MODERATE:exon10/15:c.629C>T:p.Thr210Met		rs805708	0.5649	0.6740	27226,16148,617	0.3617,0.7817,0.6933,0.7062,0.6419	0.6767	6.8340	T,T,T,T	T	D,D,P	T,T,T	23.20	113811 [COL17A1 (confirmed) Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa,junctional,localisata variant,226650|Epithelial recurrent erosion dystrophy,122400];	256276 [benign DISEASE=epidermolysis_bullosa,_junctional,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					COL17A1 (inh=AR+AD pLI=0.00)
chr10	111625108	111625108	T	C	hom	off-target	QUAL=1140;DP=38;AF=1.00;MQM=60	XPNPEP1	intron	XPNPEP1:ENST00000502935:intron:MODIFIER:exon20/20:c.1873-38A>G:,XPNPEP1:ENST00000369683:intron:MODIFIER:exon18/18:c.1531-38A>G:,XPNPEP1:ENST00000322238:intron:MODIFIER:exon19/19:c.1801-38A>G:,XPNPEP1:ENST00000369680:intron:MODIFIER:exon20/20:c.1744-38A>G:		rs483072	0.9942	0.9982	60429,33328,5008	0.9811,0.9990,1.0000,0.9999,1.0000	0.9986											n/a (AF>5%)	n/a (AF>5%)					XPNPEP1 (inh=n/a pLI=0.92)
chr10	115392919	115392919	T	A	het	gene_blacklist	QUAL=1403;DP=96;AF=0.56;MQM=60	NRAP	missense	NRAP:ENST00000369358:missense:MODERATE:exon16/42:c.1556A>T:p.Asn519Ile,NRAP:ENST00000369360:missense:MODERATE:exon15/41:c.1451A>T:p.Asn484Ile,NRAP:ENST00000360478:missense:MODERATE:exon15/41:c.1451A>T:p.Asn484Ile,NRAP:ENST00000359988:missense:MODERATE:exon16/42:c.1556A>T:p.Asn519Ile		rs2270182	0.2588	0.2638	4452,2589,654	0.3516,0.1659,0.1813,0.2779,0.2509	0.2841	2.4770	T,T,T,T,T,.	T	P,P,P	T,T,T,T	22.50				COSM3751533	n/a (AF>5%)	n/a (AF>5%)					NRAP (inh=n/a pLI=0.00)
chr10	115489152	115489152	C	G	het		QUAL=650;DP=78;AF=0.37;MQM=60	CASP7	missense	CASP7:ENST00000369321:missense:MODERATE:exon8/8:c.864C>G:p.Asp288Glu,CASP7:ENST00000369331:missense:MODERATE:exon8/8:c.731C>G:p.Thr244Ser,CASP7:ENST00000345633:missense:MODERATE:exon8/8:c.765C>G:p.Asp255Glu,CASP7:ENST00000369318:missense:MODERATE:exon7/7:c.765C>G:p.Asp255Glu,CASP7:ENST00000369315:missense:MODERATE:exon8/8:c.765C>G:p.Asp255Glu,CASP7:ENST00000452490:missense:MODERATE:exon6/6:c.690C>G:p.Asp230Glu		rs2227310	0.2498	0.2598	4335,2212,101	0.1422,0.2849,0.4223,0.2564,0.2390	0.2614	-0.7760	T,T,T,T,T,T,T	T,T	B,B,B,B,B	T,T,T,T,T,T	6.99					n/a (AF>5%)	n/a (AF>5%)					CASP7 (inh=n/a pLI=0.00)
chr10	115644040	115644040	G	A	het		QUAL=1060;DP=89;AF=0.47;MQM=60	NHLRC2	missense	NHLRC2:ENST00000369301:missense:MODERATE:exon5/11:c.940G>A:p.Val314Ile		rs7913176	0.2234	0.2720	4745,2887,117	0.1494,0.2716,0.3256,0.2918,0.1976	0.2773	2.5740	T	T	B	D	15.20				COSM427091	n/a (AF>5%)	n/a (AF>5%)					NHLRC2 (inh=n/a pLI=0.00)
chr10	118364842	118364842	A	G	hom	off-target	QUAL=784;DP=28;AF=1.00;MQM=60	PNLIPRP1	intron	PNLIPRP1:ENST00000358834:intron:MODIFIER:exon11/12:c.1173-56A>G:,PNLIPRP1:ENST00000528052:intron:MODIFIER:exon11/12:c.1173-56A>G:,PNLIPRP1:ENST00000534537:intron:MODIFIER:exon10/11:c.1173-56A>G:		rs2915753	0.5809	0.0000	0,0,0	0,0,0,0,0	0.6003											n/a (AF>5%)	n/a (AF>5%)					PNLIPRP1 (inh=n/a pLI=0.00)
chr10	118436068	118436068	G	T	hom	off-target	QUAL=4957;DP=151;AF=1.00;MQM=60	HSPA12A	intron	HSPA12A:ENST00000369209:intron:MODIFIER:exon10/11:c.1287-55C>A:		rs2166634	0.6298	0.0000	0,0,0	0,0,0,0,0	0.6122											n/a (AF>5%)	n/a (AF>5%)					HSPA12A (inh=n/a pLI=0.97)
chr10	123243197	123243197	G	A	hom		QUAL=2297;DP=70;AF=0.99;MQM=60	FGFR2	splice_region&intron	FGFR2:ENST00000457416:splice_region&intron:LOW:exon17/17:c.2304+15C>T:,FGFR2:ENST00000369061:splice_region&intron:LOW:exon14/14:c.1965+15C>T:,FGFR2:ENST00000357555:splice_region&intron:LOW:exon16/16:c.2034+15C>T:,FGFR2:ENST00000358487:splice_region&intron:LOW:exon17/17:c.2301+15C>T:,FGFR2:ENST00000478859:splice_region&intron:LOW:exon16/16:c.1617+15C>T:,FGFR2:ENST00000356226:splice_region&intron:LOW:exon15/15:c.1950+15C>T:,FGFR2:ENST00000369060:splice_region&intron:LOW:exon15/15:c.1953+15C>T:,FGFR2:ENST00000369059:splice_region&intron:LOW:exon15/15:c.1959+15C>T:,FGFR2:ENST00000346997:splice_region&intron:LOW:exon16/16:c.2295+15C>T:,FGFR2:ENST00000351936:splice_region&intron:LOW:exon17/17:c.2295+15C>T:,FGFR2:ENST00000360144:splice_region&intron:LOW:exon16/16:c.2037+15C>T:,FGFR2:ENST00000369056:splice_region&intron:LOW:exon16/16:c.2304+15C>T:		rs2278202	0.4231	0.5614	18691,10523,179	0.1912,0.7830,0.3677,0.5860,0.6457	0.5620							176943 [FGFR2 (confirmed) Crouzon syndrome,123500|Jackson-Weiss syndrome,123150|Beare-Stevenson cutis gyrata syndrome,123790|Pfeiffer syndrome,101600|Apert syndrome,101200|Saethre-Chotzen syndrome,101400|Craniosynostosis,nonspecific|Gastric cancer,somatic,613659|Craniofacial-skeletal-dermatologic dysplasia,101600|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome,149730|Scaphocephaly,maxillary retrusion,and mental retardation,609579|Bent bone dysplasia syndrome,614592];	255317 [benign DISEASE=craniosynostosis,crouzon_syndrome,acrocephalosyndactyly_type_i,saethre-chotzen_syndrome,levy-hollister_syndrome,jackson-weiss_syndrome,cutis_gyrata_syndrome_of_beare_and_stevenson,pfeiffer_syndrome,isolated_coronal_synostosis,not_specified]; 		COSN163794	n/a (AF>5%)	n/a (AF>5%)					FGFR2 (inh=AR+AD pLI=1.00)
chr10	123970530	123970530	T	C	het	gene_blacklist	QUAL=341;DP=43;AF=0.37;MQM=60	TACC2	missense,5'UTR	TACC2:ENST00000334433:missense:MODERATE:exon8/22:c.6590T>C:p.Val2197Ala,TACC2:ENST00000369005:missense:MODERATE:exon9/23:c.6590T>C:p.Val2197Ala,TACC2:ENST00000513429:missense:MODERATE:exon6/20:c.1028T>C:p.Val343Ala,TACC2:ENST00000515273:missense:MODERATE:exon8/20:c.6602T>C:p.Val2201Ala,TACC2:ENST00000515603:missense:MODERATE:exon8/20:c.6455T>C:p.Val2152Ala,TACC2:ENST00000453444:missense:MODERATE:exon7/19:c.6602T>C:p.Val2201Ala,TACC2:ENST00000358010:missense:MODERATE:exon5/19:c.1028T>C:p.Val343Ala,TACC2:ENST00000360561:missense:MODERATE:exon3/16:c.824T>C:p.Val275Ala,TACC2:ENST00000368999:missense:MODERATE:exon3/18:c.824T>C:p.Val275Ala,TACC2:ENST00000369004:missense:MODERATE:exon3/17:c.824T>C:p.Val275Ala,TACC2:ENST00000260733:missense:MODERATE:exon3/17:c.824T>C:p.Val275Ala,TACC2:ENST00000369001:5'UTR:MODIFIER:exon5/17:c.-299T>C:,TACC2:ENST00000369000:5'UTR:MODIFIER:exon4/16:c.-299T>C:		rs2295873	0.3502	0.2029	3946,480,2120	0.6518,0.2391,0.3799,0.1197,0.1965	0.2777	0.5720	T,T,T,T,T,T,T,T,T,T,T,T,T,D	T	B,B,B,B,B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T,T,T	0.01				COSM3997779, COSM3997780	n/a (AF>5%)	n/a (AF>5%)					TACC2 (inh=n/a pLI=0.00)
chr10	123970569	123970569	C	T	het	gene_blacklist	QUAL=535;DP=58;AF=0.40;MQM=60	TACC2	missense,5'UTR	TACC2:ENST00000334433:missense:MODERATE:exon8/22:c.6629C>T:p.Ala2210Val,TACC2:ENST00000369005:missense:MODERATE:exon9/23:c.6629C>T:p.Ala2210Val,TACC2:ENST00000513429:missense:MODERATE:exon6/20:c.1067C>T:p.Ala356Val,TACC2:ENST00000515273:missense:MODERATE:exon8/20:c.6641C>T:p.Ala2214Val,TACC2:ENST00000515603:missense:MODERATE:exon8/20:c.6494C>T:p.Ala2165Val,TACC2:ENST00000453444:missense:MODERATE:exon7/19:c.6641C>T:p.Ala2214Val,TACC2:ENST00000358010:missense:MODERATE:exon5/19:c.1067C>T:p.Ala356Val,TACC2:ENST00000360561:missense:MODERATE:exon3/16:c.863C>T:p.Ala288Val,TACC2:ENST00000368999:missense:MODERATE:exon3/18:c.863C>T:p.Ala288Val,TACC2:ENST00000369004:missense:MODERATE:exon3/17:c.863C>T:p.Ala288Val,TACC2:ENST00000260733:missense:MODERATE:exon3/17:c.863C>T:p.Ala288Val,TACC2:ENST00000369001:5'UTR:MODIFIER:exon5/17:c.-260C>T:,TACC2:ENST00000369000:5'UTR:MODIFIER:exon4/16:c.-260C>T:		rs2295874	0.1036	0.1156	889,376,27	0.0685,0.1480,0.1261,0.1072,0.1636	0.1157	1.7920	T,T,T,T,T,T,T,T,T,T,T,T,T,D	T	B,B,B,B,B,B,B,B,B	T,T,T,T,T,T,T,T,T,T,T,T,T	3.72				COSM3930941, COSM3930940	n/a (AF>5%)	n/a (AF>5%)					TACC2 (inh=n/a pLI=0.00)
chr10	123970722	123970722	T	A	het	gene_blacklist	QUAL=1153;DP=93;AF=0.48;MQM=60	TACC2	missense,5'UTR	TACC2:ENST00000334433:missense:MODERATE:exon8/22:c.6782T>A:p.Leu2261His,TACC2:ENST00000369005:missense:MODERATE:exon9/23:c.6782T>A:p.Leu2261His,TACC2:ENST00000513429:missense:MODERATE:exon6/20:c.1220T>A:p.Leu407His,TACC2:ENST00000515273:missense:MODERATE:exon8/20:c.6794T>A:p.Leu2265His,TACC2:ENST00000515603:missense:MODERATE:exon8/20:c.6647T>A:p.Leu2216His,TACC2:ENST00000453444:missense:MODERATE:exon7/19:c.6794T>A:p.Leu2265His,TACC2:ENST00000358010:missense:MODERATE:exon5/19:c.1220T>A:p.Leu407His,TACC2:ENST00000360561:missense:MODERATE:exon3/16:c.1016T>A:p.Leu339His,TACC2:ENST00000368999:missense:MODERATE:exon3/18:c.1016T>A:p.Leu339His,TACC2:ENST00000369004:missense:MODERATE:exon3/17:c.1016T>A:p.Leu339His,TACC2:ENST00000260733:missense:MODERATE:exon3/17:c.1016T>A:p.Leu339His,TACC2:ENST00000369001:5'UTR:MODIFIER:exon5/17:c.-107T>A:,TACC2:ENST00000369000:5'UTR:MODIFIER:exon4/16:c.-107T>A:		rs2295876	0.0891	0.1197	989,469,7	0.0252,0.1507,0.1252,0.1191,0.1583	0.1206	3.0880	D,T,D,D,D,T,D,D,T,T,T,T,T	T	D,D,P,D,D,P,P,P,D	T,T,T,T,T,T,T,T,T,T,T,T	22.70					n/a (AF>5%)	n/a (AF>5%)					TACC2 (inh=n/a pLI=0.00)
chr10	125673547	125673547	T	G	hom		QUAL=5214;DP=160;AF=0.99;MQM=60	RP11-285A18.2,CPXM2			MLT1O	rs4329614	0.5000	0.6033	12195,7861,907	0.6038,0.5075,0.3328,0.6643,0.5369	0.6092											n/a (AF>5%)	n/a (AF>5%)					RP11-285A18.2 (inh=n/a pLI=n/a), CPXM2 (inh=n/a pLI=0.00)
chr10	126093991	126093991	T	C	hom		QUAL=2424;DP=75;AF=1.00;MQM=60	OAT	splice_region&intron	OAT:ENST00000368845:splice_region&intron:LOW:exon5/9:c.648+14A>G:,OAT:ENST00000539214:splice_region&intron:LOW:exon4/8:c.234+14A>G:		rs9422807	0.8658	0.8526	44281,22831,3185	0.7820,0.8686,0.9545,0.8274,0.9314	0.8527							613349 [OAT (confirmed) Gyrate atrophy of choroid and retina with or without ornithinemia,258870];	167396 [benign DISEASE=ornithine_aminotransferase_deficiency,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					OAT (inh=AR pLI=0.00)
chr10	127483573	127483573	G	A	het	off-target	QUAL=1781;DP=122;AF=0.55;MQM=60	UROS	intron	UROS:ENST00000368786:intron:MODIFIER:exon7/8:c.562-26C>T:,UROS:ENST00000368797:intron:MODIFIER:exon8/9:c.562-26C>T:		rs3740179	0.4012	0.4110	10657,6809,975	0.4342,0.2251,0.2763,0.4522,0.4227	0.4365							606938 [UROS (provisional) Porphyria,congenital erythropoietic,263700];			COSN163808	n/a (AF>5%)	n/a (AF>5%)					UROS (inh=AR pLI=0.05)
chr10	127708428	127708428	A	T	hom	off-target	QUAL=565;DP=18;AF=1.00;MQM=60	ADAM12	intron	ADAM12:ENST00000368679:intron:MODIFIER:exon21/22:c.2539-34T>A:		rs2138280	0.5435	0.6490	16227,9939,500	0.4146,0.5410,0.6710,0.6877,0.6481	0.6282											n/a (AF>5%)	n/a (AF>5%)					ADAM12 (inh=n/a pLI=0.16)
chr10	129899578	129899578	T	C	het	gene_blacklist	QUAL=1599;DP=121;AF=0.50;MQM=60	MKI67	missense	MKI67:ENST00000368654:missense:MODERATE:exon14/15:c.9649A>G:p.Lys3217Glu,MKI67:ENST00000368653:missense:MODERATE:exon13/14:c.8569A>G:p.Lys2857Glu		rs8473	0.4637	0.5016	15573,9310,1104	0.4600,0.5980,0.4069,0.5271,0.4154	0.5073	-0.5180	T,T,T	T	B,B	T,T	0.01				COSM1128106	n/a (AF>5%)	n/a (AF>5%)					MKI67 (inh=n/a pLI=0.00)
chr10	134915832	134915832	C	T	het		QUAL=2179;DP=176;AF=0.47;MQM=60	GPR123	5'UTR,intron	GPR123:ENST00000392606:5'UTR:MODIFIER:exon1/4:c.-47C>T:,GPR123:ENST00000607359:intron:MODIFIER:exon13/15:c.2416-369C>T:,GPR123:ENST00000392607:intron:MODIFIER:exon4/6:c.256-369C>T:		rs9419103	0.1254	0.2188	710,398,24	0.1709,0.1470,0.0759,0.2461,0.1950	0.1568	-0.4070	T	T			10.94					n/a (AF>5%)	n/a (AF>5%)					ADGRA1 (inh=n/a pLI=0.44)
chr10	135184126	135184126	G	A	hom		QUAL=2130;DP=68;AF=1.00;MQM=60	ECHS1	missense	ECHS1:ENST00000368547:missense:MODERATE:exon2/8:c.224C>T:p.Thr75Ile		rs1049951	0.8213	0.9131	50266,29095,1327	0.5234,0.9548,0.9745,0.9456,0.9354	0.9199	1.0070	T	T	B	T	8.43	602292 [ECHS1 (provisional) Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency,616277];	379965 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ECHS1 (inh=AR pLI=0.81)
chr10	135197419	135197419	G	A	hom	off-target	QUAL=4926;DP=148;AF=1.00;MQM=60	PAOX	intron	PAOX:ENST00000278060:intron:MODIFIER:exon3/6:c.869-45G>A:,PAOX:ENST00000368539:intron:MODIFIER:exon2/5:c.*172-45G>A:,PAOX:ENST00000357296:intron:MODIFIER:exon3/5:c.869-45G>A:,PAOX:ENST00000480071:intron:MODIFIER:exon3/4:c.868+2256G>A:		rs4240520	0.8173	0.8589	42544,24183,1797	0.5940,0.9285,0.9719,0.8634,0.8984	0.8645											n/a (AF>5%)	n/a (AF>5%)					PAOX (inh=n/a pLI=0.00)
chr10	135347397	135347397	T	C	hom		QUAL=10694;DP=327;AF=1.00;MQM=60	CYP2E1,SPRN	synonymous,intron	CYP2E1:ENST00000252945:synonymous:LOW:exon6/9:c.963T>C:p.Ile321Ile,CYP2E1:ENST00000463117:synonymous:LOW:exon8/11:c.963T>C:p.Ile321Ile,SPRN:ENST00000541506:intron:MODIFIER:exon1/1:c.-17+35379A>G:		rs915909	0.9728	0.9912	59642,33331,4236	0.9028,0.9959,1.0000,0.9999,0.9999	0.9932								402581 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CYP2E1 (inh=n/a pLI=0.19), SPRN (inh=n/a pLI=0.39)
chr11	279798	279798	G	A	het	off-target	QUAL=997;DP=110;AF=0.40;MQM=60	NLRP6	intron	NLRP6:ENST00000312165:intron:MODIFIER:exon2/7:c.311-36G>A:,NLRP6:ENST00000534750:intron:MODIFIER:exon2/7:c.311-36G>A:		rs4758626	0.2536	0.3330	4103,2777,164	0.2728,0.3364,0.0593,0.3758,0.3081	0.3462											n/a (AF>5%)	n/a (AF>5%)					NLRP6 (inh=n/a pLI=n/a)
chr11	396915	396915	C	T	hom		QUAL=3019;DP=94;AF=1.00;MQM=60	PKP3	synonymous	PKP3:ENST00000331563:synonymous:LOW:exon3/13:c.414C>T:p.Asn138Asn		rs12419281	0.4469	0.5476	12680,7505,368	0.3732,0.4962,0.4580,0.5767,0.6025	0.5262										COSM3752360	n/a (AF>5%)	n/a (AF>5%)					PKP3 (inh=n/a pLI=0.12)
chr11	1019375	1019375	C	T	hom	gene_blacklist	QUAL=13087;DP=402;AF=1.00;MQM=60	MUC6	synonymous	MUC6:ENST00000421673:synonymous:LOW:exon30/33:c.3930G>A:p.Ala1310Ala		rs9704308	0.9233	0.9156	50621,28549,4620	0.9682,0.8491,0.8680,0.9268,0.9112	0.9312										COSM4145181, COSM4145182	n/a (AF>5%)	n/a (AF>5%)					MUC6 (inh=n/a pLI=0.00)
chr11	2187855	2187855	G	C	het		QUAL=909;DP=115;AF=0.36;MQM=60	TH	splice_region&intron,intron	TH:ENST00000381178:splice_region&intron:LOW:exon9/13:c.1070+8C>G:,TH:ENST00000381175:splice_region&intron:LOW:exon9/13:c.1058+8C>G:,TH:ENST00000352909:splice_region&intron:LOW:exon8/12:c.977+8C>G:,TH:ENST00000333684:intron:MODIFIER:exon6/10:c.708-76C>G:		rs12419447	0.1799	0.3690	2558,2162,34	0.2104,0.3679,0.0724,0.4754,0.1948	0.2785							191290 [TH (confirmed) Segawa syndrome,recessive,605407];	263250 [benign DISEASE=segawa_syndrome,_autosomal_recessive,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR pLI=0.26)
chr11	4388905	4388905	C	T	het		QUAL=2199;DP=159;AF=0.52;MQM=60	OR52B4	synonymous	OR52B4:ENST00000408920:synonymous:LOW:exon1/1:c.621G>A:p.Ser207Ser		rs11031960	0.2452	0.2936	5465,3926,330	0.2604,0.2516,0.1722,0.3420,0.2084	0.2969											n/a (AF>5%)	n/a (AF>5%)					OR52B4 (inh=n/a pLI=0.00)
chr11	5020416	5020416	A	G	hom	gene_blacklist	QUAL=8080;DP=245;AF=0.99;MQM=60	OR51L1	synonymous	OR51L1:ENST00000321543:synonymous:LOW:exon1/1:c.204A>G:p.Leu68Leu		rs2445290	0.8263	0.8348	42457,24518,3811	0.8555,0.7809,0.6893,0.8571,0.8593	0.8333										COSM3998439	n/a (AF>5%)	n/a (AF>5%)					OR51L1 (inh=n/a pLI=0.01)
chr11	5080234	5080234	T	C	het		QUAL=1259;DP=86;AF=0.56;MQM=60	OR52E2	synonymous	OR52E2:ENST00000321522:synonymous:LOW:exon1/1:c.624A>G:p.Leu208Leu		rs2445333	0.3045	0.2838	5261,2778,730	0.3713,0.1280,0.1683,0.2880,0.3869	0.2997										COSM3998444	n/a (AF>5%)	n/a (AF>5%)					OR52E2 (inh=n/a pLI=0.00)
chr11	5344681	5344681	G	A	het		QUAL=1248;DP=137;AF=0.39;MQM=60	OR51B2,HBG2,HBE1,AC104389.28	missense,intron	OR51B2:ENST00000328813:missense:MODERATE:exon1/1:c.847C>T:p.Pro283Ser,HBG2:ENST00000380252:intron:MODIFIER:exon1/2:c.63-68937C>T:,HBG2:ENST00000380259:intron:MODIFIER:exon5/7:c.-438+22322C>T:,HBE1:ENST00000380237:intron:MODIFIER:exon1/4:c.-309-41500C>T:		rs11036815	0.2648	0.2722	4620,2723,445	0.2928,0.2659,0.2137,0.2842,0.2477	0.2736	2.4600	D	T	D	T	27.60	142250 [HBG2 (confirmed) Fetal hemoglobin quantitative trait locus 1,141749|Cyanosis,transient neonatal,613977];			COSM3752427	n/a (AF>5%)	n/a (AF>5%)					OR51B2 (inh=n/a pLI=0.05), HBG2 (inh=AD pLI=0.23), HBE1 (inh=n/a pLI=0.01), AC104389.28 (inh=n/a pLI=n/a)
chr11	5776595	5776595	T	G	het		QUAL=5192;DP=340;AF=0.56;MQM=60	OR52N4,TRIM5	missense,intron	OR52N4:ENST00000317254:missense:MODERATE:exon1/1:c.625T>G:p.Trp209Gly,TRIM5:ENST00000380027:intron:MODIFIER:exon3/10:c.-440-69971A>C:		rs12363178	0.1825	0.1807	2093,952,144	0.1591,0.1885,0.2397,0.1672,0.2268	0.1822	0.3580	T	T	B	T	8.88					n/a (AF>5%)	n/a (AF>5%)					OR52N4 (inh=n/a pLI=0.00), TRIM5 (inh=n/a pLI=0.00)
chr11	5776623	5776623	A	T	hom		QUAL=9725;DP=295;AF=1.00;MQM=60	OR52N4,TRIM5	missense,intron	OR52N4:ENST00000317254:missense:MODERATE:exon1/1:c.653A>T:p.Asn218Ile,TRIM5:ENST00000380027:intron:MODIFIER:exon3/10:c.-440-69999T>A:		rs7396938	0.8958	0.9371	53214,31082,3207	0.8044,0.8697,0.8938,0.9650,0.9728	0.9361	2.6240	T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					OR52N4 (inh=n/a pLI=0.00), TRIM5 (inh=n/a pLI=0.00)
chr11	5841856	5841856	C	T	het		QUAL=3831;DP=279;AF=0.51;MQM=60	OR52N2,TRIM5	synonymous,intron	OR52N2:ENST00000317037:synonymous:LOW:exon1/1:c.291C>T:p.Asn97Asn,TRIM5:ENST00000380027:intron:MODIFIER:exon3/10:c.-441+35126G>A:		rs4758435	0.7386	0.7717	36384,21873,2808	0.7329,0.6770,0.6414,0.8094,0.7609	0.7772											n/a (AF>5%)	n/a (AF>5%)					OR52N2 (inh=n/a pLI=0.00), TRIM5 (inh=n/a pLI=0.00)
chr11	5877979	5877979	T	A	het		QUAL=1707;DP=130;AF=0.51;MQM=60	OR52E8,TRIM5	stop_lost,intron	OR52E8:ENST00000537935:stop_lost:HIGH:exon1/1:c.954A>T:p.Ter318Tyrext*?,TRIM5:ENST00000380027:intron:MODIFIER:exon2/10:c.-543-895A>T:		rs12419602	0.3748	0.4060	9483,5900,963	0.3836,0.3651,0.3706,0.4292,0.3552	0.4160	-0.1340					13.85				COSM3998493	n/a (AF>5%)	n/a (AF>5%)					OR52E8 (inh=n/a pLI=0.08), TRIM5 (inh=n/a pLI=0.00)
chr11	5906048	5906048	G	A	hom		QUAL=6696;DP=202;AF=1.00;MQM=60	OR52E4,TRIM5	missense	OR52E4:ENST00000316987:missense:MODERATE:exon1/1:c.526G>A:p.Val176Ile		rs4758168	0.7796	0.7819	37252,21002,3398	0.8083,0.7457,0.8201,0.7930,0.7028	0.8107	0.1410	T	T	B	T	6.35					n/a (AF>5%)	n/a (AF>5%)					OR52E4 (inh=n/a pLI=0.00), TRIM5 (inh=n/a pLI=0.00)
chr11	6007272	6007272	A	G	hom		QUAL=7161;DP=216;AF=1.00;MQM=60	OR52L1	missense	OR52L1:ENST00000332249:missense:MODERATE:exon1/1:c.889T>C:p.Trp297Arg		rs4237768	0.8291	0.8378	42104,23043,2954	0.7823,0.9154,0.8710,0.8344,0.8206	0.8355	-2.4510	D	T	B	T	13.05					n/a (AF>5%)	n/a (AF>5%)					OR52L1 (inh=n/a pLI=0.01)
chr11	6532519	6532519	C	T	het		QUAL=1316;DP=87;AF=0.56;MQM=60	DNHD1	missense	DNHD1:ENST00000254579:missense:MODERATE:exon7/43:c.1252C>T:p.His418Tyr,DNHD1:ENST00000354685:missense:MODERATE:exon6/8:c.1252C>T:p.His418Tyr,DNHD1:ENST00000527990:missense:MODERATE:exon5/41:c.1252C>T:p.His418Tyr		rs4758423	0.2204	0.2929	5641,3744,145	0.1650,0.3969,0.1350,0.3340,0.2191	0.2947	0.1360	T,T,T	T	B,B	T,T,T	13.67				COSM1179744, COSM1179745	n/a (AF>5%)	n/a (AF>5%)					DNHD1 (inh=n/a pLI=0.00)
chr11	6648424	6648424	G	A	het		QUAL=1523;DP=129;AF=0.47;MQM=60	DCHS1	missense	DCHS1:ENST00000299441:missense:MODERATE:exon14/21:c.5846C>T:p.Thr1949Met		rs4758443	0.2975	0.3559	7847,4875,139	0.1572,0.3449,0.4491,0.3875,0.2974	0.3558	0.9350	T	T	B	T	0.02	603057 [DCHS1 (provisional) Van Maldergem syndrome 1,601390|Mitral valve prolapse 2,607829];	259140 [benign DISEASE=not_specified]; 		COSM1356235	n/a (AF>5%)	n/a (AF>5%)					DCHS1 (inh=AR+AD pLI=1.00)
chr11	7618953	7618953	G	A	het	off-target	QUAL=457;DP=37;AF=0.51;MQM=60	PPFIBP2	intron	PPFIBP2:ENST00000299492:intron:MODIFIER:exon5/23:c.486+49G>A:,PPFIBP2:ENST00000533792:intron:MODIFIER:exon3/21:c.12+49G>A:,PPFIBP2:ENST00000528883:intron:MODIFIER:exon2/20:c.150+49G>A:		rs4758203	0.3490	0.3024	4153,1273,219	0.2494,0.3009,0.5591,0.2419,0.4303	0.2993											n/a (AF>5%)	n/a (AF>5%)					PPFIBP2 (inh=n/a pLI=0.00)
chr11	7619518	7619518	T	C	hom		QUAL=1846;DP=60;AF=1.00;MQM=60	PPFIBP2	intron	PPFIBP2:ENST00000299492:intron:MODIFIER:exon5/23:c.486+614T>C:,PPFIBP2:ENST00000533792:intron:MODIFIER:exon3/21:c.12+614T>C:,PPFIBP2:ENST00000528883:intron:MODIFIER:exon2/20:c.150+614T>C:		rs4758206	0.8546	0.9243	4217,973,42	0.0000,0.0000,0.0000,0.8827,0.9439	0.9174	-0.2190		T			1.49					n/a (AF>5%)	n/a (AF>5%)					PPFIBP2 (inh=n/a pLI=0.00)
chr11	7670353	7670353	A	C	het	off-target	QUAL=2527;DP=168;AF=0.57;MQM=60	PPFIBP2	intron	PPFIBP2:ENST00000299492:intron:MODIFIER:exon19/23:c.1910-25A>C:,PPFIBP2:ENST00000533792:intron:MODIFIER:exon17/21:c.1436-25A>C:,PPFIBP2:ENST00000528883:intron:MODIFIER:exon16/20:c.1574-25A>C:,PPFIBP2:ENST00000530181:intron:MODIFIER:exon15/19:c.1481-25A>C:		rs4758009	0.4792	0.5638	19537,11720,378	0.2722,0.5357,0.5824,0.5991,0.5637	0.5678											n/a (AF>5%)	n/a (AF>5%)					PPFIBP2 (inh=n/a pLI=0.00)
chr11	7670440	7670440	A	G	hom		QUAL=10122;DP=309;AF=1.00;MQM=60	PPFIBP2	missense	PPFIBP2:ENST00000299492:missense:MODERATE:exon20/24:c.1972A>G:p.Arg658Gly,PPFIBP2:ENST00000533792:missense:MODERATE:exon18/22:c.1498A>G:p.Arg500Gly,PPFIBP2:ENST00000528883:missense:MODERATE:exon17/21:c.1636A>G:p.Arg546Gly,PPFIBP2:ENST00000530181:missense:MODERATE:exon16/20:c.1543A>G:p.Arg515Gly		rs4758209	0.9994	0.9997	60668,33368,5167	0.9966,1.0000,1.0000,1.0000,1.0000	0.9998	7.9810	T,T,T,T,T	T	B,B,B,B,B	T,T,T,T	16.21					n/a (AF>5%)	n/a (AF>5%)					PPFIBP2 (inh=n/a pLI=0.00)
chr11	7673015	7673015	G	A	het		QUAL=159;DP=33;AF=0.33;MQM=60	PPFIBP2	synonymous	PPFIBP2:ENST00000299492:synonymous:LOW:exon23/24:c.2376G>A:p.Glu792Glu,PPFIBP2:ENST00000533792:synonymous:LOW:exon21/22:c.1902G>A:p.Glu634Glu,PPFIBP2:ENST00000528883:synonymous:LOW:exon20/21:c.2040G>A:p.Glu680Glu,PPFIBP2:ENST00000530181:synonymous:LOW:exon19/20:c.1947G>A:p.Glu649Glu		rs5864	0.6605	0.6609	26596,14668,2785	0.7303,0.5927,0.5785,0.6652,0.6871	0.6852	2.0580	T	T			11.95				COSM4146340	n/a (AF>5%)	n/a (AF>5%)					PPFIBP2 (inh=n/a pLI=0.00)
chr11	7871011	7871011	A	G	hom		QUAL=5275;DP=160;AF=1.00;MQM=60	RP11-35J10.5,RP11-494M8.4,OR5E1P	non_coding_transcript_exon	OR5E1P:ENST00000305754:non_coding_transcript_exon:MODIFIER:exon1/1:n.765A>G:,OR5E1P:ENST00000539139:non_coding_transcript_exon:MODIFIER:exon1/1:n.414A>G:		rs4758022	0.7256	0.8963	6633,2352,145	0.5550,0.8876,0.6351,0.9405,0.8942	0.8941											n/a (AF>5%)	n/a (AF>5%)					RP11-35J10.5 (inh=n/a pLI=n/a), RP11-494M8.4 (inh=n/a pLI=n/a), OR5E1P (inh=n/a pLI=n/a)
chr11	7949350	7949350	A	G	hom	gene_blacklist	QUAL=7027;DP=211;AF=1.00;MQM=60	OR10A6	missense	OR10A6:ENST00000309838:missense:MODERATE:exon1/1:c.860T>C:p.Leu287Pro		rs4758258	0.7877	0.7920	38105,20458,2890	0.7457,0.8494,0.7989,0.7835,0.7981	0.7961	7.0450	T	T	B	T	5.00					n/a (AF>5%)	n/a (AF>5%)					OR10A6 (inh=n/a pLI=0.00)
chr11	7961130	7961130	C	T	het	off-target;gene_blacklist	QUAL=1308;DP=89;AF=0.56;MQM=60	OR10A3	5'UTR	OR10A3:ENST00000360759:5'UTR:MODIFIER:exon1/1:c.-63G>A:		rs4758259	0.3205	0.0000	0,0,0	0,0,0,0,0	0.3266											n/a (AF>5%)	n/a (AF>5%)					OR10A3 (inh=n/a pLI=0.00)
chr11	8014479	8014479	C	T	hom		QUAL=431;DP=14;AF=1.00;MQM=54	EIF3F	synonymous	EIF3F:ENST00000537635:synonymous:LOW:exon4/8:c.606C>T:p.His202His,EIF3F:ENST00000533626:synonymous:LOW:exon6/10:c.561C>T:p.His187His,EIF3F:ENST00000309828:synonymous:LOW:exon4/8:c.561C>T:p.His187His,EIF3F:ENST00000449102:synonymous:LOW:exon3/7:c.114C>T:p.His38His		rs4758267	0.6883	0.7147	31431,17527,1347	0.5084,0.8045,0.8357,0.7241,0.6927	0.7206										COSM4146367, COSM4146366	n/a (AF>5%)	n/a (AF>5%)					EIF3F (inh=n/a pLI=0.59)
chr11	8118185	8118185	C	G	hom	off-target	QUAL=8266;DP=254;AF=1.00;MQM=60	TUB	intron	TUB:ENST00000305253:intron:MODIFIER:exon6/12:c.731-47C>G:,TUB:ENST00000534099:intron:MODIFIER:exon5/11:c.584-47C>G:,TUB:ENST00000299506:intron:MODIFIER:exon5/11:c.566-47C>G:		rs10160258	0.9573	0.9836	58702,33235,4183	0.8969,0.9391,1.0000,0.9987,0.9931	0.9831							601197 [TUB (provisional) Retinal dystrophy and obesity,616188];				n/a (AF>5%)	n/a (AF>5%)					TUB (inh=AR pLI=0.71)
chr11	9096189	9096189	G	C	hom	off-target	QUAL=3940;DP=122;AF=0.99;MQM=60	SCUBE2	intron	SCUBE2:ENST00000457346:intron:MODIFIER:exon3/22:c.383-27C>G:,SCUBE2:ENST00000309263:intron:MODIFIER:exon3/21:c.383-27C>G:,SCUBE2:ENST00000450649:intron:MODIFIER:exon3/17:c.383-27C>G:,SCUBE2:ENST00000520467:intron:MODIFIER:exon3/21:c.383-27C>G:		rs7930311	0.3628	0.5245	18132,13403,181	0.1803,0.4387,0.3184,0.6341,0.4210	0.5311											n/a (AF>5%)	n/a (AF>5%)					SCUBE2 (inh=n/a pLI=0.00)
chr11	9116836	9116836	G	A	hom		QUAL=3673;DP=111;AF=1.00;MQM=60	SCUBE2,KRT8P41	non_coding_transcript_exon	KRT8P41:ENST00000440275:non_coding_transcript_exon:MODIFIER:exon1/1:n.927G>A:,KRT8P41:ENST00000533985:non_coding_transcript_exon:MODIFIER:exon1/1:n.913G>A:		rs7949022	0.1719	0.0000	0,0,0	0,0,0,0,0	0.2184											n/a (AF>5%)	n/a (AF>5%)					SCUBE2 (inh=n/a pLI=0.00), KRT8P41 (inh=n/a pLI=n/a)
chr11	9199650	9199650	C	T	het	off-target	QUAL=1833;DP=114;AF=0.59;MQM=60	DENND5A	intron	DENND5A:ENST00000328194:intron:MODIFIER:exon8/22:c.1906+29G>A:,DENND5A:ENST00000530044:intron:MODIFIER:exon8/22:c.1906+29G>A:		rs60693427	0.2522	0.2675	5048,3078,1064	0.4519,0.1627,0.0056,0.3023,0.2105	0.3211							617278 [DENND5A (provisional) Epileptic encephalopathy,early infantile,49,617281];				n/a (AF>5%)	n/a (AF>5%)					DENND5A (inh=n/a pLI=0.97)
chr11	9537904	9537904	G	C	hom		QUAL=4176;DP=127;AF=1.00;MQM=60	ZNF143	missense	ZNF143:ENST00000396602:missense:MODERATE:exon14/16:c.1681G>C:p.Glu561Gln,ZNF143:ENST00000396604:missense:MODERATE:exon14/16:c.1678G>C:p.Glu560Gln,ZNF143:ENST00000530463:missense:MODERATE:exon14/16:c.1678G>C:p.Glu560Gln,ZNF143:ENST00000396597:missense:MODERATE:exon13/15:c.1588G>C:p.Glu530Gln,ZNF143:ENST00000299606:missense:MODERATE:exon13/15:c.1597G>C:p.Glu533Gln		rs10743108	0.9012	0.9261	50701,30899,4796	0.9799,0.7632,0.7481,0.9752,0.8844	0.9578	3.7910	T,T,T,T,T,T	T,T	B,B,B,.	T,T,T,T,T,T	13.99			CM152559 [CLASS=DP MUT=ALT PHEN="Psoriasis association with" GENE=ZNF143]; 		n/a (AF>5%)	n/a (AF>5%)					ZNF143 (inh=n/a pLI=0.01)
chr11	9734945	9734945	A	G	het	off-target	QUAL=159;DP=31;AF=0.32;MQM=60	SWAP70	intron	SWAP70:ENST00000318950:intron:MODIFIER:exon2/11:c.241-68A>G:,SWAP70:ENST00000447399:intron:MODIFIER:exon2/10:c.241-11260A>G:		rs1390679	0.2538	0.0000	0,0,0	0,0,0,0,0	0.3405											n/a (AF>5%)	n/a (AF>5%)					SWAP70 (inh=n/a pLI=0.89)
chr11	9748483	9748483	T	C	het		QUAL=1884;DP=139;AF=0.51;MQM=60	SWAP70	intron	SWAP70:ENST00000318950:intron:MODIFIER:exon4/11:c.643-1117T>C:,SWAP70:ENST00000447399:intron:MODIFIER:exon3/10:c.469-1117T>C:	L2d2	rs2453831	0.2955	0.2902	471,148,16	0.0000,0.0000,0.0000,0.3391,0.2712	0.3675											n/a (AF>5%)	n/a (AF>5%)					SWAP70 (inh=n/a pLI=0.89)
chr11	10555589	10555589	A	G	het		QUAL=1425;DP=103;AF=0.52;MQM=60	RNF141	synonymous	RNF141:ENST00000265981:synonymous:LOW:exon2/6:c.117T>C:p.Leu39Leu,RNF141:ENST00000528665:synonymous:LOW:exon2/5:c.117T>C:p.Leu39Leu		rs1065052	0.3566	0.4050	11163,5812,50	0.0788,0.5512,0.6734,0.4144,0.3336	0.4147										COSM3752106	n/a (AF>5%)	n/a (AF>5%)					RNF141 (inh=n/a pLI=0.00)
chr11	10821055	10821055	C	T	het	off-target	QUAL=1342;DP=125;AF=0.42;MQM=60	RP11-685M7.5,EIF4G2	intron	EIF4G2:ENST00000339995:intron:MODIFIER:exon19/21:c.2324+44G>A:,EIF4G2:ENST00000526148:intron:MODIFIER:exon19/21:c.2324+44G>A:,EIF4G2:ENST00000525681:intron:MODIFIER:exon18/20:c.2324+44G>A:,EIF4G2:ENST00000396525:intron:MODIFIER:exon18/20:c.2210+44G>A:		rs3736327	0.6366	0.6401	24889,12884,1859	0.5990,0.7433,0.5693,0.6232,0.7108	0.6429											n/a (AF>5%)	n/a (AF>5%)					RP11-685M7.5 (inh=n/a pLI=n/a), EIF4G2 (inh=n/a pLI=n/a)
chr11	14246296	14246296	G	A	hom		QUAL=5023;DP=152;AF=1.00;MQM=60	SPON1	intron	SPON1:ENST00000310358:intron:MODIFIER:exon7/16:n.1361-18582G>A:		rs1025412	0.5341	0.5271	14921,8202,957	0.5020,0.4038,0.6182,0.5263,0.5915	0.5170											n/a (AF>5%)	n/a (AF>5%)					SPON1 (inh=n/a pLI=n/a)
chr11	14810762	14810762	A	G	hom		QUAL=2206;DP=68;AF=1.00;MQM=60	PDE3B	synonymous	PDE3B:ENST00000282096:synonymous:LOW:exon4/16:c.1389A>G:p.Arg463Arg,PDE3B:ENST00000455098:synonymous:LOW:exon4/16:c.1236A>G:p.Arg412Arg		rs4757268	0.6713	0.6291	24112,12360,2459	0.6835,0.6307,0.6560,0.6077,0.6599	0.6320										COSM147149	n/a (AF>5%)	n/a (AF>5%)					PDE3B (inh=n/a pLI=0.16)
chr11	16877497	16877497	C	T	het	off-target	QUAL=928;DP=96;AF=0.41;MQM=60	PLEKHA7	intron	PLEKHA7:ENST00000531066:intron:MODIFIER:exon4/26:c.306-36G>A:,PLEKHA7:ENST00000355661:intron:MODIFIER:exon4/22:c.306-36G>A:,PLEKHA7:ENST00000448080:intron:MODIFIER:exon4/22:c.306-36G>A:,PLEKHA7:ENST00000532079:intron:MODIFIER:exon2/3:c.82-66081G>A:		rs11024058	0.1106	0.1717	2069,1744,27	0.0704,0.0821,0.0544,0.2314,0.1220	0.1692											n/a (AF>5%)	n/a (AF>5%)					PLEKHA7 (inh=n/a pLI=0.00)
chr11	17351683	17351683	C	G	het		QUAL=171;DP=11;AF=0.73;MQM=60	NUCB2	missense	NUCB2:ENST00000323688:missense:MODERATE:exon12/13:c.1012C>G:p.Gln338Glu,NUCB2:ENST00000529010:missense:MODERATE:exon12/14:c.1012C>G:p.Gln338Glu,NUCB2:ENST00000458064:missense:MODERATE:exon9/11:c.922C>G:p.Gln308Glu		rs757081	0.2378	0.3665	4317,2461,15	0.0742,0.4347,0.4014,0.3925,0.3707	0.3016	3.9920	T,T,T,.	T,.	B,B,.	T,T,T,.	17.24			CM1111626 [CLASS=DP MUT=ALT PHEN="Obesity male association with" GENE=NUCB2]; 	COSM3931289	n/a (AF>5%)	n/a (AF>5%)					NUCB2 (inh=n/a pLI=0.00)
chr11	17533635	17533635	G	A	het	off-target	QUAL=1159;DP=110;AF=0.43;MQM=60	USH1C	intron	USH1C:ENST00000005226:intron:MODIFIER:exon15/26:c.1261-34C>T:,USH1C:ENST00000318024:intron:MODIFIER:exon15/20:c.1284+5313C>T:,USH1C:ENST00000527720:intron:MODIFIER:exon14/19:c.1191+5313C>T:,USH1C:ENST00000527020:intron:MODIFIER:exon14/19:c.1227+5313C>T:		rs2190454	0.7268	0.7153	31267,15483,2488	0.6955,0.8250,0.7090,0.6809,0.7896	0.7173							605242 [USH1C (confirmed) Usher syndrome,type 1C,276904|Deafness,autosomal recessive 18A,602092];				n/a (AF>5%)	n/a (AF>5%)					USH1C (inh=AR pLI=0.00)
chr11	18555901	18555901	C	G	het		QUAL=1120;DP=71;AF=0.65;MQM=60	UEVLD	synonymous,intron	UEVLD:ENST00000396197:synonymous:LOW:exon11/12:c.1224G>C:p.Val408Val,UEVLD:ENST00000379387:synonymous:LOW:exon10/11:c.1158G>C:p.Val386Val,UEVLD:ENST00000543987:intron:MODIFIER:exon10/10:c.1125-1867G>C:,UEVLD:ENST00000535484:intron:MODIFIER:exon10/10:c.1011-1867G>C:,UEVLD:ENST00000320750:intron:MODIFIER:exon9/9:c.1059-1867G>C:,UEVLD:ENST00000541984:intron:MODIFIER:exon6/6:c.590-1867G>C:		rs56151250	0.2520	0.2174	3392,911,31	0.0717,0.2967,0.4180,0.1645,0.3184	0.1984											n/a (AF>5%)	n/a (AF>5%)					UEVLD (inh=n/a pLI=0.00)
chr11	31812215	31812215	A	C	het	off-target	QUAL=608;DP=59;AF=0.44;MQM=60	PAX6	intron	PAX6:ENST00000379107:intron:MODIFIER:exon12/12:c.1225+43T>G:,PAX6:ENST00000419022:intron:MODIFIER:exon13/13:c.1225+43T>G:,PAX6:ENST00000379132:intron:MODIFIER:exon11/11:c.1183+43T>G:,PAX6:ENST00000379129:intron:MODIFIER:exon12/12:c.1225+43T>G:,PAX6:ENST00000241001:intron:MODIFIER:exon12/12:c.1183+43T>G:,PAX6:ENST00000379115:intron:MODIFIER:exon13/13:c.1225+43T>G:,PAX6:ENST00000379111:intron:MODIFIER:exon11/11:c.1183+43T>G:,PAX6:ENST00000379123:intron:MODIFIER:exon12/12:c.1183+43T>G:		rs3026393	0.4543	0.4860	14664,8788,553	0.3217,0.3419,0.4478,0.5144,0.6012	0.4801							607108 [PAX6 (confirmed) Aniridia,106210|Cataract with late-onset corneal dystrophy,106210|Anterior segment dysgenesis 5,multiple subtypes,604229|Foveal hypoplasia 1,136520|Keratitis,148190|Optic nerve hypoplasia,165550|Morning glory disc anomaly,120430|Coloboma of optic nerve,120430|Coloboma,ocular,120200];				n/a (AF>5%)	n/a (AF>5%)					PAX6 (inh=AR+AD pLI=1.00)
chr11	34916710	34916710	A	G	hom	off-target	QUAL=1598;DP=49;AF=1.00;MQM=60	APIP	intron	APIP:ENST00000278359:intron:MODIFIER:exon2/8:c.109-53T>C:,APIP:ENST00000395787:intron:MODIFIER:exon1/6:c.58-53T>C:		rs1326941	0.5815	0.0000	0,0,0	0,0,0,0,0	0.6063											n/a (AF>5%)	n/a (AF>5%)					APIP (inh=n/a pLI=0.00)
chr11	36103228	36103228	A	G	het		QUAL=2051;DP=159;AF=0.50;MQM=60	LDLRAD3	synonymous	LDLRAD3:ENST00000315571:synonymous:LOW:exon3/6:c.219A>G:p.Pro73Pro,LDLRAD3:ENST00000524419:synonymous:LOW:exon2/6:c.72A>G:p.Pro24Pro,LDLRAD3:ENST00000528989:synonymous:LOW:exon2/5:c.72A>G:p.Pro24Pro		rs1138807	0.3411	0.3511	7810,3950,804	0.3937,0.4953,0.3606,0.3415,0.2468	0.3678										COSM3752351	n/a (AF>5%)	n/a (AF>5%)					LDLRAD3 (inh=n/a pLI=0.02)
chr11	43940644	43940644	G	T	het		QUAL=1695;DP=119;AF=0.53;MQM=60	ALKBH3,ALKBH3-AS1	synonymous,intron	ALKBH3:ENST00000302708:synonymous:LOW:exon9/10:c.726G>T:p.Gly242Gly,ALKBH3-AS1:ENST00000499194:intron:MODIFIER:exon3/5:n.209+492C>A:,ALKBH3-AS1:ENST00000528285:intron:MODIFIER:exon3/3:n.227+492C>A:,ALKBH3-AS1:ENST00000534287:intron:MODIFIER:exon3/3:n.373+492C>A:,ALKBH3-AS1:ENST00000527960:intron:MODIFIER:exon1/1:n.509+1292C>A:		rs1048928	0.6162	0.6514	26589,13181,626	0.3513,0.7471,0.8452,0.6290,0.7596	0.6594	0.1480		T			9.49					n/a (AF>5%)	n/a (AF>5%)					ALKBH3 (inh=n/a pLI=0.00), ALKBH3-AS1 (inh=n/a pLI=n/a)
chr11	55606302	55606302	G	T	het	gene_blacklist	QUAL=1065;DP=119;AF=0.39;MQM=60	OR5D16	synonymous	OR5D16:ENST00000378396:synonymous:LOW:exon1/1:c.75G>T:p.Leu25Leu		rs6591699	0.6731	0.6567	26416,12994,2023	0.6230,0.7406,0.7860,0.6233,0.6942	0.6613										COSM3752462	n/a (AF>5%)	n/a (AF>5%)					OR5D16 (inh=n/a pLI=0.00)
chr11	56113575	56113575	A	G	het	gene_blacklist	QUAL=1816;DP=150;AF=0.47;MQM=60	OR8K1	missense	OR8K1:ENST00000279783:missense:MODERATE:exon1/1:c.61A>G:p.Met21Val		rs10896271	0.4609	0.4371	12540,4794,320	0.2587,0.6578,0.6468,0.3768,0.5466	0.4460	-3.0880	T	T	B	T	0.17					n/a (AF>5%)	n/a (AF>5%)					OR8K1 (inh=n/a pLI=0.00)
chr11	57147016	57147016	A	G	hom		QUAL=4656;DP=141;AF=1.00;MQM=60	PRG3	missense	PRG3:ENST00000287143:missense:MODERATE:exon3/6:c.326T>C:p.Ile109Thr		rs540687	0.9585	0.9876	59196,33282,3906	0.8675,0.9951,0.9985,0.9998,0.9972	0.9902	-0.6230	T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					PRG3 (inh=n/a pLI=0.00)
chr11	58190136	58190136	A	G	het	gene_blacklist	QUAL=870;DP=66;AF=0.53;MQM=60	OR5B2	missense	OR5B2:ENST00000302581:missense:MODERATE:exon1/1:c.599T>C:p.Met200Thr		rs4298923	0.4914	0.4459	12471,6201,2298	0.6640,0.3700,0.3032,0.4323,0.4632	0.5026	0.5140	D	T	B	T	1.24				COSM3752519	n/a (AF>5%)	n/a (AF>5%)					OR5B2 (inh=n/a pLI=0.01)
chr11	58478039	58478039	T	C	het		QUAL=2338;DP=189;AF=0.48;MQM=60	GLYAT	3'UTR,intron	GLYAT:ENST00000278400:3'UTR:MODIFIER:exon5/5:c.*20A>G:,GLYAT:ENST00000344743:intron:MODIFIER:exon5/5:c.488+24A>G:,GLYAT:ENST00000529732:intron:MODIFIER:exon5/5:c.488+24A>G:		rs675757	0.6717	0.7456	34445,22916,2416	0.6796,0.6111,0.5068,0.8288,0.6930	0.7483											n/a (AF>5%)	n/a (AF>5%)					GLYAT (inh=n/a pLI=0.00)
chr11	62490219	62490219	G	A	het	off-target	QUAL=1246;DP=126;AF=0.40;MQM=60	HNRNPUL2-BSCL2,HNRNPUL2	intron	HNRNPUL2-BSCL2:ENST00000403734:intron:MODIFIER:exon5/23:c.983-34C>T:,HNRNPUL2:ENST00000301785:intron:MODIFIER:exon5/13:c.983-34C>T:		rs576251	0.2927	0.2395	3844,1941,1070	0.4681,0.1580,0.2304,0.2390,0.2053	0.2847											n/a (AF>5%)	n/a (AF>5%)					HNRNPUL2-BSCL2 (inh=n/a pLI=n/a), HNRNPUL2 (inh=n/a pLI=1.00)
chr11	62744899	62744899	A	G	hom	off-target	QUAL=2647;DP=80;AF=1.00;MQM=60	SLC22A6	intron	SLC22A6:ENST00000377871:intron:MODIFIER:exon8/9:c.1362-40T>C:,SLC22A6:ENST00000360421:intron:MODIFIER:exon8/9:c.1362-40T>C:,SLC22A6:ENST00000421062:intron:MODIFIER:exon8/9:c.1362-172T>C:,SLC22A6:ENST00000458333:intron:MODIFIER:exon8/9:c.1362-172T>C:		rs3017670	0.8456	0.8385	27059,15455,3077	0.9473,0.7251,0.8306,0.8498,0.7915	0.8786											n/a (AF>5%)	n/a (AF>5%)					SLC22A6 (inh=n/a pLI=0.00)
chr11	63994692	63994692	T	C	het		QUAL=2763;DP=91;AF=0.57;MQM=60	NUDT22	intron	NUDT22:ENST00000279206:intron:MODIFIER:exon2/5:c.480+88T>C:,NUDT22:ENST00000441250:intron:MODIFIER:exon2/4:c.480+88T>C:		rs1860368	0.6959	0.7571	4236,1367,167	0.6469,0.6517,0.7318,0.7232,0.7979	0.6854	0.2960					5.31					n/a (AF>5%)	n/a (AF>5%)					NUDT22 (inh=n/a pLI=0.00)
chr11	64023270	64023270	C	T	het		QUAL=2018;DP=152;AF=0.52;MQM=60	PLCB3	synonymous	PLCB3:ENST00000279230:synonymous:LOW:exon8/31:c.675C>T:p.Asp225Asp,PLCB3:ENST00000540288:synonymous:LOW:exon8/32:c.675C>T:p.Asp225Asp,PLCB3:ENST00000325234:synonymous:LOW:exon6/29:c.474C>T:p.Asp158Asp		rs12419663	0.0080	0.0157	32,28,0	0.0045,0.0106,0.0004,0.0232,0.0056	0.0160											1	125					PLCB3 (inh=n/a pLI=0.89)
chr11	64882789	64882789	C	T	het		QUAL=1430;DP=91;AF=0.58;MQM=60	TM7SF2	missense,intron	TM7SF2:ENST00000279263:missense:MODERATE:exon8/10:c.896C>T:p.Thr299Ile,TM7SF2:ENST00000540748:missense:MODERATE:exon7/9:c.548C>T:p.Thr183Ile,TM7SF2:ENST00000345348:intron:MODIFIER:exon7/8:c.893-159C>T:		rs1129195	0.3652	0.4179	10983,6558,599	0.3428,0.5558,0.2833,0.4420,0.3233	0.4264	2.5830	T,T,T,T,T,T,T	T	B,B	D,D,D,D,D,D,D	7.49				COSM4165893	n/a (AF>5%)	n/a (AF>5%)					TM7SF2 (inh=n/a pLI=0.18)
chr11	65868310	65868310	T	A	hom		QUAL=4530;DP=138;AF=1.00;MQM=60	PACS1	intron	PACS1:ENST00000320580:intron:MODIFIER:exon1/23:c.356+29997T>A:	MLT1G1	rs475817	0.9874	0.9994	5395,1373,97	0.9709,0.0000,0.0000,1.0000,1.0000	0.9971							607492 [PACS1 (provisional) Schuurs-Hoeijmakers syndrome,615009];				n/a (AF>5%)	n/a (AF>5%)					PACS1 (inh=AD pLI=1.00)
chr11	68331715	68331715	C	G	het	off-target	QUAL=163;DP=20;AF=0.45;MQM=60	PPP6R3	intron	PPP6R3:ENST00000393799:intron:MODIFIER:exon8/24:c.846-56C>G:,PPP6R3:ENST00000393800:intron:MODIFIER:exon8/23:c.846-56C>G:,PPP6R3:ENST00000534534:intron:MODIFIER:exon4/18:c.280-2767C>G:,PPP6R3:ENST00000524845:intron:MODIFIER:exon8/22:c.846-56C>G:,PPP6R3:ENST00000265637:intron:MODIFIER:exon7/21:c.846-56C>G:,PPP6R3:ENST00000524904:intron:MODIFIER:exon8/23:c.846-56C>G:,PPP6R3:ENST00000393801:intron:MODIFIER:exon8/24:c.846-56C>G:,PPP6R3:ENST00000265636:intron:MODIFIER:exon9/22:c.846-56C>G:,PPP6R3:ENST00000529710:intron:MODIFIER:exon9/22:c.846-56C>G:,PPP6R3:ENST00000527403:intron:MODIFIER:exon7/21:c.846-56C>G:		rs10501398	0.6058	0.0000	0,0,0	0,0,0,0,0	0.5949											n/a (AF>5%)	n/a (AF>5%)					PPP6R3 (inh=n/a pLI=1.00)
chr11	70200529	70200529	C	T	het		QUAL=568;DP=61;AF=0.41;MQM=60	PPFIA1,AP000487.6	synonymous	PPFIA1:ENST00000253925:synonymous:LOW:exon17/28:c.2286C>T:p.Val762Val,PPFIA1:ENST00000389547:synonymous:LOW:exon17/26:c.2286C>T:p.Val762Val		rs17853270	0.1308	0.1241	1079,454,190	0.1965,0.2290,0.0597,0.1156,0.0716	0.1393	2.0490		.,T			14.14				COSM3998561	n/a (AF>5%)	n/a (AF>5%)					PPFIA1 (inh=n/a pLI=1.00), AP000487.6 (inh=n/a pLI=n/a)
chr11	70200594	70200594	C	T	het	off-target	QUAL=85;DP=15;AF=0.40;MQM=60	PPFIA1,AP000487.6	intron	PPFIA1:ENST00000253925:intron:MODIFIER:exon17/27:c.2315+36C>T:,PPFIA1:ENST00000389547:intron:MODIFIER:exon17/25:c.2315+36C>T:		rs7943389	0.9369	0.8736	41851,20802,4337	0.9720,0.9358,0.9996,0.8328,0.8793	0.8893											n/a (AF>5%)	n/a (AF>5%)					PPFIA1 (inh=n/a pLI=1.00), AP000487.6 (inh=n/a pLI=n/a)
chr11	70794485	70794485	C	G	het	off-target	QUAL=2133;DP=149;AF=0.54;MQM=60	SHANK2	intron	SHANK2:ENST00000338508:intron:MODIFIER:exon7/32:c.918-23G>C:	L2a	rs67223333	0.2151	0.2207	409,136,30	0.2764,0.1931,0.0990,0.2401,0.2317	0.1968							603290 [SHANK2 (provisional) Autism susceptibility 17,613436];				n/a (AF>5%)	n/a (AF>5%)					SHANK2 (inh=AD pLI=1.00)
chr11	71169547	71169547	G	C	hom		QUAL=8490;DP=258;AF=1.00;MQM=60	NADSYN1	missense	NADSYN1:ENST00000319023:missense:MODERATE:exon3/21:c.220G>C:p.Val74Leu		rs2276360	0.4040	0.5599	21169,16550,902	0.4088,0.4785,0.3915,0.7026,0.2101	0.5913	0.2740	T	T	B	D	0.13				COSM3998565	n/a (AF>5%)	n/a (AF>5%)					NADSYN1 (inh=n/a pLI=0.00)
chr11	71290740	71290740	A	C	het	off-target	QUAL=37;DP=54;AF=0.19;MQM=39	KRTAP5,10,14P	intergenic_region	14P:ENSG00000204572-ENSG00000249387:intergenic_region:MODIFIER::n.71290740A>C:		rs4081429	0.6154	0.5959	19617,10452,1691	0.6240,0.7025,0.6328,0.5914,0.5355	0.6078											n/a (AF>5%)	n/a (AF>5%)					KRTAP5 (inh=n/a pLI=n/a), 10 (inh=n/a pLI=n/a), 14P (inh=n/a pLI=n/a)
chr11	72292860	72292860	C	T	het	off-target	QUAL=62;DP=10;AF=0.40;MQM=60	PDE2A	intron	PDE2A:ENST00000334456:intron:MODIFIER:exon22/30:c.1922+61G>A:,PDE2A:ENST00000376450:intron:MODIFIER:exon12/20:c.1154+61G>A:,PDE2A:ENST00000444035:intron:MODIFIER:exon22/30:c.1895+61G>A:,PDE2A:ENST00000544570:intron:MODIFIER:exon21/29:c.1901+61G>A:,PDE2A:ENST00000418754:intron:MODIFIER:exon18/26:c.1577+61G>A:,PDE2A:ENST00000540345:intron:MODIFIER:exon23/31:c.1895+61G>A:		rs376724	0.6741	0.0000	0,0,0	0,0,0,0,0	0.7441											n/a (AF>5%)	n/a (AF>5%)					PDE2A (inh=n/a pLI=0.99)
chr11	74208029	74208029	C	T	het		QUAL=1438;DP=113;AF=0.51;MQM=60	POLD3,AP001372.2			Tigger4	rs655025	0.5090	0.5495	1897,715,52	0.4393,0.0000,0.0000,0.6392,0.5137	0.5770											n/a (AF>5%)	n/a (AF>5%)					POLD3 (inh=n/a pLI=0.98), AP001372.2 (inh=n/a pLI=n/a)
chr11	74208592	74208592	G	T	het		QUAL=1117;DP=73;AF=0.56;MQM=60	POLD3,AP001372.2			Tigger4:Tigger4	rs657339	0.5084	0.5543	2762,1394,154	0.4168,0.5367,0.6341,0.6372,0.5127	0.5826										COSN163999	n/a (AF>5%)	n/a (AF>5%)					POLD3 (inh=n/a pLI=0.98), AP001372.2 (inh=n/a pLI=n/a)
chr11	74329615	74329615	T	C	het		QUAL=1321;DP=78;AF=0.62;MQM=60	POLD3	synonymous	POLD3:ENST00000263681:synonymous:LOW:exon6/12:c.426T>C:p.Pro142Pro,POLD3:ENST00000527458:synonymous:LOW:exon6/12:c.309T>C:p.Pro103Pro,POLD3:ENST00000532497:synonymous:LOW:exon5/11:c.108T>C:p.Pro36Pro		rs4944052	0.4491	0.3710	8927,3330,1644	0.5669,0.4298,0.3195,0.3145,0.5072	0.3766										COSM147289, COSM3752733	n/a (AF>5%)	n/a (AF>5%)					POLD3 (inh=n/a pLI=0.98)
chr11	75279846	75279846	C	T	het		QUAL=690;DP=66;AF=0.44;MQM=60	SERPINH1	synonymous	SERPINH1:ENST00000358171:synonymous:LOW:exon3/5:c.693C>T:p.Thr231Thr,SERPINH1:ENST00000533603:synonymous:LOW:exon4/6:c.693C>T:p.Thr231Thr,SERPINH1:ENST00000530284:synonymous:LOW:exon4/5:c.693C>T:p.Thr231Thr,SERPINH1:ENST00000524558:synonymous:LOW:exon3/5:c.693C>T:p.Thr231Thr,SERPINH1:ENST00000525876:synonymous:LOW:exon1/3:c.42C>T:p.Thr14Thr		rs649257	0.3770	0.3476	7828,3287,1075	0.4508,0.3809,0.1953,0.3110,0.4763	0.3638							600943 [SERPINH1 (provisional) Preterm premature rupture of the membranes,susceptibility to,610504|Osteogenesis imperfecta,type X,613848];	306107 [benign DISEASE=osteogenesis_imperfecta,_recessive]; 		COSM147291	n/a (AF>5%)	n/a (AF>5%)					SERPINH1 (inh=AR pLI=0.13)
chr11	76701606	76701606	G	A	hom		QUAL=1991;DP=64;AF=1.00;MQM=60	ACER3	synonymous	ACER3:ENST00000532485:synonymous:LOW:exon6/11:c.426G>A:p.Pro142Pro,ACER3:ENST00000526597:synonymous:LOW:exon6/11:c.141G>A:p.Pro47Pro,ACER3:ENST00000533873:synonymous:LOW:exon5/10:c.315G>A:p.Pro105Pro,ACER3:ENST00000538157:synonymous:LOW:exon7/12:c.300G>A:p.Pro100Pro		rs3740767	0.5329	0.6798	29529,19358,382	0.2606,0.4990,0.6730,0.7615,0.7030	0.6806							617036 [ACER3 (provisional) Leukodystrophy,progressive,early childhood-onset,617762];				n/a (AF>5%)	n/a (AF>5%)					ACER3 (inh=n/a pLI=0.77)
chr11	78277277	78277277	A	G	hom		QUAL=3330;DP=103;AF=1.00;MQM=60	NARS2	synonymous,5'UTR	NARS2:ENST00000281038:synonymous:LOW:exon4/14:c.414T>C:p.Tyr138Tyr,NARS2:ENST00000528850:5'UTR:MODIFIER:exon4/14:c.-268T>C:		rs10751296	0.6506	0.7162	31579,20428,2051	0.6273,0.5564,0.5740,0.7831,0.6978	0.7095							612803 [NARS2 (provisional) Combined oxidative phosphorylation deficiency 24,616239];	380001 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NARS2 (inh=AR pLI=0.00)
chr11	86161388	86161388	C	G	het		QUAL=1883;DP=154;AF=0.47;MQM=60	ME3,RP11-317J19.1	missense	ME3:ENST00000359636:missense:MODERATE:exon9/15:c.972G>C:p.Lys324Asn,ME3:ENST00000393324:missense:MODERATE:exon8/14:c.972G>C:p.Lys324Asn,ME3:ENST00000543262:missense:MODERATE:exon9/15:c.972G>C:p.Lys324Asn		rs1042780	0.2983	0.3157	6171,3402,263	0.2327,0.3641,0.2592,0.3206,0.3776	0.3199	2.0430	T,T,T,T	T	B	T,T,T,T	21.10				COSM147300	n/a (AF>5%)	n/a (AF>5%)					ME3 (inh=n/a pLI=0.00), RP11-317J19.1 (inh=n/a pLI=n/a)
chr11	89443808	89443808	A	C	het		QUAL=848;DP=77;AF=0.49;MQM=43	TRIM77	synonymous	TRIM77:ENST00000398290:synonymous:LOW:exon1/6:c.342A>C:p.Leu114Leu		rs11018745	0.2596	0.3105	1069,579,26	0.1599,0.2976,0.2862,0.3715,0.2847	0.3181										COSN164018	n/a (AF>5%)	n/a (AF>5%)					TRIM77 (inh=n/a pLI=n/a)
chr11	89868755	89868755	G	A	het		QUAL=1739;DP=147;AF=0.46;MQM=60	NAALAD2	synonymous	NAALAD2:ENST00000534061:synonymous:LOW:exon2/19:c.111G>A:p.Thr37Thr,NAALAD2:ENST00000321955:synonymous:LOW:exon2/18:c.111G>A:p.Thr37Thr,NAALAD2:ENST00000525171:synonymous:LOW:exon2/8:c.111G>A:p.Thr37Thr,NAALAD2:ENST00000375944:synonymous:LOW:exon2/7:c.111G>A:p.Thr37Thr		rs10734123	0.5108	0.4267	11774,4057,1975	0.6138,0.6209,0.4260,0.3499,0.4974	0.4435										COSM147303	n/a (AF>5%)	n/a (AF>5%)					NAALAD2 (inh=n/a pLI=0.00)
chr11	93408831	93408831	G	A	hom		QUAL=5945;DP=182;AF=0.99;MQM=60	KIAA1731	missense&splice_region,splice_region,5'UTR	KIAA1731:ENST00000411936:missense&splice_region:MODERATE:exon6/30:c.623G>A:p.Arg208Gln,KIAA1731:ENST00000325212:missense&splice_region:MODERATE:exon6/30:c.623G>A:p.Arg208Gln,KIAA1731:ENST00000344196:splice_region:LOW:exon6/29:c.-4694G>A:,KIAA1731:ENST00000344196:5'UTR:MODIFIER:exon6/29:c.-4694G>A:		rs10831088	0.9087	0.9627	10120,4240,599	0.7465,0.9805,0.9984,0.9848,0.9856	0.9748	4.8340	T,T	T	B	T,T	19.89					n/a (AF>5%)	n/a (AF>5%)					CEP295 (inh=n/a pLI=0.02)
chr11	100814570	100814570	A	G	het		QUAL=648;DP=54;AF=0.54;MQM=60	ARHGAP42	synonymous	ARHGAP42:ENST00000298815:synonymous:LOW:exon10/24:c.1014A>G:p.Arg338Arg,ARHGAP42:ENST00000524892:synonymous:LOW:exon9/23:c.912A>G:p.Arg304Arg		rs543146	0.4109	0.3869	1917,360,35	0.1851,0.4510,0.7468,0.2831,0.5452	0.3842											n/a (AF>5%)	n/a (AF>5%)					ARHGAP42 (inh=n/a pLI=0.15)
chr11	100863354	100863354	C	A	het		QUAL=2207;DP=175;AF=0.48;MQM=60	TMEM133	synonymous	TMEM133:ENST00000303130:synonymous:LOW:exon1/1:c.315C>A:p.Val105Val		rs471933	0.3850	0.3108	7902,1347,102	0.1315,0.5114,0.7431,0.2020,0.5017	0.3208											n/a (AF>5%)	n/a (AF>5%)					ARHGAP42 (inh=n/a pLI=0.15)
chr11	101323857	101323859	AAG	-	het		QUAL=1392;DP=104;AF=0.55;MQM=60	TRPC6	splice_region&intron	TRPC6:ENST00000344327:splice_region&intron:LOW:exon12/12:c.2645-22_2645-20delCTT:,TRPC6:ENST00000532133:splice_region&intron:LOW:exon11/11:c.2411-22_2411-20delCTT:,TRPC6:ENST00000348423:splice_region&intron:LOW:exon10/10:c.2297-22_2297-20delCTT:,TRPC6:ENST00000360497:splice_region&intron:LOW:exon11/11:c.2480-22_2480-20delCTT:		rs59743346	0.3093	0.2336	4243,1663,1779	0.5860,0.1227,0.0621,0.2261,0.2427	0.2987							603652 [TRPC6 (confirmed) Glomerulosclerosis,focal segmental,2,603965];	259461 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					TRPC6 (inh=n/a pLI=0.05)
chr11	102398593	102398593	C	T	het		QUAL=2239;DP=187;AF=0.47;MQM=60	MMP7	missense	MMP7:ENST00000260227:missense:MODERATE:exon2/6:c.230G>A:p.Arg77His		rs10502001	0.1336	0.1854	2299,1619,15	0.0437,0.1580,0.2512,0.2230,0.0915	0.1880	-0.3630	T	T	B,B	T	9.43				COSM3752093	n/a (AF>5%)	n/a (AF>5%)					MMP7 (inh=n/a pLI=0.00)
chr11	102567207	102567207	T	A	het		QUAL=2358;DP=232;AF=0.41;MQM=60	MMP27	missense	MMP27:ENST00000260229:missense:MODERATE:exon6/10:c.797A>T:p.Glu266Val		rs1276286	0.4375	0.4659	13723,6652,274	0.2317,0.5790,0.5911,0.4469,0.5239	0.4769	-0.4500	T	T	B	T	0.07				COSM428288	n/a (AF>5%)	n/a (AF>5%)					MMP27 (inh=n/a pLI=0.00)
chr11	102593248	102593248	T	C	het		QUAL=2229;DP=166;AF=0.51;MQM=60	MMP8	missense	MMP8:ENST00000236826:missense:MODERATE:exon2/10:c.259A>G:p.Lys87Glu		rs1940475	0.6000	0.5424	18029,8880,2181	0.6469,0.5100,0.6383,0.5155,0.5562	0.5537	-0.0230	.,T,T,T	T,T	.,B,B	.,T	5.67		403099 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MMP8 (inh=n/a pLI=0.00)
chr11	102649954	102649954	A	G	het		QUAL=284;DP=36;AF=0.39;MQM=60	MMP10,WTAPP1	synonymous	MMP10:ENST00000279441:synonymous:LOW:exon3/10:c.486T>C:p.Phe162Phe		rs17860950	0.0751	0.0648	383,165,190	0.1957,0.0415,0.0001,0.0703,0.0225	0.0926										COSM3752099	n/a (AF>5%)	n/a (AF>5%)					MMP10 (inh=n/a pLI=0.00), WTAPP1 (inh=n/a pLI=n/a)
chr11	102661595	102661595	A	G	het	off-target	QUAL=893;DP=70;AF=0.54;MQM=60	WTAPP1,MMP1	intron	WTAPP1:ENST00000525739:intron:MODIFIER:exon1/7:n.390-2281A>G:,MMP1:ENST00000315274:intron:MODIFIER:exon8/9:c.1197-58T>C:		rs470747	0.2887	0.0000	0,0,0	0,0,0,0,0	0.3350							120353 [MMP1 (confirmed) COPD,rate of decline of lung function in,606963|Epidermolysis bullosa dystrophica,autosomal recessive,modifier of,226600];				n/a (AF>5%)	n/a (AF>5%)					WTAPP1 (inh=n/a pLI=n/a), MMP1 (inh=n/a pLI=0.00)
chr11	102824826	102824826	T	C	hom	off-target	QUAL=146;DP=5;AF=1.00;MQM=60	MMP13	intron	MMP13:ENST00000340273:intron:MODIFIER:exon4/10:c.637+59A>G:,MMP13:ENST00000260302:intron:MODIFIER:exon4/9:c.637+59A>G:		rs478927	0.6384	0.0000	0,0,0	0,0,0,0,0	0.6778							600108 [MMP13 (confirmed) Spondyloepimetaphyseal dysplasia,Missouri type,602111|Metaphyseal anadysplasia 1,602111|Metaphyseal dysplasia,Spahr type,250400];				n/a (AF>5%)	n/a (AF>5%)					MMP13 (inh=AR+AD pLI=0.00)
chr11	103082590	103082590	G	A	hom		QUAL=1589;DP=49;AF=1.00;MQM=60	DYNC2H1	missense,intron	DYNC2H1:ENST00000398093:missense:MODERATE:exon54/90:c.8612G>A:p.Arg2871Gln,DYNC2H1:ENST00000375735:missense:MODERATE:exon54/89:c.8612G>A:p.Arg2871Gln,DYNC2H1:ENST00000334267:intron:MODIFIER:exon15/19:c.2205+77442G>A:		rs589623	0.7384	0.7874	8800,4453,565	0.6392,0.8605,0.8091,0.8181,0.7783	0.7936	4.3360	T,T	T	B,B	T,T	23.30	603297 [DYNC2H1 (provisional) Short-rib thoracic dysplasia 3 with or without polydactyly,613091];	302073 [benign DISEASE=short_rib_polydactyly_syndrome,jeune_thoracic_dystrophy,not_specified]; 		COSM147316	n/a (AF>5%)	n/a (AF>5%)					DYNC2H1 (inh=AR pLI=0.00)
chr11	104758035	104758035	G	A	hom		QUAL=2142;DP=65;AF=1.00;MQM=60	CASP12	splice_region&intron,intron	CASP12:ENST00000375726:splice_region&intron:LOW:exon5/6:c.818-3C>T:,CASP12:ENST00000422698:splice_region&intron:LOW:exon5/7:c.818-3C>T:,CASP12:ENST00000447913:splice_region&intron:LOW:exon3/4:c.331-3C>T:,CASP12:ENST00000448103:splice_region&intron:LOW:exon4/5:c.583-3C>T:,CASP12:ENST00000508062:splice_region&intron:LOW:exon4/5:c.566-3C>T:,CASP12:ENST00000433738:intron:MODIFIER:exon3/3:c.331-496C>T:,CASP12:ENST00000441710:intron:MODIFIER:exon5/5:c.790-496C>T:,CASP12:ENST00000446862:intron:MODIFIER:exon5/5:c.818-496C>T:,CASP12:ENST00000494737:intron:MODIFIER:exon4/4:c.583-496C>T:		rs484438	0.8888	0.9774	6826,1935,128	0.6774,0.0000,0.0000,0.9967,0.9845	0.9759							608633 [CASP12 (provisional) Sepsis,susceptibility to];				n/a (AF>5%)	n/a (AF>5%)					CASP12 (inh=n/a pLI=0.09)
chr11	106408071	106408071	C	T	het		QUAL=773;DP=71;AF=0.44;MQM=60	RP11,680E19.2,GUCY1A2	intergenic_region	GUCY1A2:ENSG00000255065-ENSG00000152402:intergenic_region:MODIFIER::n.106408071C>T:	L2d2	rs1791468	0.5076	0.5137	15020,7553,852	0.4573,0.5339,0.6369,0.4971,0.5248	0.5112											n/a (AF>5%)	n/a (AF>5%)					PRPF31 (inh=AD pLI=0.95), 680E19.2 (inh=n/a pLI=n/a), GUCY1A2 (inh=n/a pLI=0.25)
chr11	111156836	111156836	T	C	hom	off-target	QUAL=3626;DP=110;AF=1.00;MQM=60	C11orf53	3'UTR	C11orf53:ENST00000280325:3'UTR:MODIFIER:exon4/4:c.*57T>C:		rs3087967	0.7330	0.0000	0,0,0	0,0,0,0,0	0.7186											n/a (AF>5%)	n/a (AF>5%)					C11orf53 (inh=n/a pLI=0.00)
chr11	111782284	111782284	C	T	het		QUAL=647;DP=49;AF=0.53;MQM=60	CRYAB	synonymous	CRYAB:ENST00000227251:synonymous:LOW:exon2/4:c.165G>A:p.Leu55Leu,CRYAB:ENST00000526180:synonymous:LOW:exon1/3:c.165G>A:p.Leu55Leu,CRYAB:ENST00000533475:synonymous:LOW:exon2/4:c.165G>A:p.Leu55Leu,CRYAB:ENST00000527950:synonymous:LOW:exon2/4:c.165G>A:p.Leu55Leu,CRYAB:ENST00000531198:synonymous:LOW:exon3/5:c.165G>A:p.Leu55Leu,CRYAB:ENST00000533971:synonymous:LOW:exon1/2:c.165G>A:p.Leu55Leu		rs2228387	0.0092	0.0194	31,18,1	0.0040,0.0054,0.0003,0.0232,0.0315	0.0155							123590 [CRYAB (confirmed) Myopathy,myofibrillar,2,608810|Cataract 16,multiple types,613763|Myopathy,myofibrillar,fatal infantile hypertonic,alpha-B crystallin-related,613869|Cardiomyopathy,dilated,1II,615184];	44233 [benign DISEASE=posterior_polar_cataract,alpha-b_crystallinopathy,dilated_cardiomyopathy_1ii,not_specified,cardiovascular_phenotype,myofibrillar_myopathy,_dominant]; 			1	122					CRYAB (inh=AR+AD pLI=0.01)
chr11	112072930	112072930	G	A	het		QUAL=852;DP=56;AF=0.57;MQM=60	BCO2	splice_region&intron	BCO2:ENST00000357685:splice_region&intron:LOW:exon8/11:c.1194+17G>A:,BCO2:ENST00000393032:splice_region&intron:LOW:exon8/11:c.1092+17G>A:,BCO2:ENST00000361053:splice_region&intron:LOW:exon6/9:c.975+17G>A:,BCO2:ENST00000438022:splice_region&intron:LOW:exon8/11:c.1092+17G>A:,BCO2:ENST00000526088:splice_region&intron:LOW:exon8/11:c.1092+17G>A:,BCO2:ENST00000532593:splice_region&intron:LOW:exon7/10:c.879+17G>A:,BCO2:ENST00000531169:splice_region&intron:LOW:exon8/12:c.1092+17G>A:		rs4935984	0.4685	0.3919	9670,3729,1098	0.4620,0.3715,0.4799,0.3386,0.5893	0.3808											n/a (AF>5%)	n/a (AF>5%)					BCO2 (inh=n/a pLI=0.00)
chr11	114442103	114442103	A	G	hom		QUAL=3940;DP=121;AF=0.99;MQM=60	NXPE4	missense	NXPE4:ENST00000375478:missense:MODERATE:exon6/6:c.1192T>C:p.Tyr398His,NXPE4:ENST00000424261:missense:MODERATE:exon6/6:c.340T>C:p.Tyr114His		rs550897	0.6540	0.5404	18379,7501,3498	0.8432,0.5929,0.6832,0.4733,0.5408	0.6031	4.1780	T,T	T	B	T,T	6.85				COSM3998239	n/a (AF>5%)	n/a (AF>5%)					NXPE4 (inh=n/a pLI=0.00)
chr11	118081345	118081345	A	T	hom		QUAL=4303;DP=129;AF=1.00;MQM=60	AMICA1	missense	AMICA1:ENST00000356289:missense:MODERATE:exon4/10:c.281T>A:p.Ile94Asn,AMICA1:ENST00000292067:missense:MODERATE:exon3/9:c.251T>A:p.Ile84Asn,AMICA1:ENST00000533261:missense:MODERATE:exon3/9:c.281T>A:p.Ile94Asn,AMICA1:ENST00000526620:missense:MODERATE:exon3/9:c.164T>A:p.Ile55Asn		rs17121881	0.4675	0.5370	18623,10480,226	0.1955,0.4536,0.5314,0.5599,0.7228	0.5369	1.5140	T,T,T,T,T,T,T	T	B,P,P,P	T,T,T,T,T,T	23.50				COSM3927694, COSM147332	n/a (AF>5%)	n/a (AF>5%)					JAML (inh=n/a pLI=0.00)
chr11	118083664	118083664	A	G	hom	off-target	QUAL=4882;DP=150;AF=0.99;MQM=60	AMICA1	5'UTR,intron	AMICA1:ENST00000292067:5'UTR:MODIFIER:exon1/9:c.-32T>C:,AMICA1:ENST00000356289:intron:MODIFIER:exon2/9:c.44-388T>C:,AMICA1:ENST00000533261:intron:MODIFIER:exon1/8:c.44-388T>C:,AMICA1:ENST00000526620:intron:MODIFIER:exon1/8:c.-74-388T>C:		rs1715429	0.8105	0.7743	36686,18883,4351	0.9127,0.7805,0.6960,0.7514,0.8283	0.7849											n/a (AF>5%)	n/a (AF>5%)					JAML (inh=n/a pLI=0.00)
chr11	119005088	119005088	C	T	hom		QUAL=4744;DP=148;AF=1.00;MQM=60	HINFP	synonymous	HINFP:ENST00000350777:synonymous:LOW:exon10/10:c.1434C>T:p.Ile478Ile		rs512703	0.9872	0.9735	57556,30845,5139	0.9939,0.9900,1.0000,0.9613,0.9875	0.9755											n/a (AF>5%)	n/a (AF>5%)					HINFP (inh=n/a pLI=0.96)
chr11	124791314	124791314	T	C	het		QUAL=49;DP=8;AF=0.38;MQM=60	HEPACAM	missense	HEPACAM:ENST00000298251:missense:MODERATE:exon7/7:c.971A>G:p.Asn324Ser		rs116102273	0.0619	0.2024	8,2,2	0.0000,0.0000,0.0000,0.1856,0.0000	0.0527	0.6150	T	T	B	T	0.01	611642 [HEPACAM (provisional) Megalencephalic leukoencephalopathy with subcortical cysts 2A,613925|Megalencephalic leukoencephalopathy with subcortical cysts 2B,remitting,with or without mental retardation,613926];	262683 [benign/likely benign DISEASE=not_specified,megalencephalic_leukoencephalopathy_with_subcortical_cysts]; 		COSM4145453	n/a (AF>5%)	n/a (AF>5%)					HEPACAM (inh=AR+AD pLI=0.56)
chr11	125443473	125443473	A	C	het		QUAL=1084;DP=80;AF=0.51;MQM=60	STT3A-AS1,EI24	splice_region&intron,intron	STT3A-AS1:ENST00000530526:splice_region&intron:LOW:exon1/2:n.152-3T>G:,STT3A-AS1:ENST00000532714:splice_region&intron:LOW:exon1/1:n.162-3T>G:,EI24:ENST00000278903:intron:MODIFIER:exon2/11:c.42+1008A>C:,EI24:ENST00000343678:intron:MODIFIER:exon2/10:c.42+1008A>C:	FRAM	rs1284352	0.3668	0.3730	173,35,4	0.0000,0.0000,0.0000,0.3766,0.3717	0.3726											n/a (AF>5%)	n/a (AF>5%)					STT3A-AS1 (inh=n/a pLI=n/a), EI24 (inh=n/a pLI=0.95)
chr11	125497466	125497466	G	T	het	off-target	QUAL=545;DP=45;AF=0.49;MQM=60	CHEK1	intron	CHEK1:ENST00000427383:intron:MODIFIER:exon2/11:c.337+738G>T:,CHEK1:ENST00000438015:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000428830:intron:MODIFIER:exon2/13:c.66-36G>T:,CHEK1:ENST00000544373:intron:MODIFIER:exon2/11:c.66-36G>T:,CHEK1:ENST00000534070:intron:MODIFIER:exon2/12:c.66-36G>T:,CHEK1:ENST00000524737:intron:MODIFIER:exon1/12:c.66-36G>T:,CHEK1:ENST00000278916:intron:MODIFIER:exon1/10:c.66-36G>T:		rs491528	0.3530	0.3481	4414,2078,588	0.4026,0.2360,0.4664,0.3372,0.3769	0.3153											n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a pLI=0.00)
chr11	125788678	125788678	T	C	het		QUAL=1933;DP=230;AF=0.35;MQM=60	DDX25,RP11-680F20.9	synonymous	DDX25:ENST00000263576:synonymous:LOW:exon10/12:c.1194T>C:p.Cys398Cys		rs683155	0.6899	0.7149	13913,7523,1269	0.7212,0.8083,0.6720,0.7120,0.7072	0.6976										COSM3752220, COSM3752219	n/a (AF>5%)	n/a (AF>5%)					DDX25 (inh=n/a pLI=0.00), RP11-680F20.9 (inh=n/a pLI=n/a)
chr11	128773413	128773413	T	C	het		QUAL=1165;DP=89;AF=0.51;MQM=60	C11orf45,KCNJ5	splice_region&intron,intron	C11orf45:ENST00000310799:splice_region&intron:LOW:exon2/3:c.137-7A>G:,C11orf45:ENST00000524878:splice_region&intron:LOW:exon2/3:c.137-7A>G:,KCNJ5:ENST00000338350:intron:MODIFIER:exon1/3:c.-99-6334T>C:,KCNJ5:ENST00000529694:intron:MODIFIER:exon1/2:c.-10-7746T>C:		rs4937387	0.2103	0.2441	3798,2426,380	0.2706,0.1684,0.1090,0.2706,0.2446	0.2623							600734 [KCNJ5 (provisional) Long QT syndrome 13,613485|Hyperaldosteronism,familial,type III,613677];				n/a (AF>5%)	n/a (AF>5%)					C11orf45 (inh=n/a pLI=0.01), KCNJ5 (inh=AD pLI=0.27)
chr11	129746707	129746707	G	T	het		QUAL=990;DP=102;AF=0.41;MQM=60	NFRKB	synonymous	NFRKB:ENST00000524794:synonymous:LOW:exon15/25:c.1731C>A:p.Gly577Gly,NFRKB:ENST00000446488:synonymous:LOW:exon16/26:c.1656C>A:p.Gly552Gly,NFRKB:ENST00000304521:synonymous:LOW:exon15/25:c.1656C>A:p.Gly552Gly,NFRKB:ENST00000524746:synonymous:LOW:exon17/27:c.1656C>A:p.Gly552Gly		rs2229650	0.2738	0.2206	3241,1013,204	0.2033,0.2767,0.3704,0.1740,0.3135	0.2223											n/a (AF>5%)	n/a (AF>5%)					NFRKB (inh=n/a pLI=0.81)
chr11	130271906	130271906	G	A	het		QUAL=90;DP=13;AF=0.46;MQM=60	RP11,121M22.1,ADAMTS8	intergenic_region	ADAMTS8:ENSG00000175773-ENSG00000134917:intergenic_region:MODIFIER::n.130271906G>A:		rs66785877	0.1556	0.1175	89,18,9	0.1891,0.0000,0.0000,0.1091,0.1192	0.1151											n/a (AF>5%)	n/a (AF>5%)					PRPF31 (inh=AD pLI=0.95), 121M22.1 (inh=n/a pLI=n/a), ADAMTS8 (inh=n/a pLI=0.00)
chr11	132184394	132184394	G	C	hom	off-target	QUAL=2764;DP=85;AF=1.00;MQM=60	NTM	intron	NTM:ENST00000425719:intron:MODIFIER:exon5/7:c.783-52G>C:,NTM:ENST00000374791:intron:MODIFIER:exon6/7:c.783-52G>C:,NTM:ENST00000539799:intron:MODIFIER:exon6/8:c.783-52G>C:,NTM:ENST00000427481:intron:MODIFIER:exon6/8:c.756-52G>C:,NTM:ENST00000374786:intron:MODIFIER:exon5/6:c.783-52G>C:,NTM:ENST00000374784:intron:MODIFIER:exon5/5:c.783-52G>C:		rs730253	0.3113	0.0000	0,0,0	0,0,0,0,0	0.4140											n/a (AF>5%)	n/a (AF>5%)					NTM (inh=n/a pLI=0.81)
chr12	235143	235143	G	C	hom	off-target	QUAL=458;DP=18;AF=0.61;MQM=60	IQSEC3	intron	IQSEC3:ENST00000326261:intron:MODIFIER:exon3/14:c.903+65G>C:,IQSEC3:ENST00000538872:intron:MODIFIER:exon3/13:c.903+65G>C:,IQSEC3:ENST00000382841:intron:MODIFIER:exon2/12:c.-6-12290G>C:		rs11610983	0.3247	0.0000	0,0,0	0,0,0,0,0	0.4640											n/a (AF>5%)	n/a (AF>5%)					IQSEC3 (inh=n/a pLI=1.00)
chr12	939302	939302	A	G	het		QUAL=1739;DP=162;AF=0.44;MQM=60	WNK1	synonymous	WNK1:ENST00000530271:synonymous:LOW:exon4/30:c.1287A>G:p.Ala429Ala,WNK1:ENST00000535572:synonymous:LOW:exon4/26:c.1287A>G:p.Ala429Ala,WNK1:ENST00000315939:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala,WNK1:ENST00000537687:synonymous:LOW:exon4/28:c.1287A>G:p.Ala429Ala		rs10774466	0.6935	0.7451	34121,19376,1544	0.5494,0.7726,0.8653,0.7601,0.7040	0.7496							605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];	261066 [benign DISEASE=pseudohypoaldosteronism,_type_2,hereditary_sensory_and_autonomic_neuropathy_type_ii,hereditary_sensory_and_autonomic_neuropathy_type_iia,not_specified]; 		COSM3753538	n/a (AF>5%)	n/a (AF>5%)					WNK1 (inh=AR+AD pLI=1.00)
chr12	1889823	1889823	G	A	hom		QUAL=3511;DP=107;AF=1.00;MQM=60	ADIPOR2	splice_region&intron	ADIPOR2:ENST00000357103:splice_region&intron:LOW:exon5/7:c.650+20G>A:		rs767870	0.7115	0.8173	40530,23256,771	0.3933,0.9168,0.9090,0.8411,0.8356	0.8256											n/a (AF>5%)	n/a (AF>5%)					ADIPOR2 (inh=n/a pLI=0.74)
chr12	4677255	4677255	T	C	het	off-target	QUAL=578;DP=54;AF=0.44;MQM=60	DYRK4				rs2240766	0.4231	0.3695	888,434,68	0.5777,0.0000,0.0000,0.5307,0.2910	0.5085											n/a (AF>5%)	n/a (AF>5%)					DYRK4 (inh=n/a pLI=0.00)
chr12	4737715	4737715	C	T	hom		QUAL=4603;DP=138;AF=1.00;MQM=60	AKAP3,RP11-500M8.7	missense	AKAP3:ENST00000228850:missense:MODERATE:exon4/5:c.353G>A:p.Gly118Glu,AKAP3:ENST00000545990:missense:MODERATE:exon5/6:c.353G>A:p.Gly118Glu		rs2072355	0.7055	0.7750	36869,22280,1946	0.6088,0.8360,0.6507,0.8176,0.7007	0.7820	-0.2990	T,T,T	T	B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					AKAP3 (inh=n/a pLI=0.09), RP11-500M8.7 (inh=n/a pLI=n/a)
chr12	4830000	4830000	T	G	het		QUAL=969;DP=86;AF=0.45;MQM=60	GALNT8,RP11-234B24.6	missense	GALNT8:ENST00000252318:missense:MODERATE:exon1/11:c.157T>G:p.Tyr53Asp		rs10849133	0.3820	0.3594	8252,4418,1157	0.4736,0.4300,0.3693,0.3633,0.2181	0.3896	0.3410	T	T	B	T	0.02				COSM1128586	n/a (AF>5%)	n/a (AF>5%)					GALNT8 (inh=n/a pLI=0.00), RP11-234B24.6 (inh=n/a pLI=n/a)
chr12	5021348	5021348	G	C	het		QUAL=1872;DP=133;AF=0.54;MQM=60	KCNA1	synonymous	KCNA1:ENST00000382545:synonymous:LOW:exon2/2:c.804G>C:p.Thr268Thr		rs2227910	0.5333	0.5256	16995,8876,1081	0.4588,0.6346,0.6599,0.5160,0.4734	0.5315							176260 [KCNA1 (confirmed) Episodic ataxia/myokymia syndrome,160120];	21130 [benign/likely benign DISEASE=episodic_ataxia,myokymia,episodic_ataxia_type_1,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)			n/a (1xTP, 0xFP)		KCNA1 (inh=AD pLI=0.04)
chr12	5841733	5841733	A	C	het		QUAL=2720;DP=217;AF=0.48;MQM=60	ANO2	missense	ANO2:ENST00000356134:missense:MODERATE:exon16/27:c.1501T>G:p.Ser501Ala,ANO2:ENST00000327087:missense:MODERATE:exon15/26:c.1498T>G:p.Ser500Ala,ANO2:ENST00000546188:missense:MODERATE:exon15/26:c.1501T>G:p.Ser501Ala		rs1860961	0.1370	0.0998	700,281,231	0.2271,0.0848,0.1222,0.0868,0.0793	0.1278	1.0640	T,T,T,T,T	T	B	T,T,T,T	6.15				COSM147394	n/a (AF>5%)	n/a (AF>5%)					ANO2 (inh=n/a pLI=0.00)
chr12	6619284	6619284	C	G	het		QUAL=1779;DP=144;AF=0.49;MQM=60	NCAPD2	missense,intron	NCAPD2:ENST00000315579:missense:MODERATE:exon4/32:c.247C>G:p.Gln83Glu,NCAPD2:ENST00000545962:intron:MODIFIER:exon3/30:c.127+326C>G:		rs714774	0.7955	0.7536	34872,17538,4677	0.9483,0.8821,0.6551,0.7261,0.7013	0.8005	3.7270	T,T	T	B	T,T	8.36	615638 [NCAPD2 (provisional) Microcephaly 21,primary,autosomal recessive,617983];			COSM3753449	n/a (AF>5%)	n/a (AF>5%)					NCAPD2 (inh=n/a pLI=0.00)
chr12	7947017	7947017	T	C	het	off-target	QUAL=333;DP=25;AF=0.60;MQM=60	NANOG	intron	NANOG:ENST00000229307:intron:MODIFIER:exon2/3:c.415-36T>C:,NANOG:ENST00000526286:intron:MODIFIER:exon2/3:c.415-36T>C:		rs1860931	0.4455	0.5821	14290,8893,690	0.4741,0.5838,0.1681,0.6320,0.6155	0.5434											n/a (AF>5%)	n/a (AF>5%)					NANOG (inh=n/a pLI=0.90)
chr12	8075685	8075685	A	G	het	off-target	QUAL=119;DP=18;AF=0.39;MQM=60	SLC2A3	intron	SLC2A3:ENST00000075120:intron:MODIFIER:exon8/9:c.1069-65T>C:		rs741361	0.3411	0.0000	0,0,0	0,0,0,0,0	0.3501											n/a (AF>5%)	n/a (AF>5%)					SLC2A3 (inh=n/a pLI=0.42)
chr12	8248367	8248367	T	C	hom	off-target	QUAL=4892;DP=149;AF=1.00;MQM=60	NECAP1	intron	NECAP1:ENST00000339754:intron:MODIFIER:exon7/7:c.779+68T>C:		rs2231754	0.1210	0.0000	0,0,0	0,0,0,0,0	0.2203							611623 [NECAP1 (provisional) Epileptic encephalopathy,early infantile,21,615833];				n/a (AF>5%)	n/a (AF>5%)					NECAP1 (inh=AR pLI=0.03)
chr12	9004512	9004512	G	A	hom		QUAL=8025;DP=243;AF=1.00;MQM=60	A2ML1	synonymous	A2ML1:ENST00000299698:synonymous:LOW:exon19/36:c.2367G>A:p.Pro789Pro,A2ML1:ENST00000539547:synonymous:LOW:exon8/25:c.894G>A:p.Pro298Pro		rs1860927	0.8682	0.8700	45968,23761,2584	0.7268,0.9351,0.9999,0.8444,0.9637	0.8743								383777 [benign DISEASE=not_specified]; 		COSM1364786	n/a (AF>5%)	n/a (AF>5%)					A2ML1 (inh=n/a pLI=0.00)
chr12	9004892	9004892	C	A	hom		QUAL=4843;DP=147;AF=1.00;MQM=60	A2ML1	missense	A2ML1:ENST00000299698:missense:MODERATE:exon20/36:c.2550C>A:p.Asp850Glu,A2ML1:ENST00000539547:missense:MODERATE:exon9/25:c.1077C>A:p.Asp359Glu		rs1860926	0.9661	0.9898	59216,33349,3818	0.8828,0.9950,1.0000,0.9997,0.9997	0.9916	0.2310	T,T,T,T	T	B	T,T,T	8.75					n/a (AF>5%)	n/a (AF>5%)					A2ML1 (inh=n/a pLI=0.00)
chr12	10131939	10131939	C	T	het		QUAL=223;DP=23;AF=0.48;MQM=60	CLEC12A	synonymous	CLEC12A:ENST00000355690:synonymous:LOW:exon4/7:c.225C>T:p.His75His,CLEC12A:ENST00000304361:synonymous:LOW:exon3/6:c.195C>T:p.His65His,CLEC12A:ENST00000434319:synonymous:LOW:exon3/6:c.195C>T:p.His65His,CLEC12A:ENST00000350667:synonymous:LOW:exon2/5:c.96C>T:p.His32His		rs536947	0.1933	0.2698	1516,563,34	0.1384,0.2108,0.3047,0.2652,0.3651	0.1776										COSM3721270, COSM3721269	n/a (AF>5%)	n/a (AF>5%)					CLEC12A (inh=n/a pLI=0.00)
chr12	10137557	10137557	A	C	het		QUAL=830;DP=64;AF=0.53;MQM=60	CLEC12A	missense	CLEC12A:ENST00000355690:missense:MODERATE:exon7/7:c.760A>C:p.Lys254Gln,CLEC12A:ENST00000304361:missense:MODERATE:exon6/6:c.730A>C:p.Lys244Gln,CLEC12A:ENST00000350667:missense:MODERATE:exon5/5:c.631A>C:p.Lys211Gln		rs479499	0.7374	0.7233	14239,5560,1321	0.6838,0.7221,0.9031,0.6733,0.8138	0.6815	-0.2930	T,T,T	T	B,B,B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					CLEC12A (inh=n/a pLI=0.00)
chr12	10251385	10251385	T	C	hom	off-target	QUAL=1577;DP=48;AF=1.00;MQM=60	CLEC1A	intron	CLEC1A:ENST00000315330:intron:MODIFIER:exon1/5:c.115+22A>G:,CLEC1A:ENST00000457018:intron:MODIFIER:exon1/4:c.115+22A>G:,CLEC1A:ENST00000420265:intron:MODIFIER:exon1/3:c.115+22A>G:		rs3816845	0.5831	0.7518	29239,21397,1642	0.6277,0.4565,0.3762,0.8773,0.6300	0.7671										COSN164164	n/a (AF>5%)	n/a (AF>5%)					CLEC1A (inh=n/a pLI=0.00)
chr12	10562025	10562025	C	T	hom		QUAL=3321;DP=99;AF=1.00;MQM=60	KLRC4-KLRK1,KLRC4	synonymous	KLRC4-KLRK1:ENST00000539300:synonymous:LOW:exon1/13:c.123G>A:p.Ser41Ser,KLRC4:ENST00000309384:synonymous:LOW:exon1/4:c.150G>A:p.Ser50Ser		rs1841957	0.4940	0.6107	23528,15383,397	0.2751,0.6339,0.5462,0.6782,0.5513	0.6177										COSM3752861	n/a (AF>5%)	n/a (AF>5%)					KLRC4-KLRK1 (inh=n/a pLI=n/a), KLRC4 (inh=n/a pLI=0.01)
chr12	10978402	10978402	G	A	hom		QUAL=1923;DP=58;AF=1.00;MQM=60	TAS2R10,PRR4	missense	TAS2R10:ENST00000240619:missense:MODERATE:exon1/1:c.467C>T:p.Thr156Met		rs597468	0.9429	0.9786	57917,32911,3553	0.8336,0.9895,1.0000,0.9955,0.9734	0.9821	-3.5320	T	T	B	T	0.25					n/a (AF>5%)	n/a (AF>5%)					TAS2R10 (inh=n/a pLI=0.40), PRR4 (inh=n/a pLI=0.00)
chr12	11091693	11091693	T	A	het		QUAL=1712;DP=117;AF=0.55;MQM=60	TAS2R14,PRR4	synonymous	TAS2R14:ENST00000537503:synonymous:LOW:exon1/1:c.114A>T:p.Gly38Gly		rs7138535	0.2230	0.2415	3607,2031,247	0.2216,0.3137,0.2203,0.2461,0.1859	0.2533										COSM3998659	n/a (AF>5%)	n/a (AF>5%)					TAS2R14 (inh=n/a pLI=0.00), PRR4 (inh=n/a pLI=0.00)
chr12	11174753	11174753	G	A	het		QUAL=545;DP=47;AF=0.47;MQM=59	TAS2R19,PRR4,TAS2R14	synonymous	TAS2R19:ENST00000390673:synonymous:LOW:exon1/1:c.418C>T:p.Leu140Leu		rs1868769	0.7009	0.7805	37741,21631,1041	0.4489,0.8619,0.8867,0.8045,0.7521	0.7892											n/a (AF>5%)	n/a (AF>5%)					TAS2R19 (inh=n/a pLI=0.00), PRR4 (inh=n/a pLI=0.00), TAS2R14 (inh=n/a pLI=0.00)
chr12	14019157	14019157	C	T	het		QUAL=2596;DP=177;AF=0.54;MQM=60	GRIN2B	5'UTR	GRIN2B:ENST00000609686:5'UTR:MODIFIER:exon2/13:c.-15G>A:		rs12818068	0.0379	0.0820	509,440,1	0.0174,0.0388,0.0003,0.1190,0.0290	0.0907							138252 [GRIN2B (provisional) Mental retardation,autosomal dominant 6,613970|Epileptic encephalopathy,early infantile,27,616139];	137514 [benign/likely benign DISEASE=not_specified,intellectual_disability,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					GRIN2B (inh=AD pLI=1.00)
chr12	16397734	16397734	C	A	hom		QUAL=2785;DP=85;AF=1.00;MQM=60	SLC15A5	missense&splice_region	SLC15A5:ENST00000344941:missense&splice_region:MODERATE:exon4/9:c.755G>T:p.Arg252Leu		rs1852450	0.5020	0.5082	2825,844,263	0.4815,0.4474,0.4324,0.4460,0.6151	0.4734	0.7510	T	T		T	12.29					n/a (AF>5%)	n/a (AF>5%)					SLC15A5 (inh=n/a pLI=n/a)
chr12	18473928	18473928	T	C	het		QUAL=406;DP=27;AF=0.59;MQM=60	PIK3C2G	synonymous	PIK3C2G:ENST00000538779:synonymous:LOW:exon6/32:c.1170T>C:p.Asn390Asn,PIK3C2G:ENST00000535651:synonymous:LOW:exon7/12:c.1170T>C:p.Asn390Asn,PIK3C2G:ENST00000433979:synonymous:LOW:exon7/32:c.1170T>C:p.Asn390Asn,PIK3C2G:ENST00000266497:synonymous:LOW:exon6/31:c.1170T>C:p.Asn390Asn		rs12309666	0.2238	0.1833	1556,207,704	0.4406,0.3121,0.2557,0.1213,0.1052	0.1953										COSM147453	n/a (AF>5%)	n/a (AF>5%)					PIK3C2G (inh=n/a pLI=0.00)
chr12	21054918	21054918	T	C	het		QUAL=317;DP=25;AF=0.56;MQM=60	SLCO1B3,LST3,SLCO1B7	intron	LST3:ENST00000540229:intron:MODIFIER:exon13/15:c.1865+517T>C:,SLCO1B3:ENST00000553473:intron:MODIFIER:exon13/15:c.1865+517T>C:,SLCO1B7:ENST00000554957:intron:MODIFIER:exon3/13:c.359+43413T>C:,SLCO1B3:ENST00000261196:intron:MODIFIER:exon14/14:c.1865+517T>C:,SLCO1B3:ENST00000381545:intron:MODIFIER:exon15/15:c.1865+517T>C:,LST3:ENST00000381541:intron:MODIFIER:exon3/13:c.359+43413T>C:		rs2082518	0.5058	0.7458	2971,744,10	0.1855,0.0000,0.0000,0.7061,0.8130	0.6706							605495 [SLCO1B3 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];				n/a (AF>5%)	n/a (AF>5%)					SLCO1B3 (inh=AR pLI=0.00), SLCO1B7 (inh=n/a pLI=0.00), SLCO1B7 (inh=n/a pLI=0.00)
chr12	21176247	21176247	A	G	hom	off-target	QUAL=1928;DP=64;AF=1.00;MQM=60	LST3,SLCO1B3,SLCO1B7	intron	LST3:ENST00000540229:intron:MODIFIER:exon13/15:c.1866-44006A>G:,SLCO1B3:ENST00000553473:intron:MODIFIER:exon13/15:c.1866-44006A>G:,SLCO1B7:ENST00000554957:intron:MODIFIER:exon6/13:c.727+26A>G:,LST3:ENST00000381541:intron:MODIFIER:exon6/13:c.727+26A>G:,SLCO1B7:ENST00000421593:intron:MODIFIER:exon5/12:c.586+26A>G:		rs1546307	0.7109	0.8412	40354,23535,411	0.3090,0.8515,0.9487,0.8810,0.9160	0.8467							605495 [SLCO1B3 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];				n/a (AF>5%)	n/a (AF>5%)					SLCO1B7 (inh=n/a pLI=0.00), SLCO1B3 (inh=AR pLI=0.00), SLCO1B7 (inh=n/a pLI=0.00)
chr12	21331549	21331549	T	C	het		QUAL=1337;DP=97;AF=0.52;MQM=60	SLCO1B1	missense	SLCO1B1:ENST00000256958:missense:MODERATE:exon6/15:c.521T>C:p.Val174Ala		rs4149056	0.0877	0.1294	1226,897,4	0.0284,0.1065,0.1263,0.1603,0.0503	0.1354	7.3260	D	T	D	T	22.90	604843 [SLCO1B1 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];	37346 [drug response DISEASE=rotor_syndrome,not_specified,cerivastatin_response_-_toxicity/adr,hmg_coa_reductase_inhibitors_response_-_toxicity/adr,pravastatin_response_-_metabolism/pk,rosuvastatin_response_-_other,simvastatin_response_-_toxicity/adr,hmg_coa_reductase_inhibitors_response_-_toxicity/adr,_metabolism/pk,not_provided]; 	CM043777 [CLASS=DFP MUT=ALT PHEN="Increased rate of cholesterol synthesis association with" GENE=SLCO1B1]; 		n/a (AF>5%)	n/a (AF>5%)					SLCO1B1 (inh=AR pLI=0.00)
chr12	21331987	21331987	C	T	het	off-target	QUAL=1070;DP=76;AF=0.53;MQM=60	SLCO1B1	intron	SLCO1B1:ENST00000256958:intron:MODIFIER:exon7/14:c.727+33C>T:		rs2291076	0.2935	0.4070	10804,6793,53	0.0943,0.4534,0.2532,0.4494,0.4778	0.4144							604843 [SLCO1B1 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];			COSN164185	n/a (AF>5%)	n/a (AF>5%)					SLCO1B1 (inh=AR pLI=0.00)
chr12	26784850	26784850	G	A	het		QUAL=2874;DP=235;AF=0.47;MQM=60	ITPR2,RP11-666F17.1	synonymous	ITPR2:ENST00000381340:synonymous:LOW:exon22/57:c.2883C>T:p.His961His		rs2230372	0.4928	0.4856	14912,8218,1418	0.5380,0.2745,0.3566,0.4937,0.6167	0.4858							600144 [ITPR2 (provisional) Anhidrosis,isolated,with normal sweat glands,106190];			COSM4146967	n/a (AF>5%)	n/a (AF>5%)					ITPR2 (inh=AR+AD pLI=0.00), RP11-666F17.1 (inh=n/a pLI=n/a)
chr12	26869233	26869233	C	T	het	off-target	QUAL=942;DP=78;AF=0.47;MQM=60	ITPR2	intron	ITPR2:ENST00000381340:intron:MODIFIER:exon5/56:c.526-58G>A:		rs7957289	0.3031	0.0000	0,0,0	0,0,0,0,0	0.4329							600144 [ITPR2 (provisional) Anhidrosis,isolated,with normal sweat glands,106190];				n/a (AF>5%)	n/a (AF>5%)					ITPR2 (inh=AR+AD pLI=0.00)
chr12	27800883	27800883	T	C	hom	off-target	QUAL=67;DP=3;AF=1.00;MQM=53	PPFIBP1	3'UTR,intron	PPFIBP1:ENST00000535047:3'UTR:MODIFIER:exon6/6:c.*66T>C:,PPFIBP1:ENST00000318304:intron:MODIFIER:exon6/28:c.471+108T>C:,PPFIBP1:ENST00000537927:intron:MODIFIER:exon4/26:c.12+108T>C:,PPFIBP1:ENST00000542629:intron:MODIFIER:exon6/27:c.471+108T>C:,PPFIBP1:ENST00000228425:intron:MODIFIER:exon6/29:c.471+108T>C:		rs2288221	0.7590	0.0000	0,0,0	0,0,0,0,0	0.7297											n/a (AF>5%)	n/a (AF>5%)					PPFIBP1 (inh=n/a pLI=0.00)
chr12	30879088	30879088	T	C	het	off-target	QUAL=475;DP=29;AF=0.66;MQM=60	CAPRIN2	intron	CAPRIN2:ENST00000251071:intron:MODIFIER:exon8/17:c.1783-66A>G:,CAPRIN2:ENST00000298892:intron:MODIFIER:exon8/16:c.1783-66A>G:,CAPRIN2:ENST00000395805:intron:MODIFIER:exon8/16:c.1783-66A>G:,CAPRIN2:ENST00000308433:intron:MODIFIER:exon7/16:c.784-66A>G:,CAPRIN2:ENST00000417045:intron:MODIFIER:exon8/17:c.1783-66A>G:		rs10843822	0.2572	0.0000	0,0,0	0,0,0,0,0	0.2845											n/a (AF>5%)	n/a (AF>5%)					CAPRIN2 (inh=n/a pLI=0.00)
chr12	31908050	31908050	A	C	hom		QUAL=8470;DP=259;AF=1.00;MQM=60	RP11-467L13.5				rs6488005	0.9539	0.0000	0,0,0	0,0,0,0,0	0.9598											n/a (AF>5%)	n/a (AF>5%)					RP11-467L13.5 (inh=n/a pLI=n/a)
chr12	32791796	32791796	G	A	het		QUAL=745;DP=73;AF=0.42;MQM=60	FGD4	missense,intron	FGD4:ENST00000266482:missense:MODERATE:exon17/17:c.1366G>A:p.Gly456Arg,FGD4:ENST00000534526:intron:MODIFIER:exon16/16:c.2454+67G>A:,FGD4:ENST00000531134:intron:MODIFIER:exon16/16:c.2298+67G>A:,FGD4:ENST00000427716:intron:MODIFIER:exon16/16:c.2043+67G>A:,FGD4:ENST00000546442:intron:MODIFIER:exon15/15:c.1764+67G>A:,FGD4:ENST00000525053:intron:MODIFIER:exon16/16:c.2379+67G>A:		rs4575368	0.0667	0.1126	630,336,14	0.0600,0.2666,0.0104,0.1241,0.0786	0.0990	0.3070	D	T	B	T	3.30	611104 [FGD4 (confirmed) Charcot-Marie-Tooth disease,type 4H,609311];				n/a (AF>5%)	n/a (AF>5%)					FGD4 (inh=AR pLI=0.17)
chr12	33538179	33538179	C	T	het		QUAL=1558;DP=99;AF=0.58;MQM=60	SYT10	synonymous	SYT10:ENST00000228567:synonymous:LOW:exon4/7:c.1125G>A:p.Pro375Pro,SYT10:ENST00000535526:synonymous:LOW:exon6/9:c.582G>A:p.Pro194Pro		rs11052670	0.0268	0.0477	181,114,0	0.0121,0.0208,0.0002,0.0591,0.0739	0.0459											16	383					SYT10 (inh=n/a pLI=0.08)
chr12	40645257	40645257	C	A	het		QUAL=124;DP=37;AF=0.24;MQM=60	LRRK2	splice_region&intron	LRRK2:ENST00000298910:splice_region&intron:LOW:exon9/50:c.1102-10C>A:,LRRK2:ENST00000343742:splice_region&intron:LOW:exon9/26:c.1102-10C>A:		rs7955902	0.3195	0.3622	7529,4483,214	0.2151,0.2215,0.3494,0.3876,0.4426	0.3530							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	308613 [benign DISEASE=parkinson_disease_8,_autosomal_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					LRRK2 (inh=AD pLI=0.00)
chr12	40714785	40714785	A	T	het	off-target	QUAL=1610;DP=131;AF=0.49;MQM=60	LRRK2	intron	LRRK2:ENST00000298910:intron:MODIFIER:exon34/50:c.5016-51A>T:		rs10878368	0.5857	0.5735	20259,9833,1789	0.5866,0.6636,0.4759,0.5427,0.6916	0.5777							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				n/a (AF>5%)	n/a (AF>5%)					LRRK2 (inh=AD pLI=0.00)
chr12	43769228	43769228	A	C	het		QUAL=2102;DP=159;AF=0.51;MQM=60	ADAMTS20	synonymous	ADAMTS20:ENST00000389420:synonymous:LOW:exon36/39:c.5400T>G:p.Thr1800Thr		rs10506226	0.2224	0.2043	2923,1478,774	0.3798,0.1045,0.1128,0.2077,0.1815	0.2509										COSM3998792, COSM3998791	n/a (AF>5%)	n/a (AF>5%)					ADAMTS20 (inh=n/a pLI=0.00)
chr12	48413789	48413789	-	TATTGT	het	off-target	QUAL=387;DP=71;AF=0.31;MQM=60	RP1-228P16.5,RP1-228P16.4			L1ME4b	rs113940474;rs58640145	0.6002	0.0000	0,0,0	0,0,0,0,0	0.5162											n/a (AF>5%)	n/a (AF>5%)					RP1-228P16.5 (inh=n/a pLI=n/a), RP1-228P16.4 (inh=n/a pLI=n/a)
chr12	50393372	50393372	G	T	het	off-target	QUAL=521;DP=43;AF=0.51;MQM=60	RACGAP1	intron	RACGAP1:ENST00000312377:intron:MODIFIER:exon8/16:c.748+27C>A:,RACGAP1:ENST00000427314:intron:MODIFIER:exon10/18:c.748+27C>A:,RACGAP1:ENST00000434422:intron:MODIFIER:exon9/17:c.748+27C>A:,RACGAP1:ENST00000454520:intron:MODIFIER:exon8/16:c.748+27C>A:,RACGAP1:ENST00000551016:intron:MODIFIER:exon7/15:c.748+27C>A:,RACGAP1:ENST00000547905:intron:MODIFIER:exon10/18:c.748+27C>A:		rs378943	0.6913	0.8455	45402,28419,399	0.2693,0.8211,0.9273,0.9230,0.8206	0.8587											n/a (AF>5%)	n/a (AF>5%)					RACGAP1 (inh=n/a pLI=0.60)
chr12	50537815	50537815	A	G	het		QUAL=1341;DP=87;AF=0.59;MQM=60	CERS5,RP4-605O3.4	missense	CERS5:ENST00000317551:missense:MODERATE:exon2/10:c.223T>C:p.Cys75Arg,CERS5:ENST00000422340:missense:MODERATE:exon3/11:c.49T>C:p.Cys17Arg		rs7302981	0.8069	0.6987	30453,13019,4087	0.8855,0.7650,0.9172,0.6221,0.7663	0.7206	0.6200	T,T	T	B,B	T,T	5.59					n/a (AF>5%)	n/a (AF>5%)					CERS5 (inh=n/a pLI=0.00), RP4-605O3.4 (inh=n/a pLI=n/a)
chr12	51236802	51236802	T	C	het		QUAL=3263;DP=222;AF=0.53;MQM=60	TMPRSS12	missense	TMPRSS12:ENST00000398458:missense:MODERATE:exon1/5:c.55T>C:p.Tyr19His,TMPRSS12:ENST00000551456:missense:MODERATE:exon1/4:c.55T>C:p.Tyr19His		rs10876100	0.2989	0.3357	3654,1537,485	0.4058,0.3848,0.4904,0.3045,0.2833	0.2898	-0.0770	T,T	T	B,B	D,D	0.01				COSM3753307	n/a (AF>5%)	n/a (AF>5%)					TMPRSS12 (inh=n/a pLI=0.00)
chr12	51237816	51237816	G	A	het		QUAL=1116;DP=95;AF=0.46;MQM=60	TMPRSS12	missense	TMPRSS12:ENST00000398458:missense:MODERATE:exon2/5:c.379G>A:p.Ala127Thr,TMPRSS12:ENST00000551456:missense:MODERATE:exon2/4:c.379G>A:p.Ala127Thr		rs861204	0.1683	0.3395	3776,3163,104	0.2094,0.2400,0.0378,0.4103,0.2579	0.2686	-2.7240	T,T	T	B,B	T,T	0.02				COSM4147154	n/a (AF>5%)	n/a (AF>5%)					TMPRSS12 (inh=n/a pLI=0.00)
chr12	51890721	51890721	G	A	hom	off-target	QUAL=651;DP=22;AF=1.00;MQM=60	SLC4A8	intron	SLC4A8:ENST00000453097:intron:MODIFIER:exon21/24:c.2944-50G>A:,SLC4A8:ENST00000358657:intron:MODIFIER:exon21/21:c.3025-50G>A:		rs10783448	0.4351	0.4944	14690,9347,728	0.3882,0.4053,0.3674,0.5358,0.4872	0.4956											n/a (AF>5%)	n/a (AF>5%)					SLC4A8 (inh=n/a pLI=1.00)
chr12	52965782	52965782	T	C	het		QUAL=2486;DP=206;AF=0.46;MQM=60	KRT74	synonymous	KRT74:ENST00000549343:synonymous:LOW:exon3/10:c.693A>G:p.Glu231Glu,KRT74:ENST00000305620:synonymous:LOW:exon3/9:c.693A>G:p.Glu231Glu		rs673476	0.8071	0.7447	34277,18210,4773	0.9574,0.5592,0.7177,0.7379,0.7790	0.7966							608248 [KRT74 (provisional) Woolly hair,autosomal dominant,194300|Hypotrichosis 3,613981|Ectodermal dysplasia 7,hair/nail type,614929];			COSM4147224	n/a (AF>5%)	n/a (AF>5%)					KRT74 (inh=AR+AD pLI=0.00)
chr12	53662735	53662735	C	T	het	off-target	QUAL=2432;DP=241;AF=0.40;MQM=60	ESPL1	intron	ESPL1:ENST00000257934:intron:MODIFIER:exon2/30:c.82-73C>T:,ESPL1:ENST00000552462:intron:MODIFIER:exon2/30:c.82-73C>T:		rs4758965	0.7502	0.7283	25840,11522,1319	0.5894,0.8575,0.9598,0.6718,0.8386	0.7245											n/a (AF>5%)	n/a (AF>5%)					ESPL1 (inh=n/a pLI=1.00)
chr12	53664148	53664148	G	A	het		QUAL=1972;DP=140;AF=0.57;MQM=60	ESPL1	splice_region&intron	ESPL1:ENST00000257934:splice_region&intron:LOW:exon3/30:c.1144-14G>A:,ESPL1:ENST00000552462:splice_region&intron:LOW:exon3/30:c.1144-14G>A:		rs4758963	0.4599	0.4868	14817,7579,339	0.2676,0.5209,0.6048,0.4791,0.5853	0.4885											n/a (AF>5%)	n/a (AF>5%)					ESPL1 (inh=n/a pLI=1.00)
chr12	53693533	53693533	A	C	hom		QUAL=1725;DP=56;AF=1.00;MQM=60	C12orf10,RP11-680A11.5	missense	C12orf10:ENST00000267103:missense:MODERATE:exon1/7:c.12A>C:p.Gln4His		rs1534283	0.9497	0.9845	57093,32197,3241	0.8239,0.9930,0.9994,0.9996,0.9996	0.9876	-1.6040	T,T	T	B,B	T	0.03					n/a (AF>5%)	n/a (AF>5%)					C12orf10 (inh=n/a pLI=0.00), RP11-680A11.5 (inh=n/a pLI=n/a)
chr12	54932788	54932788	T	C	hom	off-target	QUAL=2587;DP=78;AF=1.00;MQM=60	NCKAP1L	intron	NCKAP1L:ENST00000293373:intron:MODIFIER:exon30/30:c.3273+31T>C:,NCKAP1L:ENST00000545638:intron:MODIFIER:exon30/30:c.3123+31T>C:		rs4758966	0.8892	0.8929	48247,26182,3435	0.8146,0.9531,0.9677,0.8877,0.8931	0.8972											n/a (AF>5%)	n/a (AF>5%)					NCKAP1L (inh=n/a pLI=1.00)
chr12	55714772	55714772	G	A	hom	gene_blacklist	QUAL=2989;DP=91;AF=1.00;MQM=60	OR6C1	missense	OR6C1:ENST00000379668:missense:MODERATE:exon1/1:c.389G>A:p.Cys130Tyr		rs7132431	0.7827	0.7683	35835,20605,3442	0.8157,0.7299,0.8592,0.7870,0.6692	0.7806	6.8000	T	T	B	T	0.02					n/a (AF>5%)	n/a (AF>5%)					OR6C1 (inh=n/a pLI=0.01)
chr12	55945119	55945119	A	G	hom		QUAL=5378;DP=166;AF=1.00;MQM=60	OR6C4,RP11-110A12.2	missense	OR6C4:ENST00000394256:missense:MODERATE:exon1/1:c.109A>G:p.Ile37Val		rs7313899	0.9954	0.9924	59788,32586,5178	0.9976,0.9971,1.0000,0.9882,0.9993	0.9924	-2.9740	T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					OR6C4 (inh=n/a pLI=0.00), RP11-110A12.2 (inh=n/a pLI=n/a)
chr12	56080148	56080148	T	C	het	off-target	QUAL=169;DP=25;AF=0.44;MQM=60	ITGA7	intron	ITGA7:ENST00000555728:intron:MODIFIER:exon25/25:c.3316-1076A>G:,ITGA7:ENST00000553804:intron:MODIFIER:exon24/24:c.3196-1076A>G:,ITGA7:ENST00000257879:intron:MODIFIER:exon24/24:c.3184-1076A>G:,ITGA7:ENST00000347027:intron:MODIFIER:exon24/24:c.3166-1076A>G:,ITGA7:ENST00000452168:intron:MODIFIER:exon24/24:c.2905-1076A>G:,ITGA7:ENST00000257880:intron:MODIFIER:exon25/26:c.3316-50A>G:,ITGA7:ENST00000394229:intron:MODIFIER:exon24/25:c.3184-50A>G:,ITGA7:ENST00000394230:intron:MODIFIER:exon24/25:c.3196-50A>G:		rs3782239	0.5925	0.5936	3869,1176,64	0.3021,0.6990,0.9203,0.5125,0.6970	0.5971							600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];				n/a (AF>5%)	n/a (AF>5%)					ITGA7 (inh=AR pLI=0.00)
chr12	56097025	56097025	A	C	het	off-target	QUAL=234;DP=13;AF=0.77;MQM=60	ITGA7	intron	ITGA7:ENST00000555728:intron:MODIFIER:exon1/25:c.207-63T>G:,ITGA7:ENST00000553804:intron:MODIFIER:exon1/24:c.207-63T>G:,ITGA7:ENST00000257879:intron:MODIFIER:exon1/24:c.207-63T>G:,ITGA7:ENST00000347027:intron:MODIFIER:exon1/24:c.207-63T>G:,ITGA7:ENST00000452168:intron:MODIFIER:exon2/24:c.86-1825T>G:,ITGA7:ENST00000257880:intron:MODIFIER:exon1/26:c.207-63T>G:,ITGA7:ENST00000394229:intron:MODIFIER:exon1/25:c.207-63T>G:,ITGA7:ENST00000394230:intron:MODIFIER:exon1/25:c.207-63T>G:		rs2293414	0.6128	0.0000	0,0,0	0,0,0,0,0	0.5227							600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];				n/a (AF>5%)	n/a (AF>5%)					ITGA7 (inh=AR pLI=0.00)
chr12	56647911	56647911	G	C	hom		QUAL=3017;DP=91;AF=1.00;MQM=60	ANKRD52	synonymous	ANKRD52:ENST00000267116:synonymous:LOW:exon8/28:c.846C>G:p.Ser282Ser		rs808919	0.8047	0.9050	50495,29200,1115	0.4729,0.9203,0.9724,0.9355,0.9751	0.9120											n/a (AF>5%)	n/a (AF>5%)					ANKRD52 (inh=n/a pLI=1.00)
chr12	56825311	56825311	C	T	het		QUAL=749;DP=58;AF=0.50;MQM=60	TIMELESS	synonymous	TIMELESS:ENST00000553532:synonymous:LOW:exon8/29:c.765G>A:p.Val255Val,TIMELESS:ENST00000229201:synonymous:LOW:exon8/29:c.762G>A:p.Val254Val,TIMELESS:ENST00000554616:synonymous:LOW:exon8/19:c.765G>A:p.Val255Val		rs774033	0.5042	0.4925	15835,7146,361	0.2632,0.7413,0.7388,0.4595,0.4939	0.5036										COSM3753400	n/a (AF>5%)	n/a (AF>5%)					TIMELESS (inh=n/a pLI=0.00)
chr12	57843014	57843014	C	T	hom	off-target	QUAL=3246;DP=103;AF=1.00;MQM=60	INHBC	intron	INHBC:ENST00000309668:intron:MODIFIER:exon1/1:c.314-46C>T:		rs776037	0.8464	0.9510	51789,31827,1812	0.5944,0.9782,0.9478,0.9931,0.9966	0.9551											n/a (AF>5%)	n/a (AF>5%)					INHBC (inh=n/a pLI=0.07)
chr12	58010163	58010163	A	G	het		QUAL=955;DP=109;AF=0.39;MQM=60	ARHGEF25,AC025165.8	missense	ARHGEF25:ENST00000333972:missense:MODERATE:exon15/16:c.1634A>G:p.Gln545Arg,ARHGEF25:ENST00000286494:missense:MODERATE:exon14/15:c.1517A>G:p.Gln506Arg		rs1564374	0.6302	0.6254	24281,11109,1503	0.5376,0.7447,0.7731,0.5750,0.7192	0.6267	0.3210	T,T	T	B,B	T,T	0.01				COSM4147335, COSM4147336	n/a (AF>5%)	n/a (AF>5%)					ARHGEF25 (inh=n/a pLI=0.00), AC025165.8 (inh=n/a pLI=n/a)
chr12	58124803	58124803	C	T	hom	off-target	QUAL=1594;DP=51;AF=1.00;MQM=60	AGAP2	intron	AGAP2:ENST00000547588:intron:MODIFIER:exon10/18:c.2146-67G>A:,AGAP2:ENST00000257897:intron:MODIFIER:exon10/17:c.1138-67G>A:		rs238523	0.9738	0.0000	0,0,0	0,0,0,0,0	0.9769											n/a (AF>5%)	n/a (AF>5%)					AGAP2 (inh=n/a pLI=1.00)
chr12	58144665	58144665	C	T	het	off-target	QUAL=2011;DP=139;AF=0.55;MQM=60	CDK4	intron	CDK4:ENST00000257904:intron:MODIFIER:exon4/7:c.522+41G>A:,CDK4:ENST00000312990:intron:MODIFIER:exon3/6:c.265-211G>A:,CDK4:ENST00000549606:intron:MODIFIER:exon1/3:c.-158+1293G>A:,CDK4:ENST00000540325:intron:MODIFIER:exon3/6:c.162+41G>A:		rs2069502	0.3367	0.3541	8775,3639,30	0.0775,0.3607,0.6407,0.3232,0.4990	0.3552							123829 [CDK4 (confirmed) Melanoma,cutaneous malignant,3,609048];				n/a (AF>5%)	n/a (AF>5%)					CDK4 (inh=n/a pLI=0.98)
chr12	58196447	58196447	G	A	het	off-target	QUAL=1542;DP=89;AF=0.64;MQM=60	TSFM,AVIL	3'UTR,intron	TSFM:ENST00000543727:3'UTR:MODIFIER:exon6/6:c.*33G>A:,TSFM:ENST00000550559:3'UTR:MODIFIER:exon7/7:c.*79G>A:,AVIL:ENST00000257861:intron:MODIFIER:exon15/18:c.1963-316C>T:,TSFM:ENST00000548851:intron:MODIFIER:exon5/5:c.572-5200G>A:,AVIL:ENST00000537081:intron:MODIFIER:exon15/18:c.1942-316C>T:	L2	rs10783847	0.4044	0.4730	922,113,12	0.2218,0.0000,0.0000,0.3137,0.5836	0.3859							604723 [TSFM (confirmed) Combined oxidative phosphorylation deficiency 3,610505];				n/a (AF>5%)	n/a (AF>5%)					TSFM (inh=AR pLI=0.00), AVIL (inh=n/a pLI=0.00)
chr12	58203354	58203354	C	T	het	off-target	QUAL=1332;DP=129;AF=0.44;MQM=60	AVIL	intron	AVIL:ENST00000257861:intron:MODIFIER:exon8/18:c.939+26G>A:,AVIL:ENST00000537081:intron:MODIFIER:exon8/18:c.918+26G>A:		rs3825079	0.3375	0.3529	8667,3600,30	0.0736,0.3619,0.6281,0.3231,0.4992	0.3545											n/a (AF>5%)	n/a (AF>5%)					AVIL (inh=n/a pLI=0.00)
chr12	68719216	68719216	G	A	het		QUAL=624;DP=62;AF=0.42;MQM=60	MDM1	splice_region&intron,3'UTR,intron	MDM1:ENST00000303145:splice_region&intron:LOW:exon4/13:c.633+5C>T:,MDM1:ENST00000540418:splice_region&intron:LOW:exon3/12:c.-208+5C>T:,MDM1:ENST00000393543:3'UTR:MODIFIER:exon3/3:c.*1998C>T:,MDM1:ENST00000430606:3'UTR:MODIFIER:exon3/3:c.*1050C>T:,MDM1:ENST00000411698:intron:MODIFIER:exon3/13:c.498+1221C>T:		rs2870812	0.6783	0.6976	29757,17016,3411	0.8097,0.6642,0.4221,0.7163,0.7070	0.7176											n/a (AF>5%)	n/a (AF>5%)					MDM1 (inh=n/a pLI=0.00)
chr12	70091432	70091432	T	C	hom		QUAL=773;DP=26;AF=1.00;MQM=60	BEST3	synonymous,5'UTR,intron	BEST3:ENST00000330891:synonymous:LOW:exon2/10:c.147A>G:p.Val49Val,BEST3:ENST00000331471:synonymous:LOW:exon2/10:c.147A>G:p.Val49Val,BEST3:ENST00000393365:5'UTR:MODIFIER:exon2/5:c.-172A>G:,BEST3:ENST00000553096:intron:MODIFIER:exon1/7:c.-72+1553A>G:,BEST3:ENST00000476098:intron:MODIFIER:exon1/6:c.-185+1553A>G:,BEST3:ENST00000266661:intron:MODIFIER:exon1/2:c.-72+1553A>G:,BEST3:ENST00000551160:intron:MODIFIER:exon1/3:c.-167+1553A>G:		rs775429	0.9732	0.9933	59380,33265,4182	0.9241,0.9962,1.0000,0.9998,0.9999	0.9944											n/a (AF>5%)	n/a (AF>5%)					BEST3 (inh=n/a pLI=0.00)
chr12	72416235	72416235	A	T	het		QUAL=2105;DP=159;AF=0.50;MQM=60	TPH2	synonymous	TPH2:ENST00000333850:synonymous:LOW:exon9/11:c.1125A>T:p.Ala375Ala		rs4290270	0.4872	0.5732	20411,13589,874	0.4108,0.5203,0.4860,0.6375,0.5191	0.5715							607478 [TPH2 (provisional) Unipolar depression,susceptibility to,608516|Attention deficit-hyperactivity disorder,susceptibility to,7,613003];	310388 [likely benign DISEASE=tryptophan_5-monooxygenase_deficiency]; 		COSM3753489	n/a (AF>5%)	n/a (AF>5%)					TPH2 (inh=n/a pLI=0.87)
chr12	80816492	80816492	C	T	hom	off-target	QUAL=7264;DP=220;AF=1.00;MQM=60	PTPRQ				rs4482093	0.6945	0.8256	3682,962,25	0.0000,0.0000,0.0000,0.8431,0.8278	0.7759											n/a (AF>5%)	n/a (AF>5%)					PTPRQ (inh=AR pLI=n/a)
chr12	94562875	94562875	C	G	het	off-target	QUAL=301;DP=26;AF=0.58;MQM=60	PLXNC1,RP11-74K11.2	intron	PLXNC1:ENST00000258526:intron:MODIFIER:exon1/30:c.1063-54C>G:		rs2361359	0.8780	0.0000	0,0,0	0,0,0,0,0	0.8558											n/a (AF>5%)	n/a (AF>5%)					PLXNC1 (inh=n/a pLI=1.00), RP11-74K11.2 (inh=n/a pLI=n/a)
chr12	96260947	96260947	A	G	het		QUAL=540;DP=37;AF=0.57;MQM=60	CCDC38,SNRPF	synonymous,intron	CCDC38:ENST00000344280:synonymous:LOW:exon16/16:c.1599T>C:p.Phe533Phe,SNRPF:ENST00000552085:intron:MODIFIER:exon2/4:c.129+5876A>G:,SNRPF:ENST00000553192:intron:MODIFIER:exon2/2:c.129+5876A>G:		rs7960706	0.3143	0.3809	9235,5565,340	0.2586,0.3361,0.2049,0.4052,0.4841	0.3738											n/a (AF>5%)	n/a (AF>5%)					CCDC38 (inh=n/a pLI=0.00), SNRPF (inh=n/a pLI=0.72)
chr12	99640428	99640428	T	C	het		QUAL=1635;DP=117;AF=0.54;MQM=60	ANKS1B	synonymous	ANKS1B:ENST00000329257:synonymous:LOW:exon13/26:c.1971A>G:p.Ser657Ser,ANKS1B:ENST00000547776:synonymous:LOW:exon13/26:c.1971A>G:p.Ser657Ser,ANKS1B:ENST00000547010:synonymous:LOW:exon6/18:c.711A>G:p.Ser237Ser		rs3751323	0.5483	0.4807	14818,5499,724	0.3874,0.5465,0.7926,0.4069,0.6589	0.4811										COSM3931777, COSM3931776	n/a (AF>5%)	n/a (AF>5%)					ANKS1B (inh=n/a pLI=0.98)
chr12	102053675	102053675	C	T	het	off-target	QUAL=483;DP=34;AF=0.59;MQM=60	MYBPC1,RP11-755O11.2	intron	MYBPC1:ENST00000452455:intron:MODIFIER:exon17/29:c.1852+66C>T:,MYBPC1:ENST00000547405:intron:MODIFIER:exon15/27:c.1774+66C>T:,MYBPC1:ENST00000360610:intron:MODIFIER:exon17/29:c.1852+66C>T:,MYBPC1:ENST00000441232:intron:MODIFIER:exon17/30:c.1852+66C>T:,MYBPC1:ENST00000392934:intron:MODIFIER:exon16/26:c.1813+66C>T:,MYBPC1:ENST00000547509:intron:MODIFIER:exon16/28:c.1810+66C>T:,MYBPC1:ENST00000361685:intron:MODIFIER:exon19/30:c.1927+66C>T:,MYBPC1:ENST00000549145:intron:MODIFIER:exon18/30:c.1891+66C>T:,MYBPC1:ENST00000553190:intron:MODIFIER:exon17/28:c.1852+66C>T:,MYBPC1:ENST00000536007:intron:MODIFIER:exon16/28:c.1795+66C>T:,MYBPC1:ENST00000541119:intron:MODIFIER:exon16/28:c.1816+66C>T:,MYBPC1:ENST00000545503:intron:MODIFIER:exon17/29:c.1852+66C>T:,MYBPC1:ENST00000361466:intron:MODIFIER:exon19/31:c.1927+66C>T:,MYBPC1:ENST00000551300:intron:MODIFIER:exon20/31:c.1555+66C>T:,MYBPC1:ENST00000550270:intron:MODIFIER:exon17/28:c.1852+66C>T:		rs17511481	0.1593	0.0000	0,0,0	0,0,0,0,0	0.2242							160794 [MYBPC1 (provisional) Arthrogryposis,distal,type 1B,614335|Lethal congenital contracture syndrome 4,614915];				n/a (AF>5%)	n/a (AF>5%)					MYBPC1 (inh=AR+AD pLI=0.35), RP11-755O11.2 (inh=n/a pLI=n/a)
chr12	102079418	102079418	G	A	het		QUAL=1716;DP=135;AF=0.49;MQM=60	MYBPC1	synonymous,3'UTR	MYBPC1:ENST00000392934:synonymous:LOW:exon27/27:c.3378G>A:p.Ser1126Ser,MYBPC1:ENST00000452455:3'UTR:MODIFIER:exon30/30:c.*8G>A:,MYBPC1:ENST00000547405:3'UTR:MODIFIER:exon28/28:c.*78G>A:,MYBPC1:ENST00000360610:3'UTR:MODIFIER:exon30/30:c.*88G>A:,MYBPC1:ENST00000441232:3'UTR:MODIFIER:exon31/31:c.*78G>A:,MYBPC1:ENST00000547509:3'UTR:MODIFIER:exon29/29:c.*78G>A:,MYBPC1:ENST00000361685:3'UTR:MODIFIER:exon31/31:c.*88G>A:,MYBPC1:ENST00000549145:3'UTR:MODIFIER:exon31/31:c.*88G>A:,MYBPC1:ENST00000553190:3'UTR:MODIFIER:exon29/29:c.*88G>A:,MYBPC1:ENST00000361466:3'UTR:MODIFIER:exon32/32:c.*78G>A:,MYBPC1:ENST00000551300:3'UTR:MODIFIER:exon32/32:c.*88G>A:		rs2764	0.5701	0.6293	2496,573,95	0.6061,0.0000,0.6700,0.5537,0.6689	0.5615							160794 [MYBPC1 (provisional) Arthrogryposis,distal,type 1B,614335|Lethal congenital contracture syndrome 4,614915];	306752 [benign DISEASE=distal_arthrogryposis]; 			n/a (AF>5%)	n/a (AF>5%)					MYBPC1 (inh=AR+AD pLI=0.35)
chr12	102301915	102301915	T	C	het	off-target	QUAL=573;DP=46;AF=0.52;MQM=60	DRAM1	intron	DRAM1:ENST00000258534:intron:MODIFIER:exon3/6:c.343-49T>C:,DRAM1:ENST00000544152:intron:MODIFIER:exon3/3:c.342+6704T>C:		rs61936575	0.0996	0.1053	728,382,118	0.1534,0.1774,0.0081,0.1090,0.0511	0.1140											n/a (AF>5%)	n/a (AF>5%)					DRAM1 (inh=n/a pLI=0.07)
chr12	105600935	105600935	G	A	het		QUAL=2026;DP=124;AF=0.59;MQM=60	APPL2	synonymous	APPL2:ENST00000551662:synonymous:LOW:exon8/21:c.543C>T:p.His181His,APPL2:ENST00000258530:synonymous:LOW:exon8/21:c.525C>T:p.His175His,APPL2:ENST00000539978:synonymous:LOW:exon8/21:c.396C>T:p.His132His		rs2293643	0.1835	0.2027	2604,1348,45	0.0866,0.2692,0.2534,0.2040,0.1858	0.2067											n/a (AF>5%)	n/a (AF>5%)					APPL2 (inh=AD pLI=0.00)
chr12	107126065	107126065	A	G	het	off-target	QUAL=2218;DP=140;AF=0.59;MQM=60	RP11-144F15.1,RFX4,RP11-482D24.3	intron	RFX4:ENST00000357881:intron:MODIFIER:exon14/17:c.1498+38A>G:,RFX4:ENST00000392842:intron:MODIFIER:exon14/17:c.1471+38A>G:,RFX4:ENST00000229387:intron:MODIFIER:exon10/13:c.1189+38A>G:		rs7307472	0.1623	0.2273	3449,2067,64	0.1113,0.2821,0.0634,0.2464,0.2815	0.2324											n/a (AF>5%)	n/a (AF>5%)					RP11-144F15.1 (inh=n/a pLI=n/a), RFX4 (inh=n/a pLI=1.00), RP11-482D24.3 (inh=n/a pLI=n/a)
chr12	108035805	108035805	T	C	hom	off-target	QUAL=3915;DP=123;AF=1.00;MQM=60	BTBD11	intron	BTBD11:ENST00000280758:intron:MODIFIER:exon13/16:c.2841-62T>C:,BTBD11:ENST00000420571:intron:MODIFIER:exon11/14:c.2484-62T>C:,BTBD11:ENST00000490090:intron:MODIFIER:exon13/14:c.2841-62T>C:,BTBD11:ENST00000357167:intron:MODIFIER:exon11/14:c.1452-62T>C:,BTBD11:ENST00000494235:intron:MODIFIER:exon3/6:c.78-62T>C:		rs9919699	0.1957	0.0000	0,0,0	0,0,0,0,0	0.2045											n/a (AF>5%)	n/a (AF>5%)					BTBD11 (inh=n/a pLI=0.99)
chr12	108686008	108686008	C	G	hom		QUAL=7190;DP=215;AF=1.00;MQM=60	CMKLR1	synonymous	CMKLR1:ENST00000312143:synonymous:LOW:exon3/3:c.732G>C:p.Val244Val,CMKLR1:ENST00000412676:synonymous:LOW:exon3/3:c.732G>C:p.Val244Val,CMKLR1:ENST00000397688:synonymous:LOW:exon3/3:c.726G>C:p.Val242Val,CMKLR1:ENST00000552995:synonymous:LOW:exon3/3:c.726G>C:p.Val242Val,CMKLR1:ENST00000550402:synonymous:LOW:exon4/4:c.732G>C:p.Val244Val		rs1057401	0.3704	0.3865	10322,6764,1818	0.6070,0.2393,0.0059,0.4502,0.3136	0.4481										COSM3752875	n/a (AF>5%)	n/a (AF>5%)					CMKLR1 (inh=n/a pLI=0.28)
chr12	109617865	109617865	T	C	hom		QUAL=1116;DP=36;AF=1.00;MQM=60	ACACB	synonymous	ACACB:ENST00000338432:synonymous:LOW:exon11/53:c.1791T>C:p.Asp597Asp,ACACB:ENST00000377848:synonymous:LOW:exon10/52:c.1791T>C:p.Asp597Asp,ACACB:ENST00000377854:synonymous:LOW:exon10/51:c.1791T>C:p.Asp597Asp		rs11065772	0.6773	0.7715	36831,23459,1627	0.5598,0.6007,0.7259,0.8372,0.7530	0.7705										COSM4146529	n/a (AF>5%)	n/a (AF>5%)					ACACB (inh=n/a pLI=0.00)
chr12	109685545	109685545	A	G	hom	off-target	QUAL=961;DP=31;AF=1.00;MQM=60	ACACB	intron	ACACB:ENST00000338432:intron:MODIFIER:exon40/52:c.5669+37A>G:,ACACB:ENST00000377848:intron:MODIFIER:exon39/51:c.5669+37A>G:,ACACB:ENST00000377854:intron:MODIFIER:exon38/50:c.5459+37A>G:,ACACB:ENST00000543201:intron:MODIFIER:exon12/25:c.1667+37A>G:		rs2284689	0.7316	0.7899	37664,22025,2195	0.6603,0.8844,0.7634,0.8179,0.6761	0.7988											n/a (AF>5%)	n/a (AF>5%)					ACACB (inh=n/a pLI=0.00)
chr12	110013879	110013879	G	A	het		QUAL=1642;DP=147;AF=0.44;MQM=60	MVK	missense,5'UTR,intron	MVK:ENST00000228510:missense:MODERATE:exon3/11:c.155G>A:p.Ser52Asn,MVK:ENST00000392727:missense:MODERATE:exon3/10:c.155G>A:p.Ser52Asn,MVK:ENST00000539575:missense:MODERATE:exon2/9:c.155G>A:p.Ser52Asn,MVK:ENST00000541384:5'UTR:MODIFIER:exon2/8:c.-127G>A:,MVK:ENST00000539696:intron:MODIFIER:exon1/4:c.-92+2201G>A:		rs7957619	0.0759	0.1017	834,657,46	0.0864,0.0691,0.0001,0.1341,0.0427	0.1223	0.1180	T,T,T,T,T	T	B,B	D,D,D,D,D	0.01	251170 [MVK (confirmed) Mevalonic aciduria,610377|Hyper-IgD syndrome,260920|Porokeratosis 3,multiple types,175900];	129638 [benign/likely benign DISEASE=methylmalonic_acidemia,hyperimmunoglobulin_d_with_periodic_fever,mevalonic_aciduria,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MVK (inh=AR+AD pLI=0.13)
chr12	116429689	116429689	A	G	het		QUAL=1272;DP=109;AF=0.45;MQM=60	MED13L	synonymous	MED13L:ENST00000281928:synonymous:LOW:exon17/31:c.3070T>C:p.Leu1024Leu		rs1865787	0.1558	0.1732	1904,1165,30	0.0823,0.1182,0.1403,0.1868,0.2075	0.1701							608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];				n/a (AF>5%)	n/a (AF>5%)					MED13L (inh=AD pLI=1.00)
chr12	119871387	119871387	A	G	hom		QUAL=3955;DP=119;AF=1.00;MQM=60	CCDC60,RP11-768F21.1	missense,intron	CCDC60:ENST00000536742:missense:MODERATE:exon3/3:c.367A>G:p.Thr123Ala,CCDC60:ENST00000327554:intron:MODIFIER:exon2/13:c.170+4820A>G:		rs1716471	0.6358	0.6692	2480,493,32	0.5200,0.0000,0.0000,0.5917,0.6994	0.6265	-0.0970	T	T		T	3.71					n/a (AF>5%)	n/a (AF>5%)					CCDC60 (inh=n/a pLI=0.00), RP11-768F21.1 (inh=n/a pLI=n/a)
chr12	121097622	121097622	G	A	hom	off-target	QUAL=3380;DP=106;AF=1.00;MQM=60	CABP1	intron	CABP1:ENST00000316803:intron:MODIFIER:exon1/5:c.655-59G>A:,CABP1:ENST00000288616:intron:MODIFIER:exon2/6:c.226-59G>A:,CABP1:ENST00000351200:intron:MODIFIER:exon1/5:c.46-59G>A:,CABP1:ENST00000453000:intron:MODIFIER:exon1/5:c.463-59G>A:		rs529584	0.9177	0.0000	0,0,0	0,0,0,0,0	0.8953											n/a (AF>5%)	n/a (AF>5%)					CABP1 (inh=n/a pLI=0.99)
chr12	121435587	121435587	G	T	het		QUAL=3496;DP=300;AF=0.46;MQM=60	HNF1A	synonymous,3'UTR,intron	HNF1A:ENST00000400024:synonymous:LOW:exon7/7:c.1620G>T:p.Val540Val,HNF1A:ENST00000538626:synonymous:LOW:exon2/2:c.366G>T:p.Val122Val,HNF1A:ENST00000402929:3'UTR:MODIFIER:exon6/6:c.*788G>T:,HNF1A:ENST00000541395:intron:MODIFIER:exon7/8:c.1501+119G>T:,HNF1A:ENST00000257555:intron:MODIFIER:exon7/9:c.1501+119G>T:,HNF1A:ENST00000544413:intron:MODIFIER:exon7/9:c.1501+119G>T:		rs2259816	0.3588	0.4492	1718,524,17	0.1516,0.4390,0.4525,0.4288,0.5178	0.4030							142410 [HNF1A (confirmed) MODY,type III,600496|Diabetes mellitus,noninsulin-dependent,2,125853|Diabetes mellitus,insulin-dependent,222100|Hepatic adenoma,somatic,142330|Renal cell carcinoma,144700|Diabetes mellitus,insulin-dependent,20,612520];				n/a (AF>5%)	n/a (AF>5%)					HNF1A (inh=AD pLI=0.99)
chr12	121622563	121622563	G	A	hom		QUAL=3969;DP=121;AF=1.00;MQM=60	P2RX7	synonymous	P2RX7:ENST00000546057:synonymous:LOW:exon13/13:c.1746G>A:p.Pro582Pro,P2RX7:ENST00000328963:synonymous:LOW:exon12/12:c.1236G>A:p.Pro412Pro,P2RX7:ENST00000535250:synonymous:LOW:exon14/14:c.1476G>A:p.Pro492Pro,P2RX7:ENST00000541446:synonymous:LOW:exon11/11:c.879G>A:p.Pro293Pro		rs1621388	0.3203	0.4162	1693,742,257	0.5009,0.2638,0.1815,0.4295,0.4031	0.4003										COSM430528	n/a (AF>5%)	n/a (AF>5%)					P2RX7 (inh=n/a pLI=0.00)
chr12	122674758	122674758	G	A	het		QUAL=4435;DP=323;AF=0.51;MQM=60	LRRC43	synonymous	LRRC43:ENST00000339777:synonymous:LOW:exon5/12:c.744G>A:p.Arg248Arg,LRRC43:ENST00000425921:synonymous:LOW:exon5/12:c.189G>A:p.Arg63Arg		rs4758651	0.6492	0.7073	31033,17462,770	0.3962,0.6543,0.9131,0.7225,0.7159	0.7122											n/a (AF>5%)	n/a (AF>5%)					LRRC43 (inh=n/a pLI=0.00)
chr12	122691738	122691738	C	A	hom		QUAL=8830;DP=265;AF=1.00;MQM=60	B3GNT4	synonymous	B3GNT4:ENST00000324189:synonymous:LOW:exon3/3:c.940C>A:p.Arg314Arg,B3GNT4:ENST00000546192:synonymous:LOW:exon2/2:c.865C>A:p.Arg289Arg,B3GNT4:ENST00000535274:synonymous:LOW:exon1/1:c.865C>A:p.Arg289Arg		rs4758675	0.9936	0.9979	60407,33354,4966	0.9771,0.9991,0.9999,0.9999,1.0000	0.9983											n/a (AF>5%)	n/a (AF>5%)					B3GNT4 (inh=n/a pLI=0.00)
chr12	123651162	123651162	A	G	het	off-target	QUAL=1128;DP=68;AF=0.63;MQM=60	MPHOSPH9	intron	MPHOSPH9:ENST00000606320:intron:MODIFIER:exon17/23:c.2591+40T>C:,MPHOSPH9:ENST00000302349:intron:MODIFIER:exon13/19:c.2135+40T>C:,MPHOSPH9:ENST00000541076:intron:MODIFIER:exon15/21:c.2501+40T>C:,MPHOSPH9:ENST00000392425:intron:MODIFIER:exon13/19:c.2135+40T>C:		rs1716167	0.6340	0.7333	34355,20057,316	0.2382,0.7221,0.9752,0.7744,0.7275	0.7425											n/a (AF>5%)	n/a (AF>5%)					MPHOSPH9 (inh=n/a pLI=0.01)
chr12	127229506	127229506	T	C	hom	off-target	QUAL=6709;DP=203;AF=1.00;MQM=60	LINC00944,LINC00943	intron,non_coding_transcript_exon	LINC00944:ENST00000540684:intron:MODIFIER:exon3/5:n.602+1301A>G:,LINC00943:ENST00000535544:non_coding_transcript_exon:MODIFIER:exon3/3:n.1523T>C:		rs10847208	0.6158	0.0000	0,0,0	0,0,0,0,0	0.5080											n/a (AF>5%)	n/a (AF>5%)					LINC00944 (inh=n/a pLI=n/a), LINC00943 (inh=n/a pLI=n/a)
chr12	129028708	129028708	G	C	het	off-target	QUAL=167;DP=11;AF=0.64;MQM=60	TMEM132C	intron	TMEM132C:ENST00000435159:intron:MODIFIER:exon3/8:c.1121+60G>C:,TMEM132C:ENST00000315208:intron:MODIFIER:exon1/6:c.-32+60G>C:		rs11610490	0.3622	0.0000	0,0,0	0,0,0,0,0	0.4184											n/a (AF>5%)	n/a (AF>5%)					TMEM132C (inh=n/a pLI=0.65)
chr12	132406666	132406666	G	C	het		QUAL=1828;DP=139;AF=0.50;MQM=60	ULK1	3'UTR	ULK1:ENST00000321867:3'UTR:MODIFIER:exon28/28:c.*760G>C:		rs7138581	0.2917	0.2229	130,24,25	0.0000,0.0000,0.0000,0.2134,0.2128	0.2674			T			0.46					n/a (AF>5%)	n/a (AF>5%)					ULK1 (inh=n/a pLI=0.90)
chr12	133236000	133236000	C	T	hom		QUAL=3135;DP=95;AF=1.00;MQM=60	POLE	synonymous	POLE:ENST00000320574:synonymous:LOW:exon26/49:c.3156G>A:p.Thr1052Thr,POLE:ENST00000535270:synonymous:LOW:exon25/48:c.3075G>A:p.Thr1025Thr		rs5744857	0.6054	0.5029	16066,6061,2661	0.7134,0.5822,0.7078,0.4262,0.5436	0.5300							174762 [POLE (provisional) Colorectal cancer,susceptibility to,12,615083|FILS syndrome,615139];	380212 [benign DISEASE=hereditary_cancer-predisposing_syndrome,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					POLE (inh=AR+AD pLI=0.00)
chr13	25029401	25029401	C	G	het	off-target	QUAL=1129;DP=75;AF=0.59;MQM=60	PARP4,TPTE2P6	intron	PARP4:ENST00000381989:intron:MODIFIER:exon21/33:c.2563-51G>C:		rs7317188	0.3125	0.3237	5829,3914,560	0.3325,0.1645,0.2886,0.3587,0.3018	0.3235											n/a (AF>5%)	n/a (AF>5%)					PARP4 (inh=n/a pLI=0.00), TPTE2P6 (inh=n/a pLI=n/a)
chr13	25075720	25075720	C	T	het	off-target	QUAL=2744;DP=255;AF=0.43;MQM=60	PARP4,TPTE2P6	intron	PARP4:ENST00000381989:intron:MODIFIER:exon3/33:c.334+51G>A:		rs9578753	0.0655	0.0929	592,420,46	0.0893,0.0478,0.0187,0.1133,0.0694	0.1059											n/a (AF>5%)	n/a (AF>5%)					PARP4 (inh=n/a pLI=0.00), TPTE2P6 (inh=n/a pLI=n/a)
chr13	28009920	28009920	G	C	het		QUAL=941;DP=104;AF=0.39;MQM=60	MTIF3,GTF3A	missense	MTIF3:ENST00000381116:missense:MODERATE:exon7/7:c.729C>G:p.Phe243Leu,MTIF3:ENST00000405591:missense:MODERATE:exon5/5:c.729C>G:p.Phe243Leu,MTIF3:ENST00000431572:missense:MODERATE:exon6/6:c.729C>G:p.Phe243Leu,MTIF3:ENST00000381120:missense:MODERATE:exon5/5:c.729C>G:p.Phe243Leu		rs1218825	0.8169	0.8806	48281,30347,4248	0.9043,0.6133,0.5349,0.9535,0.9158	0.9085	0.4570	T,T,T,T	T	B	T,T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					MTIF3 (inh=n/a pLI=0.02), GTF3A (inh=n/a pLI=n/a)
chr13	28519354	28519354	A	C	hom	off-target;gene_blacklist	QUAL=1774;DP=58;AF=1.00;MQM=60	ATP5EP2	5'UTR	ATP5EP2:ENST00000381026:5'UTR:MODIFIER:exon1/1:c.-43A>C:		rs2504220	0.7598	0.8449	34002,19710,1391	0.5737,0.8583,0.8027,0.8774,0.8911	0.8492											n/a (AF>5%)	n/a (AF>5%)					ATP5F1EP2 (inh=n/a pLI=0.02)
chr13	31513931	31513931	T	A	het		QUAL=1906;DP=139;AF=0.54;MQM=60	TEX26	splice_region&intron	TEX26:ENST00000380473:splice_region&intron:LOW:exon2/6:c.146+16T>A:		rs2225505	0.4105	0.3750	8306,4061,1074	0.4566,0.2997,0.4696,0.3579,0.3947	0.3787											n/a (AF>5%)	n/a (AF>5%)					TEX26 (inh=n/a pLI=0.00)
chr13	32335880	32335880	G	A	het		QUAL=2349;DP=159;AF=0.55;MQM=60	RXFP2	synonymous	RXFP2:ENST00000298386:synonymous:LOW:exon3/18:c.261G>A:p.Ala87Ala,RXFP2:ENST00000380314:synonymous:LOW:exon3/17:c.261G>A:p.Ala87Ala		rs9532479	0.0425	0.0509	207,150,3	0.0215,0.0324,0.0673,0.0614,0.0323	0.0513											n/a (AF>5%)	n/a (AF>5%)					RXFP2 (inh=AD pLI=0.00)
chr13	32758834	32758834	A	G	hom		QUAL=1952;DP=60;AF=1.00;MQM=60	FRY	splice_region&intron	FRY:ENST00000380250:splice_region&intron:LOW:exon25/60:c.3146+6A>G:		rs798971	0.8217	0.7885	37731,18675,2948	0.7753,0.7723,0.9892,0.7491,0.8482	0.7882											n/a (AF>5%)	n/a (AF>5%)					FRY (inh=n/a pLI=1.00)
chr13	32776028	32776028	C	A	het	off-target	QUAL=528;DP=60;AF=0.40;MQM=60	FRY	intron	FRY:ENST00000380250:intron:MODIFIER:exon29/60:c.3747-50C>A:		rs73169120	0.0988	0.0720	646,83,1	0.0082,0.0344,0.2880,0.0452,0.1523	0.0702											n/a (AF>5%)	n/a (AF>5%)					FRY (inh=n/a pLI=1.00)
chr13	33635463	33635463	T	C	hom		QUAL=3389;DP=104;AF=1.00;MQM=60	KL	synonymous,3'UTR	KL:ENST00000380099:synonymous:LOW:exon4/5:c.2247T>C:p.Ala749Ala,KL:ENST00000426690:3'UTR:MODIFIER:exon4/4:c.*647T>C:		rs648202	0.7109	0.8036	39816,24681,1690	0.5722,0.7757,0.5998,0.8599,0.8140	0.8101							604824 [KL (provisional) Tumoral calcinosis,hyperphosphatemic,familial,3,617994];	311701 [benign DISEASE=tumoral_calcinosis,_familial,_hyperphosphatemic]; 			n/a (AF>5%)	n/a (AF>5%)					KL (inh=AR pLI=0.00)
chr13	33703656	33703656	T	C	hom		QUAL=11845;DP=355;AF=1.00;MQM=60	STARD13	synonymous	STARD13:ENST00000336934:synonymous:LOW:exon5/14:c.1158A>G:p.Glu386Glu,STARD13:ENST00000255486:synonymous:LOW:exon5/14:c.1134A>G:p.Glu378Glu,STARD13:ENST00000399365:synonymous:LOW:exon5/14:c.804A>G:p.Glu268Glu		rs495680	0.5156	0.5859	21181,13073,717	0.3775,0.5827,0.5623,0.6251,0.5583	0.5904											n/a (AF>5%)	n/a (AF>5%)					STARD13 (inh=n/a pLI=0.00)
chr13	36244990	36244990	A	G	het	off-target	QUAL=560;DP=101;AF=0.29;MQM=60	NBEA	intron	NBEA:ENST00000310336:intron:MODIFIER:exon58/58:c.8751-48A>G:,NBEA:ENST00000400445:intron:MODIFIER:exon57/57:c.8751-48A>G:,NBEA:ENST00000540320:intron:MODIFIER:exon57/57:c.8751-48A>G:,NBEA:ENST00000379939:intron:MODIFIER:exon56/56:c.8742-48A>G:,NBEA:ENST00000537702:intron:MODIFIER:exon17/17:c.2130-48A>G:,NBEA:ENST00000379922:intron:MODIFIER:exon12/12:c.1485-48A>G:		rs3794387	0.2123	0.2435	920,397,29	0.1472,0.1852,0.2763,0.2409,0.2815	0.2224											n/a (AF>5%)	n/a (AF>5%)					NBEA (inh=AD pLI=1.00)
chr13	37439964	37439964	C	A	hom	off-target	QUAL=3554;DP=110;AF=1.00;MQM=60	SMAD9	intron	SMAD9:ENST00000379826:intron:MODIFIER:exon4/6:c.782-69G>T:,SMAD9:ENST00000399275:intron:MODIFIER:exon3/5:c.782-69G>T:,SMAD9:ENST00000350148:intron:MODIFIER:exon3/5:c.671-69G>T:		rs3748305	0.5964	0.0000	0,0,0	0,0,0,0,0	0.6276							603295 [SMAD9 (provisional) Pulmonary hypertension,primary,2,615342];				n/a (AF>5%)	n/a (AF>5%)					SMAD9 (inh=AD pLI=0.00)
chr13	37598113	37598113	A	G	het	off-target	QUAL=422;DP=34;AF=0.56;MQM=60	SUPT20H	intron	SUPT20H:ENST00000475892:intron:MODIFIER:exon19/24:c.1591+59T>C:,SUPT20H:ENST00000360252:intron:MODIFIER:exon19/24:c.1594+59T>C:,SUPT20H:ENST00000356185:intron:MODIFIER:exon19/24:c.1594+59T>C:,SUPT20H:ENST00000350612:intron:MODIFIER:exon19/25:c.1591+59T>C:,SUPT20H:ENST00000464744:intron:MODIFIER:exon19/24:c.1594+59T>C:,SUPT20H:ENST00000542180:intron:MODIFIER:exon17/17:c.1483+59T>C:		rs4943441	0.8439	0.8889	43944,25767,1680	0.5880,0.8829,0.9996,0.9062,0.9558	0.8930											n/a (AF>5%)	n/a (AF>5%)					SUPT20H (inh=n/a pLI=0.01)
chr13	38237872	38237872	A	G	hom		QUAL=1408;DP=44;AF=1.00;MQM=60	TRPC4	splice_region&intron,intron	TRPC4:ENST00000379681:splice_region&intron:LOW:exon5/10:c.1375-6T>C:,TRPC4:ENST00000379705:splice_region&intron:LOW:exon5/10:c.1375-6T>C:,TRPC4:ENST00000338947:splice_region&intron:LOW:exon4/9:c.856-6T>C:,TRPC4:ENST00000379679:splice_region&intron:LOW:exon3/8:c.856-6T>C:,TRPC4:ENST00000355779:splice_region&intron:LOW:exon5/10:c.1375-6T>C:,TRPC4:ENST00000358477:splice_region&intron:LOW:exon5/11:c.1375-6T>C:,TRPC4:ENST00000379673:splice_region&intron:LOW:exon5/10:c.1375-6T>C:,TRPC4:ENST00000447043:splice_region&intron:LOW:exon5/10:c.1375-6T>C:,TRPC4:ENST00000426868:intron:MODIFIER:exon5/9:c.1375-8452T>C:		rs2985171	0.9726	0.9931	59253,33029,4320	0.9244,0.9968,1.0000,0.9997,0.9999	0.9944											n/a (AF>5%)	n/a (AF>5%)					TRPC4 (inh=n/a pLI=0.98)
chr13	40252190	40252190	C	T	het	off-target	QUAL=2073;DP=146;AF=0.55;MQM=60	COG6	intron	COG6:ENST00000455146:intron:MODIFIER:exon5/18:c.540+474C>T:,COG6:ENST00000416691:intron:MODIFIER:exon5/18:c.540+474C>T:	HAL1	rs4941939	0.4295	0.5063	1289,246,7	0.0000,0.0000,0.0000,0.4435,0.5362	0.4610							606977 [COG6 (provisional) Congenital disorder of glycosylation,type IIl,614576|Shaheen syndrome,615328];				n/a (AF>5%)	n/a (AF>5%)					COG6 (inh=AR pLI=0.00)
chr13	42701717	42701717	A	G	het		QUAL=809;DP=80;AF=0.41;MQM=60	DGKH	splice_region&intron	DGKH:ENST00000337343:splice_region&intron:LOW:exon2/29:c.303+8A>G:,DGKH:ENST00000540693:splice_region&intron:LOW:exon3/29:c.303+8A>G:,DGKH:ENST00000379274:splice_region&intron:LOW:exon2/30:c.-106+8A>G:,DGKH:ENST00000261491:splice_region&intron:LOW:exon2/28:c.303+8A>G:		rs605371	0.3616	0.3675	8165,3957,1066	0.4569,0.4932,0.1161,0.3556,0.4274	0.3621										COSM147677	n/a (AF>5%)	n/a (AF>5%)					DGKH (inh=n/a pLI=0.83)
chr13	43155443	43155443	G	A	hom		QUAL=3195;DP=95;AF=1.00;MQM=60	TNFSF11	splice_region&intron	TNFSF11:ENST00000239849:splice_region&intron:LOW:exon2/4:c.387+14G>A:,TNFSF11:ENST00000358545:splice_region&intron:LOW:exon4/6:c.168+14G>A:,TNFSF11:ENST00000405262:splice_region&intron:LOW:exon3/5:c.168+14G>A:,TNFSF11:ENST00000398795:splice_region&intron:LOW:exon2/4:c.168+14G>A:,TNFSF11:ENST00000544862:splice_region&intron:LOW:exon3/5:c.168+14G>A:		rs2277439	0.7883	0.8115	40243,23277,3363	0.8070,0.6122,0.6968,0.8371,0.8890	0.8164							602642 [TNFSF11 (provisional) Osteopetrosis,autosomal recessive 2,259710];	195202 [benign DISEASE=osteopetrosis,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					TNFSF11 (inh=AR pLI=0.10)
chr13	43469211	43469211	G	A	hom		QUAL=3484;DP=105;AF=1.00;MQM=60	EPSTI1	synonymous	EPSTI1:ENST00000313640:synonymous:LOW:exon11/13:c.882C>T:p.Gly294Gly,EPSTI1:ENST00000313624:synonymous:LOW:exon10/11:c.849C>T:p.Gly283Gly,EPSTI1:ENST00000398762:synonymous:LOW:exon11/12:c.882C>T:p.Gly294Gly		rs1359184	0.4698	0.3905	9789,3810,815	0.3962,0.4067,0.6127,0.3350,0.5121	0.3893											n/a (AF>5%)	n/a (AF>5%)					EPSTI1 (inh=n/a pLI=0.00)
chr13	46930536	46930536	C	A	het	off-target	QUAL=2398;DP=150;AF=0.57;MQM=60	KIAA0226L,PPP1R2P4	intron	KIAA0226L:ENST00000389908:intron:MODIFIER:exon10/14:c.1330+31G>T:,PPP1R2P4:ENST00000535073:intron:MODIFIER:exon10/14:n.1920+31G>T:,KIAA0226L:ENST00000378781:intron:MODIFIER:exon9/13:c.*303+31G>T:,KIAA0226L:ENST00000378797:intron:MODIFIER:exon10/13:c.1330+31G>T:,KIAA0226L:ENST00000429979:intron:MODIFIER:exon10/14:c.1330+31G>T:,KIAA0226L:ENST00000378784:intron:MODIFIER:exon10/14:c.1129+31G>T:,KIAA0226L:ENST00000378787:intron:MODIFIER:exon9/12:c.1330+31G>T:,KIAA0226L:ENST00000409879:intron:MODIFIER:exon10/14:c.859+31G>T:,KIAA0226L:ENST00000322896:intron:MODIFIER:exon9/13:c.859+31G>T:,KIAA0226L:ENST00000534925:intron:MODIFIER:exon9/13:c.925+31G>T:		rs181977	0.4617	0.3864	8904,3733,1371	0.5305,0.4499,0.5859,0.3465,0.3135	0.4110											n/a (AF>5%)	n/a (AF>5%)					RUBCNL (inh=n/a pLI=0.00), PPP1R2P4 (inh=n/a pLI=n/a)
chr13	47469940	47469940	G	A	het		QUAL=1582;DP=119;AF=0.50;MQM=60	HTR2A	synonymous,intron	HTR2A:ENST00000378688:synonymous:LOW:exon1/3:c.102C>T:p.Ser34Ser,HTR2A:ENST00000542664:synonymous:LOW:exon2/4:c.102C>T:p.Ser34Ser,HTR2A:ENST00000543956:intron:MODIFIER:exon1/2:c.160+869C>T:		rs6313	0.4413	0.4072	10421,5657,747	0.3714,0.3264,0.5827,0.4095,0.4170	0.4070							182135 [HTR2A (confirmed) Schizophrenia,susceptibility to,181500|Obsessive-compulsive disorder,susceptibility to,164230|Seasonal affective disorder,susceptibility to,608516|Alcohol dependence,susceptibility to,103780|Anorexia nervosa,susceptibility to,606788|Major depressive disorder,response to citalopram therapy in,608516];			COSM3753711	n/a (AF>5%)	n/a (AF>5%)					HTR2A (inh=n/a pLI=0.73)
chr13	50080847	50080847	A	G	hom		QUAL=2060;DP=64;AF=1.00;MQM=60	PHF11	synonymous	PHF11:ENST00000378319:synonymous:LOW:exon2/10:c.171A>G:p.Leu57Leu,PHF11:ENST00000357596:synonymous:LOW:exon3/11:c.54A>G:p.Leu18Leu,PHF11:ENST00000488958:synonymous:LOW:exon2/10:c.54A>G:p.Leu18Leu		rs2031532	0.7821	0.7052	30644,14520,4042	0.8823,0.7886,0.8631,0.6591,0.6528	0.7359											n/a (AF>5%)	n/a (AF>5%)					PHF11 (inh=n/a pLI=0.00)
chr13	50141362	50141362	G	A	hom		QUAL=2242;DP=70;AF=1.00;MQM=60	RCBTB1	synonymous	RCBTB1:ENST00000258646:synonymous:LOW:exon1/11:c.54C>T:p.Ile18Ile,RCBTB1:ENST00000378302:synonymous:LOW:exon3/13:c.54C>T:p.Ile18Ile,RCBTB1:ENST00000546015:synonymous:LOW:exon3/10:c.54C>T:p.Ile18Ile		rs9562900	0.3071	0.2183	3390,831,1037	0.4524,0.1799,0.2577,0.1582,0.3175	0.2516							607867 [RCBTB1 (provisional) Retinal dystrophy with or without extraocular anomalies,617175];			COSM3999109	n/a (AF>5%)	n/a (AF>5%)					RCBTB1 (inh=AR pLI=0.00)
chr13	52971893	52971893	G	A	hom		QUAL=8556;DP=260;AF=1.00;MQM=60	THSD1	synonymous,intron	THSD1:ENST00000258613:synonymous:LOW:exon3/5:c.495C>T:p.Ile165Ile,THSD1:ENST00000349258:synonymous:LOW:exon3/4:c.495C>T:p.Ile165Ile,THSD1:ENST00000544466:intron:MODIFIER:exon1/2:c.-117+8273C>T:		rs3803264	0.5877	0.6380	24965,14836,1132	0.4658,0.6703,0.6654,0.6673,0.5561	0.6442										COSM1747483	n/a (AF>5%)	n/a (AF>5%)					THSD1 (inh=n/a pLI=0.00)
chr13	53287023	53287023	G	C	het		QUAL=243;DP=18;AF=0.56;MQM=60	LECT1	splice_region&intron	LECT1:ENST00000377962:splice_region&intron:LOW:exon4/6:c.469-19C>G:,LECT1:ENST00000448904:splice_region&intron:LOW:exon4/6:c.469-19C>G:		rs2147692	0.2630	0.3607	7729,5383,149	0.1736,0.3691,0.2674,0.4083,0.2629	0.3606											n/a (AF>5%)	n/a (AF>5%)					CNMD (inh=n/a pLI=0.00)
chr13	78475313	78475313	T	C	het		QUAL=695;DP=52;AF=0.52;MQM=60	EDNRB	synonymous	EDNRB:ENST00000377211:synonymous:LOW:exon5/8:c.1101A>G:p.Leu367Leu,EDNRB:ENST00000446573:synonymous:LOW:exon4/7:c.831A>G:p.Leu277Leu,EDNRB:ENST00000334286:synonymous:LOW:exon4/7:c.831A>G:p.Leu277Leu		rs5351	0.5447	0.5799	20667,12737,1588	0.5501,0.5794,0.3439,0.6189,0.5566	0.5804							131244 [EDNRB (confirmed) Hirschsprung disease,susceptibility to,2,600155|ABCD syndrome,600501|Waardenburg syndrome,type 4A,277580];	226622 [benign DISEASE=waardenburg_syndrome,not_specified,hirschsprung_disease,_recessive]; 		COSM3753748, COSM3753750, COSM3753749	n/a (AF>5%)	n/a (AF>5%)					EDNRB (inh=AR+AD pLI=0.06)
chr13	79766188	79766188	A	G	het		QUAL=1437;DP=117;AF=0.49;MQM=60	BCAS2P3,RBM26	intergenic_region	RBM26:ENSG00000226670-ENSG00000139746:intergenic_region:MODIFIER::n.79766188A>G:		rs2988039	0.5066	0.3571	7871,1863,1908	0.6999,0.4414,0.7111,0.2617,0.3608	0.4099											n/a (AF>5%)	n/a (AF>5%)					BCAS2P3 (inh=n/a pLI=n/a), RBM26 (inh=n/a pLI=1.00)
chr13	95847020	95847020	A	G	hom	off-target	QUAL=3183;DP=103;AF=1.00;MQM=60	ABCC4	intron	ABCC4:ENST00000376887:intron:MODIFIER:exon9/30:c.1263+70T>C:,ABCC4:ENST00000412704:intron:MODIFIER:exon9/29:c.1263+70T>C:,ABCC4:ENST00000536256:intron:MODIFIER:exon8/19:c.1038+70T>C:,ABCC4:ENST00000431522:intron:MODIFIER:exon9/20:c.1263+70T>C:,ABCC4:ENST00000538287:intron:MODIFIER:exon11/16:c.*1454+70T>C:		rs2274403	0.5014	0.0000	0,0,0	0,0,0,0,0	0.4804											n/a (AF>5%)	n/a (AF>5%)					ABCC4 (inh=n/a pLI=0.00)
chr13	98629334	98629334	G	C	het	off-target	QUAL=188;DP=22;AF=0.41;MQM=60	IPO5	intron	IPO5:ENST00000261574:intron:MODIFIER:exon4/28:c.144+294G>C:,IPO5:ENST00000490680:intron:MODIFIER:exon1/25:c.90+294G>C:,IPO5:ENST00000539640:intron:MODIFIER:exon1/23:c.90+294G>C:		rs9517155	0.6386	0.0000	22,2,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.6350											n/a (AF>5%)	n/a (AF>5%)					IPO5 (inh=n/a pLI=1.00)
chr13	101321067	101321067	T	C	hom		QUAL=3276;DP=99;AF=1.00;MQM=60	TMTC4	splice_region&intron	TMTC4:ENST00000342624:splice_region&intron:LOW:exon2/18:c.4-19A>G:,TMTC4:ENST00000376234:splice_region&intron:LOW:exon1/17:c.-54-19A>G:,TMTC4:ENST00000328767:splice_region&intron:LOW:exon1/15:c.-54-19A>G:		rs2791680	0.7486	0.7790	36504,19473,1429	0.5563,0.7723,0.9876,0.7697,0.8360	0.7780											n/a (AF>5%)	n/a (AF>5%)					TMTC4 (inh=n/a pLI=0.00)
chr13	101720300	101720300	T	G	hom		QUAL=2590;DP=79;AF=0.99;MQM=60	NALCN	synonymous	NALCN:ENST00000251127:synonymous:LOW:exon39/44:c.4416A>C:p.Ile1472Ile		rs1289556	0.4030	0.3529	8840,4334,2736	0.7216,0.1741,0.1236,0.3611,0.3367	0.4464							611549 [NALCN (provisional) Hypotonia,infantile,with psychomotor retardation and characteristic facies 1,615419|Congenital contractures of the limbs and face,hypotonia,and developmental delay,616266];	262263 [benign DISEASE=not_specified]; 		COSM4147544	n/a (AF>5%)	n/a (AF>5%)					NALCN (inh=AR+AD pLI=0.00)
chr13	101833450	101833450	C	T	het		QUAL=732;DP=63;AF=0.49;MQM=60	NALCN	missense,intron	NALCN:ENST00000376196:missense:MODERATE:exon15/15:c.2003G>A:p.Arg668Gln,NALCN:ENST00000251127:intron:MODIFIER:exon14/43:c.1765-4725G>A:		rs896560	0.1865	0.2594	4311,3026,85	0.1420,0.1304,0.0227,0.3126,0.2964	0.2530	-0.0780	D	T	B	D	2.97	611549 [NALCN (provisional) Hypotonia,infantile,with psychomotor retardation and characteristic facies 1,615419|Congenital contractures of the limbs and face,hypotonia,and developmental delay,616266];				n/a (AF>5%)	n/a (AF>5%)					NALCN (inh=AR+AD pLI=0.00)
chr13	103394003	103394003	G	A	hom		QUAL=2620;DP=80;AF=1.00;MQM=60	CCDC168,LINC00283	intergenic_region	LINC00283:ENSG00000175820-ENSG00000231633:intergenic_region:MODIFIER::n.103394003G>A:		rs1449707	0.6941	0.7988	6402,2759,353	0.5739,0.7500,0.6278,0.8070,0.8668	0.7656											n/a (AF>5%)	n/a (AF>5%)					CCDC168 (inh=n/a pLI=n/a), LINC00283 (inh=n/a pLI=n/a)
chr13	111109859	111109859	A	G	hom		QUAL=2892;DP=90;AF=1.00;MQM=60	COL4A2-AS2,COL4A2	splice_region&intron,intron	COL4A2-AS2:ENST00000458403:splice_region&intron:LOW:exon4/4:n.561+13T>C:,COL4A2:ENST00000360467:intron:MODIFIER:exon21/47:c.1432+77A>G:		rs9515218	0.4896	0.5764	8586,5607,942	0.6630,0.4442,0.2961,0.6380,0.5024	0.5634							120090 [COL4A2 (confirmed) Porencephaly 2,614483|Hemorrhage,intracerebral,susceptibility to,614519];				n/a (AF>5%)	n/a (AF>5%)					COL4A2-AS2 (inh=n/a pLI=n/a), COL4A2 (inh=AD pLI=0.00)
chr13	113801737	113801737	C	T	hom		QUAL=6581;DP=201;AF=1.00;MQM=60	F10	synonymous	F10:ENST00000375559:synonymous:LOW:exon7/8:c.792C>T:p.Thr264Thr,F10:ENST00000409306:synonymous:LOW:exon7/8:c.792C>T:p.Thr264Thr,F10:ENST00000375551:synonymous:LOW:exon7/8:c.792C>T:p.Thr264Thr		rs5960	0.6232	0.7597	36214,24967,1287	0.4944,0.6213,0.5002,0.8658,0.7029	0.7597							613872 [F10 (confirmed) Factor X deficiency,227600];	256308 [benign DISEASE=factor_x_deficiency,not_specified]; 		COSM147720	n/a (AF>5%)	n/a (AF>5%)					F10 (inh=AR pLI=0.40)
chr14	20666556	20666556	C	T	hom	off-target;gene_blacklist	QUAL=774;DP=26;AF=1.00;MQM=60	OR11G2	3'UTR	OR11G2:ENST00000357366:3'UTR:MODIFIER:exon1/1:c.*24C>T:		rs2318886	0.4990	0.5368	15931,9515,555	0.3449,0.5163,0.5747,0.5488,0.5906	0.5411											n/a (AF>5%)	n/a (AF>5%)					OR11G2 (inh=n/a pLI=0.00)
chr14	20698239	20698239	T	C	het		QUAL=3422;DP=276;AF=0.47;MQM=60	OR11H7	stop_lost	OR11H7:ENST00000553765:stop_lost:HIGH:exon1/1:c.679T>C:p.Ter227Glnext*?		rs1953558	0.4643	0.4866	1864,596,118	0.5352,0.4464,0.4200,0.4982,0.4889	0.4519										COSM4147957	n/a (AF>5%)	n/a (AF>5%)					OR11H7 (inh=n/a pLI=n/a)
chr14	20698298	20698298	T	G	het		QUAL=2946;DP=274;AF=0.42;MQM=60	OR11H7	synonymous	OR11H7:ENST00000553765:synonymous:LOW:exon1/1:c.738T>G:p.Val246Val		rs1953559	0.4639	0.4865	1650,476,66	0.5662,0.0000,0.0000,0.5039,0.4888	0.4520											n/a (AF>5%)	n/a (AF>5%)					OR11H7 (inh=n/a pLI=n/a)
chr14	20770036	20770036	T	C	hom		QUAL=2930;DP=90;AF=1.00;MQM=60	TTC5	missense	TTC5:ENST00000258821:missense:MODERATE:exon2/10:c.140A>G:p.Gln47Arg		rs3742945	0.7456	0.7368	33266,18133,2884	0.7420,0.8309,0.8004,0.7354,0.6492	0.7431	-0.3360	T	T	B	T	0.34				COSM1179594	n/a (AF>5%)	n/a (AF>5%)					TTC5 (inh=n/a pLI=0.00)
chr14	21570273	21570273	T	C	hom		QUAL=1349;DP=41;AF=1.00;MQM=60	TMEM253,ZNF219	synonymous,intron	TMEM253:ENST00000418511:synonymous:LOW:exon5/8:c.270T>C:p.Leu90Leu,TMEM253:ENST00000556585:synonymous:LOW:exon4/7:c.270T>C:p.Leu90Leu,ZNF219:ENST00000451119:intron:MODIFIER:exon1/4:c.-84+2397A>G:		rs745696	0.6392	0.6730	4424,2208,613	0.7537,0.6114,0.5547,0.7250,0.6055	0.6843											n/a (AF>5%)	n/a (AF>5%)					TMEM253 (inh=n/a pLI=n/a), ZNF219 (inh=n/a pLI=0.98)
chr14	21623648	21623648	G	A	hom	gene_blacklist	QUAL=4371;DP=133;AF=1.00;MQM=60	OR5AU1	synonymous	OR5AU1:ENST00000304418:synonymous:LOW:exon1/1:c.537C>T:p.Asn179Asn		rs7161544	0.3478	0.4791	15372,11573,655	0.3557,0.2837,0.1256,0.5902,0.3876	0.4909											n/a (AF>5%)	n/a (AF>5%)					OR5AU1 (inh=n/a pLI=0.00)
chr14	21624197	21624197	T	C	hom	gene_blacklist	QUAL=868;DP=28;AF=1.00;MQM=60	OR5AU1	5'UTR	OR5AU1:ENST00000304418:5'UTR:MODIFIER:exon1/1:c.-13A>G:		rs10135366	0.5615	0.6654	27544,17989,813	0.3975,0.5791,0.4092,0.7364,0.7531	0.6663											n/a (AF>5%)	n/a (AF>5%)					OR5AU1 (inh=n/a pLI=0.00)
chr14	21778792	21778792	T	C	het	off-target	QUAL=849;DP=68;AF=0.49;MQM=60	RPGRIP1	intron	RPGRIP1:ENST00000206660:intron:MODIFIER:exon6/23:c.907-281T>C:,RPGRIP1:ENST00000556336:intron:MODIFIER:exon7/20:c.849+26T>C:,RPGRIP1:ENST00000557771:intron:MODIFIER:exon7/23:c.849+26T>C:,RPGRIP1:ENST00000400017:intron:MODIFIER:exon7/23:c.930+26T>C:		rs1957414	0.3930	0.4193	4275,1482,350	0.4066,0.5685,0.6292,0.3664,0.4275	0.3252							605446 [RPGRIP1 (confirmed) Leber congenital amaurosis 6,613826|Cone-rod dystrophy 13,608194];				n/a (AF>5%)	n/a (AF>5%)					RPGRIP1 (inh=AR pLI=0.00)
chr14	21930596	21930596	G	A	het		QUAL=148;DP=33;AF=0.33;MQM=60	RAB2B	splice_region&intron	RAB2B:ENST00000397762:splice_region&intron:LOW:exon6/7:c.475-19C>T:		rs10143000	0.9201	0.9124	50790,29216,5051	0.9856,0.7571,0.8634,0.9353,0.9206	0.9267											n/a (AF>5%)	n/a (AF>5%)					RAB2B (inh=n/a pLI=0.00)
chr14	21967133	21967133	C	A	het	off-target	QUAL=643;DP=79;AF=0.39;MQM=60	TOX4,METTL3	3'UTR,intron	TOX4:ENST00000262709:3'UTR:MODIFIER:exon9/9:c.*2369C>A:,TOX4:ENST00000405508:3'UTR:MODIFIER:exon10/10:c.*2369C>A:,METTL3:ENST00000298717:intron:MODIFIER:exon10/10:c.1631+36G>T:		rs1061027	0.1919	0.2612	4489,3095,31	0.0764,0.1359,0.1998,0.3078,0.3116	0.2563											n/a (AF>5%)	n/a (AF>5%)					TOX4 (inh=n/a pLI=0.93), METTL3 (inh=n/a pLI=0.00)
chr14	22102612	22102612	T	C	het	gene_blacklist	QUAL=133;DP=80;AF=0.25;MQM=34	OR10G2	synonymous	OR10G2:ENST00000542433:synonymous:LOW:exon1/1:c.387A>G:p.Leu129Leu		rs10138704	0.4569	0.1796	1660,614,279	0.2566,0.2828,0.2847,0.1498,0.1673	0.3978										COSM3999224	n/a (AF>5%)	n/a (AF>5%)					OR10G2 (inh=n/a pLI=0.22)
chr14	22322690	22322690	G	A	het		QUAL=1594;DP=129;AF=0.48;MQM=60	TRAV8,3,TRAV13,1	intergenic_region	1:ENSG00000211787-ENSG00000211788:intergenic_region:MODIFIER::n.22322690G>A:		rs12878216	0.4499	0.4251	10605,4821,1031	0.5050,0.6139,0.3492,0.3976,0.4640	0.4334							186880 [TRA (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387];				n/a (AF>5%)	n/a (AF>5%)					TRAV8 (inh=n/a pLI=n/a), 3 (inh=n/a pLI=n/a), TRAV13 (inh=n/a pLI=n/a), 1 (inh=n/a pLI=n/a)
chr14	22392703	22392703	G	C	het		QUAL=1215;DP=111;AF=0.43;MQM=60	TRAV14DV4	missense	TRAV14DV4:ENST00000390440:missense:MODERATE:exon2/2:c.226G>C:p.Glu76Gln		rs8021861	0.4659	0.4268	11061,5228,1153	0.4915,0.5266,0.4930,0.3999,0.3889	0.4371							186880 [TRA (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387];				n/a (AF>5%)	n/a (AF>5%)					TRAV14DV4 (inh=n/a pLI=n/a)
chr14	22616554	22616554	C	A	het		QUAL=1139;DP=76;AF=0.59;MQM=60	TRAV27	missense	TRAV27:ENST00000390457:missense:MODERATE:exon2/2:c.295C>A:p.Pro99Thr		rs34355797	0.0903	0.0766	481,268,166	0.1974,0.0433,0.0001,0.0875,0.0409	0.1034							186880 [TRA (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387]:186880 [TRAC (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387];				n/a (AF>5%)	n/a (AF>5%)					TRAV27 (inh=n/a pLI=n/a)
chr14	22942890	22942890	G	T	hom		QUAL=4136;DP=126;AF=1.00;MQM=60	AE000661.37				rs2254272	0.7833	0.7172	3216,882,197	0.8482,0.0000,0.0000,0.6891,0.7203	0.7216							186880 [TRA (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387]:186880 [TRAC (confirmed) Immunodeficiency 7,TCR-alpha/beta deficient,615387];				n/a (AF>5%)	n/a (AF>5%)					AE000661.37 (inh=n/a pLI=n/a)
chr14	23239512	23239512	A	G	het	off-target	QUAL=2151;DP=174;AF=0.49;MQM=60	OXA1L	intron	OXA1L:ENST00000285848:intron:MODIFIER:exon5/9:c.849+25A>G:,OXA1L:ENST00000604262:intron:MODIFIER:exon5/9:c.669+25A>G:,OXA1L:ENST00000412791:intron:MODIFIER:exon5/8:c.669+25A>G:,OXA1L:ENST00000358043:intron:MODIFIER:exon5/9:c.621+25A>G:		rs2075846	0.3964	0.4477	13319,6712,63	0.1101,0.6507,0.7435,0.4537,0.3734	0.4598											n/a (AF>5%)	n/a (AF>5%)					OXA1L (inh=n/a pLI=0.00)
chr14	24033027	24033027	G	A	het		QUAL=2310;DP=177;AF=0.50;MQM=60	AP1G2,RP11-66N24.3	missense	AP1G2:ENST00000308724:missense:MODERATE:exon11/21:c.1130C>T:p.Ser377Phe,AP1G2:ENST00000397120:missense:MODERATE:exon12/22:c.1130C>T:p.Ser377Phe		rs12897422	0.0435	0.0972	765,663,7	0.0232,0.0580,0.0013,0.1411,0.0382	0.0965	3.3640	D,D,D,D	T	D,D	T,T	27.20					n/a (AF>5%)	n/a (AF>5%)					AP1G2 (inh=n/a pLI=0.00), RP11-66N24.3 (inh=n/a pLI=n/a)
chr14	24909362	24909362	T	C	hom		QUAL=2201;DP=70;AF=1.00;MQM=60	SDR39U1,KHNYN	missense,3'UTR	SDR39U1:ENST00000399395:missense:MODERATE:exon6/6:c.809A>G:p.Gln270Arg,SDR39U1:ENST00000399390:missense:MODERATE:exon3/3:c.524A>G:p.Gln175Arg,SDR39U1:ENST00000553930:missense:MODERATE:exon6/6:c.434A>G:p.Gln145Arg,SDR39U1:ENST00000538105:missense:MODERATE:exon4/4:c.563A>G:p.Gln188Arg,SDR39U1:ENST00000554698:missense:MODERATE:exon4/4:c.485A>G:p.Gln162Arg,SDR39U1:ENST00000555365:missense:MODERATE:exon5/5:c.308A>G:p.Gln103Arg,KHNYN:ENST00000251343:3'UTR:MODIFIER:exon8/8:c.*2871T>C:		rs1043831	0.7652	0.8634	45336,27033,1320	0.5221,0.8907,0.8232,0.9028,0.8765	0.8703	3.5810	T,T,T,T,T,T,T,T	T	B,B,B,B,B	T,T,T,T,T,T,T	13.07				COSM4148067, COSM4148068, COSM4148066	n/a (AF>5%)	n/a (AF>5%)					SDR39U1 (inh=n/a pLI=0.00), KHNYN (inh=n/a pLI=0.01)
chr14	25102160	25102160	C	T	het		QUAL=1115;DP=100;AF=0.44;MQM=60	GZMB,RP11-104E19.1	missense	GZMB:ENST00000382542:missense:MODERATE:exon2/5:c.266G>A:p.Arg89Gln,GZMB:ENST00000415355:missense:MODERATE:exon2/5:c.128G>A:p.Arg43Gln,GZMB:ENST00000216341:missense:MODERATE:exon2/5:c.164G>A:p.Arg55Gln,GZMB:ENST00000382540:missense:MODERATE:exon2/5:c.164G>A:p.Arg55Gln,GZMB:ENST00000526004:missense:MODERATE:exon2/3:c.164G>A:p.Arg55Gln		rs8192917	0.6807	0.7476	34146,19599,1755	0.5822,0.8489,0.7373,0.7666,0.6864	0.7556	-1.2930	T,T,T,T,T	T	B	T,D,D,T,T	9.86				COSM3753926, COSM3753925, COSM3753927	n/a (AF>5%)	n/a (AF>5%)					GZMB (inh=n/a pLI=0.00), RP11-104E19.1 (inh=n/a pLI=n/a)
chr14	30068194	30068194	T	G	het	off-target	QUAL=1660;DP=139;AF=0.46;MQM=60	PRKD1	intron	PRKD1:ENST00000415220:intron:MODIFIER:exon16/18:c.2190+39A>C:,PRKD1:ENST00000331968:intron:MODIFIER:exon15/17:c.2166+39A>C:		rs2273813	0.5068	0.4323	12358,4685,3006	0.7615,0.4876,0.2164,0.3763,0.5423	0.4892							605435 [PRKD1 (confirmed) Congenital heart defects and ectodermal dysplasia,617364];			COSN164654	n/a (AF>5%)	n/a (AF>5%)					PRKD1 (inh=AD pLI=0.00)
chr14	30125660	30125660	A	G	het	off-target	QUAL=250;DP=33;AF=0.39;MQM=60	PRKD1,CTD-2503I6.1	intron	PRKD1:ENST00000415220:intron:MODIFIER:exon5/18:c.720+22T>C:,PRKD1:ENST00000331968:intron:MODIFIER:exon4/17:c.696+7245T>C:		rs6571317	0.5262	0.4764	1671,273,167	0.7788,0.0000,0.0000,0.3755,0.5290	0.5142							605435 [PRKD1 (confirmed) Congenital heart defects and ectodermal dysplasia,617364];				n/a (AF>5%)	n/a (AF>5%)					PRKD1 (inh=AD pLI=0.00), CTD-2503I6.1 (inh=n/a pLI=n/a)
chr14	31355096	31355096	C	G	hom		QUAL=6971;DP=209;AF=1.00;MQM=60	COCH,RP11-829H16.3	missense	COCH:ENST00000216361:missense:MODERATE:exon10/11:c.1055C>G:p.Thr352Ser,COCH:ENST00000396618:missense:MODERATE:exon11/12:c.1055C>G:p.Thr352Ser,COCH:ENST00000475087:missense:MODERATE:exon10/11:c.1055C>G:p.Thr352Ser,COCH:ENST00000460581:missense:MODERATE:exon9/10:c.719C>G:p.Thr240Ser,COCH:ENST00000382493:missense:MODERATE:exon5/6:c.608C>G:p.Thr203Ser		rs1045644	0.4113	0.5492	19602,13470,404	0.2708,0.6536,0.3642,0.6350,0.3577	0.5589	1.4160	T,.,T,T,T,T,T	T,T	.,B,B,B	.,T,T,T,T,T	12.39	603196 [COCH (confirmed) Deafness,autosomal dominant 9,601369];	226525 [benign DISEASE=not_specified,nonsyndromic_hearing_loss,_dominant]; 		COSM3736100, COSM3736101	n/a (AF>5%)	n/a (AF>5%)					COCH (inh=AD pLI=0.00), RP11-829H16.3 (inh=n/a pLI=n/a)
chr14	31381351	31381351	T	C	hom		QUAL=4174;DP=127;AF=1.00;MQM=60	STRN3	missense	STRN3:ENST00000357479:missense:MODERATE:exon11/18:c.1412A>G:p.Asn471Ser,STRN3:ENST00000355683:missense:MODERATE:exon9/16:c.1160A>G:p.Asn387Ser		rs2273171	0.3890	0.4376	11818,7103,676	0.3508,0.4717,0.4831,0.4647,0.3069	0.4424	6.1530	D,D	T	B,B	T,T	23.10				COSM3753930, COSM147761	n/a (AF>5%)	n/a (AF>5%)					STRN3 (inh=n/a pLI=0.27)
chr14	31582526	31582526	T	C	het		QUAL=1039;DP=86;AF=0.48;MQM=60	HECTD1	synonymous	HECTD1:ENST00000399332:synonymous:LOW:exon33/43:c.6021A>G:p.Leu2007Leu,HECTD1:ENST00000553700:synonymous:LOW:exon33/43:c.6021A>G:p.Leu2007Leu		rs2273483	0.5337	0.4568	12943,5747,2314	0.6872,0.5049,0.3627,0.4175,0.5095	0.5043	0.7900		T			0.02				COSM1562663	n/a (AF>5%)	n/a (AF>5%)					HECTD1 (inh=n/a pLI=1.00)
chr14	33046388	33046388	A	G	het		QUAL=2382;DP=175;AF=0.52;MQM=60	AKAP6	synonymous	AKAP6:ENST00000280979:synonymous:LOW:exon5/14:c.2409A>G:p.Glu803Glu,AKAP6:ENST00000557354:synonymous:LOW:exon5/10:c.2409A>G:p.Glu803Glu,AKAP6:ENST00000557272:synonymous:LOW:exon5/13:c.2409A>G:p.Glu803Glu		rs1950703	0.8664	0.8353	42615,21634,3398	0.8075,0.9172,0.9995,0.8049,0.8509	0.8396											n/a (AF>5%)	n/a (AF>5%)					AKAP6 (inh=n/a pLI=1.00)
chr14	36768276	36768276	T	C	hom		QUAL=2077;DP=66;AF=1.00;MQM=60	MBIP	3'UTR	MBIP:ENST00000416007:3'UTR:MODIFIER:exon9/9:c.*13A>G:,MBIP:ENST00000318473:3'UTR:MODIFIER:exon9/9:c.*13A>G:,MBIP:ENST00000359527:3'UTR:MODIFIER:exon8/8:c.*101A>G:		rs4900833	0.8431	0.9237	52246,30184,2120	0.6405,0.9559,0.9504,0.9511,0.9308	0.9298											n/a (AF>5%)	n/a (AF>5%)					MBIP (inh=n/a pLI=0.00)
chr14	38368184	38368184	G	A	hom		QUAL=2311;DP=70;AF=1.00;MQM=60	TTC6,LINC00517	non_coding_transcript_exon	LINC00517:ENST00000554257:non_coding_transcript_exon:MODIFIER:exon2/2:n.541C>T:		rs3809444	0.4323	0.0000	0,0,0	0,0,0,0,0	0.3735											n/a (AF>5%)	n/a (AF>5%)					TTC6 (inh=n/a pLI=0.00), LINC00517 (inh=n/a pLI=n/a)
chr14	47530845	47530845	G	C	het	off-target	QUAL=153;DP=27;AF=0.37;MQM=60	MDGA2	intron	MDGA2:ENST00000399232:intron:MODIFIER:exon6/16:c.989-64C>G:,MDGA2:ENST00000439988:intron:MODIFIER:exon6/16:c.1196-64C>G:,MDGA2:ENST00000426342:intron:MODIFIER:exon6/16:c.302-64C>G:,MDGA2:ENST00000357362:intron:MODIFIER:exon6/16:c.302-64C>G:		rs7147741	0.9139	0.0000	0,0,0	0,0,0,0,0	0.9019											n/a (AF>5%)	n/a (AF>5%)					MDGA2 (inh=n/a pLI=1.00)
chr14	51057727	51057727	G	A	hom		QUAL=5609;DP=168;AF=1.00;MQM=60	ATL1	synonymous	ATL1:ENST00000357032:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu,ATL1:ENST00000441560:synonymous:LOW:exon4/14:c.351G>A:p.Glu117Glu,ATL1:ENST00000354525:synonymous:LOW:exon3/13:c.351G>A:p.Glu117Glu,ATL1:ENST00000358385:synonymous:LOW:exon3/14:c.351G>A:p.Glu117Glu		rs1060197	0.8215	0.7633	35571,17438,4515	0.9317,0.8330,0.8206,0.7237,0.7446	0.8022							606439 [ATL1 (confirmed) Spastic paraplegia 3A,autosomal dominant,182600|Neuropathy,hereditary sensory,type ID,613708];	21530 [benign/likely benign DISEASE=spastic_paraplegia_3,not_specified,spastic_paraplegia,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)			n/a (2xTP, 0xFP)		ATL1 (inh=AD pLI=1.00)
chr14	52468641	52468641	G	A	het	off-target	QUAL=425;DP=32;AF=0.53;MQM=60	C14orf166	intron	C14orf166:ENST00000261700:intron:MODIFIER:exon6/7:c.531+57G>A:,C14orf166:ENST00000556760:intron:MODIFIER:exon6/7:c.531+57G>A:		rs1151573	0.4299	0.0000	0,0,0	0,0,0,0,0	0.3510											n/a (AF>5%)	n/a (AF>5%)					RTRAF (inh=n/a pLI=0.59)
chr14	53529669	53529669	A	T	het		QUAL=1604;DP=119;AF=0.53;MQM=60	DDHD1	synonymous	DDHD1:ENST00000323669:synonymous:LOW:exon7/13:c.1758T>A:p.Thr586Thr,DDHD1:ENST00000395606:synonymous:LOW:exon8/13:c.1779T>A:p.Thr593Thr,DDHD1:ENST00000357758:synonymous:LOW:exon7/12:c.1758T>A:p.Thr586Thr		rs4898778	0.8177	0.8471	43956,23725,2063	0.6289,0.8972,0.9770,0.8431,0.8768	0.8515							614603 [DDHD1 (confirmed) Spastic paraplegia 28,autosomal recessive,609340];	379963 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR pLI=0.92)
chr14	56114866	56114866	A	T	het	off-target	QUAL=1067;DP=67;AF=0.60;MQM=60	KTN1	intron	KTN1:ENST00000395309:intron:MODIFIER:exon20/43:c.2298+33A>T:,KTN1:ENST00000413890:intron:MODIFIER:exon20/41:c.2298+33A>T:,KTN1:ENST00000438792:intron:MODIFIER:exon20/41:c.2298+33A>T:,KTN1:ENST00000395314:intron:MODIFIER:exon20/43:c.2298+33A>T:,KTN1:ENST00000395308:intron:MODIFIER:exon21/42:c.2298+33A>T:,KTN1:ENST00000395311:intron:MODIFIER:exon20/41:c.2298+33A>T:,KTN1:ENST00000416613:intron:MODIFIER:exon19/43:c.2298+33A>T:,KTN1:ENST00000554507:intron:MODIFIER:exon3/24:c.183+33A>T:		rs17128657	0.2614	0.2779	4310,2414,178	0.2013,0.1941,0.3254,0.2850,0.3194	0.2705										COSN164683	n/a (AF>5%)	n/a (AF>5%)					KTN1 (inh=n/a pLI=0.88)
chr14	56763886	56763886	G	A	het		QUAL=1555;DP=109;AF=0.54;MQM=60	PELI2	3'UTR	PELI2:ENST00000267460:3'UTR:MODIFIER:exon6/6:c.*2G>A:		rs1152466	0.1569	0.1608	931,379,242	0.2670,0.0983,0.2684,0.1501,0.1342	0.1529											n/a (AF>5%)	n/a (AF>5%)					PELI2 (inh=n/a pLI=0.93)
chr14	58060598	58060598	C	G	hom	off-target	QUAL=472;DP=18;AF=1.00;MQM=60	SLC35F4	intron	SLC35F4:ENST00000339762:intron:MODIFIER:exon2/7:c.397+59G>C:,SLC35F4:ENST00000556826:intron:MODIFIER:exon2/7:c.289+59G>C:,SLC35F4:ENST00000554729:intron:MODIFIER:exon2/7:c.-78+59G>C:		rs238377	0.3429	0.0000	0,0,0	0,0,0,0,0	0.3774											n/a (AF>5%)	n/a (AF>5%)					SLC35F4 (inh=n/a pLI=0.01)
chr14	58471445	58471445	C	G	het		QUAL=71;DP=28;AF=0.25;MQM=60	C14orf37	3'UTR	C14orf37:ENST00000267485:3'UTR:MODIFIER:exon8/8:c.*9G>C:		rs17094192	0.1038	0.0948	703,384,213	0.1962,0.0462,0.0005,0.1051,0.0752	0.1174											n/a (AF>5%)	n/a (AF>5%)					C14orf37 (inh=n/a pLI=0.00)
chr14	60935281	60935281	C	T	hom	off-target	QUAL=1030;DP=33;AF=1.00;MQM=60	C14orf39	intron	C14orf39:ENST00000321731:intron:MODIFIER:exon8/17:c.676-27G>A:		rs12878738	0.5284	0.6374	25060,15362,1222	0.5022,0.7583,0.3172,0.6856,0.5374	0.6498											n/a (AF>5%)	n/a (AF>5%)					C14orf39 (inh=n/a pLI=0.11)
chr14	61643045	61643045	C	A	het		QUAL=1745;DP=151;AF=0.46;MQM=60	SLC38A6,PRKCH	intergenic_region	PRKCH:ENSG00000139974-ENSG00000027075:intergenic_region:MODIFIER::n.61643045C>A:		rs4902033	0.4409	0.4674	12628,6668,480	0.3427,0.6205,0.5005,0.4657,0.4191	0.4747											n/a (AF>5%)	n/a (AF>5%)					SLC38A6 (inh=n/a pLI=0.00), PRKCH (inh=n/a pLI=0.99)
chr14	64491695	64491695	T	C	hom	gene_blacklist	QUAL=2704;DP=83;AF=1.00;MQM=60	SYNE2	missense,5'UTR	SYNE2:ENST00000358025:missense:MODERATE:exon40/116:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000344113:missense:MODERATE:exon40/115:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000554584:missense:MODERATE:exon39/115:c.5906T>C:p.Met1969Thr,SYNE2:ENST00000357395:5'UTR:MODIFIER:exon40/116:c.-5009T>C:		rs4902264	0.6789	0.8118	40789,25249,878	0.4132,0.8016,0.7883,0.8695,0.8087	0.8163	0.1190	T,T,T,T	T	B,B	T,T,T	0.19	608442 [SYNE2 (provisional) Emery-Dreifuss muscular dystrophy 5,autosomal dominant,612999];	130501 [benign DISEASE=emery-dreifuss_muscular_dystrophy,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SYNE2 (inh=AD pLI=0.00)
chr14	65263300	65263300	C	T	het		QUAL=784;DP=67;AF=0.46;MQM=60	SPTB	missense	SPTB:ENST00000389722:missense:MODERATE:exon10/35:c.1316G>A:p.Ser439Asn,SPTB:ENST00000556626:missense:MODERATE:exon11/36:c.1316G>A:p.Ser439Asn,SPTB:ENST00000389721:missense:MODERATE:exon10/31:c.1316G>A:p.Ser439Asn,SPTB:ENST00000542895:missense:MODERATE:exon11/32:c.1316G>A:p.Ser439Asn,SPTB:ENST00000389720:missense:MODERATE:exon10/30:c.1316G>A:p.Ser439Asn		rs229587	0.4669	0.3804	9406,4010,2133	0.6439,0.2743,0.3193,0.3463,0.4775	0.4152	0.2690	T,T,T,T,T,T	T	B,B	T,T,T,T,T	11.60	182870 [SPTB (confirmed) Elliptocytosis-3,617948|Spherocytosis,type 2,616649|Anemia,neonatal hemolytic,fatal or near-fatal,617948];	257098 [benign/likely benign DISEASE=elliptocytosis,not_specified,spherocytosis,_dominant]; 			n/a (AF>5%)	n/a (AF>5%)					SPTB (inh=AD pLI=1.00)
chr14	69117512	69117512	T	C	het		QUAL=672;DP=55;AF=0.49;MQM=60	RAD51B	missense	RAD51B:ENST00000488612:missense:MODERATE:exon11/12:c.1051T>C:p.Cys351Arg,RAD51B:ENST00000390683:missense:MODERATE:exon10/10:c.1051T>C:p.Cys351Arg	Tigger15a	rs8023214	0.5286	0.5641	14887,9319,1568	0.7041,0.5140,0.2928,0.6140,0.4997	0.5822	0.1890	T,T	T	B	T,T	0.09					n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a pLI=0.00)
chr14	71050892	71050892	A	G	het		QUAL=703;DP=61;AF=0.48;MQM=60	MED6	3'UTR,intron	MED6:ENST00000430055:3'UTR:MODIFIER:exon8/8:c.*638T>C:,MED6:ENST00000256379:3'UTR:MODIFIER:exon8/8:c.*638T>C:,MED6:ENST00000554963:intron:MODIFIER:exon8/8:c.737+642T>C:		rs11158867	0.4439	0.2930	5663,1719,1565	0.6282,0.2055,0.5582,0.2394,0.2959	0.3433											n/a (AF>5%)	n/a (AF>5%)					MED6 (inh=n/a pLI=0.01)
chr14	73963383	73963383	T	C	hom		QUAL=1525;DP=49;AF=1.00;MQM=60	HEATR4	splice_region&synonymous	HEATR4:ENST00000334988:splice_region&synonymous:LOW:exon14/17:c.2547A>G:p.Lys849Lys,HEATR4:ENST00000553558:splice_region&synonymous:LOW:exon15/18:c.2547A>G:p.Lys849Lys,HEATR4:ENST00000560393:splice_region&synonymous:LOW:exon14/17:c.2406A>G:p.Lys802Lys		rs8014577	0.8097	0.7444	34035,15767,4226	0.9006,0.8360,0.8569,0.6867,0.7625	0.7624											n/a (AF>5%)	n/a (AF>5%)					HEATR4 (inh=n/a pLI=0.00)
chr14	73989859	73989859	C	T	hom		QUAL=2575;DP=79;AF=1.00;MQM=60	HEATR4,RP3-414A15.2	5'UTR	HEATR4:ENST00000334988:5'UTR:MODIFIER:exon2/17:c.-3G>A:,HEATR4:ENST00000553558:5'UTR:MODIFIER:exon3/18:c.-3G>A:,HEATR4:ENST00000560393:5'UTR:MODIFIER:exon2/17:c.-144G>A:		rs1074501	0.6801	0.7415	21319,11056,905	0.6152,0.8767,0.8987,0.7334,0.6547	0.7289											n/a (AF>5%)	n/a (AF>5%)					HEATR4 (inh=n/a pLI=0.00), RP3-414A15.2 (inh=n/a pLI=n/a)
chr14	77332408	77332408	T	C	het		QUAL=3413;DP=266;AF=0.48;MQM=60	C14orf166B	missense	C14orf166B:ENST00000393774:missense:MODERATE:exon12/14:c.1349T>C:p.Val450Ala		rs7160583	0.2286	0.3332	3728,2635,187	0.2630,0.3560,0.1221,0.3816,0.2494	0.2902	0.2610	T	T	B	T	0.01				COSM4148265	n/a (AF>5%)	n/a (AF>5%)					LRRC74A (inh=n/a pLI=0.00)
chr14	77928476	77928476	C	T	het	off-target	QUAL=979;DP=112;AF=0.38;MQM=60	AHSA1	intron	AHSA1:ENST00000216479:intron:MODIFIER:exon2/8:c.272-27C>T:,AHSA1:ENST00000535854:intron:MODIFIER:exon2/8:c.272-27C>T:		rs12436593	0.5108	0.5226	17205,8636,317	0.2593,0.5339,0.9300,0.5166,0.4908	0.5275											n/a (AF>5%)	n/a (AF>5%)					AHSA1 (inh=n/a pLI=0.98)
chr14	78184661	78184661	T	G	het		QUAL=1370;DP=120;AF=0.45;MQM=60	SNW1,SLIRP	missense,intron	SNW1:ENST00000555761:missense:MODERATE:exon13/13:c.1461A>C:p.Lys487Asn,SLIRP:ENST00000557431:intron:MODIFIER:exon3/3:c.264+2439T>G:,SLIRP:ENST00000557623:intron:MODIFIER:exon3/3:c.265-2198T>G:,SNW1:ENST00000261531:intron:MODIFIER:exon13/13:c.1413-32A>C:,SNW1:ENST00000554775:intron:MODIFIER:exon10/10:c.927-32A>C:		rs17825620	0.1188	0.1761	2196,1739,31	0.0800,0.0956,0.0486,0.2262,0.1400	0.1765	-0.6380	T	T	B		10.00					n/a (AF>5%)	n/a (AF>5%)					SNW1 (inh=n/a pLI=1.00), SLIRP (inh=n/a pLI=0.00)
chr14	78366967	78366967	A	G	het		QUAL=3215;DP=256;AF=0.48;MQM=60	ADCK1	intron	ADCK1:ENST00000238561:intron:MODIFIER:exon6/10:c.741+1366A>G:,ADCK1:ENST00000341211:intron:MODIFIER:exon5/9:c.537+1366A>G:	Tigger9b	rs734654	0.3918	0.4263	951,240,4	0.2933,0.0000,0.0000,0.4227,0.4308	0.4493											n/a (AF>5%)	n/a (AF>5%)					ADCK1 (inh=n/a pLI=0.00)
chr14	81574959	81574959	A	G	hom		QUAL=2531;DP=78;AF=1.00;MQM=60	TSHR,RP11-114N19.3	synonymous,3'UTR,intron	TSHR:ENST00000342443:synonymous:LOW:exon9/9:c.696A>G:p.Leu232Leu,TSHR:ENST00000554435:synonymous:LOW:exon9/9:c.759A>G:p.Leu253Leu,TSHR:ENST00000554263:3'UTR:MODIFIER:exon8/8:c.*159A>G:,TSHR:ENST00000298171:intron:MODIFIER:exon8/9:c.692+163A>G:,TSHR:ENST00000541158:intron:MODIFIER:exon9/10:c.692+163A>G:		rs3783942	0.6112	0.6468	25939,14472,2079	0.6303,0.6679,0.3397,0.6584,0.7449	0.6463							603372 [TSHR (confirmed) Hypothyroidism,congenital,nongoitrous,1 275200|Thyroid adenoma,hyperfunctioning,somatic|Hyperthyroidism,nonautoimmune,609152|Thyroid carcinoma with thyrotoxicosis|Hyperthyroidism,familial gestational,603373];				n/a (AF>5%)	n/a (AF>5%)					TSHR (inh=AR+AD pLI=0.00), RP11-114N19.3 (inh=n/a pLI=n/a)
chr14	81737076	81737076	A	C	hom		QUAL=3011;DP=93;AF=0.98;MQM=60	STON2	missense	STON2:ENST00000555447:missense:MODERATE:exon7/8:c.2551T>G:p.Ser851Ala,STON2:ENST00000267540:missense:MODERATE:exon5/5:c.2551T>G:p.Ser851Ala		rs2241621	0.4329	0.5224	17142,11070,421	0.2789,0.4666,0.3825,0.5765,0.5694	0.5245	3.3010	D,D,D	T	D,D	T,T	23.00			CM1111568 [CLASS=DP MUT=ALT PHEN="Schizophrenia association with" GENE=STON2]; 	COSM4148284	n/a (AF>5%)	n/a (AF>5%)					STON2 (inh=n/a pLI=0.46)
chr14	88477413	88477413	C	T	hom		QUAL=6440;DP=193;AF=0.99;MQM=60	GPR65,RP11-300J18.2	synonymous	GPR65:ENST00000267549:synonymous:LOW:exon2/2:c.222C>T:p.Thr74Thr		rs6574978	0.8205	0.7460	34515,15160,3078	0.7675,0.8845,0.9796,0.6736,0.8489	0.7477											n/a (AF>5%)	n/a (AF>5%)					GPR65 (inh=n/a pLI=0.47), RP11-300J18.2 (inh=n/a pLI=n/a)
chr14	89094243	89094243	G	C	hom	off-target	QUAL=539;DP=20;AF=1.00;MQM=60	EML5	intron	EML5:ENST00000554922:intron:MODIFIER:exon33/43:c.4358-80C>G:,EML5:ENST00000352093:intron:MODIFIER:exon31/41:c.4219+39C>G:,EML5:ENST00000380664:intron:MODIFIER:exon31/41:c.4334-80C>G:		rs1144916	0.8183	0.8203	7136,3347,491	0.7141,0.8834,0.9310,0.8863,0.7440	0.8657											n/a (AF>5%)	n/a (AF>5%)					EML5 (inh=n/a pLI=0.38)
chr14	92344300	92344300	A	G	het		QUAL=663;DP=66;AF=0.45;MQM=60	FBLN5	intron	FBLN5:ENST00000267620:intron:MODIFIER:exon10/11:c.1113-274T>C:,FBLN5:ENST00000342058:intron:MODIFIER:exon9/10:c.990-274T>C:,FBLN5:ENST00000556154:intron:MODIFIER:exon9/10:c.1005-274T>C:		rs2498847	0.3930	0.3639	740,143,19	0.4375,0.0000,0.0000,0.3297,0.3751	0.3809							604580 [FBLN5 (confirmed) Cutis laxa,autosomal recessive,type IA,219100|Cutis laxa,autosomal dominant 2,614434|Macular degeneration,age-related,3,608895|Neuropathy,hereditary,with or without age-related macular degeneration,608895];				n/a (AF>5%)	n/a (AF>5%)					FBLN5 (inh=AR+AD pLI=0.99)
chr14	92958612	92958612	G	A	het	off-target	QUAL=2020;DP=125;AF=0.58;MQM=60	SLC24A4	intron	SLC24A4:ENST00000532405:intron:MODIFIER:exon16/16:c.1716+28G>A:,SLC24A4:ENST00000393265:intron:MODIFIER:exon16/16:c.1524+28G>A:,SLC24A4:ENST00000531433:intron:MODIFIER:exon17/17:c.1659+28G>A:,SLC24A4:ENST00000298877:intron:MODIFIER:exon16/16:c.1665+28G>A:,SLC24A4:ENST00000351924:intron:MODIFIER:exon16/16:c.1608+28G>A:		rs7150406	0.2276	0.2537	4190,2283,127	0.1609,0.3842,0.1723,0.2577,0.2666	0.2581							609840 [SLC24A4 (confirmed) Skin/hair/eye pigmentation 6,blond/brown hair,210750|Skin/hair/eye pigmentation 6,blue/green eyes,210750|Amelogenesis imperfecta,type IIA5,615887];				n/a (AF>5%)	n/a (AF>5%)					SLC24A4 (inh=AR pLI=0.00)
chr14	96136794	96136794	A	G	het		QUAL=2418;DP=176;AF=0.52;MQM=60	TCL6,RP11-1070N10.6	non_coding_transcript_exon	TCL6:ENST00000467865:non_coding_transcript_exon:MODIFIER:exon3/5:n.1904A>G:		rs2249778	0.3279	0.2381	4282,1403,1712	0.5666,0.1131,0.3144,0.2020,0.2092	0.3196							603769 [TCL1B (provisional) Leukemia/lymphoma,T-cell];			COSM3999433	n/a (AF>5%)	n/a (AF>5%)					TCL6 (inh=n/a pLI=n/a), RP11-1070N10.6 (inh=n/a pLI=n/a)
chr14	96813703	96813703	A	T	hom	off-target	QUAL=723;DP=24;AF=1.00;MQM=60	ATG2B	intron	ATG2B:ENST00000359933:intron:MODIFIER:exon1/41:c.163-25T>A:		rs4905483	0.8444	0.9217	51290,32077,4430	0.9531,0.8512,0.5597,0.9860,0.8569	0.9474											n/a (AF>5%)	n/a (AF>5%)					ATG2B (inh=n/a pLI=0.00)
chr14	101349017	101349017	A	G	het		QUAL=3577;DP=244;AF=0.53;MQM=60	RTL1	synonymous	RTL1:ENST00000534062:synonymous:LOW:exon1/1:c.2109T>C:p.Phe703Phe		rs6575805	0.6458	0.6753	5461,2815,834	0.8365,0.5634,0.4969,0.7660,0.5081	0.7706											n/a (AF>5%)	n/a (AF>5%)					RTL1 (inh=n/a pLI=0.12)
chr14	101429459	101429459	G	C	het		QUAL=1628;DP=168;AF=0.40;MQM=60	AL132709.8,SNORD114-7	intron,non_coding_transcript_exon	AL132709.8:ENST00000423708:intron:MODIFIER:exon1/1:n.736+1878G>C:,SNORD114-7:ENST00000362520:non_coding_transcript_exon:MODIFIER:exon1/1:n.69G>C:		rs72700530	0.1054	0.1742	2077,1748,11	0.0480,0.1193,0.0466,0.2366,0.1149	0.1760											n/a (AF>5%)	n/a (AF>5%)					MEG8 (inh=n/a pLI=n/a), SNORD114-7 (inh=n/a pLI=n/a)
chr14	102548384	102548384	C	T	hom	off-target	QUAL=1834;DP=58;AF=1.00;MQM=60	HSP90AA1	intron	HSP90AA1:ENST00000334701:intron:MODIFIER:exon11/11:c.2455+64G>A:,HSP90AA1:ENST00000216281:intron:MODIFIER:exon10/10:c.2089+64G>A:		rs6575895	0.9067	0.0000	0,0,0	0,0,0,0,0	0.8738											n/a (AF>5%)	n/a (AF>5%)					HSP90AA1 (inh=n/a pLI=0.84)
chr14	103342049	103342049	T	C	het		QUAL=3204;DP=234;AF=0.51;MQM=60	TRAF3	missense	TRAF3:ENST00000392745:missense:MODERATE:exon5/12:c.386T>C:p.Met129Thr,TRAF3:ENST00000560371:missense:MODERATE:exon4/11:c.386T>C:p.Met129Thr,TRAF3:ENST00000347662:missense:MODERATE:exon5/11:c.386T>C:p.Met129Thr,TRAF3:ENST00000539721:missense:MODERATE:exon4/8:c.386T>C:p.Met129Thr,TRAF3:ENST00000351691:missense:MODERATE:exon4/10:c.386T>C:p.Met129Thr		rs1131877	0.4698	0.3156	8038,1872,3596	0.8266,0.4535,0.4068,0.2370,0.1723	0.4289	2.3690	T,T,T,T	T	B,B,B	T,T,T,T	0.02	601896 [TRAF3 (provisional) Encephalopathy,acute,infection-induced (herpes-specific),susceptibility to,5,614849];				n/a (AF>5%)	n/a (AF>5%)					TRAF3 (inh=n/a pLI=1.00)
chr14	104027557	104027557	C	T	het	off-target	QUAL=872;DP=71;AF=0.51;MQM=60	RP11-894P9.2,BAG5	intron	BAG5:ENST00000337322:intron:MODIFIER:exon1/1:c.96-28G>A:,BAG5:ENST00000299204:intron:MODIFIER:exon1/1:c.-28-28G>A:,BAG5:ENST00000445922:intron:MODIFIER:exon1/1:c.-28-28G>A:		rs11625397	0.5224	0.5817	19447,12948,1460	0.5744,0.5181,0.4452,0.6406,0.4342	0.6132											n/a (AF>5%)	n/a (AF>5%)					RP11-894P9.2 (inh=n/a pLI=n/a), BAG5 (inh=n/a pLI=0.03)
chr14	105267579	105267579	A	G	hom		QUAL=5913;DP=180;AF=1.00;MQM=60	ZBTB42	synonymous	ZBTB42:ENST00000342537:synonymous:LOW:exon1/1:c.45A>G:p.Arg15Arg,ZBTB42:ENST00000555360:synonymous:LOW:exon2/2:c.45A>G:p.Arg15Arg		rs12878684	0.6745	0.8100	1655,780,152	0.8144,0.0000,0.0000,0.9119,0.7516	0.8376							613915 [ZBTB42 (provisional) Lethal congenital contracture syndrome 6,616248];			COSM3749267, COSM3749266	n/a (AF>5%)	n/a (AF>5%)					ZBTB42 (inh=AR pLI=n/a)
chr14	105309608	105309608	C	T	hom		QUAL=427;DP=15;AF=1.00;MQM=60	CTD-3051D23.1				rs12878750	0.5976	0.7630	2890,928,33	0.0000,0.0000,0.0000,0.8653,0.7372	0.7035											n/a (AF>5%)	n/a (AF>5%)					CTD-3051D23.1 (inh=n/a pLI=n/a)
chr14	105344293	105344293	C	T	hom		QUAL=2783;DP=84;AF=1.00;MQM=60	CEP170B	synonymous	CEP170B:ENST00000453495:synonymous:LOW:exon4/19:c.267C>T:p.Phe89Phe,CEP170B:ENST00000556508:synonymous:LOW:exon3/18:c.57C>T:p.Phe19Phe,CEP170B:ENST00000414716:synonymous:LOW:exon4/19:c.267C>T:p.Phe89Phe,CEP170B:ENST00000418279:synonymous:LOW:exon3/18:c.57C>T:p.Phe19Phe		rs61995995	0.3538	0.5391	14602,10173,182	0.2538,0.5240,0.2162,0.6066,0.5350	0.5004										COSM4147860, COSM4147859	n/a (AF>5%)	n/a (AF>5%)					CEP170B (inh=n/a pLI=0.94)
chr14	105415745	105415745	C	G	hom	gene_blacklist	QUAL=8666;DP=283;AF=0.99;MQM=52	AHNAK2	missense,intron	AHNAK2:ENST00000333244:missense:MODERATE:exon7/7:c.6043G>C:p.Ala2015Pro,AHNAK2:ENST00000557457:intron:MODIFIER:exon1/2:c.-221+4473G>C:		rs117379881	0.2772	0.4482	16039,11911,153	0.1326,0.2757,0.0706,0.5631,0.4938	0.4474	-2.1390	T	T	D	T	13.25				COSM4147890	n/a (AF>5%)	n/a (AF>5%)					AHNAK2 (inh=n/a pLI=n/a)
chr14	105461067	105461067	C	T	hom		QUAL=4898;DP=147;AF=1.00;MQM=60	C14orf79	synonymous	C14orf79:ENST00000547315:synonymous:LOW:exon5/5:c.949C>T:p.Leu317Leu,C14orf79:ENST00000550614:synonymous:LOW:exon4/4:c.223C>T:p.Leu75Leu,C14orf79:ENST00000549240:synonymous:LOW:exon3/3:c.223C>T:p.Leu75Leu		rs894039	0.7448	0.7831	37438,22468,3344	0.8265,0.7468,0.5415,0.8197,0.7535	0.7874											n/a (AF>5%)	n/a (AF>5%)					CLBA1 (inh=n/a pLI=0.00)
chr14	107048609	107048610	CC	-	het	off-target	QUAL=108;DP=34;AF=0.35;MQM=40	IGHV3,52,53	intergenic_region	53:ENSG00000253545-ENSG00000211967:intergenic_region:MODIFIER::n.107048609_107048610delCC:		rs535167676	0.4107	0.0000	0,0,0	0,0,0,0,0	0.5251											n/a (AF>5%)	n/a (AF>5%)					IGHV3 (inh=n/a pLI=n/a), 52 (inh=n/a pLI=n/a), 53 (inh=n/a pLI=n/a)
chr15	25427208	25427208	C	A	het	off-target	QUAL=313;DP=35;AF=0.46;MQM=60	SNHG14	non_coding_transcript_exon	SNHG14:ENST00000424208:non_coding_transcript_exon:MODIFIER:exon2/34:n.96C>A:		rs2714793	0.2925	0.0000	0,0,0	0,0,0,0,0	0.2361											n/a (AF>5%)	n/a (AF>5%)					SNHG14 (inh=n/a pLI=n/a)
chr15	25933094	25933094	C	T	het		QUAL=583;DP=62;AF=0.44;MQM=60	ATP10A	intron	ATP10A:ENST00000356865:intron:MODIFIER:exon15/20:c.3166-119G>A:		rs3743438	0.1192	0.1785	782,208,41	0.1615,0.0967,0.1799,0.1499,0.2879	0.1175	-1.1040	T	T		T	0.03					n/a (AF>5%)	n/a (AF>5%)					ATP10A (inh=n/a pLI=0.68)
chr15	27772676	27772676	C	T	het		QUAL=1375;DP=120;AF=0.46;MQM=60	GABRG3,RP11-100M12.3	synonymous	GABRG3:ENST00000333743:synonymous:LOW:exon8/10:c.963C>T:p.Thr321Thr		rs140679	0.5164	0.5373	18005,9248,501	0.3192,0.7090,0.6703,0.5256,0.5424	0.5500	-1.7070		T			16.51					n/a (AF>5%)	n/a (AF>5%)					GABRG3 (inh=n/a pLI=0.99), RP11-100M12.3 (inh=n/a pLI=n/a)
chr15	28228644	28228644	G	A	hom		QUAL=3870;DP=118;AF=1.00;MQM=60	OCA2	splice_region&intron	OCA2:ENST00000354638:splice_region&intron:LOW:exon13/23:c.1365-15C>T:,OCA2:ENST00000353809:splice_region&intron:LOW:exon12/22:c.1293-15C>T:,OCA2:ENST00000382996:splice_region&intron:LOW:exon13/18:c.1365-15C>T:		rs12910433	0.3213	0.5460	21338,17120,182	0.1820,0.3652,0.1383,0.7138,0.3518	0.5438							611409 [OCA2 (confirmed) Albinism,oculocutaneous,type II,203200|Albinism,brown oculocutaneous,203200|Skin/hair/eye pigmentation 1,blue/nonblue eyes,227220|Skin/hair/eye pigmentation 1,blond/brown hair,227220];	255720 [benign DISEASE=oculocutaneous_albinism,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					OCA2 (inh=AR pLI=0.00)
chr15	28357230	28357230	T	C	hom	off-target	QUAL=2226;DP=69;AF=1.00;MQM=60	HERC2	intron	HERC2:ENST00000261609:intron:MODIFIER:exon92/92:c.14233-49A>G:		rs4778245	0.9317	0.9680	55255,31894,4112	0.9180,0.9872,0.9860,0.9916,0.8620	0.9754							605837 [HERC2 (confirmed) Skin/hair/eye pigmentation 1,blue/nonblue eyes,227220|Skin/hair/eye pigmentation 1,blond/brown hair,227220|Mental retardation,autosomal recessive 38,615516];				n/a (AF>5%)	n/a (AF>5%)					HERC2 (inh=AR pLI=1.00)
chr15	31330280	31330280	A	G	hom		QUAL=2327;DP=72;AF=1.00;MQM=60	TRPM1,RP11-348B17.1	synonymous	TRPM1:ENST00000542188:synonymous:LOW:exon18/27:c.2457T>C:p.Asn819Asn,TRPM1:ENST00000397795:synonymous:LOW:exon18/27:c.2340T>C:p.Asn780Asn,TRPM1:ENST00000256552:synonymous:LOW:exon19/28:c.2406T>C:p.Asn802Asn	(ATTTTC)n	rs2288242	0.7594	0.8104	40212,23313,1901	0.6252,0.8905,0.9696,0.8367,0.6580	0.8184							603576 [TRPM1 (provisional) Night blindness,congenital stationary (complete),1C,autosomal recessive,613216];	315511 [benign DISEASE=congenital_stationary_night_blindness,_recessive]; 		COSM4148623	n/a (AF>5%)	n/a (AF>5%)					TRPM1 (inh=n/a pLI=0.00), RP11-348B17.1 (inh=n/a pLI=n/a)
chr15	34094201	34094201	C	T	het	off-target	QUAL=1020;DP=106;AF=0.40;MQM=60	RYR3	intron	RYR3:ENST00000389232:intron:MODIFIER:exon69/103:c.10011+39C>T:,RYR3:ENST00000415757:intron:MODIFIER:exon69/102:c.10011+39C>T:		rs2115747	0.3620	0.4212	9544,5500,394	0.3103,0.2931,0.4537,0.4356,0.4934	0.3961											n/a (AF>5%)	n/a (AF>5%)					RYR3 (inh=n/a pLI=1.00)
chr15	37026565	37026565	A	G	het		QUAL=228;DP=21;AF=0.52;MQM=60	C15orf41	intron	C15orf41:ENST00000569302:intron:MODIFIER:exon10/10:c.734+24403A>G:,C15orf41:ENST00000566621:intron:MODIFIER:exon10/10:c.716+24403A>G:,C15orf41:ENST00000437989:intron:MODIFIER:exon10/11:c.716+24403A>G:,C15orf41:ENST00000567389:intron:MODIFIER:exon11/11:c.422+24403A>G:,C15orf41:ENST00000562877:intron:MODIFIER:exon10/10:c.422+24403A>G:,C15orf41:ENST00000338183:intron:MODIFIER:exon10/10:c.422+24403A>G:,C15orf41:ENST00000562489:intron:MODIFIER:exon3/3:c.188+24403A>G:		rs1037439	0.2869	0.2200	312,118,37	0.3213,0.0000,0.2885,0.2669,0.1846	0.2633							615626 [C15ORF41 (provisional) Dyserythropoietic anemia,congenital,type Ib,615631];				n/a (AF>5%)	n/a (AF>5%)					C15orf41 (inh=AR pLI=0.01)
chr15	38614525	38614525	G	A	het		QUAL=938;DP=92;AF=0.41;MQM=60	SPRED1	synonymous	SPRED1:ENST00000299084:synonymous:LOW:exon3/7:c.291G>A:p.Lys97Lys		rs7182445	0.8001	0.8637	45684,26990,2291	0.6615,0.8207,0.7906,0.8987,0.8897	0.8664							609291 [SPRED1 (confirmed) Legius syndrome,611431];	41371 [benign/likely benign DISEASE=legius_syndrome,not_specified]; 		COSM4148687	n/a (AF>5%)	n/a (AF>5%)					SPRED1 (inh=AD pLI=0.95)
chr15	38632148	38632148	A	G	hom	off-target	QUAL=624;DP=21;AF=1.00;MQM=60	SPRED1	intron	SPRED1:ENST00000299084:intron:MODIFIER:exon5/6:c.582+52A>G:		rs7181472	0.9095	0.9747	56523,32511,2398	0.7084,0.9875,0.9998,0.9992,0.9998	0.9789							609291 [SPRED1 (confirmed) Legius syndrome,611431];				n/a (AF>5%)	n/a (AF>5%)					SPRED1 (inh=AD pLI=0.95)
chr15	39880358	39880358	C	T	het		QUAL=760;DP=60;AF=0.50;MQM=60	THBS1	synonymous	THBS1:ENST00000260356:synonymous:LOW:exon9/22:c.1410C>T:p.Asn470Asn		rs2228261	0.2668	0.1635	2235,452,882	0.4049,0.1027,0.3124,0.1141,0.1982	0.2058								403535 [benign DISEASE=not_specified]; 		COSM147874	n/a (AF>5%)	n/a (AF>5%)					THBS1 (inh=n/a pLI=1.00)
chr15	40300443	40300443	T	G	hom	off-target	QUAL=421;DP=16;AF=1.00;MQM=60	EIF2AK4	intron	EIF2AK4:ENST00000263791:intron:MODIFIER:exon25/38:c.3576+47T>G:,EIF2AK4:ENST00000382727:intron:MODIFIER:exon24/37:c.3492+47T>G:		rs2279579	0.2780	0.3366	6537,4412,273	0.2374,0.2691,0.2525,0.3679,0.3753	0.3383							609280 [EIF2AK4 (provisional) Pulmonary venoocclusive disease 2,234810];				n/a (AF>5%)	n/a (AF>5%)					EIF2AK4 (inh=AR pLI=0.00)
chr15	40573716	40573716	A	G	hom		QUAL=2703;DP=83;AF=1.00;MQM=60	ANKRD63,PLCB2	missense	ANKRD63:ENST00000434396:missense:MODERATE:exon1/1:c.1072T>C:p.Ser358Pro		rs4924446	0.9970	0.9998	4348,1067,82	0.0000,0.0000,0.0000,1.0000,1.0000	0.9993	1.8900	T	T		T	11.27					n/a (AF>5%)	n/a (AF>5%)					ANKRD63 (inh=n/a pLI=n/a), PLCB2 (inh=n/a pLI=0.00)
chr15	40590134	40590134	G	A	het		QUAL=1910;DP=164;AF=0.45;MQM=60	PLCB2	synonymous	PLCB2:ENST00000260402:synonymous:LOW:exon12/32:c.1182C>T:p.Ser394Ser,PLCB2:ENST00000557821:synonymous:LOW:exon12/32:c.1182C>T:p.Ser394Ser,PLCB2:ENST00000456256:synonymous:LOW:exon12/31:c.1182C>T:p.Ser394Ser		rs2229690	0.6905	0.5818	21490,7812,2998	0.7820,0.7436,0.8282,0.4847,0.6384	0.6044							604114 [PLCB2 (provisional) Platelet PLC beta-2 deficiency];			COSM1158649	n/a (AF>5%)	n/a (AF>5%)					PLCB2 (inh=n/a pLI=0.00)
chr15	40703609	40703609	A	G	hom	off-target	QUAL=2789;DP=85;AF=1.00;MQM=60	IVD	intron	IVD:ENST00000487418:intron:MODIFIER:exon5/11:c.559+57A>G:,IVD:ENST00000249760:intron:MODIFIER:exon5/11:c.550+57A>G:,IVD:ENST00000479013:intron:MODIFIER:exon4/10:c.469+57A>G:		rs4924466	0.9784	0.0000	0,0,0	0,0,0,0,0	0.9666							607036 [IVD (provisional) Isovaleric acidemia,243500];	197740 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					IVD (inh=AR pLI=0.00)
chr15	40855210	40855210	T	A	het		QUAL=864;DP=68;AF=0.50;MQM=60	C15orf57	missense	C15orf57:ENST00000559911:missense:MODERATE:exon2/5:c.5A>T:p.Lys2Ile,C15orf57:ENST00000560305:missense:MODERATE:exon2/4:c.5A>T:p.Lys2Ile,C15orf57:ENST00000561011:missense:MODERATE:exon2/4:c.5A>T:p.Lys2Ile,C15orf57:ENST00000558113:missense:MODERATE:exon2/4:c.5A>T:p.Lys2Ile,C15orf57:ENST00000358005:missense:MODERATE:exon2/4:c.5A>T:p.Lys2Ile,C15orf57:ENST00000416810:missense:MODERATE:exon2/4:c.5A>T:p.Lys2Ile,C15orf57:ENST00000558750:missense:MODERATE:exon2/4:c.32A>T:p.Lys11Ile,C15orf57:ENST00000558871:missense:MODERATE:exon2/3:c.5A>T:p.Lys2Ile		rs10152546	0.2584	0.3457	8100,6117,334	0.2460,0.2263,0.0837,0.4293,0.2786	0.3455	1.4540	T,.	T	B,B	T	13.05				COSM147879	n/a (AF>5%)	n/a (AF>5%)					CCDC32 (inh=n/a pLI=0.57)
chr15	41799711	41799711	C	T	het		QUAL=404;DP=47;AF=0.38;MQM=60	LTK	splice_donor,intron	LTK:ENST00000561619:splice_donor:HIGH:exon4/13:c.439+1G>A:,LTK:ENST00000263800:intron:MODIFIER:exon10/19:c.1345+49G>A:,LTK:ENST00000355166:intron:MODIFIER:exon9/18:c.1162+49G>A:,LTK:ENST00000453182:intron:MODIFIER:exon9/17:c.1162+49G>A:		rs4924549	0.0569	0.1783	657,560,3	0.0431,0.1867,0.0008,0.2504,0.0545	0.1098	0.2020	T	T			0.44					n/a (AF>5%)	n/a (AF>5%)					LTK (inh=n/a pLI=0.00)
chr15	42026764	42026764	C	T	hom		QUAL=3810;DP=117;AF=1.00;MQM=60	MGA	synonymous	MGA:ENST00000219905:synonymous:LOW:exon12/24:c.3888C>T:p.Asp1296Asp,MGA:ENST00000389936:synonymous:LOW:exon12/25:c.3888C>T:p.Asp1296Asp,MGA:ENST00000545763:synonymous:LOW:exon12/23:c.3888C>T:p.Asp1296Asp,MGA:ENST00000566586:synonymous:LOW:exon11/22:c.3888C>T:p.Asp1296Asp,MGA:ENST00000570161:synonymous:LOW:exon11/23:c.3888C>T:p.Asp1296Asp		rs1918314	0.7482	0.8016	36921,21371,1450	0.5796,0.8491,0.8874,0.8216,0.7525	0.7995											n/a (AF>5%)	n/a (AF>5%)					MGA (inh=n/a pLI=1.00)
chr15	42287578	42287578	G	A	hom		QUAL=2066;DP=64;AF=1.00;MQM=60	PLA2G4E,CTD-2382E5.1	synonymous	PLA2G4E:ENST00000399518:synonymous:LOW:exon12/20:c.1227C>T:p.Thr409Thr,PLA2G4E:ENST00000413860:synonymous:LOW:exon11/19:c.1140C>T:p.Thr380Thr		rs1668586	0.6583	0.7695	36525,24616,1504	0.5544,0.6395,0.5577,0.8591,0.7276	0.7680										COSM3999525	n/a (AF>5%)	n/a (AF>5%)					PLA2G4E (inh=n/a pLI=0.00), CTD-2382E5.1 (inh=n/a pLI=n/a)
chr15	42371752	42371752	A	T	het		QUAL=285;DP=21;AF=0.57;MQM=60	PLA2G4D	missense	PLA2G4D:ENST00000290472:missense:MODERATE:exon13/20:c.1300T>A:p.Ser434Thr		rs4924618	0.2999	0.3901	7355,3933,163	0.2346,0.5551,0.4622,0.3943,0.2649	0.3638	0.6280	T	T	B	T	13.42				COSM1162389	n/a (AF>5%)	n/a (AF>5%)					PLA2G4D (inh=n/a pLI=0.00)
chr15	42528676	42528676	C	T	hom	off-target	QUAL=2389;DP=73;AF=1.00;MQM=60	TMEM87A	intron	TMEM87A:ENST00000389834:intron:MODIFIER:exon9/19:c.869-59G>A:,TMEM87A:ENST00000448392:intron:MODIFIER:exon8/18:c.686-59G>A:		rs1679012	0.5308	0.0000	0,0,0	0,0,0,0,0	0.6149											n/a (AF>5%)	n/a (AF>5%)					TMEM87A (inh=n/a pLI=0.89)
chr15	42568547	42568547	C	G	hom		QUAL=1694;DP=54;AF=1.00;MQM=60	GANC	missense&splice_region	GANC:ENST00000318010:missense&splice_region:MODERATE:exon2/24:c.31C>G:p.Leu11Val,GANC:ENST00000566442:missense&splice_region:MODERATE:exon3/12:c.31C>G:p.Leu11Val,GANC:ENST00000440615:missense&splice_region:MODERATE:exon2/5:c.31C>G:p.Leu11Val		rs8043515	0.9545	0.9837	58423,33104,4468	0.9384,0.9952,0.9474,0.9984,0.9565	0.9857	1.6260	T,T	T	B,B	T,T	0.18					n/a (AF>5%)	n/a (AF>5%)					GANC (inh=n/a pLI=0.00)
chr15	42579948	42579948	T	C	hom		QUAL=4620;DP=140;AF=1.00;MQM=60	GANC	synonymous	GANC:ENST00000318010:synonymous:LOW:exon4/24:c.261T>C:p.Asn87Asn,GANC:ENST00000566442:synonymous:LOW:exon5/12:c.261T>C:p.Asn87Asn		rs8037627	0.8724	0.9625	56591,33207,2602	0.7063,0.9873,0.9469,0.9978,0.9565	0.9691											n/a (AF>5%)	n/a (AF>5%)					GANC (inh=n/a pLI=0.00)
chr15	43724646	43724646	T	G	hom		QUAL=8268;DP=250;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:ENST00000382044:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000263801:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln,TP53BP1:ENST00000382039:missense:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln,TP53BP1:ENST00000450115:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln		rs2602141	0.5264	0.3750	10244,3163,3807	0.8518,0.3133,0.4170,0.3043,0.4526	0.4422	3.2610	T,T,T,T	T	B,B,B,B	T,T,T,T	12.43			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43773036	43773036	A	C	het	off-target	QUAL=96;DP=18;AF=0.39;MQM=60	TP53BP1	intron	TP53BP1:ENST00000382044:intron:MODIFIER:exon5/27:c.499+57T>G:,TP53BP1:ENST00000263801:intron:MODIFIER:exon5/27:c.484+57T>G:,TP53BP1:ENST00000382039:intron:MODIFIER:exon5/26:c.499+57T>G:,TP53BP1:ENST00000450115:intron:MODIFIER:exon5/27:c.499+57T>G:		rs7173383	0.1368	0.0000	0,0,0	0,0,0,0,0	0.1652											n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a pLI=1.00)
chr15	43816917	43816917	G	A	hom		QUAL=2657;DP=81;AF=1.00;MQM=60	MAP1A	synonymous	MAP1A:ENST00000382031:synonymous:LOW:exon5/7:c.3960G>A:p.Gly1320Gly,MAP1A:ENST00000399453:synonymous:LOW:exon4/6:c.3246G>A:p.Gly1082Gly,MAP1A:ENST00000300231:synonymous:LOW:exon4/6:c.3246G>A:p.Gly1082Gly		rs1060939	0.5288	0.3671	9818,2967,3696	0.8648,0.3115,0.4520,0.2958,0.4240	0.4461										COSM3754334	n/a (AF>5%)	n/a (AF>5%)					MAP1A (inh=n/a pLI=1.00)
chr15	43893072	43893072	G	A	het		QUAL=1216;DP=113;AF=0.45;MQM=55	STRC,CKMT1B	splice_region&synonymous	STRC:ENST00000450892:splice_region&synonymous:LOW:exon25/29:c.4842C>T:p.Phe1614Phe,STRC:ENST00000541030:splice_region&synonymous:LOW:exon24/28:c.2523C>T:p.Phe841Phe		rs3097773	0.3958	0.2017	4484,509,2434	0.6876,0.2160,0.4415,0.1067,0.2023	0.2805							606440 [STRC (confirmed) Deafness,autosomal recessive 16,603720];	177982 [benign DISEASE=not_specified]; 		COSM3999536	n/a (AF>5%)	n/a (AF>5%)					STRC (inh=AR+AD pLI=0.01), CKMT1B (inh=n/a pLI=0.06)
chr15	44093927	44093927	T	C	het		QUAL=1123;DP=105;AF=0.44;MQM=60	SERF2,HYPK	missense,3'UTR	SERF2:ENST00000594896:missense:MODERATE:exon6/6:c.451T>C:p.Ser151Pro,HYPK:ENST00000406925:missense:MODERATE:exon5/5:c.313T>C:p.Ser105Pro,HYPK:ENST00000442995:missense:MODERATE:exon4/4:c.313T>C:p.Ser105Pro,SERF2:ENST00000600633:missense:MODERATE:exon4/4:c.313T>C:p.Ser105Pro,HYPK:ENST00000458412:3'UTR:MODIFIER:exon2/2:c.*149T>C:		rs12702	0.2091	0.1340	1432,371,351	0.2682,0.1941,0.2775,0.0971,0.1210	0.1483	3.9650	T,T	T	B	T,T	23.10				COSM3999538, COSM3999539	n/a (AF>5%)	n/a (AF>5%)					SERF2 (inh=n/a pLI=0.12), HYPK (inh=n/a pLI=0.02)
chr15	44102010	44102010	A	C	het		QUAL=3350;DP=234;AF=0.53;MQM=60	MFAP1	synonymous	MFAP1:ENST00000267812:synonymous:LOW:exon7/9:c.990T>G:p.Ala330Ala		rs2228368	0.2027	0.1325	1367,378,286	0.2480,0.1939,0.2757,0.0978,0.1208	0.1412											n/a (AF>5%)	n/a (AF>5%)					MFAP1 (inh=n/a pLI=0.99)
chr15	44151063	44151063	G	A	het	off-target	QUAL=871;DP=63;AF=0.56;MQM=60	WDR76	intron	WDR76:ENST00000263795:intron:MODIFIER:exon11/12:c.1562+42G>A:,WDR76:ENST00000381246:intron:MODIFIER:exon11/12:c.1370+42G>A:		rs13329084	0.1096	0.1028	818,329,4	0.0264,0.1708,0.1963,0.0925,0.1237	0.1065											n/a (AF>5%)	n/a (AF>5%)					WDR76 (inh=n/a pLI=0.01)
chr15	51502986	51502986	G	A	het		QUAL=2072;DP=147;AF=0.52;MQM=60	CYP19A1,RP11-108K3.1	3'UTR,intron	CYP19A1:ENST00000260433:3'UTR:MODIFIER:exon10/10:c.*19C>T:,CYP19A1:ENST00000396402:3'UTR:MODIFIER:exon10/10:c.*19C>T:,CYP19A1:ENST00000396404:3'UTR:MODIFIER:exon11/11:c.*19C>T:,CYP19A1:ENST00000559878:3'UTR:MODIFIER:exon9/9:c.*19C>T:,RP11-108K3.1:ENST00000559909:intron:MODIFIER:exon1/2:n.195-67194G>A:		rs10046	0.3628	0.4492	12972,8933,341	0.2556,0.3089,0.5167,0.5167,0.3288	0.4516							107910 [CYP19A1 (confirmed) Aromatase deficiency,613546|Aromatase excess syndrome,139300];	316469 [benign DISEASE=aromatase_deficiency]; 	CR005436 [CLASS=FP MUT=ALT PHEN="Increased activity in tumours" GENE=CYP19A1]; 		n/a (AF>5%)	n/a (AF>5%)					CYP19A1 (inh=AR+AD pLI=0.00), MIR4713HG (inh=n/a pLI=n/a)
chr15	51529112	51529112	T	C	het		QUAL=1141;DP=135;AF=0.36;MQM=60	CYP19A1,RP11-108K3.1	synonymous,intron	CYP19A1:ENST00000260433:synonymous:LOW:exon3/10:c.240A>G:p.Val80Val,CYP19A1:ENST00000396402:synonymous:LOW:exon3/10:c.240A>G:p.Val80Val,CYP19A1:ENST00000396404:synonymous:LOW:exon4/11:c.240A>G:p.Val80Val,CYP19A1:ENST00000559878:synonymous:LOW:exon2/9:c.240A>G:p.Val80Val,CYP19A1:ENST00000405913:synonymous:LOW:exon2/4:c.240A>G:p.Val80Val,CYP19A1:ENST00000557858:synonymous:LOW:exon3/5:c.240A>G:p.Val80Val,RP11-108K3.1:ENST00000559909:intron:MODIFIER:exon1/2:n.195-41068T>C:		rs700518	0.3259	0.4253	11719,8295,239	0.2101,0.2860,0.4349,0.4980,0.3295	0.4266							107910 [CYP19A1 (confirmed) Aromatase deficiency,613546|Aromatase excess syndrome,139300];	316477 [benign DISEASE=aromatase_deficiency]; 	CM068495 [CLASS=DP MUT=ALT PHEN="Increased cortical bone mass density association with" GENE=CYP19A1]; 	COSM147905	n/a (AF>5%)	n/a (AF>5%)					CYP19A1 (inh=AR+AD pLI=0.00), MIR4713HG (inh=n/a pLI=n/a)
chr15	51791559	51791559	A	G	het		QUAL=1971;DP=153;AF=0.49;MQM=60	DMXL2	missense,intron	DMXL2:ENST00000543779:missense:MODERATE:exon18/43:c.3862T>C:p.Ser1288Pro,DMXL2:ENST00000251076:missense:MODERATE:exon18/43:c.3862T>C:p.Ser1288Pro,DMXL2:ENST00000449909:intron:MODIFIER:exon16/40:c.2765-4228T>C:		rs12102203	0.4373	0.4925	14938,8928,1004	0.4391,0.5315,0.4247,0.5169,0.4162	0.5093	0.2510	T,T	T	B,B	T,T	0.12	612186 [DMXL2 (provisional) Polyendocrine-polyneuropathy syndrome,616113|Deafness,autosomal dominant 71,617605];			COSM147908	n/a (AF>5%)	n/a (AF>5%)					DMXL2 (inh=AR pLI=1.00)
chr15	52667552	52667552	G	A	hom		QUAL=6906;DP=208;AF=1.00;MQM=60	MYO5A	synonymous	MYO5A:ENST00000358212:synonymous:LOW:exon20/42:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000399231:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000356338:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000399233:synonymous:LOW:exon20/40:c.2526C>T:p.Ile842Ile,MYO5A:ENST00000553916:synonymous:LOW:exon20/41:c.2526C>T:p.Ile842Ile		rs2414145	0.8446	0.9518	55390,33103,1738	0.5965,0.9827,0.9735,0.9960,0.9310	0.9593							160777 [MYO5A (confirmed) Griscelli syndrome,type 1,214450];				n/a (AF>5%)	n/a (AF>5%)					MYO5A (inh=AR pLI=0.98)
chr15	52901977	52901977	G	A	hom		QUAL=3813;DP=116;AF=1.00;MQM=60	FAM214A	synonymous	FAM214A:ENST00000546305:synonymous:LOW:exon5/12:c.1155C>T:p.Ala385Ala,FAM214A:ENST00000261844:synonymous:LOW:exon6/13:c.1134C>T:p.Ala378Ala		rs2414166	0.4171	0.6195	25455,17688,383	0.2762,0.5973,0.1066,0.7279,0.6012	0.6266										COSM147916	n/a (AF>5%)	n/a (AF>5%)					FAM214A (inh=n/a pLI=0.98)
chr15	56030756	56030756	T	C	hom	off-target	QUAL=1098;DP=35;AF=1.00;MQM=60	PRTG	intron	PRTG:ENST00000389286:intron:MODIFIER:exon2/19:c.397+1824A>G:,PRTG:ENST00000561292:intron:MODIFIER:exon2/2:c.398-59A>G:		rs4774222	0.2196	0.0000	0,0,0	0,0,0,0,0	0.3610											n/a (AF>5%)	n/a (AF>5%)					PRTG (inh=n/a pLI=0.47)
chr15	56208535	56208535	G	A	het		QUAL=2397;DP=168;AF=0.54;MQM=60	NEDD4	synonymous,intron	NEDD4:ENST00000508342:synonymous:LOW:exon1/25:c.495C>T:p.Asn165Asn,NEDD4:ENST00000338963:synonymous:LOW:exon1/22:c.495C>T:p.Asn165Asn,NEDD4:ENST00000506154:synonymous:LOW:exon1/25:c.495C>T:p.Asn165Asn,NEDD4:ENST00000435532:intron:MODIFIER:exon5/28:c.291+8309C>T:		rs12440230	0.1977	0.1504	1610,476,127	0.1485,0.1367,0.3691,0.1225,0.1708	0.1502											n/a (AF>5%)	n/a (AF>5%)					NEDD4 (inh=n/a pLI=0.00)
chr15	57744311	57744311	T	A	het	off-target	QUAL=411;DP=36;AF=0.47;MQM=60	CGNL1	intron	CGNL1:ENST00000281282:intron:MODIFIER:exon5/18:c.1906-28T>A:		rs1018269	0.4982	0.4653	13157,6916,974	0.4297,0.4375,0.4531,0.4566,0.5960	0.4619											n/a (AF>5%)	n/a (AF>5%)					CGNL1 (inh=n/a pLI=0.00)
chr15	58253062	58253062	C	T	hom		QUAL=3708;DP=115;AF=0.98;MQM=60	ALDH1A2	splice_region&intron	ALDH1A2:ENST00000249750:splice_region&intron:LOW:exon11/12:c.1410-20G>A:,ALDH1A2:ENST00000347587:splice_region&intron:LOW:exon10/11:c.1296-20G>A:,ALDH1A2:ENST00000537372:splice_region&intron:LOW:exon12/13:c.1347-20G>A:,ALDH1A2:ENST00000558231:splice_region&intron:LOW:exon11/12:c.1323-20G>A:,ALDH1A2:ENST00000559517:splice_region&intron:LOW:exon9/10:c.1122-20G>A:		rs3784263	0.3059	0.3757	9454,7082,721	0.3771,0.2425,0.1958,0.4584,0.1895	0.4160											n/a (AF>5%)	n/a (AF>5%)					ALDH1A2 (inh=n/a pLI=0.94)
chr15	59510189	59510189	G	A	het		QUAL=3450;DP=247;AF=0.51;MQM=60	MYO1E	synonymous	MYO1E:ENST00000288235:synonymous:LOW:exon10/28:c.1008C>T:p.Ser336Ser		rs2230155	0.5072	0.4271	12205,3779,747	0.3850,0.6141,0.7071,0.3344,0.5296	0.4340							601479 [MYO1E (provisional) Glomerulosclerosis,focal segmental,6,614131];			COSM3999575	n/a (AF>5%)	n/a (AF>5%)					MYO1E (inh=AR pLI=0.06)
chr15	59524056	59524056	T	C	hom	off-target	QUAL=488;DP=18;AF=1.00;MQM=60	MYO1E	intron	MYO1E:ENST00000288235:intron:MODIFIER:exon5/27:c.421-66A>G:		rs7165587	0.9437	0.0000	0,0,0	0,0,0,0,0	0.9558							601479 [MYO1E (provisional) Glomerulosclerosis,focal segmental,6,614131];				n/a (AF>5%)	n/a (AF>5%)					MYO1E (inh=AR pLI=0.06)
chr15	59784493	59784493	C	T	hom		QUAL=1698;DP=52;AF=1.00;MQM=60	FAM81A	synonymous	FAM81A:ENST00000288228:synonymous:LOW:exon4/9:c.318C>T:p.Ala106Ala		rs4296198	0.7796	0.8098	39100,21499,2088	0.6647,0.9126,0.8271,0.8092,0.7877	0.8169										COSM4128313	n/a (AF>5%)	n/a (AF>5%)					FAM81A (inh=n/a pLI=0.77)
chr15	60643853	60643853	C	G	hom	off-target	QUAL=835;DP=29;AF=1.00;MQM=60	ANXA2	intron	ANXA2:ENST00000332680:intron:MODIFIER:exon10/12:c.832+70G>C:,ANXA2:ENST00000396024:intron:MODIFIER:exon11/13:c.778+70G>C:,ANXA2:ENST00000451270:intron:MODIFIER:exon10/12:c.778+70G>C:,ANXA2:ENST00000421017:intron:MODIFIER:exon11/13:c.778+70G>C:		rs8037326	0.7694	0.0000	0,0,0	0,0,0,0,0	0.7769										COSN164964	n/a (AF>5%)	n/a (AF>5%)					ANXA2 (inh=n/a pLI=0.01)
chr15	62939440	62939440	T	C	het	off-target	QUAL=561;DP=50;AF=0.50;MQM=60	TLN2	intron	TLN2:ENST00000561311:intron:MODIFIER:exon2/57:c.-36-34T>C:		rs938979	0.6294	0.0000	0,0,0	0,0,0,0,0	0.6689											n/a (AF>5%)	n/a (AF>5%)					TLN2 (inh=n/a pLI=1.00)
chr15	63953153	63953153	A	G	hom		QUAL=2303;DP=73;AF=0.99;MQM=60	HERC1	splice_region&intron	HERC1:ENST00000443617:splice_region&intron:LOW:exon46/77:c.9223+19T>C:		rs2272209	0.6356	0.7479	36679,25511,3549	0.8505,0.5189,0.0842,0.8753,0.6416	0.8115							605109 [HERC1 (provisional) Macrocephaly,dysmorphic facies,and psychomotor retardation,617011];			COSN164974	n/a (AF>5%)	n/a (AF>5%)					HERC1 (inh=AR pLI=1.00)
chr15	63984772	63984772	T	C	hom		QUAL=2158;DP=66;AF=1.00;MQM=60	HERC1,RP11-317G6.1	splice_region&intron	HERC1:ENST00000443617:splice_region&intron:LOW:exon30/77:c.5675-7A>G:		rs11630720	0.3978	0.4735	13097,9262,1504	0.5688,0.3872,0.0696,0.5497,0.3800	0.4875							605109 [HERC1 (provisional) Macrocephaly,dysmorphic facies,and psychomotor retardation,617011];			COSM147940, COSM147941	n/a (AF>5%)	n/a (AF>5%)					HERC1 (inh=AR pLI=1.00), RP11-317G6.1 (inh=n/a pLI=n/a)
chr15	64962630	64962630	A	C	het		QUAL=2324;DP=168;AF=0.52;MQM=60	ZNF609	splice_region&synonymous	ZNF609:ENST00000326648:splice_region&synonymous:LOW:exon3/9:c.1059A>C:p.Pro353Pro		rs11633399	0.2939	0.3956	10946,8545,581	0.3337,0.2165,0.0584,0.5054,0.2445	0.4265											n/a (AF>5%)	n/a (AF>5%)					ZNF609 (inh=n/a pLI=1.00)
chr15	65236875	65236875	T	C	het		QUAL=1600;DP=119;AF=0.50;MQM=60	ANKDD1A	synonymous,intron	ANKDD1A:ENST00000380230:synonymous:LOW:exon12/15:c.1092T>C:p.Ala364Ala,ANKDD1A:ENST00000395720:synonymous:LOW:exon12/15:c.1092T>C:p.Ala364Ala,ANKDD1A:ENST00000357698:intron:MODIFIER:exon11/13:c.1065+1097T>C:,ANKDD1A:ENST00000395723:intron:MODIFIER:exon8/10:c.792+1097T>C:		rs2414865	0.5529	0.5024	16010,7378,2682	0.7189,0.3520,0.4100,0.4728,0.6802	0.5174											n/a (AF>5%)	n/a (AF>5%)					ANKDD1A (inh=n/a pLI=0.00)
chr15	68605169	68605169	G	A	hom		QUAL=1361;DP=44;AF=1.00;MQM=60	ITGA11	missense	ITGA11:ENST00000423218:missense:MODERATE:exon24/30:c.2915C>T:p.Pro972Leu,ITGA11:ENST00000315757:missense:MODERATE:exon24/30:c.2915C>T:p.Pro972Leu		rs4777035	0.7165	0.6733	28281,12094,1371	0.5305,0.7819,0.9348,0.6016,0.8372	0.6767	7.3330	D,D,D	T	P,B	T,T	24.40					n/a (AF>5%)	n/a (AF>5%)					ITGA11 (inh=n/a pLI=0.01)
chr15	69003871	69003871	G	T	hom		QUAL=1690;DP=54;AF=1.00;MQM=60	CORO2B	splice_region&intron	CORO2B:ENST00000566799:splice_region&intron:LOW:exon4/11:c.484-10G>T:,CORO2B:ENST00000261861:splice_region&intron:LOW:exon4/11:c.469-10G>T:,CORO2B:ENST00000540068:splice_region&intron:LOW:exon4/11:c.469-10G>T:,CORO2B:ENST00000543950:splice_region&intron:LOW:exon4/11:c.469-10G>T:		rs3736272	0.6498	0.7254	32378,17028,675	0.3591,0.8316,0.8716,0.7192,0.8334	0.7326											n/a (AF>5%)	n/a (AF>5%)					CORO2B (inh=n/a pLI=0.92)
chr15	69709686	69709686	G	A	hom	off-target	QUAL=4578;DP=140;AF=1.00;MQM=60	KIF23	intron	KIF23:ENST00000260363:intron:MODIFIER:exon2/22:c.82-36G>A:,KIF23:ENST00000559279:intron:MODIFIER:exon2/21:c.82-36G>A:,KIF23:ENST00000395392:intron:MODIFIER:exon2/22:c.82-36G>A:,KIF23:ENST00000352331:intron:MODIFIER:exon2/21:c.82-36G>A:		rs3759825	0.8305	0.9251	52045,31841,2409	0.6798,0.8291,0.8130,0.9797,0.9735	0.9288											n/a (AF>5%)	n/a (AF>5%)					KIF23 (inh=n/a pLI=1.00)
chr15	70347362	70347362	C	A	het	off-target	QUAL=730;DP=65;AF=0.54;MQM=60	TLE3	intron	TLE3:ENST00000559929:intron:MODIFIER:exon15/19:c.1617+26G>T:,TLE3:ENST00000558939:intron:MODIFIER:exon15/19:c.1587+26G>T:,TLE3:ENST00000442299:intron:MODIFIER:exon15/19:c.1563+26G>T:,TLE3:ENST00000317509:intron:MODIFIER:exon15/19:c.1551+26G>T:,TLE3:ENST00000560589:intron:MODIFIER:exon13/17:c.1419+26G>T:,TLE3:ENST00000559048:intron:MODIFIER:exon14/18:c.1587+26G>T:,TLE3:ENST00000560939:intron:MODIFIER:exon14/18:c.1593+26G>T:,TLE3:ENST00000557997:intron:MODIFIER:exon15/19:c.1563+26G>T:,TLE3:ENST00000539550:intron:MODIFIER:exon13/17:c.1368+26G>T:,TLE3:ENST00000558201:intron:MODIFIER:exon14/18:c.1605+26G>T:,TLE3:ENST00000440567:intron:MODIFIER:exon15/19:c.1557+26G>T:,TLE3:ENST00000559191:intron:MODIFIER:exon4/8:c.330+26G>T:,TLE3:ENST00000557907:intron:MODIFIER:exon15/19:c.1563+26G>T:,TLE3:ENST00000558379:intron:MODIFIER:exon15/19:c.1572+26G>T:,TLE3:ENST00000451782:intron:MODIFIER:exon15/19:c.1578+26G>T:		rs4777227	0.7179	0.7650	16811,8252,962	0.6584,0.6668,0.8153,0.7374,0.9065	0.7150	-0.6490		T			3.31					n/a (AF>5%)	n/a (AF>5%)					TLE3 (inh=n/a pLI=1.00)
chr15	71548937	71548937	T	C	het		QUAL=849;DP=51;AF=0.67;MQM=60	THSD4	splice_region&intron	THSD4:ENST00000261862:splice_region&intron:LOW:exon4/16:c.913-15T>C:,THSD4:ENST00000355327:splice_region&intron:LOW:exon5/17:c.913-15T>C:		rs4777350	0.3369	0.3777	8954,5668,288	0.2447,0.2288,0.3255,0.4133,0.4437	0.3704											n/a (AF>5%)	n/a (AF>5%)					THSD4 (inh=n/a pLI=0.02)
chr15	72637795	72637795	T	C	hom		QUAL=7957;DP=238;AF=1.00;MQM=60	HEXA,RP11-106M3.3,RP11-106M3.2	synonymous,3'UTR	HEXA:ENST00000566304:synonymous:LOW:exon13/14:c.1551A>G:p.Glu517Glu,HEXA:ENST00000268097:synonymous:LOW:exon13/14:c.1518A>G:p.Glu506Glu,HEXA:ENST00000567159:synonymous:LOW:exon13/13:c.1518A>G:p.Glu506Glu,HEXA:ENST00000457859:3'UTR:MODIFIER:exon11/11:c.*178A>G:		rs4777502	0.8770	0.9641	57123,33251,1969	0.6142,0.9834,1.0000,0.9982,0.9992	0.9714							606869 [HEXA (confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800];	93191 [benign/likely benign DISEASE=tay-sachs_disease,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR pLI=0.00), RP11-106M3.3 (inh=n/a pLI=n/a), RP11-106M3.2 (inh=n/a pLI=n/a)
chr15	72987588	72987588	G	T	hom		QUAL=2847;DP=94;AF=0.99;MQM=60	BBS4	splice_region&intron,intron	BBS4:ENST00000395205:splice_region&intron:LOW:exon2/15:c.100+19G>T:,BBS4:ENST00000268057:splice_region&intron:LOW:exon2/15:c.76+19G>T:,BBS4:ENST00000539603:splice_region&intron:LOW:exon2/16:c.-19+19G>T:,BBS4:ENST00000542334:intron:MODIFIER:exon1/14:c.-446+8996G>T:		rs4777527	0.9419	0.9833	58756,33326,3388	0.8133,0.9927,1.0000,0.9996,0.9998	0.9869							600374 [BBS4 (confirmed) Bardet-Biedl syndrome 4,615982];	166733 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BBS4 (inh=AR pLI=0.00)
chr15	75047426	75047426	C	T	hom		QUAL=122;DP=4;AF=1.00;MQM=60	CYP1A2	synonymous	CYP1A2:ENST00000343932:synonymous:LOW:exon7/7:c.1548C>T:p.Asn516Asn		rs2470890	0.2362	0.4574	15482,13373,67	0.1145,0.2344,0.1628,0.6393,0.1989	0.4550											n/a (AF>5%)	n/a (AF>5%)					CYP1A2 (inh=AD pLI=0.00)
chr15	76078148	76078148	G	C	het	off-target	QUAL=603;DP=34;AF=0.68;MQM=54	RP11-24M17.5				rs117379723	0.0000	0.0000	0,0,0	0,0,0,0,0	0.1727											n/a (AF>5%)	n/a (AF>5%)					RP11-24M17.5 (inh=n/a pLI=n/a)
chr15	77344793	77344793	T	A	hom		QUAL=4288;DP=129;AF=1.00;MQM=60	TSPAN3	synonymous,5'UTR_premature_start_codon_gain,5'UTR	TSPAN3:ENST00000267970:synonymous:LOW:exon6/7:c.603A>T:p.Val201Val,TSPAN3:ENST00000346495:synonymous:LOW:exon5/6:c.528A>T:p.Val176Val,TSPAN3:ENST00000424443:synonymous:LOW:exon5/6:c.411A>T:p.Val137Val,TSPAN3:ENST00000559494:synonymous:LOW:exon4/5:c.336A>T:p.Val112Val,TSPAN3:ENST00000561277:5'UTR_premature_start_codon_gain:LOW:exon6/7:c.-22A>T:,TSPAN3:ENST00000558745:5'UTR_premature_start_codon_gain:LOW:exon6/7:c.-22A>T:,TSPAN3:ENST00000561277:5'UTR:MODIFIER:exon6/7:c.-22A>T:,TSPAN3:ENST00000558745:5'UTR:MODIFIER:exon6/7:c.-22A>T:		rs11737	0.4912	0.5999	22446,15313,990	0.4402,0.5063,0.4160,0.6777,0.5371	0.5992										COSM3754479	n/a (AF>5%)	n/a (AF>5%)					TSPAN3 (inh=n/a pLI=0.24)
chr15	78789488	78789488	C	T	het		QUAL=2183;DP=176;AF=0.49;MQM=60	IREB2	synonymous	IREB2:ENST00000258886:synonymous:LOW:exon21/22:c.2616C>T:p.Ala872Ala		rs13180	0.4311	0.5439	18566,12427,499	0.3086,0.4924,0.4754,0.6090,0.4883	0.5453											n/a (AF>5%)	n/a (AF>5%)					IREB2 (inh=n/a pLI=1.00)
chr15	79277511	79277511	A	G	het		QUAL=1747;DP=151;AF=0.45;MQM=60	RASGRF1,RP11-16K12.1	synonymous	RASGRF1:ENST00000419573:synonymous:LOW:exon24/28:c.3300T>C:p.Asn1100Asn,RASGRF1:ENST00000558480:synonymous:LOW:exon23/27:c.3252T>C:p.Asn1084Asn,RASGRF1:ENST00000394745:synonymous:LOW:exon10/14:c.948T>C:p.Asn316Asn		rs2230518	0.2817	0.2667	4546,2458,904	0.4176,0.2057,0.1842,0.2717,0.2365	0.3031										COSM3754500	n/a (AF>5%)	n/a (AF>5%)					RASGRF1 (inh=n/a pLI=1.00), RP11-16K12.1 (inh=n/a pLI=n/a)
chr15	79755604	79755604	A	G	het		QUAL=757;DP=67;AF=0.45;MQM=60	KIAA1024	missense	KIAA1024:ENST00000305428:missense:MODERATE:exon3/4:c.2494A>G:p.Ile832Val		rs2297773	0.2550	0.2048	2968,1457,975	0.4381,0.1088,0.1481,0.2067,0.1530	0.2755	1.6240	T	T	B	T	0.01				COSM4128444	n/a (AF>5%)	n/a (AF>5%)					KIAA1024 (inh=n/a pLI=0.00)
chr15	89169614	89169614	A	G	hom		QUAL=2166;DP=66;AF=1.00;MQM=60	AEN	synonymous	AEN:ENST00000379231:synonymous:LOW:exon2/6:c.174A>G:p.Glu58Glu,AEN:ENST00000332810:synonymous:LOW:exon2/4:c.174A>G:p.Glu58Glu		rs3743476	0.1979	0.2863	5031,3714,55	0.1081,0.1560,0.1599,0.3542,0.2159	0.2907										COSM3754551, COSM3754550	n/a (AF>5%)	n/a (AF>5%)					AEN (inh=n/a pLI=0.00)
chr15	89172558	89172558	G	C	hom		QUAL=6510;DP=198;AF=0.99;MQM=60	AEN	synonymous	AEN:ENST00000379231:synonymous:LOW:exon3/6:c.642G>C:p.Thr214Thr,AEN:ENST00000332810:synonymous:LOW:exon3/4:c.642G>C:p.Thr214Thr		rs3743475	0.7524	0.8529	44901,28429,1765	0.5747,0.7175,0.7928,0.9236,0.8341	0.8551										COSM4128525, COSM4128524	n/a (AF>5%)	n/a (AF>5%)					AEN (inh=n/a pLI=0.00)
chr15	89402051	89402051	A	G	hom	gene_blacklist	QUAL=1783;DP=54;AF=1.00;MQM=60	ACAN	missense	ACAN:ENST00000439576:missense:MODERATE:exon12/18:c.6235A>G:p.Ile2079Val,ACAN:ENST00000559004:missense:MODERATE:exon12/17:c.6235A>G:p.Ile2079Val,ACAN:ENST00000352105:missense:MODERATE:exon12/16:c.6235A>G:p.Ile2079Val,ACAN:ENST00000561243:missense:MODERATE:exon11/17:c.6235A>G:p.Ile2079Val		rs1042630	0.6460	0.6819	28352,18481,2343	0.6996,0.5115,0.5384,0.7464,0.6099	0.7074	-1.8110	T,T,T	T	B,B	T,T	0.01	155760 [ACAN (confirmed) Spondyloepiphyseal dysplasia,Kimberley type,608361|Spondyloepimetaphyseal dysplasia,aggrecan type,612813|Short stature and advanced bone age,with or without early-onset osteoarthritis and/or osteochondritis dissecans,165800];			COSM3927720, COSM146363	n/a (AF>5%)	n/a (AF>5%)					ACAN (inh=AR+AD pLI=1.00)
chr15	90161355	90161355	G	A	hom	off-target	QUAL=7078;DP=216;AF=1.00;MQM=60	TICRR,KIF7	intron	TICRR:ENST00000268138:intron:MODIFIER:exon16/21:c.2961-28G>A:,TICRR:ENST00000560985:intron:MODIFIER:exon16/21:c.2958-28G>A:		rs2289486	0.8556	0.8738	46475,27685,4538	0.9621,0.7138,0.7040,0.9109,0.8660	0.9110										COSN165042	n/a (AF>5%)	n/a (AF>5%)					TICRR (inh=n/a pLI=0.00), KIF7 (inh=AR+AD pLI=0.00)
chr15	90168693	90168693	T	A	hom		QUAL=4377;DP=133;AF=1.00;MQM=60	TICRR,KIF7	missense	TICRR:ENST00000268138:missense:MODERATE:exon20/22:c.5152T>A:p.Ser1718Thr,TICRR:ENST00000560985:missense:MODERATE:exon20/22:c.5149T>A:p.Ser1717Thr		rs1866928	0.3860	0.3355	6989,3568,900	0.4172,0.3007,0.3560,0.3240,0.3678	0.3524	0.2200	T	T	B	T	0.03				COSM3754562	n/a (AF>5%)	n/a (AF>5%)					TICRR (inh=n/a pLI=0.00), KIF7 (inh=AR+AD pLI=0.00)
chr15	90809633	90809633	G	A	hom		QUAL=2208;DP=68;AF=1.00;MQM=60	RP11-697E2.6,NGRN	splice_region&intron	NGRN:ENST00000379095:splice_region&intron:LOW:exon2/2:c.275+3G>A:		rs9635390	0.9185	0.9263	49654,29074,4770	0.9900,0.8705,0.8704,0.9544,0.8353	0.9606											n/a (AF>5%)	n/a (AF>5%)					RP11-697E2.6 (inh=n/a pLI=n/a), NGRN (inh=n/a pLI=0.09)
chr15	90969335	90969335	G	T	het		QUAL=1138;DP=93;AF=0.47;MQM=60	IQGAP1	splice_region&intron,intron	IQGAP1:ENST00000268182:splice_region&intron:LOW:exon2/37:c.156-7G>T:,IQGAP1:ENST00000560738:intron:MODIFIER:exon2/24:c.106+35279G>T:		rs2256388	0.6781	0.5566	19927,6824,3077	0.7683,0.7322,0.8470,0.4540,0.6097	0.5629											n/a (AF>5%)	n/a (AF>5%)					IQGAP1 (inh=n/a pLI=1.00)
chr15	93510603	93510603	A	G	hom		QUAL=2023;DP=63;AF=1.00;MQM=60	CHD2	synonymous	CHD2:ENST00000394196:synonymous:LOW:exon17/39:c.2049A>G:p.Glu683Glu,CHD2:ENST00000557381:synonymous:LOW:exon17/38:c.2049A>G:p.Glu683Glu		rs4777755	0.8265	0.8419	43563,23329,1930	0.6121,0.9257,0.9973,0.8350,0.9035	0.8491							602119 [CHD2 (provisional) Epileptic encephalopathy,childhood-onset,615369];	257706 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					CHD2 (inh=AD pLI=1.00)
chr15	94410296	94410296	A	G	het	off-target	QUAL=637;DP=50;AF=0.52;MQM=60	CTD-3049M7.1,RP11-76E17.3				rs12908831	0.2774	0.2906	556,297,33	0.3769,0.0000,0.0000,0.4195,0.2310	0.3452											n/a (AF>5%)	n/a (AF>5%)					CTD-3049M7.1 (inh=n/a pLI=n/a), RP11-76E17.3 (inh=n/a pLI=n/a)
chr15	99456553	99456553	G	A	het	off-target	QUAL=2041;DP=165;AF=0.48;MQM=60	IGF1R	intron	IGF1R:ENST00000268035:intron:MODIFIER:exon8/20:c.1828+42G>A:,IGF1R:ENST00000558762:intron:MODIFIER:exon8/20:c.1828+42G>A:		rs951715	0.6316	0.6396	25067,13696,2144	0.6464,0.5928,0.4998,0.6385,0.7363	0.6363							147370 [IGF1R (confirmed) Insulin-like growth factor I,resistance to,270450];				n/a (AF>5%)	n/a (AF>5%)					IGF1R (inh=AR+AD pLI=0.66)
chr15	99798934	99798934	G	A	het		QUAL=1512;DP=133;AF=0.44;MQM=60	LRRC28,HSP90B2P	intron,non_coding_transcript_exon	LRRC28:ENST00000301981:intron:MODIFIER:exon2/9:c.168+2604G>A:,LRRC28:ENST00000558879:intron:MODIFIER:exon2/2:c.168+2604G>A:,LRRC28:ENST00000422500:intron:MODIFIER:exon2/8:c.168+2604G>A:,LRRC28:ENST00000442993:intron:MODIFIER:exon2/9:c.168+2604G>A:,LRRC28:ENST00000447360:intron:MODIFIER:exon2/8:c.168+2604G>A:,LRRC28:ENST00000331450:intron:MODIFIER:exon2/3:c.168+2604G>A:,HSP90B2P:ENST00000559111:non_coding_transcript_exon:MODIFIER:exon1/1:n.1098G>A:		rs7162949	0.6412	0.0000	0,0,0	0,0,0,0,0	0.6407											n/a (AF>5%)	n/a (AF>5%)					LRRC28 (inh=n/a pLI=0.00), HSP90B2P (inh=n/a pLI=n/a)
chr15	100269796	100269796	A	G	hom		QUAL=4394;DP=134;AF=0.99;MQM=60	LYSMD4	synonymous	LYSMD4:ENST00000344791:synonymous:LOW:exon6/6:c.426T>C:p.Ser142Ser,LYSMD4:ENST00000409796:synonymous:LOW:exon3/3:c.423T>C:p.Ser141Ser,LYSMD4:ENST00000545021:synonymous:LOW:exon4/4:c.45T>C:p.Ser15Ser,LYSMD4:ENST00000332728:synonymous:LOW:exon4/4:c.423T>C:p.Ser141Ser		rs6598264	0.9655	0.9899	59531,33338,4141	0.8917,0.9942,0.9999,0.9996,0.9996	0.9916										COSM4148337	n/a (AF>5%)	n/a (AF>5%)					LYSMD4 (inh=n/a pLI=0.00)
chr15	101464915	101464915	T	C	het		QUAL=2180;DP=202;AF=0.43;MQM=60	LRRK1	synonymous,5'UTR	LRRK1:ENST00000388948:synonymous:LOW:exon2/34:c.78T>C:p.Arg26Arg,LRRK1:ENST00000532029:synonymous:LOW:exon2/6:c.78T>C:p.Arg26Arg,LRRK1:ENST00000284395:5'UTR:MODIFIER:exon2/35:c.-4T>C:		rs11630691	0.3413	0.2657	5259,2185,2014	0.6215,0.1197,0.1105,0.2566,0.2909	0.3335										COSM1128150	n/a (AF>5%)	n/a (AF>5%)					LRRK1 (inh=n/a pLI=0.00)
chr15	101527635	101527635	G	A	het		QUAL=3208;DP=277;AF=0.46;MQM=60	LRRK1	intron	LRRK1:ENST00000388948:intron:MODIFIER:exon4/33:c.434-1204G>A:,LRRK1:ENST00000284395:intron:MODIFIER:exon5/34:c.362-1141G>A:,LRRK1:ENST00000532029:intron:MODIFIER:exon4/5:c.434-1204G>A:		rs7176015	0.5288	0.0000	0,0,0	0,0,0,0,0	0.5126										COSN407633	n/a (AF>5%)	n/a (AF>5%)					LRRK1 (inh=n/a pLI=0.00)
chr15	101970308	101970308	G	A	hom	off-target	QUAL=4356;DP=133;AF=1.00;MQM=60	PCSK6	intron	PCSK6:ENST00000348070:intron:MODIFIER:exon5/22:c.655-40C>T:,PCSK6:ENST00000358417:intron:MODIFIER:exon5/21:c.655-40C>T:,PCSK6:ENST00000344273:intron:MODIFIER:exon5/15:c.655-40C>T:,PCSK6:ENST00000398181:intron:MODIFIER:exon5/14:c.655-40C>T:,PCSK6:ENST00000331826:intron:MODIFIER:exon2/11:c.160-40C>T:		rs2643354	0.8393	0.8769	45913,27629,4645	0.9783,0.8286,0.6341,0.9172,0.8005	0.9162											n/a (AF>5%)	n/a (AF>5%)					PCSK6 (inh=n/a pLI=0.00)
chr15	102277480	102277480	G	C	het		QUAL=702;DP=46;AF=0.61;MQM=60	RP11-89K11.1				rs1052887	0.1907	0.2654	496,232,66	0.3477,0.3784,0.0197,0.3016,0.1920	0.2269										COSM1477926, COSM433614	n/a (AF>5%)	n/a (AF>5%)					RP11-89K11.1 (inh=n/a pLI=n/a)
chr16	630902	630902	C	G	het		QUAL=2995;DP=232;AF=0.49;MQM=60	PIGQ	synonymous	PIGQ:ENST00000026218:synonymous:LOW:exon9/10:c.1461C>G:p.Leu487Leu,PIGQ:ENST00000409527:synonymous:LOW:exon10/12:c.1461C>G:p.Leu487Leu,PIGQ:ENST00000321878:synonymous:LOW:exon9/11:c.1461C>G:p.Leu487Leu		rs1045274	0.1380	0.1678	2016,1143,115	0.1532,0.0582,0.0247,0.1822,0.2637	0.1689										COSM435482	n/a (AF>5%)	n/a (AF>5%)					PIGQ (inh=AR+AD pLI=0.00)
chr16	2036048	2036048	T	C	het		QUAL=517;DP=45;AF=0.47;MQM=60	GFER,AC005606.14	3'UTR	GFER:ENST00000248114:3'UTR:MODIFIER:exon3/3:c.*19T>C:,GFER:ENST00000569451:3'UTR:MODIFIER:exon2/2:c.*110T>C:,GFER:ENST00000567719:3'UTR:MODIFIER:exon2/2:c.*19T>C:		rs1046495	0.1398	0.1823	2370,1063,13	0.0413,0.2159,0.0383,0.1808,0.3096	0.1840							600924 [GFER (provisional) Myopathy,mitochondrial progressive,with congenital cataract,hearing loss,and developmental delay,613076];				n/a (AF>5%)	n/a (AF>5%)					GFER (inh=AR pLI=0.00), AC005606.14 (inh=n/a pLI=n/a)
chr16	3367061	3367061	G	A	het	off-target	QUAL=610;DP=57;AF=0.47;MQM=60	ZNF75A	intron	ZNF75A:ENST00000574298:intron:MODIFIER:exon5/5:c.211+39G>A:		rs17611827	0.1569	0.2141	3139,1855,166	0.1809,0.3523,0.0390,0.2381,0.1021	0.2222											n/a (AF>5%)	n/a (AF>5%)					ZNF75A (inh=n/a pLI=0.01)
chr16	3406626	3406626	G	A	het	gene_blacklist	QUAL=2174;DP=150;AF=0.55;MQM=60	OR2C1	missense	OR2C1:ENST00000304936:missense:MODERATE:exon1/1:c.686G>A:p.Arg229His		rs11648783	0.2526	0.2629	4420,2573,652	0.3526,0.2029,0.1426,0.2730,0.2753	0.2845	-0.8880	T	T	B	T	0.09			CM141883 [CLASS=FP MUT=ALT PHEN="Altered receptor function" GENE=OR2C1]; 	COSM3754875	n/a (AF>5%)	n/a (AF>5%)					OR2C1 (inh=n/a pLI=0.09)
chr16	4016676	4016676	A	G	het		QUAL=1216;DP=118;AF=0.42;MQM=60	ADCY9	synonymous	ADCY9:ENST00000294016:synonymous:LOW:exon11/11:c.3162T>C:p.His1054His		rs2230742	0.7306	0.8052	40052,24622,2461	0.6853,0.8652,0.8450,0.8589,0.5887	0.8093										COSM4129058	n/a (AF>5%)	n/a (AF>5%)					ADCY9 (inh=n/a pLI=0.94)
chr16	4445327	4445327	C	T	hom		QUAL=1359;DP=42;AF=1.00;MQM=60	CORO7-PAM16,CORO7	missense,5'UTR	CORO7-PAM16:ENST00000572467:missense:MODERATE:exon7/31:c.578G>A:p.Arg193Gln,CORO7:ENST00000251166:missense:MODERATE:exon7/28:c.578G>A:p.Arg193Gln,CORO7:ENST00000537233:missense:MODERATE:exon7/28:c.524G>A:p.Arg175Gln,CORO7:ENST00000574025:missense:MODERATE:exon5/26:c.323G>A:p.Arg108Gln,CORO7:ENST00000423908:missense:MODERATE:exon2/16:c.74G>A:p.Arg25Gln,CORO7:ENST00000539968:5'UTR:MODIFIER:exon7/28:c.-83G>A:		rs3747579	0.5074	0.6499	27034,17615,206	0.1935,0.5919,0.7760,0.7285,0.5685	0.6536	1.0960	D,D,D	T	B,D	T,T	26.70				COSM435259	n/a (AF>5%)	n/a (AF>5%)					CORO7-PAM16 (inh=n/a pLI=0.00), CORO7 (inh=n/a pLI=0.00)
chr16	8873493	8873493	C	T	het	off-target	QUAL=1717;DP=106;AF=0.59;MQM=60	ABAT	intron	ABAT:ENST00000567812:intron:MODIFIER:exon15/15:c.1426+46C>T:,ABAT:ENST00000268251:intron:MODIFIER:exon15/15:c.1381+46C>T:,ABAT:ENST00000396600:intron:MODIFIER:exon15/15:c.1381+46C>T:,ABAT:ENST00000425191:intron:MODIFIER:exon15/15:c.1381+46C>T:,ABAT:ENST00000569156:intron:MODIFIER:exon15/15:c.1381+46C>T:		rs1079349	0.5503	0.4702	11931,4376,1605	0.6037,0.6040,0.5872,0.3962,0.5684	0.4693							137150 [ABAT (provisional) GABA-transaminase deficiency,613163];				n/a (AF>5%)	n/a (AF>5%)					ABAT (inh=AR pLI=0.24)
chr16	9916204	9916204	C	G	hom		QUAL=6405;DP=195;AF=1.00;MQM=60	GRIN2A	synonymous	GRIN2A:ENST00000330684:synonymous:LOW:exon10/13:c.2085G>C:p.Arg695Arg,GRIN2A:ENST00000396573:synonymous:LOW:exon11/14:c.2085G>C:p.Arg695Arg,GRIN2A:ENST00000562109:synonymous:LOW:exon9/13:c.2085G>C:p.Arg695Arg,GRIN2A:ENST00000535259:synonymous:LOW:exon9/13:c.1614G>C:p.Arg538Arg,GRIN2A:ENST00000404927:synonymous:LOW:exon10/14:c.2085G>C:p.Arg695Arg,GRIN2A:ENST00000396575:synonymous:LOW:exon9/12:c.2085G>C:p.Arg695Arg		rs9806806	0.2812	0.2648	4783,2582,1235	0.4929,0.2111,0.0741,0.2786,0.1996	0.3315							138253 [GRIN2A (provisional) Epilepsy,focal,with speech disorder and with or without mental retardation,245570];	129192 [benign/likely benign DISEASE=epilepsy,_focal,_with_speech_disorder_and_with_or_without_mental_retardation,not_specified]; 		COSM3755241	n/a (AF>5%)	n/a (AF>5%)					GRIN2A (inh=AD pLI=1.00)
chr16	10631985	10631985	T	C	het	off-target	QUAL=185;DP=20;AF=0.50;MQM=60	EMP2	intron	EMP2:ENST00000359543:intron:MODIFIER:exon3/4:c.170-54A>G:,EMP2:ENST00000536829:intron:MODIFIER:exon3/4:c.170-54A>G:		rs1504884	0.8235	0.0000	0,0,0	0,0,0,0,0	0.8036							602334 [EMP2 (provisional) Nephrotic syndrome,type 10,615861];				n/a (AF>5%)	n/a (AF>5%)					EMP2 (inh=AR pLI=0.00)
chr16	10861914	10861914	T	C	hom	off-target	QUAL=1711;DP=54;AF=1.00;MQM=60	TVP23A,NUBP1	3'UTR,intron	TVP23A:ENST00000299866:3'UTR:MODIFIER:exon8/8:c.*1045A>G:,NUBP1:ENST00000283027:intron:MODIFIER:exon10/10:c.904+25T>C:,NUBP1:ENST00000433392:intron:MODIFIER:exon9/9:c.871+25T>C:		rs2233541	0.3500	0.3138	6384,2860,1332	0.5075,0.1872,0.3233,0.2909,0.3703	0.3581											n/a (AF>5%)	n/a (AF>5%)					TVP23A (inh=n/a pLI=0.00), NUBP1 (inh=n/a pLI=0.00)
chr16	13002359	13002359	T	C	hom		QUAL=7539;DP=227;AF=1.00;MQM=60	SHISA9	missense,intron	SHISA9:ENST00000558318:missense:MODERATE:exon2/2:c.710T>C:p.Met237Thr,SHISA9:ENST00000423335:missense:MODERATE:exon2/2:c.587T>C:p.Met196Thr,SHISA9:ENST00000558583:intron:MODIFIER:exon1/4:c.686+5875T>C:,SHISA9:ENST00000424107:intron:MODIFIER:exon1/4:c.563+5875T>C:		rs9938751	0.8546	0.8768	9165,3725,565	0.6719,0.9184,1.0000,0.8596,0.9478	0.8850	0.9930		T	B		3.20					n/a (AF>5%)	n/a (AF>5%)					SHISA9 (inh=n/a pLI=n/a)
chr16	15781054	15781054	A	G	hom		QUAL=4677;DP=141;AF=1.00;MQM=60	NDE1	intron	NDE1:ENST00000396353:intron:MODIFIER:exon5/9:c.387-178A>G:,NDE1:ENST00000396355:intron:MODIFIER:exon5/9:c.387-178A>G:,NDE1:ENST00000396354:intron:MODIFIER:exon4/8:c.387-178A>G:,NDE1:ENST00000342673:intron:MODIFIER:exon3/7:c.387-178A>G:	MIRb	rs8044738	0.7552	0.7531	5445,2011,672	0.9079,0.7296,0.7244,0.7101,0.7720	0.7213							609449 [NDE1 (provisional) Lissencephaly 4 (with microcephaly),614019|Microhydranencephaly,605013];				n/a (AF>5%)	n/a (AF>5%)					NDE1 (inh=AR pLI=0.14)
chr16	20482368	20482368	A	G	het	off-target	QUAL=1840;DP=128;AF=0.54;MQM=56	ACSM2A	intron	ACSM2A:ENST00000219054:intron:MODIFIER:exon5/14:c.597-27A>G:,ACSM2A:ENST00000417235:intron:MODIFIER:exon3/12:c.360-27A>G:,ACSM2A:ENST00000536134:intron:MODIFIER:exon4/14:c.2-27A>G:,ACSM2A:ENST00000573854:intron:MODIFIER:exon4/13:c.597-27A>G:,ACSM2A:ENST00000575690:intron:MODIFIER:exon5/14:c.597-27A>G:,ACSM2A:ENST00000396104:intron:MODIFIER:exon3/12:c.597-27A>G:		rs1827711	0.5152	0.3710	9795,2709,1947	0.6114,0.2908,0.7834,0.2832,0.4440	0.4042											n/a (AF>5%)	n/a (AF>5%)					ACSM2A (inh=n/a pLI=0.00)
chr16	20811681	20811681	C	T	het		QUAL=3316;DP=283;AF=0.45;MQM=60	ERI2	synonymous,intron	ERI2:ENST00000357967:synonymous:LOW:exon6/9:c.504G>A:p.Lys168Lys,ERI2:ENST00000300005:synonymous:LOW:exon6/11:c.504G>A:p.Lys168Lys,ERI2:ENST00000564349:synonymous:LOW:exon7/10:c.225G>A:p.Lys75Lys,ERI2:ENST00000569729:synonymous:LOW:exon6/9:c.504G>A:p.Lys168Lys,ERI2:ENST00000563117:synonymous:LOW:exon7/10:c.225G>A:p.Lys75Lys,ERI2:ENST00000389345:intron:MODIFIER:exon5/7:c.-256-321G>A:		rs2301771	0.6298	0.6823	28804,18079,2210	0.6549,0.5089,0.4765,0.7361,0.6806	0.6964										COSM3999767, COSM3999768	n/a (AF>5%)	n/a (AF>5%)					ERI2 (inh=n/a pLI=0.00)
chr16	23364081	23364081	A	C	het	off-target	QUAL=1655;DP=146;AF=0.44;MQM=60	SCNN1B	intron	SCNN1B:ENST00000307331:intron:MODIFIER:exon3/13:c.447-41A>C:,SCNN1B:ENST00000343070:intron:MODIFIER:exon2/12:c.312-41A>C:,SCNN1B:ENST00000568085:intron:MODIFIER:exon1/10:c.312-41A>C:,SCNN1B:ENST00000568923:intron:MODIFIER:exon1/11:c.312-41A>C:		rs63982	0.3574	0.2808	5777,1526,219	0.2127,0.2273,0.6536,0.2149,0.4196	0.2802							600760 [SCNN1B (confirmed) Liddle syndrome,177200|Pseudohypoaldosteronism,type I,264350|Bronchiectasis with or without elevated sweat chloride 1,211400];				n/a (AF>5%)	n/a (AF>5%)					SCNN1B (inh=AR+AD pLI=0.00)
chr16	23701538	23701538	A	G	het		QUAL=1282;DP=96;AF=0.52;MQM=60	PLK1	3'UTR	PLK1:ENST00000300093:3'UTR:MODIFIER:exon10/10:c.*154A>G:		rs27770	0.2344	0.3153	888,421,21	0.1986,0.2495,0.5042,0.2949,0.3630	0.2320											n/a (AF>5%)	n/a (AF>5%)					PLK1 (inh=n/a pLI=0.99)
chr16	24801979	24801979	C	T	het		QUAL=1675;DP=125;AF=0.54;MQM=60	TNRC6A	synonymous	TNRC6A:ENST00000395799:synonymous:LOW:exon6/25:c.2016C>T:p.Ser672Ser,TNRC6A:ENST00000315183:synonymous:LOW:exon6/24:c.2016C>T:p.Ser672Ser		rs13336754	0.1663	0.2124	3293,2432,419	0.2858,0.1097,0.0001,0.2666,0.1141	0.2594											n/a (AF>5%)	n/a (AF>5%)					TNRC6A (inh=n/a pLI=1.00)
chr16	24816492	24816492	A	G	het		QUAL=1521;DP=119;AF=0.51;MQM=60	TNRC6A,CTD-2515A14.1	splice_region&intron	TNRC6A:ENST00000395799:splice_region&intron:LOW:exon14/24:c.4122+20A>G:,TNRC6A:ENST00000315183:splice_region&intron:LOW:exon13/23:c.3975+20A>G:		rs2059134	0.2398	0.2508	3979,2485,465	0.2981,0.1900,0.1104,0.2739,0.2512	0.2667											n/a (AF>5%)	n/a (AF>5%)					TNRC6A (inh=n/a pLI=1.00), CTD-2515A14.1 (inh=n/a pLI=n/a)
chr16	25258035	25258035	A	G	het		QUAL=1585;DP=148;AF=0.45;MQM=60	ZKSCAN2	synonymous	ZKSCAN2:ENST00000328086:synonymous:LOW:exon5/7:c.1482T>C:p.Asn494Asn		rs11649280	0.3359	0.2550	4352,1371,1035	0.4484,0.3361,0.3381,0.2019,0.2815	0.2798										COSM3754813	n/a (AF>5%)	n/a (AF>5%)					ZKSCAN2 (inh=n/a pLI=0.03)
chr16	29580611	29580611	G	A	hom		QUAL=1918;DP=66;AF=1.00;MQM=41	RP11-345J4.8				rs2161671	0.8335	0.7414	3372,788,227	0.9050,0.0000,0.0000,0.6674,0.7563	0.7214	0.4240		T			8.20					n/a (AF>5%)	n/a (AF>5%)					RP11-345J4.8 (inh=n/a pLI=n/a)
chr16	30018500	30018500	C	T	het		QUAL=1527;DP=129;AF=0.47;MQM=60	DOC2A	synonymous	DOC2A:ENST00000350119:synonymous:LOW:exon6/11:c.648G>A:p.Gln216Gln,DOC2A:ENST00000564944:synonymous:LOW:exon7/12:c.648G>A:p.Gln216Gln,DOC2A:ENST00000564979:synonymous:LOW:exon6/11:c.648G>A:p.Gln216Gln		rs3935873	0.3492	0.4095	10488,6250,169	0.1800,0.3143,0.4068,0.4371,0.5135	0.4092										COSM3721545	n/a (AF>5%)	n/a (AF>5%)					DOC2A (inh=n/a pLI=0.07)
chr16	30376486	30376486	T	C	het		QUAL=1618;DP=92;AF=0.64;MQM=60	TBC1D10B	synonymous	TBC1D10B:ENST00000409939:synonymous:LOW:exon3/9:c.1104A>G:p.Lys368Lys		rs8049108	0.3456	0.3365	7668,4188,1768	0.5865,0.2116,0.0720,0.3550,0.3265	0.4025											n/a (AF>5%)	n/a (AF>5%)					TBC1D10B (inh=n/a pLI=0.97)
chr16	30772040	30772040	A	G	hom	off-target	QUAL=5550;DP=171;AF=0.99;MQM=60	PHKG2,C16orf93	3'UTR,intron	PHKG2:ENST00000563588:3'UTR:MODIFIER:exon10/10:c.*3622A>G:,C16orf93:ENST00000541260:intron:MODIFIER:exon2/7:c.237-51T>C:,C16orf93:ENST00000543610:intron:MODIFIER:exon2/8:c.237-51T>C:,C16orf93:ENST00000545825:intron:MODIFIER:exon2/3:c.237-51T>C:		rs4889505	0.9748	0.9860	10261,4501,1134	0.8972,0.9952,1.0000,0.9999,0.9998	0.9945							172471 [PHKG2 (provisional) Glycogen storage disease IXc,613027|Cirrhosis due to liver phosphorylase kinase deficiency];				n/a (AF>5%)	n/a (AF>5%)					PHKG2 (inh=AR pLI=0.07), CCDC189 (inh=n/a pLI=0.00)
chr16	30780828	30780828	A	G	hom		QUAL=5093;DP=156;AF=0.99;MQM=60	RNF40	synonymous	RNF40:ENST00000324685:synonymous:LOW:exon17/20:c.2493A>G:p.Leu831Leu,RNF40:ENST00000402121:synonymous:LOW:exon11/14:c.1569A>G:p.Leu523Leu,RNF40:ENST00000563683:synonymous:LOW:exon16/19:c.2373A>G:p.Leu791Leu,RNF40:ENST00000357890:synonymous:LOW:exon15/18:c.2193A>G:p.Leu731Leu		rs4889506	0.9814	0.9939	59778,33240,4498	0.9322,0.9972,1.0000,0.9999,0.9999	0.9954											n/a (AF>5%)	n/a (AF>5%)					RNF40 (inh=n/a pLI=1.00)
chr16	50118245	50118245	G	A	het	off-target	QUAL=1701;DP=123;AF=0.54;MQM=60	HEATR3	intron	HEATR3:ENST00000299192:intron:MODIFIER:exon9/14:c.1290+43G>A:,HEATR3:ENST00000285767:intron:MODIFIER:exon8/13:c.1032+43G>A:		rs877639	0.6587	0.7088	29585,17060,1757	0.5872,0.7479,0.6347,0.7235,0.7171	0.7104											n/a (AF>5%)	n/a (AF>5%)					HEATR3 (inh=n/a pLI=0.00)
chr16	53341748	53341748	T	G	hom		QUAL=3850;DP=117;AF=1.00;MQM=60	CHD9	missense	CHD9:ENST00000398510:missense:MODERATE:exon32/38:c.6936T>G:p.Asp2312Glu,CHD9:ENST00000447540:missense:MODERATE:exon33/39:c.6939T>G:p.Asp2313Glu,CHD9:ENST00000566029:missense:MODERATE:exon33/39:c.6936T>G:p.Asp2312Glu,CHD9:ENST00000564845:missense:MODERATE:exon33/39:c.6936T>G:p.Asp2312Glu		rs6499548	0.8269	0.7961	38065,20547,3980	0.9073,0.8144,0.8085,0.7866,0.7715	0.8206	1.1230	T,T,T	T	B,B,B,B	D,D	2.69					n/a (AF>5%)	n/a (AF>5%)					CHD9 (inh=n/a pLI=1.00)
chr16	53513033	53513033	C	T	het	off-target	QUAL=1171;DP=89;AF=0.49;MQM=60	RBL2	intron	RBL2:ENST00000262133:intron:MODIFIER:exon17/21:c.2704-33C>T:,RBL2:ENST00000544545:intron:MODIFIER:exon11/12:c.1265-2593C>T:		rs8043918	0.4527	0.4374	12612,7466,2005	0.6205,0.2448,0.1901,0.4694,0.4919	0.4715											n/a (AF>5%)	n/a (AF>5%)					RBL2 (inh=n/a pLI=1.00)
chr16	55880534	55880534	G	C	het		QUAL=1292;DP=103;AF=0.49;MQM=60	CES5A	synonymous	CES5A:ENST00000521992:synonymous:LOW:exon14/14:c.1644C>G:p.Leu548Leu,CES5A:ENST00000319165:synonymous:LOW:exon12/12:c.1407C>G:p.Leu469Leu,CES5A:ENST00000518005:synonymous:LOW:exon13/13:c.1239C>G:p.Leu413Leu,CES5A:ENST00000290567:synonymous:LOW:exon13/13:c.1557C>G:p.Leu519Leu,CES5A:ENST00000520435:synonymous:LOW:exon13/13:c.1467C>G:p.Leu489Leu		rs11860488	0.3061	0.2575	4359,2171,947	0.4277,0.1249,0.2530,0.2524,0.2683	0.2916										COSM3754936, COSM3754937	n/a (AF>5%)	n/a (AF>5%)					CES5A (inh=n/a pLI=0.00)
chr16	56396486	56396486	C	T	het		QUAL=2724;DP=190;AF=0.53;MQM=60	AMFR	3'UTR	AMFR:ENST00000290649:3'UTR:MODIFIER:exon14/14:c.*335G>A:		rs4924	0.5988	0.5446	17148,8458,2398	0.7667,0.5715,0.4285,0.5236,0.6125	0.5721	-0.6380	D	T			3.91					n/a (AF>5%)	n/a (AF>5%)					AMFR (inh=n/a pLI=0.00)
chr16	56855496	56855496	C	G	het		QUAL=770;DP=62;AF=0.48;MQM=60	NUP93	synonymous	NUP93:ENST00000569842:synonymous:LOW:exon7/23:c.645C>G:p.Leu215Leu,NUP93:ENST00000308159:synonymous:LOW:exon7/22:c.645C>G:p.Leu215Leu,NUP93:ENST00000564887:synonymous:LOW:exon5/20:c.276C>G:p.Leu92Leu,NUP93:ENST00000542526:synonymous:LOW:exon5/20:c.276C>G:p.Leu92Leu		rs2118017	0.8758	0.8299	41989,21327,4056	0.8822,0.8762,0.9177,0.7991,0.8597	0.8319							614351 [NUP93 (provisional) Nephrotic syndrome,type 12,616892];			COSM3754944	n/a (AF>5%)	n/a (AF>5%)					NUP93 (inh=AR pLI=0.04)
chr16	57004889	57004889	G	A	het	off-target	QUAL=1188;DP=102;AF=0.45;MQM=60	CETP	intron	CETP:ENST00000200676:intron:MODIFIER:exon5/15:c.528-56G>A:,CETP:ENST00000379780:intron:MODIFIER:exon5/14:c.528-56G>A:,CETP:ENST00000566128:intron:MODIFIER:exon5/15:c.333-56G>A:	MIRb	rs7205804	0.3213	0.0000	0,0,0	0,0,0,0,0	0.3482							118470 [CETP (confirmed) Hyperalphalipoproteinemia,143470|High density lipoprotein cholesterol level QTL 10,143470];				n/a (AF>5%)	n/a (AF>5%)					CETP (inh=AD pLI=0.00)
chr16	57197745	57197745	G	T	hom	off-target	QUAL=2381;DP=74;AF=1.00;MQM=60	FAM192A	intron	FAM192A:ENST00000309137:intron:MODIFIER:exon6/6:c.547+168C>A:,FAM192A:ENST00000389447:intron:MODIFIER:exon5/6:c.547+168C>A:,FAM192A:ENST00000566077:intron:MODIFIER:exon6/6:c.316+168C>A:,FAM192A:ENST00000569266:intron:MODIFIER:exon6/6:c.547+168C>A:,FAM192A:ENST00000567439:intron:MODIFIER:exon6/6:c.547+168C>A:,FAM192A:ENST00000564108:intron:MODIFIER:exon7/7:c.547+168C>A:		rs62037356	0.9714	0.0000	0,0,0	0,0,0,0,0	0.9489											n/a (AF>5%)	n/a (AF>5%)					FAM192A (inh=n/a pLI=0.92)
chr16	57438733	57438733	C	T	het		QUAL=1353;DP=135;AF=0.43;MQM=60	CCL17	5'UTR_premature_start_codon_gain,5'UTR	CCL17:ENST00000219244:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-75C>T:,CCL17:ENST00000219244:5'UTR:MODIFIER:exon1/4:c.-75C>T:	MIR	rs72792973	0.0375	0.0000	0,0,0	0,0,0,0,0	0.0381											16	346					CCL17 (inh=n/a pLI=0.07)
chr16	57470564	57470564	G	C	het		QUAL=1189;DP=91;AF=0.51;MQM=60	CIAPIN1	splice_region&intron,intron	CIAPIN1:ENST00000394391:splice_region&intron:LOW:exon4/8:c.387+4C>G:,CIAPIN1:ENST00000567518:splice_region&intron:LOW:exon4/8:c.348+4C>G:,CIAPIN1:ENST00000569370:splice_region&intron:LOW:exon4/7:c.387+4C>G:,CIAPIN1:ENST00000568940:splice_region&intron:LOW:exon4/7:c.387+4C>G:,CIAPIN1:ENST00000569979:splice_region&intron:LOW:exon3/5:c.387+4C>G:,CIAPIN1:ENST00000565961:intron:MODIFIER:exon3/6:c.307-2440C>G:		rs17375948	0.0373	0.0479	178,108,2	0.0158,0.0255,0.0002,0.0553,0.0677	0.0478											16	353					CIAPIN1 (inh=n/a pLI=0.23)
chr16	57778488	57778488	A	G	het	off-target	QUAL=830;DP=83;AF=0.42;MQM=60	KATNB1	intron	KATNB1:ENST00000379661:intron:MODIFIER:exon4/19:c.289+65A>G:		rs2967152	0.7165	0.0000	0,0,0	0,0,0,0,0	0.7480							602703 [KATNB1 (provisional) Lissencephaly 6,with microcephaly,616212];				n/a (AF>5%)	n/a (AF>5%)					KATNB1 (inh=AR pLI=0.31)
chr16	57996932	57996932	G	A	hom		QUAL=3267;DP=103;AF=1.00;MQM=60	CNGB1	synonymous	CNGB1:ENST00000251102:synonymous:LOW:exon5/33:c.327C>T:p.Gly109Gly,CNGB1:ENST00000564448:synonymous:LOW:exon5/33:c.327C>T:p.Gly109Gly,CNGB1:ENST00000311183:synonymous:LOW:exon5/13:c.327C>T:p.Gly109Gly		rs17821448	0.3141	0.4304	11941,8091,64	0.1079,0.3458,0.3373,0.4938,0.4353	0.4312							600724 [CNGB1 (provisional) Retinitis pigmentosa 45,613767];	320109 [benign/likely benign DISEASE=not_specified,retinitis_pigmentosa,_recessive]; 			n/a (AF>5%)	n/a (AF>5%)					CNGB1 (inh=AR pLI=0.00)
chr16	68721470	68721470	T	C	het		QUAL=1960;DP=170;AF=0.44;MQM=60	CDH3	synonymous	CDH3:ENST00000264012:synonymous:LOW:exon12/16:c.1626T>C:p.Asn542Asn,CDH3:ENST00000429102:synonymous:LOW:exon12/16:c.1626T>C:p.Asn542Asn,CDH3:ENST00000581171:synonymous:LOW:exon11/15:c.1461T>C:p.Asn487Asn		rs2296405	0.5974	0.5881	21156,12321,2362	0.6751,0.4586,0.5506,0.6078,0.5555	0.6213							114019 [CDH3 (provisional) Mental retardation,autosomal dominant 3,612580]:114021 [CDH3 (confirmed) Hypotrichosis,congenital,with juvenile macular dystrophy,601553|Ectodermal dysplasia,ectrodactyly,and macular dystrophy,225280];	320243 [benign DISEASE=eem_syndrome]; 		COSM3755002, COSM3755003	n/a (AF>5%)	n/a (AF>5%)					CDH3 (inh=AR pLI=0.00)
chr16	69143577	69143577	A	G	het		QUAL=1883;DP=184;AF=0.41;MQM=60	HAS3	synonymous	HAS3:ENST00000306560:synonymous:LOW:exon2/4:c.279A>G:p.Ala93Ala,HAS3:ENST00000569188:synonymous:LOW:exon2/4:c.279A>G:p.Ala93Ala,HAS3:ENST00000219322:synonymous:LOW:exon2/4:c.279A>G:p.Ala93Ala		rs2232228	0.3423	0.3962	9794,6180,76	0.1151,0.4197,0.4787,0.4360,0.3603	0.4014								225971 [drug response DISEASE=anthracyclines_and_related_substances_response_-_toxicity/adr]; 		COSM3755013, COSM3755012	n/a (AF>5%)	n/a (AF>5%)					HAS3 (inh=n/a pLI=0.55)
chr16	69967093	69967093	G	A	het		QUAL=83;DP=31;AF=0.23;MQM=60	WWP2	intron	WWP2:ENST00000356003:intron:MODIFIER:exon15/22:c.1683-780G>A:,WWP2:ENST00000359154:intron:MODIFIER:exon16/23:c.1683-780G>A:,WWP2:ENST00000448661:intron:MODIFIER:exon16/23:c.1683-780G>A:,WWP2:ENST00000542271:intron:MODIFIER:exon13/20:c.1335-780G>A:,WWP2:ENST00000568684:intron:MODIFIER:exon6/13:c.366-780G>A:		rs2102066	0.8450	0.7888	12488,5506,1863	0.8743,0.8007,0.9692,0.7474,0.7625	0.7992											n/a (AF>5%)	n/a (AF>5%)					WWP2 (inh=n/a pLI=0.94)
chr16	71237702	71237702	C	T	het	gene_blacklist	QUAL=1302;DP=84;AF=0.60;MQM=60	HYDIN	intron	HYDIN:ENST00000393567:intron:MODIFIER:exon1/85:c.-23-16881G>A:,HYDIN:ENST00000448089:intron:MODIFIER:exon1/22:c.-23-16881G>A:,HYDIN:ENST00000448691:intron:MODIFIER:exon1/19:c.-18-16886G>A:,HYDIN:ENST00000321489:intron:MODIFIER:exon1/19:c.-23-16881G>A:,HYDIN:ENST00000538248:intron:MODIFIER:exon1/18:c.59-16881G>A:,HYDIN:ENST00000541601:intron:MODIFIER:exon1/18:c.29-16881G>A:,HYDIN:ENST00000288168:intron:MODIFIER:exon1/14:c.29-16881G>A:,HYDIN:ENST00000393550:intron:MODIFIER:exon1/16:c.-23-16881G>A:		rs764600	0.4129	0.3747	754,150,9	0.0000,0.0000,0.0000,0.3380,0.3843	0.4057	-0.5730	D,D	T			3.88	610812 [HYDIN (confirmed) Ciliary dyskinesia,primary,5,608647];				n/a (AF>5%)	n/a (AF>5%)					HYDIN (inh=AR pLI=n/a)
chr16	71678663	71678663	T	C	het	off-target	QUAL=1264;DP=137;AF=0.39;MQM=60	PHLPP2	3'UTR	PHLPP2:ENST00000540628:3'UTR:MODIFIER:exon7/9:c.*42A>G:		rs3752681	0.4171	0.4132	7787,2956,251	0.2960,0.6337,0.7354,0.3648,0.3543	0.3943											n/a (AF>5%)	n/a (AF>5%)					PHLPP2 (inh=n/a pLI=0.11)
chr16	74926520	74926520	C	T	het	off-target	QUAL=121;DP=10;AF=0.60;MQM=60	WDR59	intron	WDR59:ENST00000262144:intron:MODIFIER:exon19/25:c.2001-57G>A:		rs11149776	0.2764	0.0000	0,0,0	0,0,0,0,0	0.3202											n/a (AF>5%)	n/a (AF>5%)					WDR59 (inh=n/a pLI=0.00)
chr16	75281964	75281964	A	C	het		QUAL=2466;DP=196;AF=0.48;MQM=60	BCAR1	5'UTR,intron	BCAR1:ENST00000542031:5'UTR:MODIFIER:exon1/7:c.-7T>G:,BCAR1:ENST00000418647:intron:MODIFIER:exon2/7:c.151-4976T>G:,BCAR1:ENST00000162330:intron:MODIFIER:exon1/6:c.12+3405T>G:,BCAR1:ENST00000546196:intron:MODIFIER:exon1/6:c.-75-4976T>G:,BCAR1:ENST00000393422:intron:MODIFIER:exon1/6:c.67-4976T>G:,BCAR1:ENST00000535626:intron:MODIFIER:exon2/7:c.12+4169T>G:,BCAR1:ENST00000538440:intron:MODIFIER:exon1/6:c.13-4976T>G:,BCAR1:ENST00000420641:intron:MODIFIER:exon1/6:c.67-4976T>G:,BCAR1:ENST00000393420:intron:MODIFIER:exon1/6:c.12+3405T>G:	MIRb	rs1862737	0.5078	0.5537	18558,9439,553	0.3458,0.7681,0.5862,0.5404,0.5406	0.5598											n/a (AF>5%)	n/a (AF>5%)					BCAR1 (inh=n/a pLI=0.99)
chr16	77228866	77228866	T	C	het		QUAL=3076;DP=208;AF=0.53;MQM=60	MON1B	synonymous,intron	MON1B:ENST00000248248:synonymous:LOW:exon4/6:c.1110T>C:p.Val370Val,MON1B:ENST00000439557:synonymous:LOW:exon3/5:c.783T>C:p.Val261Val,MON1B:ENST00000545553:synonymous:LOW:exon2/4:c.672T>C:p.Val224Val,MON1B:ENST00000320859:intron:MODIFIER:exon3/3:c.330-609T>C:		rs2232504	0.7788	0.6785	28627,12138,4002	0.8761,0.7970,0.8553,0.6036,0.7309	0.6982										COSM4129373	n/a (AF>5%)	n/a (AF>5%)					MON1B (inh=n/a pLI=0.16)
chr16	77910418	77910418	A	G	het	off-target	QUAL=750;DP=49;AF=0.61;MQM=60	VAT1L	intron	VAT1L:ENST00000302536:intron:MODIFIER:exon5/8:c.826+48A>G:		rs3751765	0.4219	0.3627	8396,3215,710	0.3769,0.4966,0.5711,0.3124,0.4176	0.3613											n/a (AF>5%)	n/a (AF>5%)					VAT1L (inh=n/a pLI=0.00)
chr16	81816733	81816733	C	T	het		QUAL=685;DP=56;AF=0.48;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron:MODIFIER:exon1/32:c.-47-2815C>T:		rs8045964	0.4241	0.5194	6242,2864,337	0.4590,0.4982,0.3754,0.5004,0.6446	0.4297							600220 [PLCG2 (provisional) Familial cold autoinflammatory syndrome 3,614468|Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878];				n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD pLI=1.00)
chr16	85706047	85706047	A	C	hom		QUAL=1790;DP=54;AF=1.00;MQM=60	GSE1	synonymous	GSE1:ENST00000253458:synonymous:LOW:exon16/16:c.3556A>C:p.Arg1186Arg,GSE1:ENST00000405402:synonymous:LOW:exon15/15:c.3244A>C:p.Arg1082Arg,GSE1:ENST00000393243:synonymous:LOW:exon15/15:c.3337A>C:p.Arg1113Arg		rs9940601	0.6819	0.6568	25450,12737,2009	0.6386,0.5724,0.8839,0.6312,0.7261	0.6493	-0.0230		T			0.01				COSM4129449	n/a (AF>5%)	n/a (AF>5%)					GSE1 (inh=n/a pLI=n/a)
chr16	85711860	85711860	C	T	het		QUAL=673;DP=63;AF=0.43;MQM=60	GINS2	synonymous	GINS2:ENST00000253462:synonymous:LOW:exon5/5:c.516G>A:p.Thr172Thr		rs1053328	0.3748	0.3780	8901,4227,437	0.2989,0.3629,0.5240,0.3527,0.4450	0.3779											n/a (AF>5%)	n/a (AF>5%)					GINS2 (inh=n/a pLI=0.00)
chr16	87788864	87788864	G	A	het		QUAL=1098;DP=76;AF=0.55;MQM=60	KLHDC4	missense	KLHDC4:ENST00000270583:missense:MODERATE:exon4/12:c.305C>T:p.Thr102Ile,KLHDC4:ENST00000353170:missense:MODERATE:exon2/10:c.134C>T:p.Thr45Ile,KLHDC4:ENST00000347925:missense:MODERATE:exon4/11:c.305C>T:p.Thr102Ile		rs2303771	0.4071	0.3918	9724,4002,731	0.3743,0.5092,0.3957,0.3450,0.5224	0.3927	4.2010	T,T,T	T	B,B,B	T,T,T	0.07				COSM3755177	n/a (AF>5%)	n/a (AF>5%)					KLHDC4 (inh=n/a pLI=0.00)
chr16	89169205	89169205	C	G	hom	off-target	QUAL=5205;DP=161;AF=1.00;MQM=60	ACSF3	intron	ACSF3:ENST00000317447:intron:MODIFIER:exon4/10:c.822+38C>G:,ACSF3:ENST00000406948:intron:MODIFIER:exon3/9:c.822+38C>G:,ACSF3:ENST00000378345:intron:MODIFIER:exon2/8:c.27+38C>G:		rs4782456	0.6190	0.7117	30854,19630,1923	0.6124,0.8249,0.4607,0.7754,0.5487	0.7172							614245 [ACSF3 (provisional) Combined malonic and methylmalonic aciduria,614265];				n/a (AF>5%)	n/a (AF>5%)					ACSF3 (inh=AR pLI=0.00)
chr16	89774396	89774396	G	A	het	off-target	QUAL=1083;DP=99;AF=0.44;MQM=60	VPS9D1	intron	VPS9D1:ENST00000389386:intron:MODIFIER:exon14/14:c.1803-34C>T:,VPS9D1:ENST00000561976:intron:MODIFIER:exon13/13:c.1593-34C>T:		rs1110331	0.6697	0.6244	23642,9544,1798	0.6141,0.7603,0.7824,0.5428,0.7582	0.6271											n/a (AF>5%)	n/a (AF>5%)					VPS9D1 (inh=n/a pLI=0.00)
chr16	89857964	89857964	T	C	het		QUAL=239;DP=19;AF=0.63;MQM=60	FANCA	splice_region&intron	FANCA:ENST00000389301:splice_region&intron:LOW:exon13/42:c.1226-20A>G:,FANCA:ENST00000568369:splice_region&intron:LOW:exon13/42:c.1226-20A>G:		rs1800330	0.5719	0.4370	13077,2988,1621	0.5588,0.6678,0.7611,0.3036,0.5731	0.4402							607139 [FANCA (confirmed) Fanconi anemia,complementation group A,227650];	255232 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR pLI=0.00)
chr17	505162	505162	A	G	hom	off-target	QUAL=4935;DP=153;AF=1.00;MQM=60	VPS53	intron	VPS53:ENST00000437048:intron:MODIFIER:exon11/21:c.1117-26T>C:,VPS53:ENST00000574029:intron:MODIFIER:exon3/3:c.207-84283T>C:,VPS53:ENST00000446250:intron:MODIFIER:exon12/19:c.523-26T>C:,VPS53:ENST00000291074:intron:MODIFIER:exon10/17:c.1030-26T>C:,VPS53:ENST00000571805:intron:MODIFIER:exon11/18:c.1117-26T>C:,VPS53:ENST00000401468:intron:MODIFIER:exon4/11:c.286-26T>C:		rs4968055	0.9579	0.9735	56635,31690,4421	0.9228,0.9857,0.9825,0.9785,0.9693	0.9756							615850 [VPS53 (provisional) Pontocerebellar hypoplasia,type 2E,615851];				n/a (AF>5%)	n/a (AF>5%)					VPS53 (inh=AR pLI=0.00)
chr17	1516480	1516480	T	C	hom		QUAL=3314;DP=101;AF=1.00;MQM=60	SLC43A2	splice_region&intron	SLC43A2:ENST00000382147:splice_region&intron:LOW:exon5/13:c.501+9A>G:,SLC43A2:ENST00000301335:splice_region&intron:LOW:exon5/13:c.501+9A>G:,SLC43A2:ENST00000571650:splice_region&intron:LOW:exon5/14:c.501+9A>G:		rs7219369	0.9623	0.9895	59220,33174,4076	0.8878,0.9926,0.9997,0.9998,0.9998	0.9915											n/a (AF>5%)	n/a (AF>5%)					SLC43A2 (inh=n/a pLI=0.18)
chr17	1707893	1707893	T	A	het	off-target	QUAL=1557;DP=105;AF=0.55;MQM=60	SMYD4	intron	SMYD4:ENST00000305513:intron:MODIFIER:exon4/10:c.369+27A>T:		rs8072508	0.3327	0.2938	5832,3046,1623	0.5605,0.1806,0.1677,0.3011,0.2567	0.3556											n/a (AF>5%)	n/a (AF>5%)					SMYD4 (inh=n/a pLI=0.00)
chr17	2868935	2868935	T	C	het		QUAL=762;DP=80;AF=0.40;MQM=60	RAP1GAP2,CTD-3060P21.1	splice_region&synonymous	RAP1GAP2:ENST00000254695:splice_region&synonymous:LOW:exon8/25:c.594T>C:p.Leu198Leu,RAP1GAP2:ENST00000540393:splice_region&synonymous:LOW:exon8/25:c.537T>C:p.Leu179Leu,RAP1GAP2:ENST00000366401:splice_region&synonymous:LOW:exon7/24:c.549T>C:p.Leu183Leu,RAP1GAP2:ENST00000542807:splice_region&synonymous:LOW:exon8/26:c.594T>C:p.Leu198Leu		rs12950923	0.8011	0.8251	35656,20421,2198	0.7300,0.8444,0.8692,0.8367,0.7903	0.8228										COSM3766059, COSM3766060	n/a (AF>5%)	n/a (AF>5%)					RAP1GAP2 (inh=n/a pLI=0.91), CTD-3060P21.1 (inh=n/a pLI=n/a)
chr17	3101691	3101691	G	T	het	gene_blacklist	QUAL=1672;DP=145;AF=0.45;MQM=60	OR1A2	missense	OR1A2:ENST00000381951:missense:MODERATE:exon1/1:c.879G>T:p.Trp293Cys		rs12150427	0.2889	0.3427	7843,4588,52	0.0994,0.2918,0.5558,0.3703,0.2783	0.3451	-0.3300	D	T	B	T	12.11				COSM148148	n/a (AF>5%)	n/a (AF>5%)					OR1A2 (inh=n/a pLI=0.01)
chr17	3447914	3447914	C	T	hom		QUAL=2219;DP=68;AF=1.00;MQM=60	TRPV3	synonymous	TRPV3:ENST00000301365:synonymous:LOW:exon4/18:c.270G>A:p.Gln90Gln,TRPV3:ENST00000576742:synonymous:LOW:exon4/18:c.270G>A:p.Gln90Gln,TRPV3:ENST00000572519:synonymous:LOW:exon4/17:c.270G>A:p.Gln90Gln		rs1039519	0.6625	0.6405	24614,11388,1548	0.5605,0.8203,0.7875,0.5925,0.7030	0.6435							607066 [TRPV3 (provisional) Olmsted syndrome,614594|Palmoplantar keratoderma,nonepidermolytic,focal 2,616400];	322795 [benign DISEASE=palmoplantar_keratoderma,_mutilating,_with_periorificial_keratotic_plaques]; 			n/a (AF>5%)	n/a (AF>5%)					TRPV3 (inh=AD pLI=0.00)
chr17	4007875	4007875	C	T	hom	off-target	QUAL=5290;DP=161;AF=1.00;MQM=60	ZZEF1	intron	ZZEF1:ENST00000381638:intron:MODIFIER:exon8/54:c.1573+52G>A:		rs9907500	0.9099	0.0000	0,0,0	0,0,0,0,0	0.9157											n/a (AF>5%)	n/a (AF>5%)					ZZEF1 (inh=n/a pLI=1.00)
chr17	4856580	4856580	T	C	het		QUAL=1991;DP=151;AF=0.51;MQM=60	ENO3	missense,intron	ENO3:ENST00000323997:missense:MODERATE:exon5/12:c.254T>C:p.Val85Ala,ENO3:ENST00000518175:missense:MODERATE:exon4/11:c.254T>C:p.Val85Ala,ENO3:ENST00000519584:intron:MODIFIER:exon3/9:c.181+395T>C:		rs238239	0.3039	0.4606	14229,10734,235	0.2067,0.4552,0.1489,0.5659,0.3565	0.4620	5.0190	T,T,T,T,T	T	B	T,T,T,T,T	22.60	131370 [ENO3 (confirmed) Glycogen storage disease XIII,612932];	324138 [benign DISEASE=glycogen_storage_disease_type_13,not_specified,not_provided]; 		COSM3736167	n/a (AF>5%)	n/a (AF>5%)					ENO3 (inh=AR pLI=0.00)
chr17	6364753	6364753	A	G	hom		QUAL=5806;DP=176;AF=1.00;MQM=60	PITPNM3	synonymous	PITPNM3:ENST00000262483:synonymous:LOW:exon18/20:c.2430T>C:p.Asp810Asp,PITPNM3:ENST00000421306:synonymous:LOW:exon17/19:c.2322T>C:p.Asp774Asp		rs11654099	0.9139	0.8687	45922,24144,4931	0.9737,0.8561,0.9160,0.8505,0.8819	0.8848							608921 [PITPNM3 (confirmed) Cone-rod dystrophy 5,600977];	261946 [benign DISEASE=not_specified,cone-rod_dystrophy,_dominant]; 		COSM3766147	n/a (AF>5%)	n/a (AF>5%)					PITPNM3 (inh=AD pLI=1.00)
chr17	7193448	7193448	A	G	het	off-target	QUAL=1657;DP=130;AF=0.48;MQM=60	YBX2	intron	YBX2:ENST00000007699:intron:MODIFIER:exon5/8:c.745-58T>C:		rs222838	0.4728	0.0000	0,0,0	0,0,0,0,0	0.6113											n/a (AF>5%)	n/a (AF>5%)					YBX2 (inh=n/a pLI=0.95)
chr17	7852887	7852887	T	G	het	off-target	QUAL=433;DP=51;AF=0.37;MQM=60	CNTROB	3'UTR	CNTROB:ENST00000380262:3'UTR:MODIFIER:exon19/19:c.*59T>G:,CNTROB:ENST00000563694:3'UTR:MODIFIER:exon19/19:c.*59T>G:,CNTROB:ENST00000380255:3'UTR:MODIFIER:exon18/18:c.*943T>G:,CNTROB:ENST00000565740:3'UTR:MODIFIER:exon19/19:c.*59T>G:		rs7217194	0.7624	0.0000	0,0,0	0,0,0,0,0	0.6247											n/a (AF>5%)	n/a (AF>5%)					CNTROB (inh=n/a pLI=0.00)
chr17	8169006	8169006	T	C	hom	off-target	QUAL=8483;DP=259;AF=1.00;MQM=60	PFAS	intron	PFAS:ENST00000314666:intron:MODIFIER:exon20/27:c.2545+49T>C:,PFAS:ENST00000545834:intron:MODIFIER:exon18/25:c.1273+49T>C:		rs11655563	0.6346	0.7437	34515,22451,2255	0.6625,0.5443,0.3838,0.8213,0.7707	0.7534											n/a (AF>5%)	n/a (AF>5%)					PFAS (inh=n/a pLI=0.00)
chr17	9471711	9471711	T	G	hom		QUAL=3906;DP=120;AF=1.00;MQM=60	STX8	synonymous,intron	STX8:ENST00000306357:synonymous:LOW:exon2/8:c.94A>C:p.Arg32Arg,STX8:ENST00000574431:intron:MODIFIER:exon1/6:c.-217+7398A>C:		rs1133295	0.6801	0.7574	35364,19875,643	0.3565,0.8510,0.9854,0.7786,0.7223	0.7702											n/a (AF>5%)	n/a (AF>5%)					STX8 (inh=n/a pLI=0.00)
chr17	10404118	10404118	A	G	hom	off-target	QUAL=3333;DP=102;AF=1.00;MQM=60	RP11-799N11.1,CTC-297N7.11,MYH1	intron	MYH1:ENST00000226207:intron:MODIFIER:exon27/39:c.3739-49T>C:		rs72816758	0.1190	0.1287	1290,435,7	0.0277,0.2396,0.2764,0.1122,0.1078	0.1354											n/a (AF>5%)	n/a (AF>5%)					RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a), MYH1 (inh=n/a pLI=0.00)
chr17	10415840	10415840	A	G	hom		QUAL=4315;DP=131;AF=1.00;MQM=60	MYH1,RP11-799N11.1,CTC-297N7.11	synonymous	MYH1:ENST00000226207:synonymous:LOW:exon12/40:c.1032T>C:p.Phe344Phe		rs2007027	0.8814	0.9288	52638,29659,2732	0.7235,0.9577,0.9998,0.9428,0.9251	0.9350											n/a (AF>5%)	n/a (AF>5%)					MYH1 (inh=n/a pLI=0.00), RP11-799N11.1 (inh=n/a pLI=n/a), CTC-297N7.11 (inh=n/a pLI=n/a)
chr17	10544018	10544018	T	C	hom		QUAL=422;DP=16;AF=1.00;MQM=60	MYH3	splice_region&intron	MYH3:ENST00000226209:splice_region&intron:LOW:exon18/39:c.2166-15A>G:,MYH3:ENST00000583535:splice_region&intron:LOW:exon19/40:c.2166-15A>G:		rs876660	0.4667	0.6140	23678,17259,486	0.3041,0.4558,0.3754,0.7269,0.5392	0.6118							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	258673 [benign/likely benign DISEASE=freeman-sheldon_syndrome,arthrogryposis_multiplex_congenita,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					MYH3 (inh=AR+AD pLI=0.00)
chr17	12647490	12647490	T	C	hom		QUAL=5144;DP=156;AF=1.00;MQM=60	MYOCD,AC005358.1	splice_region&intron	MYOCD:ENST00000425538:splice_region&intron:LOW:exon7/13:c.718-10T>C:,MYOCD:ENST00000343344:splice_region&intron:LOW:exon7/12:c.718-10T>C:		rs12709295	0.7558	0.8101	40059,24509,2871	0.7432,0.6826,0.7453,0.8576,0.7478	0.8275											n/a (AF>5%)	n/a (AF>5%)					MYOCD (inh=n/a pLI=0.97), AC005358.1 (inh=n/a pLI=n/a)
chr17	15217437	15217437	C	G	hom		QUAL=2218;DP=71;AF=0.99;MQM=60	TEKT3	missense	TEKT3:ENST00000338696:missense:MODERATE:exon5/8:c.845G>C:p.Gly282Ala,TEKT3:ENST00000395930:missense:MODERATE:exon6/9:c.845G>C:p.Gly282Ala		rs230898	0.4275	0.4566	12910,7518,537	0.3223,0.3786,0.4340,0.4723,0.5235	0.4568	5.7860	T,T,T	T	B	T,T,T	13.35				COSM3755269	n/a (AF>5%)	n/a (AF>5%)					TEKT3 (inh=n/a pLI=0.00)
chr17	17127471	17127471	G	A	het		QUAL=719;DP=78;AF=0.41;MQM=60	FLCN,RP11-45M22.4	splice_region&intron	FLCN:ENST00000285071:splice_region&intron:LOW:exon5/13:c.397-14C>T:,FLCN:ENST00000389169:splice_region&intron:LOW:exon5/7:c.397-14C>T:		rs1736219	0.4052	0.4841	4822,2771,66	0.1817,0.6164,0.6861,0.5388,0.3695	0.4829							607273 [FLCN (confirmed) Birt-Hogg-Dube syndrome,135150|Pneumothorax,primary spontaneous,173600|Renal carcinoma,chromophobe,somatic,144700|Colorectal cancer,somatic,114500];	96486 [benign DISEASE=spontaneous_pneumothorax,multiple_fibrofolliculomas,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FLCN (inh=AD pLI=0.99), RP11-45M22.4 (inh=n/a pLI=n/a)
chr17	17910477	17910477	T	G	het		QUAL=119;DP=14;AF=0.50;MQM=60	LRRC48,ATPAF2	splice_region&intron	LRRC48:ENST00000313838:splice_region&intron:LOW:exon13/14:c.1326+16T>G:,LRRC48:ENST00000411504:splice_region&intron:LOW:exon13/13:c.1326+16T>G:,LRRC48:ENST00000399187:splice_region&intron:LOW:exon12/13:c.1326+16T>G:,LRRC48:ENST00000584166:splice_region&intron:LOW:exon13/13:c.1326+16T>G:,LRRC48:ENST00000399182:splice_region&intron:LOW:exon12/12:c.1326+16T>G:	MIRb	rs535141650	0.0581	0.0000	0,0,0	0,0,0,0,0	0.0000											n/a (AF>5%)	n/a (AF>5%)					DRC3 (inh=n/a pLI=0.00), ATPAF2 (inh=AR pLI=0.01)
chr17	17997209	17997209	G	A	hom		QUAL=3421;DP=103;AF=1.00;MQM=60	DRG2	synonymous	DRG2:ENST00000225729:synonymous:LOW:exon2/13:c.147G>A:p.Ser49Ser,DRG2:ENST00000395726:synonymous:LOW:exon2/13:c.147G>A:p.Ser49Ser,DRG2:ENST00000583355:synonymous:LOW:exon2/6:c.147G>A:p.Ser49Ser		rs2230316	0.2498	0.4348	13484,11317,208	0.1991,0.3308,0.0690,0.5815,0.2402	0.4369											n/a (AF>5%)	n/a (AF>5%)					DRG2 (inh=n/a pLI=0.09)
chr17	18044270	18044270	T	C	hom	off-target	QUAL=1404;DP=43;AF=1.00;MQM=60	MYO15A	intron	MYO15A:ENST00000205890:intron:MODIFIER:exon21/65:c.5407-63T>C:	MIR	rs854779	0.4457	0.0000	0,0,0	0,0,0,0,0	0.5898							602666 [MYO15A (confirmed) Deafness,autosomal recessive 3,600316];			COSN165347	n/a (AF>5%)	n/a (AF>5%)					MYO15A (inh=AR pLI=n/a)
chr17	18208544	18208544	G	A	het		QUAL=1518;DP=146;AF=0.42;MQM=60	TOP3A	splice_region&intron	TOP3A:ENST00000321105:splice_region&intron:LOW:exon4/18:c.391-10C>T:,TOP3A:ENST00000542570:splice_region&intron:LOW:exon3/17:c.106-10C>T:		rs7207123	0.3205	0.3080	6425,3372,1891	0.6067,0.2681,0.0873,0.3213,0.1935	0.3906										COSM148207	n/a (AF>5%)	n/a (AF>5%)					TOP3A (inh=n/a pLI=0.00)
chr17	18576256	18576256	G	C	hom	off-target	QUAL=540;DP=18;AF=1.00;MQM=44	ZNF286B	intron	ZNF286B:ENST00000545289:intron:MODIFIER:exon4/4:c.217+22C>G:,ZNF286B:ENST00000285274:intron:MODIFIER:exon3/3:c.126+7798C>G:		rs4924901	0.5160	0.4196	722,202,25	0.0000,0.0000,0.0000,0.4656,0.3958	0.5545											n/a (AF>5%)	n/a (AF>5%)					ZNF286B (inh=n/a pLI=0.00)
chr17	18702220	18702220	T	C	hom		QUAL=8383;DP=261;AF=1.00;MQM=53	TVP23B	synonymous	TVP23B:ENST00000307767:synonymous:LOW:exon5/7:c.426T>C:p.Ala142Ala,TVP23B:ENST00000574226:synonymous:LOW:exon5/6:c.426T>C:p.Ala142Ala,TVP23B:ENST00000476139:synonymous:LOW:exon5/7:c.234T>C:p.Ala78Ala,TVP23B:ENST00000581733:synonymous:LOW:exon5/7:c.234T>C:p.Ala78Ala		rs8080471	0.6775	0.6925	29526,16733,2084	0.6327,0.7633,0.8210,0.7073,0.5515	0.6968											n/a (AF>5%)	n/a (AF>5%)					TVP23B (inh=n/a pLI=0.76)
chr17	19247075	19247075	G	A	hom		QUAL=2371;DP=73;AF=1.00;MQM=60	B9D1	missense,intron	B9D1:ENST00000477478:missense:MODERATE:exon6/6:c.427C>T:p.His143Tyr,B9D1:ENST00000575403:intron:MODIFIER:exon6/6:c.399+28C>T:,B9D1:ENST00000461069:intron:MODIFIER:exon6/6:c.472+28C>T:,B9D1:ENST00000395615:intron:MODIFIER:exon6/6:c.472+28C>T:,B9D1:ENST00000261499:intron:MODIFIER:exon6/6:c.472+28C>T:,B9D1:ENST00000395616:intron:MODIFIER:exon6/6:c.472+28C>T:		rs4924987	0.3105	0.5994	26573,21907,194	0.1744,0.4003,0.0026,0.8108,0.3763	0.6023							614144 [B9D1 (provisional) Meckel syndrome 9,614209|Joubert syndrome 27,617120];	260675 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					B9D1 (inh=AR pLI=0.10)
chr17	19617236	19617236	G	T	hom		QUAL=2394;DP=77;AF=1.00;MQM=60	SLC47A2	synonymous	SLC47A2:ENST00000325411:synonymous:LOW:exon4/17:c.345C>A:p.Gly115Gly,SLC47A2:ENST00000350657:synonymous:LOW:exon4/18:c.345C>A:p.Gly115Gly		rs4924792	0.3616	0.3450	7423,3417,579	0.3309,0.3791,0.4397,0.3177,0.4171	0.3448										COSM3755329, COSM3755328	n/a (AF>5%)	n/a (AF>5%)					SLC47A2 (inh=n/a pLI=0.00)
chr17	19699358	19699358	T	C	hom	off-target	QUAL=5407;DP=166;AF=0.99;MQM=60	ULK2	intron	ULK2:ENST00000361658:intron:MODIFIER:exon19/27:c.1997+50A>G:,ULK2:ENST00000395544:intron:MODIFIER:exon19/26:c.1997+50A>G:		rs192511	0.7526	0.8878	45556,30066,2144	0.6463,0.8722,0.6171,0.9635,0.8411	0.8905											n/a (AF>5%)	n/a (AF>5%)					ULK2 (inh=n/a pLI=0.00)
chr17	26851501	26851501	G	A	hom		QUAL=4023;DP=124;AF=1.00;MQM=60	FOXN1,RP11-192H23.4	splice_region&intron	FOXN1:ENST00000226247:splice_region&intron:LOW:exon1/7:c.124-20G>A:,FOXN1:ENST00000579795:splice_region&intron:LOW:exon2/8:c.124-20G>A:		rs614434	0.6508	0.7149	31602,17681,866	0.4113,0.8441,0.9023,0.7307,0.6330	0.7250							600838 [FOXN1 (provisional) T-cell immunodeficiency,congenital alopecia,and nail dystrophy,601705];	379390 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					FOXN1 (inh=AR pLI=0.95), RP11-192H23.4 (inh=n/a pLI=n/a)
chr17	26947652	26947652	G	A	het		QUAL=1468;DP=114;AF=0.50;MQM=60	KIAA0100	splice_region&intron	KIAA0100:ENST00000528896:splice_region&intron:LOW:exon28/38:c.5243-4C>T:,KIAA0100:ENST00000544884:splice_region&intron:LOW:exon28/38:c.4814-4C>T:,KIAA0100:ENST00000389003:splice_region&intron:LOW:exon28/38:c.4814-4C>T:		rs688536	0.2298	0.2342	3573,1847,548	0.3315,0.3044,0.1684,0.2337,0.1446	0.2712										COSM148222	n/a (AF>5%)	n/a (AF>5%)					KIAA0100 (inh=n/a pLI=0.81)
chr17	27093542	27093542	G	A	het	off-target	QUAL=487;DP=56;AF=0.41;MQM=60	FAM222B	intron	FAM222B:ENST00000341217:intron:MODIFIER:exon2/2:c.82+62C>T:,FAM222B:ENST00000581407:intron:MODIFIER:exon2/2:c.82+62C>T:,FAM222B:ENST00000582266:intron:MODIFIER:exon2/2:c.82+62C>T:,FAM222B:ENST00000452648:intron:MODIFIER:exon2/2:c.82+62C>T:,FAM222B:ENST00000582059:intron:MODIFIER:exon2/2:c.82+62C>T:,FAM222B:ENST00000583953:intron:MODIFIER:exon3/3:c.82+62C>T:,FAM222B:ENST00000577682:intron:MODIFIER:exon3/3:c.82+62C>T:,FAM222B:ENST00000583522:intron:MODIFIER:exon4/4:c.82+62C>T:,FAM222B:ENST00000581381:intron:MODIFIER:exon4/4:c.82+62C>T:		rs9900141	0.7802	0.0000	0,0,0	0,0,0,0,0	0.7371											n/a (AF>5%)	n/a (AF>5%)					FAM222B (inh=n/a pLI=0.48)
chr17	28296327	28296327	T	G	hom		QUAL=4892;DP=148;AF=1.00;MQM=60	EFCAB5	missense,intron	EFCAB5:ENST00000394835:missense:MODERATE:exon4/23:c.709T>G:p.Leu237Val,EFCAB5:ENST00000536908:missense:MODERATE:exon4/15:c.541T>G:p.Leu181Val,EFCAB5:ENST00000378738:missense:MODERATE:exon4/15:c.709T>G:p.Leu237Val,EFCAB5:ENST00000320856:missense:MODERATE:exon4/21:c.709T>G:p.Leu237Val,EFCAB5:ENST00000394832:missense:MODERATE:exon4/15:c.709T>G:p.Leu237Val,EFCAB5:ENST00000541045:intron:MODIFIER:exon4/13:c.-106+450T>G:		rs9897794	0.5423	0.5288	16439,8240,908	0.4436,0.6144,0.6847,0.5077,0.5502	0.5270	3.5770	T,T,T,T,T,T,T	T	B,B,B,B	T,T,T,T,T,T	12.25				COSM3755371	n/a (AF>5%)	n/a (AF>5%)					EFCAB5 (inh=n/a pLI=0.00)
chr17	29563073	29563073	-	TG	het	off-target	QUAL=1196;DP=78;AF=0.72;MQM=60	NF1	intron	NF1:ENST00000358273:intron:MODIFIER:exon29/57:c.3974+36_3974+37dupGT:,NF1:ENST00000356175:intron:MODIFIER:exon29/56:c.3974+36_3974+37dupGT:	(T)n	rs371036783;rs59745739	0.0016	0.0010	0,0,0	0.0025,0.0021,0.0008,0.0007,0.0009	0.0012							613113 [NF1 (confirmed) Neurofibromatosis,type 1,162200|Leukemia,juvenile myelomonocytic,607785|Neurofibromatosis,familial spinal,162210|Neurofibromatosis-Noonan syndrome,601321|Watson syndrome,193520];				25	294					NF1 (inh=AD pLI=1.00)
chr17	30222002	30222002	T	C	het		QUAL=922;DP=64;AF=0.58;MQM=60	UTP6	missense	UTP6:ENST00000261708:missense:MODERATE:exon3/19:c.206A>G:p.Gln69Arg		rs3760454	0.3554	0.4413	10296,5580,32	0.0888,0.4297,0.6636,0.4647,0.4355	0.4281	4.6090	T	T	B	T	17.52					n/a (AF>5%)	n/a (AF>5%)					UTP6 (inh=n/a pLI=0.00)
chr17	30980972	30980972	G	A	hom		QUAL=3000;DP=93;AF=1.00;MQM=60	MYO1D,RP11-220C2.1	splice_region&intron	MYO1D:ENST00000318217:splice_region&intron:LOW:exon18/21:c.2491-7C>T:,MYO1D:ENST00000394649:splice_region&intron:LOW:exon20/23:c.2227-7C>T:,MYO1D:ENST00000579584:splice_region&intron:LOW:exon18/21:c.2491-7C>T:		rs2249638	0.6468	0.6826	27240,15553,1550	0.5602,0.6159,0.7631,0.6979,0.6700	0.6783											n/a (AF>5%)	n/a (AF>5%)					MYO1D (inh=n/a pLI=0.00), RP11-220C2.1 (inh=n/a pLI=n/a)
chr17	33326780	33326780	G	A	het	off-target	QUAL=1371;DP=108;AF=0.48;MQM=60	LIG3	intron	LIG3:ENST00000378526:intron:MODIFIER:exon15/19:c.2257-21G>A:,LIG3:ENST00000262327:intron:MODIFIER:exon15/19:c.2257-21G>A:		rs2066505	0.2833	0.1720	3151,415,2108	0.6373,0.1091,0.1541,0.1105,0.1997	0.2640											n/a (AF>5%)	n/a (AF>5%)					LIG3 (inh=n/a pLI=0.00)
chr17	33353332	33353332	T	C	hom	off-target	QUAL=282;DP=9;AF=1.00;MQM=60	RFFL,RAD51L3-RFFL	intron	RFFL:ENST00000315249:intron:MODIFIER:exon2/6:c.180+61A>G:,RFFL:ENST00000268850:intron:MODIFIER:exon2/4:c.180+61A>G:,RFFL:ENST00000378516:intron:MODIFIER:exon2/5:c.180+61A>G:,RFFL:ENST00000584655:intron:MODIFIER:exon2/4:c.180+61A>G:,RFFL:ENST00000394597:intron:MODIFIER:exon2/6:c.180+61A>G:,RFFL:ENST00000447669:intron:MODIFIER:exon3/7:c.180+61A>G:,RFFL:ENST00000415395:intron:MODIFIER:exon3/7:c.180+61A>G:,RFFL:ENST00000413582:intron:MODIFIER:exon2/5:c.180+61A>G:		rs3926358	0.6851	0.0000	0,0,0	0,0,0,0,0	0.7016											n/a (AF>5%)	n/a (AF>5%)					RFFL (inh=n/a pLI=0.69), RAD51L3-RFFL (inh=n/a pLI=n/a)
chr17	33802156	33802156	T	G	het		QUAL=4867;DP=366;AF=0.49;MQM=60	SLFN12L	missense	SLFN12L:ENST00000449046:missense:MODERATE:exon5/5:c.1646A>C:p.Tyr549Ser,SLFN12L:ENST00000260908:missense:MODERATE:exon4/4:c.1553A>C:p.Tyr518Ser,SLFN12L:ENST00000361112:missense:MODERATE:exon5/5:c.1640A>C:p.Tyr547Ser		rs3744372	0.2286	0.1806	2253,729,464	0.2982,0.1279,0.1527,0.1491,0.2937	0.1903	-1.8780	T,T,T	T	B	T,T,T	2.85				COSM1135910, COSM977940, COSM977941	n/a (AF>5%)	n/a (AF>5%)					SLFN12L (inh=n/a pLI=0.00)
chr17	34328461	34328461	A	G	hom		QUAL=3784;DP=116;AF=1.00;MQM=60	CCL15-CCL14,CCL15,CCL14,RP11-104J23.1	missense,5'UTR	CCL15-CCL14:ENST00000481427:missense:MODERATE:exon1/7:c.71T>C:p.Ile24Thr,CCL15:ENST00000354059:missense:MODERATE:exon1/4:c.71T>C:p.Ile24Thr,CCL14:ENST00000536149:5'UTR:MODIFIER:exon1/8:c.-373T>C:		rs854625	0.7490	0.8782	47763,30673,1698	0.5686,0.9013,0.6657,0.9589,0.8263	0.8854	-3.3000	T	T	B	T	1.32					n/a (AF>5%)	n/a (AF>5%)					CCL15-CCL14 (inh=n/a pLI=n/a), CCL15 (inh=n/a pLI=0.07), CCL14 (inh=n/a pLI=0.00), RP11-104J23.1 (inh=n/a pLI=n/a)
chr17	35632979	35632979	C	A	hom	off-target	QUAL=7050;DP=216;AF=1.00;MQM=60	ACACA	intron	ACACA:ENST00000353139:intron:MODIFIER:exon7/55:c.803-37G>T:,ACACA:ENST00000360679:intron:MODIFIER:exon5/53:c.518-37G>T:,ACACA:ENST00000394406:intron:MODIFIER:exon7/55:c.692-37G>T:,ACACA:ENST00000335166:intron:MODIFIER:exon6/54:c.458-37G>T:		rs2542660	0.6843	0.7564	35495,22790,1787	0.5838,0.4882,0.7590,0.8266,0.7493	0.7502							200350 [ACACA (confirmed) Acetyl-CoA carboxylase deficiency,613933];				n/a (AF>5%)	n/a (AF>5%)					ACACA (inh=AR pLI=1.00)
chr17	37054772	37054772	C	T	het		QUAL=2535;DP=195;AF=0.49;MQM=60	LASP1	splice_region&synonymous	LASP1:ENST00000318008:splice_region&synonymous:LOW:exon4/7:c.357C>T:p.Asn119Asn,LASP1:ENST00000433206:splice_region&synonymous:LOW:exon3/6:c.189C>T:p.Asn63Asn,LASP1:ENST00000435347:splice_region&synonymous:LOW:exon4/8:c.357C>T:p.Asn119Asn		rs1130638	0.2324	0.3367	1319,873,43	0.1727,0.3350,0.1396,0.4448,0.2892	0.3492										COSM1382766	n/a (AF>5%)	n/a (AF>5%)					LASP1 (inh=n/a pLI=0.83)
chr17	38938591	38938591	C	G	het		QUAL=618;DP=94;AF=0.32;MQM=60	KRT27	missense	KRT27:ENST00000301656:missense:MODERATE:exon1/8:c.155G>C:p.Ser52Thr		rs2469826	0.3081	0.2806	4951,2192,665	0.3610,0.4283,0.2408,0.2584,0.2485	0.2913	1.2150	T	T	B	D	11.63				COSM148267	n/a (AF>5%)	n/a (AF>5%)					KRT27 (inh=n/a pLI=0.00)
chr17	39305775	39305775	-	GGCAGCAGCTGGGGC	het		QUAL=2883;DP=178;AF=0.63;MQM=60	KRTAP4-5	conservative_inframe_insertion	KRTAP4-5:ENST00000343246:conservative_inframe_insertion:MODERATE:exon1/1:c.244_245insGCCCCAGCTGCTGCC:p.Cys81_Gln82insArgProSerCysCys		rs535144703;rs58117746;rs878860917	0.4231	0.5700	18344,9665,2387	0.7688,0.5075,0.4419,0.5622,0.5976	0.6434											n/a (AF>5%)	n/a (AF>5%)					KRTAP4-5 (inh=n/a pLI=0.01)
chr17	39388852	39388852	T	C	hom		QUAL=2941;DP=90;AF=1.00;MQM=51	KRTAP9-3	synonymous	KRTAP9-3:ENST00000411528:synonymous:LOW:exon1/1:c.99T>C:p.Cys33Cys		rs1860551	0.9589	0.9446	54023,29000,4525	0.9508,0.9761,0.9543,0.9319,0.9706	0.9458											n/a (AF>5%)	n/a (AF>5%)					KRTAP9-3 (inh=n/a pLI=0.04)
chr17	39594679	39594679	A	G	het	off-target	QUAL=2130;DP=159;AF=0.50;MQM=60	KRT38	intron	KRT38:ENST00000246646:intron:MODIFIER:exon5/6:c.1020+64T>C:		rs7209968	0.2191	0.0000	0,0,0	0,0,0,0,0	0.2521											n/a (AF>5%)	n/a (AF>5%)					KRT38 (inh=n/a pLI=0.00)
chr17	40025264	40025264	G	T	hom	off-target	QUAL=1644;DP=52;AF=1.00;MQM=60	ACLY	intron	ACLY:ENST00000352035:intron:MODIFIER:exon27/28:c.3134+32C>A:,ACLY:ENST00000590151:intron:MODIFIER:exon27/28:c.3134+32C>A:,ACLY:ENST00000353196:intron:MODIFIER:exon26/27:c.3104+32C>A:,ACLY:ENST00000537919:intron:MODIFIER:exon19/20:c.2321+32C>A:,ACLY:ENST00000393896:intron:MODIFIER:exon26/27:c.3104+32C>A:		rs9912300	0.7774	0.7819	37460,19796,2758	0.7248,0.8931,0.8235,0.7692,0.8233	0.7804											n/a (AF>5%)	n/a (AF>5%)					ACLY (inh=n/a pLI=1.00)
chr17	40025285	40025285	A	G	hom		QUAL=2153;DP=66;AF=1.00;MQM=60	ACLY	splice_region&intron	ACLY:ENST00000352035:splice_region&intron:LOW:exon27/28:c.3134+11T>C:,ACLY:ENST00000590151:splice_region&intron:LOW:exon27/28:c.3134+11T>C:,ACLY:ENST00000353196:splice_region&intron:LOW:exon26/27:c.3104+11T>C:,ACLY:ENST00000537919:splice_region&intron:LOW:exon19/20:c.2321+11T>C:,ACLY:ENST00000393896:splice_region&intron:LOW:exon26/27:c.3104+11T>C:		rs9914829	0.9235	0.9280	52390,28388,3820	0.8562,0.9481,0.9999,0.9220,0.9639	0.9274											n/a (AF>5%)	n/a (AF>5%)					ACLY (inh=n/a pLI=1.00)
chr17	40256498	40256498	G	C	het	off-target	QUAL=450;DP=86;AF=0.28;MQM=60	DHX58	intron	DHX58:ENST00000251642:intron:MODIFIER:exon11/13:c.1563+286C>G:		rs2074159	0.2266	0.0000	0,0,0	0,0,0,0,0	0.1923											n/a (AF>5%)	n/a (AF>5%)					DHX58 (inh=n/a pLI=0.00)
chr17	40737117	40737117	G	A	het	off-target	QUAL=1831;DP=156;AF=0.46;MQM=60	FAM134C	intron	FAM134C:ENST00000309428:intron:MODIFIER:exon6/8:c.727+26C>T:,FAM134C:ENST00000585894:intron:MODIFIER:exon6/8:c.436+26C>T:,FAM134C:ENST00000543197:intron:MODIFIER:exon5/7:c.142+26C>T:		rs4792992	0.3564	0.3833	9350,5469,210	0.1994,0.4195,0.5421,0.4010,0.3250	0.3921											n/a (AF>5%)	n/a (AF>5%)					RETREG3 (inh=n/a pLI=0.09)
chr17	41154817	41154817	A	C	het		QUAL=1772;DP=168;AF=0.42;MQM=60	RPL27	splice_region&intron	RPL27:ENST00000589037:splice_region&intron:LOW:exon4/4:c.362+17A>C:,RPL27:ENST00000253788:splice_region&intron:LOW:exon4/4:c.362+17A>C:,RPL27:ENST00000589913:splice_region&intron:LOW:exon3/3:c.362+17A>C:,RPL27:ENST00000590864:splice_region&intron:LOW:exon2/2:c.194+17A>C:		rs11871636	0.7490	0.7815	37268,20892,2437	0.6802,0.8709,0.8499,0.7919,0.7282	0.7852							607526 [RPL27 (provisional) Diamond-Blackfan anemia 16,617408];				n/a (AF>5%)	n/a (AF>5%)					RPL27 (inh=AD pLI=0.80)
chr17	45894735	45894735	A	G	hom		QUAL=1324;DP=41;AF=1.00;MQM=60	OSBPL7	splice_region&intron	OSBPL7:ENST00000007414:splice_region&intron:LOW:exon7/22:c.599-10T>C:,OSBPL7:ENST00000392507:splice_region&intron:LOW:exon7/23:c.599-10T>C:		rs9914156	0.8421	0.9059	47859,28740,3515	0.8433,0.8393,0.8111,0.9483,0.8403	0.9112											n/a (AF>5%)	n/a (AF>5%)					OSBPL7 (inh=n/a pLI=0.28)
chr17	45904163	45904163	A	G	het		QUAL=1199;DP=86;AF=0.53;MQM=60	MRPL10	splice_region&intron	MRPL10:ENST00000290208:splice_region&intron:LOW:exon3/4:c.418-16T>C:,MRPL10:ENST00000351111:splice_region&intron:LOW:exon3/4:c.388-16T>C:,MRPL10:ENST00000414011:splice_region&intron:LOW:exon4/5:c.418-16T>C:		rs3809869	0.3347	0.3593	8513,4328,42	0.0807,0.3413,0.6200,0.3607,0.3832	0.3641											n/a (AF>5%)	n/a (AF>5%)					MRPL10 (inh=n/a pLI=0.25)
chr17	47241604	47241604	T	C	hom		QUAL=3969;DP=123;AF=1.00;MQM=60	B4GALNT2	synonymous	B4GALNT2:ENST00000300404:synonymous:LOW:exon8/11:c.1101T>C:p.Asn367Asn,B4GALNT2:ENST00000504681:synonymous:LOW:exon8/11:c.843T>C:p.Asn281Asn,B4GALNT2:ENST00000393354:synonymous:LOW:exon8/11:c.921T>C:p.Asn307Asn		rs8074457	0.9962	0.9986	60532,33365,5037	0.9838,0.9998,1.0000,0.9999,1.0000	0.9988											n/a (AF>5%)	n/a (AF>5%)					B4GALNT2 (inh=n/a pLI=0.00)
chr17	49237562	49237562	C	T	het		QUAL=1162;DP=88;AF=0.52;MQM=60	NME2,NME1-NME2,NME1	intron	NME2:ENST00000555572:intron:MODIFIER:exon4/8:c.303+120C>T:,NME1-NME2:ENST00000608447:intron:MODIFIER:exon4/8:c.303+120C>T:,NME1:ENST00000013034:intron:MODIFIER:exon4/5:c.303+120C>T:,NME1:ENST00000393196:intron:MODIFIER:exon3/4:c.228+120C>T:,NME1-NME2:ENST00000393198:intron:MODIFIER:exon3/7:c.228+120C>T:,NME1:ENST00000336097:intron:MODIFIER:exon4/5:c.303+120C>T:,NME1:ENST00000480143:intron:MODIFIER:exon4/4:c.303+120C>T:,NME1:ENST00000511355:intron:MODIFIER:exon3/3:c.228+120C>T:,NME2:ENST00000393193:intron:MODIFIER:exon3/7:c.228+120C>T:,NME2:ENST00000376392:intron:MODIFIER:exon3/6:c.228+120C>T:	L2b	rs2041296	0.2149	0.2365	1577,790,304	0.3434,0.2680,0.2951,0.2391,0.1466	0.2191							156490 [NME1 (confirmed) Neuroblastoma,256700];				n/a (AF>5%)	n/a (AF>5%)					NME2 (inh=n/a pLI=0.01), NME1-NME2 (inh=n/a pLI=0.01), NME1 (inh=AD pLI=0.01)
chr17	54450038	54450038	C	A	hom		QUAL=944;DP=32;AF=1.00;MQM=60	ANKFN1	synonymous	ANKFN1:ENST00000566473:synonymous:LOW:exon6/20:c.642C>A:p.Leu214Leu,ANKFN1:ENST00000318698:synonymous:LOW:exon6/17:c.642C>A:p.Leu214Leu		rs957724	0.6156	0.6653	28335,14959,341	0.2565,0.8025,0.9689,0.6690,0.6467	0.6820											n/a (AF>5%)	n/a (AF>5%)					ANKFN1 (inh=n/a pLI=0.00)
chr17	59544863	59544863	G	A	het		QUAL=1904;DP=129;AF=0.55;MQM=60	TBX4	splice_region&intron	TBX4:ENST00000393853:splice_region&intron:LOW:exon4/8:c.402-8G>A:,TBX4:ENST00000240335:splice_region&intron:LOW:exon3/7:c.402-8G>A:		rs758596	0.3478	0.2802	5050,2304,925	0.4221,0.1803,0.3677,0.2635,0.3048	0.3126							601719 [TBX4 (provisional) Ischiocoxopodopatellar syndrome,147891];	261034 [benign DISEASE=ischiopatellar_dysplasia,not_specified]; 		COSM4000245	n/a (AF>5%)	n/a (AF>5%)					TBX4 (inh=AD pLI=0.29)
chr17	59760996	59760996	A	G	hom		QUAL=4419;DP=140;AF=0.99;MQM=60	BRIP1	synonymous	BRIP1:ENST00000259008:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.5941	22043,11338,2201	0.6531,0.8008,0.7230,0.5842,0.4525	0.5973							605882 [BRIP1 (confirmed) Breast cancer,early-onset,114480|Fanconi anemia,complementation group J,609054];	183702 [benign/likely benign DISEASE=neoplasm_of_ovary,neoplasm_of_the_breast,fanconi_anemia,hereditary_cancer-predisposing_syndrome,familial_cancer_of_breast,fanconi_anemia,_complementation_group_j,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD pLI=0.00)
chr17	61565998	61565998	A	C	hom		QUAL=3573;DP=114;AF=0.97;MQM=60	ACE	splice_region&intron	ACE:ENST00000290866:splice_region&intron:LOW:exon15/24:c.2306-11A>C:,ACE:ENST00000577647:splice_region&intron:LOW:exon4/30:c.584-11A>C:,ACE:ENST00000428043:splice_region&intron:LOW:exon15/23:c.2306-11A>C:,ACE:ENST00000490216:splice_region&intron:LOW:exon4/30:c.584-11A>C:,ACE:ENST00000290863:splice_region&intron:LOW:exon4/13:c.584-11A>C:,ACE:ENST00000421982:splice_region&intron:LOW:exon4/11:c.236-11A>C:,ACE:ENST00000413513:splice_region&intron:LOW:exon4/12:c.584-11A>C:		rs4342	0.5300	0.4996	15565,7078,892	0.4160,0.5957,0.6591,0.4590,0.5911	0.5002							106180 [ACE (confirmed) Myocardial infarction,susceptibility to|Microvascular complications of diabetes 3,612624|Angiotensin I-converting enzyme,benign serum increase|SARS,progression of|Renal tubular dysgenesis,267430|Stroke,hemorrhagic,614519];	256801 [benign DISEASE=renal_dysplasia,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					ACE (inh=AR pLI=0.00)
chr17	62122677	62122677	G	A	hom	off-target	QUAL=856;DP=30;AF=1.00;MQM=60	ERN1	intron	ERN1:ENST00000433197:intron:MODIFIER:exon20/21:c.2653+42C>T:		rs196917	0.9097	0.9761	57311,33043,2454	0.7207,0.9870,1.0000,0.9994,0.9996	0.9795											n/a (AF>5%)	n/a (AF>5%)					ERN1 (inh=n/a pLI=0.96)
chr17	64737717	64737717	T	A	het	off-target	QUAL=1277;DP=95;AF=0.52;MQM=60	PRKCA	intron	PRKCA:ENST00000413366:intron:MODIFIER:exon11/16:c.1323-60T>A:		rs3803821	0.5467	0.0000	0,0,0	0,0,0,0,0	0.5716							176960 [PRKCA (confirmed) Pituitary tumor,invasive];				n/a (AF>5%)	n/a (AF>5%)					PRKCA (inh=n/a pLI=0.89)
chr17	65212042	65212042	C	T	hom		QUAL=1042;DP=33;AF=1.00;MQM=60	HELZ	missense	HELZ:ENST00000580168:missense:MODERATE:exon5/33:c.220G>A:p.Val74Met,HELZ:ENST00000358691:missense:MODERATE:exon5/33:c.220G>A:p.Val74Met		rs8080100	0.1959	0.2080	1409,579,234	0.2700,0.1749,0.2109,0.2017,0.1884	0.2062	5.0950	D,T	T	B,P	T,T	24.50					n/a (AF>5%)	n/a (AF>5%)					HELZ (inh=n/a pLI=1.00)
chr17	66364749	66364749	T	C	het		QUAL=740;DP=53;AF=0.55;MQM=60	ARSG	synonymous	ARSG:ENST00000448504:synonymous:LOW:exon7/12:c.765T>C:p.Pro255Pro,ARSG:ENST00000452479:synonymous:LOW:exon6/11:c.273T>C:p.Pro91Pro		rs1558877	0.5114	0.5229	17163,8996,2126	0.6396,0.6694,0.2867,0.5189,0.5014	0.5437											n/a (AF>5%)	n/a (AF>5%)					ARSG (inh=n/a pLI=0.00)
chr17	66449122	66449122	G	A	hom		QUAL=4623;DP=138;AF=1.00;MQM=60	WIPI1,RP11-120M18.2	missense,intron	WIPI1:ENST00000262139:missense:MODERATE:exon2/13:c.92C>T:p.Thr31Ile,WIPI1:ENST00000546360:intron:MODIFIER:exon1/11:c.-83-2084C>T:		rs883541	0.7362	0.7469	34411,20044,3679	0.8411,0.6101,0.5190,0.7750,0.7854	0.7790	6.3910	T	T	B	T	15.93					n/a (AF>5%)	n/a (AF>5%)					WIPI1 (inh=n/a pLI=0.39), RP11-120M18.2 (inh=n/a pLI=n/a)
chr17	66899710	66899710	C	G	het	off-target	QUAL=203;DP=31;AF=0.39;MQM=60	ABCA8	intron	ABCA8:ENST00000430352:intron:MODIFIER:exon17/37:c.2399-70G>C:,ABCA8:ENST00000269080:intron:MODIFIER:exon17/37:c.2279-70G>C:,ABCA8:ENST00000586539:intron:MODIFIER:exon19/39:c.2399-70G>C:		rs3744494	0.4537	0.0000	0,0,0	0,0,0,0,0	0.4123											n/a (AF>5%)	n/a (AF>5%)					ABCA8 (inh=n/a pLI=0.00)
chr17	67031369	67031369	T	C	hom		QUAL=2333;DP=72;AF=1.00;MQM=60	ABCA9	splice_region&intron	ABCA9:ENST00000340001:splice_region&intron:LOW:exon8/38:c.1128+18A>G:,ABCA9:ENST00000453985:splice_region&intron:LOW:exon8/37:c.1128+18A>G:,ABCA9:ENST00000370732:splice_region&intron:LOW:exon8/37:c.1128+18A>G:		rs1860448	0.9489	0.9571	53845,30195,4308	0.9104,0.9784,0.9997,0.9594,0.9464	0.9524											n/a (AF>5%)	n/a (AF>5%)					ABCA9 (inh=n/a pLI=0.00)
chr17	67031457	67031457	C	T	hom		QUAL=3177;DP=100;AF=0.98;MQM=60	ABCA9	missense	ABCA9:ENST00000340001:missense:MODERATE:exon8/39:c.1058G>A:p.Arg353His,ABCA9:ENST00000453985:missense:MODERATE:exon8/38:c.1058G>A:p.Arg353His,ABCA9:ENST00000370732:missense:MODERATE:exon8/38:c.1058G>A:p.Arg353His		rs1860447	0.8578	0.9204	51814,29532,2416	0.6761,0.9619,0.9994,0.9408,0.9178	0.9250	2.4880	T,T,T,T	T	B,B	D,D	10.90					n/a (AF>5%)	n/a (AF>5%)					ABCA9 (inh=n/a pLI=0.00)
chr17	67081732	67081732	C	T	het	off-target	QUAL=356;DP=33;AF=0.52;MQM=60	ABCA6	intron	ABCA6:ENST00000284425:intron:MODIFIER:exon31/38:c.4029+34G>A:		rs2302133	0.4824	0.5825	20788,13904,801	0.3990,0.5594,0.2659,0.6542,0.5891	0.5735											n/a (AF>5%)	n/a (AF>5%)					ABCA6 (inh=n/a pLI=0.00)
chr17	67081830	67081830	T	C	het		QUAL=908;DP=97;AF=0.39;MQM=60	ABCA6	missense	ABCA6:ENST00000284425:missense:MODERATE:exon31/39:c.3965A>G:p.Asn1322Ser		rs2302134	0.4599	0.5867	22027,14335,320	0.2440,0.6883,0.3270,0.6544,0.5864	0.5925	2.1030	T,D	T	P	D	12.68				COSM4000276	n/a (AF>5%)	n/a (AF>5%)					ABCA6 (inh=n/a pLI=0.00)
chr17	67186446	67186446	T	G	het	off-target	QUAL=406;DP=31;AF=0.55;MQM=60	ABCA10	intron	ABCA10:ENST00000269081:intron:MODIFIER:exon19/39:c.2131+53A>C:,ABCA10:ENST00000416101:intron:MODIFIER:exon18/38:c.*554+53A>C:		rs17776227	0.0687	0.0000	0,0,0	0,0,0,0,0	0.1030											n/a (AF>5%)	n/a (AF>5%)					ABCA10 (inh=n/a pLI=0.00)
chr17	67260926	67260926	A	G	het		QUAL=347;DP=23;AF=0.65;MQM=60	ABCA5	synonymous	ABCA5:ENST00000392677:synonymous:LOW:exon24/39:c.3268T>C:p.Leu1090Leu,ABCA5:ENST00000392676:synonymous:LOW:exon24/39:c.3265T>C:p.Leu1089Leu,ABCA5:ENST00000588877:synonymous:LOW:exon23/38:c.3265T>C:p.Leu1089Leu		rs12449649	0.3794	0.4369	11967,7682,276	0.2375,0.3171,0.3810,0.4805,0.4960	0.4347										COSM3755781	n/a (AF>5%)	n/a (AF>5%)					ABCA5 (inh=n/a pLI=0.00)
chr17	71195949	71195949	C	T	hom	off-target	QUAL=2974;DP=92;AF=1.00;MQM=60	COG1	intron	COG1:ENST00000299886:intron:MODIFIER:exon4/13:c.914-55C>T:		rs1009110	0.5260	0.0000	0,0,0	0,0,0,0,0	0.5112							606973 [COG1 (confirmed) Congenital disorder of glycosylation,type IIg,611209];				n/a (AF>5%)	n/a (AF>5%)					COG1 (inh=AR pLI=0.04)
chr17	71223837	71223837	C	T	hom	off-target	QUAL=6824;DP=207;AF=1.00;MQM=60	FAM104A	intron	FAM104A:ENST00000405159:intron:MODIFIER:exon1/3:c.222-434G>A:,FAM104A:ENST00000403627:intron:MODIFIER:exon1/2:c.222-434G>A:,FAM104A:ENST00000580032:intron:MODIFIER:exon1/3:c.-113+24G>A:,FAM104A:ENST00000581110:intron:MODIFIER:exon1/1:c.221+4388G>A:,FAM104A:ENST00000583024:intron:MODIFIER:exon1/2:c.222-516G>A:		rs9904267	0.4904	0.0000	0,0,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.4796											n/a (AF>5%)	n/a (AF>5%)					FAM104A (inh=n/a pLI=0.57)
chr17	71746479	71746479	C	G	het		QUAL=1038;DP=85;AF=0.48;MQM=60	CTD-2532D12.4,LINC00469	non_coding_transcript_exon	LINC00469:ENST00000321800:non_coding_transcript_exon:MODIFIER:exon4/4:n.698G>C:		rs2683163	0.6156	0.5908	2492,602,194	0.8269,0.0000,0.0000,0.5575,0.6186	0.6095											n/a (AF>5%)	n/a (AF>5%)					CTD-2532D12.4 (inh=n/a pLI=n/a), LINC00469 (inh=n/a pLI=n/a)
chr17	71752086	71752086	T	C	het	off-target	QUAL=452;DP=30;AF=0.60;MQM=60	CTD-2532D12.4,LINC00469	intron	LINC00469:ENST00000321800:intron:MODIFIER:exon3/3:n.303+4988A>G:		rs2683151	0.6494	0.0000	0,0,0	0,0,0,0,0	0.6296											n/a (AF>5%)	n/a (AF>5%)					CTD-2532D12.4 (inh=n/a pLI=n/a), LINC00469 (inh=n/a pLI=n/a)
chr17	72939446	72939446	C	T	hom		QUAL=2956;DP=93;AF=1.00;MQM=60	OTOP3	splice_region&intron	OTOP3:ENST00000328801:splice_region&intron:LOW:exon4/6:c.686+7C>T:		rs4789110	0.5413	0.5693	19952,10731,1282	0.4919,0.6805,0.4713,0.5667,0.5801	0.5746											n/a (AF>5%)	n/a (AF>5%)					OTOP3 (inh=n/a pLI=0.00)
chr17	73096951	73096951	A	G	hom	off-target	QUAL=703;DP=24;AF=0.96;MQM=60	SLC16A5	intron	SLC16A5:ENST00000329783:intron:MODIFIER:exon5/6:c.1153+40A>G:,SLC16A5:ENST00000580123:intron:MODIFIER:exon5/6:c.1153+40A>G:,SLC16A5:ENST00000450736:intron:MODIFIER:exon4/5:c.1153+40A>G:,SLC16A5:ENST00000538213:intron:MODIFIER:exon4/4:c.1273+40A>G:		rs4238978	0.4910	0.5123	3866,2245,151	0.2637,0.5869,0.7579,0.5375,0.5417	0.5363											n/a (AF>5%)	n/a (AF>5%)					SLC16A5 (inh=n/a pLI=0.00)
chr17	73110279	73110279	C	T	het		QUAL=1505;DP=129;AF=0.46;MQM=60	ARMC7	3'UTR,intron	ARMC7:ENST00000582136:3'UTR:MODIFIER:exon3/3:c.*2C>T:,ARMC7:ENST00000245543:intron:MODIFIER:exon2/2:c.235+3578C>T:,ARMC7:ENST00000581078:intron:MODIFIER:exon2/2:c.171+3642C>T:,ARMC7:ENST00000584947:intron:MODIFIER:exon2/2:c.236-545C>T:		rs1531564	0.5238	0.5889	306,218,22	0.3253,0.0000,0.0000,0.6735,0.0000	0.6702											n/a (AF>5%)	n/a (AF>5%)					ARMC7 (inh=n/a pLI=0.08)
chr17	73951864	73951864	T	C	hom	off-target	QUAL=7402;DP=224;AF=1.00;MQM=60	ACOX1	intron	ACOX1:ENST00000293217:intron:MODIFIER:exon5/13:c.658+45A>G:,ACOX1:ENST00000537812:intron:MODIFIER:exon5/13:c.544+45A>G:,ACOX1:ENST00000301608:intron:MODIFIER:exon5/13:c.658+45A>G:		rs10852766	0.5495	0.6422	26266,14655,242	0.2104,0.7199,0.7928,0.6631,0.6481	0.6536							609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency,264470];				n/a (AF>5%)	n/a (AF>5%)					ACOX1 (inh=AR pLI=0.05)
chr17	74286082	74286082	C	T	het	gene_blacklist	QUAL=1336;DP=100;AF=0.52;MQM=60	QRICH2	synonymous	QRICH2:ENST00000262765:synonymous:LOW:exon5/19:c.3291G>A:p.Glu1097Glu		rs4789273	0.4539	0.3437	7962,2810,1974	0.6213,0.2967,0.5642,0.2872,0.3515	0.3807											n/a (AF>5%)	n/a (AF>5%)					QRICH2 (inh=n/a pLI=0.00)
chr17	74286106	74286106	C	T	het	gene_blacklist	QUAL=1335;DP=112;AF=0.47;MQM=60	QRICH2	synonymous	QRICH2:ENST00000262765:synonymous:LOW:exon5/19:c.3267G>A:p.Thr1089Thr		rs4789274	0.4541	0.3438	7966,2812,1973	0.6208,0.2968,0.5646,0.2873,0.3514	0.3804										COSM3755885	n/a (AF>5%)	n/a (AF>5%)					QRICH2 (inh=n/a pLI=0.00)
chr17	74286173	74286173	A	G	het	gene_blacklist	QUAL=939;DP=82;AF=0.46;MQM=60	QRICH2	splice_region&intron	QRICH2:ENST00000262765:splice_region&intron:LOW:exon4/18:c.3215-15T>C:		rs17509527	0.6160	0.4829	15241,5471,3358	0.8106,0.5364,0.6672,0.4026,0.5263	0.5181											n/a (AF>5%)	n/a (AF>5%)					QRICH2 (inh=n/a pLI=0.00)
chr17	76497920	76497920	C	A	hom		QUAL=3666;DP=112;AF=1.00;MQM=60	DNAH17,DNAH17-AS1	missense,3'UTR	DNAH17:ENST00000389840:missense:MODERATE:exon34/81:c.5193G>T:p.Met1731Ile,DNAH17:ENST00000585328:missense:MODERATE:exon34/81:c.5217G>T:p.Met1739Ile,DNAH17-AS1:ENST00000598378:3'UTR:MODIFIER:exon1/1:c.*1357C>A:		rs690844	0.7388	0.6823	28779,12792,2312	0.6818,0.8275,0.9499,0.6187,0.7015	0.6903	-1.4540	T,T	T		T	4.18		402686 [benign DISEASE=not_specified]; 		COSM3755938, COSM3755939	n/a (AF>5%)	n/a (AF>5%)					DNAH17 (inh=n/a pLI=n/a), DNAH17-AS1 (inh=n/a pLI=0.45)
chr17	79614481	79614481	A	G	hom		QUAL=2933;DP=91;AF=1.00;MQM=60	TSPAN10,NPLOC4	intron	TSPAN10:ENST00000572675:intron:MODIFIER:exon2/2:c.675-446A>G:,TSPAN10:ENST00000328585:intron:MODIFIER:exon2/3:c.675-446A>G:		rs9906358	0.6655	0.5598	1787,222,34	0.0000,0.0000,0.0000,0.3970,0.6115	0.5500	-0.6970					0.70					n/a (AF>5%)	n/a (AF>5%)					TSPAN10 (inh=n/a pLI=0.00), NPLOC4 (inh=n/a pLI=1.00)
chr17	80356187	80356187	G	A	het		QUAL=1565;DP=132;AF=0.45;MQM=60	OGFOD3	synonymous	OGFOD3:ENST00000329197:synonymous:LOW:exon8/10:c.708C>T:p.Tyr236Tyr,OGFOD3:ENST00000313056:synonymous:LOW:exon8/9:c.708C>T:p.Tyr236Tyr		rs4789767	0.0170	0.0445	210,167,0	0.0110,0.0144,0.0004,0.0630,0.0117	0.0519											n/a (AF>5%)	n/a (AF>5%)					OGFOD3 (inh=n/a pLI=0.00)
chr17	80367353	80367353	G	A	het	off-target	QUAL=1237;DP=145;AF=0.36;MQM=60	OGFOD3	intron	OGFOD3:ENST00000329197:intron:MODIFIER:exon3/9:c.381-67C>T:,OGFOD3:ENST00000313056:intron:MODIFIER:exon3/8:c.381-67C>T:		rs7211306	0.5044	0.0000	0,0,0	0,0,0,0,0	0.3527											n/a (AF>5%)	n/a (AF>5%)					OGFOD3 (inh=n/a pLI=0.00)
chr17	80439733	80439733	C	T	het	off-target	QUAL=1476;DP=114;AF=0.49;MQM=60	NARF	intron	NARF:ENST00000457415:intron:MODIFIER:exon8/11:c.907+646C>T:,NARF:ENST00000390006:intron:MODIFIER:exon7/10:c.592+646C>T:,NARF:ENST00000309794:intron:MODIFIER:exon7/10:c.769+646C>T:,NARF:ENST00000345415:intron:MODIFIER:exon6/9:c.625+646C>T:,NARF:ENST00000412079:intron:MODIFIER:exon7/7:c.385+646C>T:		rs9909476	0.1745	0.1785	134,15,3	0.0986,0.0000,0.0000,0.1222,0.2728	0.1496											n/a (AF>5%)	n/a (AF>5%)					NARF (inh=n/a pLI=0.00)
chr17	80585033	80585033	T	A	het	off-target	QUAL=81;DP=9;AF=0.56;MQM=60	WDR45B,FOXK2	intron	WDR45B:ENST00000392325:intron:MODIFIER:exon4/9:c.332+47A>T:		rs2291392	0.8608	0.8133	40396,20493,4162	0.8947,0.8297,0.7809,0.7825,0.9132	0.8136							609226 [WDR45B (provisional) Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures,617977];				n/a (AF>5%)	n/a (AF>5%)					WDR45B (inh=n/a pLI=0.53), FOXK2 (inh=n/a pLI=0.88)
chr17	80887206	80887206	A	G	het	off-target	QUAL=3202;DP=304;AF=0.42;MQM=60	TBCD	intron	TBCD:ENST00000539345:intron:MODIFIER:exon31/39:c.2853-32A>G:,TBCD:ENST00000355528:intron:MODIFIER:exon31/38:c.2853-32A>G:		rs729124	0.3171	0.3012	5551,3045,243	0.2232,0.2264,0.4373,0.3069,0.3055	0.3016							604649 [TBCD (confirmed) Encephalopathy,progressive,early-onset,with brain atrophy and thin corpus callosum,617193];				n/a (AF>5%)	n/a (AF>5%)					TBCD (inh=AR pLI=0.00)
chr18	224184	224184	C	G	het		QUAL=661;DP=52;AF=0.52;MQM=60	THOC1	splice_region&intron	THOC1:ENST00000261600:splice_region&intron:LOW:exon15/20:c.1209-5G>C:		rs631343	0.7011	0.7068	23936,12067,2162	0.7188,0.8186,0.5983,0.6851,0.7774	0.6805											n/a (AF>5%)	n/a (AF>5%)					THOC1 (inh=n/a pLI=0.77)
chr18	662103	662103	G	A	hom	off-target	QUAL=1259;DP=40;AF=1.00;MQM=60	TYMS	intron	TYMS:ENST00000323274:intron:MODIFIER:exon2/6:c.280-43G>A:,TYMS:ENST00000323250:intron:MODIFIER:exon1/4:c.205+4156G>A:,TYMS:ENST00000323224:intron:MODIFIER:exon2/5:c.280-43G>A:		rs1001761	0.6142	0.5137	15512,7034,3122	0.7787,0.3853,0.6926,0.4692,0.5610	0.5512										COSN505266	n/a (AF>5%)	n/a (AF>5%)					TYMS (inh=n/a pLI=0.90)
chr18	724612	724612	A	G	hom		QUAL=6501;DP=199;AF=0.99;MQM=60	YES1	synonymous	YES1:ENST00000577961:synonymous:LOW:exon12/12:c.1459T>C:p.Leu487Leu,YES1:ENST00000584307:synonymous:LOW:exon12/12:c.1444T>C:p.Leu482Leu,YES1:ENST00000314574:synonymous:LOW:exon12/12:c.1444T>C:p.Leu482Leu		rs537141	0.9898	0.9973	60355,33351,4890	0.9724,0.9985,1.0000,0.9997,1.0000	0.9978											n/a (AF>5%)	n/a (AF>5%)					YES1 (inh=n/a pLI=0.02)
chr18	6928180	6928180	G	T	het		QUAL=10;DP=13;AF=0.23;MQM=60	LINC00668,SCML2P1	non_coding_transcript_exon	LINC00668:ENST00000580197:non_coding_transcript_exon:MODIFIER:exon2/3:n.175C>A:,SCML2P1:ENST00000584511:non_coding_transcript_exon:MODIFIER:exon2/2:n.1071G>T:		rs4797265	0.5144	0.4986	1522,432,85	0.5390,0.0000,0.0000,0.4956,0.4988	0.5109											n/a (AF>5%)	n/a (AF>5%)					LINC00668 (inh=n/a pLI=n/a), SCML2P1 (inh=n/a pLI=n/a)
chr18	6928422	6928422	C	T	het		QUAL=1019;DP=114;AF=0.38;MQM=60	LINC00668	splice_region&intron	LINC00668:ENST00000580197:splice_region&intron:LOW:exon1/2:n.136+14G>A:	LTR9	rs4797267	0.5517	0.5480	1821,495,118	0.6201,0.0000,0.0000,0.5339,0.5529	0.5444											n/a (AF>5%)	n/a (AF>5%)					LINC00668 (inh=n/a pLI=n/a)
chr18	6928547	6928547	T	A	het		QUAL=450;DP=36;AF=0.53;MQM=60	LINC00668	non_coding_transcript_exon	LINC00668:ENST00000580197:non_coding_transcript_exon:MODIFIER:exon1/3:n.25A>T:	LTR9	rs4797268	0.5717	0.5610	1904,517,126	0.6539,0.0000,0.0000,0.5527,0.5615	0.5762											n/a (AF>5%)	n/a (AF>5%)					LINC00668 (inh=n/a pLI=n/a)
chr18	6928596	6928596	C	T	het	off-target	QUAL=37;DP=7;AF=0.43;MQM=60	LINC00668			LTR9	rs4797269	0.5325	0.0000	0,0,0	0,0,0,0,0	0.5334											n/a (AF>5%)	n/a (AF>5%)					LINC00668 (inh=n/a pLI=n/a)
chr18	8069868	8069868	C	T	het		QUAL=1150;DP=106;AF=0.43;MQM=60	PTPRM	synonymous	PTPRM:ENST00000400060:synonymous:LOW:exon8/33:c.1317C>T:p.Asn439Asn,PTPRM:ENST00000580170:synonymous:LOW:exon8/33:c.1317C>T:p.Asn439Asn,PTPRM:ENST00000332175:synonymous:LOW:exon8/31:c.1317C>T:p.Asn439Asn,PTPRM:ENST00000400053:synonymous:LOW:exon8/31:c.1131C>T:p.Asn377Asn,PTPRM:ENST00000444013:synonymous:LOW:exon4/27:c.678C>T:p.Asn226Asn		rs2230601	0.4744	0.5032	15486,9197,1603	0.5594,0.4738,0.2699,0.5273,0.4993	0.5284										COSM4000474, COSM4000475	n/a (AF>5%)	n/a (AF>5%)					PTPRM (inh=n/a pLI=1.00)
chr18	11644785	11644785	C	T	hom		QUAL=140;DP=9;AF=1.00;MQM=23	RP11-677O4.4				rs4797569	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3012											n/a (AF>5%)	n/a (AF>5%)					RP11-677O4.4 (inh=n/a pLI=n/a)
chr18	11644795	11644795	T	G	hom		QUAL=52;DP=4;AF=1.00;MQM=24	RP11-677O4.4				rs4797570	0.0000	0.0000	0,0,0	0,0,0,0,0	0.3104											n/a (AF>5%)	n/a (AF>5%)					RP11-677O4.4 (inh=n/a pLI=n/a)
chr18	12125657	12125657	G	A	het		QUAL=812;DP=51;AF=0.61;MQM=60	ANKRD62	missense	ANKRD62:ENST00000587848:missense:MODERATE:exon13/14:c.1837G>A:p.Ala613Thr,ANKRD62:ENST00000314074:missense:MODERATE:exon13/14:c.1795G>A:p.Ala599Thr		rs7243248	0.5465	0.6118	2914,1051,146	0.6287,0.6184,0.2518,0.6612,0.5956	0.5953	0.6580	T,T	T	B	T,T	1.16				COSM437908	n/a (AF>5%)	n/a (AF>5%)					ANKRD62 (inh=n/a pLI=0.46)
chr18	12702610	12702610	G	A	het	off-target	QUAL=741;DP=53;AF=0.58;MQM=60	CEP76,PSMG2	5'UTR_premature_start_codon_gain,5'UTR,intron	CEP76:ENST00000262127:5'UTR_premature_start_codon_gain:LOW:exon1/12:c.-63C>T:,CEP76:ENST00000423709:5'UTR_premature_start_codon_gain:LOW:exon1/11:c.-63C>T:,CEP76:ENST00000262127:5'UTR:MODIFIER:exon1/12:c.-63C>T:,PSMG2:ENST00000317615:5'UTR:MODIFIER:exon1/7:c.-497G>A:,CEP76:ENST00000423709:5'UTR:MODIFIER:exon1/11:c.-63C>T:,PSMG2:ENST00000585331:intron:MODIFIER:exon1/6:c.-36-3939G>A:		rs4797701	0.1763	0.0000	0,0,0	0,0,0,0,0	0.1603											n/a (AF>5%)	n/a (AF>5%)					CEP76 (inh=n/a pLI=0.53), PSMG2 (inh=n/a pLI=0.02)
chr18	13884566	13884566	C	T	hom	off-target	QUAL=3152;DP=96;AF=1.00;MQM=60	MC2R	3'UTR	MC2R:ENST00000327606:3'UTR:MODIFIER:exon2/2:c.*58G>A:		rs4797825	0.5046	0.0000	0,0,0	0,0,0,0,0	0.5562							607397 [MC2R (confirmed) Glucocorticoid deficiency,due to ACTH unresponsiveness,202200];	326189 [benign DISEASE=glucocorticoid_deficiency]; 		COSN165595	n/a (AF>5%)	n/a (AF>5%)					MC2R (inh=AR pLI=0.05)
chr18	14179603	14179603	A	G	hom		QUAL=601;DP=23;AF=1.00;MQM=50	ANKRD20A5P	splice_region&intron	ANKRD20A5P:ENST00000581935:splice_region&intron:LOW:exon1/2:n.501+7A>G:		rs4797872	0.5869	0.7513	30505,19655,398	0.3260,0.7076,0.3915,0.8369,0.8204	0.7590											n/a (AF>5%)	n/a (AF>5%)					ANKRD20A5P (inh=n/a pLI=n/a)
chr18	14377682	14377682	C	T	het		QUAL=2405;DP=222;AF=0.43;MQM=55	TERF1P2	non_coding_transcript_exon	TERF1P2:ENST00000583350:non_coding_transcript_exon:MODIFIER:exon1/1:n.1075G>A:,TERF1P2:ENST00000543068:non_coding_transcript_exon:MODIFIER:exon1/1:n.955G>A:		rs4797919	0.7061	0.0000	0,0,0	0,0,0,0,0	0.6513											n/a (AF>5%)	n/a (AF>5%)					TERF1P2 (inh=n/a pLI=n/a)
chr18	21119777	21119777	G	A	hom		QUAL=354;DP=12;AF=1.00;MQM=60	NPC1	splice_region&synonymous	NPC1:ENST00000269228:splice_region&synonymous:LOW:exon18/25:c.2793C>T:p.Asn931Asn,NPC1:ENST00000412552:splice_region&synonymous:LOW:exon11/18:c.1839C>T:p.Asn613Asn		rs1140458	0.4840	0.4902	15043,7063,759	0.3823,0.6585,0.6266,0.4595,0.4861	0.4990							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];	21136 [benign/likely benign DISEASE=niemann-pick_disease,_type_c,niemann-pick_disease_type_c1,not_specified]; 		COSM437978	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR pLI=0.00)
chr18	21120035	21120035	T	C	hom	off-target	QUAL=736;DP=24;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron:MODIFIER:exon17/24:c.2605-70A>G:,NPC1:ENST00000412552:intron:MODIFIER:exon10/17:c.1651-70A>G:		rs7239575	0.5867	0.0000	0,0,0	0,0,0,0,0	0.5515							607623 [NPC1 (confirmed) Niemann-Pick disease,type C1,257220|Niemann-Pick disease,type D,257220];				n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR pLI=0.00)
chr18	21413869	21413869	T	C	het		QUAL=1677;DP=143;AF=0.45;MQM=60	LAMA3	synonymous	LAMA3:ENST00000313654:synonymous:LOW:exon24/75:c.2901T>C:p.Ala967Ala,LAMA3:ENST00000399516:synonymous:LOW:exon24/74:c.2901T>C:p.Ala967Ala		rs9962023	0.6244	0.6631	27016,16761,1443	0.5386,0.5095,0.7650,0.7075,0.6205	0.6592							600805 [LAMA3 (provisional) Epidermolysis bullosa,junctional,Herlitz type,226700|Epidermolysis bullosa,generalized atrophic benign,226650|Laryngoonychocutaneous syndrome,245660];	403025 [benign DISEASE=not_specified]; 		COSM4130939	n/a (AF>5%)	n/a (AF>5%)					LAMA3 (inh=AR pLI=0.00)
chr18	28986333	28986333	A	C	hom		QUAL=5169;DP=159;AF=1.00;MQM=60	DSG4,RP11-534N16.1	missense	DSG4:ENST00000359747:missense:MODERATE:exon12/15:c.1930A>C:p.Ile644Leu,DSG4:ENST00000308128:missense:MODERATE:exon12/16:c.1930A>C:p.Ile644Leu		rs4799570	0.9659	0.9203	51450,26162,5017	0.9829,0.9639,0.9998,0.8864,0.9519	0.9310	1.6010	T,T	T	B,B	T,T	2.10	607892 [DSG4 (provisional) Hypotrichosis 6,607903];	326441 [benign DISEASE=localized_ar_hypotrichosis]; 			n/a (AF>5%)	n/a (AF>5%)					DSG4 (inh=AR pLI=0.00), RP11-534N16.1 (inh=n/a pLI=n/a)
chr18	29797921	29797921	C	T	het		QUAL=3263;DP=259;AF=0.48;MQM=60	MEP1B,GAREM	missense	MEP1B:ENST00000269202:missense:MODERATE:exon14/15:c.2084C>T:p.Pro695Leu,MEP1B:ENST00000581447:missense:MODERATE:exon14/15:c.2084C>T:p.Pro695Leu		rs616114	0.3558	0.3710	8347,5082,759	0.3989,0.2834,0.2429,0.3928,0.3990	0.3757	0.9160	T	T	B	T	6.16			CM065309 [CLASS=DP MUT=ALT PHEN="Colorectal cancer increased risk association with" GENE=MEP1B]; 	COSM3756126	n/a (AF>5%)	n/a (AF>5%)					MEP1B (inh=n/a pLI=0.00), GAREM1 (inh=n/a pLI=0.93)
chr18	33718326	33718326	A	C	het		QUAL=960;DP=84;AF=0.45;MQM=60	ELP2	missense	ELP2:ENST00000442325:missense:MODERATE:exon4/23:c.382A>C:p.Thr128Pro,ELP2:ENST00000358232:missense:MODERATE:exon4/22:c.382A>C:p.Thr128Pro,ELP2:ENST00000351393:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:ENST00000423854:missense:MODERATE:exon4/19:c.382A>C:p.Thr128Pro,ELP2:ENST00000350494:missense:MODERATE:exon4/21:c.382A>C:p.Thr128Pro,ELP2:ENST00000542824:missense:MODERATE:exon4/20:c.382A>C:p.Thr128Pro		rs1785934	0.3205	0.3427	7445,4635,756	0.3715,0.4047,0.1893,0.3724,0.2376	0.3649	0.6540	T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	5.90	616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];				n/a (AF>5%)	n/a (AF>5%)					ELP2 (inh=AR pLI=0.00)
chr18	33725931	33725931	G	A	het		QUAL=2869;DP=213;AF=0.50;MQM=60	ELP2	missense	ELP2:ENST00000442325:missense:MODERATE:exon11/23:c.1108G>A:p.Val370Met,ELP2:ENST00000358232:missense:MODERATE:exon10/22:c.913G>A:p.Val305Met,ELP2:ENST00000351393:missense:MODERATE:exon9/21:c.835G>A:p.Val279Met,ELP2:ENST00000423854:missense:MODERATE:exon7/19:c.703G>A:p.Val235Met,ELP2:ENST00000350494:missense:MODERATE:exon10/21:c.1030G>A:p.Val344Met,ELP2:ENST00000542824:missense:MODERATE:exon9/20:c.835G>A:p.Val279Met		rs1785928	0.3217	0.3427	7458,4632,762	0.3752,0.4040,0.1889,0.3721,0.2377	0.3660	0.2480	T,T,T,T,T,T	T	B,B,B,B,B,B	T,T,T,T,T,T	3.76	616054 [ELP2 (provisional) Mental retardation,autosomal recessive 58,617270];			COSM1388588	n/a (AF>5%)	n/a (AF>5%)					ELP2 (inh=AR pLI=0.00)
chr18	33795425	33795425	G	A	hom	off-target	QUAL=381;DP=14;AF=1.00;MQM=60	MOCOS	intron	MOCOS:ENST00000261326:intron:MODIFIER:exon7/14:c.1336-54G>A:		rs631108	0.8355	0.0000	0,0,0	0,0,0,0,0	0.8769							613274 [MOCOS (provisional) Xanthinuria,type II,603592];				n/a (AF>5%)	n/a (AF>5%)					MOCOS (inh=AR pLI=0.00)
chr18	41559321	41559321	C	G	het		QUAL=1128;DP=123;AF=0.39;MQM=60	RNU6,443P,AC083760.1	intergenic_region	AC083760.1:ENSG00000202250-ENSG00000267716:intergenic_region:MODIFIER::n.41559321C>G:		rs7229587	0.7109	0.6253	5795,2251,476	0.6275,0.7086,0.7939,0.5819,0.6497	0.6359											n/a (AF>5%)	n/a (AF>5%)					RNU6 (inh=n/a pLI=n/a), 443P (inh=n/a pLI=n/a), AC083760.1 (inh=n/a pLI=n/a)
chr18	43247001	43247001	C	G	het		QUAL=1120;DP=93;AF=0.46;MQM=60	SLC14A2	synonymous	SLC14A2:ENST00000255226:synonymous:LOW:exon13/20:c.1659C>G:p.Val553Val,SLC14A2:ENST00000586448:synonymous:LOW:exon14/21:c.1659C>G:p.Val553Val,SLC14A2:ENST00000589658:synonymous:LOW:exon2/9:c.90C>G:p.Val30Val		rs2156609	0.6502	0.7684	36615,23208,2084	0.6343,0.7878,0.4042,0.8338,0.7492	0.7696										COSM148425	n/a (AF>5%)	n/a (AF>5%)					SLC14A2 (inh=n/a pLI=0.00)
chr18	43316538	43316538	A	G	hom		QUAL=6671;DP=199;AF=1.00;MQM=60	SLC14A1,RP11-116O18.3	synonymous	SLC14A1:ENST00000415427:synonymous:LOW:exon7/11:c.756A>G:p.Pro252Pro,SLC14A1:ENST00000321925:synonymous:LOW:exon6/10:c.588A>G:p.Pro196Pro,SLC14A1:ENST00000502059:synonymous:LOW:exon5/9:c.264A>G:p.Pro88Pro,SLC14A1:ENST00000535474:synonymous:LOW:exon4/8:c.192A>G:p.Pro64Pro,SLC14A1:ENST00000402943:synonymous:LOW:exon5/9:c.273A>G:p.Pro91Pro,SLC14A1:ENST00000436407:synonymous:LOW:exon5/9:c.756A>G:p.Pro252Pro,SLC14A1:ENST00000586142:synonymous:LOW:exon4/8:c.588A>G:p.Pro196Pro,SLC14A1:ENST00000589700:synonymous:LOW:exon4/7:c.588A>G:p.Pro196Pro		rs2298718	0.7113	0.6357	25271,10474,2219	0.6524,0.7800,0.9288,0.5611,0.6883	0.6379							613868 [SLC14A1 (confirmed) Blood group,Kidd,111000];			COSM438130, COSM1480332	n/a (AF>5%)	n/a (AF>5%)					SLC14A1 (inh=n/a pLI=0.00), RP11-116O18.3 (inh=n/a pLI=n/a)
chr18	43319519	43319519	G	A	hom		QUAL=6355;DP=190;AF=1.00;MQM=60	SLC14A1,RP11-116O18.3	missense,synonymous,5'UTR	SLC14A1:ENST00000415427:missense:MODERATE:exon9/11:c.1006G>A:p.Asp336Asn,SLC14A1:ENST00000321925:missense:MODERATE:exon8/10:c.838G>A:p.Asp280Asn,SLC14A1:ENST00000502059:missense:MODERATE:exon7/9:c.514G>A:p.Asp172Asn,SLC14A1:ENST00000535474:missense:MODERATE:exon6/8:c.442G>A:p.Asp148Asn,SLC14A1:ENST00000402943:missense:MODERATE:exon7/9:c.523G>A:p.Asp175Asn,SLC14A1:ENST00000436407:missense:MODERATE:exon7/9:c.1006G>A:p.Asp336Asn,SLC14A1:ENST00000586142:missense:MODERATE:exon6/8:c.838G>A:p.Asp280Asn,SLC14A1:ENST00000589700:synonymous:LOW:exon5/7:c.690G>A:p.Arg230Arg,SLC14A1:ENST00000591541:5'UTR:MODIFIER:exon1/3:c.-51G>A:		rs1058396	0.4109	0.4695	13694,8027,366	0.2685,0.5252,0.5368,0.4912,0.4243	0.4722	0.7000	T,T,T,T,T,T	T	B,B,B	T,T,T,T,T,T	9.06	613868 [SLC14A1 (confirmed) Blood group,Kidd,111000];	17717 [benign DISEASE=kidd_blood_polymorphism_jk(a)/jk(b)]; 		COSM3736180, COSM3736181	n/a (AF>5%)	n/a (AF>5%)					SLC14A1 (inh=n/a pLI=0.00), RP11-116O18.3 (inh=n/a pLI=n/a)
chr18	46384073	46384073	A	G	het	off-target	QUAL=1461;DP=102;AF=0.56;MQM=60	CTIF	intron	CTIF:ENST00000382998:intron:MODIFIER:exon12/12:c.1587+61A>G:,CTIF:ENST00000256413:intron:MODIFIER:exon11/11:c.1581+61A>G:		rs937021	0.3856	0.0000	0,0,0	0,0,0,0,0	0.4385										COSN165655	n/a (AF>5%)	n/a (AF>5%)					CTIF (inh=n/a pLI=0.99)
chr18	47488625	47488625	A	G	het		QUAL=1982;DP=165;AF=0.46;MQM=60	MYO5B	splice_region&intron	MYO5B:ENST00000285039:splice_region&intron:LOW:exon12/39:c.1545+11T>C:		rs17715416	0.3223	0.3825	9479,4856,201	0.1945,0.4877,0.2568,0.3796,0.5222	0.3874							606540 [MYO5B (confirmed) Microvillus inclusion disease,251850];	327063 [benign DISEASE=not_specified,diarrhea_with_microvillus_atrophy]; 		COSN165659	n/a (AF>5%)	n/a (AF>5%)					MYO5B (inh=AR pLI=0.00)
chr18	50994208	50994208	G	T	hom	off-target	QUAL=2600;DP=80;AF=1.00;MQM=60	DCC	intron	DCC:ENST00000442544:intron:MODIFIER:exon24/28:c.3620-56G>T:,DCC:ENST00000581580:intron:MODIFIER:exon21/26:c.2525-56G>T:		rs1502229	0.4874	0.0000	0,0,0	0,0,0,0,0	0.6138							120470 [DCC (confirmed) Mirror movements 1 and/or agenesis of the corpus callosum,157600|Gaze palsy,familial horizontal,with progressive scoliosis,2,617542|Colorectal cancer,somatic,114500|Esophageal carcinoma,somatic,133239];				n/a (AF>5%)	n/a (AF>5%)					DCC (inh=AD pLI=1.00)
chr18	52921673	52921673	T	C	hom	off-target	QUAL=903;DP=29;AF=1.00;MQM=60	TCF4	intron	TCF4:ENST00000398339:intron:MODIFIER:exon16/20:c.1656+55A>G:,TCF4:ENST00000354452:intron:MODIFIER:exon15/19:c.1350+55A>G:,TCF4:ENST00000356073:intron:MODIFIER:exon15/19:c.1350+55A>G:,TCF4:ENST00000568673:intron:MODIFIER:exon14/18:c.1278+55A>G:,TCF4:ENST00000457482:intron:MODIFIER:exon8/12:c.870+55A>G:,TCF4:ENST00000543082:intron:MODIFIER:exon13/17:c.1224+55A>G:,TCF4:ENST00000540999:intron:MODIFIER:exon14/18:c.1278+55A>G:,TCF4:ENST00000537578:intron:MODIFIER:exon14/18:c.1278+55A>G:,TCF4:ENST00000564999:intron:MODIFIER:exon15/19:c.1350+55A>G:,TCF4:ENST00000568740:intron:MODIFIER:exon14/18:c.1275+55A>G:,TCF4:ENST00000537856:intron:MODIFIER:exon10/14:c.960+55A>G:,TCF4:ENST00000544241:intron:MODIFIER:exon11/15:c.1137+55A>G:,TCF4:ENST00000561992:intron:MODIFIER:exon11/15:c.960+55A>G:,TCF4:ENST00000561831:intron:MODIFIER:exon8/12:c.870+55A>G:,TCF4:ENST00000565018:intron:MODIFIER:exon15/19:c.1350+55A>G:,TCF4:ENST00000570287:intron:MODIFIER:exon8/12:c.870+55A>G:,TCF4:ENST00000564228:intron:MODIFIER:exon11/15:c.1137+55A>G:,TCF4:ENST00000567880:intron:MODIFIER:exon12/16:c.1170+55A>G:,TCF4:ENST00000566286:intron:MODIFIER:exon14/18:c.1341+55A>G:,TCF4:ENST00000566279:intron:MODIFIER:exon13/17:c.1170+55A>G:,TCF4:ENST00000564403:intron:MODIFIER:exon15/19:c.1368+55A>G:,TCF4:ENST00000570177:intron:MODIFIER:exon10/14:c.960+55A>G:	(TATCTA)n	rs1539951	0.2218	0.0000	0,0,0	0,0,0,0,0	0.2621							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];				n/a (AF>5%)	n/a (AF>5%)					TCF4 (inh=AD pLI=1.00)
chr18	53177774	53177774	G	C	het	off-target	QUAL=321;DP=39;AF=0.38;MQM=60	TCF4	intron	TCF4:ENST00000398339:intron:MODIFIER:exon4/20:c.452-46406C>G:,TCF4:ENST00000354452:intron:MODIFIER:exon3/19:c.146-46406C>G:,TCF4:ENST00000356073:intron:MODIFIER:exon3/19:c.146-46406C>G:,TCF4:ENST00000568673:intron:MODIFIER:exon2/18:c.74-46406C>G:,TCF4:ENST00000543082:intron:MODIFIER:exon1/17:c.19+36C>G:,TCF4:ENST00000540999:intron:MODIFIER:exon2/18:c.74-46406C>G:,TCF4:ENST00000537578:intron:MODIFIER:exon2/18:c.74-46406C>G:,TCF4:ENST00000564999:intron:MODIFIER:exon3/19:c.146-46406C>G:,TCF4:ENST00000568740:intron:MODIFIER:exon2/18:c.74-46406C>G:,TCF4:ENST00000565018:intron:MODIFIER:exon3/19:c.146-46406C>G:,TCF4:ENST00000567880:intron:MODIFIER:exon2/16:c.146-46406C>G:,TCF4:ENST00000566286:intron:MODIFIER:exon2/18:c.140-46406C>G:,TCF4:ENST00000566279:intron:MODIFIER:exon3/17:c.146-46406C>G:,TCF4:ENST00000564403:intron:MODIFIER:exon3/19:c.146-46406C>G:		rs9964328	0.3427	0.3558	741,245,24	0.3073,0.0000,0.0000,0.3801,0.3434	0.3413							602272 [TCF4 (confirmed) Pitt-Hopkins syndrome,610954|Corneal dystrophy,Fuchs endothelial,3,613267];				n/a (AF>5%)	n/a (AF>5%)					TCF4 (inh=AD pLI=1.00)
chr18	55397871	55397871	T	C	hom		QUAL=3979;DP=120;AF=1.00;MQM=60	RP11-35G9.5,RP11-35G9.3,ATP8B1	intron	ATP8B1:ENST00000283684:intron:MODIFIER:exon1/26:c.181+988A>G:,ATP8B1:ENST00000536015:intron:MODIFIER:exon2/27:c.181+988A>G:		rs319434	0.9836	0.0000	0,0,0	0,0,0,0,0	0.9832							602397 [ATP8B1 (provisional) Cholestasis,progressive familial intrahepatic 1,211600|Cholestasis,benign recurrent intrahepatic,243300|Cholestasis,intrahepatic,of pregnancy,1,147480];				n/a (AF>5%)	n/a (AF>5%)					RP11-35G9.5 (inh=n/a pLI=n/a), RP11-35G9.3 (inh=n/a pLI=n/a), ATP8B1 (inh=AR+AD pLI=0.00)
chr18	58291479	58291479	T	C	het		QUAL=1193;DP=87;AF=0.53;MQM=60	RP11-325K19.2				rs9947661	0.6296	0.0000	0,0,0	0,0,0,0,0	0.5666											n/a (AF>5%)	n/a (AF>5%)					RP11-325K19.2 (inh=n/a pLI=n/a)
chr18	59781800	59781800	A	G	het		QUAL=917;DP=74;AF=0.51;MQM=60	PIGN	synonymous	PIGN:ENST00000357637:synonymous:LOW:exon15/31:c.1245T>C:p.Asp415Asp,PIGN:ENST00000400334:synonymous:LOW:exon14/30:c.1245T>C:p.Asp415Asp		rs13381627	0.0956	0.1748	401,287,1	0.0473,0.1745,0.0127,0.2482,0.1193	0.1743							606097 [PIGN (provisional) Multiple congenital anomalies-hypotonia-seizures syndrome 1,614080];	403304 [benign DISEASE=not_specified]; 		COSM3756186	n/a (AF>5%)	n/a (AF>5%)					PIGN (inh=AR pLI=0.00)
chr18	59954765	59954765	G	T	het	off-target	QUAL=681;DP=88;AF=0.36;MQM=60	KIAA1468	intron	KIAA1468:ENST00000256858:intron:MODIFIER:exon27/29:c.3472+65G>T:,KIAA1468:ENST00000398130:intron:MODIFIER:exon26/28:c.3370+65G>T:		rs1567038	0.3520	0.0000	0,0,0	0,0,0,0,0	0.3874											n/a (AF>5%)	n/a (AF>5%)					KIAA1468 (inh=n/a pLI=1.00)
chr18	61261565	61261565	C	G	hom	off-target	QUAL=4364;DP=130;AF=1.00;MQM=60	SERPINB13	intron	SERPINB13:ENST00000344731:intron:MODIFIER:exon5/7:c.473-24C>G:,SERPINB13:ENST00000269489:intron:MODIFIER:exon5/6:c.473-24C>G:		rs11152396	0.7857	0.7859	37384,20655,2691	0.7219,0.7441,0.8761,0.7889,0.7830	0.7845											n/a (AF>5%)	n/a (AF>5%)					SERPINB13 (inh=n/a pLI=0.00)
chr18	65179829	65179829	G	A	het		QUAL=1269;DP=115;AF=0.43;MQM=60	DSEL,CTD-2541J13.2	missense	DSEL:ENST00000310045:missense:MODERATE:exon2/2:c.2047C>T:p.Pro683Ser		rs2279269	0.4355	0.4941	15268,9504,530	0.3203,0.4771,0.5245,0.5317,0.4034	0.4972	1.6020	T,T	T	B	T	6.84					n/a (AF>5%)	n/a (AF>5%)					DSEL (inh=n/a pLI=0.00), CTD-2541J13.2 (inh=n/a pLI=n/a)
chr18	67365668	67365668	A	G	het		QUAL=668;DP=96;AF=0.33;MQM=60	DOK6	synonymous	DOK6:ENST00000382713:synonymous:LOW:exon5/8:c.438A>G:p.Thr146Thr		rs4426448	0.4850	0.4675	13538,6907,990	0.4380,0.3716,0.7528,0.4561,0.4378	0.4771											n/a (AF>5%)	n/a (AF>5%)					DOK6 (inh=n/a pLI=0.37)
chr18	72103782	72103782	T	C	het		QUAL=366;DP=40;AF=0.40;MQM=60	FAM69C	missense	FAM69C:ENST00000343998:missense:MODERATE:exon4/4:c.1214A>G:p.Gln405Arg,FAM69C:ENST00000400291:missense:MODERATE:exon3/3:c.317A>G:p.Gln106Arg		rs2278154	0.3351	0.3741	5885,3868,360	0.3310,0.2891,0.2452,0.4114,0.3635	0.3648	1.3150	T,T	T	B		0.04				COSM4131078, COSM4131079	n/a (AF>5%)	n/a (AF>5%)					FAM69C (inh=n/a pLI=0.01)
chr18	77097360	77097360	A	T	het		QUAL=2416;DP=195;AF=0.49;MQM=60	ATP9B	missense	ATP9B:ENST00000426216:missense:MODERATE:exon19/30:c.2194A>T:p.Met732Leu,ATP9B:ENST00000307671:missense:MODERATE:exon19/29:c.2194A>T:p.Met732Leu,ATP9B:ENST00000543761:missense:MODERATE:exon3/14:c.157A>T:p.Met53Leu		rs585033	0.0323	0.0611	316,267,0	0.0170,0.0460,0.0002,0.0852,0.0237	0.0614	6.8090	T,T,T	T	B,B,B	T,T,D	9.73					n/a (AF>5%)	n/a (AF>5%)					ATP9B (inh=n/a pLI=0.00)
chr19	367089	367089	G	A	het		QUAL=819;DP=69;AF=0.46;MQM=60	THEG	missense	THEG:ENST00000342640:missense:MODERATE:exon7/8:c.889C>T:p.His297Tyr,THEG:ENST00000346878:missense:MODERATE:exon6/7:c.817C>T:p.His273Tyr		rs10422863	0.0651	0.0429	167,43,39	0.0922,0.0211,0.0955,0.0324,0.0379	0.0541	0.0400	T,T	T	B,B	T,T	0.01				COSM3756683	n/a (AF>5%)	n/a (AF>5%)					THEG (inh=n/a pLI=0.00)
chr19	1650134	1650134	A	G	hom	off-target	QUAL=3728;DP=119;AF=1.00;MQM=60	TCF3	intron	TCF3:ENST00000395423:intron:MODIFIER:exon1/14:c.72+42T>C:,TCF3:ENST00000344749:intron:MODIFIER:exon2/18:c.72+42T>C:,TCF3:ENST00000262965:intron:MODIFIER:exon2/18:c.72+42T>C:,TCF3:ENST00000588136:intron:MODIFIER:exon1/18:c.72+42T>C:		rs1860661	0.7404	0.5724	4039,654,908	0.8251,0.6250,0.8679,0.3728,0.6936	0.5551							147141 [TCF3 (confirmed) Agammaglobulinemia 8,autosomal dominant,616941];				n/a (AF>5%)	n/a (AF>5%)					TCF3 (inh=AD pLI=0.12)
chr19	2790394	2790394	G	A	het	off-target	QUAL=271;DP=27;AF=0.48;MQM=60	THOP1	intron	THOP1:ENST00000307741:intron:MODIFIER:exon1/12:c.17-25G>A:		rs1736176	0.3646	0.3297	6211,3046,829	0.4017,0.3012,0.4888,0.3092,0.3118	0.3440											n/a (AF>5%)	n/a (AF>5%)					THOP1 (inh=n/a pLI=0.01)
chr19	2796021	2796021	G	A	het	off-target	QUAL=1636;DP=109;AF=0.57;MQM=60	THOP1	5'UTR,intron	THOP1:ENST00000586677:5'UTR:MODIFIER:exon1/10:c.-43G>A:,THOP1:ENST00000307741:intron:MODIFIER:exon3/12:c.379-58G>A:	L1MD1	rs1736180	0.3614	0.3427	4909,2318,585	0.4001,0.3321,0.5003,0.3236,0.3248	0.3413											n/a (AF>5%)	n/a (AF>5%)					THOP1 (inh=n/a pLI=0.01)
chr19	2810248	2810248	G	A	het	off-target	QUAL=729;DP=68;AF=0.46;MQM=60	THOP1	5'UTR,intron	THOP1:ENST00000395212:5'UTR:MODIFIER:exon1/5:c.-66G>A:,THOP1:ENST00000307741:intron:MODIFIER:exon9/12:c.1456-54G>A:,THOP1:ENST00000586677:intron:MODIFIER:exon6/9:c.1093-54G>A:		rs1736184	0.3508	0.0000	0,0,0	0,0,0,0,0	0.3307											n/a (AF>5%)	n/a (AF>5%)					THOP1 (inh=n/a pLI=0.01)
chr19	2896818	2896818	C	T	hom		QUAL=5106;DP=158;AF=0.99;MQM=60	AC119403.1				rs8100809	0.7931	0.8312	5733,1938,200	0.6793,0.8771,0.8396,0.8419,0.8213	0.8557	-3.9880	T	T			6.05					n/a (AF>5%)	n/a (AF>5%)					AC119403.1 (inh=n/a pLI=n/a)
chr19	6156483	6156483	T	C	het		QUAL=2126;DP=131;AF=0.59;MQM=60	ACSBG2,RFX2	missense,intron	ACSBG2:ENST00000252669:missense:MODERATE:exon5/15:c.428T>C:p.Val143Ala,ACSBG2:ENST00000588304:missense:MODERATE:exon5/15:c.278T>C:p.Val93Ala,ACSBG2:ENST00000591403:missense:MODERATE:exon5/15:c.428T>C:p.Val143Ala,ACSBG2:ENST00000586696:missense:MODERATE:exon5/15:c.428T>C:p.Val143Ala,ACSBG2:ENST00000588485:intron:MODIFIER:exon5/14:c.-55+4677T>C:		rs4807840	0.7121	0.7088	30689,15766,2744	0.7244,0.7860,0.6933,0.6867,0.7077	0.7125	5.3460	T	T	B	T	1.39					n/a (AF>5%)	n/a (AF>5%)					ACSBG2 (inh=n/a pLI=0.00), RFX2 (inh=n/a pLI=1.00)
chr19	6452305	6452305	A	G	hom		QUAL=3262;DP=99;AF=1.00;MQM=60	SLC25A23	splice_region&intron,intron	SLC25A23:ENST00000301454:splice_region&intron:LOW:exon8/9:c.1071+18T>C:,SLC25A23:ENST00000334510:splice_region&intron:LOW:exon8/9:c.1071+18T>C:,SLC25A23:ENST00000414491:intron:MODIFIER:exon3/4:c.354+1687T>C:		rs173229	0.5250	0.5733	12111,6517,2337	0.7788,0.3718,0.3984,0.5742,0.5651	0.6062											n/a (AF>5%)	n/a (AF>5%)					SLC25A23 (inh=n/a pLI=0.05)
chr19	6495736	6495736	A	G	hom		QUAL=7080;DP=216;AF=1.00;MQM=60	TUBB4A	synonymous	TUBB4A:ENST00000264071:synonymous:LOW:exon4/4:c.774T>C:p.Val258Val,TUBB4A:ENST00000540257:synonymous:LOW:exon4/5:c.774T>C:p.Val258Val		rs2071347	0.6294	0.6680	27452,16303,2442	0.6872,0.7415,0.4578,0.7007,0.5428	0.7013							602662 [TUBB4A (provisional) Dystonia 4,torsion,autosomal dominant,128101|Leukodystrophy,hypomyelinating,6,612438];	330263 [benign DISEASE=dystonia,leukodystrophy,_hypomyelinating,_6]; 			n/a (AF>5%)	n/a (AF>5%)					TUBB4A (inh=AD pLI=0.01)
chr19	6977409	6977409	C	T	het	off-target	QUAL=869;DP=64;AF=0.53;MQM=60	EMR4P	intron	EMR4P:ENST00000600751:intron:MODIFIER:exon6/15:n.590-43G>A:		rs7255801	0.5887	0.6451	24156,13546,811	0.4166,0.7247,0.6371,0.6549,0.6761	0.6490											n/a (AF>5%)	n/a (AF>5%)					ADGRE4P (inh=n/a pLI=n/a)
chr19	7833690	7833690	G	T	het	off-target	QUAL=1334;DP=112;AF=0.49;MQM=60	CLEC4M	intron	CLEC4M:ENST00000327325:intron:MODIFIER:exon6/6:c.1050-34G>T:,CLEC4M:ENST00000248228:intron:MODIFIER:exon7/7:c.984-34G>T:,CLEC4M:ENST00000334806:intron:MODIFIER:exon6/6:c.897-34G>T:,CLEC4M:ENST00000357361:intron:MODIFIER:exon5/5:c.937-34G>T:,CLEC4M:ENST00000359059:intron:MODIFIER:exon6/6:c.849-34G>T:,CLEC4M:ENST00000394122:intron:MODIFIER:exon8/8:c.1014-34G>T:,CLEC4M:ENST00000596363:intron:MODIFIER:exon4/4:c.853-34G>T:,CLEC4M:ENST00000595496:intron:MODIFIER:exon5/5:c.642-34G>T:,CLEC4M:ENST00000596707:intron:MODIFIER:exon5/5:c.849-34G>T:,CLEC4M:ENST00000597522:intron:MODIFIER:exon5/5:c.661-34G>T:		rs3745376	0.1268	0.1353	1307,917,107	0.1399,0.0652,0.1564,0.1618,0.0518	0.1518							605872 [CLEC4M (provisional) SARS infection,protection against];				n/a (AF>5%)	n/a (AF>5%)					CLEC4M (inh=n/a pLI=0.00)
chr19	8161450	8161450	C	T	het	gene_blacklist	QUAL=395;DP=34;AF=0.50;MQM=60	FBN3	missense	FBN3:ENST00000270509:missense:MODERATE:exon43/63:c.5417G>A:p.Arg1806Gln,FBN3:ENST00000600128:missense:MODERATE:exon44/64:c.5417G>A:p.Arg1806Gln,FBN3:ENST00000601739:missense:MODERATE:exon44/64:c.5417G>A:p.Arg1806Gln		rs3829817	0.1837	0.2144	2860,1758,112	0.1416,0.1898,0.1768,0.2277,0.2476	0.2123	1.2820	T	T	B	D	17.66				COSM3757423	n/a (AF>5%)	n/a (AF>5%)					FBN3 (inh=n/a pLI=0.00)
chr19	9005719	9005719	A	G	hom	gene_blacklist	QUAL=3155;DP=96;AF=0.99;MQM=60	MUC16	synonymous	MUC16:ENST00000397910:synonymous:LOW:exon46/84:c.39687T>C:p.Asp13229Asp		rs4804375	0.7332	0.7382	31915,17604,2534	0.7179,0.8079,0.7473,0.7322,0.7333	0.7478	-0.8020		T			0.24				COSM3757464, COSM3757463	n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	9069892	9069892	A	C	het	gene_blacklist	QUAL=1947;DP=184;AF=0.41;MQM=60	MUC16	missense	MUC16:ENST00000397910:missense:MODERATE:exon3/84:c.17554T>G:p.Phe5852Val		rs1862460	0.2546	0.2128	2991,1077,402	0.2817,0.3271,0.3037,0.1802,0.1800	0.2231	-2.1470	T	T	B	T	0.05					n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	9070194	9070194	A	G	hom	gene_blacklist	QUAL=9267;DP=277;AF=1.00;MQM=60	MUC16	missense	MUC16:ENST00000397910:missense:MODERATE:exon3/84:c.17252T>C:p.Ile5751Thr		rs1344572	0.9421	0.9312	52479,28840,4814	0.9901,0.9749,0.8609,0.9291,0.9406	0.9345	-0.3810	T	T	B	T	0.08					n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	9074073	9074073	G	A	het	gene_blacklist	QUAL=3277;DP=217;AF=0.55;MQM=60	MUC16	missense	MUC16:ENST00000397910:missense:MODERATE:exon3/84:c.13373C>T:p.Pro4458Leu		rs72486387	0.1865	0.1677	1985,623,51	0.1039,0.2999,0.3033,0.1366,0.1635	0.1737	2.3890	D	T	B	T	12.02					n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	9074950	9074950	G	T	het	gene_blacklist	QUAL=3879;DP=275;AF=0.52;MQM=60	MUC16	missense	MUC16:ENST00000397910:missense:MODERATE:exon3/84:c.12496C>A:p.His4166Asn		rs2591591	0.2386	0.2600	4233,2609,170	0.1799,0.2119,0.2629,0.2768,0.2781	0.2605	-0.2960	D	T	B	T	0.36					n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	9075346	9075346	T	A	het	gene_blacklist	QUAL=2251;DP=184;AF=0.47;MQM=60	MUC16	missense	MUC16:ENST00000397910:missense:MODERATE:exon3/84:c.12100A>T:p.Ile4034Phe		rs2591592	0.4383	0.5152	16607,11033,868	0.4205,0.4186,0.2675,0.5752,0.5313	0.5147	-0.6020	T	T	P	T	2.57					n/a (AF>5%)	n/a (AF>5%)					MUC16 (inh=n/a pLI=n/a)
chr19	12222861	12222861	T	C	het		QUAL=1528;DP=122;AF=0.49;MQM=60	ZNF788,ZNF20	missense,3'UTR,intron	ZNF788:ENST00000339302:missense:MODERATE:exon3/3:c.499T>C:p.Cys167Arg,ZNF788:ENST00000430298:3'UTR:MODIFIER:exon3/3:c.*742T>C:,ZNF20:ENST00000600335:intron:MODIFIER:exon3/3:c.192-18994A>G:		rs1975349	0.3900	0.3364	1379,362,606	0.7406,0.3411,0.4672,0.3241,0.2490	0.3584	0.7710	D	T	B	T	14.17				COSM438590	n/a (AF>5%)	n/a (AF>5%)					ZNF788 (inh=n/a pLI=0.05), ZNF20 (inh=n/a pLI=0.08)
chr19	12692001	12692001	G	A	het		QUAL=3181;DP=207;AF=0.56;MQM=60	ZNF490	synonymous	ZNF490:ENST00000311437:synonymous:LOW:exon5/5:c.888C>T:p.His296His		rs3745651	0.2063	0.3698	10082,8384,60	0.0974,0.1940,0.0531,0.5005,0.2540	0.3708										COSM3756331	n/a (AF>5%)	n/a (AF>5%)					ZNF490 (inh=n/a pLI=0.05)
chr19	14520829	14520829	G	A	het	off-target	QUAL=600;DP=75;AF=0.37;MQM=60	DDX39A	intron	DDX39A:ENST00000242776:intron:MODIFIER:exon6/10:c.733-144C>T:,DDX39A:ENST00000454233:intron:MODIFIER:exon5/5:c.733-36C>T:		rs12461754	0.1100	0.1192	684,269,2	0.0215,0.2051,0.2020,0.1086,0.1135	0.1181											n/a (AF>5%)	n/a (AF>5%)					DDX39A (inh=n/a pLI=0.78)
chr19	14817062	14817062	G	A	het	off-target	QUAL=795;DP=48;AF=0.63;MQM=60	ZNF333	intron	ZNF333:ENST00000292530:intron:MODIFIER:exon6/11:c.424-436G>A:,ZNF333:ENST00000536363:intron:MODIFIER:exon7/12:c.97-436G>A:,ZNF333:ENST00000540689:intron:MODIFIER:exon6/11:c.424-436G>A:,ZNF333:ENST00000601134:intron:MODIFIER:exon4/6:c.245-436G>A:		rs4808319	0.6919	0.6639	3051,533,132	0.6520,0.0000,0.7905,0.5486,0.7389	0.5994											n/a (AF>5%)	n/a (AF>5%)					ZNF333 (inh=n/a pLI=0.00)
chr19	14975040	14975040	G	A	hom		QUAL=8445;DP=253;AF=1.00;MQM=60	AC005255.6				rs10407682	0.3429	0.2730	4500,1815,1576	0.5671,0.2152,0.2814,0.2435,0.2600	0.3346	-0.4480	T	T			3.57					n/a (AF>5%)	n/a (AF>5%)					AC005255.6 (inh=n/a pLI=n/a)
chr19	15905002	15905002	T	C	het	gene_blacklist	QUAL=6656;DP=468;AF=0.53;MQM=54	OR10H5	synonymous	OR10H5:ENST00000308940:synonymous:LOW:exon1/1:c.144T>C:p.Thr48Thr		rs4808379	0.4854	0.4087	11285,3824,896	0.4220,0.5971,0.7835,0.3389,0.3851	0.4147										COSM4131335	n/a (AF>5%)	n/a (AF>5%)					OR10H5 (inh=n/a pLI=0.21)
chr19	15905431	15905431	T	C	het	gene_blacklist	QUAL=2564;DP=213;AF=0.48;MQM=55	OR10H5	synonymous	OR10H5:ENST00000308940:synonymous:LOW:exon1/1:c.573T>C:p.Asp191Asp		rs4808381	0.4561	0.3999	10855,3783,574	0.3338,0.5927,0.7816,0.3381,0.3850	0.4080										COSM3756409	n/a (AF>5%)	n/a (AF>5%)					OR10H5 (inh=n/a pLI=0.21)
chr19	15918802	15918802	C	G	het	gene_blacklist	QUAL=1452;DP=155;AF=0.40;MQM=56	OR10H1	missense	OR10H1:ENST00000334920:missense:MODERATE:exon1/1:c.46G>C:p.Gly16Arg		rs4808383	0.1530	0.1874	2194,1312,97	0.1364,0.1709,0.1354,0.1973,0.2032	0.1853	1.9390	D	T	D	T	24.50				COSM3756414	n/a (AF>5%)	n/a (AF>5%)					OR10H1 (inh=n/a pLI=0.62)
chr19	15932941	15932941	A	G	hom		QUAL=6033;DP=184;AF=1.00;MQM=60	ZNF861P	non_coding_transcript_exon	ZNF861P:ENST00000588126:non_coding_transcript_exon:MODIFIER:exon2/2:n.304T>C:		rs3761012	0.8151	0.0000	0,0,0	0,0,0,0,0	0.7785											n/a (AF>5%)	n/a (AF>5%)					ZNF861P (inh=n/a pLI=n/a)
chr19	16040473	16040473	T	C	hom	off-target	QUAL=3363;DP=103;AF=1.00;MQM=60	CYP4F11	intron	CYP4F11:ENST00000248041:intron:MODIFIER:exon2/12:c.199-62A>G:,CYP4F11:ENST00000326742:intron:MODIFIER:exon1/10:c.199-62A>G:,CYP4F11:ENST00000402119:intron:MODIFIER:exon1/11:c.199-62A>G:	MLT2B2	rs4808414	0.4982	0.0000	0,0,0	0,0,0,0,0	0.5653											n/a (AF>5%)	n/a (AF>5%)					CYP4F11 (inh=n/a pLI=0.00)
chr19	16136405	16136405	C	T	het	off-target	QUAL=103;DP=26;AF=0.27;MQM=60	LINC00661	non_coding_transcript_exon	LINC00661:ENST00000549354:non_coding_transcript_exon:MODIFIER:exon9/9:n.1475C>T:		rs4808423	0.7240	0.0000	0,0,0	0,0,0,0,0	0.6657											n/a (AF>5%)	n/a (AF>5%)					LINC00661 (inh=n/a pLI=n/a)
chr19	16178587	16178587	A	C	het	off-target	QUAL=1666;DP=120;AF=0.53;MQM=60	TPM4	intron	TPM4:ENST00000344824:intron:MODIFIER:exon1/8:c.114+39A>C:,TPM4:ENST00000538887:intron:MODIFIER:exon1/9:c.114+39A>C:		rs4808031	0.5445	0.4760	12684,5956,2336	0.7192,0.4543,0.5929,0.4494,0.3692	0.5493											n/a (AF>5%)	n/a (AF>5%)					TPM4 (inh=n/a pLI=0.70)
chr19	16275772	16275772	A	G	hom	off-target	QUAL=809;DP=27;AF=1.00;MQM=60	CIB3	intron	CIB3:ENST00000269878:intron:MODIFIER:exon4/5:c.347-48T>C:,CIB3:ENST00000379859:intron:MODIFIER:exon2/3:c.200-48T>C:		rs4808461	0.7861	0.7961	38367,20647,2276	0.6678,0.8872,0.9582,0.7885,0.7620	0.8006											n/a (AF>5%)	n/a (AF>5%)					CIB3 (inh=n/a pLI=0.00)
chr19	17003789	17003789	T	G	het	gene_blacklist	QUAL=2911;DP=183;AF=0.58;MQM=60	CPAMD8	3'UTR	CPAMD8:ENST00000443236:3'UTR:MODIFIER:exon42/42:c.*130A>C:	L1MD2	rs773901	0.5641	0.5377	17448,9179,2740	0.7568,0.5211,0.3251,0.5330,0.5475	0.5852							608841 [CPAMD8 (provisional) Anterior segment dysgenesis 8,617319];				n/a (AF>5%)	n/a (AF>5%)					CPAMD8 (inh=AR pLI=0.00)
chr19	17301880	17301880	T	C	het	off-target	QUAL=3374;DP=213;AF=0.57;MQM=60	MYO9B	intron	MYO9B:ENST00000594824:intron:MODIFIER:exon19/39:c.2689-26T>C:,MYO9B:ENST00000595618:intron:MODIFIER:exon19/39:c.2689-26T>C:,MYO9B:ENST00000397274:intron:MODIFIER:exon18/38:c.2689-26T>C:		rs4808072	0.7534	0.6550	25219,10693,3764	0.9204,0.8282,0.7503,0.5820,0.6434	0.6953							602129 [MYO9B (provisional) Celiac disease,susceptibility to,4,609753];				n/a (AF>5%)	n/a (AF>5%)					MYO9B (inh=n/a pLI=1.00)
chr19	17450446	17450446	G	A	hom	off-target	QUAL=915;DP=40;AF=0.40;MQM=60	GTPBP3	intron	GTPBP3:ENST00000358792:intron:MODIFIER:exon6/7:c.1070+38G>A:,GTPBP3:ENST00000361619:intron:MODIFIER:exon7/8:c.1040+38G>A:,GTPBP3:ENST00000324894:intron:MODIFIER:exon7/8:c.974+38G>A:,GTPBP3:ENST00000600625:intron:MODIFIER:exon7/8:c.974+38G>A:		rs4808623	0.5489	0.6185	7676,4179,862	0.7260,0.5119,0.3126,0.6326,0.5981	0.6332							608536 [GTPBP3 (provisional) Combined oxidative phosphorylation deficiency 23,616198];				n/a (AF>5%)	n/a (AF>5%)					GTPBP3 (inh=AR pLI=0.14)
chr19	17535546	17535546	C	T	hom	off-target	QUAL=2163;DP=69;AF=1.00;MQM=60	MVB12A	intron	MVB12A:ENST00000317040:intron:MODIFIER:exon8/8:c.759+60C>T:,MVB12A:ENST00000392702:intron:MODIFIER:exon7/7:c.639+60C>T:,MVB12A:ENST00000529939:intron:MODIFIER:exon7/7:c.702+670C>T:,MVB12A:ENST00000543795:intron:MODIFIER:exon8/9:c.759+60C>T:		rs4808636	0.8580	0.0000	0,0,0	0,0,0,0,0	0.9296											n/a (AF>5%)	n/a (AF>5%)					MVB12A (inh=n/a pLI=0.00)
chr19	17547292	17547292	A	G	hom		QUAL=5068;DP=157;AF=1.00;MQM=60	TMEM221	missense	TMEM221:ENST00000341130:missense:MODERATE:exon3/3:c.851T>C:p.Met284Thr		rs4808641	0.8952	0.8894	4602,1556,276	0.9676,0.0000,0.0000,0.9483,0.8549	0.9489	0.3430	T	T			0.02				COSM4131409	n/a (AF>5%)	n/a (AF>5%)					TMEM221 (inh=n/a pLI=n/a)
chr19	17559076	17559076	T	C	hom		QUAL=1187;DP=37;AF=1.00;MQM=60	TMEM221,CTD-2521M24.10	missense	TMEM221:ENST00000341130:missense:MODERATE:exon1/3:c.196A>G:p.Thr66Ala		rs4808643	0.7043	0.5972	39,4,0	0.0000,0.0000,0.0000,0.0000,0.0000	0.8718	0.9200	T	T			3.70				COSM4131410	n/a (AF>5%)	n/a (AF>5%)					TMEM221 (inh=n/a pLI=n/a), CTD-2521M24.10 (inh=n/a pLI=n/a)
chr19	17660300	17660300	G	A	hom		QUAL=4587;DP=142;AF=0.99;MQM=60	FAM129C	missense,intron	FAM129C:ENST00000335393:missense:MODERATE:exon15/16:c.1807G>A:p.Gly603Ser,FAM129C:ENST00000595684:missense:MODERATE:exon15/15:c.1807G>A:p.Gly603Ser,FAM129C:ENST00000352727:missense:MODERATE:exon14/15:c.1699G>A:p.Gly567Ser,FAM129C:ENST00000332386:missense:MODERATE:exon15/16:c.1807G>A:p.Gly603Ser,FAM129C:ENST00000601861:missense:MODERATE:exon14/15:c.1714G>A:p.Gly572Ser,FAM129C:ENST00000599164:missense:MODERATE:exon14/15:c.1714G>A:p.Gly572Ser,FAM129C:ENST00000449408:missense:MODERATE:exon13/14:c.985G>A:p.Gly329Ser,FAM129C:ENST00000599124:missense:MODERATE:exon13/14:c.1606G>A:p.Gly536Ser,FAM129C:ENST00000600871:intron:MODIFIER:exon13/13:c.1598-2295G>A:		rs11666267	0.4030	0.4849	15025,10485,668	0.3601,0.3307,0.3512,0.5573,0.4225	0.4848	1.2280	T,D,D,T	T	B,B,B,B	T,T,T,T	10.11				COSM3756467, COSM148530, COSM3756468	n/a (AF>5%)	n/a (AF>5%)					FAM129C (inh=n/a pLI=0.00)
chr19	18108956	18108956	C	G	het		QUAL=874;DP=65;AF=0.52;MQM=60	KCNN1	splice_region&intron	KCNN1:ENST00000222249:splice_region&intron:LOW:exon10/10:c.1378-5C>G:		rs4808732	0.5250	0.5034	10657,5665,1193	0.5843,0.3546,0.6697,0.4919,0.5457	0.4918											n/a (AF>5%)	n/a (AF>5%)					KCNN1 (inh=n/a pLI=0.91)
chr19	18276856	18276856	T	C	hom	off-target	QUAL=196;DP=7;AF=1.00;MQM=60	PIK3R2	intron	PIK3R2:ENST00000222254:intron:MODIFIER:exon11/15:c.1417-114T>C:,PIK3R2:ENST00000593731:intron:MODIFIER:exon11/24:c.1417-114T>C:	L2c	rs4808755	0.8736	0.0000	0,0,0	0,0,0,0,0	0.9010							603157 [PIK3R2 (provisional) Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1,603387];				n/a (AF>5%)	n/a (AF>5%)					PIK3R2 (inh=AD pLI=0.89)
chr19	18375815	18375815	G	A	het	gene_blacklist	QUAL=5902;DP=431;AF=0.51;MQM=60	KIAA1683	synonymous	KIAA1683:ENST00000392413:synonymous:LOW:exon3/4:c.2535C>T:p.Asn845Asn,KIAA1683:ENST00000600328:synonymous:LOW:exon3/4:c.2535C>T:p.Asn845Asn,KIAA1683:ENST00000600359:synonymous:LOW:exon3/4:c.2397C>T:p.Asn799Asn		rs8103177	0.3001	0.2216	3344,958,950	0.4288,0.2551,0.3253,0.1722,0.2349	0.2557											n/a (AF>5%)	n/a (AF>5%)					IQCN (inh=n/a pLI=0.00)
chr19	18980213	18980213	A	G	hom		QUAL=224;DP=7;AF=1.00;MQM=60	GDF1,CERS1	splice_region&intron	GDF1:ENST00000247005:splice_region&intron:LOW:exon7/7:c.326-14T>C:,CERS1:ENST00000427170:splice_region&intron:LOW:exon7/7:c.*595-14T>C:		rs4808864	1.0000	0.9998	5620,1552,114	1.0000,0.0000,0.0000,0.9994,1.0000	0.9999							602880 [GDF1 (provisional) Congenital heart defects,multiple types,6,613854|Right atrial isomerism (Ivemark),208530];	198776 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					GDF1 (inh=AR+AD pLI=0.54), CERS1 (inh=AR pLI=0.04)
chr19	19105131	19105131	G	A	het	off-target	QUAL=4102;DP=274;AF=0.56;MQM=60	SUGP2	3'UTR,intron	SUGP2:ENST00000600377:3'UTR:MODIFIER:exon10/10:c.*44C>T:,SUGP2:ENST00000601879:3'UTR:MODIFIER:exon10/10:c.*44C>T:,SUGP2:ENST00000337018:intron:MODIFIER:exon10/10:c.3249+44C>T:,SUGP2:ENST00000452918:intron:MODIFIER:exon10/10:c.3249+44C>T:		rs4808896	0.0407	0.0637	326,256,10	0.0307,0.0391,0.0001,0.0821,0.0632	0.0640											n/a (AF>5%)	n/a (AF>5%)					SUGP2 (inh=n/a pLI=1.00)
chr19	19105259	19105259	G	A	het		QUAL=3436;DP=266;AF=0.50;MQM=60	SUGP2	synonymous	SUGP2:ENST00000600377:synonymous:LOW:exon10/10:c.3207C>T:p.Asp1069Asp,SUGP2:ENST00000337018:synonymous:LOW:exon10/11:c.3165C>T:p.Asp1055Asp,SUGP2:ENST00000452918:synonymous:LOW:exon10/11:c.3165C>T:p.Asp1055Asp,SUGP2:ENST00000601879:synonymous:LOW:exon10/10:c.3165C>T:p.Asp1055Asp		rs4808897	0.0407	0.0639	331,258,10	0.0306,0.0393,0.0001,0.0822,0.0634	0.0649										COSM1179782	n/a (AF>5%)	n/a (AF>5%)					SUGP2 (inh=n/a pLI=1.00)
chr19	19136541	19136541	C	T	het		QUAL=1348;DP=137;AF=0.40;MQM=60	SUGP2	missense,intron	SUGP2:ENST00000600377:missense:MODERATE:exon3/10:c.658G>A:p.Gly220Ser,SUGP2:ENST00000337018:missense:MODERATE:exon3/11:c.616G>A:p.Gly206Ser,SUGP2:ENST00000452918:missense:MODERATE:exon3/11:c.616G>A:p.Gly206Ser,SUGP2:ENST00000601879:missense:MODERATE:exon3/10:c.616G>A:p.Gly206Ser,SUGP2:ENST00000456085:intron:MODIFIER:exon2/8:c.198+123G>A:		rs4808907	0.7877	0.7552	34766,18575,2574	0.7018,0.7897,0.8863,0.7462,0.7497	0.7564	-0.0820	T,T,T	T	B,B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					SUGP2 (inh=n/a pLI=1.00)
chr19	19165156	19165156	G	A	het	off-target	QUAL=2043;DP=163;AF=0.48;MQM=60	ARMC6	intron	ARMC6:ENST00000392336:intron:MODIFIER:exon5/7:c.1023+26G>A:,ARMC6:ENST00000392335:intron:MODIFIER:exon5/7:c.948+26G>A:,ARMC6:ENST00000535612:intron:MODIFIER:exon6/8:c.1023+26G>A:,ARMC6:ENST00000269932:intron:MODIFIER:exon5/7:c.948+26G>A:,ARMC6:ENST00000546344:intron:MODIFIER:exon3/6:c.744+26G>A:		rs4808910	0.0699	0.0714	336,240,55	0.1092,0.0422,0.0006,0.0823,0.0663	0.0823											n/a (AF>5%)	n/a (AF>5%)					ARMC6 (inh=n/a pLI=0.00)
chr19	19740729	19740729	C	G	hom	off-target	QUAL=1146;DP=38;AF=1.00;MQM=60	GMIP	3'UTR	GMIP:ENST00000203556:3'UTR:MODIFIER:exon21/21:c.*43G>C:,GMIP:ENST00000445806:3'UTR:MODIFIER:exon20/20:c.*43G>C:,GMIP:ENST00000587238:3'UTR:MODIFIER:exon20/20:c.*43G>C:		rs880090	0.6945	0.7183	19672,11340,1102	0.5806,0.6664,0.7668,0.7227,0.7593	0.7159											n/a (AF>5%)	n/a (AF>5%)					GMIP (inh=n/a pLI=0.00)
chr19	19868879	19868879	A	C	het	off-target	QUAL=975;DP=79;AF=0.49;MQM=60	LINC00663			MSTA-int	rs247782	0.3712	0.0000	0,0,0	0,0,0,0,0	0.4068											n/a (AF>5%)	n/a (AF>5%)					LINC00663 (inh=n/a pLI=n/a)
chr19	20116963	20116963	C	T	hom		QUAL=2895;DP=88;AF=1.00;MQM=60	ZNF682	missense,intron	ZNF682:ENST00000597972:missense:MODERATE:exon3/3:c.1366G>A:p.Val456Ile,ZNF682:ENST00000397162:missense:MODERATE:exon4/4:c.1252G>A:p.Val418Ile,ZNF682:ENST00000397165:missense:MODERATE:exon4/4:c.1348G>A:p.Val450Ile,ZNF682:ENST00000358523:missense:MODERATE:exon6/6:c.1252G>A:p.Val418Ile,ZNF682:ENST00000595736:missense:MODERATE:exon2/2:c.1120G>A:p.Val374Ile,ZNF682:ENST00000596019:intron:MODIFIER:exon3/3:c.227-8891G>A:		rs17679334	0.1947	0.1943	2513,1247,360	0.2711,0.2428,0.0667,0.1880,0.2157	0.2058	2.7200	D,D,D,D	T	B	T,T,T	13.80					n/a (AF>5%)	n/a (AF>5%)					ZNF682 (inh=n/a pLI=0.00)
chr19	20807300	20807300	A	G	het		QUAL=156;DP=18;AF=0.44;MQM=28	ZNF626,CTC-513N18.7	synonymous	ZNF626:ENST00000601440:synonymous:LOW:exon4/4:c.1383T>C:p.Ala461Ala		rs4808252	0.4161	0.0000	0,0,0	0,0,0,0,0	0.0000										COSM1750757	n/a (AF>5%)	n/a (AF>5%)					ZNF626 (inh=n/a pLI=0.00), CTC-513N18.7 (inh=n/a pLI=n/a)
chr19	20975455	20975455	C	G	het		QUAL=508;DP=70;AF=0.37;MQM=60	ZNF66	splice_region&intron	ZNF66:ENST00000344519:splice_region&intron:LOW:exon2/3:c.130+11C>G:,ZNF66:ENST00000360204:splice_region&intron:LOW:exon2/2:c.64+11C>G:,ZNF66:ENST00000594534:splice_region&intron:LOW:exon2/3:c.130+11C>G:,ZNF66:ENST00000425625:splice_region&intron:LOW:exon2/4:c.268+11C>G:		rs62125618	0.1635	0.1397	1306,716,335	0.2641,0.0823,0.1370,0.1452,0.1110	0.1654											n/a (AF>5%)	n/a (AF>5%)					ZNF66 (inh=n/a pLI=0.00)
chr19	23328940	23328940	G	A	het		QUAL=1621;DP=109;AF=0.54;MQM=60	ZNF730	missense	ZNF730:ENST00000597761:missense:MODERATE:exon4/4:c.1094G>A:p.Gly365Glu		rs7247102	0.7238	0.7668	33316,17329,1191	0.5499,0.8981,0.8467,0.7513,0.8140	0.7692	1.9590	T	T			0.05					n/a (AF>5%)	n/a (AF>5%)					ZNF730 (inh=n/a pLI=0.00)
chr19	32873698	32873698	A	G	hom		QUAL=2037;DP=62;AF=1.00;MQM=60	ZNF507	synonymous	ZNF507:ENST00000544431:synonymous:LOW:exon8/8:c.2583A>G:p.Ser861Ser,ZNF507:ENST00000311921:synonymous:LOW:exon6/6:c.2571A>G:p.Ser857Ser,ZNF507:ENST00000355898:synonymous:LOW:exon7/7:c.2571A>G:p.Ser857Ser		rs2270399	0.9117	0.8988	49094,26753,5021	0.9825,0.9365,0.8173,0.8957,0.8779	0.9220											n/a (AF>5%)	n/a (AF>5%)					ZNF507 (inh=n/a pLI=0.95)
chr19	33134425	33134425	G	A	hom	off-target	QUAL=5080;DP=154;AF=1.00;MQM=60	ANKRD27	intron	ANKRD27:ENST00000306065:intron:MODIFIER:exon6/28:c.586-35C>T:,ANKRD27:ENST00000587352:intron:MODIFIER:exon6/11:c.586-35C>T:		rs259229	0.3700	0.5346	18840,13895,230	0.2083,0.4376,0.2664,0.6443,0.4793	0.5376											n/a (AF>5%)	n/a (AF>5%)					ANKRD27 (inh=n/a pLI=0.00)
chr19	35657351	35657351	A	C	hom	off-target	QUAL=3487;DP=108;AF=1.00;MQM=60	FXYD5	splice_region&intron,3'UTR,intron	FXYD5:ENST00000588699:splice_region&intron:LOW:exon8/8:c.*5+20A>C:,FXYD5:ENST00000543307:3'UTR:MODIFIER:exon8/8:c.*25A>C:,FXYD5:ENST00000392219:intron:MODIFIER:exon8/8:c.487+123A>C:,FXYD5:ENST00000541435:intron:MODIFIER:exon8/8:c.487+123A>C:,FXYD5:ENST00000590686:intron:MODIFIER:exon8/8:c.487+123A>C:,FXYD5:ENST00000342879:intron:MODIFIER:exon7/7:c.487+123A>C:,FXYD5:ENST00000423817:intron:MODIFIER:exon8/8:c.487+123A>C:,FXYD5:ENST00000392217:intron:MODIFIER:exon3/3:c.274+123A>C:	MLT1H	rs8106303	0.8770	0.8191	27514,14275,3171	0.9530,0.9049,0.8033,0.7830,0.8791	0.8228											n/a (AF>5%)	n/a (AF>5%)					FXYD5 (inh=n/a pLI=0.78)
chr19	40149297	40149297	T	A	hom		QUAL=7948;DP=241;AF=1.00;MQM=60	LGALS16	missense	LGALS16:ENST00000392051:missense:MODERATE:exon3/4:c.290T>A:p.Leu97His		rs1860134	1.0000	1.0000	39507,22178,3473	1.0000,1.0000,1.0000,1.0000,1.0000	1.0000	-0.7920	T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					LGALS16 (inh=n/a pLI=0.00)
chr19	40197924	40197924	T	C	hom		QUAL=6534;DP=197;AF=1.00;MQM=60	LGALS14	missense	LGALS14:ENST00000360675:missense:MODERATE:exon4/5:c.286T>C:p.Cys96Arg,LGALS14:ENST00000392052:missense:MODERATE:exon3/4:c.199T>C:p.Cys67Arg		rs4830	0.6372	0.6421	26152,15491,3289	0.7942,0.3845,0.3498,0.6811,0.7004	0.6915	0.2320	T,T	T	B,B	T,T	0.02				COSM3756789, COSM148619	n/a (AF>5%)	n/a (AF>5%)					LGALS14 (inh=n/a pLI=0.01)
chr19	40373890	40373890	C	T	het	off-target;gene_blacklist	QUAL=1241;DP=372;AF=0.27;MQM=44	FCGBP	intron	FCGBP:ENST00000221347:intron:MODIFIER:exon26/35:c.12133+55G>A:	(TCCCCA)n	rs543146061	0.1861	0.0000	0,0,0	0,0,0,0,0	0.0868											n/a (AF>5%)	n/a (AF>5%)					FCGBP (inh=n/a pLI=n/a)
chr19	41869468	41869468	G	C	hom	off-target	QUAL=3238;DP=99;AF=1.00;MQM=60	TMEM91,B9D2,CTC-435M10.3	intron	TMEM91:ENST00000604123:intron:MODIFIER:exon1/3:c.142+9248G>C:,B9D2:ENST00000243578:intron:MODIFIER:exon1/3:c.-4-40C>G:,TMEM91:ENST00000539627:intron:MODIFIER:exon1/2:c.-30+12361G>C:	MIRb	rs2241713	0.5417	0.5725	18057,10747,1610	0.5870,0.4719,0.4556,0.5983,0.5424	0.5966							611951 [B9D2 (provisional) Meckel syndrome 10,614175|Joubert syndrome 34,614175];				n/a (AF>5%)	n/a (AF>5%)					TMEM91 (inh=n/a pLI=0.39), B9D2 (inh=AR pLI=0.00), CTC-435M10.3 (inh=n/a pLI=n/a)
chr19	44418077	44418077	C	T	het		QUAL=2099;DP=153;AF=0.51;MQM=60	ZNF45,RP11-15A1.2	missense	ZNF45:ENST00000269973:missense:MODERATE:exon10/10:c.1511G>A:p.Arg504Lys,ZNF45:ENST00000589703:missense:MODERATE:exon4/4:c.1511G>A:p.Arg504Lys		rs407731	0.5252	0.5279	17847,8917,603	0.3421,0.7188,0.8223,0.5164,0.4076	0.5370	0.7940	T,T	T,T	.,B	.,T	11.15					n/a (AF>5%)	n/a (AF>5%)					ZNF45 (inh=n/a pLI=0.00), RP11-15A1.2 (inh=n/a pLI=n/a)
chr19	44471209	44471209	T	A	het		QUAL=1753;DP=129;AF=0.51;MQM=60	ZNF221	missense	ZNF221:ENST00000251269:missense:MODERATE:exon6/6:c.1555T>A:p.Ser519Thr,ZNF221:ENST00000587682:missense:MODERATE:exon5/5:c.1555T>A:p.Ser519Thr,ZNF221:ENST00000592350:missense:MODERATE:exon6/6:c.1555T>A:p.Ser519Thr		rs365745	0.7364	0.8242	41780,24403,1526	0.5392,0.8922,0.8483,0.8549,0.8221	0.8335	-0.3190	T	T	B	T	12.40					n/a (AF>5%)	n/a (AF>5%)					ZNF221 (inh=n/a pLI=0.00)
chr19	48250320	48250320	G	C	hom	off-target	QUAL=2114;DP=66;AF=1.00;MQM=60	GLTSCR2	intron	GLTSCR2:ENST00000246802:intron:MODIFIER:exon2/12:c.289+32G>C:		rs2334293	0.5190	0.6340	25134,15697,451	0.2863,0.5508,0.5289,0.6889,0.7266	0.6380											n/a (AF>5%)	n/a (AF>5%)					NOP53 (inh=n/a pLI=0.18)
chr19	48543862	48543862	G	A	hom		QUAL=3252;DP=101;AF=1.00;MQM=60	CABP5	splice_region&synonymous	CABP5:ENST00000293255:splice_region&synonymous:LOW:exon3/6:c.238C>T:p.Leu80Leu		rs8105198	0.7867	0.8134	40305,22426,2370	0.6782,0.8330,0.8674,0.8191,0.8123	0.8167										COSM4132213	n/a (AF>5%)	n/a (AF>5%)					CABP5 (inh=n/a pLI=0.00)
chr19	49812403	49812403	G	T	het	off-target	QUAL=382;DP=34;AF=0.50;MQM=60	SLC6A16	intron	SLC6A16:ENST00000335875:intron:MODIFIER:exon6/11:c.988-29C>A:,SLC6A16:ENST00000454748:intron:MODIFIER:exon6/10:c.988-29C>A:		rs2278405	0.3051	0.2575	4367,1629,514	0.3201,0.2076,0.3391,0.2214,0.4041	0.2500											n/a (AF>5%)	n/a (AF>5%)					SLC6A16 (inh=n/a pLI=0.00)
chr19	50140092	50140092	G	A	hom		QUAL=6099;DP=185;AF=1.00;MQM=60	RRAS	synonymous	RRAS:ENST00000246792:synonymous:LOW:exon3/6:c.333C>T:p.Asn111Asn		rs1865077	0.7382	0.7034	30402,15322,3111	0.7738,0.8420,0.8169,0.6770,0.6128	0.7243										COSM3757043	n/a (AF>5%)	n/a (AF>5%)					RRAS (inh=n/a pLI=0.64)
chr19	52003331	52003331	G	C	hom		QUAL=8000;DP=246;AF=1.00;MQM=60	SIGLEC12	missense	SIGLEC12:ENST00000291707:missense:MODERATE:exon2/8:c.651C>G:p.His217Gln,SIGLEC12:ENST00000598614:missense:MODERATE:exon1/7:c.297C>G:p.His99Gln		rs6509544	0.8259	0.8399	43470,23947,4647	0.9447,0.9125,0.5020,0.8469,0.8829	0.8497	-0.1220	T	T	B,B	T	0.01				COSM4000847	n/a (AF>5%)	n/a (AF>5%)					SIGLEC12 (inh=n/a pLI=0.00)
chr19	52004903	52004903	G	A	het		QUAL=1425;DP=115;AF=0.48;MQM=60	SIGLEC12	stop_gained	SIGLEC12:ENST00000291707:stop_gained:HIGH:exon1/8:c.85C>T:p.Gln29*		rs16982743	0.1859	0.1797	2232,1228,574	0.3311,0.0965,0.0518,0.1921,0.1571	0.2170	0.8870					24.40				COSM4000848	n/a (AF>5%)	n/a (AF>5%)					SIGLEC12 (inh=n/a pLI=0.00)
chr19	52497250	52497250	G	A	het		QUAL=1550;DP=134;AF=0.45;MQM=60	ZNF615	missense	ZNF615:ENST00000594083:missense:MODERATE:exon6/6:c.1112C>T:p.Thr371Ile,ZNF615:ENST00000602063:missense:MODERATE:exon6/6:c.1079C>T:p.Thr360Ile,ZNF615:ENST00000376716:missense:MODERATE:exon6/6:c.1079C>T:p.Thr360Ile,ZNF615:ENST00000391795:missense:MODERATE:exon4/4:c.1094C>T:p.Thr365Ile,ZNF615:ENST00000598071:missense:MODERATE:exon7/7:c.1112C>T:p.Thr371Ile		rs1978717	0.4760	0.3666	9059,2768,1795	0.5913,0.4115,0.3532,0.2850,0.5425	0.3792	-0.9870	T,T,T,T	T	B,B,B	T,T	0.01				COSM148712, COSM148711	n/a (AF>5%)	n/a (AF>5%)					ZNF615 (inh=n/a pLI=0.00)
chr19	53454789	53454789	A	T	het		QUAL=2010;DP=136;AF=0.56;MQM=60	ZNF816,ZNF321P	missense,3'UTR,intron	ZNF816:ENST00000357666:missense:MODERATE:exon5/5:c.239T>A:p.Ile80Asn,ZNF816:ENST00000444460:missense:MODERATE:exon4/4:c.239T>A:p.Ile80Asn,ZNF816:ENST00000391786:3'UTR:MODIFIER:exon4/4:c.*45T>A:,ZNF321P:ENST00000391777:intron:MODIFIER:exon3/3:c.190+1215T>A:,ZNF816:ENST00000434371:intron:MODIFIER:exon4/4:c.190+1215T>A:		rs12459008	0.4627	0.3862	9365,4346,2403	0.6835,0.2448,0.3420,0.3637,0.4506	0.4316	-1.6950	T,T,T	T	B	T,T,T	0.01				COSM3757158	n/a (AF>5%)	n/a (AF>5%)					ZNF816 (inh=n/a pLI=0.00), ZNF321P (inh=n/a pLI=0.16)
chr19	53518514	53518514	C	T	het		QUAL=438;DP=60;AF=0.37;MQM=51	ERVV-1,ZNF702P	missense	ERVV-1:ENST00000602168:missense:MODERATE:exon1/1:c.1171C>T:p.Leu391Phe	MER50-int	rs11670105	0.0527	0.0996	81,10,1	0.0304,0.0000,0.0000,0.0595,0.1279	0.0671											n/a (AF>5%)	n/a (AF>5%)					ERVV-1 (inh=n/a pLI=n/a), ZNF702P (inh=n/a pLI=n/a)
chr19	53793042	53793042	G	A	hom		QUAL=3655;DP=117;AF=0.97;MQM=60	BIRC8	missense	BIRC8:ENST00000426466:missense:MODERATE:exon1/1:c.586C>T:p.His196Tyr		rs8109165	0.5623	0.5600	19254,10101,2431	0.6859,0.6103,0.5030,0.5501,0.5415	0.5830	-0.4850	D	T	B	T	4.97				COSM4000895	n/a (AF>5%)	n/a (AF>5%)					BIRC8 (inh=n/a pLI=0.00)
chr19	53912242	53912242	G	A	hom		QUAL=8013;DP=244;AF=1.00;MQM=60	ZNF765	synonymous,intron	ZNF765:ENST00000396408:synonymous:LOW:exon4/4:c.1434G>A:p.Thr478Thr,ZNF765:ENST00000594030:intron:MODIFIER:exon3/3:c.142+6798G>A:		rs10426347	0.7712	0.8307	42138,24902,2886	0.7503,0.9002,0.6567,0.8636,0.7768	0.8344											n/a (AF>5%)	n/a (AF>5%)					ZNF765 (inh=n/a pLI=0.00)
chr19	55048270	55048270	C	T	het	gene_blacklist	QUAL=1474;DP=158;AF=0.39;MQM=60	KIR3DX1	synonymous	KIR3DX1:ENST00000335056:synonymous:LOW:exon5/8:c.837C>T:p.Asn279Asn		rs17606836	0.2171	0.2559	4145,2554,95	0.1415,0.1895,0.2136,0.2773,0.3002	0.2553										COSM4000922, COSM4000921	n/a (AF>5%)	n/a (AF>5%)					KIR3DX1 (inh=n/a pLI=n/a)
chr19	55441995	55441995	A	G	het		QUAL=1995;DP=135;AF=0.56;MQM=60	NLRP7	synonymous	NLRP7:ENST00000446217:synonymous:LOW:exon11/13:c.2766T>C:p.Tyr922Tyr,NLRP7:ENST00000340844:synonymous:LOW:exon9/10:c.2682T>C:p.Tyr894Tyr,NLRP7:ENST00000448121:synonymous:LOW:exon9/11:c.2598T>C:p.Tyr866Tyr,NLRP7:ENST00000328092:synonymous:LOW:exon8/10:c.2598T>C:p.Tyr866Tyr,NLRP7:ENST00000590030:synonymous:LOW:exon8/9:c.2682T>C:p.Tyr894Tyr,NLRP7:ENST00000588756:synonymous:LOW:exon11/13:c.2682T>C:p.Tyr894Tyr,NLRP7:ENST00000592784:synonymous:LOW:exon9/11:c.2682T>C:p.Tyr894Tyr		rs269951	0.5905	0.5815	20785,10241,1393	0.5165,0.6511,0.7140,0.5543,0.6291	0.5868							609661 [NLRP7 (confirmed) Hydatidiform mole,recurrent,1,231090];	330158 [benign/likely benign DISEASE=hydatidiform_mole,not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					NLRP7 (inh=AR pLI=0.00)
chr19	55447612	55447612	G	T	het		QUAL=294;DP=30;AF=0.47;MQM=60	NLRP7	splice_region&intron	NLRP7:ENST00000446217:splice_region&intron:LOW:exon8/12:c.2384+17C>A:,NLRP7:ENST00000340844:splice_region&intron:LOW:exon6/9:c.2300+17C>A:,NLRP7:ENST00000448121:splice_region&intron:LOW:exon6/10:c.2216+17C>A:,NLRP7:ENST00000328092:splice_region&intron:LOW:exon5/9:c.2216+17C>A:,NLRP7:ENST00000590030:splice_region&intron:LOW:exon5/8:c.2300+17C>A:,NLRP7:ENST00000588756:splice_region&intron:LOW:exon8/12:c.2300+17C>A:,NLRP7:ENST00000592784:splice_region&intron:LOW:exon6/10:c.2300+17C>A:		rs17699561	0.2029	0.2142	2792,1459,159	0.1734,0.2460,0.1393,0.2129,0.2583	0.2161							609661 [NLRP7 (confirmed) Hydatidiform mole,recurrent,1,231090];				n/a (AF>5%)	n/a (AF>5%)					NLRP7 (inh=AR pLI=0.00)
chr19	55708557	55708557	A	G	hom		QUAL=1659;DP=52;AF=1.00;MQM=60	PTPRH	synonymous	PTPRH:ENST00000376350:synonymous:LOW:exon9/20:c.1918T>C:p.Leu640Leu,PTPRH:ENST00000263434:synonymous:LOW:exon7/18:c.1384T>C:p.Leu462Leu		rs2288521	0.6789	0.6652	27257,14630,3687	0.8398,0.7164,0.4140,0.6634,0.6753	0.6812											n/a (AF>5%)	n/a (AF>5%)					PTPRH (inh=n/a pLI=0.00)
chr19	56421861	56421861	C	T	hom	off-target	QUAL=2566;DP=78;AF=1.00;MQM=60	NLRP13	intron	NLRP13:ENST00000342929:intron:MODIFIER:exon6/10:c.2282+68G>A:,NLRP13:ENST00000588751:intron:MODIFIER:exon6/11:c.2282+68G>A:		rs12982043	0.5533	0.0000	0,0,0	0,0,0,0,0	0.5165										COSN165984	n/a (AF>5%)	n/a (AF>5%)					NLRP13 (inh=n/a pLI=0.00)
chr19	56896574	56896574	A	G	het	off-target	QUAL=406;DP=42;AF=0.43;MQM=60	ZNF582	intron	ZNF582:ENST00000301310:intron:MODIFIER:exon4/4:c.233-21T>C:,ZNF582:ENST00000586929:intron:MODIFIER:exon4/4:c.233-21T>C:		rs2304127	0.1054	0.0860	647,88,13	0.0577,0.1519,0.2980,0.0519,0.0736	0.0835											n/a (AF>5%)	n/a (AF>5%)					ZNF582 (inh=n/a pLI=0.00)
chr19	57335022	57335022	G	A	het		QUAL=2978;DP=224;AF=0.50;MQM=60	ZIM2,PEG3	synonymous	ZIM2:ENST00000221722:synonymous:LOW:exon4/11:c.42C>T:p.Ser14Ser,PEG3:ENST00000326441:synonymous:LOW:exon5/10:c.420C>T:p.Ser140Ser,ZIM2:ENST00000593711:synonymous:LOW:exon4/11:c.42C>T:p.Ser14Ser,ZIM2:ENST00000391708:synonymous:LOW:exon5/12:c.42C>T:p.Ser14Ser,ZIM2:ENST00000601070:synonymous:LOW:exon4/11:c.42C>T:p.Ser14Ser,ZIM2:ENST00000599935:synonymous:LOW:exon5/12:c.42C>T:p.Ser14Ser,PEG3:ENST00000423103:synonymous:LOW:exon4/9:c.420C>T:p.Ser140Ser,PEG3:ENST00000598410:synonymous:LOW:exon4/9:c.42C>T:p.Ser14Ser,PEG3:ENST00000593695:synonymous:LOW:exon4/9:c.42C>T:p.Ser14Ser,ZIM2:ENST00000593931:synonymous:LOW:exon2/3:c.42C>T:p.Ser14Ser		rs1860565	0.2037	0.2740	5096,2566,37	0.0777,0.4503,0.1911,0.2771,0.3190	0.2835										COSM4001002, COSM4001000, COSM4001001	n/a (AF>5%)	n/a (AF>5%)					ZIM2 (inh=n/a pLI=0.73), PEG3 (inh=n/a pLI=0.00)
chr19	57642782	57642782	C	A	het		QUAL=338;DP=28;AF=0.50;MQM=60	USP29	stop_gained	USP29:ENST00000254181:stop_gained:HIGH:exon4/4:c.2739C>A:p.Tyr913*,USP29:ENST00000598197:stop_gained:HIGH:exon1/1:c.2739C>A:p.Tyr913*		rs9973206	0.9521	0.8913	47927,23041,4652	0.9771,0.9367,1.0000,0.8355,0.9790	0.8948	0.2770					35.00					n/a (AF>5%)	n/a (AF>5%)					USP29 (inh=n/a pLI=0.00)
chr19	57949426	57949426	A	G	hom		QUAL=3245;DP=100;AF=1.00;MQM=60	AC004076.9,AC004076.7,ZNF749	intron	ZNF749:ENST00000334181:intron:MODIFIER:exon1/2:c.15+2465A>G:		rs4801481	0.9091	0.0000	55,29,20	0.0000,0.0000,0.0000,0.0000,0.0000	0.9365											n/a (AF>5%)	n/a (AF>5%)					AC004076.9 (inh=n/a pLI=n/a), AC004076.7 (inh=n/a pLI=n/a), ZNF749 (inh=n/a pLI=0.00)
chr19	57985566	57985566	G	C	het		QUAL=2268;DP=165;AF=0.53;MQM=60	ZNF772,AC004076.9	missense,3'UTR,intron	ZNF772:ENST00000343280:missense:MODERATE:exon5/5:c.546C>G:p.Cys182Trp,ZNF772:ENST00000427512:missense:MODERATE:exon2/2:c.210C>G:p.Cys70Trp,ZNF772:ENST00000356584:missense:MODERATE:exon4/4:c.423C>G:p.Cys141Trp,ZNF772:ENST00000425074:3'UTR:MODIFIER:exon3/3:c.*167C>G:,ZNF772:ENST00000600175:intron:MODIFIER:exon2/2:c.72+2436C>G:,ZNF772:ENST00000601768:intron:MODIFIER:exon1/1:c.33+3079C>G:		rs2074060	0.6769	0.6601	26595,13448,2006	0.6211,0.7370,0.7210,0.6351,0.7145	0.6606	-1.7160	T,T,T,T,T	T,T	B,B,B,.	T,T,T,.	3.98				COSM3757333	n/a (AF>5%)	n/a (AF>5%)					ZNF772 (inh=n/a pLI=0.15), AC004076.9 (inh=n/a pLI=n/a)
chr19	58920302	58920302	A	G	het		QUAL=2288;DP=232;AF=0.40;MQM=60	ZNF584	5'UTR_premature_start_codon_gain,5'UTR	ZNF584:ENST00000306910:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-213A>G:,ZNF584:ENST00000593920:5'UTR_premature_start_codon_gain:LOW:exon1/4:c.-283A>G:,ZNF584:ENST00000596281:5'UTR_premature_start_codon_gain:LOW:exon1/2:c.-213A>G:,ZNF584:ENST00000599238:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-283A>G:,ZNF584:ENST00000322834:5'UTR_premature_start_codon_gain:LOW:exon1/5:c.-213A>G:,ZNF584:ENST00000306910:5'UTR:MODIFIER:exon1/4:c.-213A>G:,ZNF584:ENST00000593920:5'UTR:MODIFIER:exon1/4:c.-283A>G:,ZNF584:ENST00000596281:5'UTR:MODIFIER:exon1/2:c.-213A>G:,ZNF584:ENST00000599238:5'UTR:MODIFIER:exon1/5:c.-283A>G:,ZNF584:ENST00000322834:5'UTR:MODIFIER:exon1/5:c.-213A>G:		rs11878198	0.1520	0.0000	0,0,0	0,0,0,0,0	0.1812											n/a (AF>5%)	n/a (AF>5%)					ZNF584 (inh=n/a pLI=0.00)
chr20	168728	168728	T	A	hom		QUAL=8487;DP=261;AF=0.99;MQM=60	DEFB128	missense	DEFB128:ENST00000334391:missense:MODERATE:exon2/2:c.81A>T:p.Lys27Asn		rs4813043	0.6104	0.5851	21129,11711,2997	0.7576,0.5772,0.4805,0.5901,0.5362	0.6189	-0.8290	T	T	B	T	0.01					n/a (AF>5%)	n/a (AF>5%)					DEFB128 (inh=n/a pLI=0.55)
chr20	744450	744450	G	A	hom		QUAL=4222;DP=132;AF=0.99;MQM=60	SLC52A3	synonymous	SLC52A3:ENST00000217254:synonymous:LOW:exon3/5:c.765C>T:p.Leu255Leu,SLC52A3:ENST00000381944:synonymous:LOW:exon3/4:c.765C>T:p.Leu255Leu		rs3746805	0.3087	0.4312	12236,7279,179	0.1723,0.5354,0.1468,0.4683,0.4793	0.4383							613350 [SLC52A3 (provisional) Brown-Vialetto-Van Laere syndrome 1,211530|Fazio-Londe disease,211500];	262238 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					SLC52A3 (inh=AR pLI=0.01)
chr20	1610939	1610939	G	A	het		QUAL=205;DP=20;AF=0.50;MQM=60	SIRPG	synonymous	SIRPG:ENST00000303415:synonymous:LOW:exon5/6:c.1095C>T:p.Ser365Ser,SIRPG:ENST00000381580:synonymous:LOW:exon5/6:c.996C>T:p.Ser332Ser,SIRPG:ENST00000344103:synonymous:LOW:exon3/4:c.444C>T:p.Ser148Ser,SIRPG:ENST00000381583:synonymous:LOW:exon4/5:c.762C>T:p.Ser254Ser,SIRPG:ENST00000216927:synonymous:LOW:exon4/4:c.762C>T:p.Ser254Ser		rs3746722	0.8275	0.7528	11710,4575,1985	0.8912,0.7853,0.8204,0.6743,0.8391	0.7410										COSM443479	n/a (AF>5%)	n/a (AF>5%)					SIRPG (inh=n/a pLI=0.00)
chr20	2618140	2618140	T	C	het		QUAL=813;DP=81;AF=0.41;MQM=60	TMC2	synonymous	TMC2:ENST00000358864:synonymous:LOW:exon19/20:c.2406T>C:p.Ser802Ser		rs6083915	0.7790	0.7765	36804,18927,2557	0.6984,0.8803,0.8625,0.7535,0.8038	0.7811											n/a (AF>5%)	n/a (AF>5%)					TMC2 (inh=n/a pLI=0.00)
chr20	5294496	5294496	C	T	het	off-target	QUAL=478;DP=45;AF=0.53;MQM=60	PROKR2	intron	PROKR2:ENST00000217270:intron:MODIFIER:exon1/1:c.458+62G>A:,PROKR2:ENST00000546004:intron:MODIFIER:exon2/2:c.458+62G>A:		rs8116897	0.5290	0.0000	0,0,0	0,0,0,0,0	0.5112							607123 [PROKR2 (provisional) Hypogonadotropic hypogonadism 3 with or without anosmia,244200];				n/a (AF>5%)	n/a (AF>5%)					PROKR2 (inh=AD pLI=0.00)
chr20	13053018	13053018	T	G	hom		QUAL=2334;DP=71;AF=1.00;MQM=60	SPTLC3	missense	SPTLC3:ENST00000399002:missense:MODERATE:exon3/12:c.418T>G:p.Leu140Val,SPTLC3:ENST00000378194:missense:MODERATE:exon3/10:c.418T>G:p.Leu140Val		rs243887	0.7360	0.7138	31391,17834,4326	0.9392,0.6989,0.5781,0.7303,0.5915	0.7795	-0.8080	T,T,T	T	B	T,T,T	0.01					n/a (AF>5%)	n/a (AF>5%)					SPTLC3 (inh=n/a pLI=0.01)
chr20	13053035	13053035	A	G	hom		QUAL=2446;DP=75;AF=1.00;MQM=60	SPTLC3	synonymous	SPTLC3:ENST00000399002:synonymous:LOW:exon3/12:c.435A>G:p.Ser145Ser,SPTLC3:ENST00000378194:synonymous:LOW:exon3/10:c.435A>G:p.Ser145Ser		rs243888	0.6538	0.6293	24230,13256,2843	0.7617,0.6555,0.5770,0.6288,0.5613	0.6587											n/a (AF>5%)	n/a (AF>5%)					SPTLC3 (inh=n/a pLI=0.01)
chr20	13060331	13060331	G	A	het	off-target	QUAL=2820;DP=209;AF=0.51;MQM=60	SPTLC3	intron	SPTLC3:ENST00000399002:intron:MODIFIER:exon4/11:c.607+5186G>A:,SPTLC3:ENST00000378194:intron:MODIFIER:exon4/9:c.607+5186G>A:		rs8120012	0.2506	0.0000	0,0,0	0,0,0,0,0	0.2714											n/a (AF>5%)	n/a (AF>5%)					SPTLC3 (inh=n/a pLI=0.01)
chr20	18296473	18296473	C	T	het		QUAL=3806;DP=296;AF=0.49;MQM=60	ZNF133	synonymous	ZNF133:ENST00000396026:synonymous:LOW:exon5/5:c.987C>T:p.Tyr329Tyr,ZNF133:ENST00000377671:synonymous:LOW:exon7/7:c.975C>T:p.Tyr325Tyr,ZNF133:ENST00000402618:synonymous:LOW:exon5/5:c.789C>T:p.Tyr263Tyr,ZNF133:ENST00000401790:synonymous:LOW:exon5/5:c.978C>T:p.Tyr326Tyr,ZNF133:ENST00000538547:synonymous:LOW:exon2/2:c.693C>T:p.Tyr231Tyr,ZNF133:ENST00000535822:synonymous:LOW:exon3/3:c.693C>T:p.Tyr231Tyr,ZNF133:ENST00000316358:synonymous:LOW:exon4/4:c.978C>T:p.Tyr326Tyr		rs1050475	0.0701	0.0772	442,265,39	0.0948,0.0372,0.0152,0.0846,0.1035	0.0792										COSM3758462	n/a (AF>5%)	n/a (AF>5%)					ZNF133 (inh=n/a pLI=0.98)
chr20	18462518	18462518	C	G	hom	off-target	QUAL=507;DP=18;AF=1.00;MQM=60	POLR3F	intron	POLR3F:ENST00000377603:intron:MODIFIER:exon8/8:c.873+64C>G:		rs6111983	0.8197	0.0000	0,0,0	0,0,0,0,0	0.8303											n/a (AF>5%)	n/a (AF>5%)					POLR3F (inh=n/a pLI=0.00)
chr20	18794714	18794714	C	T	het		QUAL=1650;DP=112;AF=0.54;MQM=60	SCP2D1,C20orf78	synonymous,intron	SCP2D1:ENST00000377428:synonymous:LOW:exon1/1:c.255C>T:p.Thr85Thr,C20orf78:ENST00000278779:intron:MODIFIER:exon2/2:c.117-3955G>A:		rs1053834	0.2117	0.1788	2349,906,778	0.3859,0.1184,0.0290,0.1629,0.2287	0.2189											n/a (AF>5%)	n/a (AF>5%)					SCP2D1 (inh=n/a pLI=0.03), C20orf78 (inh=n/a pLI=n/a)
chr20	25004071	25004071	G	T	hom	off-target	QUAL=849;DP=27;AF=1.00;MQM=60	ACSS1	intron	ACSS1:ENST00000323482:intron:MODIFIER:exon4/13:c.807+31C>A:,ACSS1:ENST00000537502:intron:MODIFIER:exon2/11:c.558+31C>A:,ACSS1:ENST00000432802:intron:MODIFIER:exon4/11:c.807+31C>A:,ACSS1:ENST00000542618:intron:MODIFIER:exon3/12:c.444+31C>A:		rs4813543	0.9828	0.9689	56790,30605,5129	0.9940,0.9872,1.0000,0.9595,0.9650	0.9731											n/a (AF>5%)	n/a (AF>5%)					ACSS1 (inh=n/a pLI=0.09)
chr20	31673846	31673846	A	G	hom		QUAL=1836;DP=58;AF=1.00;MQM=60	BPIFB4	missense	BPIFB4:ENST00000375483:missense:MODERATE:exon5/16:c.802A>G:p.Ile268Val		rs2070325	0.4655	0.4094	11133,4173,384	0.2683,0.4488,0.7967,0.3536,0.4836	0.4132	3.4180	D	T	B	T	19.11			CM1510105 [CLASS=DP MUT=ALT PHEN="Longevity association with" GENE=BPIFB4]; 	COSM3758518	n/a (AF>5%)	n/a (AF>5%)					BPIFB4 (inh=n/a pLI=0.00)
chr20	31676804	31676804	A	C	hom		QUAL=5127;DP=155;AF=1.00;MQM=60	BPIFB4	missense	BPIFB4:ENST00000375483:missense:MODERATE:exon6/16:c.959A>C:p.Asn320Thr		rs2889732	0.5515	0.4388	12576,4388,1496	0.5323,0.4671,0.7952,0.3619,0.4862	0.4583	3.2610	T	T	P	T	23.50				COSM4001878	n/a (AF>5%)	n/a (AF>5%)					BPIFB4 (inh=n/a pLI=0.00)
chr20	33867697	33867697	A	G	hom	off-target	QUAL=2648;DP=85;AF=1.00;MQM=60	RP4-614O4.11,EIF6	intron	EIF6:ENST00000374436:intron:MODIFIER:exon4/5:c.546+48T>C:,EIF6:ENST00000374443:intron:MODIFIER:exon3/4:c.489+48T>C:,EIF6:ENST00000374450:intron:MODIFIER:exon5/6:c.546+48T>C:		rs619865	0.9738	0.9397	52660,27568,5040	0.9852,0.9761,0.9995,0.9132,0.9520	0.9449											n/a (AF>5%)	n/a (AF>5%)					RP4-614O4.11 (inh=n/a pLI=n/a), EIF6 (inh=n/a pLI=0.74)
chr20	36919758	36919758	A	G	hom		QUAL=1487;DP=46;AF=1.00;MQM=60	BPI,CTD-2308N23.2	synonymous	BPI:ENST00000451435:synonymous:LOW:exon3/3:c.210A>G:p.Thr70Thr		rs10446011	0.1785	0.2989	720,353,5	0.0975,0.2273,0.1017,0.3714,0.2804	0.2869											n/a (AF>5%)	n/a (AF>5%)					BPI (inh=n/a pLI=0.00), CTD-2308N23.2 (inh=n/a pLI=n/a)
chr20	42157237	42157237	C	T	het	off-target	QUAL=1059;DP=97;AF=0.44;MQM=60	L3MBTL1	intron	L3MBTL1:ENST00000418998:intron:MODIFIER:exon7/21:c.797-60C>T:,L3MBTL1:ENST00000427442:intron:MODIFIER:exon7/21:c.797-60C>T:,L3MBTL1:ENST00000444063:intron:MODIFIER:exon4/17:c.593-60C>T:,L3MBTL1:ENST00000373135:intron:MODIFIER:exon4/18:c.593-60C>T:,L3MBTL1:ENST00000373134:intron:MODIFIER:exon4/17:c.593-60C>T:		rs2071972	0.3596	0.0000	0,0,0	0,0,0,0,0	0.3393											n/a (AF>5%)	n/a (AF>5%)					L3MBTL1 (inh=n/a pLI=0.00)
chr20	44506418	44506418	G	A	het		QUAL=2025;DP=139;AF=0.53;MQM=60	ZSWIM3	synonymous	ZSWIM3:ENST00000255152:synonymous:LOW:exon2/2:c.1221G>A:p.Arg407Arg,ZSWIM3:ENST00000454862:synonymous:LOW:exon3/3:c.1203G>A:p.Arg401Arg		rs1045493	0.4770	0.5490	18754,10990,776	0.3809,0.6562,0.4747,0.5723,0.5002	0.5562											n/a (AF>5%)	n/a (AF>5%)					ZSWIM3 (inh=n/a pLI=0.00)
chr20	47886684	47886684	G	A	hom		QUAL=5441;DP=165;AF=1.00;MQM=60	ZNFX1	synonymous	ZNFX1:ENST00000371752:synonymous:LOW:exon3/14:c.1665C>T:p.Tyr555Tyr,ZNFX1:ENST00000371754:synonymous:LOW:exon3/15:c.1665C>T:p.Tyr555Tyr,ZNFX1:ENST00000396105:synonymous:LOW:exon3/14:c.1665C>T:p.Tyr555Tyr		rs57950	0.7794	0.7911	38524,23382,4410	0.9226,0.5854,0.6309,0.8378,0.7281	0.8445											n/a (AF>5%)	n/a (AF>5%)					ZNFX1 (inh=n/a pLI=1.00)
chr20	52611540	52611540	C	A	het		QUAL=1117;DP=157;AF=0.32;MQM=60	BCAS1	splice_region&intron	BCAS1:ENST00000371440:splice_region&intron:LOW:exon6/11:c.927+11G>T:,BCAS1:ENST00000371435:splice_region&intron:LOW:exon6/9:c.927+11G>T:,BCAS1:ENST00000395961:splice_region&intron:LOW:exon6/11:c.927+11G>T:,BCAS1:ENST00000434986:splice_region&intron:LOW:exon2/5:c.66+11G>T:		rs208381	0.3189	0.2002	3327,482,923	0.4224,0.2434,0.4859,0.1194,0.2345	0.2190											n/a (AF>5%)	n/a (AF>5%)					BCAS1 (inh=n/a pLI=0.01)
chr20	53205396	53205396	A	G	hom	off-target	QUAL=1484;DP=49;AF=1.00;MQM=60	DOK5	intron	DOK5:ENST00000262593:intron:MODIFIER:exon4/7:c.409+51A>G:,DOK5:ENST00000395939:intron:MODIFIER:exon4/7:c.85+51A>G:		rs6014067	0.1801	0.1000	1459,248,1170	0.4794,0.0634,0.0008,0.0855,0.0292	0.1801											n/a (AF>5%)	n/a (AF>5%)					DOK5 (inh=n/a pLI=0.81)
chr20	55072472	55072472	A	G	het		QUAL=1003;DP=76;AF=0.53;MQM=60	GCNT7,RTFDC1	5'UTR,intron	GCNT7:ENST00000243913:5'UTR:MODIFIER:exon5/7:c.-174T>C:,RTFDC1:ENST00000357348:intron:MODIFIER:exon6/9:c.567+13227A>G:,RTFDC1:ENST00000023939:intron:MODIFIER:exon5/8:c.477+13227A>G:,RTFDC1:ENST00000395881:intron:MODIFIER:exon5/7:c.477+13227A>G:		rs6024911	0.8401	0.8031	7013,2584,609	0.7650,0.8390,0.9920,0.7684,0.8236	0.8255											n/a (AF>5%)	n/a (AF>5%)					GCNT7 (inh=n/a pLI=n/a), RTF2 (inh=n/a pLI=0.00)
chr20	56793899	56793899	G	A	hom	off-target	QUAL=232;DP=8;AF=1.00;MQM=60	ANKRD60	intron	ANKRD60:ENST00000457363:intron:MODIFIER:exon3/3:c.728-38C>T:		rs596084	0.6771	0.7890	2464,1815,159	0.4733,0.9141,0.6156,0.9055,0.7790	0.8285											n/a (AF>5%)	n/a (AF>5%)					ANKRD60 (inh=n/a pLI=n/a)
chr20	56820880	56820880	C	T	hom	off-target;gene_blacklist	QUAL=4146;DP=126;AF=1.00;MQM=60	PPP4R1L	3'UTR	PPP4R1L:ENST00000334187:3'UTR:MODIFIER:exon10/18:c.*134G>A:,PPP4R1L:ENST00000244070:3'UTR:MODIFIER:exon10/10:c.*134G>A:		rs3746406	0.4227	0.4123	1528,772,35	0.3241,0.4788,0.5268,0.5296,0.2808	0.4874											n/a (AF>5%)	n/a (AF>5%)					PPP4R1L (inh=n/a pLI=n/a)
chr20	56821127	56821127	A	G	hom	gene_blacklist	QUAL=2696;DP=81;AF=1.00;MQM=60	PPP4R1L	missense	PPP4R1L:ENST00000334187:missense:MODERATE:exon10/18:c.1135T>C:p.Cys379Arg,PPP4R1L:ENST00000244070:missense:MODERATE:exon10/10:c.1048T>C:p.Cys350Arg		rs3746405	0.4215	0.3951	1406,669,40	0.3179,0.4718,0.4876,0.5011,0.2790	0.4797	0.0890	T,T	T	B	T,T	1.07				COSM4134695	n/a (AF>5%)	n/a (AF>5%)					PPP4R1L (inh=n/a pLI=n/a)
chr21	15918577	15918577	G	C	het		QUAL=986;DP=80;AF=0.48;MQM=60	SAMSN1	synonymous,intron	SAMSN1:ENST00000400564:synonymous:LOW:exon1/4:c.6C>G:p.Leu2Leu,SAMSN1:ENST00000400566:synonymous:LOW:exon1/8:c.6C>G:p.Leu2Leu,SAMSN1:ENST00000285670:intron:MODIFIER:exon2/8:c.262-25035C>G:		rs7281104	0.3035	0.2586	4265,2053,624	0.3619,0.1358,0.2726,0.2463,0.3387	0.2633										COSM3758805	n/a (AF>5%)	n/a (AF>5%)					SAMSN1 (inh=n/a pLI=0.23)
chr21	19670118	19670118	G	A	hom		QUAL=2483;DP=77;AF=1.00;MQM=60	TMPRSS15	missense	TMPRSS15:ENST00000284885:missense:MODERATE:exon19/25:c.2194C>T:p.Pro732Ser		rs2824721	0.7009	0.7543	34725,20916,2594	0.7084,0.6827,0.6634,0.7914,0.7097	0.7602	1.9140	T	T	B	T	0.12	606635 [TMPRSS15 (confirmed) Enterokinase deficiency,226200];			COSM4001990	n/a (AF>5%)	n/a (AF>5%)					TMPRSS15 (inh=AR pLI=0.00)
chr21	34726127	34726127	T	A	het	off-target	QUAL=570;DP=53;AF=0.47;MQM=60	IFNAR1	intron	IFNAR1:ENST00000270139:intron:MODIFIER:exon10/10:c.1440+38T>A:,IFNAR1:ENST00000416947:intron:MODIFIER:exon10/10:c.1233+38T>A:,IFNAR1:ENST00000442357:intron:MODIFIER:exon10/10:c.1257+926T>A:		rs2856973	0.8712	0.7979	38973,18177,3971	0.8739,0.8952,0.9979,0.7403,0.8518	0.7886											n/a (AF>5%)	n/a (AF>5%)					IFNAR1 (inh=n/a pLI=0.00)
chr21	35276209	35276209	A	G	het	off-target	QUAL=298;DP=20;AF=0.60;MQM=60	AP000304.12,ATP5O	intron	ATP5O:ENST00000290299:intron:MODIFIER:exon6/6:c.528+30T>C:		rs2834293	0.3405	0.3034	5627,2819,854	0.4091,0.2343,0.3430,0.2934,0.3009	0.3204							611428 [DONSON (provisional) Microcephaly-micromelia syndrome,251230|Microcephaly,short stature,and limb abnormalities,617604];				n/a (AF>5%)	n/a (AF>5%)					AP000304.12 (inh=n/a pLI=n/a), ATP5PO (inh=n/a pLI=0.37)
chr21	37729088	37729088	G	C	het	off-target	QUAL=864;DP=81;AF=0.43;MQM=60	MORC3	intron	MORC3:ENST00000400485:intron:MODIFIER:exon10/16:c.1208+66G>C:		rs2835339	0.7073	0.0000	0,0,0	0,0,0,0,0	0.6030											n/a (AF>5%)	n/a (AF>5%)					MORC3 (inh=n/a pLI=1.00)
chr21	41032804	41032804	G	A	hom		QUAL=4250;DP=129;AF=0.99;MQM=60	B3GALT5,AF064860.5	synonymous	B3GALT5:ENST00000343118:synonymous:LOW:exon3/3:c.318G>A:p.Thr106Thr,B3GALT5:ENST00000380620:synonymous:LOW:exon5/5:c.318G>A:p.Thr106Thr,B3GALT5:ENST00000380618:synonymous:LOW:exon3/3:c.318G>A:p.Thr106Thr,B3GALT5:ENST00000398714:synonymous:LOW:exon2/2:c.318G>A:p.Thr106Thr		rs734413	0.6294	0.7511	35079,21452,703	0.3628,0.7684,0.6550,0.8029,0.8019	0.7593										COSM4002025, COSM149225	n/a (AF>5%)	n/a (AF>5%)					B3GALT5 (inh=n/a pLI=0.00), AF064860.5 (inh=n/a pLI=n/a)
chr21	42622657	42622657	G	C	hom	off-target	QUAL=2325;DP=74;AF=1.00;MQM=60	BACE2	intron	BACE2:ENST00000330333:intron:MODIFIER:exon6/8:c.985-22G>C:,BACE2:ENST00000328735:intron:MODIFIER:exon6/7:c.985-22G>C:,BACE2:ENST00000347667:intron:MODIFIER:exon6/7:c.984+4667G>C:		rs960231	0.8069	0.7155	31839,13614,3602	0.8305,0.8589,0.9276,0.6384,0.8008	0.7183											n/a (AF>5%)	n/a (AF>5%)					BACE2 (inh=n/a pLI=0.99)
chr21	43548239	43548239	T	C	hom	gene_blacklist	QUAL=2640;DP=89;AF=1.00;MQM=60	UMODL1	intron	UMODL1:ENST00000408989:intron:MODIFIER:exon19/21:c.4074+298T>C:,UMODL1:ENST00000400427:intron:MODIFIER:exon19/21:c.3858+298T>C:,UMODL1:ENST00000400424:intron:MODIFIER:exon20/22:c.3474+298T>C:,UMODL1:ENST00000408910:intron:MODIFIER:exon20/22:c.3690+298T>C:		rs2839470	0.5122	0.0000	0,0,0	0,0,0,0,0	0.5525											n/a (AF>5%)	n/a (AF>5%)					UMODL1 (inh=n/a pLI=0.00)
chr21	43810084	43810084	C	T	het		QUAL=634;DP=71;AF=0.38;MQM=60	TMPRSS3	missense	TMPRSS3:ENST00000380399:missense:MODERATE:exon3/13:c.409G>A:p.Val137Ile,TMPRSS3:ENST00000398405:missense:MODERATE:exon2/12:c.151G>A:p.Val51Ile,TMPRSS3:ENST00000433957:missense:MODERATE:exon3/13:c.157G>A:p.Val53Ile,TMPRSS3:ENST00000291532:missense:MODERATE:exon3/13:c.157G>A:p.Val53Ile,TMPRSS3:ENST00000398397:missense:MODERATE:exon3/9:c.157G>A:p.Val53Ile		rs928302	0.1030	0.0732	461,123,70	0.1066,0.1047,0.1926,0.0604,0.0277	0.0873	1.1000	T,T,T,T,T	T	B,B,B	D,D,D,D,D	13.72	605511 [TMPRSS3 (confirmed) Deafness,autosomal recessive 8/10,601072];	46105 [benign/likely benign DISEASE=not_specified,nonsyndromic_hearing_loss,_recessive]; 		COSM4002043, COSM4002044, COSM4002045	n/a (AF>5%)	n/a (AF>5%)					TMPRSS3 (inh=AR pLI=0.00)
chr21	44437142	44437142	A	G	het		QUAL=1757;DP=141;AF=0.48;MQM=60	PKNOX1	intron	PKNOX1:ENST00000291547:intron:MODIFIER:exon6/10:c.622+25A>G:,PKNOX1:ENST00000432907:intron:MODIFIER:exon5/9:c.271+25A>G:		rs3737434	0.3910	0.3672	7891,3491,427	0.3138,0.4727,0.5157,0.3360,0.3626	0.3633											n/a (AF>5%)	n/a (AF>5%)					PKNOX1 (inh=n/a pLI=0.98)
chr21	45217753	45217753	C	T	het	off-target	QUAL=450;DP=44;AF=0.43;MQM=60	RRP1	intron	RRP1:ENST00000497547:intron:MODIFIER:exon7/12:c.618-35C>T:		rs2070538	0.3265	0.2364	3843,969,1296	0.5179,0.3483,0.2244,0.1739,0.3021	0.2692										COSN166674	n/a (AF>5%)	n/a (AF>5%)					RRP1 (inh=n/a pLI=0.03)
chr21	47632995	47632995	T	C	het	off-target	QUAL=271;DP=30;AF=0.43;MQM=60	LSS	intron	LSS:ENST00000356396:intron:MODIFIER:exon10/22:c.1110-29A>G:,LSS:ENST00000397728:intron:MODIFIER:exon10/21:c.1110-29A>G:,LSS:ENST00000457828:intron:MODIFIER:exon9/20:c.870-29A>G:,LSS:ENST00000522411:intron:MODIFIER:exon10/21:c.1077-29A>G:		rs2839151	0.1186	0.0820	647,219,389	0.2798,0.0465,0.0001,0.0829,0.0375	0.1248							600909 [LSS (provisional) Cataract 44,616509];				n/a (AF>5%)	n/a (AF>5%)					LSS (inh=AR pLI=0.00)
chr21	48022230	48022230	C	G	hom		QUAL=2461;DP=74;AF=1.00;MQM=60	S100B	synonymous	S100B:ENST00000367071:synonymous:LOW:exon2/4:c.99G>C:p.Leu33Leu,S100B:ENST00000291700:synonymous:LOW:exon2/3:c.99G>C:p.Leu33Leu,S100B:ENST00000397648:synonymous:LOW:exon1/2:c.99G>C:p.Leu33Leu		rs1051169	0.5669	0.6402	25272,14521,875	0.4156,0.7623,0.5460,0.6604,0.6394	0.6527										COSM4135107	n/a (AF>5%)	n/a (AF>5%)					S100B (inh=n/a pLI=0.18)
chr22	19048449	19048449	G	A	het		QUAL=2415;DP=167;AF=0.53;MQM=60	DGCR2	synonymous,intron	DGCR2:ENST00000545799:synonymous:LOW:exon6/11:c.636C>T:p.Thr212Thr,DGCR2:ENST00000263196:intron:MODIFIER:exon5/9:c.625+2266C>T:,DGCR2:ENST00000537045:intron:MODIFIER:exon4/8:c.502+2266C>T:		rs2238740	0.1819	0.2150	1955,987,104	0.1856,0.1575,0.1591,0.2144,0.3219	0.1819											n/a (AF>5%)	n/a (AF>5%)					DGCR2 (inh=AD pLI=0.00)
chr22	19455836	19455836	A	G	het		QUAL=2098;DP=154;AF=0.51;MQM=60	UFD1L	intron	UFD1L:ENST00000263202:intron:MODIFIER:exon4/11:c.292-310T>C:,UFD1L:ENST00000360834:intron:MODIFIER:exon3/10:c.259-310T>C:,UFD1L:ENST00000399523:intron:MODIFIER:exon4/11:c.292-310T>C:		rs756658	0.3109	0.0000	0,0,0	0,0,0,0,0	0.3679											n/a (AF>5%)	n/a (AF>5%)					UFD1 (inh=n/a pLI=1.00)
chr22	22055394	22055394	A	G	het	off-target	QUAL=2411;DP=191;AF=0.48;MQM=60	YPEL1	3'UTR	YPEL1:ENST00000339468:3'UTR:MODIFIER:exon5/5:c.*24T>C:		rs1860	0.6695	0.6400	24999,12658,2268	0.6622,0.6457,0.7410,0.6147,0.6304	0.6519							151410 [BCR (confirmed) Leukemia,chronic myeloid,somatic,608232|Leukemia,acute lymphocytic,somatic,613065];				n/a (AF>5%)	n/a (AF>5%)					YPEL1 (inh=n/a pLI=0.56)
chr22	22673639	22673639	T	C	het	off-target	QUAL=235;DP=77;AF=0.22;MQM=60	BMS1P20	intron	BMS1P20:ENST00000426066:intron:MODIFIER:exon8/9:n.1300+33T>C:		rs737765	0.3592	0.0000	0,0,0	0,0,0,0,0	0.4045							151410 [BCR (confirmed) Leukemia,chronic myeloid,somatic,608232|Leukemia,acute lymphocytic,somatic,613065];				n/a (AF>5%)	n/a (AF>5%)					BMS1P20 (inh=n/a pLI=n/a)
chr22	23503651	23503651	C	T	het	off-target	QUAL=2071;DP=177;AF=0.45;MQM=60	RAB36	intron	RAB36:ENST00000263116:intron:MODIFIER:exon10/10:c.938-36C>T:,RAB36:ENST00000341989:intron:MODIFIER:exon9/9:c.872-36C>T:		rs713682	0.5553	0.5351	14729,7196,1323	0.5488,0.5285,0.6478,0.5093,0.5997	0.5155							151410 [BCR (confirmed) Leukemia,chronic myeloid,somatic,608232|Leukemia,acute lymphocytic,somatic,613065];				n/a (AF>5%)	n/a (AF>5%)					RAB36 (inh=n/a pLI=0.00)
chr22	24936970	24936970	A	G	hom		QUAL=10027;DP=303;AF=1.00;MQM=60	GUCD1	3'UTR	GUCD1:ENST00000407471:3'UTR:MODIFIER:exon6/6:c.*2004T>C:,GUCD1:ENST00000435822:3'UTR:MODIFIER:exon6/6:c.*2004T>C:		rs9704	0.6681	0.0000	0,0,0	0,0,0,0,0	0.7295											n/a (AF>5%)	n/a (AF>5%)					GUCD1 (inh=n/a pLI=0.07)
chr22	25145471	25145471	A	G	hom		QUAL=1743;DP=53;AF=1.00;MQM=60	PIWIL3	missense	PIWIL3:ENST00000332271:missense:MODERATE:exon11/21:c.1234T>C:p.Cys412Arg,PIWIL3:ENST00000527701:missense:MODERATE:exon12/22:c.907T>C:p.Cys303Arg,PIWIL3:ENST00000533313:missense:MODERATE:exon12/22:c.907T>C:p.Cys303Arg		rs1892722	0.6729	0.6206	23485,11597,2260	0.6627,0.7104,0.7426,0.5904,0.6304	0.6225	-0.2160	T,T,T	T	B,B,B	T,T,T	0.01				COSM3759090	n/a (AF>5%)	n/a (AF>5%)					PIWIL3 (inh=n/a pLI=0.00)
chr22	26388337	26388337	C	T	hom		QUAL=4366;DP=135;AF=0.99;MQM=60	MYO18B	synonymous	MYO18B:ENST00000407587:synonymous:LOW:exon40/44:c.6168C>T:p.Tyr2056Tyr,MYO18B:ENST00000536101:synonymous:LOW:exon40/43:c.6165C>T:p.Tyr2055Tyr,MYO18B:ENST00000335473:synonymous:LOW:exon40/44:c.6165C>T:p.Tyr2055Tyr		rs916425	0.1140	0.1358	1287,921,181	0.1968,0.0753,0.0004,0.1667,0.0861	0.1573	-0.8380		T			8.27	607295 [MYO18B (provisional) Klippel-Feil syndrome 4,autosomal recessive,with myopathy and facial dysmorphism,616549];			COSM3759096	n/a (AF>5%)	n/a (AF>5%)					MYO18B (inh=AR pLI=0.00)
chr22	29755888	29755888	T	C	het		QUAL=2694;DP=200;AF=0.51;MQM=60	AP1B1	synonymous	AP1B1:ENST00000357586:synonymous:LOW:exon4/23:c.204A>G:p.Leu68Leu,AP1B1:ENST00000356015:synonymous:LOW:exon4/22:c.204A>G:p.Leu68Leu,AP1B1:ENST00000432560:synonymous:LOW:exon4/21:c.204A>G:p.Leu68Leu,AP1B1:ENST00000405198:synonymous:LOW:exon3/22:c.204A>G:p.Leu68Leu,AP1B1:ENST00000317368:synonymous:LOW:exon4/21:c.204A>G:p.Leu68Leu,AP1B1:ENST00000402502:synonymous:LOW:exon3/20:c.204A>G:p.Leu68Leu,AP1B1:ENST00000415447:synonymous:LOW:exon3/20:c.204A>G:p.Leu68Leu		rs2072051	0.6689	0.5840	21447,10347,3636	0.8369,0.4645,0.7146,0.5535,0.5489	0.6499										COSM3759111, COSM3759112	n/a (AF>5%)	n/a (AF>5%)					AP1B1 (inh=n/a pLI=0.98)
chr22	29904519	29904519	T	C	hom		QUAL=3184;DP=96;AF=1.00;MQM=60	THOC5	splice_region&intron	THOC5:ENST00000397871:splice_region&intron:LOW:exon19/19:c.1989-10A>G:,THOC5:ENST00000490103:splice_region&intron:LOW:exon19/19:c.1989-10A>G:,THOC5:ENST00000397872:splice_region&intron:LOW:exon20/20:c.1989-10A>G:,THOC5:ENST00000397873:splice_region&intron:LOW:exon20/20:c.1989-10A>G:		rs2283859	0.2019	0.2267	3159,2105,131	0.1648,0.1972,0.2080,0.2516,0.2140	0.2275											n/a (AF>5%)	n/a (AF>5%)					THOC5 (inh=n/a pLI=0.00)
chr22	29908154	29908154	G	T	het	off-target	QUAL=984;DP=86;AF=0.45;MQM=60	THOC5	intron	THOC5:ENST00000397871:intron:MODIFIER:exon17/19:c.1682-29C>A:,THOC5:ENST00000490103:intron:MODIFIER:exon17/19:c.1682-29C>A:,THOC5:ENST00000397872:intron:MODIFIER:exon18/20:c.1682-29C>A:,THOC5:ENST00000397873:intron:MODIFIER:exon18/20:c.1682-29C>A:		rs2007668	0.4459	0.4628	12992,7773,582	0.3514,0.3866,0.7568,0.4987,0.2976	0.4671											n/a (AF>5%)	n/a (AF>5%)					THOC5 (inh=n/a pLI=0.00)
chr22	31013419	31013419	C	T	het		QUAL=1004;DP=79;AF=0.51;MQM=60	TCN2	missense	TCN2:ENST00000215838:missense:MODERATE:exon7/9:c.1043C>T:p.Ser348Phe,TCN2:ENST00000405742:missense:MODERATE:exon7/9:c.1031C>T:p.Ser344Phe,TCN2:ENST00000407817:missense:MODERATE:exon7/9:c.962C>T:p.Ser321Phe		rs9621049	0.1086	0.1119	910,466,136	0.1561,0.1450,0.0001,0.1166,0.0805	0.1278	-0.7280	T,T,T	T	B,B,B	T,T,T	1.82	613441 [TCN2 (confirmed) Transcobalamin II deficiency,275350];	341211 [likely benign DISEASE=transcobalamin_ii_deficiency]; 			n/a (AF>5%)	n/a (AF>5%)					TCN2 (inh=AR pLI=0.07)
chr22	32097775	32097775	T	C	het	off-target	QUAL=663;DP=58;AF=0.48;MQM=60	PRR14L	intron	PRR14L:ENST00000327423:intron:MODIFIER:exon6/8:c.6001-27A>G:,PRR14L:ENST00000397493:intron:MODIFIER:exon6/8:c.6001-27A>G:,PRR14L:ENST00000434485:intron:MODIFIER:exon6/7:c.6000+1761A>G:		rs6518754	0.3516	0.4392	12344,8784,327	0.2581,0.2313,0.3450,0.5137,0.4455	0.4318										COSN166738	n/a (AF>5%)	n/a (AF>5%)					PRR14L (inh=n/a pLI=0.98)
chr22	32266546	32266546	A	T	het	off-target	QUAL=1234;DP=103;AF=0.47;MQM=60	DEPDC5	intron	DEPDC5:ENST00000382112:intron:MODIFIER:exon32/41:c.3304-30A>T:,DEPDC5:ENST00000535622:intron:MODIFIER:exon30/39:c.3031-30A>T:,DEPDC5:ENST00000266091:intron:MODIFIER:exon32/41:c.3265-30A>T:,DEPDC5:ENST00000382105:intron:MODIFIER:exon31/39:c.3097-30A>T:,DEPDC5:ENST00000400246:intron:MODIFIER:exon33/41:c.3331-30A>T:,DEPDC5:ENST00000400249:intron:MODIFIER:exon32/41:c.3238-30A>T:,DEPDC5:ENST00000382111:intron:MODIFIER:exon32/40:c.3331-30A>T:,DEPDC5:ENST00000400248:intron:MODIFIER:exon31/40:c.3238-30A>T:,DEPDC5:ENST00000539165:intron:MODIFIER:exon2/11:c.-302-30A>T:		rs5994441	0.3502	0.3050	5250,2310,1222	0.5101,0.3220,0.1872,0.2744,0.3691	0.3469							614191 [DEPDC5 (confirmed) Epilepsy,familial focal,with variable foci 1,604364];				n/a (AF>5%)	n/a (AF>5%)					DEPDC5 (inh=AD pLI=1.00)
chr22	32621619	32621619	C	T	het	off-target	QUAL=1508;DP=143;AF=0.43;MQM=60	RP1-90G24.10,SLC5A4	intron	RP1-90G24.10:ENST00000434942:intron:MODIFIER:exon2/3:n.274+18356C>T:,SLC5A4:ENST00000266086:intron:MODIFIER:exon12/14:c.1449+23G>A:		rs2294208	0.4503	0.4357	12030,6827,2607	0.7193,0.2949,0.1424,0.4574,0.4322	0.5056											n/a (AF>5%)	n/a (AF>5%)					SLC5A4-AS1 (inh=n/a pLI=n/a), SLC5A4 (inh=n/a pLI=0.00)
chr22	32795641	32795641	C	T	het		QUAL=854;DP=66;AF=0.50;MQM=60	RTCB	synonymous,intron	RTCB:ENST00000216038:synonymous:LOW:exon6/12:c.603G>A:p.Gln201Gln,RTCB:ENST00000451746:intron:MODIFIER:exon5/7:c.477+2113G>A:		rs5749426	0.4457	0.3881	9748,4204,1955	0.6169,0.3569,0.5366,0.3516,0.3344	0.4427											n/a (AF>5%)	n/a (AF>5%)					RTCB (inh=n/a pLI=0.15)
chr22	35679951	35679951	T	C	het		QUAL=1230;DP=93;AF=0.52;MQM=60	HMGXB4	splice_region&intron	HMGXB4:ENST00000216106:splice_region&intron:LOW:exon5/10:c.1216-4T>C:,HMGXB4:ENST00000444518:splice_region&intron:LOW:exon6/11:c.889-4T>C:		rs2272789	0.5539	0.6336	24960,16033,617	0.3416,0.5948,0.6189,0.6933,0.6064	0.6367											n/a (AF>5%)	n/a (AF>5%)					HMGXB4 (inh=n/a pLI=0.14)
chr22	37578807	37578807	G	A	het		QUAL=635;DP=104;AF=0.30;MQM=60	C1QTNF6,RP1-151B14.6	synonymous,intron	C1QTNF6:ENST00000255836:synonymous:LOW:exon1/2:c.39C>T:p.Ser13Ser,C1QTNF6:ENST00000337843:intron:MODIFIER:exon2/2:c.290-32C>T:,C1QTNF6:ENST00000397110:intron:MODIFIER:exon2/3:c.290-32C>T:		rs229520	0.3411	0.3612	1525,543,333	0.5567,0.3073,0.5588,0.3359,0.2990	0.2826										COSM4156226	n/a (AF>5%)	n/a (AF>5%)					C1QTNF6 (inh=n/a pLI=0.02), RP1-151B14.6 (inh=n/a pLI=n/a)
chr22	37770357	37770357	A	G	hom		QUAL=9213;DP=281;AF=1.00;MQM=60	ELFN2,RP1-63G5.5	synonymous	ELFN2:ENST00000402918:synonymous:LOW:exon3/3:c.1218T>C:p.Phe406Phe		rs7292751	0.4461	0.4221	11807,4857,2024	0.6217,0.7115,0.3490,0.3822,0.3014	0.4528										COSM3759171	n/a (AF>5%)	n/a (AF>5%)					ELFN2 (inh=n/a pLI=0.81), RP1-63G5.5 (inh=n/a pLI=n/a)
chr22	38564041	38564041	C	G	het	off-target	QUAL=2390;DP=183;AF=0.49;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron:MODIFIER:exon2/16:c.209+1184G>C:,PLA2G6:ENST00000335539:intron:MODIFIER:exon2/15:c.209+1184G>C:,PLA2G6:ENST00000402064:intron:MODIFIER:exon2/15:c.209+1184G>C:,PLA2G6:ENST00000436218:intron:MODIFIER:exon2/3:c.209+1184G>C:,PLA2G6:ENST00000447598:intron:MODIFIER:exon2/3:c.209+1184G>C:,PLA2G6:ENST00000435484:intron:MODIFIER:exon2/3:c.209+1184G>C:,PLA2G6:ENST00000417303:intron:MODIFIER:exon2/3:c.209+1184G>C:	L2b	rs9622746	0.2951	0.0000	0,0,0	0,0,0,0,0	0.2985							603604 [PLA2G6 (confirmed) Infantile neuroaxonal dystrophy 1,256600|Neurodegeneration with brain iron accumulation 2B,610217|Parkinson disease 14,autosomal recessive,612953];				n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR pLI=0.00)
chr22	40043812	40043812	A	G	het		QUAL=1551;DP=95;AF=0.59;MQM=60	CACNA1I	splice_region&intron,intron	CACNA1I:ENST00000336649:splice_region&intron:LOW:exon10/39:c.1463-15A>G:,CACNA1I:ENST00000401624:splice_region&intron:LOW:exon8/35:c.1463-15A>G:,CACNA1I:ENST00000402142:splice_region&intron:LOW:exon8/36:c.1463-15A>G:,CACNA1I:ENST00000407673:intron:MODIFIER:exon8/34:c.1462+926A>G:,CACNA1I:ENST00000400164:intron:MODIFIER:exon10/38:c.1462+926A>G:,CACNA1I:ENST00000404898:intron:MODIFIER:exon8/35:c.1462+926A>G:	MIRc	rs5757759	0.5783	0.4681	14277,5269,1268	0.5084,0.5554,0.8853,0.3974,0.4542	0.4749											n/a (AF>5%)	n/a (AF>5%)					CACNA1I (inh=n/a pLI=1.00)
chr22	42793873	42793873	A	G	het		QUAL=601;DP=46;AF=0.52;MQM=60	NFAM1	synonymous	NFAM1:ENST00000329021:synonymous:LOW:exon4/6:c.654T>C:p.Ser218Ser		rs5996153	0.1288	0.1524	1673,876,233	0.2102,0.2356,0.0008,0.1592,0.0911	0.1693										COSM4156353	n/a (AF>5%)	n/a (AF>5%)					NFAM1 (inh=n/a pLI=0.02)
chr22	43455592	43455592	G	A	het	off-target	QUAL=345;DP=36;AF=0.42;MQM=60	TTLL1	intron	TTLL1:ENST00000266254:intron:MODIFIER:exon7/10:c.748-59C>T:,TTLL1:ENST00000331018:intron:MODIFIER:exon7/9:c.748-59C>T:		rs17415203	0.0585	0.0000	0,0,0	0,0,0,0,0	0.0880											n/a (AF>5%)	n/a (AF>5%)					TTLL1 (inh=n/a pLI=0.02)
chr22	43529314	43529314	G	C	het		QUAL=1444;DP=141;AF=0.41;MQM=60	MCAT	missense,3'UTR	MCAT:ENST00000290429:missense:MODERATE:exon4/4:c.908C>G:p.Ala303Gly,MCAT:ENST00000327555:3'UTR:MODIFIER:exon3/3:c.*147C>G:		rs13815	0.4896	0.6045	23203,15323,412	0.2737,0.5617,0.5944,0.6766,0.5168	0.6074	2.9870	T	T	B	T	8.02				COSM3759241	n/a (AF>5%)	n/a (AF>5%)					MCAT (inh=n/a pLI=0.00)
chr22	46657261	46657261	A	G	het		QUAL=901;DP=85;AF=0.42;MQM=60	PKDREJ	synonymous	PKDREJ:ENST00000253255:synonymous:LOW:exon1/1:c.1959T>C:p.Asp653Asp		rs6007747	0.2454	0.1597	2788,697,1888	0.6076,0.0818,0.0013,0.1464,0.0888	0.2657											n/a (AF>5%)	n/a (AF>5%)					PKDREJ (inh=n/a pLI=0.00)
chr22	50278438	50278438	A	G	het		QUAL=1840;DP=134;AF=0.52;MQM=60	ZBED4	synonymous	ZBED4:ENST00000216268:synonymous:LOW:exon2/2:c.1128A>G:p.Pro376Pro		rs910798	0.9343	0.9092	49843,26559,4975	0.9808,0.9458,0.9668,0.8956,0.8694	0.9175										COSM4156405	n/a (AF>5%)	n/a (AF>5%)					ZBED4 (inh=n/a pLI=0.98)
chr22	50964153	50964153	T	C	hom	off-target	QUAL=2311;DP=73;AF=1.00;MQM=60	SCO2	intron	SCO2:ENST00000535425:intron:MODIFIER:exon1/1:c.-14+277A>G:,SCO2:ENST00000543927:intron:MODIFIER:exon1/1:c.-14+522A>G:		rs131805	0.8840	0.8394	26668,12944,1886	0.8968,0.8952,0.9554,0.7915,0.8889	0.8370							604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908];				n/a (AF>5%)	n/a (AF>5%)					SCO2 (inh=AR+AD pLI=0.00)
chr22	50964862	50964862	G	A	het		QUAL=301;DP=20;AF=0.60;MQM=60	TYMP,SCO2	synonymous,5'UTR	TYMP:ENST00000395681:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000395680:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000252029:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,TYMP:ENST00000395678:synonymous:LOW:exon8/10:c.972C>T:p.Ala324Ala,SCO2:ENST00000543927:5'UTR:MODIFIER:exon1/2:c.-201C>T:		rs131804	0.5329	0.6721	3624,1538,63	0.4903,0.7336,0.7800,0.6702,0.6641	0.6106							604272 [SCO2 (confirmed) Cardioencephalomyopathy,fatal infantile,due to cytochrome c oxidase deficiency 1,604377|Myopia 6,608908]:131222 [TYMP (confirmed) Mitochondrial DNA depletion syndrome 1 (MNGIE type),603041];	130694 [benign/likely benign DISEASE=cytochrome-c_oxidase_deficiency,mitochondrial_dna_depletion_syndrome_1_(mngie_type),not_specified,fatal_infantile_cardioencephalomyopathy]; 			n/a (AF>5%)	n/a (AF>5%)					TYMP (inh=AR pLI=0.00), SCO2 (inh=AR+AD pLI=0.00)
chrX	3238167	3238167	T	G	het		QUAL=527;DP=52;AF=0.44;MQM=60	MXRA5	synonymous	MXRA5:ENST00000217939:synonymous:LOW:exon5/7:c.5559A>C:p.Pro1853Pro		rs1635245	0.4707	0.5269	7517,4697,611	0.4242,0.5233,0.3903,0.5697,0.5006	0.5283										COSM3759482, COSM150754	n/a (AF>5%)	n/a (AF>5%)					MXRA5 (inh=n/a pLI=0.18)
chrX	9935844	9935844	C	T	het		QUAL=2182;DP=178;AF=0.47;MQM=60	AC002365.1				rs5934731	0.5166	0.5544	638,272,71	0.5800,0.0000,0.0000,0.4956,0.5932	0.5008										COSM4157056	n/a (AF>5%)	n/a (AF>5%)					AC002365.1 (inh=n/a pLI=n/a)
chrX	12837558	12837558	C	T	hom	off-target	QUAL=6135;DP=185;AF=0.99;MQM=60	PRPS2	intron	PRPS2:ENST00000398491:intron:MODIFIER:exon4/6:c.540-68C>T:,PRPS2:ENST00000380668:intron:MODIFIER:exon4/6:c.531-68C>T:		rs5935399	0.8305	0.0000	0,0,0	0,0,0,0,0	0.8028											n/a (AF>5%)	n/a (AF>5%)					PRPS2 (inh=n/a pLI=0.90)
chrX	13056654	13056654	T	C	het	off-target	QUAL=486;DP=37;AF=0.54;MQM=60	FAM9C	intron	FAM9C:ENST00000333995:intron:MODIFIER:exon6/6:c.439-32A>G:,FAM9C:ENST00000542843:intron:MODIFIER:exon5/5:c.*2375-32A>G:,FAM9C:ENST00000380625:intron:MODIFIER:exon6/7:c.439-32A>G:		rs4830483	0.4980	0.5637	8092,3564,180	0.2393,0.8251,0.6547,0.5306,0.6724	0.5581											n/a (AF>5%)	n/a (AF>5%)					FAM9C (inh=n/a pLI=0.00)
chrX	13337059	13337059	C	T	het		QUAL=2793;DP=261;AF=0.42;MQM=60	ATXN3L,GS1-600G8.3	missense	ATXN3L:ENST00000380622:missense:MODERATE:exon1/1:c.995G>A:p.Gly332Asp		rs4830842	0.6535	0.4870	8023,1584,1822	0.7723,0.7931,0.8282,0.3317,0.5407	0.4937	-0.0550	T	T	B	T	0.01				COSM3759363	n/a (AF>5%)	n/a (AF>5%)					ATXN3L (inh=n/a pLI=0.00), GS1-600G8.3 (inh=n/a pLI=n/a)
chrX	13681638	13681638	C	T	het		QUAL=636;DP=88;AF=0.34;MQM=60	TCEANC	synonymous	TCEANC:ENST00000314720:synonymous:LOW:exon4/4:c.1101C>T:p.Asn367Asn,TCEANC:ENST00000545566:synonymous:LOW:exon5/5:c.1011C>T:p.Asn337Asn,TCEANC:ENST00000544987:synonymous:LOW:exon3/3:c.1011C>T:p.Asn337Asn,TCEANC:ENST00000380600:synonymous:LOW:exon2/2:c.1011C>T:p.Asn337Asn		rs5935649	0.5563	0.5886	2867,1617,218	0.4382,0.5867,0.6574,0.5703,0.7554	0.5442										COSM3759375, COSM3759376, COSM3759377	n/a (AF>5%)	n/a (AF>5%)					TCEANC (inh=n/a pLI=0.35)
chrX	15353689	15353689	T	C	het	off-target	QUAL=223;DP=30;AF=0.37;MQM=60	PIGA,FIGF	intergenic_region	FIGF:ENSG00000165195-ENSG00000165197:intergenic_region:MODIFIER::n.15353689T>C:		rs4830938	0.8657	0.0000	0,0,0	0,0,0,0,0	0.7603							311770 [PIGA (provisional) Paroxysmal nocturnal hemoglobinuria,somatic,300818|Multiple congenital anomalies-hypotonia-seizures syndrome 2,300868];				n/a (AF>5%)	n/a (AF>5%)					PIGA (inh=XLR pLI=0.90), VEGFD (inh=n/a pLI=0.04)
chrX	16762002	16762002	A	G	hom	off-target	QUAL=1737;DP=57;AF=1.00;MQM=60	SYAP1	intron	SYAP1:ENST00000380155:intron:MODIFIER:exon5/8:c.575+39A>G:		rs4830562	0.8673	0.8406	19252,10041,2584	0.8817,0.8338,0.9417,0.8317,0.8322	0.8396											n/a (AF>5%)	n/a (AF>5%)					SYAP1 (inh=n/a pLI=0.79)
chrX	17167204	17167204	C	T	het	off-target	QUAL=433;DP=30;AF=0.60;MQM=60	REPS2	3'UTR	REPS2:ENST00000357277:3'UTR:MODIFIER:exon18/18:c.*1600C>T:,REPS2:ENST00000303843:3'UTR:MODIFIER:exon18/18:c.*1600C>T:		rs12557633	0.1046	0.0000	0,0,0	0,0,0,0,0	0.0816											n/a (AF>5%)	n/a (AF>5%)					REPS2 (inh=n/a pLI=0.94)
chrX	21516016	21516016	T	C	het	off-target	QUAL=225;DP=20;AF=0.50;MQM=60	CNKSR2	intron	CNKSR2:ENST00000379510:intron:MODIFIER:exon7/21:c.741+52T>C:,CNKSR2:ENST00000543067:intron:MODIFIER:exon7/19:c.741+52T>C:,CNKSR2:ENST00000425654:intron:MODIFIER:exon7/20:c.741+52T>C:,CNKSR2:ENST00000279451:intron:MODIFIER:exon7/20:c.741+52T>C:		rs12387312	0.1139	0.1069	362,176,6	0.0547,0.0482,0.2576,0.1223,0.0398	0.1045							300724 [CNKSR2 (provisional) Mental retardation,X-linked,syndromic,Houge type,301008];				n/a (AF>5%)	n/a (AF>5%)					CNKSR2 (inh=XLR+XLD pLI=1.00)
chrX	23723261	23723261	T	C	het	off-target	QUAL=1048;DP=81;AF=0.53;MQM=60	ACOT9	intron	ACOT9:ENST00000379303:intron:MODIFIER:exon13/15:c.1020-64A>G:,ACOT9:ENST00000336430:intron:MODIFIER:exon12/14:c.993-64A>G:,ACOT9:ENST00000379295:intron:MODIFIER:exon14/16:c.813-64A>G:		rs2270142	0.5224	0.0000	0,0,0	0,0,0,0,0	0.5729											n/a (AF>5%)	n/a (AF>5%)					ACOT9 (inh=n/a pLI=0.00)
chrX	48054740	48054740	C	G	hom		QUAL=7456;DP=232;AF=0.99;MQM=60	SSX5	missense	SSX5:ENST00000311798:missense:MODERATE:exon2/9:c.55G>C:p.Glu19Gln,SSX5:ENST00000376923:missense:MODERATE:exon1/7:c.55G>C:p.Glu19Gln,SSX5:ENST00000347757:missense:MODERATE:exon2/8:c.55G>C:p.Glu19Gln		rs4824675	0.8596	0.9525	24395,14588,1399	0.6493,0.9532,0.9240,0.9983,0.9863	0.9589	-0.1980	D,D,D	T	P,P	T,T,T	20.60					n/a (AF>5%)	n/a (AF>5%)					SSX5 (inh=n/a pLI=0.00)
chrX	48208935	48208935	T	A	hom	off-target	QUAL=990;DP=30;AF=1.00;MQM=60	SSX3	intron	SSX3:ENST00000298396:intron:MODIFIER:exon6/7:c.466+487A>T:,SSX3:ENST00000376895:intron:MODIFIER:exon2/3:c.202+487A>T:,SSX3:ENST00000376893:intron:MODIFIER:exon7/7:c.*1+40A>T:	Tigger1	rs11798425	0.3245	0.4774	5860,4407,103	0.1799,0.3665,0.3874,0.5815,0.3718	0.4621											n/a (AF>5%)	n/a (AF>5%)					SSX3 (inh=n/a pLI=0.13)
chrX	55757744	55757744	T	G	hom	off-target	QUAL=386;DP=13;AF=1.00;MQM=60	RRAGB	intron	RRAGB:ENST00000262850:intron:MODIFIER:exon5/10:c.378-53T>G:,RRAGB:ENST00000374941:intron:MODIFIER:exon4/9:c.294-53T>G:		rs5960480	0.8368	0.0000	0,0,0	0,0,0,0,0	0.8642											n/a (AF>5%)	n/a (AF>5%)					RRAGB (inh=n/a pLI=0.85)
chrX	69250308	69250308	C	T	hom		QUAL=4694;DP=141;AF=1.00;MQM=60	EDA	splice_region&intron	EDA:ENST00000374552:splice_region&intron:LOW:exon5/7:c.742-11C>T:,EDA:ENST00000374553:splice_region&intron:LOW:exon5/7:c.742-11C>T:,EDA:ENST00000524573:splice_region&intron:LOW:exon5/7:c.742-11C>T:		rs2296765	0.2217	0.3442	2434,1847,106	0.2133,0.2717,0.1082,0.4178,0.2849	0.3036							300451 [EDA (confirmed) Ectodermal dysplasia 1,hypohidrotic,X-linked,305100|Tooth agenesis,selective,X-linked 1,313500];	44207 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					EDA (inh=XLR+XLD pLI=0.90)
chrX	69749852	69749852	A	G	hom		QUAL=5463;DP=163;AF=1.00;MQM=60	TEX11	splice_region&intron	TEX11:ENST00000344304:splice_region&intron:LOW:exon27/28:c.2566-3T>C:,TEX11:ENST00000374333:splice_region&intron:LOW:exon28/29:c.2521-3T>C:,TEX11:ENST00000374320:splice_region&intron:LOW:exon17/18:c.1591-3T>C:,TEX11:ENST00000395889:splice_region&intron:LOW:exon29/30:c.2566-3T>C:		rs1536250	0.8996	0.9334	23396,13138,2253	0.8270,0.9758,0.8770,0.9491,0.9546	0.9368							300311 [TEX11 (provisional) Spermatogenic failure,X-linked,2,309120];				n/a (AF>5%)	n/a (AF>5%)					TEX11 (inh=XLR pLI=1.00)
chrX	100742551	100742551	G	A	hom	off-target	QUAL=2588;DP=80;AF=1.00;MQM=60	ARMCX4				rs2361298	0.4411	0.0000	0,0,0	0,0,0,0,0	0.5437											n/a (AF>5%)	n/a (AF>5%)					ARMCX4 (inh=n/a pLI=n/a)
chrX	101437635	101437635	A	G	hom		QUAL=8141;DP=244;AF=1.00;MQM=58	TCP11X3P	splice_region&non_coding_transcript_exon	TCP11X3P:ENST00000508552:splice_region&non_coding_transcript_exon:LOW:exon2/3:n.252A>G:		rs5945049	0.1383	0.0000	0,0,0	0,0,0,0,0	0.2735											n/a (AF>5%)	n/a (AF>5%)					TCP11X3P (inh=n/a pLI=n/a)
chrX	107437848	107437848	G	C	het		QUAL=1615;DP=141;AF=0.46;MQM=60	COL4A6	missense,intron	COL4A6:ENST00000394872:missense:MODERATE:exon16/45:c.921C>G:p.Phe307Leu,COL4A6:ENST00000372216:intron:MODIFIER:exon15/44:c.952-31C>G:,COL4A6:ENST00000334504:intron:MODIFIER:exon15/44:c.949-31C>G:,COL4A6:ENST00000538570:intron:MODIFIER:exon15/42:c.949-31C>G:,COL4A6:ENST00000545689:intron:MODIFIER:exon15/43:c.949-31C>G:		rs1266719	0.4498	0.6335	11504,8881,489	0.3857,0.3030,0.2751,0.7788,0.5863	0.6506	-0.6700	T	T		D	3.23	303631 [COL4A6 (confirmed) Deafness,X-linked 6,300914];				n/a (AF>5%)	n/a (AF>5%)					COL4A6 (inh=XLR pLI=0.99)
chrX	107448639	107448639	G	T	het	off-target	QUAL=1885;DP=124;AF=0.56;MQM=60	COL4A6	intron	COL4A6:ENST00000372216:intron:MODIFIER:exon11/44:c.690+30C>A:,COL4A6:ENST00000334504:intron:MODIFIER:exon11/44:c.687+30C>A:,COL4A6:ENST00000394872:intron:MODIFIER:exon11/44:c.626-853C>A:,COL4A6:ENST00000538570:intron:MODIFIER:exon11/42:c.687+30C>A:,COL4A6:ENST00000545689:intron:MODIFIER:exon11/43:c.687+30C>A:		rs1266730	0.5812	0.6893	13334,9289,1473	0.6690,0.3604,0.3890,0.7941,0.6286	0.7479							303631 [COL4A6 (confirmed) Deafness,X-linked 6,300914];			COSN168790	n/a (AF>5%)	n/a (AF>5%)					COL4A6 (inh=XLR pLI=0.99)
chrX	122336448	122336448	T	C	het	off-target	QUAL=169;DP=19;AF=0.53;MQM=60	GRIA3	intron	GRIA3:ENST00000264357:intron:MODIFIER:exon2/15:c.268+16606T>C:,GRIA3:ENST00000371266:intron:MODIFIER:exon3/4:c.269-40T>C:,GRIA3:ENST00000371264:intron:MODIFIER:exon2/3:c.269-40T>C:,GRIA3:ENST00000542149:intron:MODIFIER:exon2/16:c.268+16606T>C:,GRIA3:ENST00000371251:intron:MODIFIER:exon2/14:c.268+16606T>C:,GRIA3:ENST00000371256:intron:MODIFIER:exon2/15:c.268+16606T>C:,GRIA3:ENST00000541091:intron:MODIFIER:exon2/10:c.220+16606T>C:		rs2285127	0.4193	0.3873	434,182,54	0.4139,0.4350,0.4582,0.3774,0.4176	0.4053							305915 [GRIA3 (confirmed) Mental retardation,X-linked 94,300699];				n/a (AF>5%)	n/a (AF>5%)					GRIA3 (inh=XLR pLI=1.00)
chrX	129147079	129147079	T	C	hom		QUAL=4940;DP=152;AF=1.00;MQM=60	BCORL1	missense	BCORL1:ENST00000303743:missense:MODERATE:exon4/14:c.331T>C:p.Phe111Leu,BCORL1:ENST00000218147:missense:MODERATE:exon4/13:c.331T>C:p.Phe111Leu,BCORL1:ENST00000359304:missense:MODERATE:exon4/12:c.331T>C:p.Phe111Leu,BCORL1:ENST00000540052:missense:MODERATE:exon3/12:c.331T>C:p.Phe111Leu		rs4830173	1.0000	1.0000	26847,14463,3278	1.0000,1.0000,0.9999,1.0000,1.0000	1.0000	0.6570	T,.,T,T	T	B,B	T,T,T,T	5.67					n/a (AF>5%)	n/a (AF>5%)					BCORL1 (inh=n/a pLI=0.95)
chrX	130410965	130410965	A	G	het		QUAL=2105;DP=140;AF=0.56;MQM=60	IGSF1	synonymous	IGSF1:ENST00000370903:synonymous:LOW:exon14/20:c.2571T>C:p.Tyr857Tyr,IGSF1:ENST00000370910:synonymous:LOW:exon13/19:c.2529T>C:p.Tyr843Tyr,IGSF1:ENST00000361420:synonymous:LOW:exon14/20:c.2556T>C:p.Tyr852Tyr,IGSF1:ENST00000370904:synonymous:LOW:exon20/26:c.2529T>C:p.Tyr843Tyr		rs4830219	0.2437	0.2999	2949,1828,622	0.4316,0.2839,0.0015,0.3482,0.1447	0.3490							300137 [IGSF1 (provisional) Hypothyroidism,central,and testicular enlargement,300888];	257591 [benign DISEASE=not_specified]; 		COSM1465651	n/a (AF>5%)	n/a (AF>5%)					IGSF1 (inh=XLR pLI=0.99)
chrX	130420415	130420415	T	C	hom		QUAL=6766;DP=204;AF=1.00;MQM=60	IGSF1	synonymous,intron	IGSF1:ENST00000370903:synonymous:LOW:exon3/20:c.93A>G:p.Ser31Ser,IGSF1:ENST00000361420:synonymous:LOW:exon3/20:c.93A>G:p.Ser31Ser,IGSF1:ENST00000370900:synonymous:LOW:exon3/5:c.93A>G:p.Ser31Ser,IGSF1:ENST00000370901:synonymous:LOW:exon3/5:c.93A>G:p.Ser31Ser,IGSF1:ENST00000370910:intron:MODIFIER:exon2/18:c.70+164A>G:,IGSF1:ENST00000370904:intron:MODIFIER:exon9/25:c.70+164A>G:		rs4495600	0.9735	0.9921	26555,14627,2823	0.9214,0.9981,1.0000,0.9999,0.9998	0.9940							300137 [IGSF1 (provisional) Hypothyroidism,central,and testicular enlargement,300888];			COSM4156586, COSM4156585	n/a (AF>5%)	n/a (AF>5%)					IGSF1 (inh=XLR pLI=0.99)
chrX	131518737	131518737	C	T	het		QUAL=490;DP=56;AF=0.39;MQM=60	MBNL3,RAP2C-AS1	splice_region&intron,intron	MBNL3:ENST00000370853:splice_region&intron:LOW:exon5/7:c.923-11G>A:,MBNL3:ENST00000394311:splice_region&intron:LOW:exon5/7:c.635-11G>A:,MBNL3:ENST00000370849:splice_region&intron:LOW:exon5/7:c.773-11G>A:,MBNL3:ENST00000370839:splice_region&intron:LOW:exon5/8:c.818-11G>A:,MBNL3:ENST00000370844:splice_region&intron:LOW:exon6/8:c.635-11G>A:,RAP2C-AS1:ENST00000441399:intron:MODIFIER:exon2/2:n.424-45104C>T:,RAP2C-AS1:ENST00000421483:intron:MODIFIER:exon2/2:n.156-45104C>T:,MBNL3:ENST00000538204:intron:MODIFIER:exon5/6:c.772+1952G>A:,MBNL3:ENST00000370857:intron:MODIFIER:exon5/6:c.922+1952G>A:		rs3736748	0.3544	0.3357	3153,1113,1713	0.7705,0.1859,0.0951,0.3355,0.2002	0.4108											n/a (AF>5%)	n/a (AF>5%)					MBNL3 (inh=n/a pLI=0.79), RAP2C-AS1 (inh=n/a pLI=n/a)
chrX	134986700	134986700	T	C	het		QUAL=2307;DP=184;AF=0.47;MQM=60	SAGE1	synonymous	SAGE1:ENST00000324447:synonymous:LOW:exon4/20:c.285T>C:p.Asn95Asn,SAGE1:ENST00000535938:synonymous:LOW:exon4/20:c.285T>C:p.Asn95Asn,SAGE1:ENST00000537770:synonymous:LOW:exon4/12:c.285T>C:p.Asn95Asn,SAGE1:ENST00000370709:synonymous:LOW:exon3/19:c.285T>C:p.Asn95Asn		rs12014884	0.1616	0.2230	1458,982,78	0.1386,0.2258,0.1252,0.2565,0.1505	0.2229											n/a (AF>5%)	n/a (AF>5%)					SAGE1 (inh=n/a pLI=0.00)
chrX	134991078	134991078	A	G	het		QUAL=1829;DP=174;AF=0.42;MQM=60	SAGE1	synonymous,intron	SAGE1:ENST00000324447:synonymous:LOW:exon13/20:c.1497A>G:p.Gln499Gln,SAGE1:ENST00000535938:synonymous:LOW:exon13/20:c.1497A>G:p.Gln499Gln,SAGE1:ENST00000370709:synonymous:LOW:exon12/19:c.1497A>G:p.Gln499Gln,SAGE1:ENST00000537770:intron:MODIFIER:exon5/11:c.455-720A>G:		rs5974570	0.1619	0.2223	1458,982,78	0.1394,0.2252,0.1245,0.2561,0.1492	0.2295											n/a (AF>5%)	n/a (AF>5%)					SAGE1 (inh=n/a pLI=0.00)
chrX	135480126	135480126	T	C	het		QUAL=2228;DP=168;AF=0.50;MQM=60	GPR112	synonymous	GPR112:ENST00000370652:synonymous:LOW:exon18/24:c.8271T>C:p.Phe2757Phe,GPR112:ENST00000394143:synonymous:LOW:exon20/26:c.8271T>C:p.Phe2757Phe,GPR112:ENST00000412101:synonymous:LOW:exon17/23:c.7656T>C:p.Phe2552Phe,GPR112:ENST00000287534:synonymous:LOW:exon12/17:c.7530T>C:p.Phe2510Phe,GPR112:ENST00000394141:synonymous:LOW:exon17/23:c.7656T>C:p.Phe2552Phe		rs5974595	0.7679	0.6719	12836,5163,2007	0.7797,0.8079,0.9086,0.5990,0.6901	0.6730											n/a (AF>5%)	n/a (AF>5%)					ADGRG4 (inh=n/a pLI=0.00)
chrX	138811003	138811003	G	A	hom	off-target	QUAL=3894;DP=118;AF=1.00;MQM=60	ATP11C	3'UTR	ATP11C:ENST00000327569:3'UTR:MODIFIER:exon30/30:c.*122C>T:,ATP11C:ENST00000370557:3'UTR:MODIFIER:exon29/29:c.*56C>T:,ATP11C:ENST00000361648:3'UTR:MODIFIER:exon29/29:c.*56C>T:		rs2094702	0.9359	0.0000	0,0,0	0,0,0,0,0	0.9508											n/a (AF>5%)	n/a (AF>5%)					ATP11C (inh=n/a pLI=1.00)
chrX	150349871	150349871	A	G	hom		QUAL=6575;DP=206;AF=1.00;MQM=60	GPR50	missense	GPR50:ENST00000218316:missense:MODERATE:exon2/2:c.1816A>G:p.Ile606Val		rs13440581	0.2734	0.4595	6169,5018,224	0.2761,0.2685,0.0094,0.5893,0.3737	0.4611	-1.2240	T	T	B	T	1.02				COSM3759396	n/a (AF>5%)	n/a (AF>5%)					GPR50 (inh=n/a pLI=0.41)
chrX	151821277	151821277	T	A	het		QUAL=2497;DP=193;AF=0.49;MQM=60	GABRQ	missense	GABRQ:ENST00000370306:missense:MODERATE:exon9/9:c.1432T>A:p.Phe478Ile		rs3810651	0.4355	0.5341	8090,4979,274	0.3351,0.7026,0.3268,0.5791,0.4401	0.5435	-0.9390	T	T	B	T	0.01				COSM3759407	n/a (AF>5%)	n/a (AF>5%)					GABRQ (inh=n/a pLI=0.01)
chrX	153994596	153994596	G	T	hom		QUAL=4685;DP=142;AF=1.00;MQM=60	DKC1	synonymous	DKC1:ENST00000369550:synonymous:LOW:exon5/15:c.369G>T:p.Thr123Thr		rs2728532	0.9926	0.9974	26889,14628,3152	0.9749,0.9990,1.0000,1.0000,1.0000	0.9980	-3.5150		T			10.62	300126 [DKC1 (confirmed) Dyskeratosis congenita,X-linked,305000];	166994 [benign DISEASE=not_specified]; 			n/a (AF>5%)	n/a (AF>5%)					DKC1 (inh=XLR pLI=1.00)
